Citrus Sinensis ID: 013558

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-
Protein Sequence
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Secondary Structure (PSIPRED)
cccccccccccHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccHHHcccccccccccccEEEEEEcccccEEEEEEEEcccccccccEEEEEEEccccHHcccHHHHHHHHHHHHHHcccccEEcccccccccccEEEEEEcccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccc
Secondary Structure Prediction (SSPRO)
cccHcccccHHHHHHHHHHHcccccHcHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccEccHcHcEEEEEEcccccHHEEEEEEEcccccccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccEcHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccHHHHccHHHccccHHHHHHcccccccccccccccccccccHHHccccccccccccHHHHHHccccEEcccHHHHccc
Coil and Loop (DISEMBL)
mvstsqknLHSLLTTKLkkltitppsasspdfdftevfgpltpcrhnnqspastsaslgdpqvihnrshsfvgpspryalssslplqIQELEHENDaeleaeserkigpgdfeIFRVVGQGAFGKVFQVKkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYrqgifredqaRFYTAEIVSAVSHLHkcgivhrdlkpenilmdsdghvmltdfglakeidessrsnsmcgtteymapeillskghnkdadwWSVGILLYEmltgqppfthaNRQKLQQRIINekvklppfltSEAHSLLKGllhkdpskrlgsgpggvdaikhhkwFRSINWKTLearemqpkfkpdvsgkdcianfdkcwttmpaddspaptptagehfkgytyvapnpwlssv
Flexible Loop (DISEMBL)
mvstsqknLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKvfqvkkkgvddgdsdgiyamkvmrkdtiikknHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSgpggvdaikhhkWFRSINWKTLEAREMqpkfkpdvsgkDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTyvapnpwlssv
Low Complexity Region (SEG)
MVSTSQKNLHSllttklkkltITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFgkvfqvkkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWttmpaddspaptptaGEHFKGYTYVAPNPWLSSV
Disordered region (IsUnstruct)
************************************VF***********************************************************************GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK***********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL*************GVDAIKHHKWFRSINWKTLEARE****FKPDVSGKDCIANFDKCWTTM***************FKGYTYVAP*******
Disordered Region (DISOPRED)
*************TTKLK*LT**********FDFTE**************************************************************************DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD**********EHFKGYTYVAPNPWL***
Disordered Region (DISEMBL)
*********HSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNN**********GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI*********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Disordered Region (DISPRO)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTE******************************************************LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNP*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	441	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.913	0.855	0.591	1e-148
P42818	465	Serine/threonine-protein	no	no	0.920	0.873	0.560	1e-139
Q6TJY3	527	Ribosomal protein S6 kina	no	no	0.743	0.622	0.507	3e-94
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.716	0.659	0.501	4e-94
Q9UBS0	482	Ribosomal protein S6 kina	yes	no	0.784	0.717	0.484	4e-94
P67999	525	Ribosomal protein S6 kina	yes	no	0.743	0.624	0.504	6e-94
P23443	525	Ribosomal protein S6 kina	no	no	0.743	0.624	0.504	7e-94
P67998	525	Ribosomal protein S6 kina	yes	no	0.743	0.624	0.504	7e-94
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.743	0.624	0.504	7e-94
Q9Z1M4	485	Ribosomal protein S6 kina	no	no	0.784	0.713	0.481	5e-93

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  525 bits (1353), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 265/448 (59%), Positives = 326/448 (72%), Gaps = 45/448 (10%)

Query: 20  LTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSP 76
           L+I+PP +   D     F++VFGP+        S  +   +  +P V+++RSHS VGPS 
Sbjct: 24  LSISPPKSVLGDNLELQFSDVFGPMPEA----NSEEACDVAYDEPAVVYSRSHSLVGPS- 78

Query: 77  RYALSSSLP---LQIQELE--------------HEND---AELEAESERK-------IGP 109
              +S SL    L ++E E               END      + +SE+        +G 
Sbjct: 79  -LVVSHSLKMNKLTLRETEDSVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGI 137

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +VVGQGAFGKV+QV+KK     D+  IYAMKVMRKD I++KNH +YMKAERDIL
Sbjct: 138 EDFEVLKVVGQGAFGKVYQVRKK-----DTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 192

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           TK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVS
Sbjct: 193 TKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVS 252

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           HLH+ GI+HRDLKPENILMD DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAPEI+  K
Sbjct: 253 HLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGK 312

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL 349
           GH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKGLL
Sbjct: 313 GHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKGLL 371

Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT 409
            K+P +RLGSGP G + IK HKWF++INWK LEARE+QP FKP VSG+ CIANFDKCWT 
Sbjct: 372 QKEPERRLGSGPSGAEEIKKHKWFKAINWKKLEAREVQPSFKPAVSGRQCIANFDKCWTD 431

Query: 410 MPADDSPAPTPTA---GEHFKGYTYVAP 434
           M   DSPA +P +      F  +TYV P
Sbjct: 432 MSVLDSPASSPNSDAKANPFTNFTYVRP 459

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  494 bits (1271), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 256/457 (56%), Positives = 323/457 (70%), Gaps = 51/457 (11%)

Query: 16  KLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           K + L+I+P ++   D    +F++VFGPL P   N+        +  +P V+++RSHS V
Sbjct: 14  KQQYLSISPSNSVLKDDVELEFSDVFGPL-PEEAND-------IAYDEPAVVYSRSHSLV 65

Query: 73  GPSPRYALS------------SSLPLQIQELEHE---------------NDAELEAESER 105
           GP    + S             S+ L ++ LE E               N+  LE +  +
Sbjct: 66  GPCSLDSHSLKLTKLTLLETEDSIDL-VECLEGESLKENDDFSGNDDSDNEKALEGDLVK 124

Query: 106 K---IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  DFE+ +VVG+GAFGKV+QV+KK     ++  IYAMKVMRKD I++KNH +YM
Sbjct: 125 VSGVVGIDDFEVMKVVGKGAFGKVYQVRKK-----ETSEIYAMKVMRKDHIMEKNHAEYM 179

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           KAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTA
Sbjct: 180 KAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTA 239

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           EIVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E++RSNSMCGTTEYMA
Sbjct: 240 EIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMA 299

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH
Sbjct: 300 PEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAH 358

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 402
           ++LKGLL K+P +RLGSG  G + IK HKWF+ INWK LEARE+ P FKP+VSG+ CIAN
Sbjct: 359 AILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMPSFKPEVSGRQCIAN 418

Query: 403 FDKCWTTMPA---DDSPAPTPTAGEHFKGYTYVAPNP 436
           FDKCWT M       S   +      F  +TYV P P
Sbjct: 419 FDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  346 bits (887), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 170/335 (50%), Positives = 235/335 (70%), Gaps = 7/335 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 404 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
           D  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  345 bits (885), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 165/329 (50%), Positives = 228/329 (69%), Gaps = 13/329 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+  V+G+G+FGKV QVKKKG      D I+AMKV+RKD II +  V++ K+E+ IL 
Sbjct: 152 DFELLNVIGKGSFGKVMQVKKKG-----EDKIFAMKVLRKDAIIARKQVNHTKSEKTILQ 206

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G F E + + Y AEIVSA+ H
Sbjct: 207 CISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDH 266

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK  IV+RDLKPENIL+DS+GH+ +TDFGL+K+I+ +  + + CGT EY+APE+L   G
Sbjct: 267 LHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGHG 326

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H    DWWS+G LLYEMLTG PPF   N   + Q+I+N ++K+P +++ EA SLL+GLL 
Sbjct: 327 HGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEGLLT 386

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM 410
           ++  KRLG+  GG   +K H WF++I+W+ L+ +E++  FKP V     I+  D  +T  
Sbjct: 387 REVDKRLGTKGGG--EVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQIDPVFTQE 444

Query: 411 PADDSPAPTPTAGE------HFKGYTYVA 433
              DS   T   G+       F+G+TYVA
Sbjct: 445 RPMDSLVETSALGDAMGKDTSFEGFTYVA 473

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  345 bits (885), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 173/357 (48%), Positives = 238/357 (66%), Gaps = 11/357 (3%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+ RV+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL 
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 263 KE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
              +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    ++ H +FR +NW  L
Sbjct: 277 TMDKIIRGKLALPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAADVQRHPFFRHMNWDDL 336

Query: 382 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
            A  + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 337 LAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESANQAFLGFTYVAPS 393

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  344 bits (883), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 169/335 (50%), Positives = 234/335 (69%), Gaps = 7/335 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 404 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  344 bits (883), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 169/335 (50%), Positives = 234/335 (69%), Gaps = 7/335 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 404 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  344 bits (883), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 169/335 (50%), Positives = 234/335 (69%), Gaps = 7/335 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 404 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  344 bits (883), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 169/335 (50%), Positives = 234/335 (69%), Gaps = 7/335 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 404 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1

 Score =  341 bits (875), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 172/357 (48%), Positives = 235/357 (65%), Gaps = 11/357 (3%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+  V+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LETVGHYEEVELTESSVNLGPERIGPHCFELLSVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I+       + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL 
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 263 KE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAITHTFCGTIEYMAPEILVRTGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
              +II  K+ LPP+LT +A  L K  L ++P++R+G G G    ++ H +FR INW  L
Sbjct: 277 TMDKIIKGKLVLPPYLTPDARDLAKKFLKRNPTQRIGGGLGDAADVQRHPFFRHINWDDL 336

Query: 382 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 435
            AR + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 337 LARRVDPPFRPSLQSEEDVSQFDARFTRQTPVDSPDDTALSESANQAFLGFTYVAPS 393

Phosphorylates specifically ribosomal protein S6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
225457176	452	PREDICTED: serine/threonine-protein kina	0.979	0.955	0.761	0.0
224119194	470	predicted protein [Populus trichocarpa]	0.986	0.925	0.744	0.0
147817142	463	hypothetical protein VITISV_040765 [Viti	0.979	0.933	0.738	0.0
449440730	483	PREDICTED: serine/threonine-protein kina	0.975	0.890	0.694	0.0
449527582	486	PREDICTED: serine/threonine-protein kina	0.975	0.884	0.690	0.0
62183960	466	putative ribosomal-protein S6 kinase-lik	0.979	0.927	0.696	1e-179
358248554	415	uncharacterized protein LOC100798259 [Gl	0.857	0.910	0.798	1e-174
297733856	296	unnamed protein product [Vitis vinifera]	0.671	1.0	0.881	1e-156
167999486	452	predicted protein [Physcomitrella patens	0.918	0.896	0.615	1e-155
255540831	297	ribosomal protein S6 kinase, putative [R	0.671	0.996	0.861	1e-155

>gi|225457176|ref|XP_002280523.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/448 (76%), Positives = 379/448 (84%), Gaps = 16/448 (3%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR SFQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 352
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKGLL K+
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKGLLQKE 364

Query: 353 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 412
           PS+RLGSGP G D I++HKWFRSINWK LEARE+QPKFKPDVSGKDC ANFD+CWT MP 
Sbjct: 365 PSRRLGSGPTGGDEIQNHKWFRSINWKKLEARELQPKFKPDVSGKDCTANFDQCWTAMPL 424

Query: 413 DDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 425 DDSPAPTPTAGGHFQGYTYVAPNPWLSS 452

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119194|ref|XP_002318010.1| predicted protein [Populus trichocarpa] gi|222858683|gb|EEE96230.1| predicted protein [Populus trichocarpa]

 Score =  676 bits (1745), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/469 (74%), Positives = 385/469 (82%), Gaps = 34/469 (7%)

Query: 1   MVSTSQK-NLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPL-TPCRHNNQSPASTSASL 58
           +VSTSQK  L SLL+  LKKLTITPP+    D +F++VFGP  TP   N+    STS+S+
Sbjct: 6   LVSTSQKKTLLSLLSINLKKLTITPPN----DLEFSDVFGPSSTPHDPNHSHSPSTSSSV 61

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAES--------------- 103
            DP VIHNRSHSFVGPSPRY L SS PL    ++ +++A +E ES               
Sbjct: 62  LDPPVIHNRSHSFVGPSPRYPLPSS-PLPFHHIQEDDEAVIENESCDNEKGKSEDDEGQV 120

Query: 104 -----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKD 151
                  KIGP DFEI RVVG+GAFGKVFQV+KK  D  +  G       IYAMKVMRKD
Sbjct: 121 GSCGNNNKIGPADFEILRVVGKGAFGKVFQVRKKTGDGKEKGGGGGSGDGIYAMKVMRKD 180

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           TIIKK HVDYMKAERDILTKV HPFIVQLRYSFQT+SKLYLILDF+NGGHLFFHLYRQGI
Sbjct: 181 TIIKKKHVDYMKAERDILTKVVHPFIVQLRYSFQTKSKLYLILDFMNGGHLFFHLYRQGI 240

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F EDQARFYTAEIVSAV+HLHKCGIVHRDLKPENIL+D+DGHV+LTDFGLAKEIDESSRS
Sbjct: 241 FSEDQARFYTAEIVSAVAHLHKCGIVHRDLKPENILLDADGHVLLTDFGLAKEIDESSRS 300

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH+NR+KLQ+RII E+V
Sbjct: 301 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHSNRKKLQERIIKERV 360

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
           KLPP+L+SEAHSLLKGLL K+PS+RLGSG  G D IK HKW R INWK LEARE+QPK+ 
Sbjct: 361 KLPPYLSSEAHSLLKGLLQKEPSRRLGSGLDGGDEIKGHKWLRPINWKKLEARELQPKYI 420

Query: 392 PDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           PDVSGKDC ANFD+CWTTMP DDSPAPTPTAGEHF+GYTYVAPNPWLSS
Sbjct: 421 PDVSGKDCTANFDQCWTTMPLDDSPAPTPTAGEHFQGYTYVAPNPWLSS 469

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147817142|emb|CAN77683.1| hypothetical protein VITISV_040765 [Vitis vinifera]

 Score =  676 bits (1743), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/459 (73%), Positives = 377/459 (82%), Gaps = 27/459 (5%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR  FQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCFFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG----- 347
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKG     
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKGLLTRK 364

Query: 348 ------LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 401
                 LL K+PS+RLGSGP G D I++HKWFRSINWK LE RE+QPKFKPDVSGKDC A
Sbjct: 365 LLSHCQLLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEXRELQPKFKPDVSGKDCTA 424

Query: 402 NFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           NFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 425 NFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 463

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440730|ref|XP_004138137.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  655 bits (1690), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/491 (69%), Positives = 376/491 (76%), Gaps = 61/491 (12%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP---------DFDFTEVFGPLTPCRHNNQS 50
           MVS S QKN+HSLL   L KLTI   S+SS          DFDF +VFGP  P       
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAVHDFDFNDVFGPTNP------- 53

Query: 51  PASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE-------- 94
             S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +        
Sbjct: 54  --SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEEEEE 110

Query: 95  --NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQVKKK 132
             ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V+KK
Sbjct: 111 EENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLVRKK 170

Query: 133 GVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
           G   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT+SK
Sbjct: 171 GNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQTKSK 230

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           LYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENILMD
Sbjct: 231 LYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENILMD 290

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYEML+
Sbjct: 291 ADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYEMLS 350

Query: 310 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+GLL K+PSKRLGSGP G D IK+
Sbjct: 351 GQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRGLLEKEPSKRLGSGPKGGDEIKN 410

Query: 370 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY 429
           HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTPT G HF+GY
Sbjct: 411 HKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTPTDGGHFQGY 470

Query: 430 TYVAPNPWLSS 440
           +YVAPN WLSS
Sbjct: 471 SYVAPNLWLSS 481

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449527582|ref|XP_004170789.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  654 bits (1688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/494 (69%), Positives = 376/494 (76%), Gaps = 64/494 (12%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP------------DFDFTEVFGPLTPCRHN 47
           MVS S QKN+HSLL   L KLTI   S+SS             DFDF +VFGP  P    
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAAAAVHDFDFNDVFGPTNP---- 56

Query: 48  NQSPASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE----- 94
                S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +     
Sbjct: 57  -----SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEE 110

Query: 95  -----NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQV 129
                ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V
Sbjct: 111 EEEEENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLV 170

Query: 130 KKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
           +KKG   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT
Sbjct: 171 RKKGNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQT 230

Query: 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
           +SKLYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENI
Sbjct: 231 KSKLYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENI 290

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
           LMD+DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYE
Sbjct: 291 LMDADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYE 350

Query: 307 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA 366
           ML+GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+GLL K+PSKRLGSGP G D 
Sbjct: 351 MLSGQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRGLLQKEPSKRLGSGPKGGDE 410

Query: 367 IKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHF 426
           IK+HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTPT G HF
Sbjct: 411 IKNHKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTPTDGGHF 470

Query: 427 KGYTYVAPNPWLSS 440
           +GY+YVAPN WLSS
Sbjct: 471 QGYSYVAPNLWLSS 484

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62183960|gb|AAX73301.1| putative ribosomal-protein S6 kinase-like protein [Solanum lycopersicum]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 328/471 (69%), Positives = 369/471 (78%), Gaps = 39/471 (8%)

Query: 1   MVSTSQKNLHSLLTTKLKKLTITPPSASSPD------FDFTEVFGPLTPCRHNNQSPAST 54
             +  +K +HS+L  KL  L I   S+SS        FDF++VFG  T       SP+S+
Sbjct: 3   FAAQQKKAIHSMLANKLTHLKIPDSSSSSSPPPTDPDFDFSDVFGAPT-------SPSSS 55

Query: 55  SASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAEL--------------- 99
           S+ L DPQ+IH+RSHSFVGPSPR  LS  LP   QE++ E +++                
Sbjct: 56  SSFLTDPQIIHSRSHSFVGPSPRITLSKPLPFH-QEVDSEGESDSDKVNTHVGTHQTECS 114

Query: 100 ---------EAESERKIGPGDFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMR 149
                    E  +  K GPGDFEI R++G+G+FGKVFQVK K    +G+ DGI AMKVMR
Sbjct: 115 DGIEEISGDEGSAVTKFGPGDFEILRMIGKGSFGKVFQVKMKGYGGEGEGDGILAMKVMR 174

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           KDT+IK NHVDYM+AERDILTKV HPFIVQLRYSFQT+SKLYLILDFINGGHLF+HLYRQ
Sbjct: 175 KDTVIKNNHVDYMRAERDILTKVEHPFIVQLRYSFQTKSKLYLILDFINGGHLFYHLYRQ 234

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           GIF EDQAR Y AEIVSAVSHLH+ GIVHRDLKPENILMD DGHVMLTDFGLAKEIDESS
Sbjct: 235 GIFSEDQARIYAAEIVSAVSHLHQRGIVHRDLKPENILMDGDGHVMLTDFGLAKEIDESS 294

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           RSNSMCGT EYMAPEI+ SKGHNKDADWWSVG+LLYEMLTGQPPFTHANR+KLQ++II+E
Sbjct: 295 RSNSMCGTMEYMAPEIIQSKGHNKDADWWSVGVLLYEMLTGQPPFTHANRKKLQEKIISE 354

Query: 330 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 389
           K+KL P LT EAHSLLKGLL KDPSKRLGSGP G D IK HKWFR+INWK L+ARE+QPK
Sbjct: 355 KLKLLPRLTGEAHSLLKGLLQKDPSKRLGSGPRGGDEIKSHKWFRTINWKKLDARELQPK 414

Query: 390 FKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           FKPDV G+DC ANFDKCWTTMP DDSPA TPT GEHF+GYTYVAPNPWLSS
Sbjct: 415 FKPDVIGRDCTANFDKCWTTMPPDDSPASTPTTGEHFQGYTYVAPNPWLSS 465

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248554|ref|NP_001239901.1| uncharacterized protein LOC100798259 [Glycine max] gi|255634893|gb|ACU17805.1| unknown [Glycine max]

 Score =  619 bits (1595), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 305/382 (79%), Positives = 330/382 (86%), Gaps = 4/382 (1%)

Query: 62  QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE---AESERKIGPGDFEIFRVV 118
            VI +RSHSFVGPSPR+ + SS PL   E E E + E E        KIGP DF I RVV
Sbjct: 31  HVIFSRSHSFVGPSPRF-VPSSTPLFFLEEEEEEEEEEELPFGPDPPKIGPSDFHILRVV 89

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178
           GQGAFGKVF V+KKG    D+DG++AMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIV
Sbjct: 90  GQGAFGKVFLVRKKGDCFDDADGVFAMKVMRKDTIIKKNHVDYMKAERDILTKVLHPFIV 149

Query: 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           QLRYSFQT+SKLYL+LDFINGGHLFF LYRQGIF EDQAR YTAEIVSAVSHLHK GIVH
Sbjct: 150 QLRYSFQTKSKLYLVLDFINGGHLFFQLYRQGIFSEDQARLYTAEIVSAVSHLHKNGIVH 209

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           RDLKPENILMD+DGHVMLTDFGL+KEI+E  RSNS CGT EYMAPEILL+KGHNKDADWW
Sbjct: 210 RDLKPENILMDADGHVMLTDFGLSKEINELGRSNSFCGTVEYMAPEILLAKGHNKDADWW 269

Query: 299 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLG 358
           SVGILLYEMLTG+ PFTH NR+KLQ++II EKVKLPPFLTSEAHSLLKGLL KDPS RLG
Sbjct: 270 SVGILLYEMLTGKAPFTHNNRKKLQEKIIKEKVKLPPFLTSEAHSLLKGLLQKDPSTRLG 329

Query: 359 SGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP 418
           +GP G   IK HKWFRSINWK LEARE++PKFKPDVS KDC +NFD+CWT MPADDSPAP
Sbjct: 330 NGPNGDGHIKSHKWFRSINWKKLEARELEPKFKPDVSAKDCTSNFDQCWTAMPADDSPAP 389

Query: 419 TPTAGEHFKGYTYVAPNPWLSS 440
           TPTAG+HF+GYTYVAPNPWLSS
Sbjct: 390 TPTAGDHFQGYTYVAPNPWLSS 411

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733856|emb|CBI15103.3| unnamed protein product [Vitis vinifera]

 Score =  559 bits (1441), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 261/296 (88%), Positives = 275/296 (92%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKDTII KNH+DYMKAERDIL KV HPFIV LR SFQT SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDTIISKNHMDYMKAERDILIKVEHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HLYRQGIF EDQAR Y AEIVSAVSHLHK GIVHRDLKPENILMD+DGHVMLTDFGLAKE
Sbjct: 61  HLYRQGIFSEDQARVYIAEIVSAVSHLHKSGIVHRDLKPENILMDADGHVMLTDFGLAKE 120

Query: 265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWS+GILLYEMLTGQPPFTHANRQKLQQ
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSIGILLYEMLTGQPPFTHANRQKLQQ 180

Query: 325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
           RII EKVKLP +L+SEAHSLLKGLL K+PS+RLGSGP G D I++HKWFRSINWK LEAR
Sbjct: 181 RIIKEKVKLPSYLSSEAHSLLKGLLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEAR 240

Query: 385 EMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           E+QPKFKPDVSGKDC ANFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 241 ELQPKFKPDVSGKDCTANFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 296

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|167999486|ref|XP_001752448.1| predicted protein [Physcomitrella patens subsp. patens] gi|162696348|gb|EDQ82687.1| predicted protein [Physcomitrella patens subsp. patens]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 278/452 (61%), Positives = 334/452 (73%), Gaps = 47/452 (10%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
           P   + +FDF++VFGP+ P   +  SP    A  G           DP V+++RSHS VG
Sbjct: 8   PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 64

Query: 74  PSPRYALSSSLPLQIQELEHENDA-----------------ELEAE------SERKIGPG 110
           PSP+ +L+    LQ + +  E D+                 EL ++         K+GP 
Sbjct: 65  PSPKPSLTR---LQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKDFVNGIGTEKLGPQ 121

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ RVVGQGAFGKVFQV+KKG  +     IYAMKVMRK+ II++NH DYMKAERDILT
Sbjct: 122 DFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILT 176

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           KV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQG F ED AR YTAEIV AV+H
Sbjct: 177 KVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQGTFNEDLARMYTAEIVLAVAH 236

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK GI+HRDLKPENIL+D DG+VMLTDFGLAKE+ E S SNS+CGT EYMAPEI+LSKG
Sbjct: 237 LHKNGIIHRDLKPENILLDGDGYVMLTDFGLAKEVKEDSHSNSLCGTMEYMAPEIILSKG 296

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H K ADWWSVGILLYEMLTGQPPF H N+QKLQQ+II +K+KLP +LT++A++LLKGLL 
Sbjct: 297 HGKPADWWSVGILLYEMLTGQPPFAHKNKQKLQQKIIKDKIKLPTYLTADANNLLKGLLQ 356

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM 410
           KDPSKRLG+GP G + IK +KWF+ INW+ LEAR++ PKF P V+GK C ANFD+ WTT+
Sbjct: 357 KDPSKRLGNGPTGSEDIKQNKWFKGINWRKLEARQVTPKFLPAVNGKQCTANFDEAWTTL 416

Query: 411 PADDSPAPTPTAGEH--FKGYTYVAPNPWLSS 440
           P DDSP  TP +G+   F+GYTYVAPN WL S
Sbjct: 417 PLDDSPVGTPKSGDRDFFRGYTYVAPNVWLKS 448

Source: Physcomitrella patens subsp. patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255540831|ref|XP_002511480.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223550595|gb|EEF52082.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 255/296 (86%), Positives = 275/296 (92%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKD IIKKNHVDYMKAERDILTKV HPF+VQLRYSFQT+SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDIIIKKNHVDYMKAERDILTKVVHPFVVQLRYSFQTKSKLYLIMDFMNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HLYRQG+F EDQAR YTAEIVSAVSHLHKCGIVHRDLKPENI++DSDGHVMLTDFGLAKE
Sbjct: 61  HLYRQGLFSEDQARVYTAEIVSAVSHLHKCGIVHRDLKPENIILDSDGHVMLTDFGLAKE 120

Query: 265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           IDESSRSNSMCGTTEYMAPEIL SKGHNKDADWWS+GILLYEMLTGQPPF H +R+KLQ+
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILQSKGHNKDADWWSIGILLYEMLTGQPPFEHKDRKKLQE 180

Query: 325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
           RII EK+KLP FL+SEAHSLLKGLL K+PS+RLGSGP G D +K HKWFRSINWK LEAR
Sbjct: 181 RIIKEKIKLPSFLSSEAHSLLKGLLQKEPSRRLGSGPSGGDEVKSHKWFRSINWKKLEAR 240

Query: 385 EMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 440
           E+ PKFKPDVSGK C  NFD+CWTTMP DDSPA TPTAGEHF+GYTY+APNPWLSS
Sbjct: 241 ELIPKFKPDVSGKYCTENFDRCWTTMPPDDSPACTPTAGEHFQGYTYIAPNPWLSS 296

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.768	0.729	0.621	3.1e-123
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.902	0.845	0.563	1.6e-118
UNIPROTKB|J9NU84	482	RPS6KB2 "Uncharacterized prote	0.839	0.767	0.443	4.1e-81
UNIPROTKB|E1BLQ5	485	RPS6KB2 "Uncharacterized prote	0.820	0.746	0.428	3.7e-80
UNIPROTKB|E2R7K9	482	RPS6KB2 "Uncharacterized prote	0.816	0.746	0.444	3.7e-80
UNIPROTKB|F1RUZ0	485	RPS6KB2 "Uncharacterized prote	0.816	0.742	0.433	2e-79
UNIPROTKB|Q9UBS0	482	RPS6KB2 "Ribosomal protein S6	0.820	0.751	0.431	3.3e-79
UNIPROTKB|F1MNP4	525	RPS6KB1 "Ribosomal protein S6	0.789	0.662	0.452	1.1e-78
UNIPROTKB|Q6TJY3	527	RPS6KB1 "Ribosomal protein S6	0.789	0.660	0.452	1.1e-78
UNIPROTKB|E2RMD8	525	RPS6KB1 "Uncharacterized prote	0.789	0.662	0.452	1.1e-78

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1154 (411.3 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
 Identities = 218/351 (62%), Positives = 264/351 (75%)

Query:    92 EHENDAELEAESERK---IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
             + +N+  LE +  +    +G  DFE+ +VVG+GAF                  IYAMKVM
Sbjct:   111 DSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSE-----IYAMKVM 165

Query:   149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
             RKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY 
Sbjct:   166 RKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 225

Query:   209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
             QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E+
Sbjct:   226 QGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEEN 285

Query:   269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
             +RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ 
Sbjct:   286 TRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVK 344

Query:   329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 388
             +K+KLP FL++EAH++LKGLL K+P +RLGSG  G + IK HKWF+ INWK LEARE+ P
Sbjct:   345 DKIKLPQFLSNEAHAILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMP 404

Query:   389 KFKPDVSGKDCIANFDKCWXXXXXXXXXXXXXXX---GEHFKGYTYVAPNP 436
              FKP+VSG+ CIANFDKCW                     F  +TYV P P
Sbjct:   405 SFKPEVSGRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
 Identities = 241/428 (56%), Positives = 292/428 (68%)

Query:    31 DFDFTEVFGPLTP------CRHNNQSPA---STSASLGDPQVIHNRSHSFVGPSPRYALS 81
             +  F++VFGP+        C      PA   S S SL  P ++ + S      + R    
Sbjct:    38 ELQFSDVFGPMPEANSEEACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETED 97

Query:    82 SSLPLQIQELEH--END---AELEAESERK-------IGPGDFEIFRVVGQGAFXXXXXX 129
             S   ++  E E   END      + +SE+        +G  DFE+ +VVGQGAF      
Sbjct:    98 SVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQV 157

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                         IYAMKVMRKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +
Sbjct:   158 RKKDTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYR 212

Query:   190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
             LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD
Sbjct:   213 LYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMD 272

Query:   250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLT
Sbjct:   273 VDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLT 332

Query:   310 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             G+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKGLL K+P +RLGSGP G + IK 
Sbjct:   333 GKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKK 391

Query:   370 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXXXXXX---XXXGEHF 426
             HKWF++INWK LEARE+QP FKP VSG+ CIANFDKCW                     F
Sbjct:   392 HKWFKAINWKKLEAREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPF 451

Query:   427 KGYTYVAP 434
               +TYV P
Sbjct:   452 TNFTYVRP 459

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

UNIPROTKB|J9NU84 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
 Identities = 171/386 (44%), Positives = 234/386 (60%)

Query:    57 SLGDPQVIHNRSHSFVGPSPRYALSSSLPL-QIQELE-HENDAELEAESERKIGPGDFEI 114
             S G+P+     S S  GP P      + P+   +E+E  E    L  E   +IGP  FE+
Sbjct:    15 SEGEPEF----SPSVSGPPPPLTSCINRPVGHCEEVELTETSVNLGPE---RIGPHCFEL 67

Query:   115 FRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT 173
              RV+G+G +                  IYAMKV+RK  I++      + +AER+IL  V 
Sbjct:    68 LRVLGKGGYGKVFQVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVK 125

Query:   174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
             HPFIV+L Y+FQT  KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH 
Sbjct:   126 HPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHS 185

Query:   234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
              GI++RDLKPENI+++S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN
Sbjct:   186 QGIIYRDLKPENIMLNSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHN 245

Query:   293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 352
             +  DWWS+G L+Y+MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++
Sbjct:   246 RAVDWWSLGALMYDMLTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVKKFLKRN 305

Query:   353 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXX 412
             PS+R+G GPG    ++ H +FR INW  L AR + P F+P +  ++ ++ FD  +     
Sbjct:   306 PSQRIGGGPGDSADVQRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTHFTRQTP 365

Query:   413 XXX---XXXXXXXGEHFKGYTYVAPN 435
                           + F G+TYVAP+
Sbjct:   366 VDSPDDTALSESANQAFLGFTYVAPS 391

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|E1BLQ5 RPS6KB2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
 Identities = 160/373 (42%), Positives = 227/373 (60%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTESSVNPGPERIGPHCFELLRVLGKGNYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGSNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY +EI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 305
             ++ S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   306 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 365
             +MLTG PPFT  NR+K   +II  K++LPP+LT +A  L+K  L ++P++R+G GPG   
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLELPPYLTPDARDLVKKFLKRNPNQRIGGGPGDAA 320

Query:   366 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXX 422
              ++ H +FR +NW  L AR + P F+P +  ++ ++ FD  +                  
Sbjct:   321 DVQRHPFFRHVNWDDLLARRVDPPFRPSLQSEEDVSQFDSHFTKQTPVDSPDDTTLSESA 380

Query:   423 GEHFKGYTYVAPN 435
              + F G+TYVAP+
Sbjct:   381 NQAFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2R7K9 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
 Identities = 165/371 (44%), Positives = 226/371 (60%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             PS    L+ S     + + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    23 PSDVCPLAESRAAGPEPVGHCEEVELTETSVNLGPERIGPHCFELLRVLGKGGYGKVFQV 82

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    83 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 140

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++
Sbjct:   141 KLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIML 200

Query:   249 DSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
             +S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   201 NSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 260

Query:   308 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    +
Sbjct:   261 LTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVKKFLKRNPSQRIGGGPGDSADV 320

Query:   368 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGE 424
             + H +FR INW  L AR + P F+P +  ++ ++ FD  +                   +
Sbjct:   321 QRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTALSESANQ 380

Query:   425 HFKGYTYVAPN 435
              F G+TYVAP+
Sbjct:   381 AFLGFTYVAPS 391

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1RUZ0 RPS6KB2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
 Identities = 161/371 (43%), Positives = 226/371 (60%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             P+    L+ S    ++ + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    25 PADACPLAESRAAGLEPVGHYEEVELTETSVNPGPERIGPHCFELLRVLGKGNYGKVFQV 84

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    85 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 142

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF  L R+GIF ED A FY +EI  A+ HLH  GI++RDLKPEN+++
Sbjct:   143 KLYLILECLSGGELFTRLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENVML 202

Query:   249 DSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
              S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   203 SSQGHIKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 262

Query:   308 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    +
Sbjct:   263 LTGSPPFTAENRKKTMDKIIRGKLVLPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAADV 322

Query:   368 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGE 424
             + H +FR INW+ L AR + P F+P +  ++ ++ FD  +                   +
Sbjct:   323 QKHPFFRHINWEDLLARRVDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTALSESANQ 382

Query:   425 HFKGYTYVAPN 435
              F G+TYVAP+
Sbjct:   383 AFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q9UBS0 RPS6KB2 "Ribosomal protein S6 kinase beta-2" [Homo sapiens (taxid:9606)]

 Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
 Identities = 161/373 (43%), Positives = 225/373 (60%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 305
             ++ S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   306 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 365
             +MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG   
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLALPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAA 320

Query:   366 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXX 422
              ++ H +FR +NW  L A  + P F+P +  ++ ++ FD  +                  
Sbjct:   321 DVQRHPFFRHMNWDDLLAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESA 380

Query:   423 GEHFKGYTYVAPN 435
              + F G+TYVAP+
Sbjct:   381 NQAFLGFTYVAPS 393

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006412 "translation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

UNIPROTKB|F1MNP4 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 163/360 (45%), Positives = 225/360 (62%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   385 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 441
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPSV-LESV 422

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q6TJY3 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 163/360 (45%), Positives = 225/360 (62%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   385 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 441
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPSV-LESV 422

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0043005 "neuron projection" evidence=IEA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RMD8 RPS6KB1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 163/360 (45%), Positives = 225/360 (62%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   385 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 441
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPSV-LESV 422

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.5915	0.9138	0.8556	yes	no
Q8BSK8	KS6B1_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5044	0.7437	0.6247	yes	no
P67999	KS6B1_RAT	2, ., 7, ., 1, 1, ., 1	0.5044	0.7437	0.6247	yes	no
P67998	KS6B1_RABIT	2, ., 7, ., 1, 1, ., 1	0.5044	0.7437	0.6247	yes	no
P28178	PK2_DICDI	2, ., 7, ., 1, 1, ., 1	0.5015	0.7165	0.6597	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XII.372.1 hypothetical protein (440 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	441
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-146
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-133
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-132
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-121
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-115
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-113
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-111
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-109
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-109
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-108
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-103
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-103
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-101
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-101
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-99
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-98
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-97
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-97
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-96
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-95
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-95
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-95
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-94
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-92
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-92
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-92
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-91
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-91
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-91
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-91
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-91
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-90
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-90
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-89
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-89
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-88
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-86
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-85
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-85
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-84
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-82
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-79
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-79
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-77
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-76
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-75
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-74
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-74
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-73
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-72
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-72
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-71
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-71
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-70
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-69
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-69
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-68
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-68
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-67
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-64
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-63
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-61
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-61
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-61
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-59
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-58
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-57
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-56
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-56
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-52
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-47
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-46
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-46
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-43
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-41
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-41
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-40
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-40
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-40
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-40
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-39
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-39
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-38
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-38
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-37
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-36
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-36
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-35
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-35
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-35
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-34
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-33
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-33
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-33
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-33
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-32
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-31
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-30
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-30
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-30
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-29
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-29
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-29
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-28
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-28
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-28
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-27
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-27
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-26
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-26
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-26
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-25
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-25
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-25
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-24
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-24
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-24
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-23
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-23
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-21
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-21
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-19
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-18
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-18
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-07
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	5e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	8e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05151	170	cd05151, ChoK, Choline Kinase (ChoK)	0.002
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	0.002
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  416 bits (1072), Expect = e-146
 Identities = 140/257 (54%), Positives = 194/257 (75%), Gaps = 8/257 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV  V+KK     D+  +YAMKV++K  IIK+  V++   ER+IL+++ HPFI
Sbjct: 1   LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L Y+FQT  KLYL+L++  GG LF HL ++G F E++ARFY AEIV A+ +LH  GI+
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D+DGH+ LTDFGLAKE   E SR+N+ CGT EY+APE+LL KG+ K  D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           WWS+G+LLYEMLTG+PPF   +R+++ ++I+ + ++ P FL+ EA  L+ GLL KDP+KR
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 357 LGSGPGGVDAIKHHKWF 373
           LGSG    + IK H +F
Sbjct: 236 LGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  385 bits (991), Expect = e-133
 Identities = 133/295 (45%), Positives = 193/295 (65%), Gaps = 7/295 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  + +G G+FG+V  V+ K      S   YA+K++ K  I+K   V+++  E+ IL 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HPF+V L  SFQ  S LYL+++++ GG LF HL + G F E  ARFY A++V A+ +
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPEN+L+DSDG++ +TDFG AK +    R+ ++CGT EY+APEI+LSKG
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           + K  DWW++GIL+YEML G PPF   N  ++ ++I+  KV+ P F + +A  L++ LL 
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
            D +KRLG+   GV+ IK+H WF  I+W  L  R+++  F P V G    +NFD 
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  384 bits (987), Expect = e-132
 Identities = 171/325 (52%), Positives = 230/325 (70%), Gaps = 9/325 (2%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDILTKVT 173
           +V+G+G +GKVFQV+K  V   D+  I+AMKV++K TI++ N  D  + KAER+IL  V 
Sbjct: 2   KVLGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVK 58

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPFIV L Y+FQT  KLYLIL++++GG LF HL R+GIF ED A FY +EI  A+ HLH+
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
            GI++RDLKPENIL+D+ GHV LTDFGL KE I E + +++ CGT EYMAPEIL+  GH 
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 352
           K  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  LLK LL ++
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238

Query: 353 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 412
           PS RLG+GPG    ++ H +FR +NW  L AR+++P FKP +  ++ ++ FD  +T    
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTP 298

Query: 413 DDSPAPT---PTAGEHFKGYTYVAP 434
            DSP  +    +A + F G+TYVAP
Sbjct: 299 VDSPDDSTLSESANQIFLGFTYVAP 323

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  356 bits (915), Expect = e-121
 Identities = 157/320 (49%), Positives = 220/320 (68%), Gaps = 6/320 (1%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+GQG+FGKVF V+K  +   D+  +YAMKV++K T+  ++ V   K ERDIL +V HP
Sbjct: 2   KVLGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           FIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY AE+  A+ HLH  G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           I++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EYMAPE++  +GH + 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 354
           ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ EA SLL+ L  ++P+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238

Query: 355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 414
            RLG+GP GV+ IK H +F +I+W  L  RE++P FKP V   D    FD  +T+    D
Sbjct: 239 NRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKD 298

Query: 415 SPAPTPTAGEH--FKGYTYV 432
           SP   P+A  H  F+G+++V
Sbjct: 299 SPGIPPSANAHQLFRGFSFV 318

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  340 bits (873), Expect = e-115
 Identities = 148/329 (44%), Positives = 210/329 (63%), Gaps = 18/329 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K K          YA+KV++K  I+KK    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            I++RDLKPENIL+DS GHV+LTDFGL KE I+ S  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW +G +LYEML G PPF   +  ++   I+N+ ++L P ++  A  LL+GLL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 413
           +KRLG+       IK+H +F SINW  L  +++ P F P+VSG   + +FD  +T  P  
Sbjct: 236 TKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVP 294

Query: 414 DSPAPTPT----------AGEHFKGYTYV 432
           +S   +P           A + F G++Y 
Sbjct: 295 NSVGKSPDSVLVSASVKEADDAFLGFSYA 323

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  336 bits (863), Expect = e-113
 Identities = 159/334 (47%), Positives = 227/334 (67%), Gaps = 12/334 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   D+  +YAMKV++K  +++K   V++ + ER++L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD+++GG +F HLY++  F ED+ RFY+ EI+ A+
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GIV+RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPEI+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 287 LSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLPPFLTSEA 341
             K GH K  DWWS+GIL++E+LTG  PFT    +  Q    +RI+      P F+  EA
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 401
             LL  LL KDP KRLG+GP G   IK H +F+ ++W+ L  R++ P F+P +  +  + 
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298

Query: 402 NFDKCWTTMPADDSPAPTPTAGEH-FKGYTYVAP 434
           NF + +T +    SPA TP +G   F+GY++VAP
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFVAP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  329 bits (846), Expect = e-111
 Identities = 134/323 (41%), Positives = 207/323 (64%), Gaps = 11/323 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + V+    E+ +L     H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT+ +L+ +++++NGG L FH+ R G F E +ARFY AEIV  +  LH+ 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ + DFG+ KE I     +++ CGT +Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW++G+LLYEML GQ PF   +  +L Q I+ ++V+ P +L+ EA S+LK  L K+P
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 413
            KRLG  P G   IK H +FR I+W  LE +E++P FKP + G+  ++NFD  +T     
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPV 295

Query: 414 DSPAPTPTAG----EHFKGYTYV 432
            +P           E F+G++Y+
Sbjct: 296 LTPPDEAIIRNIDQEEFRGFSYI 318

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  323 bits (830), Expect = e-109
 Identities = 142/292 (48%), Positives = 199/292 (68%), Gaps = 14/292 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-DYMKAERDIL 169
           +FE+ RV+G GA+GKVF V+K G    D+  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD++NGG LF HLY++  F E + R Y AEIV A+
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLH+ GI++RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 287 LSK--GHNKDADWWSVGILLYEMLTGQPPFT---HANRQK-LQQRIINEKVKLPPFLTSE 340
                GH+K  DWWS+G+L +E+LTG  PFT     N Q  + +RI+  K   P  +++E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           A   ++ LL KDP KRLG+   G D IK+H +F+ I+W  L A+ +   FKP
Sbjct: 239 ARDFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  321 bits (826), Expect = e-109
 Identities = 115/266 (43%), Positives = 164/266 (61%), Gaps = 16/266 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G+G+FGKV+  + K      +  + A+KV++K  I K    + +  E  IL K
Sbjct: 1   YEILEKLGEGSFGKVYLARDK-----KTGKLVAIKVIKKKKIKKD--RERILREIKILKK 53

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L   F+   KLYL++++  GG LF  L ++G   ED+ARFY  +I+SA+ +L
Sbjct: 54  LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GIVHRDLKPENIL+D DGHV L DFGLA+++D   +  +  GT EYMAPE+LL KG+
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF---LTSEAHSLLKG 347
            K  D WS+G++LYE+LTG+PPF       +L ++I   K   PP    ++ EA  L++ 
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 348 LLHKDPSKRLGSGPGGVDAIKHHKWF 373
           LL KDP KRL       +    H +F
Sbjct: 234 LLVKDPEKRL-----TAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  321 bits (824), Expect = e-108
 Identities = 146/319 (45%), Positives = 210/319 (65%), Gaps = 12/319 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV QV+K+     D+  IYA+K +RK  I+ ++ V +  AER +L +V  PFI
Sbjct: 1   IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V L++SFQ+  KLYL+L FINGG LF HL R+G F   +ARFYTAE++ A+ +LHK  ++
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D  GH+ L DFGL K  + +  ++N+ CGT EY+APE+LL  G+ K  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           WW++G+LLYEMLTG PPF   N  ++ ++I+ E ++ P     +A  LL GLL +DP++R
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235

Query: 357 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT-MPAD-- 413
           LG    G   IK+H +F  ++WK L  + +QP FKP VS     +NFD+ +T   P D  
Sbjct: 236 LGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSV 293

Query: 414 -DSPAPTPTAGEHFKGYTY 431
            D    + T  + F G++Y
Sbjct: 294 VDDSHLSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  311 bits (798), Expect = e-103
 Identities = 140/361 (38%), Positives = 207/361 (57%), Gaps = 51/361 (14%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +V+G+GAFG+V+ V+ K     D+  +YAMKV+RK  +IK+N + +++AERDIL
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                P+IV+L YSFQ    LYL+++++ GG L   L R+ +F E+ ARFY AE+V A+ 
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
            +HK G +HRD+KP+NIL+D+DGH+ L DFGL K+++++                     
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 270 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                     R+NS  GT +Y+APE+L    +  + DWWS+G++LYEML G PPF     
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 320 QKLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           Q+   +IIN K  L  PP   ++ EA  L+  LL  DP  RLGS     + IK H +F+ 
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGS----FEEIKSHPFFKG 290

Query: 376 INWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPADDSPAPTPTAGEH----FKGYT 430
           I+W+ L  RE +P F P++S     +NFD        +D     +    +     F G+T
Sbjct: 291 IDWENL--RETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFT 348

Query: 431 Y 431
           Y
Sbjct: 349 Y 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  307 bits (789), Expect = e-103
 Identities = 120/272 (44%), Positives = 175/272 (64%), Gaps = 18/272 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           + +GA+G+VF  KKK   D     IYA+KV++K  +I+KN VD +  ERDIL++   P++
Sbjct: 1   ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L YSFQ +  LYL+++++ GG L   L   G   ED AR Y AEIV A+ +LH  GI+
Sbjct: 56  VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE---------IDESSRSNSMCGTTEYMAPEILLS 288
           HRDLKP+NIL+DS+GH+ LTDFGL+K           D+      + GT +Y+APE++L 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLK 346
           +GH+K  DWWS+G +LYE L G PPF     +++ Q I+N K++ P    ++ EA  L+ 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 378
            LL  DP KRLG+    ++ IK+H +F+ I+W
Sbjct: 236 KLLVPDPEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  304 bits (780), Expect = e-101
 Identities = 138/332 (41%), Positives = 203/332 (61%), Gaps = 19/332 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG     +D +YA+K+++KD II+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++D++GH+ + DFG+ KE I     + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 408
           L K P+KRLG GP G   I+ H +FR I+W+ LE RE+QP FKP V G+    NFDK +T
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFT 295

Query: 409 TMPADDSPAPTPT--------AGEHFKGYTYV 432
             P    P  TP             F+G+++V
Sbjct: 296 REP----PVLTPPDKLVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  304 bits (780), Expect = e-101
 Identities = 131/307 (42%), Positives = 200/307 (65%), Gaps = 7/307 (2%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH C 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 354
            DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL GLL KDP 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235

Query: 355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 414
           +RLG GP     I  H++F SINW+ +  ++++P FKP V+ +     FD+ +T      
Sbjct: 236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITI 295

Query: 415 SPAPTPT 421
           +P P   
Sbjct: 296 TP-PDRY 301

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  300 bits (770), Expect = 1e-99
 Identities = 130/319 (40%), Positives = 193/319 (60%), Gaps = 8/319 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+   +G G+FG+V   K KG  +      YA+K ++K  I+K   V ++  E+ IL 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HPFIV +  SFQ  +++Y +L+F+ GG LF HL + G F  D A+FY AE+V A  +
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPEN+L+D+ GHV +TDFG AK++ +  R+ ++CGT EY+APE++ SKG
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKG 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H K  DWW++G+LLYE + G PPF      ++ ++I+  ++K P +    A  L+KGLL 
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM 410
            D +KRLG+  GGV  +K+H +F   NW  L AR         V      +NF+K +   
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEK-YPDS 310

Query: 411 PADDSPAPTPTAGEHFKGY 429
           P D  P  T      F G+
Sbjct: 311 PVDRLPPLTAAQQAEFAGF 329

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  298 bits (763), Expect = 2e-98
 Identities = 141/336 (41%), Positives = 213/336 (63%), Gaps = 28/336 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--- 174
           +G+G FG+V+QV+KK     D+  IYAMKV+ K  I+ K  V +   ER+IL +      
Sbjct: 1   IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PFIV L++SFQT S LYL+ D+++GG LF+HL ++G F ED+A+FY AE+V A+ HLHK 
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILL-SKGHN 292
            IV+RDLKPENIL+D+ GH+ L DFGL+K  + ++  +N+ CGTTEY+APE+LL  KG+ 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-FLTSEAHSLLKGLLHK 351
           K  D+WS+G+L++EM  G  PF   + Q++ + I   KV+ P   L+ E    +KGLL++
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235

Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT-- 409
           +P  RLG+    V+ +K H +F  I+W  L  +++ P FKP V   + ++NFD  +T   
Sbjct: 236 NPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSS 294

Query: 410 --------------MPADDSPAPTPTAGEHFKGYTY 431
                         +P  +S   + +  E+F+G+T+
Sbjct: 295 LLNAGIVPWEDVPGLPGANSTPLSSSVQENFRGFTF 330

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  294 bits (754), Expect = 3e-97
 Identities = 145/328 (44%), Positives = 211/328 (64%), Gaps = 17/328 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTK-VT 173
           +V+G+G+FGKV   K+K      SDG  YA+KV++K TI+KK   +++ AER++L K + 
Sbjct: 1   KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AE+ SA+ +LH 
Sbjct: 55  HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPENIL+DS GHV+LTDFGL KE ++    +++ CGT EY+APE+L  + ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 352
           +  DWW +G +LYEML G PPF   +  ++   I+++ ++LP   T  A  LL GLLHKD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234

Query: 353 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 412
             +RLG+    ++ IK+H +F  INW  L  + + P + P+V+G   + +FD  +T    
Sbjct: 235 QRRRLGAKADFLE-IKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAV 293

Query: 413 DDSPAPTP-------TAGEHFKGYTYVA 433
             S   TP       +A   F G++Y  
Sbjct: 294 SSSVGQTPDLTASSSSASSAFLGFSYAP 321

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  293 bits (750), Expect = 9e-97
 Identities = 147/331 (44%), Positives = 215/331 (64%), Gaps = 18/331 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   + K       +  YA+KV++K  I+KK    ++ +ER++L K V H
Sbjct: 1   KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GH++LTDFGL KE I+ +  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+GLL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 413
           +KRLG+    ++ IK+H +F  INW  L  +++ P F P+VSG + + +FD  +T  P  
Sbjct: 236 TKRLGAKDDFME-IKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVP 294

Query: 414 DSPAPTP----------TAGEHFKGYTYVAP 434
           +S   +P           A E F G++Y  P
Sbjct: 295 NSIGQSPDSILVTASVKEAAEAFLGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  290 bits (744), Expect = 8e-96
 Identities = 131/329 (39%), Positives = 203/329 (61%), Gaps = 21/329 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTH 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + VD    E+ IL     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L   FQT+ +L+ +++++NGG L F + R   F E ++RFY AE+  A+  LH+ 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           G+++RDLK +NIL+D++GH  L DFG+ KE I     + + CGT +Y+APEIL    +  
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW++G+L+YEM+ GQPPF   N   L + I+++ V  P +L+ EA S+LK  + K+P
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235

Query: 354 SKRLGSGP--GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP 411
           +KRLG     GG DAIK H +F+ I+W  LE R+++P FKP +  K  + NFD+ +T   
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTK-- 293

Query: 412 ADDSPAPTPTAG--------EHFKGYTYV 432
             + P  TP           E F+G+++ 
Sbjct: 294 --EEPVLTPVDPAVIKQINQEEFRGFSFF 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  288 bits (738), Expect = 2e-95
 Identities = 140/292 (47%), Positives = 201/292 (68%), Gaps = 12/292 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   DS  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +   PF+V L Y+FQT +KL+LILD+INGG LF HL ++  F+E + + Y+ EIV A+
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE   DE  R+ S CGT EYMAP+I+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 287 L--SKGHNKDADWWSVGILLYEMLTGQPPFT----HANRQKLQQRIINEKVKLPPFLTSE 340
                GH+K  DWWS+G+L+YE+LTG  PFT      ++ ++ +RI+  +   P  +++ 
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           A  +++ LL KDP KRLG GP   D IK H +F+ INW  L A+++   FKP
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  288 bits (738), Expect = 2e-95
 Identities = 121/294 (41%), Positives = 186/294 (63%), Gaps = 7/294 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  + VG G FG+V  V+ +      S+  YA+KVM    +I+     ++  E+ +L 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +V+HPFI++L ++   +  LY++++++ GG LF +L   G F      FY +EIV A+ +
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPENIL+D +GH+ LTDFG AK++    R+ ++CGT EY+APE++ SKG
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPEYLAPEVIQSKG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           HNK  DWW++GIL+YEML G PPF   N   + ++I+  K++ P  L   A  L+K LL 
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
            D ++RLG+   G D +K+H+WF+S++W  +  R+++P   P VS     +NFD
Sbjct: 235 VDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  285 bits (732), Expect = 9e-95
 Identities = 108/265 (40%), Positives = 174/265 (65%), Gaps = 9/265 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V  VK K       +  +A+K ++K  I++    +++ +E++IL +  HPFI
Sbjct: 1   LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L  +F+ +  +Y+++++  GG L+  L  +G+F E  ARFY A +V A  +LH  GI+
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADW 297
           +RDLKPEN+L+DS+G+V L DFG AK++    ++ + CGT EY+APEI+L+KG++   D+
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 298 WSVGILLYEMLTGQPPFTHANR--QKLQQRII--NEKVKLPPFLTSEAHSLLKGLLHKDP 353
           WS+GILLYE+LTG+PPF   +    ++   I+  N K++ P ++   A  L+K LL ++P
Sbjct: 176 WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINW 378
            +RLG+  GG+  IK HKWF   +W
Sbjct: 236 EERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  285 bits (732), Expect = 2e-94
 Identities = 107/285 (37%), Positives = 165/285 (57%), Gaps = 28/285 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F  V   K+K     +++  YA+K++ K  +IK+  V Y+K E+++LT
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++  HP I++L Y+FQ    LY +L++   G L  ++ + G   E   RFY AEI+ A+ 
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
           +LH  GI+HRDLKPENIL+D D H+ +TDFG AK +D +S                    
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            R  S  GT EY++PE+L  K   K +D W++G ++Y+MLTG+PPF  +N     Q+I+ 
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
            +   PP    +A  L++ LL  DP  RLG    G D +K H +F
Sbjct: 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  282 bits (722), Expect = 2e-92
 Identities = 145/331 (43%), Positives = 209/331 (63%), Gaps = 18/331 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K+K   DG     YA+KV++K  ++ +    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKRK--LDGK---CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LDF+NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GHV+LTDFGL KE I +S  + + CGT EY+APE++  + ++ 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW +G +LYEML G PPF   +  ++   I+++ + L P  +  A S+L+ LL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT--TMP 411
            +RLG+       I+ H +F S++W  LE +++ P F P+V G D I+NFD  +T  T+P
Sbjct: 236 QRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVP 294

Query: 412 ADDSPAPTPT--------AGEHFKGYTYVAP 434
                +   +        A + F G++Y  P
Sbjct: 295 YSVCFSSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  282 bits (722), Expect = 2e-92
 Identities = 129/327 (39%), Positives = 202/327 (61%), Gaps = 14/327 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIVSA+ +LH   
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 354
            DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SLL GLL KDP 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235

Query: 355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 414
           +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD  +T      
Sbjct: 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 295

Query: 415 SP--------APTPTAGEHFKGYTYVA 433
           +P                HF  ++Y A
Sbjct: 296 TPPDRYDSLGLLELDQRTHFPQFSYSA 322

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  281 bits (721), Expect = 2e-92
 Identities = 127/326 (38%), Positives = 202/326 (61%), Gaps = 14/326 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G+FGKV   + K     +S  +YA+KV++KD I++ + V+    E+ IL+    H
Sbjct: 1   RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY AEI SA+  LH  
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D +GH  L DFG+ KE I     +++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW++G+LLYEML G  PF   N   L + I+N++V  P +L+ +A  +LK  + K+P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235

Query: 354 SKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT--- 409
           + RLGS   GG +AI  H +F+ ++W+ L  R+++P F+P +  ++ ++NFD  +     
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDP 295

Query: 410 --MPADDSPAPTPTAGEHFKGYTYVA 433
              P ++S  P     + F+ ++Y A
Sbjct: 296 VLTPIEESLLP-MINQDEFRNFSYTA 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  279 bits (715), Expect = 1e-91
 Identities = 128/327 (39%), Positives = 200/327 (61%), Gaps = 19/327 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG ++      +A+K ++KD +++ + V+    ER +L     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+   G F E +ARFY AEI+  +  LHK 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D DGH+ + DFG+ KE ++   ++++ CGT +Y+APEIL  + +N+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWWS G+LLYEML GQ PF   +  +L   I+N++   P +++ EA   L  L  +DP
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235

Query: 354 SKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDKCWTTMP 411
           +KRLG  G      I+ H +FR I+W+ LE RE+ P FKP V S  D  +NFD+ +T   
Sbjct: 236 TKRLGVDGD-----IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDA-SNFDREFTNEK 289

Query: 412 ADDSPAPTPTAG----EHFKGYTYVAP 434
              SP           E F+G+++  P
Sbjct: 290 VRLSPVDKKLLASMDQEQFRGFSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  277 bits (710), Expect = 2e-91
 Identities = 105/266 (39%), Positives = 163/266 (61%), Gaps = 13/266 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+ RV+G+GAFGKV  V+K+     D+  ++AMK M K   ++K  V  +  ER IL +
Sbjct: 2   FELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +YL++D + GG L +HL ++  F E+Q +F+  EIV A+ +L
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GI+HRD+KP+NIL+D  GHV +TDF +A ++   + + S  GT  YMAPE+L  +G+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----LPPFLTSEAHSLLKG 347
           +   DWWS+G+  YE L G+ P+   + + ++ +I  ++       P   ++EA   +  
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235

Query: 348 LLHKDPSKRLGSGPGGVDAIKHHKWF 373
           LL +DP KRLG        +K+H +F
Sbjct: 236 LLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  280 bits (718), Expect = 3e-91
 Identities = 130/369 (35%), Positives = 202/369 (54%), Gaps = 58/369 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK +RK  +++K  V +++AERDIL 
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +  +P++V+L YSFQ  + LYLI++++ GG +   L ++  F E++ RFY AE + A+  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+N+L+D+ GH+ L+DFGL   + +S R+                   
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 273 ---------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                                S  GT +Y+APE+ L  G+NK+ DWWS+G+++YEML G 
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236

Query: 312 PPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
           PPF   N Q+  ++IIN  E ++ P    L+ EA  L+K L   +  +RLG+   GV+ I
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGN--NGVNEI 293

Query: 368 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH-- 425
           K H +F+ ++W+ +  RE      P++      +NFD          +    P       
Sbjct: 294 KSHPFFKGVDWEHI--RERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSK 351

Query: 426 ---FKGYTY 431
              F GYTY
Sbjct: 352 DLAFIGYTY 360

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  278 bits (712), Expect = 5e-91
 Identities = 139/328 (42%), Positives = 204/328 (62%), Gaps = 12/328 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH+ GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 408
           + K PSKRLG GP G   I+ H +FR I+W  LE RE+QP FKP V GK    NFDK +T
Sbjct: 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGA-ENFDKFFT 294

Query: 409 -TMPADDSPAPTPTAG---EHFKGYTYV 432
              P    P     A      F+G++YV
Sbjct: 295 RGQPVLTPPDQLVIANIDQADFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  278 bits (712), Expect = 6e-91
 Identities = 128/322 (39%), Positives = 180/322 (55%), Gaps = 42/322 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+  +++G+G  G+VF V+ KG     +  ++A+KV+ K  +IK+N V  +  E++IL 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAV 228
            + HPF+  L  SFQT + L L++D+  GG LF  L RQ      E+ ARFY AE++ A+
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE--------------------- 267
            +LH  GIV+RDLKPENIL+   GH+ML+DF L+K+ D                      
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 268 ---------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
                    S RSNS  GT EY+APE++   GH    DWW++GILLYEML G  PF  +N
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 319 RQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
           R +    I+ ++V  P  P ++S A  L++ LL KDPSKRLGS  G  + IK H +FR +
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE-IKQHPFFRGV 295

Query: 377 NWKTLEAREMQPKFKPDVSGKD 398
           NW  +  R   P   P      
Sbjct: 296 NWALI--RHTTPPIIPRPDDGI 315

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  277 bits (710), Expect = 1e-90
 Identities = 129/302 (42%), Positives = 198/302 (65%), Gaps = 6/302 (1%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      S   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT+ +L  +++++NGG LFFHL R+ +F ED+ RFY AEIVSA+ +LH   
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           IV+RDLK EN+++D DGH+ +TDFGL KE I +++   + CGT EY+APE+L    + + 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 354
            DWW +G+++YEM+ G+ PF + + +KL + I+ E +K P  L+++A SLL GLL KDP+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235

Query: 355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 414
           KRLG GP     I  H +F  +NW+ +  +++ P FKP V+ +     FD+ +T      
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITI 295

Query: 415 SP 416
           +P
Sbjct: 296 TP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  276 bits (708), Expect = 2e-90
 Identities = 118/330 (35%), Positives = 196/330 (59%), Gaps = 15/330 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-- 169
           F    V+G+G FGKV   + K      +  +YA+K ++K  II ++ V+ +  E+ I   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFET 55

Query: 170 -TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
                HPF+V L   FQT   +  ++++  GG L  H++   +F E +A FY A +V  +
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILL 287
            +LH+  IV+RDLK +N+L+D++G V + DFGL KE +    R+++ CGT E++APE+L 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
              + +  DWW +G+L+YEML G+ PF   + +++   I+N++V+ P FL+ EA S+++ 
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234

Query: 348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 407
           LL ++P +RLGSG    + +K   +FR INW  L AR+++P F P + G + ++NFD+ +
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEF 294

Query: 408 TTMPADDSPAPTPTA-----GEHFKGYTYV 432
           T+     +P   P        E F+G+ YV
Sbjct: 295 TSEAPVLTPPREPRLLTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  274 bits (701), Expect = 2e-89
 Identities = 134/329 (40%), Positives = 204/329 (62%), Gaps = 15/329 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  VK+K      +   YAMK+++K+ I+ K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KC 234
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH + 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL GLL KDP
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT----T 409
            +RLG GP     I  HK+F  I W+ +  +++ P FKP V+ +     FD+ +T    T
Sbjct: 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMIT 295

Query: 410 MPADDSPAPTPTAGE----HFKGYTYVAP 434
           +   D      T       HF  ++Y A 
Sbjct: 296 ITPPDQDDSMETVDNERRPHFPQFSYSAS 324

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  273 bits (698), Expect = 5e-89
 Identities = 133/332 (40%), Positives = 202/332 (60%), Gaps = 20/332 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L + + + G F+E  A FY AEI   + 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 408
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G+D   NFDK +T
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDA-ENFDKFFT 294

Query: 409 TMPADDSPAPTPTAGE--------HFKGYTYV 432
             P    P  TP   E         F+G++YV
Sbjct: 295 RHP----PVLTPPDQEVIMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  269 bits (689), Expect = 3e-88
 Identities = 106/271 (39%), Positives = 156/271 (57%), Gaps = 20/271 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ R +G G+FG V++ K KG        I A+K+++K +   K      + E  IL +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQ-TARREIRILRR 54

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++HP IV+L  +F+ +  LYL++++  GG LF +L R G   ED+A+    +I+  + +L
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL-SK 289
           H  GI+HRDLKPENIL+D +G V + DFGLAK++ +SS S  +  GT  YMAPE+LL   
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-------LTSEAH 342
           G+    D WS+G++LYE+LTG+PPF+  N     Q I         F        + EA 
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
            L+K  L+KDPSKR        + I  H WF
Sbjct: 235 DLIKKCLNKDPSKRP-----TAEEILQHPWF 260

Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  264 bits (677), Expect = 2e-86
 Identities = 107/282 (37%), Positives = 164/282 (58%), Gaps = 11/282 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + K      +  +YA K + K  + K+        E+ IL KV+  FI
Sbjct: 1   LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG 235
           V L Y+F+T+  L L++  +NGG L +H+Y  G   F E +A FY A+I+  + HLH+  
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
           IV+RDLKPEN+L+D  G+V ++D GLA E+    +     GT  YMAPE+L  + ++   
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 296 DWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           DW+++G  LYEM+ G+ PF        +++L++R +   V+ P   + EA  L + LL K
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235

Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           DP KRLG   G  D ++ H  F+ +NW+ LEA  ++P F PD
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  263 bits (675), Expect = 3e-85
 Identities = 122/303 (40%), Positives = 179/303 (59%), Gaps = 22/303 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF+I   VGQG +G+VF  KKK     D+  I A+K M+K  + K N V ++  ERDIL
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T     ++V+L Y+FQ    LYL ++++ GG     L   G+  ED ARFY AE+  AV 
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+ G +HRDLKPEN L+D+ GH+ LTDFGL+K I   + +NS+ G+ +YMAPE+L  K
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGK 173

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--------PPFLTSEA 341
           G++   D+WS+G +LYE L G PPF+ +   +  + +   K  L           L+ EA
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233

Query: 342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 401
             L+  L+  DPS+R GS    ++ IK+H +F+ ++W  L  RE++P F P++  +    
Sbjct: 234 WDLITKLI-NDPSRRFGS----LEDIKNHPFFKEVDWNEL--RELKPPFVPELESEIDTG 286

Query: 402 NFD 404
            FD
Sbjct: 287 YFD 289

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  263 bits (674), Expect = 3e-85
 Identities = 124/333 (37%), Positives = 203/333 (60%), Gaps = 21/333 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTH 174
           RV+G+G++ KV  V+ K      +  IYAMKV++K+ +     +D+++ E+ +  T   H
Sbjct: 1   RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++F++GG L FH+ RQ    E+ ARFY+AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D++GH+ LTD+G+ KE I     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQK---------LQQRIINEKVKLPPFLTSEAHSL 344
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235

Query: 345 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LKG L+KDP +RLG  P  G   IK H +FR+I+W  LE +++ P +KP++     + NF
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNF 295

Query: 404 DKCWTTMPADDSPAPTPTAGE----HFKGYTYV 432
           D  +T  P   +P             F+G+ Y+
Sbjct: 296 DPQFTDEPVQLTPDDPDVIARIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  261 bits (669), Expect = 7e-84
 Identities = 129/360 (35%), Positives = 188/360 (52%), Gaps = 62/360 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V  V+K      D++ +YAMK +RK  ++ +N   ++KAERDIL +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLA--------------------------KEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                           +E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 266 DESSR------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
            E  R                  ++S+ GT  Y+APE+LL  G+ +  DWWSVG++LYEM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 308 LTGQPPFTHANRQKLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGSGPGG 363
           L GQPPF      + Q ++IN +  L  P    L+ EA  L+  L       RLG    G
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NG 294

Query: 364 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD-----KCWTTMPADDSPAP 418
            D IK H +F+ I++ +L  R  +  + P ++     +NFD     K  +    + SP  
Sbjct: 295 ADEIKAHPFFKGIDFASL-IRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDR 353

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  255 bits (653), Expect = 4e-82
 Identities = 127/331 (38%), Positives = 205/331 (61%), Gaps = 19/331 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D+++ E+ +  +  ++
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+L+++++NGG L FH+ RQ    E+ ARFY AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D+DGH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPF-------THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
             DWW++G+L++EM+ G+ PF              L Q I+ + +++P FL+ +A  +LK
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK 235

Query: 347 GLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
           G L+KDP +RLG  P  G   IK H +FRSI+W  LE +++ P FKP ++    + NFD 
Sbjct: 236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDT 295

Query: 406 CWTTMPA----DDSPAPTPTAGEHFKGYTYV 432
            +T+ P     DD           F+G+ Y+
Sbjct: 296 QFTSEPVQLTPDDEDVIKRIDQSEFEGFEYI 326

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  249 bits (636), Expect = 1e-79
 Identities = 122/333 (36%), Positives = 208/333 (62%), Gaps = 21/333 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           RV+G+G++ KV  V+ K      ++ IYAMKV++K+ +     +D+++ E+ +  + + H
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPPFLTSEAHSL 344
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 345 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+  + NF
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF 295

Query: 404 DKCWTT----MPADDSPAPTPTAGEHFKGYTYV 432
           D  +T     +  DD           F+G+ Y+
Sbjct: 296 DAQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  245 bits (628), Expect = 8e-79
 Identities = 115/291 (39%), Positives = 169/291 (58%), Gaps = 17/291 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-ERDI 168
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I KK   + M   E+ I
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRI-KKRKGEAMALNEKQI 53

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVS 226
           L KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI  
Sbjct: 54  LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA EI E        GT  YMAPE++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            ++ +    DWW +G L+YEM+ G+ PF        R+++++R+  ++ +     +  A 
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           S+ + LL KDP  RLG    G + +K H +FR+ N+K LEA  ++P F PD
Sbjct: 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  243 bits (622), Expect = 1e-77
 Identities = 117/292 (40%), Positives = 182/292 (62%), Gaps = 11/292 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +++G+G+FGKVF  + KG     ++  +A+K ++KD ++  + V+    E+ +L+    H
Sbjct: 1   KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+     F   +A FY AEI+  +  LH  
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GIV+RDLK +NIL+D+DGH+ + DFG+ KE +   +++ + CGT +Y+APEILL + +N 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWWS G+LLYEML GQ PF   + ++L Q I  +    P +LT EA  +L  L  ++P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
            +RLG        I+ H +FR I+W  LE RE++P FKP V   +  +NFDK
Sbjct: 236 ERRLGVK----GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  240 bits (613), Expect = 6e-76
 Identities = 124/312 (39%), Positives = 182/312 (58%), Gaps = 6/312 (1%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           ++D+  E + + K+   DF   R +G G+FG+V     K   + D   + A+K   K  I
Sbjct: 14  DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPV-AIKRFEKSKI 69

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           IK+  VD++ +ER IL  + HPF V L  SF+  S LYL+L+F+ GG  F  L R   F 
Sbjct: 70  IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
            D   FY A+IV    +L    IV+RDLKPEN+L+D DG + +TDFG AK +D  +R+ +
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYT 187

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           +CGT EY+APEILL+ GH K ADWW++GI +YE+L G PPF       + Q+I+   +  
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247

Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           P FL +    L+K LL  D +KR G+   G   +K H WF +I+W +L  + ++  +KP 
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307

Query: 394 VSGKDCIANFDK 405
                  +NF++
Sbjct: 308 YKNVFDSSNFER 319

Length = 340

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  238 bits (608), Expect = 8e-75
 Identities = 119/334 (35%), Positives = 182/334 (54%), Gaps = 22/334 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
                +IVQL Y+FQ    LY++++++ GG L   +    I  E  ARFYTAE+V A+  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++D +   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KGHN----KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G +    ++ DWWSVG+ LYEML G  PF   +      +I++ K  L       ++ +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A  L+   L  D   RLG    GVD IK H +F++  W     RE      P++S     
Sbjct: 278 AKDLICAFL-TDREVRLGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDT 334

Query: 401 ANFDKCWT-TMPADDSPAPTPTAGEH--FKGYTY 431
           +NFD         +  P P   AG    F G+TY
Sbjct: 335 SNFDDIEDDDKNEETFPLPKAFAGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  232 bits (594), Expect = 4e-74
 Identities = 110/267 (41%), Positives = 163/267 (61%), Gaps = 17/267 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPF 176
           + +GAFG V+  KK+   D      +A+KV++K  +I KN V  +KAER I+  +   P+
Sbjct: 4   ISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           + +L YSFQ++  LYL+++++NGG     +   G   ED A+ Y AE+V  V  LH+ GI
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +HRD+KPEN+L+D  GH+ LTDFGL++   E+ +     GT +Y+APE +L  G +K +D
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANR-----QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           WWS+G +++E L G PPF HA         +  R IN   ++  F + EA  L+  LL  
Sbjct: 176 WWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234

Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINW 378
           DP+KRLG+   G   IK H +F+SINW
Sbjct: 235 DPAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  233 bits (596), Expect = 9e-74
 Identities = 113/292 (38%), Positives = 179/292 (61%), Gaps = 11/292 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G+G+FGKV   + KG  +      +A+K ++KD ++  + V+    E+ +L     +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++F+NGG L FH+  +G F   +A FY AEIV  +  LH  
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+++D DGH+ + DFG+ KE +   +R+++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
             DWWS G+LLYEML GQ PF   +  +L + I  +    P ++T E+  +L+ L  +DP
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235

Query: 354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
           ++RLG     V  I+ H +F++INW  LE RE+ P FKP V      +NFD+
Sbjct: 236 TRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  232 bits (594), Expect = 3e-73
 Identities = 119/331 (35%), Positives = 181/331 (54%), Gaps = 26/331 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  +VG+G FG+V  V++K   D     IYAMKVM+K  ++ +  V + + ERDIL+
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILS 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
               P+I QL+Y+FQ +  LYL++++  GG L   L R +  F ED A+FY AE+V A+ 
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--CGTTEYMAPEILL 287
            +H+ G VHRD+KPEN+L+D  GH+ L DFG A  +  +   NS    GT +Y+APE+L 
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 288 -----SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFL 337
                 KG +  + DWWS+G++ YEM+ G+ PF      K    I+N +  +K P  P +
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236

Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
           +S+   L++ LL     +RL     G + +  H +F  I+W  +  R   P F P +   
Sbjct: 237 SSDFLDLIQSLL-CGQKERL-----GYEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKSD 288

Query: 398 DCIANFDKCWTTMPADDSPAPTPTAGEHFKG 428
           D  +NFD+           + T      F G
Sbjct: 289 DDTSNFDEPEKNSTRRSQSSTTQLKPNGFSG 319

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  230 bits (587), Expect = 2e-72
 Identities = 112/314 (35%), Positives = 181/314 (57%), Gaps = 28/314 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE  +++  GA+G V+ V+ K     ++   +AMK + K  +I +N +  +  ERDIL
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T   +PF+V +  SF+T+  L ++++++ GG     L   G    D AR Y AE V A+ 
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-------------EIDESSRS---NS 273
           +LH  GIVHRDLKP+N+L+ S GH+ LTDFGL+K              I++ +R      
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           +CGT EY+APE++L +G+ K  DWW++GI+LYE L G  PF     ++L  ++I++ ++ 
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 334 P---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 390
           P     L ++A  L+  LL ++P +RLG+  GG   +K H++F  ++W  L     + +F
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGL--LRQKAEF 291

Query: 391 KPDVSGKDCIANFD 404
            P +  +D  + FD
Sbjct: 292 IPQLESEDDTSYFD 305

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  232 bits (592), Expect = 3e-72
 Identities = 127/382 (33%), Positives = 186/382 (48%), Gaps = 71/382 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF   +V+G+GAFG+V  V+KK  D G    IYAMK + K  + KK+ + ++KAERD+L 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKK--DTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P++V L YSFQ    LYLI++F+ GG L   L +   F ED  RFY AE V A+  
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+NIL+D  GH+ L+DFGL+    +   S                   
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 273 ------------------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                                         S  GT +Y+APEI L +G+ ++ DWWS+G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 303 LLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLG 358
           +++E L G PPF   N  +  ++IIN  E +  P    L+ EA  L++ L+  +   RLG
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLG 295

Query: 359 SGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG---------KDCIANFDKCWTT 409
              GG   IK H +FR ++W T+  R+++  F P +            +     +     
Sbjct: 296 R--GGAHEIKSHPFFRGVDWDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALK 351

Query: 410 MPADDSPAPTPTAGEHFKGYTY 431
             A      +      F GYTY
Sbjct: 352 QAAPAQQEESVELDLAFIGYTY 373

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  225 bits (575), Expect = 4e-71
 Identities = 114/290 (39%), Positives = 166/290 (57%), Gaps = 15/290 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI+  
Sbjct: 55  EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+   V+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE+L 
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           ++ +    D+W +G L+YEM+ GQ PF        R+++ +R++  +       + EA S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           + K LL KDP +RLG    G   +K H +FR++N+K LEA  + P F PD
Sbjct: 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  226 bits (579), Expect = 5e-71
 Identities = 122/339 (35%), Positives = 183/339 (53%), Gaps = 28/339 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K         +YAMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEILL 287
            +H+ G VHRD+KP+N+L+D +GH+ L DFG  L    D + +SN   GT +Y++PEIL 
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 288 S----KGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 338
           +    KG    + DWWS+G+ +YEML G+ PF   +  +   +I+N  E  + PP +T  
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 339 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
             EA  L++ L+   P  RLG    G+   K H +F  I+W  +  R     + P+VS  
Sbjct: 237 SEEAKDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNI--RNSTAPYVPEVSSP 291

Query: 398 DCIANFD---KCWTTMPADDSPAPTPTAGEH--FKGYTY 431
              +NFD          +    +    +G H  F G+TY
Sbjct: 292 TDTSNFDVDDDDLRNTESLPPSSHGAFSGNHLPFVGFTY 330

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  223 bits (570), Expect = 2e-70
 Identities = 84/253 (33%), Positives = 147/253 (58%), Gaps = 14/253 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +EI + +G+G+FGKV+ V++K      SDG +Y +K +    + +K   D +  E  IL
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK------SDGKLYVLKEIDLSNMSEKEREDALN-EVKIL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIV 225
            K+ HP I++   SF+ + KL +++++ +GG L   + +Q      F E+Q   +  ++ 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
            A+ +LH   I+HRD+KP+NI + S+G V L DFG++K +  +     ++ GT  Y++PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHS 343
           +  +K +N  +D WS+G +LYE+ T + PF   N  +L  +I+  +   +P   +SE  +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233

Query: 344 LLKGLLHKDPSKR 356
           L+  LL KDP +R
Sbjct: 234 LVSSLLQKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  221 bits (563), Expect = 3e-69
 Identities = 120/291 (41%), Positives = 166/291 (57%), Gaps = 17/291 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ 
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AH 342
           ++ +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK      SE     A 
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYSEKFSPDAR 233

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           SL K LL KDP +RLG   GG   +K H  F+ IN+K LEA  ++P FKPD
Sbjct: 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  220 bits (562), Expect = 4e-69
 Identities = 110/290 (37%), Positives = 165/290 (56%), Gaps = 15/290 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AE+   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  L +  IV+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE++ 
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           ++ +    DWW +G L+YEM+ GQ PF        R+++ +R+  ++ +     + +A S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           + + LL K+P +RLG    G   +K H  F++IN+K LEA  ++P F PD
Sbjct: 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  221 bits (564), Expect = 4e-68
 Identities = 126/345 (36%), Positives = 186/345 (53%), Gaps = 61/345 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V   +K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  AV  +
Sbjct: 58  ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL--------------------------AKEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                          + E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 266 DESSR----------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
            + +                       ++S+ GT  Y+APE+LL  G+ +  DWWSVG++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQPPFTHANRQKLQQRIINEKVKL--PP--FLTSEAHSLLKGLLHKDPSKRLGS 359
           LYEML GQPPF      + Q ++IN +  L  PP   L+ EA  L+  L  + P  RLG 
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296

Query: 360 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
              G D IK H +F++I++ + + R+    + P ++     +NFD
Sbjct: 297 --NGADEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHPTDTSNFD 338

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  217 bits (555), Expect = 4e-68
 Identities = 109/285 (38%), Positives = 170/285 (59%), Gaps = 14/285 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + +      +  +YA K + K  + K+   +    E+ IL KV   FI
Sbjct: 1   LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHK 233
           V L Y+FQT++ L L++  +NGG L +H+Y        F E +A FYTA+I+S + HLH+
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPEN+L+D+DG+V ++D GLA E+ D  S++    GT  +MAPE+L  + ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 293 KDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
              D++++G+ LYEM+  + PF         ++L+QRI+N+ V  P   +  + S  + L
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           L KDP KRLG   G  D ++ H  FR +NW+ LEA  + P F PD
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  218 bits (556), Expect = 3e-67
 Identities = 124/368 (33%), Positives = 192/368 (52%), Gaps = 60/368 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E+  +FY AE V A+  
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+D+ GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 315 THANRQKLQQRIIN--EKVKLPPFL-TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
                Q+  ++++N  E +  PP +  SE    L      D   R+GS   GV+ IK H 
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGS--NGVEEIKSHP 294

Query: 372 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH------ 425
           +F  ++W  +  RE       ++   D  +NFD+     P  D   P     E       
Sbjct: 295 FFEGVDWGHI--RERPAAIPIEIKSIDDTSNFDE----FPESDILQPAENTIEPDYKSKD 348

Query: 426 --FKGYTY 431
             F  YTY
Sbjct: 349 WVFLNYTY 356

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  211 bits (538), Expect = 3e-64
 Identities = 125/377 (33%), Positives = 191/377 (50%), Gaps = 68/377 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V    K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R  +F E  ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL------------------------------ 261
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                              
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 262 ------------------AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                             A +  +   ++S+ GT  Y+APE+LL KG+ +  DWWSVG++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGS 359
           L+EML GQPPF      + Q ++IN    + +PP   L+ EA  L+   L     +RLG 
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGR 296

Query: 360 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT 419
              G D IK H +F  +++ + + R     + P +S     +NFD      P ++     
Sbjct: 297 --NGADDIKAHPFFSEVDFSS-DIRTQPAPYVPKISHPMDTSNFD------PVEEESPWN 347

Query: 420 PTAGEHFKGY-TYVAPN 435
             +G+  + + T  +PN
Sbjct: 348 DASGDSTRTWDTLCSPN 364

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  208 bits (530), Expect = 2e-63
 Identities = 122/371 (32%), Positives = 195/371 (52%), Gaps = 63/371 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  +YAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E++ +FY AE V A+  
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+DS GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 315 THANRQKLQQRIIN--EKVKLPPFL-TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
                Q+  ++++N  E +  PP +  SE    L      +   R+G+   GV+ IK + 
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNP 294

Query: 372 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH------ 425
           +F  ++W+ +  RE       ++   D  +NFD+     P  D   PT     H      
Sbjct: 295 FFEGVDWEHI--RERPAAIPIEIKSIDDTSNFDE----FPDSDILKPTVATSNHPETDYK 348

Query: 426 -----FKGYTY 431
                F  YTY
Sbjct: 349 NKDWVFINYTY 359

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  202 bits (516), Expect = 2e-62
 Identities = 110/284 (38%), Positives = 167/284 (58%), Gaps = 15/284 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY AEI+  + H+H 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +     S+ GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV-LQKGVAY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPF-THANRQKLQ--QRIINEKVKLPPFLTSEAHSLLKGL 348
           +  ADW+S+G +L+++L G  PF  H  + K +  +  +   V+LP   + E  SLL+GL
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           L +D ++RLG    G   +K H +FRS++W+ +  ++  P   P
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  200 bits (510), Expect = 2e-61
 Identities = 83/249 (33%), Positives = 137/249 (55%), Gaps = 14/249 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
            ++G+G+FG V+      +D  D+  + A+K +      ++  ++ ++ E  IL+ + HP
Sbjct: 6   ELLGRGSFGSVYL----ALDK-DTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59

Query: 176 FIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+   S +   K  L + L++++GG L   L + G   E   R YT +I+  +++LH 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLSKG 290
            GIVHRD+K  NIL+DSDG V L DFG AK + +      + S+ GT  +MAPE++  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK--LPPFLTSEAHSLLKG 347
           + + AD WS+G  + EM TG+PP++   N      +I +      +P  L+ EA   L+ 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 348 LLHKDPSKR 356
            L +DP KR
Sbjct: 240 CLRRDPKKR 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  199 bits (508), Expect = 4e-61
 Identities = 107/284 (37%), Positives = 166/284 (58%), Gaps = 15/284 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY  EI+  + H+H 
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-LQKGTAY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           +  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  SLL+GL
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL 233

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           L +D SKRLG    G   +K H +F+ I+W+ +  ++  P   P
Sbjct: 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  199 bits (506), Expect = 8e-61
 Identities = 104/285 (36%), Positives = 160/285 (56%), Gaps = 17/285 (5%)

Query: 118 VGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+G FG+V   QVK  G        +YA K + K  + KK+       E++IL KV  P
Sbjct: 1   LGKGGFGEVCAVQVKNTG-------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR--FYTAEIVSAVSHLHK 233
           FIV L Y+F++++ L L++  +NGG L +H+Y  G    +  R   Y+A+I   + HLH 
Sbjct: 54  FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK 293
             IV+RD+KPEN+L+D  G+  L+D GLA E+ +        GT  YMAPEIL  + ++ 
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 294 DADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGL 348
             DW+++G  +YEM+ G+ PF        +++L++R + ++VK      T E+  + +  
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           L K P  RLGS     D  KH  +F++IN+  LEA  + P F PD
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHE-FFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  196 bits (499), Expect = 4e-59
 Identities = 123/344 (35%), Positives = 195/344 (56%), Gaps = 34/344 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
              + +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 338
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236

Query: 339 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
             +A  L++ L+    S+    G  G++  K H +F  I+W  +  R  +  + P+VS  
Sbjct: 237 SEDAKDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSSP 291

Query: 398 DCIANFD------KCWTTMPADDSPAPTPTAGEH--FKGYTYVA 433
              +NFD      K   TMP    P+ T  +G H  F G+TY +
Sbjct: 292 TDTSNFDVDDDCLKNSETMP---PPSHTAFSGHHLPFVGFTYTS 332

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  195 bits (496), Expect = 1e-58
 Identities = 121/339 (35%), Positives = 190/339 (56%), Gaps = 28/339 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K      ++ IYAMK++ K  ++K+      + ER++L 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEIL- 286
            +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y++PEIL 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 287 -LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 338
            +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236

Query: 339 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
             EA  L++ L+     +RLG    G++  K H +F  I+W+ +  R ++  + PDVS  
Sbjct: 237 SEEAKDLIQRLICSR-ERRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSP 291

Query: 398 DCIANFDKCWTTMPADDSPAP---TPTAGEH--FKGYTY 431
              +NFD     +   +   P   T  +G H  F G+TY
Sbjct: 292 SDTSNFDVDDDVLRNPEIAPPSSHTGFSGLHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  196 bits (499), Expect = 1e-58
 Identities = 117/334 (35%), Positives = 185/334 (55%), Gaps = 22/334 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 278 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 334

Query: 401 ANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTY 431
           +NFD        +++ P P    G    F G+TY
Sbjct: 335 SNFDDIEEDKGEEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  188 bits (480), Expect = 1e-57
 Identities = 81/243 (33%), Positives = 127/243 (52%), Gaps = 42/243 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG V+  +     D  +    A+K+++K+     + ++ +  E +IL K+ HP I
Sbjct: 1   LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNI 53

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+L   F+  + LYL++++  GG L   L    G   ED+      +I+  + +LH  GI
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113

Query: 237 VHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGH-NK 293
           +HRDLKPENIL+DSD G V L DFGL+K +        ++ GT  YMAPE+LL KG+ ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 353
            +D WS+G++LYE+                                E   L++ +L KDP
Sbjct: 174 KSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDP 202

Query: 354 SKR 356
            KR
Sbjct: 203 EKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  191 bits (485), Expect = 1e-56
 Identities = 114/334 (34%), Positives = 183/334 (54%), Gaps = 22/334 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFLTSE 340
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L       ++  
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     RE      P++S     
Sbjct: 278 AKNLICAFL-TDREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDS 334

Query: 401 ANFDKCWTTM-PADDSPAPTPTAGEH--FKGYTY 431
           +NFD         +  P P    G    F G+TY
Sbjct: 335 SNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  185 bits (471), Expect = 6e-56
 Identities = 84/259 (32%), Positives = 134/259 (51%), Gaps = 30/259 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            FEI   +G+G FG+V++ + K        G   A+KV++ ++  KK  +     E  IL
Sbjct: 1   LFEILEKIGKGGFGEVYKARHK------RTGKEVAIKVIKLESKEKKEKI---INEIQIL 51

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAE 223
            K  HP IV+   S+  + +L+++++F +GG L     +           E Q  +   E
Sbjct: 52  KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL-----KDLLKSTNQTLTESQIAYVCKE 106

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  + +LH  GI+HRD+K  NIL+ SDG V L DFGL+ ++ ++   N+M GT  +MAP
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL------ 337
           E++  K ++  AD WS+GI   E+  G+PP++     K   +I       PP L      
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPGLRNPEKW 223

Query: 338 TSEAHSLLKGLLHKDPSKR 356
           + E    LK  L K+P KR
Sbjct: 224 SDEFKDFLKKCLQKNPEKR 242

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  179 bits (455), Expect = 3e-52
 Identities = 100/299 (33%), Positives = 144/299 (48%), Gaps = 36/299 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I R +G+G+FG+V+  + +         + A+KV+ K    K   V+    E  IL 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK--------LVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVS 226
            + HP  IV+L   FQ    LYL++++++GG    L   + R+G   E +A F  A+I+S
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESS-------RSNSMCGTT 278
           A+ +LH  GI+HRD+KPENIL+D DG  V L DFGLAK + +           ++  GT 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 279 EYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPF-------------THANRQKL 322
            YMAPE+LL       +  +D WS+GI LYE+LTG PPF                     
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
                      P  ++  A  LLK LL KDP  RL S       +  H   +  +   L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  163 bits (414), Expect = 2e-47
 Identities = 85/247 (34%), Positives = 134/247 (54%), Gaps = 12/247 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
            ++G G+FG V++    G++  D    +A+K +    D    +  V  ++ E  +L+K+ 
Sbjct: 6   ELLGSGSFGSVYE----GLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IVQ   + +    LY+ L+ + GG L   L + G F E   R YT +I+  + +LH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HN 292
              VHRD+K  NIL+D++G V L DFG+AK++ E S + S  G+  +MAPE++  +G + 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSEAHSLLKGLL 349
             AD WS+G  + EM TG+PP++         +I   K  LPP    L+ EA   +   L
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPIPDHLSDEAKDFILKCL 239

Query: 350 HKDPSKR 356
            +DPS R
Sbjct: 240 QRDPSLR 246

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  161 bits (410), Expect = 1e-46
 Identities = 81/260 (31%), Positives = 140/260 (53%), Gaps = 21/260 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G+G+FG V +V++K      SDG I   K +    + +K     + +E +IL
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEK-QQLVSEVNIL 53

Query: 170 TKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHL--FFHLYRQ--GIFREDQARFYTAE 223
            ++ HP IV+   R   ++   LY+++++  GG L       ++      E+       +
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCGT 277
           ++ A+   H        ++HRDLKP NI +D++ +V L DFGLAK +   SS + +  GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 336
             YM+PE L    +++ +D WS+G L+YE+    PPFT  N+ +L  +I   K  ++P  
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233

Query: 337 LTSEAHSLLKGLLHKDPSKR 356
            +SE + ++K +L+ DP KR
Sbjct: 234 YSSELNEVIKSMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 4e-46
 Identities = 81/265 (30%), Positives = 140/265 (52%), Gaps = 13/265 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++  ++G+GAFG V+    KG++  ++    A+K +  + I ++     M  E D+L 
Sbjct: 1   NYQLGDLIGRGAFGVVY----KGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLK 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+   S +T   LY+IL++   G L   + + G F E     Y  +++  +++
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSK 289
           LH+ G++HRD+K  NIL   DG V L DFG+A ++++ S+   S+ GT  +MAPE++   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGL 348
           G +  +D WS+G  + E+LTG PP+   N      RI+ +    LP  ++ E    L   
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWF 373
             KDP+ R  +       +  H W 
Sbjct: 235 FQKDPNLRPTA-----KQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  152 bits (386), Expect = 4e-43
 Identities = 74/253 (29%), Positives = 127/253 (50%), Gaps = 14/253 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  +V+GQG+ G V++V+ K    G    IYA+K +  D   +      +  E   L 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKP--TGK---IYALKKIHVDGDEEFRKQ--LLRELKTLR 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++V+   +F    ++ ++L++++GG L   L + G   E    +   +I+  + +
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 231 LHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLS 288
           LH    I+HRD+KP N+L++S G V + DFG++K ++ +  + N+  GT  YM+PE +  
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RIIN--EKVKLPPFLTS-EAHS 343
           + ++  AD WS+G+ L E   G+ PF    +    +  + I       LP    S E   
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 344 LLKGLLHKDPSKR 356
            +   L KDP KR
Sbjct: 235 FISACLQKDPKKR 247

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  148 bits (377), Expect = 1e-41
 Identities = 79/270 (29%), Positives = 136/270 (50%), Gaps = 18/270 (6%)

Query: 96  DAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
           + EL+A  +  +  GD    ++    +G+GA G+V++   +    G      A+K MR  
Sbjct: 1   EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMR-- 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QG 210
             ++K + + +  E  I+    HP IV    S+    +L++++++++GG L   + +   
Sbjct: 54  --LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESS 269
              E Q  +   E++  + +LH   ++HRD+K +NIL+  DG V L DFG A ++  E S
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + NS+ GT  +MAPE++  K +    D WS+GI+  EM  G+PP+      +    I  +
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231

Query: 330 ---KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
               +K P   + E    L   L KDP KR
Sbjct: 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  146 bits (372), Expect = 4e-41
 Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 22/271 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F +   +G+G+FG+V+    K +D   +  + A+KV+  +    ++ ++ ++ E   L++
Sbjct: 3   FTLLECIGKGSFGEVY----KAIDKRTNQ-VVAIKVIDLEE--AEDEIEDIQQEIQFLSQ 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P+I +   SF   SKL++I+++  GG     L + G   E    F   E++  + +L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H+ G +HRD+K  NIL+  +G V L DFG++ ++    S+ N+  GT  +MAPE++   G
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LLKGLL 349
           +++ AD WS+GI   E+  G+PP +  +  ++   I       PP L     S   K  +
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231

Query: 350 H----KDPSKRLGSGPGGVDAIKHHKWFRSI 376
                KDP +R    P   + +K HK+ +  
Sbjct: 232 SLCLNKDPKER----PSAKELLK-HKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  145 bits (367), Expect = 1e-40
 Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 28/256 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV+        + D+  + A+K +R      K     +  E  +L  + HP +
Sbjct: 8   IGGGTFGKVYTAV-----NLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNL 61

Query: 178 VQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+  Y  +  R K+Y+ +++ +GG L   L    I  E   R YT +++  +++LH  GI
Sbjct: 62  VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEILL---S 288
           VHRD+KP NI +D +G + L DFG A ++  ++ +      S+ GT  YMAPE++     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPF-----LTSE 340
           KGH + AD WS+G ++ EM TG+ P+      + Q   I   V     PP      L+ E
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPW-SELDNEFQ---IMFHVGAGHKPPIPDSLQLSPE 236

Query: 341 AHSLLKGLLHKDPSKR 356
               L   L  DP KR
Sbjct: 237 GKDFLDRCLESDPKKR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 2e-40
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 47/296 (15%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           ++    +G+G +G V++ +     D  +  I A+K ++      ++      A R+I  L
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ HP I++L   F+ +  LYL+ +F++         RQ    E   + Y  +++  ++
Sbjct: 53  KELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL- 287
             H  GI+HRDLKPEN+L++++G + L DFGLA+      R       T  Y APE+LL 
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------------------QKLQQRIIN 328
            KG++   D WSVG +  E+L+ +P F   +                     K      N
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232

Query: 329 EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
            K   P           P  + +A  LL  +LH DP KR+       +    H +F
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  143 bits (363), Expect = 4e-40
 Identities = 82/250 (32%), Positives = 136/250 (54%), Gaps = 12/250 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   RV+G+GAFG+    ++      + D +   K +    + +K   D +  E  IL+ 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSL 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP I+     F   + L + +++ NGG L+  + RQ   +F E+   +Y  +IVSAVS
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           ++HK GI+HRD+K  NI +   G + L DFG++K +  E S + ++ GT  YM+PE+   
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAHSLLK 346
             +N  +D W++G +LYE+LT +  F   N   L  +I+  N    +  + +SE  SL+ 
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY-SSELISLVH 234

Query: 347 GLLHKDPSKR 356
            LL +DP KR
Sbjct: 235 SLLQQDPEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  151 bits (383), Expect = 5e-40
 Identities = 66/155 (42%), Positives = 105/155 (67%), Gaps = 9/155 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F I + + +GAFGKV+  +KK     ++  +YA+KV++K  +I KN V  ++AERD L 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALA 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
               PFIV L YS Q+ + +YL+++++ GG +    H+Y  G F E+ A  Y +E+  A+
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALAL 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            +LH+ GI+HRDLKP+N+L+ ++GH+ LTDFGL+K
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  143 bits (361), Expect = 1e-39
 Identities = 82/260 (31%), Positives = 132/260 (50%), Gaps = 19/260 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK-------VMRKDTIIKKNHVDYMKA 164
           + +   +G GAFG V++V+KK     +   + A+K          KD   +   +  + +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57

Query: 165 ERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARF 219
           E  I+ + + HP IV+   +F    +LY+++D I G  L  H      ++  F E++   
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 220 YTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
              ++V A+ +LHK   IVHRDL P NI++  D  V +TDFGLAK+    S+  S+ GT 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFL 337
            Y  PEI+ ++ + + AD W+ G +LY+M T QPPF   N   L  +I+    + LP  +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 338 TSE-AHSLLKGLLHKDPSKR 356
            SE    ++   L  D   R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  141 bits (357), Expect = 4e-39
 Identities = 77/254 (30%), Positives = 139/254 (54%), Gaps = 18/254 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
           DFEI   +G+G+FG VF+V +K   D     +YAMK   + + +   ++  +D    E  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK--ADKR---VYAMKQIDLSKMNRREREEAID----EAR 51

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQA-RFYTAEI 224
           +L K+   +I++   SF  + KL +++++   G  H    + R     EDQ  RF+  +I
Sbjct: 52  VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QI 110

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAP 283
           +  ++HLH   I+HRD+K  N+ +D+  +V + D G+AK + +++  +N++ GT  Y++P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAH 342
           E+   K +N+ +D W++G++LYE  TG+ PF   N+  L  +II      +    + +  
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230

Query: 343 SLLKGLLHKDPSKR 356
            L+   L KD  +R
Sbjct: 231 QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  140 bits (355), Expect = 4e-39
 Identities = 75/231 (32%), Positives = 122/231 (52%), Gaps = 8/231 (3%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHL 202
           M    + T I K      +  R+ LT + H  P +V L     +   ++L+L    GG L
Sbjct: 13  MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           + H+ +     E+  + + AE+V A+  LH+ GIV RDL P NIL+D  GH+ LT F   
Sbjct: 73  WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132

Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            E+++S    ++     Y APE+       +  DWWS+G +L+E+LTG+      +   +
Sbjct: 133 SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTGK-TLVECHPSGI 189

Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
                +  + +P +++ EA SLL+ LL  +P++RLG+G  GV+ IK H +F
Sbjct: 190 NT---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  139 bits (353), Expect = 1e-38
 Identities = 75/243 (30%), Positives = 130/243 (53%), Gaps = 10/243 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGK   VK K  +DG    I  + + +    +     +  + E  +L+ + HP I
Sbjct: 8   IGEGSFGKAILVKSK--EDGKQYVIKEINISK----MSPKEREESRKEVAVLSNMKHPNI 61

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GI-FREDQARFYTAEIVSAVSHLHKCG 235
           VQ + SF+    LY+++D+  GG L+  +  Q G+ F EDQ   +  +I  A+ H+H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTEYMAPEILLSKGHNKD 294
           I+HRD+K +NI +  DG + L DFG+A+ ++ +      C GT  Y++PEI  ++ +N  
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDP 353
           +D W++G +LYEM T +  F   N + L  +II      +    + +  +L+  L  ++P
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNP 241

Query: 354 SKR 356
             R
Sbjct: 242 RDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  139 bits (351), Expect = 3e-38
 Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 13/268 (4%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++   +++GQGAFG+V+      VD G    +  +         K   V+ ++ E  +
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETK-KEVNALECEIQL 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L  + H  IVQ     +    L + ++++ GG +   L   G   E   R YT +I+  V
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID----ESSRSNSMCGTTEYMAPE 284
            +LH   IVHRD+K  NIL DS G+V L DFG +K +       +   S+ GT  +M+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAH 342
           ++  +G+ + AD WSVG  + EMLT +PP+          +I       +LP  ++ +A 
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
           + L+    ++  KR    P   + ++H 
Sbjct: 238 NFLRRTFVENAKKR----PSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 4e-38
 Identities = 74/314 (23%), Positives = 137/314 (43%), Gaps = 79/314 (25%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E    +G+G +G+V++ + K   +     + A+K +R +             E++    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMEN------------EKEGFPI 43

Query: 168 -------ILTKVTHPFIVQLR--YSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFRE 214
                  +L K+ HP IV+L+   + + +  +Y++ +++     G         +  F E
Sbjct: 44  TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTE 99

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---S 271
            Q + Y  +++  + +LH  GI+HRD+K  NIL+++DG + L DFGLA+   + +    +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 328
           N +  T  Y  PE+LL +  +  + D WSVG +L E+  G+P F  +   +  ++I    
Sbjct: 160 NRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218

Query: 329 --------EKVKLPP---------------------FLTSEAHSLLKGLLHKDPSKRLGS 359
                     V   P                      +   A  LL  LL  DP KR+ +
Sbjct: 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278

Query: 360 GPGGVDAIKHHKWF 373
                 A+  H++F
Sbjct: 279 D----QAL-QHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (348), Expect = 8e-38
 Identities = 71/254 (27%), Positives = 135/254 (53%), Gaps = 14/254 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DF++ + +G+G++G V++VK+       SD   YA+K +   ++ +K   D +   R IL
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKR------LSDNQFYALKEVDLGSMSQKEREDAVNEIR-IL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             V HP I+  + +F   +KL +++++   G L   + ++     +  E +      +++
Sbjct: 54  ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             +  LH+  I+HRDLK  NIL+ ++  V + D G++K + + + + +  GT  YMAPE+
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEV 172

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL 344
              + ++  +D WS+G LLYEM T  PPF   + Q L+ ++   K   +PP  + +  + 
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232

Query: 345 LKGLLHKDPSKRLG 358
           ++ +L   P  R  
Sbjct: 233 IRSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  137 bits (346), Expect = 1e-37
 Identities = 70/267 (26%), Positives = 136/267 (50%), Gaps = 25/267 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+I   +G+G++G V++   K     ++  + A+KV+  +  +++     +  E  IL 
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEEDLQE-----IIKEISILK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVS 229
           +   P+IV+   S+   + L++++++   G +   +        E++      + +  + 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           +LH    +HRD+K  NIL++ +G   L DFG++ ++ D  ++ N++ GT  +MAPE++  
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT------SEAH 342
            G+N  AD WS+GI   EM  G+PP++  +  +    I N   K PP L+       E +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFN 230

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             +K  L KDP +R    P  +  ++H
Sbjct: 231 DFVKKCLVKDPEER----PSAIQLLQH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  135 bits (342), Expect = 4e-37
 Identities = 78/250 (31%), Positives = 132/250 (52%), Gaps = 11/250 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI + +G+G+FGK++  K K     DS+     ++      +K+      K E  +L K
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAK 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP IV    SFQ   +L++++++ +GG L   + RQ   +F EDQ   +  +I   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC-GTTEYMAPEILL 287
           H+H   I+HRD+K +NI +  +G V  L DFG+A+++++S      C GT  Y++PEI  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK 346
           ++ +N   D WS+G +LYE+ T + PF   N  +L  +I       + P  + +  SL+ 
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235

Query: 347 GLLHKDPSKR 356
            L    P  R
Sbjct: 236 QLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 1e-36
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 51/286 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+  VVG+GA+G V + + K    G+   I   K    D  +KK       A R++  L
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKK------TALREVKVL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVS 226
            ++ H  IV L+ +F+ + +LYL+ +++        L      G+   D  R Y  +++ 
Sbjct: 55  RQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQ 111

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPE 284
           A+++ H   I+HRD+KPENIL+   G + L DFG A+ +     S       T  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLTGQP-------------------PFTHANRQKLQQ 324
           +L+    + K  D W++G ++ E+L G+P                   P   ++++    
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 325 RIINEKVKLPPFLTSE-------------AHSLLKGLLHKDPSKRL 357
                 V  P     E             A   LK  L  DP +RL
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  133 bits (337), Expect = 4e-36
 Identities = 77/264 (29%), Positives = 128/264 (48%), Gaps = 33/264 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAER 166
            D E    +G G  G V +V  +      +  I A+K +R    + I K+     +  E 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINEAIQKQ-----ILREL 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           DIL K   P+IV    +F     + + +++++GG L       +  I  E         +
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV 109

Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++LH K  I+HRD+KP NIL++S G + L DFG++ + ++  S + +  GT+ YMA
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMA 167

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEKVKLPPFL 337
           PE +    ++  +D WS+G+ L E+ TG+ P+   N       +L Q I+NE    PP L
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRL 224

Query: 338 TS-----EAHSLLKGLLHKDPSKR 356
            S     +    +   L KDP +R
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  132 bits (334), Expect = 6e-36
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 13/251 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
            + + RVVG+G+FG+   V+       +SD  YAMK +R   + K +  V+  + E  +L
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIR---LPKSSSAVEDSRKEAVLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSA 227
            K+ HP IV  + SF+    LY+++++ +GG L     L R  +F ED    +  ++   
Sbjct: 53  AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           V H+H+  ++HRD+K +NI +  +G V L DFG A+ +    + + +  GT  Y+ PEI 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL 345
            +  +N  +D WS+G +LYE+ T + PF   + + L  ++     K LP   + E  SL+
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232

Query: 346 KGLLHKDPSKR 356
           K +  ++P  R
Sbjct: 233 KQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 26/260 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ + +G G +G V++ +     D  +  + A+KV++ +     +  + ++ E  +L 
Sbjct: 4   DYELIQRIGSGTYGDVYKAR-----DIATGELVAIKVIKLE---PGDDFEIIQQEISMLK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
           +  HP IV    S+  R KL++++++  GG L   + + R G   E Q  +   E +  +
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILL 287
           ++LH+ G +HRD+K  NIL+  DG V L DFG++ ++  + ++  S  GT  +MAPE+  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 288 SK---GHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFL----- 337
            +   G++   D W++GI   E+   QPP    H  R      +I++    PP L     
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSNFPPPKLKDKEK 231

Query: 338 -TSEAHSLLKGLLHKDPSKR 356
            +   H  +K  L KDP KR
Sbjct: 232 WSPVFHDFIKKCLTKDPKKR 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 2e-35
 Identities = 80/275 (29%), Positives = 146/275 (53%), Gaps = 26/275 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++   ++G+GA+G V+  + K V  G    + A+K++  DT    + V  ++ E  +L++
Sbjct: 3   YQRLELIGRGAYGAVY--RGKHVPTGR---VVALKIINLDT--PDDDVSDIQREVALLSQ 55

Query: 172 VTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +     P I +   S+    +L++I+++  GG +   L + G   E        E++ A+
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAPEILL 287
            ++HK G++HRD+K  NIL+ + G+V L DFG+A  ++++S   S   GT  +MAPE++ 
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 288 S-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LL 345
             K ++  AD WS+GI +YEM TG PP++  +  +    I   K   PP L    +S LL
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLL 231

Query: 346 K----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
           +      L ++P +RL +     + +   KW ++ 
Sbjct: 232 REFVAACLDEEPKERLSA-----EELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  130 bits (329), Expect = 3e-35
 Identities = 77/257 (29%), Positives = 138/257 (53%), Gaps = 26/257 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM-KAER---- 166
           +E  RVVG+GAFG V   ++K   D            +K  IIK+  V+ M K ER    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRK--AD------------QKLVIIKQIPVEQMTKDERLAAQ 47

Query: 167 ---DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
               +L  ++HP I++   +F     L +++++  GG L  ++ ++   +  ED    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            +I+ A+ H+H   I+HRDLK +NIL+D    V+ + DFG++K +   S++ ++ GT  Y
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTS 339
           ++PE+   K +N+ +D W++G +LYE+ + +  F  AN   L  +I++     +    + 
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP 227

Query: 340 EAHSLLKGLLHKDPSKR 356
           +   L+  +L+ DPSKR
Sbjct: 228 DLRQLILSMLNLDPSKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 2e-34
 Identities = 87/312 (27%), Positives = 138/312 (44%), Gaps = 80/312 (25%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + K      +  I A+K +R D        T ++        
Sbjct: 1   YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALR-------- 47

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQAR 218
            E  +L ++ HP IV+L     T  KLYL+ ++ +       L      R G    +  +
Sbjct: 48  -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIK 101

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +++  +++ H   I+HRDLKP+NIL++ DG + L DFGLA+             T 
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTH 157

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII--- 327
           E     Y APEILL SK ++   D WSVG +  EM+TG+P F      ++ Q  +I    
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQIL 215

Query: 328 ---NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGSGP 361
               E+      KLP                  P L  E   LL  +L  +P+KR+ +  
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK- 274

Query: 362 GGVDAIKHHKWF 373
              +A+K H +F
Sbjct: 275 ---EALK-HPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 2e-33
 Identities = 87/275 (31%), Positives = 140/275 (50%), Gaps = 29/275 (10%)

Query: 109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D  EI   +G GAFGKV++ + K     ++    A K++      ++   D+M  E D
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKII--QIESEEELEDFM-VEID 54

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVS 226
           IL++  HP IV L  ++   +KL+++++F +GG L    L  +    E Q R+   +++ 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYMAPEI 285
           A++ LH   ++HRDLK  NIL+  DG V L DFG+ AK      + ++  GT  +MAPE+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Query: 286 LL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL--- 337
           +         ++  AD WS+GI L E+   +PP    N  ++  +I+  +   PP L   
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQP 231

Query: 338 ---TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
              +S  +  LK  L KDP  R    P   + +KH
Sbjct: 232 SKWSSSFNDFLKSCLVKDPDDR----PTAAELLKH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  127 bits (319), Expect = 2e-33
 Identities = 90/282 (31%), Positives = 142/282 (50%), Gaps = 33/282 (11%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P + +EI   +G GAFGKV++ K K     ++  + A KV+  +T  ++   DYM
Sbjct: 5   RRDLDPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVI--ETKSEEELEDYM 57

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARF 219
             E +IL    HP+IV+L  +F    KL+++++F  GG    +   L R     E Q + 
Sbjct: 58  -VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQV 114

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTT 278
              +++ A+ +LH   I+HRDLK  N+L+  DG + L DFG+ AK +    R +S  GT 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 279 EYMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
            +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--- 231

Query: 334 PPFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           PP L+       E    LK  L K P  R    P     ++H
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETR----PSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  125 bits (315), Expect = 5e-33
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 44/272 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDIL 169
           D+E+  V+G GA   V+                A+ +   + + IK+  ++  +   D L
Sbjct: 2   DYELIEVIGVGATAVVYA---------------AICLPNNEKVAIKRIDLEKCQTSVDEL 46

Query: 170 TK-------VTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARF 219
            K         HP +V+   SF    +L+L++ +++GG    +    Y +G   E     
Sbjct: 47  RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS-NSM 274
              E++  + +LH  G +HRD+K  NIL+  DG V + DFG    LA   D + +   + 
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
            GT  +MAPE++    G++  AD WS GI   E+ TG  P++     K+    +      
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND 223

Query: 334 PPFLTSEAHS---------LLKGLLHKDPSKR 356
           PP L + A           ++   L KDPSKR
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKR 255

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  125 bits (316), Expect = 6e-33
 Identities = 86/304 (28%), Positives = 137/304 (45%), Gaps = 60/304 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
            ++I   +G+GA G VF+ K +      +    A+K   + R +  I    +  +KA   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLEGGIPNQALREIKA--- 52

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQARFYTA 222
            L    HP++V+L   F   S   L+++++        L       +    E Q + Y  
Sbjct: 53  -LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMR 106

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS-MCGTTEY 280
            ++  V+++H  GI+HRDLKP N+L+ +DG + + DFGLA+    E  R  S    T  Y
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-- 331
            APE+L  ++ ++   D W+VG +  E+L G P F   N  +    +       NE+   
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226

Query: 332 ---KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
               LP                   P  + EA  LLKGLL  DPSKRL +     +A++ 
Sbjct: 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA----EALR- 281

Query: 370 HKWF 373
           H +F
Sbjct: 282 HPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  123 bits (311), Expect = 2e-32
 Identities = 83/267 (31%), Positives = 125/267 (46%), Gaps = 49/267 (18%)

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN------HV-DYMKAERDILTKVT 173
           G FGKV  +K K             K+  +  I  KN       V   MK          
Sbjct: 27  GKFGKVSVLKHKPTQ----------KLFVQKIIKAKNFNAIEPMVHQLMK---------D 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P  ++L YS  T     LI+D+I  G LF  L ++G   E + +    ++V A++ LHK
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 234 CGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I+H D+K EN+L D +   + L D+GL K I   S      GT +Y +PE +  KGHN
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKI--KGHN 182

Query: 293 KDA--DWWSVGILLYEMLTGQPPF--------THANRQKLQQRIINEKVKLPPFLTSEAH 342
            D   DWW+VG+L YE+LTG+ PF           +  K QQ+    K+     ++  A+
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNAN 238

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             ++ +L  + + RL +     + IKH
Sbjct: 239 DFVQSMLKYNINYRLTN---YNEIIKH 262

Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 3e-32
 Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 58/298 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +++ + +G G FG V+  + K     ++  + A+K M+K      +  + M   R++  L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKF---YSWEECMN-LREVKSL 51

Query: 170 TKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIV 225
            K+  HP IV+L+  F+   +LY + +++ G    + L +      F E   R    +I+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             ++H+HK G  HRDLKPEN+L+     V + DFGLA+EI           T  Y APEI
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANR----------------------QKL 322
           LL S  ++   D W++G ++ E+ T +P F  ++                        KL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 323 QQRIINEKVKLPPFL-----------TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             ++     + P F            + EA  L+K +L  DP KR    P    A++H
Sbjct: 230 ASKL---GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR----PTASQALQH 280

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  120 bits (302), Expect = 4e-31
 Identities = 77/260 (29%), Positives = 133/260 (51%), Gaps = 20/260 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-DTIIKKNHVDYMKAERDI 168
           G+F+I + +G+G F  V++             + A+K ++  + +  K   D +K E D+
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLK-EIDL 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQG-IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G    +  H  +Q  +  E     Y  ++
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
            SA+ H+H   I+HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----L 337
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  EK   PP      
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EKCDYPPLPADHY 233

Query: 338 TSEAHSLLKGLLHKDPSKRL 357
           + E   L+   ++ DP KR 
Sbjct: 234 SEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 8e-31
 Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 35/271 (12%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            G FE+  V+G+G +GKV++ + K      +  + A+K+M     I ++  + +K E +I
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMD----IIEDEEEEIKEEYNI 55

Query: 169 LTKVT-HPFIVQLRYSFQTRS------KLYLILDFINGG---HLFFHLYRQG-IFREDQA 217
           L K + HP I     +F  ++      +L+L+++   GG    L   L ++G   +E+  
Sbjct: 56  LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCG 276
            +   E +  +++LH+  ++HRD+K +NIL+  +  V L DFG++ ++D    R N+  G
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 277 TTEYMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPFT--HANRQKLQQRIIN 328
           T  +MAPE++       DA      D WS+GI   E+  G+PP    H  R   +  I  
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--IPR 232

Query: 329 E---KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                +K P   + + +  +   L K+  +R
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQR 263

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 9e-31
 Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 35/273 (12%)

Query: 117 VVGQGAFGKVF-----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G G+FG V+            VK+  +    +          KD   K++ +D +  E
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------KDR--KRSMLDALARE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L ++ H  IVQ   S      L + L+++ GG +   L   G F E   R +  +I+
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN-------SMCGTT 278
             +++LH  GI+HRD+K  NIL+D+ G + ++DFG++K+++ +S S        S+ G+ 
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPF 336
            +MAPE++    + + AD WS+G L+ EMLTG+ PF    + +   + I E     +P  
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENASPEIPSN 235

Query: 337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           ++SEA   L+     D +KR    P   + +KH
Sbjct: 236 ISSEAIDFLEKTFEIDHNKR----PTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 1e-30
 Identities = 70/256 (27%), Positives = 134/256 (52%), Gaps = 19/256 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR----KDTIIKKNHVDYMKAERDILTKV 172
           ++G+G +G+V+      V  G+   +  +++      +    +K+ V  +++E + L  +
Sbjct: 8   LIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            H  IVQ      T   L + L+++ GG +   L   G F E   RF+T +++  +++LH
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLS- 288
             GI+HRDLK +N+L+D+DG   ++DFG++K+ D+   + ++ SM G+  +MAPE++ S 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 289 -KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-------LTSE 340
            +G++   D WS+G ++ EM  G+ P++         ++ N++   PP        L+  
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSPV 244

Query: 341 AHSLLKGLLHKDPSKR 356
           A   L      +P  R
Sbjct: 245 ALDFLNACFTINPDNR 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 2e-30
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 22/257 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++ K KG D   ++   A+K +++D   ++   D++K E  ++ K+ HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEE-RKDFLK-EARVMKKLGHP 56

Query: 176 FIVQLR-YSFQTRSKLYLILDFINGGHL----------FFHLYRQGIFREDQARFYTAEI 224
            +V+L          LYL+L+++ GG L          F    +  +  +D   F   +I
Sbjct: 57  NVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQI 114

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YM 281
              + +L     VHRDL   N L+  D  V ++DFGL++++ +        G      +M
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS 339
           APE L        +D WS G+LL+E+ T G  P+   + +++ + +    ++  P +   
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 340 EAHSLLKGLLHKDPSKR 356
           E + L+      DP  R
Sbjct: 235 ELYELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  119 bits (302), Expect = 2e-30
 Identities = 87/311 (27%), Positives = 138/311 (44%), Gaps = 77/311 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK------NHVDYMKAE 165
           +EI + +G+GA+G V+    K +D          +  ++   +KK      N  D  +  
Sbjct: 9   YEILQKLGKGAYGIVW----KAID----------RRTKEVVALKKIFDAFRNATDAQRTF 54

Query: 166 RDI--LTKVT-HPFIVQLR--YSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARF 219
           R+I  L ++  HP IV+L      +    +YL+ +++       H + R  I  +   R+
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKRY 111

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++ A+ ++H   ++HRDLKP NIL++SD  V L DFGLA+ + E   +      T+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 280 YMA------PEILL-SKGHNKDADWWSVGILLYEMLTGQP-------------------- 312
           Y+A      PEILL S  + K  D WSVG +L EML G+P                    
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 313 -----------PFTHANRQKLQQRIINEKVKLPPFLTS---EAHSLLKGLLHKDPSKRLG 358
                      PF       L  R    +  L   L     +A  LLK LL  +P+KRL 
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSR---PRKPLDELLPKASDDALDLLKKLLVFNPNKRLT 288

Query: 359 SGPGGVDAIKH 369
           +     +A++H
Sbjct: 289 A----EEALEH 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  118 bits (297), Expect = 2e-30
 Identities = 90/266 (33%), Positives = 136/266 (51%), Gaps = 29/266 (10%)

Query: 107 IGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           + P +F EI   +G GAFGKV++ + K     ++  + A KV+  DT  ++   DYM  E
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVI--DTKSEEELEDYM-VE 52

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQGIFREDQARFYTA 222
            DIL    HP IV+L  +F   + L+++++F  GG +      L R     E Q R    
Sbjct: 53  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCK 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH+  I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 282 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPT 227

Query: 337 L------TSEAHSLLKGLLHKDPSKR 356
           L      +SE    LK  L K+   R
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  118 bits (297), Expect = 3e-30
 Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 23/257 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
               + F  +G+G+ G V     K      +    A+K M    + K+   + +  E  I
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKM---DLRKQQRRELLFNEVVI 69

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +    HP IV++  S+    +L+++++F+ GG L   +       E+Q       ++ A+
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLAVLKAL 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILL 287
           S LH  G++HRD+K ++IL+ SDG V L+DFG   ++  E  R  S+ GT  +MAPE++ 
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ--QRIINEKVKLPPFL------TS 339
              +  + D WS+GI++ EM+ G+PP+   N   LQ  +RI +     PP L      + 
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNL---PPKLKNLHKVSP 243

Query: 340 EAHSLLKGLLHKDPSKR 356
              S L  +L +DP++R
Sbjct: 244 RLRSFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (295), Expect = 3e-30
 Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 27/256 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++   KG  +G  +   A+K +++    ++   ++++ E  I+ K++HP
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEGAS-EEEREEFLE-EASIMKKLSHP 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKC 234
            IV+L         LY++ +++ GG L   L + G             +I   + +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YMAPEILLSKGH 291
             VHRDL   N L+  +  V ++DFGL+++I E        G      +MAPE L     
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL----------PPFLTSE 340
              +D WS G+LL+E+ T G+ P+           + NE+V            P     E
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPY---------PGMSNEEVLELLEDGYRLPRPENCPDE 232

Query: 341 AHSLLKGLLHKDPSKR 356
            + L+      DP  R
Sbjct: 233 LYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (292), Expect = 7e-30
 Identities = 61/250 (24%), Positives = 112/250 (44%), Gaps = 15/250 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G  DG     A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSH 230
            HP IV+L         L ++++++ GG L  +    R           +  +I   + +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--TTEYMAPEILLS 288
           L     +HRDL   N L+  +  V ++DFGL++++ +        G     +MAPE L  
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 289 KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLK 346
                 +D WS G+LL+E+ T G+ P+   +  ++ + +        P       + L+ 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 347 GLLHKDPSKR 356
               +DP  R
Sbjct: 239 QCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  115 bits (289), Expect = 2e-29
 Identities = 80/258 (31%), Positives = 136/258 (52%), Gaps = 22/258 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P++
Sbjct: 12  IGKGSFGEVF----KGIDN-RTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L R G F E Q      EI+  + +LH    +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPFLTSEAHSLLK----GLLHK 351
            WS+GI   E+  G+PP    N      R++    K  PP LT E     K      L+K
Sbjct: 184 IWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239

Query: 352 DPSKRLGSGPGGVDAIKH 369
           DPS R    P   + +KH
Sbjct: 240 DPSFR----PTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  114 bits (286), Expect = 5e-29
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 37/273 (13%)

Query: 117 VVGQGAFGKVF----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           V+G+GA+G V+           VK+  +D  +     A K   K           ++ E 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK-----------LQEEV 53

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
           D+L  + H  IVQ   +    + + + ++F+ GG +   L R G   E     YT +I+ 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-------DESSRSNSMCGTTE 279
            V++LH   +VHRD+K  N+++  +G + L DFG A+ +         S+   SM GT  
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 336
           +MAPE++   G+ + +D WS+G  ++EM TG+PP    +R      I   +  +P     
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233

Query: 337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            ++ A   +   L +D  +R    P  +  ++H
Sbjct: 234 FSAAAIDFVTSCLTRDQHER----PSALQLLRH 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  118 bits (297), Expect = 6e-29
 Identities = 92/290 (31%), Positives = 141/290 (48%), Gaps = 45/290 (15%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           D     E  +K     + I RV+G GA G V   K+  V DG+    +A+KV+  + +  
Sbjct: 23  DEATAKEQAKK-----YWISRVLGSGATGTVLCAKR--VSDGEP---FAVKVVDMEGM-- 70

Query: 156 KNHVDYMKA--ERDILTKVTHPFIVQLRYSFQTR--------SKLYLILDFINGGHLFFH 205
            +  D  +A  E   L       IV+    F  +          + L+LD+ N G L   
Sbjct: 71  -SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL--- 126

Query: 206 LYRQGI---------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
             RQ I         FRE +A     +++ AV H+H   ++HRD+K  NIL+ S+G V L
Sbjct: 127 --RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 257 TDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            DFG +K       D+  R+   CGT  Y+APEI   K ++K AD +S+G+LLYE+LT +
Sbjct: 185 GDFGFSKMYAATVSDDVGRT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Query: 312 PPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSG 360
            PF   N +++  + +  +   LPP ++ E   ++  LL  DP +R  S 
Sbjct: 243 RPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  113 bits (285), Expect = 6e-29
 Identities = 78/249 (31%), Positives = 125/249 (50%), Gaps = 17/249 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAER 166
           P ++ + +++GQGAFG+V+        D D+    A+K ++   ++      V+ ++ E 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSF---QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            +L  + H  IVQ  Y          L + ++ + GG +   L   G   E+  R YT +
Sbjct: 56  QLLKNLLHERIVQY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTE 279
           I+  VS+LH   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPFL 337
           +M+PE++  +G+ + AD WSVG  + EMLT +PP+          +I  +     LPP +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234

Query: 338 TSEAHSLLK 346
           +      LK
Sbjct: 235 SDHCRDFLK 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 9e-29
 Identities = 78/254 (30%), Positives = 129/254 (50%), Gaps = 15/254 (5%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAER 166
           P ++ + +++G+GAFG+V+        D D+    A+K +  D   ++    V+ ++ E 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
            +L  + H  IVQ     +     KL + ++++ GG +   L   G   E+  R YT +I
Sbjct: 56  QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEY 280
           +  VS+LH   IVHRD+K  NIL DS G+V L DFG +K I     S     S+ GT  +
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLT 338
           M+PE++  +G+ + AD WSV   + EMLT +PP+          +I  +  K  LP  ++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235

Query: 339 SEAHSLLKGLLHKD 352
                 LK +  ++
Sbjct: 236 DACRDFLKQIFVEE 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  111 bits (280), Expect = 3e-28
 Identities = 74/248 (29%), Positives = 135/248 (54%), Gaps = 15/248 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVT 173
           RVVG+G++G+V  V+ +      +DG     V++K  +   +  +   AE++  +L+++ 
Sbjct: 6   RVVGKGSYGEVSLVRHR------TDG--KQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57

Query: 174 HPFIVQLRYSFQTRS-KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSH 230
           HP IV  R S++     LY+++ F  GG L+  L  Q   +  E+Q   +  +I  A+ +
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSK 289
           LH+  I+HRDLK +N+ +     + + D G+A+ ++ +   ++++ GT  YM+PE+  +K
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGL 348
            +N  +D W++G  +YEM T +  F   +   L  RII  K+  +P   + E   L+  +
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237

Query: 349 LHKDPSKR 356
           L K P KR
Sbjct: 238 LSKRPEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (281), Expect = 3e-28
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 14/249 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G         A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHL 231
            HP +V+L         LY++++++ GG L  +L   +          +  +I   + +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSK 289
                +HRDL   N L+  +  V ++DFGL++++ +    R         +MAPE L   
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLKG 347
                +D WS G+LL+E+ T G+ P+   + +++ + + N      P       + L+  
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 348 LLHKDPSKR 356
              +DP  R
Sbjct: 239 CWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  112 bits (281), Expect = 4e-28
 Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 8/205 (3%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+  VVG+GA+G V + + K     ++  I A+K   KD+   +   +    E  +L  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKF-KDSEENEEVKETTLRELKMLRT 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           +    IV+L+ +F+ R KLYL+ +++    L            ++ R Y  +++ A+   
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPEILLSK 289
           HK  IVHRD+KPEN+L+  +  + L DFG A+ + E S +N      T  Y +PE+LL  
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF 314
            + K  D WSVG +L E+  GQP F
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  111 bits (279), Expect = 4e-28
 Identities = 71/259 (27%), Positives = 131/259 (50%), Gaps = 18/259 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHP 175
           +G+G+FG V+ VK K     +      +KV+++  +  +  N       E  +L+K+ HP
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQG--IFREDQARFYTAEIVSAVSHL 231
            IV+   SF  R    +I ++  G  L   L   +       E+Q   +  +++  V ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSKG 290
           H+  I+HRDLK +NI + ++  + + DFG+++ +  S   + +  GT  YM+PE L  +G
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLL 349
           ++  +D WS+G +LYEM      F   N   +  RI+      LP   + + +S+++ +L
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSML 241

Query: 350 HKDPSKRLGSGPGGVDAIK 368
           +KDPS R    P   + ++
Sbjct: 242 NKDPSLR----PSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  111 bits (279), Expect = 5e-28
 Identities = 69/265 (26%), Positives = 127/265 (47%), Gaps = 17/265 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G GAF   +Q +   V  G    +  +  +R  +  ++  V+ ++ E  ++ ++ HP
Sbjct: 6   QQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I+++  +    S   L ++++ GG +   L + G F+E     YT +++  +S+LH+  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 236 IVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK 289
           I+HRD+K  N+L+DS G  + + DFG A  +             + GT  +MAPE+L  +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRI--INEKVKLPPFLTSEAHSL 344
            + +  D WSVG ++ EM T +PP+    H+N   L  +I        +P  L+     +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKH 369
               L   P  R    P   + +KH
Sbjct: 244 TLRCLELQPEDR----PPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 8e-28
 Identities = 72/301 (23%), Positives = 116/301 (38%), Gaps = 60/301 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+GA+G V++ +          KK       +GI  +  +R+  ++K+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTLREIALLKQ----- 54

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRS-----KLYLILDFINGG-HLFFHLYRQGIFRED 215
                  L    HP IV+L             KL L+ + ++     +     +     +
Sbjct: 55  -------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE 107

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +    +++  V  LH   IVHRDLKP+NIL+ SDG V + DFGLA+         S+ 
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF--------------------- 314
            T  Y APE+LL   +    D WSVG +  E+   +P F                     
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227

Query: 315 ------THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 368
                     R               P +  E   LLK +L  +P KR+ +     +A++
Sbjct: 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA----FEALQ 283

Query: 369 H 369
           H
Sbjct: 284 H 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  111 bits (278), Expect = 8e-28
 Identities = 81/285 (28%), Positives = 142/285 (49%), Gaps = 21/285 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F     +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++
Sbjct: 6   FTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQ 58

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P++ +   S+   +KL++I++++ GG     L   G   E Q      EI+  + +L
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYL 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK---- 346
           ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L       LK    
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVE 234

Query: 347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
             L+K+PS R    P   + +KH    R    KT    E+  ++K
Sbjct: 235 ACLNKEPSFR----PTAKELLKHKFIVRFAK-KTSYLTELIDRYK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  110 bits (277), Expect = 9e-28
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 25/259 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ + +G G +G V+  K + V+ G+   + A+KV++ +          ++ E  ++ 
Sbjct: 10  DFELIQRIGSGTYGDVY--KARNVNTGE---LAAIKVIKLE---PGEDFAVVQQEIIMMK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
              H  IV    S+  R KL++ ++F  GG L    +  G   E Q  + + E +  + +
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSK 289
           LH  G +HRD+K  NIL+  +GHV L DFG++ +I  + ++  S  GT  +MAPE+   +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 290 ---GHNKDADWWSVGILLYEMLTGQPPF--THANR-------QKLQQRIINEKVKLPPFL 337
              G+N+  D W+VGI   E+   QPP    H  R          Q   + +K+K     
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK----W 237

Query: 338 TSEAHSLLKGLLHKDPSKR 356
           ++  H  +K  L K+P KR
Sbjct: 238 SNSFHHFVKMALTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  108 bits (272), Expect = 5e-27
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 18/258 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F +V+  +   + DG    +  +++   D +  K   D +K E D+L
Sbjct: 2   ANFRIEKKIGRGQFSEVY--RATCLLDGVPVALKKVQIF--DLMDAKARADCIK-EIDLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----LT 338
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP      +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 234

Query: 339 SEAHSLLKGLLHKDPSKR 356
            E   L+   ++ DP KR
Sbjct: 235 EELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  109 bits (273), Expect = 6e-27
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  +     
Sbjct: 24  FEKIGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELII--NEILVMRENK----- 74

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             HP IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 75  --HPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (276), Expect = 6e-27
 Identities = 80/329 (24%), Positives = 139/329 (42%), Gaps = 68/329 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+ + +G GA+G V         D  +    A+K +     +  + +D  +  R+I  L
Sbjct: 2   YELLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKISN---VFDDLIDAKRILREIKLL 53

Query: 170 TKVTHPFIVQLRYSFQTRSK-----LYLILDFINGGHLFFH--LYRQGIFREDQARFYTA 222
             + H  I+ L    +  S      +Y++ + +       H  +       +D  +++  
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLY 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM- 281
           +I+  + +LH   ++HRDLKP NIL++S+  + + DFGLA+ +D           TEY+ 
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF--LTEYVV 168

Query: 282 -----APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ----------- 323
                APE+LLS   + K  D WSVG +  E+LT +P F       +L            
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228

Query: 324 ---QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 364
              + I +EK +     LP           P  + EA  LL+ +L  DP KR+ +     
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD---- 284

Query: 365 DAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           +A+  H +   ++       E   K   D
Sbjct: 285 EALA-HPYLAQLH---DPEDEPVAKPPFD 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  107 bits (267), Expect = 2e-26
 Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 18/264 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           +++GQGAFG+V+        D D+    A K ++   ++      V  ++ E  +L  + 
Sbjct: 8   KLLGQGAFGRVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 174 HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           H  IVQ     + R++  L + ++++ GG +   L   G   E   R YT +I+  +S+L
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTEYMAPEILL 287
           H   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  +M+PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-PFLTSEAHSLLK 346
            +G+ + AD WS+G  + EMLT +PP+          +I  +      P   SE      
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 347 GLLHKDPSKRLGSGPGGVDAIKHH 370
           G +  +   R    P   + ++H 
Sbjct: 243 GCIFVEARHR----PSAEELLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  107 bits (267), Expect = 2e-26
 Identities = 72/258 (27%), Positives = 135/258 (52%), Gaps = 22/258 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+V+    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P+I
Sbjct: 12  IGKGSFGEVY----KGIDN-RTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L + G   E        EI+  + +LH    +
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-----LLKGLLHK 351
            WS+GI   E+  G+PP +  +  ++   I       PP L  + +S      ++  L+K
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQ-YSKPFKEFVEACLNK 239

Query: 352 DPSKRLGSGPGGVDAIKH 369
           DP  R    P   + +KH
Sbjct: 240 DPRFR----PTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  106 bits (266), Expect = 3e-26
 Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 18/257 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+I + +G+G F +V+    +     D   +   KV   + +  K   D +K E D+L 
Sbjct: 3   NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLK 57

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIVS 226
           ++ HP +++   SF   ++L ++L+  + G L     +  +Q  +  E     Y  ++ S
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEI 285
           AV H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           +   G+N  +D WS+G LLYEM   Q PF     N   L Q+I  E+   PP  T     
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTEHYSE 235

Query: 344 LLKGL----LHKDPSKR 356
            L+ L    ++ DP +R
Sbjct: 236 KLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  107 bits (267), Expect = 4e-26
 Identities = 77/272 (28%), Positives = 137/272 (50%), Gaps = 27/272 (9%)

Query: 98  ELEAESERKIGPGD----FEIFRVVGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKD 151
           +  A  +  + PGD     + F  +G+G+ G V    VK  G           +  ++K 
Sbjct: 4   QFRAALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSG----------KLVAVKKM 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +     
Sbjct: 54  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIVTHTR 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
             E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  E  R
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
             S+ GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I   +
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R 229

Query: 331 VKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
             LPP L +  +    LKG    LL +DP++R
Sbjct: 230 DNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  106 bits (266), Expect = 4e-26
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 25  FEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELII--NEILVMRENKN---- 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 77  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  109 bits (273), Expect = 5e-26
 Identities = 82/256 (32%), Positives = 128/256 (50%), Gaps = 31/256 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +VG+      F V  +G D    + + A  VM  D    +    Y ++E   L    H  
Sbjct: 74  LVGRNPTTAAF-VATRGSDP--KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG 126

Query: 177 IVQLRYSFQTRSKLYLILDFINGG------------HLFFHLYRQGIFREDQARFYTAEI 224
           IV+    F++  KL LI+++ +GG            HL F  Y  G+       FY  +I
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL------FY--QI 178

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
           V A+  +H   ++HRDLK  NI +   G + L DFG +K+  +S     ++S CGT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPFLTSE 340
           APE+   K ++K AD WS+G++LYE+LT   PF   + R+ +QQ +  +    P  ++S 
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298

Query: 341 AHSLLKGLLHKDPSKR 356
             +LL  LL K+P+ R
Sbjct: 299 MKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  105 bits (264), Expect = 8e-26
 Identities = 74/262 (28%), Positives = 138/262 (52%), Gaps = 25/262 (9%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           + PGD     + F  +G+G+ G V    +K      +    A+K M    + K+   + +
Sbjct: 15  VSPGDPREYLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKM---DLRKQQRRELL 66

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V +  S+    +L+++++F+ GG L   +       E+Q      
Sbjct: 67  FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCL 125

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYM 281
            ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++  E  +  S+ GT  +M
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI   +  LPP +  ++
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRV-KDS 241

Query: 342 H---SLLKGLLH----KDPSKR 356
           H   S+L+G L     ++PS+R
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQR 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  105 bits (264), Expect = 1e-25
 Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      +  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 24  FEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELII--NEILVMRENKN---- 75

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 76  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALDFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 72/260 (27%), Positives = 130/260 (50%), Gaps = 22/260 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E+   +G+G +G V++V  +      +    AMK +R +  + ++  + +  E DIL 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLE--LDESKFNQIIMELDILH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           K   P+IV    +F     +Y+ +++++ G    L+          ED  R  T  +V  
Sbjct: 55  KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 228 VSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           +  L  +  I+HRD+KP N+L++ +G V L DFG++  +  +S + +  G   YMAPE +
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERI 173

Query: 287 LSKGHNK------DADWWSVGILLYEMLTGQ---PPFTHAN-RQKLQQRIINEKVKLPPF 336
            S G N+       +D WS+G+ + EM  G+   PP T+AN   +L   +  +   LP  
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Query: 337 LTSEAHSLLKGLLHKDPSKR 356
            + +A   +   L+K P++R
Sbjct: 234 YSDDAQDFVAKCLNKIPNRR 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 46/290 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-- 164
           +   D E    +G G  G V +VK           I    VM K  +    H+    +  
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKH----------IPTGTVMAKKVV----HIGAKSSVR 47

Query: 165 -----ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
                E  I+ +   P+IV    +F   + + + ++F++ G L     + G    +    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107

Query: 220 YTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +V  +++L+    I+HRD+KP NIL++S G + L DFG++ E+  +S +++  GT+
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTS 166

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----------LQQRII 327
            YM+PE +    +   +D WS+GI + E+  G+ PF  +N              L Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 328 NEKVKLPPFLTSE-----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
            E    PP L S          +   L KDP++R    P          +
Sbjct: 227 QEP---PPRLPSSDFPEDLRDFVDACLLKDPTER----PTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  104 bits (262), Expect = 3e-25
 Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 56/303 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E  + +G+G +  V++ +     D ++  I A+K ++     +        A R+I  L
Sbjct: 2   YEKGKKLGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS--- 226
            ++ HP I+ L   F  +S + L+ +F+    L      + + ++       A+I S   
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL------EKVIKDKSIVLTPADIKSYML 109

Query: 227 ----AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
                + +LH   I+HRDLKP N+L+ SDG + L DFGLA+     + +      T  Y 
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------------------THAN--- 318
           APE+L  ++ +    D WSVG +  E+L   P                     T  N   
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 319 RQKLQQRIINEKVKLPPF------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
              L   +  +     P        + +A  LL+ LL  +P+KR         A++ H +
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR----ITARQALE-HPY 284

Query: 373 FRS 375
           F +
Sbjct: 285 FSN 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  104 bits (260), Expect = 3e-25
 Identities = 70/262 (26%), Positives = 134/262 (51%), Gaps = 25/262 (9%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  GD     E +  +G+G+ G V   ++K      S    A+K+M    + K+   + +
Sbjct: 14  VDQGDPRSLLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMM---DLRKQQRRELL 65

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q      
Sbjct: 66  FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIATVCE 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
            ++ A+ +LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +  S+ GT  +M
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +     PP     A
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKLKNA 240

Query: 342 HSL-------LKGLLHKDPSKR 356
           H +       L+ +L ++P +R
Sbjct: 241 HKISPVLRDFLERMLTREPQER 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  103 bits (257), Expect = 8e-25
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDS-DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +  +GQGA G VF           +   I   K  +K+ II  N +  MK       ++ 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII--NEILVMK-------ELK 74

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    SF    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTETCMDEAQIAAVCRECLQALEFLHA 133

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHN 292
             ++HRD+K +N+L+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K + 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 293 KDADWWSVGILLYEMLTGQPPFTHAN 318
              D WS+GI+  EM+ G+PP+ + N
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  107 bits (269), Expect = 8e-25
 Identities = 67/234 (28%), Positives = 116/234 (49%), Gaps = 18/234 (7%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHL 202
           A+K++R D   +++     + E  +  ++ HP IV L  S +     L+ + +++ G  L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDF 259
              L   G     +      +++ A++  H  GIVHRDLKP+NI++   G   H  + DF
Sbjct: 67  REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126

Query: 260 GL------AKEIDES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G+       ++ D +  +R+  + GT  Y APE L  +    ++D ++ G++  E LTGQ
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 312 PPFTHANRQK-LQQRIINEKVKLPPFLTSEAHSL---LKGLLHKDPSKRLGSGP 361
                A+  + L Q++    V LPP++    H L   L+  L+KDP +R  S P
Sbjct: 187 RVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQRAASAP 238

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  102 bits (256), Expect = 9e-25
 Identities = 68/221 (30%), Positives = 115/221 (52%), Gaps = 26/221 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  VVG G +G+V+  K + V  G    + A+KVM     + ++  + +K E ++L
Sbjct: 16  GIFELVEVVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTEDEEEEIKLEINML 66

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  +S      +L+L+++F   G +       +    +ED   + 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  ++HLH   ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 187 WMAPEVIACD-ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  102 bits (254), Expect = 1e-24
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 25/268 (9%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +  R+    D+E+ + VG G +G V++ +   +  G+   +  +K+   D          
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARN--LHTGELAAVKIIKLEPGDDF------SL 52

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  ++ +  H  IV    S+ +R KL++ +++  GG L    +  G   E Q  +  
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEY 280
            E +  +++LH  G +HRD+K  NIL+  +G V L DFG+A +I  + ++  S  GT  +
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 281 MAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPF--THANR-------QKLQQRIIN 328
           MAPE+   +   G+N+  D W+VGI   E+   QPP    H  R          Q   + 
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +K K         H+ +K  L K+P KR
Sbjct: 233 DKTKWSSTF----HNFVKISLTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  101 bits (254), Expect = 2e-24
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 38/278 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++ 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-S 288
            H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y APEILL  
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV----------- 331
           K ++   D WS+G +  EM+T +  F   +      RI       +E V           
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 332 ------------KLPPFLTSEAHSLLKGLLHKDPSKRL 357
                       K+ P L  +   LL  +LH DP+KR+
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  101 bits (253), Expect = 3e-24
 Identities = 86/301 (28%), Positives = 132/301 (43%), Gaps = 56/301 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI 168
           +E   +VG+G++G V + K K     ++  I A+K       D ++KK       A R+I
Sbjct: 3   YENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKK------IAMREI 51

Query: 169 --LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIV 225
             L ++ H  +V L   F+ + +LYL+ +F++   L     Y  G+  E + R Y  +I+
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQIL 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
             +   H   I+HRD+KPENIL+   G V L DFG A+ +            T  Y APE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQPPF--------------THANRQKLQQRIINE 329
           +L+    + +  D W+VG L+ EMLTG+P F                 N     Q I  +
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230

Query: 330 K-----VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
                 ++LP            P L+     L K  L  DP  R  S       + HH++
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS-----QLLHHEF 285

Query: 373 F 373
           F
Sbjct: 286 F 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 63/283 (22%)

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVT-HP 175
           G+G F +V   K +    G     YA+K M+K        ++ +   R+I  L +++ HP
Sbjct: 8   GEGTFSEVL--KAQSRKTGKY---YAIKCMKK----HFKSLEQVNNLREIQALRRLSPHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGI----------FREDQARFYTAEI 224
            I++L         + ++ D   G   L F L    +            E + + Y  ++
Sbjct: 59  NILRL---------IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           + ++ H+H+ GI HRD+KPENIL+  D  + L DFG  + I           T  Y APE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHAN--------------------RQKLQ 323
            LL+ G +    D W+VG + +E+L+  P F   N                    ++  +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228

Query: 324 QRIINEKV---------KLPPFLTSEAHSLLKGLLHKDPSKRL 357
            R +N            KL P  ++E   LLK LL  DP +R+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 46/296 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ER 166
                   +G+GA G V + + K      +  I+A+K     TI    + D  K    E 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALK-----TITTDPNPDLQKQILREL 50

Query: 167 DILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
           +I      P+IV+   +F  ++ S + + +++  GG L   +Y++   ++   R    E 
Sbjct: 51  EINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGR--IGEK 105

Query: 224 --------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
                   ++  +S+LH   I+HRD+KP NIL+   G V L DFG++ E+  S    +  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-TFT 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEK 330
           GT+ YMAPE +  K ++  +D WS+G+ L E+   + PF           +L   I+N  
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Query: 331 V-------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
                         + E    +K  L KDP++R    P   D ++H      +  K
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR----PTPWDMLEHPWIKAQMKKK 276

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 29/268 (10%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
                 D E    +G G  G+V++++ K      +  + A+K MR+    ++N    M  
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILM-- 62

Query: 165 ERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFY 220
           + D++ K +H  P+IV+    F T S +++ ++ +        L +  QG   ED     
Sbjct: 63  DLDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM 119

Query: 221 TAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D+ G+V L DFG++  + +S       G   
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 280 YMAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP 334
           YMAPE +     N      AD WS+GI L E+ TGQ P+ +   + ++  +I+ E+   P
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---P 236

Query: 335 PFLTSEAH------SLLKGLLHKDPSKR 356
           P L           S +   L KD  KR
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 78/293 (26%), Positives = 124/293 (42%), Gaps = 60/293 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRK--DTIIKKNHVDYMKAE 165
           P  ++    VG GA+G+V              G   A+K + +   + I   H      E
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAI---HAKRTYRE 64

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
             +L  + H  ++ L   F   S L      YL+   +  G    ++ +     +D  +F
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF 122

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
              +I+  + ++H  GI+HRDLKP NI ++ D  + + DFGLA+  D+      M G   
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVA 177

Query: 277 TTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---------------THANRQ 320
           T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F                    +
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 321 KLQQRIINEKVK-----LPPF-----------LTSEAHSLLKGLLHKDPSKRL 357
           +L Q+I +E  +     LP                 A  LL+ +L  DP KR+
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 97.9 bits (244), Expect = 5e-23
 Identities = 75/298 (25%), Positives = 134/298 (44%), Gaps = 63/298 (21%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + +   +     I A+K +  D       T I+         E  ++ 
Sbjct: 8   LGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIR---------EISLMK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ H  IV+L     T +KL L+ ++++     ++  H  R G    +  + +T +++  
Sbjct: 54  ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE--IDESSRSNSMCGTTEYMAPEI 285
           ++  H+  ++HRDLKP+N+L++  G + L DFGLA+   I  ++ SN +  T  Y AP++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------EKVKL 333
           LL S+ ++   D WSVG ++ EM+TG+P F   N +    +I                +L
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 334 P------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           P                  P        LL  LL  +P  R+       DA+  H WF
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI----SAHDAL-QHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 68/287 (23%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMKAERDIL 169
           +G+G +G V++ + K   +     I A+K +R +        T I+         E  +L
Sbjct: 7   IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIR---------EISLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSA 227
            ++ HP IV+L     + +KLYL+ +F++             G+      + Y  +++  
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQG 111

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMA 282
           +++ H   ++HRDLKP+N+L+D +G + L DFGLA+      R+     T E     Y A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY----THEVVTLWYRA 167

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII------NEKV-- 331
           PEILL S+ ++   D WS+G +  EM+  +P F      ++ Q  RI       +E V  
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF--PGDSEIDQLFRIFRTLGTPDEDVWP 225

Query: 332 ---KLPPF------------------LTSEAHSLLKGLLHKDPSKRL 357
               LP +                  L  +   LL  +L  DP+KR+
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 75/311 (24%), Positives = 129/311 (41%), Gaps = 71/311 (22%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
           +FE    +G+G +G V++ +     D  S  I A+K +R            M  ERD   
Sbjct: 8   EFEKLNRIGEGTYGIVYRAR-----DTTSGEIVALKKVR------------MDNERDGIP 50

Query: 168 --------ILTKVTHPFIVQLRYSFQTRS--KLYLILDFING--GHLFFHLYRQGIFRED 215
                   +L  + HP IV+L+     +    ++L++++       L  ++     F E 
Sbjct: 51  ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSES 108

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
           Q +    +++  + +LH+  I+HRDLK  N+L+   G + + DFGLA+     ++  +  
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 276 GTT-EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN----- 328
             T  Y APE+LL    +    D W+VG +L E+L  +P     +  +    II      
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 329 --------------EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGG 363
                          K  LP           P+L+     LL  LL  DP KR  +    
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE--- 285

Query: 364 VDAIKHHKWFR 374
            +A++   +F+
Sbjct: 286 -EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 98.2 bits (245), Expect = 8e-23
 Identities = 69/302 (22%), Positives = 119/302 (39%), Gaps = 58/302 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDI 168
           ++    +G GA+G V       +D      +   K+       T+ K+        E  I
Sbjct: 7   YKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKI 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L    H  I+ +R   +         Y+++D +    L   ++      E+  R++  ++
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-----CGTTE 279
           +  + ++H   ++HRDLKP N+L++ D  + + DFG+A+ +  S   +         T  
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 280 YMAPEILLS-KGHNKDADWWSVGILLYEML---------------------TGQPPFTHA 317
           Y APE+LLS   +    D WSVG +  EML                      G P     
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 318 NR----------QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
           NR          Q L ++      K+ P  + EA  LL  +L  DP +R+        A+
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV----EQAL 292

Query: 368 KH 369
           +H
Sbjct: 293 QH 294

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 66/221 (29%), Positives = 115/221 (52%), Gaps = 26/221 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+  K + V  G    + A+KVM     +  +  + +K E ++L
Sbjct: 6   GIFELVELVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTGDEEEEIKQEINML 56

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 177 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 69/301 (22%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDY- 161
           +GP  ++    +G+GA+G V                  +KV      IKK     H  + 
Sbjct: 3   VGP-RYQNLSYIGEGAYGMVCSAT---------HKPTGVKVA-----IKKISPFEHQTFC 47

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +  R+I  L +  H  I+ +       SF++ + +Y++ + +      + L +      
Sbjct: 48  QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSN 105

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           D  +++  +I+  + ++H   ++HRDLKP N+L++++  + + DFGLA+  D        
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 275 CGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQ-- 323
              TEY+      APEI+L SKG+ K  D WSVG +L EML+ +P F       Q     
Sbjct: 166 --LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223

Query: 324 -----------QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKR 356
                        II+ + +     LP           P    +A  LL  +L  +P KR
Sbjct: 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 357 L 357
           +
Sbjct: 284 I 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 71/299 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           F+I   +G+G +G+V++ +     D D+  + A+K +R D        T I+        
Sbjct: 9   FDIIGQIGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIR-------- 55

Query: 164 AERDILTKVTHPFIVQLR---------YSFQTRSK-LYLILDFINGGHLFFHLYRQGI-- 211
            E  IL ++ H  IV L+           F+      YL+ ++++  H    L   G+  
Sbjct: 56  -EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVH 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS 269
           F ED  + +  +++  +++ HK   +HRD+K  NIL+++ G + L DFGLA+    +ES 
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
              +   T  Y  PE+LL +     A D WS G +L E+ T +P F  AN++  Q  +I+
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELIS 231

Query: 329 ------------EKVKLPPFLT-------------------SEAHSLLKGLLHKDPSKR 356
                       + +KLP F T                   + A  LL  +L  DPSKR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 92/336 (27%), Positives = 148/336 (44%), Gaps = 45/336 (13%)

Query: 48  NQSPASTSASLGDPQVIHNRSH-----SFVGPSPRYALSSSLPLQIQELEHENDAELEAE 102
            Q P              +R       +   P    +L+  LPL        + +   A 
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63

Query: 103 SERKIGPGDF-EIFRV--VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
                      E+ RV  +G GA G V++V  +      +  +YA+KV      I  NH 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHE 112

Query: 160 DYMK----AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           D ++     E +IL  V HP +V+    F    ++ ++L+F++GG L         F  D
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS 271
            AR    +I+S +++LH+  IVHRD+KP N+L++S  +V + DFG    LA+ +D     
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---C 225

Query: 272 NSMCGTTEYMAPEIL---LSKGHNKD--ADWWSVGILLYEMLTGQPPFTHANRQ----KL 322
           NS  GT  YM+PE +   L+ G       D WS+G+ + E   G+ PF    RQ     L
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG-VGRQGDWASL 284

Query: 323 QQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
              I +++  + P   + E    +   L ++P+KR 
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRW 320

Length = 353

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 32/266 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             +G GAFG+V++     +   G      A+K +RK    ++   +++K E  +++   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 175 PFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA----------- 222
           P IV  L          Y+I++ + GG L  +L    +      RF              
Sbjct: 59  PNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDIC 112

Query: 223 -EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEI---DESSRSNS 273
            ++     +L +   +HRDL   N L+   G+     V + DFGLA++I   D   +   
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV 331
                 +MAPE LL       +D WS G+L++E+LT GQ P+   N Q++ Q +    ++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKRL 357
           + P     + + L+     +DPS+R 
Sbjct: 233 QKPENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 83/330 (25%), Positives = 142/330 (43%), Gaps = 83/330 (25%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDI- 168
           +EI   +G+G +G+V++ K+K   +G     YA+K  + D    K         A R+I 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRK---NGKDGKEYAIKKFKGD----KEQYTGISQSACREIA 54

Query: 169 -LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHL---YRQGIFREDQARFY-- 220
            L ++ H  +V L   F   +   +YL+ D+    H  + +   +RQ             
Sbjct: 55  LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEIDESSRS---- 271
              +I++ V +LH   ++HRDLKP NIL+  +G     V + D GLA+  +   +     
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ------- 323
           + +  T  Y APE+LL ++ + K  D W++G +  E+LT +P F      K++       
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-KGREAKIKKSNPFQR 231

Query: 324 ---QRIIN------EK-----VKLPPFLT--------------------------SEAHS 343
              +RI        EK      K+P + T                          S+   
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           LL+ LL  DP+KR+ +     +A++ H +F
Sbjct: 292 LLRKLLEYDPTKRITAE----EALE-HPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 78/281 (27%), Positives = 134/281 (47%), Gaps = 33/281 (11%)

Query: 109 PGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D +EI   +G+G +GKVF+V  K   +G      A+K++     I +     ++AE +
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNK--KNGSKA---AVKILDPIHDIDEE----IEAEYN 66

Query: 168 ILTKVT-HPFIVQL-----RYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQA 217
           IL  ++ HP +V+      +   +   +L+L+L+  NGG +       L R     E   
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCG 276
            +   E +  + HLH    +HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 277 TTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-- 329
           T  +MAPE++     L   ++   D WS+GI   E+  G PP    +  +   +I     
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246

Query: 330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             +  P   ++E +  ++  L KD  KR    P   D ++H
Sbjct: 247 PTLHQPELWSNEFNDFIRKCLTKDYEKR----PTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 29/260 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-----AMKVMRKDTIIKKNHVDY 161
           I   + ++   +G+G FG V              G Y     A+K ++ D+         
Sbjct: 3   INSKELKLGATIGKGEFGDVML------------GDYRGQKVAVKCLKDDS----TAAQA 46

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY---RQGIFREDQAR 218
             AE  ++T + HP +VQL       + LY++ +++  G L  +L    R  I    Q  
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   ++   + +L +   VHRDL   N+L+  D    ++DFGLAKE  +   S  +    
Sbjct: 107 F-ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PV 163

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPF 336
           ++ APE L  K  +  +D WS GILL+E+ + G+ P+     + +   +    +++ P  
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223

Query: 337 LTSEAHSLLKGLLHKDPSKR 356
              E + ++K     DP+KR
Sbjct: 224 CPPEVYKVMKDCWELDPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 61/306 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E    + +G +G V++ + K      +  I A+K ++ +   +   +  ++ E +IL 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           K+ HP IV ++         K+Y++++++       H  +  +    Q  F  +E+    
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE------HDLKSLMETMKQ-PFLQSEVKCLM 112

Query: 225 ---VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEY 280
              +S V+HLH   I+HRDLK  N+L+++ G + + DFGLA+E     +    +  T  Y
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWY 172

Query: 281 MAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-- 331
            APE+LL       A D WSVG +  E+LT +P F   +      +I        EK+  
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232

Query: 332 ---KLP---------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
              +LP                       L+     LL  LL  DP+KR+ +     DA+
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE----DAL 288

Query: 368 KHHKWF 373
           K H +F
Sbjct: 289 K-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 76/311 (24%), Positives = 126/311 (40%), Gaps = 73/311 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ + +GQGA+G V   +     + ++  I      +K T +             IL K
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAI------KKITNVFSK---------KILAK 46

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYR---QGIFREDQA---- 217
                +  LR+ F+    +  + D         N  +L+  L       I R  Q     
Sbjct: 47  RALRELKLLRH-FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105

Query: 218 --RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-- 273
             + +  +I+  + ++H   ++HRDLKP N+L+++D  + + DFGLA+   E+   N+  
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 274 ---MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--------------- 314
                 T  Y APEI+LS + + K  D WSVG +L E+L  +P F               
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 315 ---------THANRQKLQQRIIN----EKVKLP---PFLTSEAHSLLKGLLHKDPSKRLG 358
                    +     K Q  I +     K       P     A  LL+ LL  DP+KR+ 
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285

Query: 359 SGPGGVDAIKH 369
                 +A++H
Sbjct: 286 VE----EALEH 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 33/264 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKV--------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           I P +    + +G G FG V         +V  K +++G          M ++  I+   
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---------AMSEEDFIE--- 48

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
                 E  ++ K++HP +VQL Y   T+ K LY++ +F+  G L  +L  RQG   +D 
Sbjct: 49  ------EAKVMMKLSHPKLVQL-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSM 274
                 ++   + +L +   +HRDL   N L+ S G V ++DFG+ + +  DE + S+  
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVK 332
               ++  PE+     ++  +D WS G+L++E+ T G+ PF   +N + ++      ++ 
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221

Query: 333 LPPFLTSEAHSLLKGLLHKDPSKR 356
            P   +   + ++    H+ P  R
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 72/224 (32%), Positives = 115/224 (51%), Gaps = 31/224 (13%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +EI   +G+G +GKV++V  K   DG    + A+K++  D I   +  + ++AE +IL
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNK--KDGS---LAAVKIL--DPI--SDVDEEIEAEYNIL 72

Query: 170 TKVT-HPFIVQLRYSFQTRSK-----LYLILDFINGG---HLFFHLYRQGIFREDQAR-- 218
             +  HP +V+    F    K     L+L+L+  NGG    L   L   G  R D+A   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMIS 131

Query: 219 --FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMC 275
              Y A +   + HLH   I+HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  
Sbjct: 132 YILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 276 GTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPF 314
           GT  +MAPE++  +      ++   D WS+GI   E+  G PP 
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 61/262 (23%), Positives = 129/262 (49%), Gaps = 29/262 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSEDEFIE----EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            ++ K++H  +VQL      +  +Y++ ++++ G L  +L      RE   RF  ++++ 
Sbjct: 51  KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLE 104

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
                   +++L     +HRDL   N L+D  G V ++DFGL++ + +   ++S+ G+  
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKF 163

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
              +  PE+LL    +  +D W+ G+L++E+ + G+ P+   N  +  +++        P
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223

Query: 336 FLTSE-AHSLLKGLLHKDPSKR 356
            L SE  ++++    H+   +R
Sbjct: 224 HLASEKVYAIMYSCWHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 39/273 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
              + R +GQG+FG V++   KGV  G+ +   A+K + ++  +++      +A   ++ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVMK 64

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY---------- 220
           +     +V+L     T     ++++ +  G L  +L R      +               
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQ 123

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
             AEI   +++L     VHRDL   N ++  D  V + DFG+ ++I E          T+
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----------TD 173

Query: 280 Y-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
           Y             MAPE L        +D WS G++L+EM T   QP    +N + L+ 
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233

Query: 325 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            I    + LP     +   L++     +P  R 
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 51/151 (33%), Positives = 85/151 (56%), Gaps = 7/151 (4%)

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSR 270
            E    FYT +I+  + +LH   IVHRD+K +N+L+++  G V ++DFG +K +   +  
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165

Query: 271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRII 327
           + +  GT +YMAPE++    +G+   AD WS+G  + EM TG+PPF      Q    ++ 
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225

Query: 328 NEKV--KLPPFLTSEAHSLLKGLLHKDPSKR 356
             K+  ++P  L++EA + +      DP KR
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 55/281 (19%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI--LTKV 172
           +G+G++G VF+ + +     ++  I A+K       D +IKK       A R+I  L ++
Sbjct: 9   IGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKK------IALREIRMLKQL 57

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVS 229
            HP +V L   F+ + KL+L+ ++ +  H   +      +G+  E   +    + + AV+
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCD--HTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-YMAPEILLS 288
             HK   +HRD+KPENIL+   G + L DFG A+ +       +    T  Y APE+L+ 
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 289 K-GHNKDADWWSVGILLYEMLTGQPPFT--------HANRQKLQQRIINEK--------- 330
              +    D W++G +  E+LTGQP +         +  R+ L   I   +         
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234

Query: 331 --VKLP------------PFLTSEAHSLLKGLLHKDPSKRL 357
             + +P            P ++S A S LKG L  DP++RL
Sbjct: 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 9/215 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
            ++  +D WS+G+ L EM  G+ P    + ++L+ 
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 66/313 (21%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-----------ER 166
           +G+G +GKV +       D  +  I A+K ++   I      D               E 
Sbjct: 17  LGEGTYGKVEKAY-----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            I+ ++ H  I+ L   +     + L++D +    L   + R+    E Q +    +I++
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE------IDESSRSNSMCGTTE- 279
            ++ LHK   +HRDL P NI ++S G   + DFGLA+        D  S+  +M    E 
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 280 --------YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 328
                   Y APE+L+ ++ ++   D WSVG +  E+LTG+P F   N      RI    
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 329 ---------EKVKLP-----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPG 362
                    +  KLP                 P  + +A  LL+ LL  +P +R+ +   
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK-- 308

Query: 363 GVDAIKHHKWFRS 375
             +A+K H++F+S
Sbjct: 309 --EALK-HEYFKS 318

Length = 335

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 65/228 (28%), Positives = 115/228 (50%), Gaps = 22/228 (9%)

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+KV+  D  ++      + +E +IL K   P+I+    +F   +++ +  +F++GG 
Sbjct: 28  ILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L   +YR+ I      R   A +V  +++L    I+HRD+KP N+L+++ G V L DFG+
Sbjct: 86  L--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-----TH 316
           + ++  +S + +  GT  YMAPE +  + +   +D WS+GI   E+  G+ P+       
Sbjct: 142 STQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200

Query: 317 ANRQKLQ--QRIINEKVKLPPFLTSEAHS-----LLKGLLHKDPSKRL 357
            +   LQ  Q I++E    PP L     S      +   + K P +R 
Sbjct: 201 GSLMPLQLLQCIVDED---PPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 81/311 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYM 162
           D+     +G+G +G V++ + K      +  I AMK +R +        T I+       
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIR------- 48

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN------------GGHLFFHLYRQG 210
             E  +L ++ HP IV L+      S+LYLI +F++            G ++   L +  
Sbjct: 49  --EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS- 105

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                    Y  +I+  +   H   ++HRDLKP+N+L+D+ G + L DFGLA+      R
Sbjct: 106 ---------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156

Query: 271 SNSM-CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ-RII 327
             +    T  Y APE+LL S  ++   D WS+G +  EM T +P F H + +  Q  RI 
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF-HGDSEIDQLFRIF 215

Query: 328 ------NEKV-----KLPPF------------------LTSEAHSLLKGLLHKDPSKRLG 358
                  E V      LP +                  L  +   LL+ +L  DP+KR+ 
Sbjct: 216 RILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI- 274

Query: 359 SGPGGVDAIKH 369
                  A+ H
Sbjct: 275 ---SAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 63/259 (24%), Positives = 128/259 (49%), Gaps = 23/259 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V   K +G  D       A+K++R+  +   +  D+++ E 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAM---SEDDFIE-EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEI 224
            ++ K++HP +VQL Y   T+ + ++++ +++  G L  +L  + G    +      +++
Sbjct: 51  KVMMKLSHPNLVQL-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
             A+ +L   G +HRDL   N L+  D  V ++DFGLA+ +  D+ + S       ++  
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQ---KLQQRIINEKVKLPPFL 337
           PE+      +  +D WS G+L++E+ + G+ P+   +N +    +       + KL P  
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP-- 227

Query: 338 TSEAHSLLKGLLHKDPSKR 356
            +E ++++    H+ P  R
Sbjct: 228 -TEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 28/265 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FGKV   +   + D   + + A+K +      ++ H    + E +IL  + H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66

Query: 176 FIVQLRY--SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
            IV+ +          L LI++++  G L  +L R    + +  R   ++++I   + +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT-TEYMAPEILL 287
                +HRDL   NIL++S+  V ++DFGLAK + E            +   + APE L 
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTH-----------ANRQKLQQRIIN-----EKV 331
           +   +  +D WS G+ LYE+ T   P              A  Q +  R++      E++
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKR 356
             PP    E + L+K     +P  R
Sbjct: 246 PRPPSCPDEVYDLMKLCWEAEPQDR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 89.6 bits (222), Expect = 4e-19
 Identities = 46/127 (36%), Positives = 70/127 (55%), Gaps = 12/127 (9%)

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP- 334
           GT +Y+APE+LL K H    DWW++G+ L+E LTG PPF     Q++ Q I+N  +  P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 335 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM----QP 388
               L+  A + ++ LL  DP+KR      G+  +K H  F  ++W+ L+ + M    QP
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKR-----AGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656

Query: 389 KFKPDVS 395
             + D S
Sbjct: 657 DDETDTS 663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 28/262 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAER 166
            + E  +V+G GAFG V+    KGV   +G+   I  A+KV+R++T   K + + +  E 
Sbjct: 7   TELEKIKVLGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLREETS-PKANKEILD-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF------- 219
            ++  V HP +V+L       S++ LI   +  G L  ++      R  +          
Sbjct: 61  YVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLN 113

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
           +  +I   +S+L +  +VHRDL   N+L+ +  HV +TDFGLAK +D   +     G   
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 334
             ++MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  P
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233

Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
           P  T + + +L      D   R
Sbjct: 234 PICTIDVYMVLVKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 31/266 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G+GAFGKVF  +   ++  +   + A+K + K+T       D+ + E ++LT   H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELLTNFQHE 68

Query: 176 FIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG-----IFREDQARF---------Y 220
            IV+  Y   T      ++ +++  G L   L   G     +   D              
Sbjct: 69  NIVKF-YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I S + +L     VHRDL   N L+  D  V + DFG+++++  ++    + G T  
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTML 186

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK---LQQRIINEKV 331
              +M PE ++ +    ++D WS G++L+E+ T   QP +  +N +    + Q  + ++ 
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR- 245

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKRL 357
             P    SE + ++ G   +DP +R+
Sbjct: 246 --PRTCPSEVYDIMLGCWKRDPQQRI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 79/313 (25%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+VF+ + K         I A+K +  +   +   +  ++ E  IL  + H  +
Sbjct: 20  IGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALR-EIKILQLLKHENV 73

Query: 178 VQL------------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI- 224
           V L            RY    +   YL+ +F    H        G+      +F  +EI 
Sbjct: 74  VNLIEICRTKATPYNRY----KGSFYLVFEFCE--HDL-----AGLLSNKNVKFTLSEIK 122

Query: 225 ------VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
                 ++ + ++H+  I+HRD+K  NIL+  DG + L DFGLA+    S  S     T 
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 279 E-----YMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---- 328
                 Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242

Query: 329 ---------------EKVKLP------------PFLTS-EAHSLLKGLLHKDPSKRLGSG 360
                          +K++LP            P++    A  L+  LL  DP+KR+ + 
Sbjct: 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA- 301

Query: 361 PGGVDAIKHHKWF 373
               D   +H +F
Sbjct: 302 ----DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 78/312 (25%), Positives = 133/312 (42%), Gaps = 77/312 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+G +GKV++ +          KK   + D +GI         T ++      
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-------PPTALR------ 49

Query: 162 MKAERDILTKVTH-PFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFR- 213
              E  +L  ++   +IV+L        K     LYL+ ++++     F     +G  R 
Sbjct: 50  ---EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106

Query: 214 --EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAK--EIDES 268
                 + +  +++  V+H HK G++HRDLKP+N+L+D    ++ + D GL +   I   
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQ--- 324
           S ++ +  T  Y APE+LL   H     D WSVG +  EM   QP F      +LQQ   
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSELQQLLH 223

Query: 325 --RII---NEKV----------------------KLPPFLTSEAHSLLKGLLHKDPSKRL 357
             +++    E+V                      +  P L+ E   LL+ +L  DP+KR+
Sbjct: 224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283

Query: 358 GSGPGGVDAIKH 369
            +      A+ H
Sbjct: 284 SA----KAALTH 291

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 88.7 bits (220), Expect = 1e-18
 Identities = 80/322 (24%), Positives = 147/322 (45%), Gaps = 62/322 (19%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDI 168
             ++I R++G+G  G+V+       D   S  + A+K +R+D          +++ E  I
Sbjct: 2   QRYDIIRLIGKGGMGEVYL----AYDPVCSRRV-ALKKIREDLSENPLLKKRFLR-EAKI 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKL-YLILDFING---GHLFFHLYRQGIFREDQAR------ 218
              + HP IV + YS  +     Y  + +I G     L   ++++    ++ A       
Sbjct: 56  AADLIHPGIVPV-YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--------EID 266
               F+   I + + ++H  G++HRDLKP+NIL+   G V++ D+G A          +D
Sbjct: 115 FLSIFHK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 267 ESSRSNSMC-----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
                 ++C           GT +YMAPE LL    ++  D +++G++LY+MLT   P+ 
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 316 HANRQKL--QQRIIN-EKV----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 368
               +K+  +  I++  +V    ++PPFL+  A   +K  L  DP++R  S       ++
Sbjct: 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIA---MKA-LAVDPAERYSSVQELKQDLE 288

Query: 369 HH-----KWFRSINWKTLEARE 385
            H     +W       TL  ++
Sbjct: 289 PHLQGSPEWTVKA---TLMTKK 307

Length = 932

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 11/205 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V  +      S  I A K++  +  IK    + +  E  +L 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLE--IKPAIRNQIIRELKVLH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E+     +  ++  +++
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
           L  K  I+HRD+KP NIL++S G + L DFG++ + ID  S +NS  GT  YM+PE L  
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 172

Query: 289 KGHNKDADWWSVGILLYEMLTGQPP 313
             +   +D WS+G+ L EM  G+ P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 46/286 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G+G +G VF+ K +     ++  I A+K +R D     +      A R+I  L ++ H 
Sbjct: 8   IGEGTYGTVFKAKNR-----ETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHK 59

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            IV+L     +  KL L+ ++ +     +     G    +  + +  +++  ++  H   
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-SKGHNK 293
           ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L  +K ++ 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 294 DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII------NEK-----VKLP------- 334
             D WS G +  E+   G+P F   +     +RI        E+      KLP       
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239

Query: 335 -----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
                      P L S    LL+ LL  +P +R+ +     +A++H
Sbjct: 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQH 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 67/267 (25%), Positives = 120/267 (44%), Gaps = 25/267 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDI 168
           F   R +G G+FG V+  +     D  ++ + A+K M    K +  K    D +K E   
Sbjct: 17  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQ--DIIK-EVRF 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L ++ HP  ++ +  +      +L++++ +        ++++ + +E +        +  
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICHGALQG 127

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +++LH    +HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL 184

Query: 288 S--KGHNKD-ADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEA-H 342
           +  +G      D WS+GI   E+   +PP  + N       I  N+   L     S+   
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           + +   L K P  R    P   + +KH
Sbjct: 245 NFVDSCLQKIPQDR----PSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 67/245 (27%), Positives = 119/245 (48%), Gaps = 17/245 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T+  +  +     E  ++ K+ H  +
Sbjct: 14  LGQGCFGEVW----MGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG 235
           VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I S ++++ +  
Sbjct: 64  VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L      
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 294 DADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
            +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP      H L+     K
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242

Query: 352 DPSKR 356
           +P +R
Sbjct: 243 EPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 44/240 (18%)

Query: 115 FRVVGQGAFGKVFQ-----------VKKKGVDDGDS--DGIYAMKVMRK---DTIIKKNH 158
            R +G G+ G VF            VKK  + D  S    +  +K++R+   D I+K   
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 159 VDYMKAERD-----ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           V              LT++   +IVQ           Y+  D  N       +  QG   
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQE----------YMETDLAN-------VLEQGPLS 112

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID-ESSRS 271
           E+ AR +  +++  + ++H   ++HRDLKP N+ ++++  V+ + DFGLA+ +D   S  
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 272 N--SMCGTTE-YMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
              S    T+ Y +P +LLS  +  K  D W+ G +  EMLTG+P F  A+  +  Q I+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 69/254 (27%), Positives = 127/254 (50%), Gaps = 24/254 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   + DG++  I  A+KV+R++T  K N    +  E  ++  V  
Sbjct: 13  KVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGS 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSA 227
           P++ +L       S + L+   +  G L  ++      RE++ R        +  +I   
Sbjct: 69  PYVCRL-LGICLTSTVQLVTQLMPYGCLLDYV------RENKDRIGSQDLLNWCVQIAKG 121

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS-RSNSMCGTTEYMAPE 284
           +S+L +  +VHRDL   N+L+ S  HV +TDFGLA+  +IDE+   ++      ++MA E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAH 342
            +L +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241

Query: 343 SLLKGLLHKDPSKR 356
            ++      D   R
Sbjct: 242 MIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 80/324 (24%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM--KAERD 167
            D+EI   +G+G FG+V++ ++       +  + A+K      I+  N  D     A R+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQI-----KTGRVVALK-----KILMHNEKDGFPITALRE 57

Query: 168 I--LTKVTHPFIVQL------RYSFQTRSK--LYLILDFINGGH-LFFHLYRQGI-FRED 215
           I  L K+ HP +V L      R     R +  +Y++  +++  H L   L    +   E 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTES 115

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--- 272
           Q + Y  +++  +++LH+  I+HRD+K  NIL+D+ G + + DFGLA+  D    +    
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 273 ---------SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF-------- 314
                    ++  T  Y  PE+LL  + +    D W +G +  EM T +P          
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 315 --------------THANRQKL-----------QQRIINEKVKLPPFLTSEAHSLLKGLL 349
                         T    + L             R + E+      L  E   LL  LL
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLL 292

Query: 350 HKDPSKRLGSGPGGVDAIKHHKWF 373
             DP KRL +     DA   H +F
Sbjct: 293 SLDPYKRLTA----SDA-LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 28/233 (12%)

Query: 109 PGDFEIFRVVGQGAFGKV---------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 16  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---- 71

Query: 160 DYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            +MK E  I L  V  P       S +  + +YL+   +  G    ++ +     +D  +
Sbjct: 72  -HMKHENVIGLLDVFTP-----ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T 
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATR 181

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
            Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 63/251 (25%), Positives = 118/251 (47%), Gaps = 19/251 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + ++ + +G+G FG V     +G          A+K ++ D   +        AE  ++T
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA-----FLAEASVMT 54

Query: 171 KVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSA 227
           ++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ ++  A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ APE L 
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALR 172

Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       + ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 346 KGLLHKDPSKR 356
           K   H D + R
Sbjct: 233 KQCWHLDAATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 86.3 bits (213), Expect = 6e-18
 Identities = 73/282 (25%), Positives = 139/282 (49%), Gaps = 45/282 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E+ + +G G FG+VF VK K   +      +  K +    + K+     +  E +++ 
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRGL-KEREKSQLVIEVNVMR 67

Query: 171 KVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHL---YRQ-GIFREDQARFYTAEI 224
           ++ H  IV+   R+  +   KLY++++F + G L  ++   Y+  G   E      T ++
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 225 VSAVSHLHKCG-------IVHRDLKPENILMDSD----GHVM-------------LTDFG 260
           + A+++ H          ++HRDLKP+NI + +     G +              + DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           L+K I   S ++S  GT  Y +PE+LL  +K ++  +D W++G ++YE+ +G+ PF  AN
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 319 RQKLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKR 356
                 ++I+E  + P       + E + L+K LL+    +R
Sbjct: 248 N---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286

Length = 1021

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 85.1 bits (210), Expect = 7e-18
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 48/289 (16%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFR-------- 116
           H  +    G        +   L  +E  H N+A  + + E+ I   D +I R        
Sbjct: 18  HKANKGGSGKFEM----NDKKLDEEERSHNNNAGEDEDEEKMI---DNDINRSPNKSYKL 70

Query: 117 --VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             ++G G+FG V++     +    S+ +   KV++           Y   E  I+  + H
Sbjct: 71  GNIIGNGSFGVVYE----AICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNH 118

Query: 175 PFIVQLRYSFQTRSK--------LYLILDFINGGHLFFHLYRQGIFREDQA------RFY 220
             I+ L+  + T           L ++++FI       H Y +   R + A      + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT---VHKYMKHYARNNHALPLFLVKLY 175

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
           + ++  A++++H   I HRDLKP+N+L+D + H + L DFG AK +    RS S   +  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           Y APE++L +  +    D WS+G ++ EM+ G P F+  +      RII
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 28/258 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F + R +G G FG+V++   K           A+K+++ D        D+ K E   L 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDD--LLKQQDFQK-EVQALK 57

Query: 171 KVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
           ++ H  ++ L ++  +  + +Y+I + +  G L   L      R  + +           
Sbjct: 58  RLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMA 110

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-TEY 280
            ++   +++L +   +HRDL   NIL+  D    + DFGLA+ I E    +S      ++
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLT 338
            APE       +  +D WS GILLYEM T GQ P+   N  ++  +I    ++  P    
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP 230

Query: 339 SEAHSLLKGLLHKDPSKR 356
            E + ++      +P  R
Sbjct: 231 QEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 39/190 (20%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
           D  + +  +I+  + +LH  GI+HRD+KP N+L++S+  + + DFGLA+  E DES    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 273 SMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTG------QPPFTHAN------- 318
               T  Y APEIL+   H   A D WSVG +  E+L        Q P    +       
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 319 ----------RQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSKRLGS 359
                      +  +  I+    K P            T EA  LL  +L  DP KR+  
Sbjct: 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-- 280

Query: 360 GPGGVDAIKH 369
                DA+ H
Sbjct: 281 --SAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 21/259 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E+   +G+GA+G V +++        +  I A+K +R     ++     M  + DI  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLM--DLDISM 54

Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIF-REDQARFYTAEIVS 226
           +    P+ V    +      +++ ++ ++      +  +Y +G+   ED        IV 
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 227 AVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE- 284
           A+ +LH K  ++HRD+KP N+L++ +G V L DFG++  + +S       G   YMAPE 
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174

Query: 285 ---ILLSKGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVKLP--PFL 337
               L  KG++  +D WS+GI + E+ TG+ P+       Q+L+Q +     +LP   F 
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF- 233

Query: 338 TSEAHSLLKGLLHKDPSKR 356
           + E    +   L K+  +R
Sbjct: 234 SPEFQDFVNKCLKKNYKER 252

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 36/203 (17%)

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
            YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ ++
Sbjct: 95  FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
            D  + + DFGLA++ D  S       T  Y APE++L+  H  +  D WSVG ++ EML
Sbjct: 153 EDCELKILDFGLARQTD--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Query: 309 TGQPPFT---HANR----------------QKLQQRIINEKVK-LP-----------PFL 337
           TG+P F    H ++                QKLQ       VK LP           P  
Sbjct: 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNA 270

Query: 338 TSEAHSLLKGLLHKDPSKRLGSG 360
              A ++L+ +L  D   R+ + 
Sbjct: 271 NPLAVNVLEKMLVLDAESRITAA 293

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 30/254 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G G FG+V+     G  +G +    A+K ++  T+  +    +++ E  I+ K+ H 
Sbjct: 12  RKLGAGQFGEVW----MGTWNGTTK--VAVKTLKPGTMSPE---AFLQ-EAQIMKKLRHD 61

Query: 176 FIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--------YTAEIVS 226
            +VQL Y+  +  + +Y++ ++++ G L   L      +  + +           A+I  
Sbjct: 62  KLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPE 284
            +++L     +HRDL   NIL+  +    + DFGLA+  E DE +         ++ APE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAH 342
                     +D WS GILL E++T G+ P+    NR+ L+Q     ++  PP    E +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234

Query: 343 SLLKGLLHKDPSKR 356
            L+     KDP +R
Sbjct: 235 DLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 68/252 (26%), Positives = 123/252 (48%), Gaps = 20/252 (7%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ R +G G FG+V++    G+ +  +    A+K ++  T+  K+ +    AE  I+ K+
Sbjct: 9   QLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLKPGTMDPKDFL----AEAQIMKKL 58

Query: 173 THPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
            HP ++QL Y+  T  + +Y++ + +  G L  +L        +  Q     A++ S ++
Sbjct: 59  RHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEYMAPEIL 286
           +L     +HRDL   N+L+  +    + DFGLA+ I E     +  G     ++ APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAA 176

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           L    +  +D WS GILL E++T G+ P+    N + LQQ     ++  PP    E + +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236

Query: 345 LKGLLHKDPSKR 356
           +     +DP  R
Sbjct: 237 MLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 44/217 (20%)

Query: 118 VGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           VG GA+G V          +V  K +       I+A +  R+ T++K    + +    D+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYRQGIFREDQARFYT 221
            T            S       YL++ +       I G              ED+ ++  
Sbjct: 83  FTSAV---------SGDEFQDFYLVMPYMQTDLQKIMGHP----------LSEDKVQYLV 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TT 278
            +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA+  D       M G   T 
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTR 178

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
            Y APE++L+  H N+  D WSVG ++ EMLTG+  F
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 42/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGL 261
           + +   + +  E+         V A+++L +   I+HRD+KP NIL+D +G++ L DFG+
Sbjct: 95  YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           + ++ +S       G   YMAPE +      G++  +D WS+GI LYE+ TG+ P+   N
Sbjct: 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Query: 319 R--QKLQQRIINEKVKLPP 335
               +L Q +  +   L  
Sbjct: 215 SVFDQLTQVVKGDPPILSN 233

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 64/252 (25%), Positives = 124/252 (49%), Gaps = 19/252 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            ++ + +G G FG+V+     G  +G++    A+K ++  T+  ++ ++    E  I+ K
Sbjct: 8   LQLIKKLGNGQFGEVWM----GTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKK 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAV 228
           + H  +VQL Y+  +   +Y++ ++++ G L   L + G  R           A++ + +
Sbjct: 58  LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGM 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEIL 286
           +++ +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ APE  
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHA-NRQKLQQRIINEKVKLPPFLTSEAHSL 344
           L       +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235

Query: 345 LKGLLHKDPSKR 356
           +     KDP +R
Sbjct: 236 MLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 9/214 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V+ K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
            ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 14/197 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +  G+ G+VF   K G  D        +K+ +K T +          E  +L  
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDP-----VVLKIGQKGTTL---------IEAMLLQN 113

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V HP +++++ +  + +   ++L   +     +   R      DQA     +I+  + +L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   I+HRD+K ENI ++    V + D G A+    +     + GT E  APE+L    +
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 292 NKDADWWSVGILLYEML 308
           N  AD WS GI+L+EML
Sbjct: 234 NSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 45/127 (35%), Positives = 71/127 (55%), Gaps = 11/127 (8%)

Query: 214 EDQ-ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           E Q  +++  +I+  + ++H  G+VHRDLKP NIL++ +  + + DFGLA+  D   +  
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMT 163

Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIIN 328
               T  Y APEI+L+ + ++ + D WS G +  EML G+P F    H N    Q  II 
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN----QFSIIT 219

Query: 329 EKVKLPP 335
           + +  PP
Sbjct: 220 DLLGTPP 226

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 64/261 (24%), Positives = 121/261 (46%), Gaps = 28/261 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKAERD 167
           +F+  +V+G GAFG V+    KG+   + + +    A+K +R+ T  K N    +  E  
Sbjct: 8   EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAY 61

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           ++  V +P + +L       S + LI   +  G L  ++      RE +          +
Sbjct: 62  VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNW 114

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---T 277
             +I   +++L +  +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
             T + + ++      D   R
Sbjct: 235 ICTIDVYMIMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 13  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      +      + +  +++  +S+
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            HK  I+HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
           S  ++   D W VG +LYEM TG+P F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 65/263 (24%), Positives = 127/263 (48%), Gaps = 22/263 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G FG V + + K  +DG    + A+K+++ D     +  ++++ E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLK-SEDGSFQKV-AVKMLKADIFSSSDIEEFLR-EAACMKE 57

Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP +++L   S ++R+K  L     IL F+  G  H F  + R G     +  +   R
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I S + +L     +HRDL   N +++ +  V + DFGL+K+I         C + 
Sbjct: 118 FMI-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 333
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           PP    + + L+      +P  R
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 15/156 (9%)

Query: 168 ILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQAR-- 218
           ++  V H  I+ L      + S +    +YL+++ ++          Q I  + D  R  
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD------ANLCQVIQMDLDHERMS 121

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T 
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 33/221 (14%)

Query: 109 PGDFEIFRVVGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 14  PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---- 69

Query: 160 DYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +MK E      D+ T  T         S +  +++YL+ + +  G    ++ +     +
Sbjct: 70  -HMKHENVIGLLDVFTPAT---------SIENFNEVYLVTNLM--GADLNNIVKCQKLSD 117

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           +  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D+       
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGY 175

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
             T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 39/235 (16%)

Query: 92  EHENDAE----LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           E E+DA+    L AE+   I    F I      GA G  F                    
Sbjct: 70  EDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKT------------- 116

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
             +  +IK         E  IL  + HP I+QL+ +F       LIL            Y
Sbjct: 117 -CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RY 165

Query: 208 RQGIF--REDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
           +  ++     +      +I++       A+ +LH+  I+HRD+K ENI ++  G V L D
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225

Query: 259 FGLA-KEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           FG A   +D  +++     GT    APE+L    +    D WS GI+L+EM T  
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 37/92 (40%), Positives = 55/92 (59%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 18/233 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--DYMKAERDILTKVTH 174
            +G+G FG+VF  K KG+++   + +  +K ++K    K  ++  ++ + E D+  K++H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRR-ELDMFRKLSH 67

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV---- 228
             +V+L    +     Y+IL++ + G L  F    +    +       T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 229 ---SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
               HL     VHRDL   N L+ S   V ++   L+K++   E  +  +      ++AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
           E +     +  +D WS G+L++E+ T G+ PF   + +++  R+   K++LP 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 27/208 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + K  D+     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
            + H  IV L     T   L L+ ++++   L  +L   G        + +  +++  ++
Sbjct: 60  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L++  G + L DFGL  AK I   + SN +  T  Y  P+ILL
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S  ++   D W VG + YEM TG+P F
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 10/200 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G FGKV        +DG  + + A+K ++++    + +    K E +IL  + H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGE-MVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 176 FIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+ +   S Q    L LI++++  G L  +L +  +    Q   +  +I   +++LH 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHS 125

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSK 289
              +HRDL   N+L+D+D  V + DFGLAK + E      +    +    + A E L   
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 290 GHNKDADWWSVGILLYEMLT 309
             +  +D WS G+ LYE+LT
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 58/244 (23%), Positives = 119/244 (48%), Gaps = 19/244 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG V Q +  G          A+K ++ D   +         E  ++TK+ H  
Sbjct: 13  IIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQA-----FLEETAVMTKLHHKN 60

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKC 234
           +V+L       + LY++++ ++ G+L   L  +G       +   ++ ++   + +L   
Sbjct: 61  LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
            +VHRDL   NIL+  DG   ++DFGLA+    S   ++     ++ APE L  K  +  
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKFSSK 177

Query: 295 ADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKD 352
           +D WS G+LL+E+ + G+ P+   + +++++ +    +++ P    ++ + L+      +
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETE 237

Query: 353 PSKR 356
           P KR
Sbjct: 238 PKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 6/154 (3%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E DIL  ++H  I+ L ++++ +S + +++       LF ++ R G    +QA      +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC----GTTEY 280
           + A+++LH  GI+HRD+K ENI +D   + +L DFG A ++D    +   C    GT E 
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLET 253

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            +PE+L    +    D WS G++L+EM       
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 13/168 (7%)

Query: 156 KNHVDYMKAERDI--LTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHL-FFHL 206
           +N     +A R++  L  V H  I+ L      + S +    +YL+++ ++       H+
Sbjct: 59  QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM 118

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 119 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G   F
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 23/266 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  ++ + A+K M             +  E   L +
Sbjct: 27  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  ++ +  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A      S +NS  GT  +MAPE++L+   
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDE 198

Query: 291 --HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS----- 343
             ++   D WS+GI   E+   +PP  + N       I   +    P L S   S     
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPTLQSNEWSDYFRN 255

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKH 369
            +   L K P  R    P   + +KH
Sbjct: 256 FVDSCLQKIPQDR----PTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 17/176 (9%)

Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 15/208 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--IL 169
           +E    +G+G++  V++ K K      +  + A+KV+R    +++       A R+  +L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIR----LQEEEGTPFTAIREASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G    +  + +  +++  +S
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           ++H+  I+HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S  ++   D W VG +  EM+ G   F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 67/246 (27%), Positives = 121/246 (49%), Gaps = 19/246 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T++ +  +     E  I+ K+ H  +
Sbjct: 14  LGQGCFGEVWM----GTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKC 234
           V L Y+  +   +Y++ +F+  G L   L ++G     +  Q     A+I   ++++ + 
Sbjct: 64  VPL-YAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHN 292
             +HRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L     
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 293 KDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
             +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H L+K    
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK 241

Query: 351 KDPSKR 356
           KDP +R
Sbjct: 242 KDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 40/231 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPVQLPRGMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 66/263 (25%), Positives = 129/263 (49%), Gaps = 26/263 (9%)

Query: 118 VGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D D   + +     M KD   +K+  D + +E +++  +  H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY---- 220
            I+ L  +      LY+I+++ + G+L  +L         Y   I R  ++Q  F     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
            T ++   + +L     +HRDL   N+L+  +  + + DFGLA++   ID   ++ +   
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE L  + +   +D WS G+L++E+ T G  P+     ++L  +++ E  ++  
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDK 260

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P   T+E + +++   H  PS R
Sbjct: 261 PANCTNELYMMMRDCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 11/210 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDE 188

Query: 291 --HNKDADWWSVGILLYEMLTGQPPFTHAN 318
             ++   D WS+GI   E+   +PP  + N
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 4/153 (2%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T+  L  + ++++     + +   G       R +  ++
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA--KEIDESSRSNSMCGTTEYMA 282
           +  ++++H   I+HRDLKP+N+L+   G + L DFGLA  K I   + S+ +  T  Y  
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRP 171

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           P++LL +  ++   D W  G +  EML GQP F
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 66/269 (24%), Positives = 124/269 (46%), Gaps = 26/269 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAFGKVF  +   +       + A+K ++  T+  +   D+ + E ++LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
            + H  IV+          L ++ +++  G L   L   G    I  + Q R    E   
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                    I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 181

Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN 328
            G T     +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++     
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
             ++ P     E + ++ G   ++P +RL
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 70/266 (26%), Positives = 133/266 (50%), Gaps = 30/266 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           I P    I +V+G G FG+V +  +K  G  + D     A+K   K     K  +D++  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEID----VAIK-TLKAGSSDKQRLDFL-T 54

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP I++L     T+S+ + +I +++  G L   L      RE+  +F   +
Sbjct: 55  EASIMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFL------RENDGKFTVGQ 107

Query: 224 IV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMC 275
           +V       S + +L +   VHRDL   NIL++S+    ++DFGL++ +++S  +  +  
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167

Query: 276 GTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 332
           G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q + +  + +  +
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYR 226

Query: 333 LPPFLT--SEAHSLLKGLLHKDPSKR 356
           LPP +   S  + L+     KD ++R
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + +  ++       A+K +R +        T I+        
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIR-------- 50

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ--ARFYT 221
            E  +L ++ H  IV+L+    +  +LYL+ ++++   L  H+     F ++    + Y 
Sbjct: 51  -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSM-CGTTE 279
            +I+  +++ H   ++HRDLKP+N+L+D     + L DFGLA+      R+ +    T  
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           Y APEILL S+ ++   D WSVG +  EM+  +P F
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 41/268 (15%)

Query: 106 KIGPGDFEIFRVVGQGAF----GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           K+G G F    VV +G +    GKV  V              A+K ++ D +      D+
Sbjct: 2   KLGDGSF---GVVRRGEWSTSGGKVIPV--------------AVKCLKSDKL-SDIMDDF 43

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARF 219
           +K E  I+  + H  +++L Y       L ++ +    G L         G F       
Sbjct: 44  LK-EAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  +I + + +L     +HRDL   NIL+ SD  V + DFGL + + +    N      E
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ----NEDHYVME 157

Query: 280 --------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK 330
                   + APE L ++  +  +D W  G+ L+EM T G+ P+   +  ++ ++I  E 
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217

Query: 331 VKL--PPFLTSEAHSLLKGLLHKDPSKR 356
            +L  P     + ++++      +P+ R
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 27/265 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     +I +V+G G FG+V   + K    G  +   A+K + K    +K   D++ +E 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK--LPGKREIPVAIKTL-KAGYTEKQRRDFL-SEA 56

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            I+ +  HP I+ L     T+SK + ++ +++  G L          R+   +F   ++V
Sbjct: 57  SIMGQFDHPNIIHLE-GVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLV 109

Query: 226 -------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
                  S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   +  G
Sbjct: 110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 277 T--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
                + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I E  +L
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYRL 228

Query: 334 PPFLTSEA--HSLLKGLLHKDPSKR 356
           P  +   A  H L+     KD ++R
Sbjct: 229 PAPMDCPAALHQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      I      + +  +I+  +++
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            H+  ++HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
           S  ++   D W VG + +EM +G+P F
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 24/252 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
             +G+G FG V++   KG      +   A+K  R            +K     E +IL +
Sbjct: 1   EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTL------PPDLKRKFLQEAEILKQ 48

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSH 230
             HP IV+L      +  +Y++++ + GG L   L ++       +    + +  + + +
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+  +  + ++DFG+++E +    + S  G  +    + APE L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEAL 167

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSL 344
               +  ++D WS GILL+E  + G  P+   + Q+ ++RI    ++  P     E + L
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRL 227

Query: 345 LKGLLHKDPSKR 356
           +      DP  R
Sbjct: 228 MLQCWAYDPENR 239

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDIL 169
           +E    +G+GA+GKVF+ +    D  +     A+K +R  T  +   +  ++  A    L
Sbjct: 3   YECVAEIGEGAYGKVFKAR----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 170 TKVTHPFIVQL----RYSFQTR-SKLYLILDFINGGHLFFHLYR---QGIFREDQARFYT 221
               HP +V+L      S   R +KL L+ + ++   L  +L +    G+  E   +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKDMM 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           APE+LL   +    D WSVG +  EM   +P F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 40/231 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  +  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + S  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPMQLPRSMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
           D +   V+G+G FG+V + + K       DG+    A+K M K+   K +H D+   E +
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIK------KDGLRMDAAIKRM-KEYASKDDHRDF-AGELE 59

Query: 168 ILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----------- 215
           +L K+  HP I+ L  + + R  LYL +++   G+L   L +  +   D           
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 216 -----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-IN 328
                    +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++   
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            +++ P     E + L++    + P +R
Sbjct: 240 YRLEKPLNCDDEVYDLMRQCWREKPYER 267

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 70/293 (23%), Positives = 137/293 (46%), Gaps = 32/293 (10%)

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           + E E   D   E   +R +      + + +G+G FG+V   +  G+D    + +  + V
Sbjct: 2   VSEYELPEDPRWEVPRDRLV------LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV 55

Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 56  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114

Query: 206 L-----------YRQGIFREDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           L           Y      E+Q  F        ++   + +L     +HRDL   N+L+ 
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174

Query: 250 SDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++I   D   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Query: 307 MLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           + T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 235 IFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 43/182 (23%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +++  +++  + ++H   ++HRDLKP N+L++++  + + DFGLA+    S + + 
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDF 164

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ 323
           M   TEY+      APE+LL+   +    D WSVG +  E+L  +P F    + ++ KL 
Sbjct: 165 M---TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221

Query: 324 QRII------------NEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSK 355
             ++            NEK +     LP           P     A  LL+ +L  DPSK
Sbjct: 222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK 281

Query: 356 RL 357
           R+
Sbjct: 282 RI 283

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDIL 169
            +G+G++  V++ + K         + A+K +R +       T I+         E  +L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIR---------EASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G       R +  +++  ++
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S  ++   D W VG + YEM TG+P F
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 21/235 (8%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++      + R +G GAFG+V++   +G D    +   A+K + +    +++  D++  E
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-E 59

Query: 166 RDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR---- 218
             I++K  H  IV+L   SF+   + +++L+ + GG L  F    R    R         
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 219 -FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--RSN 272
            F   ++     +L +   +HRD+   N L+   G      + DFG+A++I  +S  R  
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 273 --SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQ 323
             +M    ++M PE  L        D WS G+LL+E+ + G  P+    N++ ++
Sbjct: 179 GRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 12/202 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           R +G+G FGKV   +     +GD+ G   A+K ++ ++    NH+  +K E +IL  + H
Sbjct: 10  RDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYH 65

Query: 175 PFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHL 231
             IV+ +   +    + + LI++F+  G L  +L R +      Q   Y  +I   + +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILL 287
                VHRDL   N+L++S+  V + DFGL K I+         + +     + APE L+
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
                  +D WS G+ LYE+LT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 61/253 (24%), Positives = 118/253 (46%), Gaps = 29/253 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+VF  + +       +   A+K  R +T+       +++  R IL + +HP I
Sbjct: 3   IGRGNFGEVFSGRLRA-----DNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV-------SAVSH 230
           V+L      +  +Y++++ + GG            R +  R    E++       + + +
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEY 109

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+     + ++DFG+++E +E     S  G  +    + APE L
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP--FLTSEAHS 343
               ++ ++D WS GILL+E  + G  P+ + + Q+ ++  I + V+LP         + 
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPCPELCPDAVYR 227

Query: 344 LLKGLLHKDPSKR 356
           L++     DP +R
Sbjct: 228 LMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 29/274 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            + E  R +GQGAFG+VFQ +  G+   +   + A+K M K+        D+ + E  ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 62

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYT- 221
            +  HP IV+L         + L+ +++  G L   L                 AR    
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 222 --------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-- 265
                          ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKL 322
            D    S +      +M PE +    +  ++D W+ G++L+E+ +   QP +  A+ + +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242

Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                   +  P     E ++L++    K PS R
Sbjct: 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 64/276 (23%), Positives = 124/276 (44%), Gaps = 43/276 (15%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMK--AERDILTK 171
           + +G+G FGKV  VK          G    A+K+++++     +  +     +E ++L +
Sbjct: 6   KTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQ 59

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQ--------GIFREDQARF-- 219
           V HP +++L  +      L LI+++   G L  F    R+           R        
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 220 ------------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID 266
                       +  +I   + +L +  +VHRDL   N+L+ ++G  M ++DFGL++++ 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178

Query: 267 ES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
           E      RS       ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 179 EEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L   +    +++ P   + E ++L+     ++P KR
Sbjct: 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 62/261 (23%), Positives = 117/261 (44%), Gaps = 25/261 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G G+FG V+        +  ++ + A+K M      K+ +  +    +++  L ++ HP
Sbjct: 29  IGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHP 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
             ++ +  +      +L++++  G         +   +E +    T   +  +++LH   
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG---HN 292
           ++HRD+K  NIL+   G V L DFG A    +SS +NS  GT  +MAPE++L+     ++
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL---- 348
              D WS+GI   E+   +PP  + N       I       P   ++E     +G     
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVDYC 256

Query: 349 LHKDPSKRLGSGPGGVDAIKH 369
           L K P +R    P   + ++H
Sbjct: 257 LQKIPQER----PASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 19/254 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV 172
           + +G GAFGKV +    G+   D+     MKV   M K T    +  + + +E  I++ +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95

Query: 173 -THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVS 229
             H  IV L  +      + +I ++   G L  F    R+     +    ++ ++   ++
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGT---TEYMAPEI 285
            L     +HRDL   N+L+ + G ++ + DFGLA++I   S            ++MAPE 
Sbjct: 156 FLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 342
           + +  +  ++D WS GILL+E+ + G  P+          ++I E  ++  P    +E +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274

Query: 343 SLLKGLLHKDPSKR 356
            ++K     DP KR
Sbjct: 275 DIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 67.0 bits (164), Expect = 3e-14
 Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 374 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGY 429
           R I+W  LE +E++P F P +      +NFD  +T      +P  +P +G    E F+G+
Sbjct: 1   RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGF 60

Query: 430 TYVA 433
           +YV 
Sbjct: 61  SYVF 64

Length = 64

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 34/266 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G+G FG V   +   +   D+ G + A+K ++  T     H+   + E +IL  + H  
Sbjct: 12  LGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDN 66

Query: 177 IVQLR---YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
           IV+ +   YS   R  L L+++++  G L  +L +    R D  +   Y ++I   + +L
Sbjct: 67  IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL 124

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILL 287
                VHRDL   NIL++S+  V + DFGL K + +      +    E    + APE L 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 288 SKGHNKDADWWSVGILLYEMLT-----GQPP--FTHA-NRQKLQQRII---------NEK 330
               +  +D WS G++LYE+ T       PP  F       K  Q I+         N +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244

Query: 331 VKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  PP   +E ++++K   + DPS+R
Sbjct: 245 LPAPPGCPAEIYAIMKECWNNDPSQR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 49/217 (22%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++ +G FG++F         G  + ++   V    + I+   V  +  E  +L  ++H  
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSHQN 69

Query: 177 IVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA--------EIVSA 227
           I+  L    +     +++  ++N G+L   L +  +   +  +  +         +I   
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---------DESSRSNSMCGTT 278
           +S+LHK G++H+D+   N ++D +  V +TD  L++++         D  +R        
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP------V 183

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           ++MA E L++K ++  +D WS G+LL+E++T GQ P+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 67/263 (25%), Positives = 125/263 (47%), Gaps = 26/263 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V + +  G+D    D    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-SEMELMKLIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L         LY+I+++   G+L   L         Y   I +  + +    ++VS
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 227 AV-------SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCG 276
                     +L     +HRDL   N+L+  D  + + DFGLA+   +ID   ++++   
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE L  + +   +D WS GIL++E+ T G  P+     ++L  +++ E  ++  
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKLLREGHRMDK 257

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P   T E + L++   H  P++R
Sbjct: 258 PSNCTHELYMLMRECWHAVPTQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 61/245 (24%), Positives = 120/245 (48%), Gaps = 31/245 (12%)

Query: 118 VGQGAFG----KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +G G FG     V++++KK +D        A+KV++ +   +K+  D M  E +I+ ++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNEN--EKSVRDEMMREAEIMHQLD 53

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVS-- 229
           +P+IV++    +  + L L+++  +GG  + F    +  I   +       E++  VS  
Sbjct: 54  NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN-----VVELMHQVSMG 107

Query: 230 --HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAP 283
             +L     VHRDL   N+L+ +  +  ++DFGL+K +  D+S       G    ++ AP
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEA 341
           E +  +  +  +D WS GI ++E  + GQ P+      ++   I   +++  P     E 
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Query: 342 HSLLK 346
           ++L+K
Sbjct: 228 YALMK 232

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 67/253 (26%), Positives = 122/253 (48%), Gaps = 14/253 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D  + R +G+G FG V+Q V     ++  +  +   K     ++ +K        E  I+
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIM 61

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSA 227
            +  HP IV+L     T + ++++++    G L  +L +   +  D A    Y+ ++ +A
Sbjct: 62  RQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S   V L DFGL++ +++ S   +  G    ++MAPE 
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239

Query: 344 LLKGLLHKDPSKR 356
           L+      DPSKR
Sbjct: 240 LMTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 27/261 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKVF  +   +       + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTVLQHQHI 69

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG----IFREDQAR-----------FYT 221
           V+  Y   T  + L ++ +++  G L   L   G    I    +                
Sbjct: 70  VRF-YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
           ++I S + +L     VHRDL   N L+     V + DFG++++I  S+    + G T   
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187

Query: 279 -EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPP 335
             +M PE +L +    ++D WS G++L+E+ T   QP +  +N + ++      +++ P 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
               E +++++G   ++P +R
Sbjct: 248 TCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 63/238 (26%), Positives = 121/238 (50%), Gaps = 14/238 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   V +G++  I  A+K++ + T  K N V++M  E  I+  + H
Sbjct: 13  KVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMD-EALIMASMDH 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           P +V+L         + L+   +  G L  + H ++  I  +     +  +I   + +L 
Sbjct: 69  PHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLE 126

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEILLSK 289
           +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E +  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + ++
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 244

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 53/214 (24%), Positives = 110/214 (51%), Gaps = 12/214 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG+VF   K  + D       A+K  ++D + ++  + ++   R IL +  HP 
Sbjct: 2   LLGKGNFGEVF---KGTLKDKTP---VAVKTCKED-LPQELKIKFLSEAR-ILKQYDHPN 53

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCG 235
           IV+L      R  +Y++++ + GG     L ++    +  Q   +  +  + +++L    
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            +HRDL   N L+  +  + ++DFG++++ D+   S+S       ++ APE L    ++ 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 294 DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
           ++D WS GILL+E  + G  P+     Q+ ++++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 60/235 (25%), Positives = 114/235 (48%), Gaps = 11/235 (4%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+VF+   K    G  +   A+K + K    +K   D++ +E
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTL-KPGYTEKQRQDFL-SE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEI 224
             I+ + +H  I++L           +I +++  G L  +L    G F   Q       I
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCG---TTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ + D+   + +  G      +
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
            APE +  +     +D WS GI+++E+++ G+ P+   +  ++  + IN+  +LP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 28/263 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPF 176
           +G+GAFG+V + +  G+D+ +     A+K M KD   +K+  D + +E +++  +  H  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLV-SEMEMMKMIGKHKN 77

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS- 226
           I+ L         LY+++++   G+L   L               R  +      ++VS 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 227 ------AVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE----SSRSNSMC 275
                  +  L     +HRDL   N+L+ ++ HVM + DFGLA++I         +N   
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 333
              ++MAPE L  + +   +D WS G+LL+E+ T G  P+     ++L + +    +++ 
Sbjct: 197 -PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEK 255

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P   T E + L++   H+ PS+R
Sbjct: 256 PQNCTQELYHLMRDCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 52/216 (24%), Positives = 107/216 (49%), Gaps = 22/216 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVF----QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           I P +  + + +G G FG V+      K+K           A+K +R+  + +++     
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRK----------VAIKTIREGAMSEED----F 46

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYT 221
             E  ++ K++HP +VQL      RS + L+ +F+  G L  +L  Q G F ++      
Sbjct: 47  IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
            ++   +++L    ++HRDL   N L+  +  V ++DFG+ + +  D+ + S       +
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + +PE+     ++  +D WS G+L++E+ + G+ P+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 74/320 (23%), Positives = 131/320 (40%), Gaps = 48/320 (15%)

Query: 18  KKLTITPPSASSPDFDFTEV-----FGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           +K++I  P  + P      +      G L   R N    AS        +        F 
Sbjct: 64  EKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFD 123

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVG---QGAFGKVF-- 127
              P  A    +PL   +L+H+++                  FRV+     GAFGK+F  
Sbjct: 124 EAPPDAA--GPVPLAQAKLKHDDEF--------------LAHFRVIDDLPAGAFGKIFIC 167

Query: 128 --------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
                      ++GV+  +       +++ K           ++ E   L ++ H  I++
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 180 LRYSFQTRSKLYLI---LDFINGGHLFFHLYRQGIFRED-----QARFYTAEIVSAVSHL 231
           +    ++ +  Y+I    DF     L+  +Y +    +D     Q R    +++ AV ++
Sbjct: 228 IEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSK 289
           H   ++HRD+K ENI ++ DG ++L DFG A   E +  +      GT    +PEIL   
Sbjct: 284 HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343

Query: 290 GHNKDADWWSVGILLYEMLT 309
           G+ +  D WS G++L +ML+
Sbjct: 344 GYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 66/261 (25%), Positives = 129/261 (49%), Gaps = 29/261 (11%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           +I  V+G G FG+V + + K    G  +   A+K + K    +K   D++ +E  I+ + 
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLP--GKREIFVAIKTL-KSGYTEKQRRDFL-SEASIMGQF 62

Query: 173 THPFIVQLRYSFQTRSKLYLIL-DFINGGHLFFHLYRQGIFREDQARFYTAEIV------ 225
            HP I+ L     T+S+  +I+ +F+  G L          R++  +F   ++V      
Sbjct: 63  DHPNIIHLE-GVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGI 115

Query: 226 -SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT--T 278
            + + +L +   VHRDL   NIL++S+    ++DFGL++ +++ +     ++S+ G    
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFL 337
            + APE +  +     +D WS GI+++E+++ G+ P+   + Q +    I +  +LPP +
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIEQDYRLPPPM 234

Query: 338 TSEA--HSLLKGLLHKDPSKR 356
                 H L+     KD + R
Sbjct: 235 DCPTALHQLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 62/249 (24%), Positives = 120/249 (48%), Gaps = 23/249 (9%)

Query: 118 VGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G G +G+V++ V KK           A+K +++DT+     V+    E  ++ ++ HP 
Sbjct: 14  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPN 63

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYTA-EIVSAVSHLH 232
           +VQL          Y+I +F+  G+L  +L      R++       Y A +I SA+ +L 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE 121

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEILLSK 289
           K   +HRDL   N L+  +  V + DFGL++ +   + + +  G     ++ APE L   
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN 180

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKG 347
             +  +D W+ G+LL+E+ T G  P+   +  ++ + +    +++ P     + + L++ 
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240

Query: 348 LLHKDPSKR 356
               +PS R
Sbjct: 241 CWQWNPSDR 249

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 62/262 (23%), Positives = 117/262 (44%), Gaps = 27/262 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAFGKVF  +   +       + A+K ++   D   K  H      E ++LT + 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 65

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-------------FREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I + + +L     VHRDL   N L+  +  V + DFG+++++  S+    + G T  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTML 184

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLP 334
              +M PE ++ +    ++D WS+G++L+E+ T G+ P+   +  ++ + I   +V + P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
                E + L+ G   ++P  R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/263 (24%), Positives = 126/263 (47%), Gaps = 26/263 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D    +    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L  +      LY+++++ + G+L  +L         Y     +  + +    ++VS
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
                   + +L     +HRDL   N+L+  D  + + DFGLA++   ID   ++ +   
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE L  + +   +D WS G+LL+E+ T G  P+     ++L  +++ E  ++  
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDK 257

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P   T E + +++   H  PS+R
Sbjct: 258 PANCTHELYMIMRECWHAVPSQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 72/311 (23%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G GAFGKV +    G+D   S    A+K M K+      H   M +E  IL  +  H
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVK-MLKEGATASEHKALM-SELKILIHIGNH 70

Query: 175 PFIVQLRYS-FQTRSKLYLILDFINGGHL---------FFHLYRQ--------------- 209
             +V L  +  +    L +I++F   G+L         FF  YR+               
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 210 ---------GIFREDQARF-----------------------------YTAEIVSAVSHL 231
                    G      +RF                             Y+ ++   +  L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLS 288
                +HRDL   NIL+  +  V + DFGLA++I    +  R  S     ++MAPE +  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 289 KGHNKDADWWSVGILLYEMLT-GQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
           K +   +D WS G+LL+E+ + G  P+     N +  Q+     +++ P   T E + ++
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIM 310

Query: 346 KGLLHKDPSKR 356
                 DP +R
Sbjct: 311 LACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 60/267 (22%), Positives = 121/267 (45%), Gaps = 28/267 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           D +   V+G+G FG+V +  +KK      D   + A   M K+   + +H D+   E ++
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKK------DGLKMNAAIKMLKEFASENDHRDF-AGELEV 55

Query: 169 LTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED------------ 215
           L K+  HP I+ L  + + R  LY+ +++   G+L   L +  +   D            
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 216 ----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               Q   + +++ + + +L +   +HRDL   N+L+  +    + DFGL++  +   + 
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE- 329
                   +MA E L    +   +D WS G+LL+E+++ G  P+      +L +++    
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235

Query: 330 KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +++ P     E + L++      P +R
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 63/262 (24%), Positives = 120/262 (45%), Gaps = 30/262 (11%)

Query: 117 VVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           V+G+G FG+V +  +KK G+       + A     K+   K +H D+   E ++L K+ H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLR------MDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 54

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA---------------- 217
            P I+ L  + + R  LYL +++   G+L   L +  +   D A                
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 218 -RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
             F  A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 115 LHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 334
              +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    +++ P
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233

Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
                E + L++    + P +R
Sbjct: 234 LNCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 57/261 (21%), Positives = 119/261 (45%), Gaps = 25/261 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKV++ +  G ++  S    A+K ++++   K       + E ++++ + HP I
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR----------------QGIFREDQARFYT 221
           V L           ++ +++  G L   L R                +            
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT 277
            +I + + +L     VHRDL   N L+     V ++DFGL+++I  +     +S S+   
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-P 189

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 335
             +M PE +L      ++D WS G++L+E+ + G  P+   + Q++ + I + ++   P 
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
              +  ++L+    ++ P++R
Sbjct: 250 DCPARVYALMIECWNEIPARR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 118 VGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +G G FG V     KGV     G    + A+K ++++ I           E  ++ ++ H
Sbjct: 3   LGHGNFGSV----VKGVYLMKSGKEVEV-AVKTLKQEHI--AAGKKEFLREASVMAQLDH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L    +    L L+++    G L  +L ++        +    ++   +++L   
Sbjct: 56  PCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MA 282
             VHRDL   N+L+ +     ++DFG+++ +          G+  Y             A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG--------AGSDYYRATTAGRWPLKWYA 166

Query: 283 PE-ILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           PE I   K  +K +D WS G+ L+E  + G  P+
Sbjct: 167 PECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 24/235 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV   +      G S     +K +R  +      + +++ E     ++ HP +
Sbjct: 3   IGNGWFGKVLLGE---AHRGMSKARVVVKELR-ASATPDEQLLFLQ-EVQPYRELNHPNV 57

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFRED-----QARFYTAEIVSAVSHL 231
           +Q            L+L+F   G L  +L   +G+  +        R    E+ S +  L
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGLLWL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEI--- 285
           H+   +H DL   N  + +D  V + D+GLA E    D     +       ++APE+   
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 286 ----LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLP 334
               LL K   K ++ WS+G+ ++E+ T   QP    ++ Q L+Q +  + +KLP
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 24/260 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FG V + +    DDG S    A+K M+ D        +++  E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQ-DDG-SQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHP 61

Query: 176 FIVQL-RYSFQTRS-----KLYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
            +++L    F+  S     K  +IL F+  G L   L    +                  
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFM 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I   + +L     +HRDL   N ++  D  V + DFGL+K+I                
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPF 336
           +++A E L  + +   +D W+ G+ ++E+ T GQ P+      ++   + +  ++K P  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239

Query: 337 LTSEAHSLLKGLLHKDPSKR 356
              E + L+      DP  R
Sbjct: 240 CLDELYDLMYSCWRADPKDR 259

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 59/264 (22%), Positives = 118/264 (44%), Gaps = 31/264 (11%)

Query: 118 VGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+ AFGK+++  +   G+D      + A+K ++   I         + E  ++ ++ HP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ---LVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ------------GIFRE--DQARFY 220
            IV L         + ++ +++N G L  F + R             G  +   D   F 
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 221 --TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSM 274
               +I + + +L     VH+DL   NIL+    HV ++D GL++EI  +     +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKLQQRIINEKVK 332
                +M PE ++    + D+D WS G++L+E+ +   QP +  +N++ ++     + + 
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP 246

Query: 333 LPPFLTSEAHSLLKGLLHKDPSKR 356
                    +SL+     + PS+R
Sbjct: 247 CSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 19/221 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNH--V 159
           R +   +    +++G G FG V     KG+   +GDS  I  A+K ++  +  +      
Sbjct: 2   RILKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEIT 57

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQAR 218
           D+M A    +  + H +IV+L       + L L+      G L  H+   +      +  
Sbjct: 58  DHMLA----MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMC 275
            +  +I   + +L +  +VHR+L   NIL+ SD  V + DFG+A  +   D+    +   
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT 315
              ++MA E +L   +   +D WS G+ ++EM++ G  P+ 
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 8/130 (6%)

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSK 289
           KC  +HRDL   NIL+  +  V + DFGLA++I +     R        ++MAPE +  K
Sbjct: 193 KC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
            +   +D WS G+LL+E+ + G  P+      +   R + E  ++  P + T E +S++ 
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Query: 347 GLLHKDPSKR 356
              H +P  R
Sbjct: 311 DCWHNNPEDR 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 6/143 (4%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I    +  R      
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF--THANRQKLQQRIINEKVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+     + +  ++     +++ 
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 304 PDYTTPEMYQTMLDCWHGEPSQR 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 82/351 (23%), Positives = 142/351 (40%), Gaps = 52/351 (14%)

Query: 2   VSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDP 61
              S K  +S  T +    +      S    D        +    +++  A+T  +   P
Sbjct: 28  SGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTP 87

Query: 62  QVIHNRSHSFVGPSP-RYALSSSLPLQIQELEHEN---DAELEAESERKIGPGDFEIFRV 117
                 ++  V P P +  ++ +LP Q +E  H       +++  ++R      F+I  +
Sbjct: 88  T-----TNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQR------FKILSL 136

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDILTKVTH 174
           +G+G FGKV +       D       A+K++R   K T   K  + +M+  R        
Sbjct: 137 LGEGTFGKVVEAW-----DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV----SAVSH 230
           P +   RY FQ  +    I+    G  L   + + G F       + A+I+     A+ +
Sbjct: 192 PLMKIQRY-FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR----HLAQIIFQTGVALDY 246

Query: 231 LH-KCGIVHRDLKPENILMDSDG----------------HVMLTDFGLAKEIDESSRSNS 273
            H +  ++H DLKPENILM++                   V + D G     DE     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQ 323
           +  T  Y +PE++L  G     D WS+G ++YE+ TG+  + TH N + L 
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355

Length = 467

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG+V+          +     A+K M+  ++     V+   AE +++  + H 
Sbjct: 12  KKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHK 233
            +V+L ++  T+  +Y+I +F+  G L   L      ++   +   ++A+I   ++ + +
Sbjct: 62  KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSKGH 291
              +HRDL+  NIL+ +     + DFGLA+  E +E +         ++ APE +     
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 292 NKDADWWSVGILLYEMLT-GQPPF 314
              +D WS GILL E++T G+ P+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 27/255 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHV------DYMKAERDIL 169
           +G G FG V    KKG+        Y MK   K   +K  KN        D +  E +++
Sbjct: 3   LGSGNFGTV----KKGM--------YKMKKSEKTVAVKILKNDNNDPALKDELLREANVM 50

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ +P+IV++    +  S   L+++    G L   L +     E        ++   + 
Sbjct: 51  QQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK 109

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAPEI 285
           +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G    ++ APE 
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +     +  +D WS G+L++E  + GQ P+      ++ Q I + E+++ P     E + 
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD 229

Query: 344 LLKGLLHKDPSKRLG 358
           L+K        +R G
Sbjct: 230 LMKLCWTYGVDERPG 244

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 54/202 (26%), Positives = 104/202 (51%), Gaps = 16/202 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V+     G  +G +    A+K +++ ++      +   AE +++ ++ HP +
Sbjct: 14  LGAGQFGEVWM----GYYNGHTK--VAIKSLKQGSM----SPEAFLAEANLMKQLQHPRL 63

Query: 178 VQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCG 235
           V+L Y+  T+  +Y+I +++ NG  + F    +GI    ++     A+I   ++ + +  
Sbjct: 64  VRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            +HRDL+  NIL+       + DFGLA+  E +E +         ++ APE +       
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 294 DADWWSVGILLYEMLT-GQPPF 314
            +D WS GILL E++T G+ P+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 44/184 (23%), Positives = 88/184 (47%), Gaps = 16/184 (8%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFINGGH--- 201
            ++K  +   +  D    +++I+T  ++ HP I+    SF   S+LY++   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L    + +G   E    F   ++++A+ ++H  G +HR +K  +IL+  DG V+L+    
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 262 AKEIDESS-RSNSMCGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQ 311
           +  + +   R   +    +        ++PE+L    +G+N+ +D +SVGI   E+  G 
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207

Query: 312 PPFT 315
            PF 
Sbjct: 208 VPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 36/111 (32%), Positives = 60/111 (54%), Gaps = 8/111 (7%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--- 271
           +  +F+  +++ A+ ++H   + HRDLKP+NIL ++D  + + DFGLA+     + +   
Sbjct: 103 EHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162

Query: 272 -NSMCGTTEYMAPEI---LLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
                 T  Y APE+     SK +    D WS+G +  E+LTG+P F   N
Sbjct: 163 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKN 212

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 52/214 (24%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY------AMKVMRKDTIIKKNHVDYMKAER 166
           ++ + +G G FG+V+             G Y      A+K ++  T+     V     E 
Sbjct: 9   KLVKKLGAGQFGEVWM------------GYYNNSTKVAVKTLKPGTM----SVQAFLEEA 52

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--YTAE 223
           +++  + H  +V+L Y+  T+ + +Y+I +++  G L   L      +    +   ++A+
Sbjct: 53  NLMKTLQHDKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYM 281
           I   ++++ +   +HRDL+  N+L+       + DFGLA+ I  +E +         ++ 
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           APE +        +D WS GILLYE++T G+ P+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 21/225 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +GQG+FG V++   KGV   + +   A+K + +   +++  ++++  E  ++ +    
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLN-EASVMKEFNCH 69

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA------------E 223
            +V+L           +I++ +  G L  +L  + +  E +     A            E
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEY 280
           I   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +         +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 323
           M+PE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTT 278
           +++SA+ ++H  GI+HRD+K EN+L++    + L DFG A      S S      + GT 
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIAGTV 326

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYE 306
           +  APE+L    +    D WS G++++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 18/178 (10%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARFYTAEIVSAVS 229
           HP I+Q            L+ ++   G L  +L ++   R +      +    EI + V+
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTTEYMAPEI 285
           H+HK   +H DL   N  + SD  V + D+G+     KE D     +  C    ++APE+
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 286 -------LLSKGHNKDADWWSVGILLYEML-TGQPPFTH-ANRQKLQQRIINEKVKLP 334
                  L++    K ++ W++G+ L+E+      P++H ++R+ L   I +++VKL 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           +G+G FG+V   + +G+ +              + A+K++R D + K    D++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE------------DQ 216
           ++++ +P I++L     +   L +I +++  G L   L ++ I                 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNS 273
             +   +I S + +L     VHRDL   N L+ +   + + DFG+++ +   D       
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E +L       +D W+ G+ L+EM T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 65/265 (24%), Positives = 120/265 (45%), Gaps = 35/265 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FG V + +   ++  DS    A+K M K  I  ++ ++   +E   + +  HP
Sbjct: 5   KTLGEGEFGSVMEGQ---LNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 176 FIVQL-RYSFQ-TRSKLY----LILDFINGG--HLFFHLYRQGIFREDQARF-------- 219
            +++L     Q   S+ Y    +IL F+  G  H F    R G    D  ++        
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVK 116

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           +  +I S + +L     +HRDL   N +++ + +V + DFGL+K+I   D   +      
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK----LQQRIINEKV 331
             +++A E L  + +   +D WS G+ ++E+ T GQ P+      +    L+Q     ++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GNRL 233

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKR 356
           K PP      +SL+      +P  R
Sbjct: 234 KQPPDCLDGLYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 57/261 (21%), Positives = 113/261 (43%), Gaps = 23/261 (8%)

Query: 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           + R +GQG+FG V++   + +  G+++   A+K + +   +++  ++++  E  ++   T
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLN-EASVMKGFT 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARF---------Y 220
              +V+L           ++++ +  G L  +L      R +      R           
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS---LRPEAENNPGRPPPTLQEMIQM 124

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQQRIINEKVKLPP 335
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+  +    +  P 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
                   L++     +P  R
Sbjct: 245 NCPERVTDLMRMCWQFNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 6/88 (6%)

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           VHRDL   N ++D    V + DFGLA     KE              ++MA E L ++  
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHAN 318
              +D WS G+LL+E++T G PP+   +
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 14/125 (11%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTT 278
           EI   + HLHK   +H DL   N L+ +D  V + D+GL+    KE D     + +    
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPL 166

Query: 279 EYMAPEI-------LLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQQRIINE 329
            ++APE+       LL     K+++ WS+G+ ++E+  L  QP    ++ Q L   +  +
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Query: 330 KVKLP 334
           ++KLP
Sbjct: 227 QLKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 8/144 (5%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   +S L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GILL+E+ + G  P+          ++I E  ++ 
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337

Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    SE + ++K     DP KR
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 22/238 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+  FGKV++    G   G+     A+K ++          +  K E  + +++ HP I
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ-----GIFREDQ--------ARFY--T 221
           V L         L +I  + +   L  F + R      G   +D+        A F    
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I + +  L    +VH+DL   N+L+    +V ++D GL +E+  +     M  +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
            +M+PE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 16/148 (10%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           +T ++   +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-------THANRQKLQQRIIN 328
             ++MAPE +    +   +D WS GILL+E+ + G  P+       T  N+ K   R+  
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                P   T E + ++    + +P KR
Sbjct: 362 -----PDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS--- 269
           +D  RF ++++   +  L     +HRD+   N+L+ +DG V  + DFGLA++I   S   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII 327
            + N+     ++MAPE +    +   +D WS GILL+E+ + G+ P+          +++
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 328 NEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
               ++  P F   E +S++K   + +P++R
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 33/228 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G+G FG+V   + +G++            G+   + A+K++R+D   K    D++K E 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLK-EI 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA--------- 217
            I++++  P I++L     T   L +I +++  G L   L R    +E            
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTISY 129

Query: 218 ---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRS 271
               F   +I S + +L     VHRDL   N L+  +  + + DFG+++ +   D     
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 272 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
                   +M+ E ILL K     +D W+ G+ L+E+LT   + P++ 
Sbjct: 190 GRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 18/176 (10%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           HP I+     F T S L++I  F+  G    L    + +G+  E          +  +++
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFG-LAKEIDESSRS-------NSMCGTTEYMA 282
           LH+ G +HR++K  +IL+  DG V L+    L   +    ++               +++
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 283 PEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           PE+L     G+N  +D +SVGI   E+ TG+ PF    R ++    + +K+K PP+
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPY 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           ++ ++ + +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++MAPE + +  +   +D WS GILL+E+ T G  P+
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 27/269 (10%)

Query: 98  ELEAES---ERKIGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           EL+ +S   ER +G G F E+ R   +    +   V    +  G SD             
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD------------- 47

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIF 212
             K    ++ AE   L +  H  IV+L       + + ++ ++++ G L   L + +G  
Sbjct: 48  --KQRRGFL-AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL 104

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
              Q       + S + +L + G VH+ L    +L++SD    ++ F   +E    +   
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164

Query: 273 SMCGTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           +M G +   + APE +     +  +D WS GI+++E+++ G+ P+   + Q +  + + +
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVED 223

Query: 330 KVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             +LP         H L+     K+  +R
Sbjct: 224 GFRLPAPRNCPNLLHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 26/67 (38%), Positives = 41/67 (61%), Gaps = 2/67 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE--Y 280
           ++++ +  LH+ GIVHRD+KPEN+L+  DG V + DFG A ++      N + G  +  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 281 MAPEILL 287
             PE L+
Sbjct: 377 SPPEELV 383

Length = 507

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 29/80 (36%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDS 250
           L+  +  G  L  HL R      D A F +A    A+  LH+ GI H DL KP+N LM  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 251 DGHVMLTDFGLAKEIDESSR 270
           DG   + DF LA        
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 54/252 (21%), Positives = 106/252 (42%), Gaps = 42/252 (16%)

Query: 134 VDDGDSDGIYAMKVMRKDTIIK------KNH---VDYMKAERDILTKVTHPFIVQLRYSF 184
           + + D + IY      K+ II+      K H   +D  + E   L ++    I+++ Y F
Sbjct: 28  IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI-YGF 86

Query: 185 -----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-----EIVSAVSHLHK- 233
                    +L LIL++   G+L     R+ + +E    F T      +    + +L+K 
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYL-----REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL---S 288
               +++L   + L+  +  + +   GL K +        N M     Y + ++L    S
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + +    D +S+G++L+E+ TG+ PF +   +++   IIN+   L   L  +    +K +
Sbjct: 198 E-YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEIKCI 254

Query: 349 ----LHKDPSKR 356
                  D  KR
Sbjct: 255 VEACTSHDSIKR 266

Length = 283

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 43.8 bits (104), Expect = 2e-06
 Identities = 13/46 (28%), Positives = 20/46 (43%), Gaps = 4/46 (8%)

Query: 394 VSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGYTYVAPN 435
           V      +NFD  +T+ P   SP  +          F+G++YV P 
Sbjct: 2   VKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47

Length = 47

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++R D   K    D++K E  IL+++  P I++L         L +I +++  G L 
Sbjct: 50  AVKILRPDAN-KNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 204 FHLYR------------------QGIFREDQARFYTA-EIVSAVSHLHKCGIVHRDLKPE 244
             L                            +  + A +I S + +L     VHRDL   
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 245 NILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N L+  +  + + DFG+++ +   D             +MA E +L       +D W+ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 302 ILLYEML 308
           + L+E+L
Sbjct: 228 VTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 14/169 (8%)

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 43  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-SEL 101

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF-GLAKEIDESSRSNSM 274
              +    ++ A+ ++H  G VHR +K  +IL+  DG V L+        I+   R   +
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161

Query: 275 CGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 314
               +Y       ++PE+L    +G++  +D +SVGI   E+  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 13/114 (11%)

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +  + +  E++     A  +  +  L +    HR  K  NIL+  DG + L      K  
Sbjct: 9   VRGRPL-NEEEI---WAVCLQCLGALREL---HRQAKSGNILLTWDGLLKLDGSVAFKT- 60

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
            E SR +       +MAPE++  + + + AD +S+GI LYE L  + P+     
Sbjct: 61  PEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLA 262
           +I+ A+  LH  GIVHRD+KP+NI+     G   + D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           E+   V  LHK GIVH DL   NI++     +   DFGL +
Sbjct: 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 16/33 (48%), Positives = 22/33 (66%), Gaps = 1/33 (3%)

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           LH  GI+H DL   N+++ S G + L DFGLA+
Sbjct: 111 LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 16/141 (11%)

Query: 131 KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY----MKAERDILTKV-THPFIV-QLRYSF 184
            K +  G ++ +Y +    +D ++K N         + E  IL  +      V ++  S 
Sbjct: 3   IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDL 241
           ++    YL++++I G  L      +   +ED A     ++   ++ LH+     + H DL
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEE---KEDIAE----QLAELLAKLHQLPLLVLCHGDL 115

Query: 242 KPENILMDSDGHVMLTDFGLA 262
            P NIL+D    + + D+  A
Sbjct: 116 HPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 53/259 (20%), Positives = 117/259 (45%), Gaps = 34/259 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDILTKVTH 174
           +GQG F K+F+  ++ V  GD   ++  +V+ K  ++ K+H +Y ++      ++++++H
Sbjct: 3   LGQGTFTKIFKGIRREV--GDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSH 58

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V          +  ++ +++  G L  +L +         +   A ++  A+  L  
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118

Query: 234 CGIVHRDLKPENILMDSDGH--------VMLTDFG-----LAKEIDESSRSNSMCGTTEY 280
            G+ H ++  +N+L+  +          + L+D G     L KEI        +     +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPW 170

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKLQQRIINEKVKLPPFL 337
           + PE +   +  +  AD WS G  L+E+ +G  +P     +++KLQ     ++ +LP   
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYEDRHQLPAPK 228

Query: 338 TSEAHSLLKGLLHKDPSKR 356
            +E  +L+   +  +P  R
Sbjct: 229 WTELANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           + K+ HP IV+L    ++    YLI ++I G +L   L  + +  E + +     I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 229 SHLH-KCG--IVHRDLKPENILMD--SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
             LH +C   +V  +L PE I++D   + H+ L+  GL    D     +S      Y+AP
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC-TDTKCFISS-----AYVAP 847

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPP 313
           E   +K   + +D +  G++L E+LTG+ P
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 35/228 (15%)

Query: 119 GQGAFGKV----------FQVKK-KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           G+G FG+V          F  K     D+ D+  + A+KV+R D        D++K E  
Sbjct: 14  GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLK-EVK 71

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT------ 221
           IL++++ P I +L         L +I++++  G L   L +  +         +      
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETSGLACNSKSLSFS 130

Query: 222 ------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RS 271
                  +I S + +L     VHRDL   N L+  +  + + DFG+++ +  S     + 
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 272 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
            +      +MA E +LL K     +D W+ G+ L+E+LT   + P+ H
Sbjct: 191 RAPL-PIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 33/259 (12%)

Query: 119 GQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DILTKVTH 174
           GQG F  +++  ++ +   D    G     V++   ++  +H D +       ++++++H
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLSH 60

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V+L Y    R +  ++ +++  G L   L+R+        +   A ++ SA+ +L  
Sbjct: 61  KHLVKL-YGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 234 CGIVHRDLKPENILMDSDGH-------VMLTDFG-----LAKEIDESSRSNSMCGTTEYM 281
             +VH ++  +NIL+   G        + L+D G     L++E               ++
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER--------IPWI 171

Query: 282 APEIL--LSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLT 338
           APE +          AD WS G  L E+ +    P +  +  + ++R   ++ +LP    
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQDQHRLPMPDC 230

Query: 339 SEAHSLLKGLLHKDPSKRL 357
           +E  +L+      DP+KR 
Sbjct: 231 AELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 19/37 (51%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            V  LHK GIVH DL   NI++  D  + L DFGL K
Sbjct: 102 LVGKLHKAGIVHGDLTTSNIIVRDDK-LYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 6e-04
 Identities = 21/52 (40%), Positives = 25/52 (48%), Gaps = 5/52 (9%)

Query: 220 YTAEIVSAVSH----LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
              E+V  V      LHK GIVH DL   N ++  D  + L DFGL K  D 
Sbjct: 429 GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 14/42 (33%), Positives = 29/42 (69%)

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             ++++ + ++H+ GI H D+KPENI++D +    + D+G+A
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK)

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 18/119 (15%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDFINGGHLFFH 205
           V+R      +  ++  + E +         I  +L Y         LI +FI G  L   
Sbjct: 25  VVRIPGNGTELLIN-RENEAENSKLAAEAGIGPKLYYFDPETG--VLITEFIEGSELLTE 81

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIV-----HRDLKPENILMDSDGHVMLTDF 259
            +      E        +I   +  LH   +      H DL P N L   DG + L D+
Sbjct: 82  DFSDPENLE--------KIAKLLKKLHSSPLPDLVPCHNDLLPGNFL-LDDGRLWLIDW 131

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 39.0 bits (92), Expect = 0.002
 Identities = 14/37 (37%), Positives = 22/37 (59%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
           EI+  +   +K GI+H DL   NIL+D D  + + D+
Sbjct: 133 EILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 38.6 bits (91), Expect = 0.002
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS 250
           L+++FI G  +     +     ED    Y  +I+  +  L  + G+VH DL   NIL+D 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVRLLEDPEELY-DQILELMRKLYREAGLVHGDLSEYNILVD- 149

Query: 251 DGHVMLTDFGLAKEID 266
           DG V + D   A EID
Sbjct: 150 DGKVYIIDVPQAVEID 165

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 60/256 (23%), Positives = 114/256 (44%), Gaps = 22/256 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKA---ERDILTK 171
           +G+G   +++       DD + DG      +KV+ K  ++  +H D   A      ++ +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK--VLDPSHRDISLAFFETASMMRQ 60

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSH 230
           V+H  IV L        +  ++ +F+  G L   ++R+        +F  A ++ SA+S+
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 231 LHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           L    +VH ++  +NIL+  +G        + L+D G+   I   SR   +     ++AP
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECV-ERIPWIAP 177

Query: 284 EILL-SKGHNKDADWWSVGILLYEM-LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           E +  SK  +  AD WS G  L+E+   G+ P       + ++R    +  L      E 
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCMLVTPSCKEL 236

Query: 342 HSLLKGLLHKDPSKRL 357
             L+   ++ DP++R 
Sbjct: 237 ADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	441
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.65
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.24
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.97
PRK09902	216	hypothetical protein; Provisional	98.92
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.86
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.83
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.5
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.17
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.99
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
PRK10593	297	hypothetical protein; Provisional	97.88
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.83
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.62
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
PRK05231	319	homoserine kinase; Provisional	97.61
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.55
KOG2270	520	consensus Serine/threonine protein kinase involved	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.1
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.07
PLN02236	344	choline kinase	97.02
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.68
PLN02756	418	S-methyl-5-thioribose kinase	96.48
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.47
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.46
PRK12396	409	5-methylribose kinase; Reviewed	96.35
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.07
PRK11768	325	serine/threonine protein kinase; Provisional	96.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.96
PTZ00384	383	choline kinase; Provisional	95.93
PRK06148	1013	hypothetical protein; Provisional	95.9
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	95.89
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.12

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-77  Score=560.08  Aligned_cols=323  Identities=55%  Similarity=1.000  Sum_probs=299.3

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|+++++||+|+||+||+|+.+.     +++.||+|+++|..+.....++.+.+|..||.+++||+||+++..|+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~d-----t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKD-----TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcc-----cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            3556789999999999999999999985     99999999999999999989999999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc-
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~-  264 (441)
                      +.+++|+|+||+.||+|+.+|.+++.|+|+.+++|+++|+.||.|||++|||||||||+|||||.+|+++|+|||+++. 
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999996 


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CCCCCcHHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHS  343 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~  343 (441)
                      ...+..+.++|||+.|||||++.+.+|+..+||||||+++|||++|.+||.+.+..++.++|..++.. .|..++.++++
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARD  255 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHH
Confidence            45555677899999999999999999999999999999999999999999999999999999999954 45569999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----  419 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  419 (441)
                      ||+++|++||++|+| +..++++|.+||||++++|+.+.++++.|||+|...+..|+++||.+++....+.++...    
T Consensus       256 ll~~LL~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~  334 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDM  334 (357)
T ss_pred             HHHHHhccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCccc
Confidence            999999999999998 456899999999999999999999999999999999999999999999887555544321    


Q ss_pred             -------CCCCCcccCeeeeCC
Q 013558          420 -------PTAGEHFKGYTYVAP  434 (441)
Q Consensus       420 -------~~~~~~f~~~~~~~~  434 (441)
                             ......|.||+|+.+
T Consensus       335 ~~~~~~~~~~~~~f~gft~~~~  356 (357)
T KOG0598|consen  335 SAFTAFSRTYNKIFPGFTYVAS  356 (357)
T ss_pred             ccccccccccccccCCccccCC
Confidence                   134677999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-73  Score=561.91  Aligned_cols=324  Identities=39%  Similarity=0.810  Sum_probs=304.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  183 (441)
                      ..++.++|.++++||+|+||+|+++..++     +++.||||+++|+.+...+.++..+.|.+|+...+ ||++++|+..
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            46778899999999999999999999997     88899999999999999999999999999999885 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      |++.+++|+||||+.||++ .++...+.|++..+++|+++|+.||.|||++||||||||.+|||||.+|++||+|||+++
T Consensus       438 fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999994 444555889999999999999999999999999999999999999999999999999999


Q ss_pred             cc-CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          264 EI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       264 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      .. ..+..+.++|||+.|||||++.+..|+..+|||||||+|||||.|..||.+.+.++++..|+...+.+|.+++.++.
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            74 36667889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC---
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  419 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  419 (441)
                      ++|+++|.+||++|+|+++.++++|+.||||++|+|+.+++++++|||+|.+.+..+.+|||..++.++...++...   
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l  676 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPL  676 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcccc
Confidence            99999999999999999988999999999999999999999999999999999999999999999988776665221   


Q ss_pred             -CCCCCcccCeeeeCC
Q 013558          420 -PTAGEHFKGYTYVAP  434 (441)
Q Consensus       420 -~~~~~~f~~~~~~~~  434 (441)
                       ...+++|.||+|+++
T Consensus       677 ~~~~q~~F~~Fs~~~~  692 (694)
T KOG0694|consen  677 TEEEQEAFRDFSFVAE  692 (694)
T ss_pred             chhhHHHhcCccccCC
Confidence             146899999999985

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-73  Score=512.59  Aligned_cols=293  Identities=44%  Similarity=0.863  Sum_probs=283.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|++++.||.|+||+|.+++.+.     ++..||+|++.+..+.+..+++...+|..+|+.+.||++++|++.|.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-----~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKH-----SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEcc-----CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            667899999999999999999999987     899999999999999999999999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      .+.+|+||||++||.|+.++++.++|++..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+.+.
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      ..  +.+.||||.|+|||++..++|+.++|||||||++|||+.|.+||...++..++++|+.+++.+|..++.++++||+
T Consensus       196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence            63  7789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC-CCCCcccccCcccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP-DVSGKDCIANFDKC  406 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p-~~~~~~~~~~~~~~  406 (441)
                      ++|+.|-.+|.|...++.++|+.||||++++|.++..++++|||+| ......++++||..
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y  334 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDY  334 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCccccccccc
Confidence            9999999999999888999999999999999999999999999998 77888899999965

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.6e-70  Score=527.31  Aligned_cols=323  Identities=41%  Similarity=0.801  Sum_probs=284.9

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ...++..++|+++++||+|+||.||+|+.+.     +|.+||+|+++|......++++.++.|..+|...++|+||+||.
T Consensus       134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             ccccCCcccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            3446788999999999999999999999987     99999999999999999999999999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .|++.+++||||||++||++..+|.+.+.|+++.+++|+++++.|++-||+.|+|||||||+|+|||..|++||+||||+
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-------------------------C-----------------------CCCccccCCCCCCCcchhcCCCCCCc
Q 013558          263 KEIDE-------------------------S-----------------------SRSNSMCGTTEYMAPEILLSKGHNKD  294 (441)
Q Consensus       263 ~~~~~-------------------------~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  294 (441)
                      ..+..                         .                       ......+|||.|||||++.+++|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            54310                         0                       01134579999999999999999999


Q ss_pred             chhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       295 ~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +||||||||+||||.|.+||.+.++.+.+++|+.-+  +.+|.  .++++++|||.+||. ||++|+|+  .+++||++|
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~H  445 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKH  445 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcC
Confidence            999999999999999999999999999999999876  56665  578999999999999 99999985  489999999


Q ss_pred             cccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCC-C---CCC-----------CCCCCcccCeeeeCCC
Q 013558          371 KWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDS-P---APT-----------PTAGEHFKGYTYVAPN  435 (441)
Q Consensus       371 ~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~-~---~~~-----------~~~~~~f~~~~~~~~~  435 (441)
                      |||++++|+.+-  +..|||+|.+.+..++.+||+ +++...... .   .+.           ...+..|.||+|.+.+
T Consensus       446 PfF~~v~W~~l~--~~~apfvP~v~~~~DT~yFdd-F~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~  522 (550)
T KOG0605|consen  446 PFFKGVDWDHLR--EMPAPFVPQVNSELDTQYFDD-FPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFD  522 (550)
T ss_pred             CccccCCcchhh--cCCCCCCCCCCCccccccccc-CcccccCcccccccccchhhhhcccccCCcccccccceeeeccc
Confidence            999999999994  556999999999999999994 333211111 0   000           0234569999998865


Q ss_pred             c
Q 013558          436 P  436 (441)
Q Consensus       436 ~  436 (441)
                      .
T Consensus       523 ~  523 (550)
T KOG0605|consen  523 G  523 (550)
T ss_pred             c
Confidence            3

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-69  Score=493.82  Aligned_cols=327  Identities=42%  Similarity=0.819  Sum_probs=308.0

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ..++..++|..+++||+|.||+|-+|+.+.     +++.||+|+++|..+..++.+..-..|-++|+..+||++..|...
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs  236 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKA-----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS  236 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecc-----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence            345677899999999999999999999987     999999999999999999999999999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      |++.+++|+||||+.||.|+.+|.+...|+|+.++++.++|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             c-cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          264 E-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       264 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      . +..+....++||||.|+|||++....|+..+|||.+||++|||++|+.||...+.+.++..|+.+.+++|..++++++
T Consensus       317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAK  396 (516)
T ss_pred             hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHH
Confidence            6 455566788999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCC--
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--  420 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  420 (441)
                      .|+..+|.+||.+|+|.++.++.+|.+|+||.+++|+.+-.+++.|||+|.+.+..+.+.||+.++..+....|+...  
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~  476 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGS  476 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCc
Confidence            999999999999999999999999999999999999999999999999999999999999999999887655544321  


Q ss_pred             ------CCCCcccCeeeeCCC
Q 013558          421 ------TAGEHFKGYTYVAPN  435 (441)
Q Consensus       421 ------~~~~~f~~~~~~~~~  435 (441)
                            ..+.+|..|+|.++.
T Consensus       477 ~~~~~~e~~~~FpQFsy~~~~  497 (516)
T KOG0690|consen  477 TVDEDEERRPHFPQFSYSASM  497 (516)
T ss_pred             ccchhhhhccCCcceeeecch
Confidence                  346899999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-65  Score=481.15  Aligned_cols=324  Identities=43%  Similarity=0.837  Sum_probs=301.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  185 (441)
                      +...+|..+.+||+|+||+|.++..++     +.+.||||+++++.+...+.++--..|.++|.... -|++++|+.+|+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ  420 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ  420 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence            455689999999999999999999887     88899999999999888887777778888888774 689999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc-
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~-  264 (441)
                      +-+.+|+||||+.||+|..+++.-+++.|..+.+|+++|+.||-|||++|||+||||.+|||+|.+|++||+|||+++. 
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999986 


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      +.....+.++|||+.|+|||++..++|+..+||||+||+||||+.|++||++.+..++++.|......+|..+|.++.++
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i  580 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI  580 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence            44555677899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----C
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----P  420 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  420 (441)
                      ++.+|.+.|.+|+|+++.+-++|..||||+.|+|+.++.++++|||+|.+.-..+..|||+.++..+.+..|+-.    .
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~n  660 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMMN  660 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHhc
Confidence            999999999999999999999999999999999999999999999999997777889999999988776665422    2


Q ss_pred             CCCCcccCeeeeCCC
Q 013558          421 TAGEHFKGYTYVAPN  435 (441)
Q Consensus       421 ~~~~~f~~~~~~~~~  435 (441)
                      -++..|.||+|+++.
T Consensus       661 ldq~eF~gFsfvNpe  675 (683)
T KOG0696|consen  661 LDQSEFEGFSFVNPE  675 (683)
T ss_pred             CchhhcCceeeeChh
Confidence            478999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-63  Score=480.97  Aligned_cols=268  Identities=41%  Similarity=0.743  Sum_probs=254.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .....||.+++.||.|+|++|++|+.+.     +++.||||++.|.-+..+..++.+..|..+|.+| .||.|++|+..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-----t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA-----TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC-----CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            4456799999999999999999999986     8999999999999999999999999999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +++..+|+|+||+++|+|.++|++.|.|++..+++|++||+.||+|||++|||||||||+|||||.+|++||+|||.|+.
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCCC--------------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Q 013558          265 IDESSR--------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK  330 (441)
Q Consensus       265 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~  330 (441)
                      +.....              ..+++||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.+..-++++|+.-.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            643211              256899999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhh
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  383 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  383 (441)
                      +.||+.+++.+++||+++|..||++|+     ++++|++||||.+++|+.+-.
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rl-----t~~qIk~HpFF~~Vdw~nlw~  351 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRL-----TSQQIKAHPFFEGVDWENLWQ  351 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccc-----cHHHHhhCcccccCChhhhhh
Confidence            999999999999999999999999999     789999999999999999753

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-63  Score=470.17  Aligned_cols=327  Identities=39%  Similarity=0.717  Sum_probs=295.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..+.|...++||+||||.||-|+.+.     +|+.||+|.+.|..+..+.......+|..||.+++.++||.|-.+|+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvra-----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRA-----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEec-----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            4667789999999999999999999886     99999999999988888777788899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +.+.+|+||..|.||+|..+|.+.+  .|+|..+++|+++|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|.
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence            9999999999999999999998887  79999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCCCCcH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~~~s~  339 (441)
                      .+.........+||.+|||||++.+..|+...|||||||+||||+.|+.||...    ..+++-++++....++++.+|+
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~  415 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE  415 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence            998888777789999999999999999999999999999999999999999753    3457888889999999999999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc-cCCCCCCCCCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPADDSPAP  418 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  418 (441)
                      ++++|.+.+|++||.+|+||...+++++++||||+++||..++...+.|||+|+....++..-||-. +.+...   -..
T Consensus       416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKG---V~l  492 (591)
T KOG0986|consen  416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKG---VKL  492 (591)
T ss_pred             HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccc---eec
Confidence            9999999999999999999999999999999999999999999999999999999877665544421 111111   112


Q ss_pred             CCCCCCcccCeee-eCCCccccC
Q 013558          419 TPTAGEHFKGYTY-VAPNPWLSS  440 (441)
Q Consensus       419 ~~~~~~~f~~~~~-~~~~~~~~~  440 (441)
                      .+++++-|+.|.- +.+.+||+.
T Consensus       493 d~~D~~fy~~F~tg~vsipWQnE  515 (591)
T KOG0986|consen  493 DDTDTDFYKNFATGSVSIPWQNE  515 (591)
T ss_pred             ccccHHHHHhccCCcccchHHHH
Confidence            3467889999998 889999974

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-61  Score=453.36  Aligned_cols=287  Identities=40%  Similarity=0.728  Sum_probs=261.3

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++++.||.|.-|+||+|+.++     ++..+|+|++.+..+..+....++..|.+||+.++||++..||..|
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            45667789999999999999999999987     7789999999999988888889999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +.+...|+|||||+||+|...++++  +.|++..+++|+++++.||+|||..|||+|||||+||||-++|+|.|+||.++
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence            9999999999999999999888776  57999999999999999999999999999999999999999999999999986


Q ss_pred             cccC------------------------------------C---------------------CCCCccccCCCCCCCcch
Q 013558          263 KEID------------------------------------E---------------------SSRSNSMCGTTEYMAPEI  285 (441)
Q Consensus       263 ~~~~------------------------------------~---------------------~~~~~~~~gt~~y~aPE~  285 (441)
                      ....                                    .                     ..++..++||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            4321                                    0                     012345789999999999


Q ss_pred             hcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCC
Q 013558          286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGG  363 (441)
Q Consensus       286 ~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~  363 (441)
                      +.|.+++.++|||+|||++|||+.|..||.+.+..+.+.+|+...+.+|.  .++..++|||+++|.+||.+|+|+. .+
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~-rG  385 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK-RG  385 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc-cc
Confidence            99999999999999999999999999999999999999999999999985  5789999999999999999999875 47


Q ss_pred             hHHhhhCcccCCCChhhhhhcccCCCCCCCCCCccc
Q 013558          364 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC  399 (441)
Q Consensus       364 ~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~  399 (441)
                      +.||++||||++++|.-  -|-..||++|...+..+
T Consensus       386 A~eIK~HpFF~gVnWaL--ir~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  386 AAEIKRHPFFEGVNWAL--IRCARPPEIPKPVDGGL  419 (459)
T ss_pred             hHHhhcCccccCCChhh--eeccCCCcCCCccccCc
Confidence            99999999999999993  37789999998765543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-61  Score=476.86  Aligned_cols=255  Identities=31%  Similarity=0.625  Sum_probs=246.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      .+|+..++||+|||++||.+++..     +|+.||+|++.+..+....+.+.+.+|++|.+.|+|||||+++++|++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~-----tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD-----TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC-----CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            469999999999999999999865     899999999999998889999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|||+|+|..++|..++++++.++|.+++.|++||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+... 
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998744 


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      .+..++||||.|+|||++...+++..+||||+|||||.||.|++||...+..+++.+|....+.+|..++.++++||++|
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHH
Confidence            67889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      |++||.+||     ++++|+.|+||+
T Consensus       253 L~~~P~~Rp-----sl~~vL~h~Ff~  273 (592)
T KOG0575|consen  253 LRPNPSERP-----SLDEVLDHPFFK  273 (592)
T ss_pred             hcCCcccCC-----CHHHHhcCHhhh
Confidence            999999999     899999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-62  Score=459.36  Aligned_cols=262  Identities=34%  Similarity=0.610  Sum_probs=238.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc----hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .+.|.+.+.||+|+||.|-+|..+.     +++.||||++.++....    ......+.+|+++|++|+|||||+++++|
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~-----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK-----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc-----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            4568999999999999999999987     99999999999876654    22334577999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC---CcEEEEecCC
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGL  261 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkl~DFG~  261 (441)
                      ...+..|+||||++||+|++.+-.++.+.|+..+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999999999999999999999999999999999999999999999999999766   7899999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCCC---CCcchhhhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhccccCCC--
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVKLPP--  335 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvvl~elltG~~pf~~~~~~~-~~~~i~~~~~~~p~--  335 (441)
                      |+..++.....++|||+.|.|||++.++++   ..++|+||+||+||-+|+|.+||.+..... +.+.|..+++.+-+  
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence            999998888999999999999999997654   457899999999999999999998866555 88999999887653  


Q ss_pred             --CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          336 --FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       336 --~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                        .+++++++||++||..||++||     +++++++||||+......
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~-----s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRP-----SADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCc-----CHHHHhcChhhhcccccc
Confidence              5899999999999999999999     889999999999776433

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-61  Score=443.46  Aligned_cols=326  Identities=39%  Similarity=0.825  Sum_probs=301.6

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+...+|.++++||+|+|++|.+++.+.     +.++||+|+++|.-..+.+.+++++.|..+.... +||++|.|+.
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~-----t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcc-----cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence            455778899999999999999999999987     8899999999998888888889999999988776 7999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +|+++..+++|.||++||+|..+++++.+++|+.++++..+|..||.|||++|||+||||.+|||||..|++||+|+|++
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cc-cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhccccC
Q 013558          263 KE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--------ANRQKLQQRIINEKVKL  333 (441)
Q Consensus       263 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~--------~~~~~~~~~i~~~~~~~  333 (441)
                      +. +..+..+.++|||+.|+|||++.+..|+..+|||+|||+++||+.|+.||+-        .+...+++-|+...+++
T Consensus       399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence            87 5566667899999999999999999999999999999999999999999952        23456788889999999


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCC-ChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCC
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPG-GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA  412 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~-~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~  412 (441)
                      |..+|-.+..+++..|++||.+|+||.+. ++.+++.|+||+.++|+.++++++-|||.|.+.+.....+||..++.++.
T Consensus       479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~  558 (593)
T KOG0695|consen  479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPV  558 (593)
T ss_pred             cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCc
Confidence            99999999999999999999999999874 69999999999999999999999999999999999999999999998877


Q ss_pred             CCCCCCCC----CCCCcccCeeeeCC
Q 013558          413 DDSPAPTP----TAGEHFKGYTYVAP  434 (441)
Q Consensus       413 ~~~~~~~~----~~~~~f~~~~~~~~  434 (441)
                      ..+|...+    -++..|.||+|+++
T Consensus       559 qltpdd~d~i~ridqsefegfeyinp  584 (593)
T KOG0695|consen  559 QLTPDDEDAIKRIDQSEFEGFEYINP  584 (593)
T ss_pred             ccCCCCHHHHHhcchhhcCcceecch
Confidence            66665443    57899999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-60  Score=442.28  Aligned_cols=257  Identities=30%  Similarity=0.518  Sum_probs=237.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++.+.++.||+|..|+||+|+++.     +++.||+|++...  .+....+++.+|+++|+.++|||||.+|++|..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~-----t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKP-----TGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcC-----CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            556688999999999999999999997     8999999999433  455666789999999999999999999999999


Q ss_pred             CC-EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RS-KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~-~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++ .++++||||+||+|...+...++++|..+..++.++++||.|||+ ++||||||||+||||+..|.|||||||.++.
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            99 599999999999999999999999999999999999999999995 9999999999999999999999999999998


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhc-cccCCCC-C
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLPPF-L  337 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-----~~~~~~~~i~~~-~~~~p~~-~  337 (441)
                      +... ...+++||..|||||.+.+..|+.++||||||++++||++|+.||...     +..+++..|+.+ .+.+|.. +
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            7765 678899999999999999999999999999999999999999999875     677889999884 5678886 9


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |+++++||..||++||.+|+     +++|+++|||++..
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~-----s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERP-----SAKQLLQHPFIKKF  341 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCC-----CHHHHhcCHHHhhc
Confidence            99999999999999999999     89999999999854

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-60  Score=491.19  Aligned_cols=321  Identities=39%  Similarity=0.724  Sum_probs=284.0

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ...++..++|+++++||+|+||.|.+|+.+.     ++++||+|++.|...........|..|..+|-..+.+.|++|+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS-----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeec-----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            4456788999999999999999999999997     89999999999988887888888999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +|+++.++|+|||||+||+|..++.+.++++++.+++|+++|+.||.-||+.|+|||||||+|||||..|++||+|||.+
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccC
Q 013558          263 KEIDESS--RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKL  333 (441)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~  333 (441)
                      -.+....  .+...+|||.|++||++..     +.|++.+||||+||++|||+.|..||+.....+.+.+|++.  .+.|
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF  302 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence            7765333  3567799999999999972     56899999999999999999999999999999999999876  6778


Q ss_pred             C--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCC
Q 013558          334 P--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP  411 (441)
Q Consensus       334 p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~  411 (441)
                      |  ..+|+++++||+++|. +|+.|+|  .+++++++.||||.+++|..+  |...|||+|.+.+.++++|||..-....
T Consensus       303 P~~~~VSeeakdLI~~ll~-~~e~RLg--rngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd~~~dd~~  377 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALLC-DREVRLG--RNGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFDVDEDDLR  377 (1317)
T ss_pred             CcccccCHHHHHHHHHHhc-Chhhhcc--cccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCccccccccccccc
Confidence            8  4699999999999996 8899995  348999999999999999777  7889999999999999999965433222


Q ss_pred             CCC-CC----CCCCCCCCcccCeeeeC
Q 013558          412 ADD-SP----APTPTAGEHFKGYTYVA  433 (441)
Q Consensus       412 ~~~-~~----~~~~~~~~~f~~~~~~~  433 (441)
                      ... .|    ....+..-.|.||+|..
T Consensus       378 ~~e~~p~~~~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  378 DAETFPPRIPKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             hhhccCCCCCCCCcCCcCCeeeeeecc
Confidence            111 12    11223456789999984

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.5e-58  Score=449.76  Aligned_cols=314  Identities=42%  Similarity=0.832  Sum_probs=278.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987665555566678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCccc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~~  274 (441)
                      |+.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            99999999999988999999999999999999999999999999999999999999999999999997632 22334457


Q ss_pred             cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcC
Q 013558          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      +||+.|+|||++.+..++.++|||||||++|||++|..||...+...+...+......+|..+++++.+||++||++||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            89999999999999999999999999999999999999999999888889998888899999999999999999999999


Q ss_pred             CCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC--------CCCCCcc
Q 013558          355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------PTAGEHF  426 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~f  426 (441)
                      +||+....+++++++||||.+++|..+..+.+.|++.|......+...|+..++.......++..        ......|
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  315 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHF  315 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCcccccccccccccccC
Confidence            99987777899999999999999999999999999999988888888888776654333322211        1246789


Q ss_pred             cCeeeeCC
Q 013558          427 KGYTYVAP  434 (441)
Q Consensus       427 ~~~~~~~~  434 (441)
                      .+|+|.++
T Consensus       316 ~~~~~~~~  323 (323)
T cd05571         316 PQFSYSAS  323 (323)
T ss_pred             CCCeeeCC
Confidence            99999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-57  Score=446.75  Aligned_cols=315  Identities=41%  Similarity=0.783  Sum_probs=278.3

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+|++++||||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKG-----TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            445789999999999999999999876     788999999987765555666778999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ++.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+..+.+..+...+|..++..+++||+
T Consensus       170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  247 (329)
T PTZ00263        170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK  247 (329)
T ss_pred             CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence            42  3356899999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCCCCCCcc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHF  426 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f  426 (441)
                      +||+.||.+|+++..+++++++.||||++.+|..+..+.+.+|+.+......+..+|+.. .+-+....+......+..|
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~~~~~~~~~~~~  326 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY-PDSPVDRLPPLTAAQQAEF  326 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccCC-cccccccCCCCchhhhhhc
Confidence            999999999998777789999999999999999999888888887777666677777642 2222222233334567778


Q ss_pred             cCe
Q 013558          427 KGY  429 (441)
Q Consensus       427 ~~~  429 (441)
                      .||
T Consensus       327 ~~~  329 (329)
T PTZ00263        327 AGF  329 (329)
T ss_pred             CCC
Confidence            776

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.1e-57  Score=439.75  Aligned_cols=317  Identities=41%  Similarity=0.819  Sum_probs=276.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  189 (441)
                      +|++++.||+|+||.||+|+++.     +++.||+|++.+.........+.+..|..++..+ +|++|+++++++...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            58999999999999999999876     7889999999876554455556677788888877 58999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~  268 (441)
                      +|+||||+++|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997643 22


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+||.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence            23446789999999999999999999999999999999999999999999999999999988889999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----CCCCC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGE  424 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  424 (441)
                      |++||.+|+++.+...+++++|+||+.++|..+..+.++||+.|.... .+..+|+..+...+....+...    ...+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPPDQEVIMNLDQS  314 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCCCcccccccccc
Confidence            999999999887777899999999999999999999999999998754 5566676655543332222222    13468


Q ss_pred             cccCeeeeC
Q 013558          425 HFKGYTYVA  433 (441)
Q Consensus       425 ~f~~~~~~~  433 (441)
                      +|+||+|++
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05616         315 EFEGFSYVN  323 (323)
T ss_pred             ccCCCcccC
Confidence            999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.5e-57  Score=439.82  Aligned_cols=315  Identities=37%  Similarity=0.763  Sum_probs=277.3

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHH---HhcCCCCceeeeEEEEeCC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL---TKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~  188 (441)
                      |++++.||+|+||.||+|.++.     +++.||||++.+.........+.+..|+.++   +.++||||+++++++....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            7889999999999999999876     7889999999876555555566777777766   4567999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-C
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-E  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~  267 (441)
                      .+|+||||++|++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999999999887754 579999999999999999999999999999999999999999999999999987532 2


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      .......+|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.+||.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR  234 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            23344578999999999999999999999999999999999999999999999999999888888999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC-----CCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-----TPTA  422 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  422 (441)
                      ||+.||.+||++...+++++++||||++++|..+..+.+.|++.|......+..+|+..+........+..     .+..
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPREPRLLTEEE  314 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCccccccchhh
Confidence            99999999998887889999999999999999999999999999998888888888877655443333322     3367


Q ss_pred             CCcccCeeee
Q 013558          423 GEHFKGYTYV  432 (441)
Q Consensus       423 ~~~f~~~~~~  432 (441)
                      ++.|.+|+|+
T Consensus       315 ~~~~~~~~~~  324 (324)
T cd05589         315 QELFRGFDYV  324 (324)
T ss_pred             hcccCCcccC
Confidence            8999999985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-56  Score=439.51  Aligned_cols=314  Identities=42%  Similarity=0.816  Sum_probs=277.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987665555666778899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCccc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~~  274 (441)
                      |+++|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999987632 22233456


Q ss_pred             cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcC
Q 013558          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..+++++.+||++||++||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence            89999999999999999999999999999999999999999888888888888888889999999999999999999999


Q ss_pred             CCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----------CCCCCC
Q 013558          355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----------TPTAGE  424 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~  424 (441)
                      +|++..+.+++++++|+||.+++|..+....+.|++.|......+...|+..++.......++.          ......
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRP  315 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCcccccccccccccccccc
Confidence            9998877899999999999999999999999999999998888888888876654432222111          112358


Q ss_pred             cccCeeeeCC
Q 013558          425 HFKGYTYVAP  434 (441)
Q Consensus       425 ~f~~~~~~~~  434 (441)
                      +|.+|+|.++
T Consensus       316 ~~~~~~~~~~  325 (328)
T cd05593         316 HFPQFSYSAS  325 (328)
T ss_pred             ccCCceeeCC
Confidence            8999999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-56  Score=437.10  Aligned_cols=318  Identities=42%  Similarity=0.844  Sum_probs=279.3

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~  189 (441)
                      +|++++.||+|+||.||+|+++.     +++.||||++.+.........+.+..|+.++..+.| ++|+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            58999999999999999999876     788999999987665555566778889999999976 568889999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~  268 (441)
                      +|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987532 22


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..+++++.+||++|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            23345689999999999999999999999999999999999999999999999999999888889999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----CCCCC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGE  424 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  424 (441)
                      |++||.+|++++....+++++||||+.++|..+..+.+.+++.|.........+|+..+........+...    .-.+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLVIANIDQS  315 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCCcccccccccc
Confidence            99999999987666789999999999999999999999999999988888888998776654333332211    23467


Q ss_pred             cccCeeeeC
Q 013558          425 HFKGYTYVA  433 (441)
Q Consensus       425 ~f~~~~~~~  433 (441)
                      .|.+|+|++
T Consensus       316 ~~~~~~~~~  324 (324)
T cd05587         316 EFQGFSFVN  324 (324)
T ss_pred             ccCCCcccC
Confidence            899998864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-56  Score=441.20  Aligned_cols=295  Identities=41%  Similarity=0.742  Sum_probs=268.2

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||.||+|.++.    ..+..||+|++.+.........+.+.+|+.+++.++||||+++++++
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKN----EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEEC----CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            34556789999999999999999998764    13468999999876655556667788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+.+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999999999999988999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.....+.+......+|..++++++++
T Consensus       181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  258 (340)
T PTZ00426        181 VDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL  258 (340)
T ss_pred             cCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            643  234578999999999999999999999999999999999999999999988889999998888999999999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccc
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  405 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~  405 (441)
                      |++||+.||.+|++....+++++++||||++++|..+..+.+.+|+.|......+.++|+.
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  319 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFER  319 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCC
Confidence            9999999999999877779999999999999999999999999999999877777777754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-57  Score=433.56  Aligned_cols=290  Identities=41%  Similarity=0.801  Sum_probs=266.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|.++.     +++.||+|++...........+.+.+|+.+|+.++||||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            379999999999999999999876     788999999987654444556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999999876432 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhc
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  349 (441)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..+.+......+|..++..+++||++||
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence             3356899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          350 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +.||.+|+++...+++++++||||+.++|..+..+...|++.|......+..+|+.+
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  290 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDY  290 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccCC
Confidence            999999998777789999999999999999999999999999998888888888753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-57  Score=427.80  Aligned_cols=257  Identities=33%  Similarity=0.628  Sum_probs=237.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|.+.+.||+|+||+||+++++.     ++..||||.+.+... .+..++.+..|+.+|+.++|||||.|++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~-----~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK-----SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc-----CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            4689999999999999999999987     779999999988764 5566778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC------CcEEEEecCCc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHVMLTDFGLA  262 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~------~~vkl~DFG~a  262 (441)
                      .+|||||||+||+|.+++++++.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999999999999999999999999999999999999999999999999865      46999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc---CCCCCcH
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTS  339 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~  339 (441)
                      +.+.......+.||++.|||||++..+.|+.|+|+||+|+|||+|++|+.||...+..+++..+..+...   ++..++.
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            9999888889999999999999999999999999999999999999999999999999999988776543   3456888


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+.+|+..+|+.++..|.     +..+-+.|++...-
T Consensus       243 ~~~~Ll~~ll~~~~~~~~-----~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRI-----SFEDFFDHPFLAAN  274 (429)
T ss_pred             chhhhhhHHHhcCccccC-----chHHhhhhhhcccC
Confidence            889999999999999998     77888888887653

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.2e-56  Score=436.57  Aligned_cols=313  Identities=40%  Similarity=0.791  Sum_probs=273.8

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||||++.+.........+.+..|+.++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999876555555666777888888876 6999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987642 2233445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+......+|..++.++++||++||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            68999999999999999999999999999999999999999999999999999988888999999999999999999999


Q ss_pred             CCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCC----CCCCCCCCcccC
Q 013558          354 SKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP----APTPTAGEHFKG  428 (441)
Q Consensus       354 ~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~f~~  428 (441)
                      .+|+++.. .+.+++++||||++++|..+..+.+.|+|.|......+..+|+..........++    ......+..|++
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRN  315 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCcccccccccccCcCC
Confidence            99996532 2359999999999999999999999999999999888889998665444322222    123356789999


Q ss_pred             eeeeC
Q 013558          429 YTYVA  433 (441)
Q Consensus       429 ~~~~~  433 (441)
                      |+|.+
T Consensus       316 ~~~~~  320 (320)
T cd05590         316 FSYTA  320 (320)
T ss_pred             CcccC
Confidence            99864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-59  Score=445.53  Aligned_cols=297  Identities=37%  Similarity=0.740  Sum_probs=284.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+...+++++..||-|+||.|-+++.+.     ....+|+|+++|..+.+..+.+.+..|..||..++.|+||+||-.|
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            34667789999999999999999999875     4446999999999999999999999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+...+|++||-|-||.|...++.++.|++..+++|+..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+.
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAH  342 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  342 (441)
                      +..+..+.++|||+.|.|||++.+++++.++|.||||+++|||++|.+||.+.++...++.|+++  .+.+|..+++.+.
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~  649 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT  649 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence            99999999999999999999999999999999999999999999999999999999999999986  5779999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +||+++...+|.+|+|...+++.+|++|.||.+.||+.+..+.+.||++|.+....+.+|||..
T Consensus       650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~  713 (732)
T KOG0614|consen  650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF  713 (732)
T ss_pred             HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence            9999999999999999888899999999999999999999999999999999999999999964

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-56  Score=436.41  Aligned_cols=314  Identities=41%  Similarity=0.807  Sum_probs=277.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence            479999999999999876     788999999987655555566677889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCccc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~~  274 (441)
                      |+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999987632 22233456


Q ss_pred             cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcC
Q 013558          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||+.||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            89999999999999999999999999999999999999999988888888888888889999999999999999999999


Q ss_pred             CCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC--------CCCCCCcc
Q 013558          355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP--------TPTAGEHF  426 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~f  426 (441)
                      +|++..+.++.++++|+||.+++|..+..+.+.|++.|..........|+..++.......++.        ..+...+|
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHF  315 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCccCCCCccccccccccccccccc
Confidence            9998877899999999999999999999999999999999888888888877765432222211        12345789


Q ss_pred             cCeeeeCC
Q 013558          427 KGYTYVAP  434 (441)
Q Consensus       427 ~~~~~~~~  434 (441)
                      ..|+|..+
T Consensus       316 ~~~~~~~~  323 (323)
T cd05595         316 PQFSYSAS  323 (323)
T ss_pred             CCCcccCC
Confidence            99999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-56  Score=433.00  Aligned_cols=307  Identities=47%  Similarity=0.868  Sum_probs=271.1

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.+|++++||||+++++++...+.+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRD-----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            7999999999999875     78899999998765555556677889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCccccC
Q 013558          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCG  276 (441)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~~~g  276 (441)
                      ++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            999999999988899999999999999999999999999999999999999999999999999998642 2233445789


Q ss_pred             CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCC
Q 013558          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  356 (441)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  356 (441)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+......+|..+++++++||.+||+.||.+|
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            99999999999999999999999999999999999999999999999999999899999999999999999999999999


Q ss_pred             CCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCC----CCCCCCCCcccCeee
Q 013558          357 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP----APTPTAGEHFKGYTY  431 (441)
Q Consensus       357 ~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~f~~~~~  431 (441)
                      |+..  ++.+++.||||...+|..+..+.+++++.|......+.++|+..++......+.    ......++.|.+|+|
T Consensus       236 ~~~~--~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (312)
T cd05585         236 LGYN--GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQFGGWSY  312 (312)
T ss_pred             CCCC--CHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccccchhccccCCCCC
Confidence            9653  789999999999999999999999999999888777788888766543222221    122346788888887

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-55  Score=431.49  Aligned_cols=318  Identities=53%  Similarity=0.949  Sum_probs=276.5

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      ++.||+|+||.||+|++...  ...++.||+|++.+.... .......+.+|+.+|+.++||||++++++|..++.+|+|
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             CceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            36899999999999986431  136789999999875432 223345677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCc
Q 013558          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSN  272 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~  272 (441)
                      |||+.|++|.+++.+.+.+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            9999999999999998999999999999999999999999999999999999999999999999999987542 223344


Q ss_pred             cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccC
Q 013558          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD  352 (441)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  352 (441)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||++||++|
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            56899999999999998899999999999999999999999999998888999998888999999999999999999999


Q ss_pred             cCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCC---CCCCCCCcccCe
Q 013558          353 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA---PTPTAGEHFKGY  429 (441)
Q Consensus       353 P~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~f~~~  429 (441)
                      |++||++...++++++.||||+..+|..+..+...+++.+......+...|+..++......++.   ........|.||
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLGF  318 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccccccccccCcCCC
Confidence            99999888889999999999999999999988999999998887778888887665543333322   223457899999


Q ss_pred             eeeCC
Q 013558          430 TYVAP  434 (441)
Q Consensus       430 ~~~~~  434 (441)
                      +|.+.
T Consensus       319 ~~~~~  323 (323)
T cd05584         319 TYVAP  323 (323)
T ss_pred             eecCC
Confidence            99863

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-55  Score=431.13  Aligned_cols=312  Identities=43%  Similarity=0.850  Sum_probs=273.6

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||||++.+.........+.+..|+.+++.+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            479999999999999876     7889999999887655555666778899999888 6999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||++||+|..++.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987532 2223345


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..++.++.+||++||+.||
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence            67999999999999999999999999999999999999999998888888889888888899999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----CCCCCCcccCe
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGY  429 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~~  429 (441)
                      ++||++......+++.||||+.++|.....+.+.|++.|......+..+|+..+...+...++..    ....++.|.||
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGF  315 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCcccccccccccccCCC
Confidence            99996554455999999999999999999999999999999888888888866544333222221    22467999999


Q ss_pred             eee
Q 013558          430 TYV  432 (441)
Q Consensus       430 ~~~  432 (441)
                      +|+
T Consensus       316 ~~~  318 (318)
T cd05570         316 SYI  318 (318)
T ss_pred             CCC
Confidence            985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-55  Score=430.39  Aligned_cols=317  Identities=43%  Similarity=0.838  Sum_probs=275.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  189 (441)
                      +|++.+.||+|+||+||+|+++.     +++.||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence            48899999999999999999876     78899999998765545555667778999998886 5788899999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC-C
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-S  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~  268 (441)
                      +|+||||++||+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999876432 2


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+.+.+......+|..++.++.+|+.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            22345679999999999999999999999999999999999999999999999999999888889999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCC----CCCCCCC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTAGE  424 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  424 (441)
                      |++||.+|+++.....+++++||||+.++|..+..+.+++||.|....+ ...+|++..+......++.    -.+.+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVIANIDQA  314 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCccccccccccc
Confidence            9999999998776678999999999999999999999999999976654 3677777665432222221    2234567


Q ss_pred             cccCeeeeC
Q 013558          425 HFKGYTYVA  433 (441)
Q Consensus       425 ~f~~~~~~~  433 (441)
                      .|.+|+|++
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05615         315 DFEGFSYVN  323 (323)
T ss_pred             ccCCCcccC
Confidence            999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-55  Score=430.66  Aligned_cols=312  Identities=41%  Similarity=0.821  Sum_probs=271.7

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||.||+|+++.     +++.||+|++.+.........+.+..|.+++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG-----TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            469999999999999876     7889999999876655555666777899999876 7999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+++|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987642 2223445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+......+|..++.++.+||.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCH
Confidence            68999999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             CCCCCCCCC--ChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----CCCCCCccc
Q 013558          354 SKRLGSGPG--GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFK  427 (441)
Q Consensus       354 ~~R~~~~~~--~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~f~  427 (441)
                      ++|+++...  +++++++||||.+++|..+..+...++|.|......+..+|+..++.......+..    ....++.|.
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFR  315 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccccccccccccC
Confidence            999977543  78999999999999999999999999999988777777788765543322222221    123467799


Q ss_pred             Ceeee
Q 013558          428 GYTYV  432 (441)
Q Consensus       428 ~~~~~  432 (441)
                      ||+|.
T Consensus       316 ~~~~~  320 (321)
T cd05591         316 GFSFF  320 (321)
T ss_pred             CCccc
Confidence            99874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.8e-55  Score=429.14  Aligned_cols=321  Identities=47%  Similarity=0.904  Sum_probs=273.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      +|++++.||+|+||+||+|++...  ..+++.||+|++.+..... ....+.+..|+.+|+.+ +|+||+++++++..++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            589999999999999999987531  2368899999998754332 33445678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999865332


Q ss_pred             --CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCCCCcHHH
Q 013558          269 --SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTSEA  341 (441)
Q Consensus       269 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~  341 (441)
                        ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...    ....+...+......++..++..+
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence              223456899999999999875 4788999999999999999999999643    344556666777778888899999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC-CC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-TP  420 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  420 (441)
                      ++||.+||+.||++||++...+++++++||||++.+|..+..+.+.++|.|......+..+|...+.......++.. .+
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPP  318 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCCCc
Confidence            99999999999999998887899999999999999999999999999999988877777777766555444344443 44


Q ss_pred             CCCCcccCeeeeC
Q 013558          421 TAGEHFKGYTYVA  433 (441)
Q Consensus       421 ~~~~~f~~~~~~~  433 (441)
                      .....|.||+|+.
T Consensus       319 ~~~~~~~~~~~~~  331 (332)
T cd05614         319 SGARVFQGYSFVA  331 (332)
T ss_pred             ccccccCCceecC
Confidence            6678999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-56  Score=436.07  Aligned_cols=259  Identities=39%  Similarity=0.714  Sum_probs=240.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch--hHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVT-HPFIVQLRYS  183 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~  183 (441)
                      ...+.|++.+.||+|+||+|+++.+..     ++..||+|++.+......  ...+.+.+|+.++++++ ||||++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~-----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL-----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc-----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            345789999999999999999999886     779999998776533211  34566779999999999 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG~a  262 (441)
                      +.....+|+||||+.||+|++++.+.+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 99999999999


Q ss_pred             ccc-CCCCCCccccCCCCCCCcchhcCCC-CC-CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCC-c
Q 013558          263 KEI-DESSRSNSMCGTTEYMAPEILLSKG-HN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-T  338 (441)
Q Consensus       263 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~-s  338 (441)
                      ... .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++.+|..+.+.+|..+ +
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S  248 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLS  248 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCC
Confidence            987 4666788999999999999999987 85 789999999999999999999999999999999999999999999 9


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .++++||++||..||.+|+     ++.+|+.||||+.
T Consensus       249 ~~~~~Li~~mL~~~P~~R~-----t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRI-----TLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCC-----CHHHHhhChhhcc
Confidence            9999999999999999999     8999999999986

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-55  Score=427.84  Aligned_cols=310  Identities=40%  Similarity=0.836  Sum_probs=271.9

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||+|++++.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG-----TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            479999999999999876     7889999999876544444555566677777654 8999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC-CCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~  273 (441)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999986432 233455


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            78999999999999999999999999999999999999999999988888888888888899999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----CCCCCCcccCe
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGY  429 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~~  429 (441)
                      .+|++.    .++++.||||+.++|..+..+++.|+|.|......+..+|+..++......++..    ....+..|.+|
T Consensus       236 ~~R~~~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
T cd05592         236 TKRLGV----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGF  311 (316)
T ss_pred             HHcCCC----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCccccccccccccccCCC
Confidence            999942    4689999999999999999999999999998888888899988776655444333    22578999999


Q ss_pred             eeeCC
Q 013558          430 TYVAP  434 (441)
Q Consensus       430 ~~~~~  434 (441)
                      +|.++
T Consensus       312 ~~~~~  316 (316)
T cd05592         312 SFTNP  316 (316)
T ss_pred             cccCc
Confidence            99864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.6e-55  Score=430.55  Aligned_cols=313  Identities=39%  Similarity=0.811  Sum_probs=269.6

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||.||+|+++.     +++.||+|++++.........+.+..|+.+++.+ +||||++++++|.+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK-----TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            479999999999999876     7889999999886655556667788999999998 7999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-CCCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-~~~~~~~~  273 (441)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999998752 23333456


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...         ......+.+......+|..++.++.+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            78999999999999999999999999999999999999999631         223456667777888899999999999


Q ss_pred             HHHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----C
Q 013558          345 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----T  419 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~  419 (441)
                      |++||+.||.+|+++.. .+++++++||||.+++|..+...+..|++.|.........+|+..+...+....|..    .
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  315 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVIA  315 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCccccc
Confidence            99999999999997532 358999999999999999999888999999998888788888877765544333322    2


Q ss_pred             CCCCCcccCeeeeC
Q 013558          420 PTAGEHFKGYTYVA  433 (441)
Q Consensus       420 ~~~~~~f~~~~~~~  433 (441)
                      ...+..|.||.|++
T Consensus       316 ~~~~~~~~~~~~~~  329 (329)
T cd05588         316 RIDQSEFEGFEYIN  329 (329)
T ss_pred             cccccccCCCcccC
Confidence            24568999998863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-56  Score=442.87  Aligned_cols=260  Identities=30%  Similarity=0.557  Sum_probs=247.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .+-|++++.||.|+-|.|.+|++..     +|+..|||++.+...........+.+|+.||+.+.||||+.||++|++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~-----TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAE-----TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhccc-----ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            4569999999999999999999876     99999999998875555666677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ++|+|+||++||.|++++.++|++++.++..++.||+.|+.|||..+|+||||||+|+|||..+++||+|||+|....++
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      ....+.||++.|.|||++.|..| +.++||||.|||||.||+|+.||++.|...++.++..+.+.+|..++.++++||++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            88889999999999999999988 57899999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ||..||.+|+     +.++|++|||+.+..-
T Consensus       246 ml~VDp~~Ri-----T~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 MLDVDPSTRI-----TTEEILKHPFLSGYTS  271 (786)
T ss_pred             HhccCccccc-----cHHHHhhCchhhcCCC
Confidence            9999999999     8999999999987653

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-55  Score=427.74  Aligned_cols=311  Identities=47%  Similarity=0.846  Sum_probs=270.1

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA-----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence            479999999999999876     78899999998765444444445555555 567899999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987642 2233445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++...+......+++.++.++.+||++||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            68999999999999999999999999999999999999999999999999999988888888999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----------CCCC
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----------PTAG  423 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~  423 (441)
                      .+||++. ..+.++++||||.+++|..+..+.+.+|+.|..........|+..+++.+...+....          ....
T Consensus       236 ~~R~~~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05575         236 TKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD  314 (323)
T ss_pred             HhCCCCC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccc
Confidence            9999764 4678999999999999999999999999999988877788888776655443332211          2457


Q ss_pred             CcccCeeee
Q 013558          424 EHFKGYTYV  432 (441)
Q Consensus       424 ~~f~~~~~~  432 (441)
                      ..|.||+|.
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05575         315 DAFLGFSYA  323 (323)
T ss_pred             cccCCCccC
Confidence            899999883

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-54  Score=432.11  Aligned_cols=315  Identities=36%  Similarity=0.716  Sum_probs=260.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.++..++|+||+++++.+.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD-----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            479999999999999999999876     788999999987665556666788899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999987543211


Q ss_pred             ------------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC
Q 013558          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (441)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p  313 (441)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                01246899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--cccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCC
Q 013558          314 FTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  389 (441)
Q Consensus       314 f~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~  389 (441)
                      |.+.+..+...++...  ...+|+  .+++++++||.+|+. +|.+|++.  .++++|++||||++++|+.+..+...+|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~~~~~  312 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIP  312 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCCCCCC
Confidence            9998888888888753  345564  478999999999885 67777532  3899999999999999999977655554


Q ss_pred             CCCCCCCcccccCcccccCCC---CCCCC-CCCC---CCCCCcccCeeeeCC
Q 013558          390 FKPDVSGKDCIANFDKCWTTM---PADDS-PAPT---PTAGEHFKGYTYVAP  434 (441)
Q Consensus       390 ~~p~~~~~~~~~~~~~~~~~~---~~~~~-~~~~---~~~~~~f~~~~~~~~  434 (441)
                      +  ......+..+|+......   +...+ ..+.   ......|.||+|.+.
T Consensus       313 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (363)
T cd05628         313 I--EIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF  362 (363)
T ss_pred             c--cCCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence            3  344556666776532211   11111 0111   134577999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.7e-55  Score=427.80  Aligned_cols=313  Identities=40%  Similarity=0.831  Sum_probs=270.0

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+.+.     +++.||+|++.+.........+.+..|+.++.++ +||||+++++++.....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK-----NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            479999999999999876     7889999999887655566677788999999888 6999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-CCCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-~~~~~~~~  273 (441)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            99999999999988889999999999999999999999999999999999999999999999999999753 22333456


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-------NRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...       ......+.+......+|..++..+.++|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            78999999999999999999999999999999999999999532       23445666677777889999999999999


Q ss_pred             HhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----CC
Q 013558          347 GLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PT  421 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  421 (441)
                      +||++||.+|+++.+ .++++++.||||++++|..+..++..|+|.|......+..+|+..+...+...++...    ..
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKRI  315 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCccccccc
Confidence            999999999997532 3588999999999999999999999999999998888888998776555433332221    23


Q ss_pred             CCCcccCeeeeC
Q 013558          422 AGEHFKGYTYVA  433 (441)
Q Consensus       422 ~~~~f~~~~~~~  433 (441)
                      .+..|.||+|++
T Consensus       316 ~~~~~~~~~~~~  327 (327)
T cd05617         316 DQSEFEGFEYIN  327 (327)
T ss_pred             cccccCCCcCCC
Confidence            567899998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.4e-55  Score=420.26  Aligned_cols=278  Identities=38%  Similarity=0.712  Sum_probs=246.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++.+.||+|+||.||+|.++.     +++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+.+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec-----CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            38899999999999999999876     7889999999876554444455678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ++||||+++|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999999998887653  36899999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccccCCCCCcHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.    ......+......++..++.++.+|
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            444566899999999999999999999999999999999999999987543    2334444445566778899999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      |++||+.||.+|+++...+++++++||||.+++|+.++.+.++|||+|+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            9999999999999876678999999999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.7e-55  Score=428.02  Aligned_cols=314  Identities=42%  Similarity=0.805  Sum_probs=272.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+..|+++++.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987665555556677889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      |++||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            99999999999888899999999999999999999997 899999999999999999999999999987532 2223345


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999999999999999999999999999999999888888888888889999999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC--------CCCCCc
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------PTAGEH  425 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  425 (441)
                      ++|++..+.+++++++|+||.++.|..+..+.+.|++.|......+...|+..++.......+...        ......
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNERRPH  315 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcCccccCCCcccccccccccccccc
Confidence            999987777999999999999999999998889999999888777777887665433221111111        123567


Q ss_pred             ccCeeeeCC
Q 013558          426 FKGYTYVAP  434 (441)
Q Consensus       426 f~~~~~~~~  434 (441)
                      |..++|..+
T Consensus       316 ~~~~~~~~~  324 (325)
T cd05594         316 FPQFSYSAS  324 (325)
T ss_pred             cCCceecCC
Confidence            777777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-55  Score=424.63  Aligned_cols=309  Identities=39%  Similarity=0.784  Sum_probs=269.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||+|+||+||+|+++.     +++.||||++++.........+....|..+++.+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            479999999999999876     7889999999876543344445566788888764 8999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC-CCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~  273 (441)
                      ||++||+|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875322 223345


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++.+.+......+|..++.++++||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence            67999999999999999999999999999999999999999998888888888877778888899999999999999999


Q ss_pred             CCCCCCCCCCh-HHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----CCCCCCcccC
Q 013558          354 SKRLGSGPGGV-DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKG  428 (441)
Q Consensus       354 ~~R~~~~~~~~-~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~  428 (441)
                      ++|+     ++ ++++.||||+.++|..+..+.+.|++.|......+..+|+..+.+.....+...    ...+++.|.+
T Consensus       236 ~~R~-----~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (316)
T cd05619         236 ERRL-----GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFEN  310 (316)
T ss_pred             hhcC-----CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCcccccccccccccCC
Confidence            9999     55 489999999999999999999999999999999899999988766544333211    1246788999


Q ss_pred             eeeeCC
Q 013558          429 YTYVAP  434 (441)
Q Consensus       429 ~~~~~~  434 (441)
                      |+|.++
T Consensus       311 ~~~~~~  316 (316)
T cd05619         311 FSFINP  316 (316)
T ss_pred             CcccCc
Confidence            999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-54  Score=426.24  Aligned_cols=313  Identities=39%  Similarity=0.807  Sum_probs=266.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||+|+||+||+|+++.     +++.||+|++.+.........+.+..|+.++.++ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            479999999999999876     7889999999886655555667788899998877 7999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999997632 2233445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|..++.++.+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            7899999999999999999999999999999999999999952         1233455667777888999999999999


Q ss_pred             HHHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCC----CC
Q 013558          345 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PT  419 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~  419 (441)
                      |++||+.||++|+++.+ .+++++++||||++++|..+..++..|++.|.........+|+...+..+....+.    ..
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVR  315 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCcccccc
Confidence            99999999999997532 24789999999999999999999999999999888777777776554433322222    12


Q ss_pred             CCCCCcccCeeeeC
Q 013558          420 PTAGEHFKGYTYVA  433 (441)
Q Consensus       420 ~~~~~~f~~~~~~~  433 (441)
                      ......|.||.|++
T Consensus       316 ~~~~~~~~~~~~~~  329 (329)
T cd05618         316 KIDQSEFEGFEYIN  329 (329)
T ss_pred             cccccccCCCcccC
Confidence            24678899998863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-54  Score=423.48  Aligned_cols=310  Identities=38%  Similarity=0.769  Sum_probs=268.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||.||+|+++.     +++.||+|++++.........+.+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG-----KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            479999999999999886     7889999999876544344455667788888765 8999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+.||+|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            999999999999888899999999999999999999999999999999999999999999999999987532 2223445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++.+.+......+|..++.++++||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            78999999999999999999999999999999999999999998888888888888888889999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----CCCCCcccCe
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGEHFKGY  429 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~f~~~  429 (441)
                      ++|++.    .+++++||||++++|..+..+.+.+++.|......+..+|++.........+....    ...+..|.||
T Consensus       236 ~~R~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
T cd05620         236 TRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGF  311 (316)
T ss_pred             HHcCCC----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCcccccccccccCcCCC
Confidence            999932    36899999999999999999999999999988888888888766554333332211    1356799999


Q ss_pred             eeeCC
Q 013558          430 TYVAP  434 (441)
Q Consensus       430 ~~~~~  434 (441)
                      +|.++
T Consensus       312 ~~~~~  316 (316)
T cd05620         312 SFINP  316 (316)
T ss_pred             cccCC
Confidence            99763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-54  Score=425.24  Aligned_cols=313  Identities=45%  Similarity=0.805  Sum_probs=270.1

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL-----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence            469999999999999875     78899999998765444444455555655 567899999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987532 2233446


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++.+.+......+++.++.++.++|++||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCH
Confidence            78999999999999999999999999999999999999999999988999999888888888899999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC----------CCCCC
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----------TPTAG  423 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~  423 (441)
                      .+||+.. .++++++.||||+.++|..+..+.+.+++.|......+..+|+..+.+.....+...          .....
T Consensus       236 ~~R~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (325)
T cd05604         236 QRRLGAK-EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEAD  314 (325)
T ss_pred             HhcCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccc
Confidence            9999763 468899999999999999999999999999988888888888876655443222211          11356


Q ss_pred             CcccCeeeeCC
Q 013558          424 EHFKGYTYVAP  434 (441)
Q Consensus       424 ~~f~~~~~~~~  434 (441)
                      ..|.||+|..+
T Consensus       315 ~~~~~~~~~~~  325 (325)
T cd05604         315 DAFVGFSYAPP  325 (325)
T ss_pred             cccCCCEecCC
Confidence            88999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.1e-55  Score=425.02  Aligned_cols=314  Identities=49%  Similarity=0.904  Sum_probs=269.7

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||++++...  ..+++.||+|++.+.... ......+..|+++|++++||||+++++++.+++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG--PDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc--CCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999986421  237889999999875432 2233456789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-CCCccc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSM  274 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~  274 (441)
                      |+.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999999988888999999999999999999999999999999999999999999999999999865433 234457


Q ss_pred             cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcC
Q 013558          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+|..+++++.+||++||+.||+
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            89999999999999889999999999999999999999999999888888898888889999999999999999999999


Q ss_pred             CCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCC--CCCCCCCCcccCeeee
Q 013558          355 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP--APTPTAGEHFKGYTYV  432 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~f~~~~~~  432 (441)
                      +||++....+++++.|+||..++|..+..++..|++.|......+...++..+........+  +..+.....|.||+|+
T Consensus       239 ~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~  318 (318)
T cd05582         239 NRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSFV  318 (318)
T ss_pred             HcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccCCCCccccccccccCCCEeC
Confidence            99987666699999999999999999999999999999877666666666554432222221  2233567889999985

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-54  Score=431.44  Aligned_cols=312  Identities=39%  Similarity=0.699  Sum_probs=260.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD-----THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence            69999999999999999999876     7889999999887666666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC--
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--  268 (441)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+...  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999999999998889999999999999999999999999999999999999999999999999997643100  


Q ss_pred             ----------------------------------------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHH
Q 013558          269 ----------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (441)
Q Consensus       269 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  302 (441)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0112457999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHh--ccccCCC--CCcHHHHHHHHHhccc--CcCCCCCCCCCChHHhhhCcccCCC
Q 013558          303 LLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHK--DPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       303 vl~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~--dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++|||++|..||...+..+....+..  ....+|.  .+++++++||.+||..  ++..|+     +++++++||||.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~-----~~~~~l~hp~f~~~  311 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN-----GADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC-----CHHHHhcCcccCCC
Confidence            99999999999998887776666654  2344554  5899999999996654  444588     89999999999999


Q ss_pred             ChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCC----CCC------CCC--CCCCCcccCeeeeC
Q 013558          377 NWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD----DSP------APT--PTAGEHFKGYTYVA  433 (441)
Q Consensus       377 ~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~----~~~------~~~--~~~~~~f~~~~~~~  433 (441)
                      +|.... +...+|+.|......+..+|+....+.+..    ++.      ...  ......|.+|+|.+
T Consensus       312 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         312 DFSSDI-RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             ChhHHh-hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeec
Confidence            998865 355678999888888888887654332211    000      111  12368999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-54  Score=427.62  Aligned_cols=310  Identities=44%  Similarity=0.833  Sum_probs=268.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.++..++||||+++++++.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD-----TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence            479999999999999999999876     788999999988766555667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998754432


Q ss_pred             ------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH
Q 013558          270 ------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (441)
Q Consensus       270 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~  319 (441)
                                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                          23456799999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHh--ccccCCCC--CcHHHHHHHHHhcccCcCCCCCCCCCC-hHHhhhCcccCCCChhhhhhcccCCCCCCCC
Q 013558          320 QKLQQRIIN--EKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGG-VDAIKHHKWFRSINWKTLEAREMQPKFKPDV  394 (441)
Q Consensus       320 ~~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~-~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~  394 (441)
                      .....++..  ....+|..  +++++.+||.+||. ||.+|+     + ++++++||||++++|....  ...+++.|..
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~-----~s~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~  307 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRL-----GSFEEIKSHPFFKGIDWENLR--ETKPPFVPEL  307 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcC-----CCHHHHhcCCCcCCCCHHHHh--hCCCCcCCCC
Confidence            888888876  44555543  59999999999997 999999     5 9999999999999999876  5668888988


Q ss_pred             CCcccccCcccccCCCCCCC-----CCCCCCCCCCcccCeeee
Q 013558          395 SGKDCIANFDKCWTTMPADD-----SPAPTPTAGEHFKGYTYV  432 (441)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~f~~~~~~  432 (441)
                      ....+..+|+..-...+...     +.......+..|.+|+|.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         308 SSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             CCchhhhhcCCCCcccccccccccccccccccccCccCCCccC
Confidence            87777778876543332221     111223568899999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-54  Score=427.28  Aligned_cols=315  Identities=40%  Similarity=0.764  Sum_probs=263.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||++++++|.+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD-----TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            479999999999999999999876     788999999987665555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987542211


Q ss_pred             ---------------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC
Q 013558          270 ---------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG  310 (441)
Q Consensus       270 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG  310 (441)
                                                             .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   11235799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcc--ccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhccc
Q 013558          311 QPPFTHANRQKLQQRIINEK--VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM  386 (441)
Q Consensus       311 ~~pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~  386 (441)
                      ..||...+..+....+....  ..+|.  .+++++++||++||. +|.+|++.  .++++++.||||++++|..+.  ..
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~--~~  310 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIR--ER  310 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hc
Confidence            99999988888777776543  33443  478999999999997 99999953  259999999999999999865  44


Q ss_pred             CCCCCCCCCCcccccCcccccCCCCCCCC-----CCCCCCCCCcccCeeeeCC
Q 013558          387 QPKFKPDVSGKDCIANFDKCWTTMPADDS-----PAPTPTAGEHFKGYTYVAP  434 (441)
Q Consensus       387 ~p~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~f~~~~~~~~  434 (441)
                      .+++.|......+..+|+..-........     .......+..|.||+|.+.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (364)
T cd05599         311 PAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAFIGYTYKRF  363 (364)
T ss_pred             CCCCCCCCCCchhhhhccccccccccccCCCccccccccccCCCCCCCeeeCC
Confidence            67788887777777777643221111111     1112256788999999874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-54  Score=429.31  Aligned_cols=315  Identities=40%  Similarity=0.746  Sum_probs=261.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++++.++||||++++++|.+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD-----TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence            379999999999999999999876     788999999987665556667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999986421100


Q ss_pred             ------------------------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHH
Q 013558          270 ------------------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVG  301 (441)
Q Consensus       270 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  301 (441)
                                                                      .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                            00135799999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          302 ILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       302 vvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      |++|||++|..||...+..+.+..+...  ...+|.  .++.++++||++||+ +|.+|++.  .++.+++.||||++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~  312 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCC
Confidence            9999999999999988887777777653  344554  478999999999997 88888643  3899999999999999


Q ss_pred             hhhhhhcccCCCCCCCCCCcccccCcccccCCC-C---CCCC--C---CCCCCCCCcccCeeeeCC
Q 013558          378 WKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM-P---ADDS--P---APTPTAGEHFKGYTYVAP  434 (441)
Q Consensus       378 ~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~-~---~~~~--~---~~~~~~~~~f~~~~~~~~  434 (441)
                      |..+  +.+.+|+.|......+...|....... +   ....  +   ...+...-.|-||+|.+.
T Consensus       313 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
T cd05629         313 WDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRF  376 (377)
T ss_pred             HHHH--ccCCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCC
Confidence            9888  567788988877666666564332211 1   1000  0   111245688899999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-56  Score=390.42  Aligned_cols=260  Identities=34%  Similarity=0.636  Sum_probs=246.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|-||.||+|+.+.     ++.++|+|++.|..+........+.+|++|-..|+||||+++|++|
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekk-----s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKK-----SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeecc-----CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            34567899999999999999999999986     8899999999999887777778899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+...+||++||..+|+|+..|.  +..++++..+..|++|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            99999999999999999999998  6678999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      ..-. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+.+++|..-+..+|..++.+++
T Consensus       172 V~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  172 VHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAA  250 (281)
T ss_pred             eecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHH
Confidence            7755 556778999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |||.+||.++|.+|.     .+.|++.|||...
T Consensus       251 dlI~~ll~~~p~~r~-----~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  251 DLISRLLVKNPIERL-----ALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHhccCccccc-----cHHHHhhhHHHHh
Confidence            999999999999999     8999999999854

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-55  Score=430.13  Aligned_cols=318  Identities=40%  Similarity=0.730  Sum_probs=273.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      +....-|..++.||-|+||.|++|+...     +..+||+|.++|..+..++++..++.|..||...+.+.||+||..|+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            3556679999999999999999999775     78899999999999999999999999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +.+.+|+||||++||++..+|-+.+.|.|+.+++|++++.+|+++.|..|+|||||||+|||||.+|+|||+||||+.-+
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998643


Q ss_pred             C---------CC----------------------------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHH
Q 013558          266 D---------ES----------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (441)
Q Consensus       266 ~---------~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  302 (441)
                      .         .+                                  ......+||+.|+|||++...+|+..+||||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         00                                  0123457999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          303 LLYEMLTGQPPFTHANRQKLQQRIINE--KVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       303 vl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      |||||+.|++||....+.+...++++-  .+.++  ..+++++.+||.++. .+++.|+|..  ++++|+.||||++|||
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkn--g~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKN--GADQVKAHPFFKGIDF  936 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhccc--chhhhhcCccccccch
Confidence            999999999999988888777776543  23344  479999999999875 5899999764  7889999999999999


Q ss_pred             hhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCC---CCCCCC----CCCcccCeeeeC
Q 013558          379 KTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDS---PAPTPT----AGEHFKGYTYVA  433 (441)
Q Consensus       379 ~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~f~~~~~~~  433 (441)
                      ..+  |+.+.+|+|.+.-..+++|||....+....+.   +....+    -.-.|-+|+|-+
T Consensus       937 ssl--Rkq~ApYIP~ItHptDTSNFdpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRr  996 (1034)
T KOG0608|consen  937 SSL--RKQRAPYIPRITHPTDTSNFDPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRR  996 (1034)
T ss_pred             Hhh--hhccCCcCccccCCCccccCCcCCccccccccccCCCcccccccCCccceeEeeeeh
Confidence            995  67788899999999999999866443322221   111112    235677888754

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.8e-54  Score=426.24  Aligned_cols=314  Identities=37%  Similarity=0.726  Sum_probs=262.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD-----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            479999999999999999999876     788999999987665556667788899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987542210


Q ss_pred             ------------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC
Q 013558          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (441)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p  313 (441)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                11245799999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--cccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCC
Q 013558          314 FTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  389 (441)
Q Consensus       314 f~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~  389 (441)
                      |...+......++...  ...+|+  .+++++++||.+|+. ||.+|++..  +++++++||||++++|..+..+...+|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~--~~~ei~~hp~f~~~~~~~~~~~~~~~~  312 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSN--GVEEIKSHPFFEGVDWGHIRERPAAIP  312 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC--CHHHHhcCCCCCCCCHHHHhcCCCCCC
Confidence            9998888888887753  344554  378999999999874 999999653  799999999999999999987765555


Q ss_pred             CCCCCCCcccccCcccccCCC----CCCCCCCCCCCCCCcccCeeeeC
Q 013558          390 FKPDVSGKDCIANFDKCWTTM----PADDSPAPTPTAGEHFKGYTYVA  433 (441)
Q Consensus       390 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~f~~~~~~~  433 (441)
                      +  ......+..+|+..-...    ......+........|.+|+|..
T Consensus       313 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (360)
T cd05627         313 I--EIKSIDDTSNFDEFPESDILQPAENTIEPDYKSKDWVFLNYTYKR  358 (360)
T ss_pred             c--cCCCcchhhhcCCCCcccccCCCccccccccCcCCcccCCceeec
Confidence            3  344566667776321111    11111112224567899999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.2e-54  Score=419.23  Aligned_cols=312  Identities=46%  Similarity=0.843  Sum_probs=267.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHH-HHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||+|+||+||+|+++.     +++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence            469999999999999876     7789999999876543333333444444 4578899999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+.||+|..++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999997642 2233446


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+++.++..+.++|.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence            78999999999999999999999999999999999999999999988888888888888888999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC----------CCCC
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----------PTAG  423 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~  423 (441)
                      .+|+++. +.+.++++|+||..++|..+......+++.|.....++...|+..++..+...+....          ....
T Consensus       236 ~~R~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (325)
T cd05602         236 TKRLGAK-DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAA  314 (325)
T ss_pred             HHCCCCC-CCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccc
Confidence            9999763 4678999999999999999998889999999888888888888766654443322111          1345


Q ss_pred             CcccCeeeeC
Q 013558          424 EHFKGYTYVA  433 (441)
Q Consensus       424 ~~f~~~~~~~  433 (441)
                      ..|.||+|-.
T Consensus       315 ~~~~g~~~~~  324 (325)
T cd05602         315 EAFLGFSYAP  324 (325)
T ss_pred             cccCCCccCC
Confidence            6788998854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.2e-56  Score=401.60  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=220.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|+.+.++|+|+||+||+|+++.     +|++||||++.... .++.-.+-..+|+++|++++|+|+|.|+++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            469999999999999999999986     99999999986543 233444556799999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-C
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-E  267 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~  267 (441)
                      ++||+|||+.. +.+.|.+. ..++++.++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. .
T Consensus        76 lhLVFE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   76 LHLVFEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eEEEeeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99999999874 44555444 568999999999999999999999999999999999999999999999999999987 5


Q ss_pred             CCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------c---
Q 013558          268 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------E---  329 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--------------~---  329 (441)
                      +...+.++.|.+|+|||++.+ ..|+..+||||+||++.||++|.+.|.+...-+.+..|..              .   
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            566777899999999999998 7899999999999999999999999999877666655542              1   


Q ss_pred             --cccCC------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 --KVKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 --~~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                        .+.+|            +.++..+.||+++||+.||.+|+     +.++++.|+||.++
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~-----sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL-----SCEQLLHHPYFDGF  290 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc-----cHHHHhcChHHHHH
Confidence              11122            24677899999999999999999     66999999999543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-53  Score=424.46  Aligned_cols=320  Identities=34%  Similarity=0.662  Sum_probs=266.0

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ....+..++|++.++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3455667899999999999999999999876     78899999998765544555566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ++.++..+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999999988654 6899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC--CCccccCCCCCCCcchhcCCC----CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC
Q 013558          263 KEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  334 (441)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p  334 (441)
                      .......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+......++....  +.+|
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence            8764322  234678999999999997643    7889999999999999999999999988888888887643  4555


Q ss_pred             C--CCcHHHHHHHHHhcccCcCC--CCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCC
Q 013558          335 P--FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  410 (441)
Q Consensus       335 ~--~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~  410 (441)
                      .  .++..++++|.+||..++.+  |+     +++++++||||++..|.....+...+|+.|......+..+|+......
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~-----~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  344 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRN-----GVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDK  344 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCC-----CHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccc
Confidence            4  46999999999999854433  55     899999999999988877766778889999988888888887532222


Q ss_pred             CCCCC-CCC--CCCCCCcccCeeeeC
Q 013558          411 PADDS-PAP--TPTAGEHFKGYTYVA  433 (441)
Q Consensus       411 ~~~~~-~~~--~~~~~~~f~~~~~~~  433 (441)
                      ....+ +.+  .-..+..|.||+|.+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (370)
T cd05621         345 GDVETFPIPKAFVGNQLPFIGFTYYR  370 (370)
T ss_pred             cccccCCCCccccccccccCCCEecC
Confidence            11111 112  224579999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-53  Score=417.52  Aligned_cols=311  Identities=45%  Similarity=0.830  Sum_probs=265.9

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS-----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            479999999999999875     78899999998765444444445555554 678899999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-CCCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-~~~~~~~~  273 (441)
                      ||++|++|...+.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.. ........
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998763 22233445


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..||...+...+...+......+|...+.++.++|.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            68999999999999999999999999999999999999999999988889999888888899999999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC-------CCCCCCcc
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-------TPTAGEHF  426 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~f  426 (441)
                      .+|+++. .++.++++|+||..++|..+..+.+.|++.|..........|+..++......+...       .......|
T Consensus       236 ~~R~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (321)
T cd05603         236 RRRLGAK-ADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAF  314 (321)
T ss_pred             hhcCCCC-CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCccccccccccccc
Confidence            9999763 357899999999999999999888899998888877777777766554333222221       12345678


Q ss_pred             cCeeee
Q 013558          427 KGYTYV  432 (441)
Q Consensus       427 ~~~~~~  432 (441)
                      .||+|.
T Consensus       315 ~~~~~~  320 (321)
T cd05603         315 LGFSYA  320 (321)
T ss_pred             CCCccC
Confidence            898874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-53  Score=426.95  Aligned_cols=287  Identities=43%  Similarity=0.788  Sum_probs=250.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+++++||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++.|.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD-----TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence            69999999999999999999876     7889999999877655566677889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC--
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--  268 (441)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+...  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999997532100  


Q ss_pred             ----------------------------------------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHH
Q 013558          269 ----------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (441)
Q Consensus       269 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  302 (441)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                          0112357999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          303 LLYEMLTGQPPFTHANRQKLQQRIINE--KVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       303 vl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ++|||++|+.||...+..+....+...  ...+|  ..+++++.+||.+|+ .+|.+|++.  .+++++++||||++++|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcCh
Confidence            999999999999988887777776653  23344  358999999999987 599999953  36999999999999999


Q ss_pred             hhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          379 KTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       379 ~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      .... ++..+|+.|......+..+|+..
T Consensus       314 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
T cd05625         314 SSDL-RQQSAPYIPKITHPTDTSNFDPV  340 (382)
T ss_pred             HHHH-hcCCCCccCcCCCcchhhhcCCC
Confidence            8765 45678899999888888888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-53  Score=424.37  Aligned_cols=319  Identities=35%  Similarity=0.663  Sum_probs=269.0

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ....+..++|++.++||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~  110 (370)
T cd05596          36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY  110 (370)
T ss_pred             ccCCCCHHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3455677899999999999999999999876     78899999998765545555566788999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ++.++..+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            99999999999999999999988865 46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC--CCccccCCCCCCCcchhcCC----CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC
Q 013558          263 KEIDESS--RSNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  334 (441)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p  334 (441)
                      .......  .....+||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+....+.++....  ..+|
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC
Confidence            8764322  23456899999999998754    37889999999999999999999999988888888887643  4555


Q ss_pred             C--CCcHHHHHHHHHhcccCcCC--CCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCC
Q 013558          335 P--FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  410 (441)
Q Consensus       335 ~--~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~  410 (441)
                      .  .++.++++||++||+.+|.+  |+     +++++++||||++.+|.....+...+++.|......+..+|+......
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~-----s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  344 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRN-----GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDD  344 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCC-----CHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccc
Confidence            5  57999999999999999987  87     899999999999999988877888899999888777778887554332


Q ss_pred             CCCC---CCCCCCCCCCcccCeeee
Q 013558          411 PADD---SPAPTPTAGEHFKGYTYV  432 (441)
Q Consensus       411 ~~~~---~~~~~~~~~~~f~~~~~~  432 (441)
                      ....   .+.........|.||+|.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~  369 (370)
T cd05596         345 KNEETFPLPKAFAGNQLPFIGFTYS  369 (370)
T ss_pred             cccccCCCccccccccCccCCCeec
Confidence            1111   122222446679999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-53  Score=419.36  Aligned_cols=284  Identities=46%  Similarity=0.870  Sum_probs=250.2

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEeCCEEEEEE
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      ||+|+||+||+|+++.     +++.||||++.+..............|..++..+   +||||+++++++.+...+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            7999999999999875     7889999999876554444445556677777765   6999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-CCCCCcc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  273 (441)
                      ||+.+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            999999999999988999999999999999999999999999999999999999999999999999987642 2233446


Q ss_pred             ccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC-CCcHHHHHHHHHhccc
Q 013558          274 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-FLTSEAHSLLKGLLHK  351 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~~L~~  351 (441)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+..+...+|. .+++++++||++||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            7899999999998764 5899999999999999999999999999888888888888777775 4799999999999999


Q ss_pred             CcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccccc
Q 013558          352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  407 (441)
Q Consensus       352 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~  407 (441)
                      ||.+||++. .+++++++||||...+|..+..+.+++++.|.........+|+..+
T Consensus       236 ~P~~R~~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (330)
T cd05586         236 NPQHRLGAH-RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEF  290 (330)
T ss_pred             CHHHCCCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccc
Confidence            999999763 4799999999999999999999999999999887777777776543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.2e-55  Score=423.60  Aligned_cols=254  Identities=33%  Similarity=0.628  Sum_probs=239.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|.+.+.||+|+||+||+++.|.     +.+.||+|.+.|.... +...+.+.+|++|++.++|||||.++++|++..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~-----t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY-----TIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc-----ceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            579999999999999999999887     8899999999887643 4456779999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +++|.||+.| +|+.++...+.++|+.++.++++++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+......
T Consensus        76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9999999987 999999999999999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          270 R-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      . ...+.|||.|||||++.++.|+..+|+|||||++|||++|++||......++.+.|..+....|...+..++.||..+
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence            3 456789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |++||.+|+     ++.+++.|||.++
T Consensus       235 L~kdP~~Rl-----tW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  235 LIKDPAQRL-----TWTDLLGHPFWKG  256 (808)
T ss_pred             hhcChhhcc-----cHHHHhcChHHhh
Confidence            999999999     9999999999875

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-52  Score=416.72  Aligned_cols=326  Identities=35%  Similarity=0.674  Sum_probs=267.6

Q ss_pred             HHHhhhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce
Q 013558           99 LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus        99 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  178 (441)
                      ........+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+
T Consensus        32 ~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv  106 (371)
T cd05622          32 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  106 (371)
T ss_pred             hhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            33344556777899999999999999999999886     7889999999875554455556678899999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      ++++++.++..+|+||||++||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|
T Consensus       107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             eEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999999988865 4689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC--CCccccCCCCCCCcchhcCCC----CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--
Q 013558          259 FGLAKEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  330 (441)
Q Consensus       259 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--  330 (441)
                      ||+++......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|..||...+......++....  
T Consensus       186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  265 (371)
T cd05622         186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS  265 (371)
T ss_pred             CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence            99998764322  234568999999999997643    7889999999999999999999999998888888887643  


Q ss_pred             ccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccC
Q 013558          331 VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT  408 (441)
Q Consensus       331 ~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~  408 (441)
                      ..+|.  .++.++++||.+||. +|.+|++.  .+++++++|+||++..|.....+...+|+.|.........+|++.-.
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (371)
T cd05622         266 LTFPDDNDISKEAKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEE  342 (371)
T ss_pred             ccCCCcCCCCHHHHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcc
Confidence            34443  689999999999998 66665532  28999999999999877766667888899998877777777765433


Q ss_pred             CCCCCC-CCCC--CCCCCCcccCeeeeC
Q 013558          409 TMPADD-SPAP--TPTAGEHFKGYTYVA  433 (441)
Q Consensus       409 ~~~~~~-~~~~--~~~~~~~f~~~~~~~  433 (441)
                      +..... .+.+  .......|.||+|..
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T cd05622         343 DKGEEETFPIPKAFVGNQLPFVGFTYYS  370 (371)
T ss_pred             cccccccCCCCccccccccccCCCeecC
Confidence            222111 1112  113458999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.5e-53  Score=419.93  Aligned_cols=288  Identities=42%  Similarity=0.784  Sum_probs=249.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++|+||+++++.|.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD-----TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            479999999999999999999876     788999999987655555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+... 
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999997532100 


Q ss_pred             -------------------------------------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHH
Q 013558          269 -------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY  305 (441)
Q Consensus       269 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~  305 (441)
                                                                 ......+||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0112457999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCHHHHHHHHHhcc--ccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          306 EMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       306 elltG~~pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      ||++|+.||...+..+....+....  ..++  ..+++++.+||.+|+ .+|.+|++.  .+++++++||||++++|..+
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~--~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC--CCHHHHhCCCCcCCCCHHHH
Confidence            9999999999888777766665432  2333  368999999999977 599999954  27899999999999999888


Q ss_pred             hhcccCCCCCCCCCCcccccCcccc
Q 013558          382 EAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       382 ~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      . +...+++.|......+.++|+..
T Consensus       313 ~-~~~~~~~~~~~~~~~~~~~~~~~  336 (376)
T cd05598         313 I-RRQKAPYIPKITHPTDTSNFDPV  336 (376)
T ss_pred             h-hcCCCCCCCcCCCcchhhhcCCC
Confidence            7 56677888888777777777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-52  Score=410.52  Aligned_cols=281  Identities=41%  Similarity=0.731  Sum_probs=248.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence            479999999999999999999875     788999999987665555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999986544  


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCCC------CCcHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP------FLTSEA  341 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~  341 (441)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....  ...|.      .++.++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            3456789999999999999999999999999999999999999999988888777765432  22222      458999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcc
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  404 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~  404 (441)
                      .+||.+||..+|.+|+     +++++++||||++++|..+.  ...|++.|......+...|+
T Consensus       234 ~~li~~~l~~~~~rr~-----s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  289 (333)
T cd05600         234 WDLITKLINDPSRRFG-----SLEDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYFD  289 (333)
T ss_pred             HHHHHHHhhChhhhcC-----CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhcc
Confidence            9999999999999999     89999999999999998876  67888988876655544444

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-55  Score=394.09  Aligned_cols=243  Identities=29%  Similarity=0.511  Sum_probs=219.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE-EEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~  188 (441)
                      .+|+++++||+|+||+||+|++..     ++..+|.|.+.... .+....+.+..|+.+|++|+|||||++++ .|.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~-----~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL-----DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc-----Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            479999999999999999999986     88999999998544 45556677889999999999999999998 555555


Q ss_pred             E-EEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccccCCCceecCCCCcEEEEec
Q 013558          189 K-LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK--CG--IVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~--~~--iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                      . ++||||||.+|+|...++.    +..++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 9999999999999888754    3569999999999999999999998  44  999999999999999999999999


Q ss_pred             CCccccCCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CC-CC
Q 013558          260 GLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-PF  336 (441)
Q Consensus       260 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p-~~  336 (441)
                      |+++.+.... ...+.+|||.||+||++.+.+|+.++||||+||++|||+.-+.||.+.+..++.++|..+.+. +| ..
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            9999876543 356789999999999999999999999999999999999999999999999999999998775 77 67


Q ss_pred             CcHHHHHHHHHhcccCcCCCCC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLG  358 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~  358 (441)
                      +|.++..||..|+..||+.||+
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCC
Confidence            9999999999999999999995

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-52  Score=401.25  Aligned_cols=278  Identities=39%  Similarity=0.719  Sum_probs=245.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++.++||+|+||+||++.+..     +++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC-----CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence            48999999999999999999875     7889999999876544444445677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999999999888654  46899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhccccCCCCCcHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK----LQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      ......+|+..|+|||++.+..++.++|||||||++|||++|+.||.+.+...    +...+......++..++..+.+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            44455689999999999998889999999999999999999999998765533    33334444556677899999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      |.+||+.||.+||++...+++++++|+||...+|+.+..++++|||+|.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            9999999999999887778999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-55  Score=386.51  Aligned_cols=257  Identities=33%  Similarity=0.594  Sum_probs=237.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.++||+|.|+.|+++.++.     +|+.||+|++........ ..+.+.+|+.|-+.|+|||||+|++.+.+.+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~-----tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc-----chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            3579999999999999999998876     899999999977665444 4567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEEecCCcccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~DFG~a~~~  265 (441)
                      ..|+|+|+|.|++|..-+-.+..++|..+-.+++||+++|.|+|.+||||||+||+|+|+..   ..-+||+|||+|..+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999888877788999999999999999999999999999999999999953   346999999999999


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  341 (441)
                      .........+|||.|||||++....|+..+|||+.||+||-|+.|.+||.+.+...+++.|+.+.+.+|.    .+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            8777778899999999999999999999999999999999999999999999999999999999988875    689999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++||++||..||.+|+     ++.|+++|||+++-
T Consensus       244 k~LvrrML~~dP~kRI-----ta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRI-----TADEALKHPWICNR  273 (355)
T ss_pred             HHHHHHHhccChhhhc-----cHHHHhCCchhcch
Confidence            9999999999999999     89999999999863

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-54  Score=403.09  Aligned_cols=254  Identities=31%  Similarity=0.593  Sum_probs=241.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      .+|++.+.||+|+||+|-+|....     .|+.||||.++++.+.++...-.+++|++||..|+||||+.+|.+|+..+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~-----sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK-----SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc-----CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            369999999999999999998765     899999999999999988888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +.|||||..+|.|++++.+.+.++|.+++.|++||+.|+.|+|.++|+|||||.+|||+|.++++||+|||++-.+....
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             CCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      ...++||++.|.+||++.|..| ++.+|.|||||+||.|+.|..||++.+...+.++|..+.+.-|+. +..+.-||+.|
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwm  286 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWM  286 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHH
Confidence            8899999999999999999988 578999999999999999999999999999999999998877664 55778999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      |..||++|.     ++++|..|-|.+
T Consensus       287 LmVNP~RRA-----TieDiAsHWWvN  307 (668)
T KOG0611|consen  287 LMVNPERRA-----TIEDIASHWWVN  307 (668)
T ss_pred             HhcCcccch-----hHHHHhhhheee
Confidence            999999998     999999999974

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=405.37  Aligned_cols=261  Identities=31%  Similarity=0.586  Sum_probs=226.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----------hhHHHHHHHHHHHHHhcC
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------KNHVDYMKAERDILTKVT  173 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~  173 (441)
                      .....++|++++.||+|.||.|-+|++..     +++.||||++.+.....           ....+.+.+||.+|++|+
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            34456789999999999999999999876     88999999998754322           223467899999999999


Q ss_pred             CCCceeeeEEEEe--CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          174 HPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       174 hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      |||||+|+.+..+  .+.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||.|+||+.+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            9999999999876  46899999999999874433222239999999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCC------CCccccCCCCCCCcchhcCCC----CCCcchhhhHHHHHHHHHcCCCCCCCCCHHH
Q 013558          252 GHVMLTDFGLAKEIDESS------RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQK  321 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltG~~pf~~~~~~~  321 (441)
                      |+|||+|||.+.......      .....+|||.|+|||.+.+..    .+.+.||||+||+||.|+.|+.||-+....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            999999999987652221      123468999999999998732    2578999999999999999999999999999


Q ss_pred             HHHHHHhccccCCCC--CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          322 LQQRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       322 ~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ++.+|++..+.+|..  +.++++|||.+||++||++|+     ++.+|+.|||...
T Consensus       327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri-----~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI-----TLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee-----ehhhheecceecc
Confidence            999999999999975  899999999999999999999     9999999999853

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6e-52  Score=406.84  Aligned_cols=310  Identities=36%  Similarity=0.707  Sum_probs=259.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|+++.     +++.||+|++++.........+.+.+|+.+++.++|+||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA-----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            379999999999999999999876     788999999988765555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999999999876 78999999999999999999999999999999999999999999999999999876443


Q ss_pred             CC--CccccCCCCCCCcchhc------CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC--CC
Q 013558          269 SR--SNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PF  336 (441)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p--~~  336 (441)
                      ..  .....||+.|+|||++.      ...++.++|||||||++|||++|+.||...+....+.++....  ..+|  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence            22  23457999999999987      4567889999999999999999999999888877777776542  3334  35


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  416 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~  416 (441)
                      ++.++.+||.+||+ +|.+||     ++++++.||||..++|..+..  ..|++.|......+..+|+......+.....
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~-----t~~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERL-----GYEGLCCHPFFSKIDWNNIRN--SLPPFVPTLKSDDDTSNFDEPEKNSTRRSQS  307 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCC-----CHHHHhCCCCcCCCCHHHHhh--CCCCccCcCCCcchhhhcCCCcccccccccc
Confidence            79999999999998 999999     889999999999999998863  5577888887777778886543322211111


Q ss_pred             -------CCCCCCCCcccCeeee
Q 013558          417 -------APTPTAGEHFKGYTYV  432 (441)
Q Consensus       417 -------~~~~~~~~~f~~~~~~  432 (441)
                             .........|-||+|.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         308 STTQLKPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             ccccCCCcCCCCCCCCccCceeC
Confidence                   1112345778888774

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=408.61  Aligned_cols=255  Identities=31%  Similarity=0.527  Sum_probs=224.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  187 (441)
                      .++|.++++||.|+||.||+|+.+.     ++..||||.|++.-.. -+.. .-.+|++.|++|+ |||||+|.+++.+.
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~-----~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKE-----TGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecC-----CCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            4579999999999999999999886     8889999999775432 2222 2357999999998 99999999999988


Q ss_pred             C-EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 S-KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 ~-~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      + .+|+|||||+. +|+++++.+ ..|++..++.|++||++||+|+|.+|++|||+|||||||..+..|||+|||+||.+
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            8 99999999976 798888755 57999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------
Q 013558          266 DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN----------------  328 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~----------------  328 (441)
                      ......+.++.|.+|+|||++.. ..|+.++||||+|||++|+.+-++.|.+.+..+...+|..                
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88778888999999999999874 6789999999999999999999999999988887777752                


Q ss_pred             ---ccccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 ---EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ---~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                         ..+.+|           +..+.++.+||.+||..||++||     +++++++||||+..
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp-----TA~~al~~pffq~~  297 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP-----TASQALQHPFFQVG  297 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc-----cHHHHhcCcccccc
Confidence               122233           24789999999999999999999     89999999999854

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-51  Score=402.71  Aligned_cols=287  Identities=37%  Similarity=0.732  Sum_probs=245.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+++++.     +++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            479999999999999999999876     788999999987554445556668889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+.||+|..++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--CccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCCC---C
Q 013558          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP---F  336 (441)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~---~  336 (441)
                      ..  ....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||...+..+...++....  ..+|.   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence            22  234579999999999876     467889999999999999999999999888888888776643  33443   4


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +++++++||.+||..++ +|++.  .+++++++|+||++++|..+.  ...+++.|.........+|+..
T Consensus       236 ~~~~~~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~  300 (331)
T cd05624         236 VSEEAKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENIR--NLEAPYIPDVSSPSDTSNFDVD  300 (331)
T ss_pred             CCHHHHHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHHh--hCCCCccCCCCCcchhhhcCCc
Confidence            68999999999999655 45432  389999999999999999884  5678888887776666666543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.5e-51  Score=393.97  Aligned_cols=289  Identities=46%  Similarity=0.876  Sum_probs=265.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||++.+..     +++.||+|++.+.........+.+.+|+++|++++||||+++++++.....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            379999999999999999999875     788999999987665555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++...... 
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999999876543 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhc
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  349 (441)
                       ....+|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.....+.+..+...+|..++..++++|.+||
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence             3456799999999999888889999999999999999999999998888888888888888899999999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccc
Q 013558          350 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  405 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~  405 (441)
                      +.||.+|+++..++++++++||||+.++|..+....+.+|+.|......+.+.|++
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence            99999999888889999999999999999999999999999998877777777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-51  Score=395.01  Aligned_cols=270  Identities=39%  Similarity=0.743  Sum_probs=237.5

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|+||+||++.++.     +++.||+|++.+.........+.+..|+.+++.++|+||+++++++.....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEcc-----CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            7999999999999876     78899999998765544445567788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-CCc
Q 013558          198 NGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSN  272 (441)
Q Consensus       198 ~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  272 (441)
                      +||+|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            99999887743    3468999999999999999999999999999999999999999999999999998654332 233


Q ss_pred             cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.    ......+......++..++.++.+|+.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            46799999999999999999999999999999999999999976432    34445555566677788999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      |+.||++|++....+++++++||||++++|..++.....+||.|
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~  279 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP  279 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence            99999999988777899999999999999999998888888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-53  Score=411.88  Aligned_cols=253  Identities=30%  Similarity=0.516  Sum_probs=230.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ...|....+||+|+.|.||.|+...     +++.||||.+......   ..+.+.+|+.+|+..+|+|||++++.|-..+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~-----~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKIS-----TKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhhcchhhhccccccceeeeeecc-----CCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            3468999999999999999999887     7888999999876533   3456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+++|||||+||+|.+.+.. ..++|.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+...
T Consensus       344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999999999888755 45999999999999999999999999999999999999999999999999999887655


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      . ...+.+||++|||||++..+.|+.++||||||++++||+-|++||-..++...+..|...   .+..++.+|.++++|
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            4 567899999999999999999999999999999999999999999988888777777653   455678999999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |.+||+.|+++|+     ++.+||+||||+-
T Consensus       503 L~~cL~~dv~~Ra-----sA~eLL~HpFl~~  528 (550)
T KOG0578|consen  503 LDRCLVVDVEQRA-----SAKELLEHPFLKM  528 (550)
T ss_pred             HHHHhhcchhcCC-----CHHHHhcChhhhh
Confidence            9999999999999     8899999999953

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8e-51  Score=399.29  Aligned_cols=313  Identities=36%  Similarity=0.708  Sum_probs=253.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||+||+++.+.     +++.||+|++.+...........+.+|+.++..++|+||+++++++.+...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            479999999999999999999876     788999999987655555556668889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999998765332


Q ss_pred             C--CCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC---CC
Q 013558          269 S--RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP---PF  336 (441)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p---~~  336 (441)
                      .  .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+...++....  ..+|   ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence            2  223467999999999986     3457889999999999999999999999988888888887653  2334   35


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccc---ccCCCCCC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK---CWTTMPAD  413 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~---~~~~~~~~  413 (441)
                      +++++++||++||..++++ ++  ..+++++++||||.+++|..+..  ..+++.|.........+++.   +.+. ...
T Consensus       236 ~s~~~~~li~~ll~~~~~r-~~--r~~~~~~~~h~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  309 (332)
T cd05623         236 VSEDAKDLIRRLICSREHR-LG--QNGIEDFKQHPFFTGIDWDNIRN--CEAPYIPEVSSPTDTSNFDVDDDCLKN-SET  309 (332)
T ss_pred             CCHHHHHHHHHHccChhhh-cC--CCCHHHHhCCCCcCCCCHHHHhh--CCCCccCCCCCCcccccCCCCcccccc-cCC
Confidence            7999999999999865544 32  12899999999999999998853  55677777766666555532   2111 111


Q ss_pred             CCCCC---CCCCCCcccCeeeeC
Q 013558          414 DSPAP---TPTAGEHFKGYTYVA  433 (441)
Q Consensus       414 ~~~~~---~~~~~~~f~~~~~~~  433 (441)
                      ..++.   .......|.+|+|.+
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~  332 (332)
T cd05623         310 MPPPSHTAFSGHHLPFVGFTYTS  332 (332)
T ss_pred             CCCCCccccccCCCCcCCeeecC
Confidence            11111   113457788888863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=397.43  Aligned_cols=254  Identities=32%  Similarity=0.566  Sum_probs=219.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      .++...+.||+|+||.||++.++.     ++..+|||.+.....   ...+.+.+|+.+|++++|||||+++|...... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~-----~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK-----TGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC-----CCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            468888999999999999999875     688999999876521   12667899999999999999999999755444 


Q ss_pred             -EEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCcccc
Q 013558          189 -KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 -~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~~  265 (441)
                       .+++.|||++||+|.+++.+.+ .++|..++.+.+||++||.|||++|||||||||+||||+. +|.+||+|||+++..
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence             6999999999999999999887 8999999999999999999999999999999999999999 799999999999876


Q ss_pred             CC----CCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--ccCCCCC
Q 013558          266 DE----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK--VKLPPFL  337 (441)
Q Consensus       266 ~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~  337 (441)
                      ..    ........||+.|||||++... ....++|||||||++.||+||+.||.. .......-.+....  +.+|..+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l  248 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL  248 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence            53    2224467899999999999963 334599999999999999999999987 44444444554433  5788999


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++++++||.+||.+||++||     ++++++.|||.+..
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rp-----ta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRP-----TAEELLEHPFLKQN  282 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCc-----CHHHHhhChhhhcc
Confidence            99999999999999999999     89999999999754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-52  Score=402.52  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=224.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..+.|+.+++||+|+||.||+|++..     ++++||+|.++.+. .+......+.+||.||++|+||||++|.+...+.
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~-----tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLE-----TGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecc-----cCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            34579999999999999999999886     89999999998865 3455667788999999999999999999998876


Q ss_pred             --CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                        +.+|||+|||+. ||.-++... -.|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence              789999999987 787777664 3799999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCC--CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------cc
Q 013558          265 IDESS--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------KV  331 (441)
Q Consensus       265 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------~~  331 (441)
                      +....  ..+..+-|.+|+|||++.| ..|+..+|+||.||||.||++|++.|.+.+..+.+.+|.+-          ..
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            65443  3566778999999999997 57999999999999999999999999999998888888641          11


Q ss_pred             cCC-------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          332 KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       332 ~~p-------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      .+|                   ..++..+.+|+..||..||.+|.     ++.+++.|+||.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~-----tA~~aL~seyF~  404 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG-----TASSALQSEYFT  404 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc-----cHHHHhcCcccc
Confidence            222                   23688999999999999999999     889999999994

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=398.02  Aligned_cols=287  Identities=38%  Similarity=0.737  Sum_probs=242.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+++.+.     +++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN-----TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence            479999999999999999999876     788999999987655555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999999999976 467999999999999999999999999999999999999999999999999998765433


Q ss_pred             CC--CccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC---CC
Q 013558          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP---PF  336 (441)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p---~~  336 (441)
                      ..  ....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||...+..+....+....  ..++   ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence            22  223579999999999973     457889999999999999999999999888877777776533  3333   34


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +++++++||++||.. |.+|++-  .+++++++||||.+++|..+..  ..+++.|......+..+|+..
T Consensus       236 ~~~~~~~li~~ll~~-~~~r~~r--~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  300 (331)
T cd05597         236 VSEEAKDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVD  300 (331)
T ss_pred             CCHHHHHHHHHHccC-cccccCC--CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCc
Confidence            799999999999975 4444321  2899999999999999998864  456788877666666666543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-51  Score=387.76  Aligned_cols=263  Identities=29%  Similarity=0.487  Sum_probs=231.3

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+..+.++|++..+||.|..++||+|+...     .+..||||++..+....  ..+.+.+|+..|+.++||||++++..
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~s   92 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCS   92 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEE
Confidence            345667899999999999999999999987     77899999998876543  37889999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      |..+..+|+||.||.+|++.++++..  ..++|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.
T Consensus        93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence            99999999999999999999999865  4599999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-CC----CccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC
Q 013558          262 AKEIDES-SR----SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (441)
Q Consensus       262 a~~~~~~-~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p  334 (441)
                      +..+... .+    ..+++||++|||||++..  .+|+.|+||||||++.+||.+|..||....+.+++-.-+++.++.+
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL  252 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence            7654322 11    156789999999999653  6799999999999999999999999998888877766666665422


Q ss_pred             ----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          335 ----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       335 ----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                ..++..++.+|..||++||.+||     ++.++++|+||+...-
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp-----tAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP-----TASKLLKHAFFKKAKS  301 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCC-----CHHHHhccHHHhhccc
Confidence                      24678899999999999999999     8899999999987643

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-50  Score=387.70  Aligned_cols=278  Identities=40%  Similarity=0.731  Sum_probs=239.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++.++||+|+||.||++.++.     +++.||+|.+.+...........+.+|+.++++++|+||+.+++.+.+.+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC-----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            37889999999999999999886     7889999999876544444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+.|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999999888654  35899999999999999999999999999999999999999999999999999776544


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---HHHHHH-HhccccCCCCCcHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---KLQQRI-INEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~l  344 (441)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......   +....+ ......++..+++++++|
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            4444567999999999999999999999999999999999999999864321   122222 222334567789999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      |++||+.||++|+++...+++++++||||+.++|..+...+..|+|+|.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD  284 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence            9999999999999654345999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=399.50  Aligned_cols=256  Identities=35%  Similarity=0.632  Sum_probs=238.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      ..|++.+.||+|.||.||+|+.+.     +++.||+|++.+.........+.+.+|+.+|+++. |||||.++++|++..
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            469999999999999999999987     79999999999987766666778999999999998 999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC----CCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~----~~~vkl~DFG~a~~  264 (441)
                      .+++|||++.||.|++.+... .++|..+..++.|++.++.|||+.||+||||||+|+|+..    ++.+|++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999877 4999999999999999999999999999999999999963    35799999999999


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE  340 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  340 (441)
                      ..........|||+.|+|||++....|+..+||||+||++|.|++|..||.+.+......+|..+.+.++    +.++..
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            8876678889999999999999999999999999999999999999999999999999999999988766    358999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +++||++||..||.+|+     ++.++++|||+++.
T Consensus       269 akd~i~~ll~~dp~~R~-----ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRL-----TAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCC-----CHHHHhcCccccCC
Confidence            99999999999999999     89999999999865

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-51  Score=365.15  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=221.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      .+|..+++||+|.||.||+|++..     +++.||||.++.....+... ....+|+++|+.++|+||+.|+++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~-----t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE-----TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC-----CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            468899999999999999999886     89999999998765443333 345679999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +.||+|||+. +|...++.. ..++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9999999976 898888765 46899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-ccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------
Q 013558          269 SRS-NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  330 (441)
Q Consensus       269 ~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------------  330 (441)
                      ... ...+-|.+|+|||++.| +.|+..+|+||.|||+.||+-|.+-|.+.+.-+....|...-                
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            333 33478999999999887 579999999999999999999999999998888887776310                


Q ss_pred             ---cc-CC--------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          331 ---VK-LP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       331 ---~~-~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                         +. +|        +..+.++.||+.+||..||.+|+     ++.|+++|+||+..
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri-----ta~qaL~~~yf~~~  287 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI-----TASQALKHPYFKSL  287 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc-----cHHHHhcchhhhcC
Confidence               00 11        23578889999999999999999     88999999999753

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.2e-50  Score=383.66  Aligned_cols=278  Identities=39%  Similarity=0.710  Sum_probs=243.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+..++||+|+||+||++.+..     +++.||+|++.+...........+.+|+++|+.++|+||+.+++.+..++.+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC-----CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            37888999999999999999876     7889999999876554444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999999998888654  36999999999999999999999999999999999999999999999999999765444


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhccccCCCCCcHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .......|+..|+|||++.+..++.++|+|||||++|+|++|..||........    ..++......++..++.++.+|
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            334456799999999999998999999999999999999999999987655433    3333344455667789999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      +.+||+.||++||++....+++++.|+||+.++|+.+..+++.|+|.|.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD  284 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence            9999999999999876666999999999999999999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-50  Score=384.18  Aligned_cols=270  Identities=37%  Similarity=0.699  Sum_probs=230.5

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|+||.||+++.+.     +++.||+|++.+...........+..|++++++++||||+++++++..+..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKN-----TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEcc-----CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            7999999999999876     78899999997755444444455667999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCcccc
Q 013558          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (441)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  275 (441)
                      +|++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            9999988886543  58899999999999999999999999999999999999999999999999998765544444567


Q ss_pred             CCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccccCC-CCCcHHHHHHHHHhcc
Q 013558          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLP-PFLTSEAHSLLKGLLH  350 (441)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~  350 (441)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||.....    .++...+......++ ..++.++++||++||+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            99999999999998899999999999999999999999976432    334444444444333 4689999999999999


Q ss_pred             cCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       351 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      +||++||++. +-+++++.|+||++++|..++.....|||.|+
T Consensus       236 ~~P~~R~~~~-~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05607         236 KKPEDRLGSR-EKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD  277 (277)
T ss_pred             cCHhhCCCCc-cchhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence            9999999552 12478999999999999999999988998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-51  Score=374.92  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=223.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      -..++|+.+..|++|+||.||+|+++.     ++++||+|.++.+.. ....--.-.+||.+|.+++|||||.+-.+...
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~-----t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKK-----TDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCC-----cceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            345679999999999999999999987     889999999987652 22222334679999999999999999887764


Q ss_pred             --CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          187 --RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                        -+.+|+|||||+. +|...+...+ +|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+|+
T Consensus       147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             cccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence              4679999999987 8988888775 89999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------
Q 013558          264 EIDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------  329 (441)
Q Consensus       264 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~------------  329 (441)
                      .++... ..+..+-|.+|+|||++.+ ..|+..+|+||+|||+.||+++++.|.+....+...+|...            
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            986653 3556788999999999987 56999999999999999999999999999888888887631            


Q ss_pred             -------cccCC------------CC-CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 -------KVKLP------------PF-LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 -------~~~~p------------~~-~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                             ...++            .. +++...+|++.+|.+||.+|.     ++++.++|.||...
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~-----tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI-----TAEDGLKHEYFRET  367 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc-----cHHHhhcccccccC
Confidence                   11121            11 568999999999999999999     88999999999864

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-51  Score=368.98  Aligned_cols=256  Identities=29%  Similarity=0.559  Sum_probs=232.1

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      +|+-.+.||+|..++|.++.++.     +++.+|+|++......     .....+.-..|+.||+++ .||+|+++.++|
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~-----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKE-----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcc-----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            57778899999999999988876     8889999998643221     123345556899999998 699999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +++..+++|+|.|+.|.|+++|...-.++|...+.|++|+++|++|||.++|+||||||+|||+|++.++||+|||+|+.
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccccCCCCCCCcchhcC------CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC---
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP---  335 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~---  335 (441)
                      +..+......||||+|+|||.+..      .+|+..+|+|++||+||.|+.|.+||.+....-++..|+.+++.|..   
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            999998999999999999999873      46889999999999999999999999998888889999999888753   


Q ss_pred             -CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 -FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 -~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                       .++...++||++||+.||.+|+     ++++++.||||..+
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ri-----take~LaHpff~q~  289 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRI-----TAKEALAHPFFIQI  289 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcc-----cHHHHhcChHHHHH
Confidence             5899999999999999999999     88999999999543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-50  Score=390.90  Aligned_cols=252  Identities=29%  Similarity=0.489  Sum_probs=220.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+...+..+.+.||.|+||+||++.+++      ...+|+|++......... .+.+.+|+.+|.+++|||||+++|++.
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g------~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRG------TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCC------ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3444566777789999999999999864      223999999876654444 778999999999999999999999999


Q ss_pred             eCC-EEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccccCCCceecCCCC-cEEEEecC
Q 013558          186 TRS-KLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENILMDSDG-HVMLTDFG  260 (441)
Q Consensus       186 ~~~-~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~-~vkl~DFG  260 (441)
                      +.. .+++|||||++|+|..++..  .+.++...+..++.||+.||+|||+++ |||||||++||||+.++ ++||+|||
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence            887 79999999999999999988  688999999999999999999999999 99999999999999998 99999999


Q ss_pred             CccccCCC-CCCccccCCCCCCCcchhc--CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccccCCC
Q 013558          261 LAKEIDES-SRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP  335 (441)
Q Consensus       261 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~  335 (441)
                      +++..... ...+...||+.|||||++.  ...|+.++|||||||+||||+||+.||...........+..  .++.+|.
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            99886654 3344478999999999999  66999999999999999999999999999887766666653  3566777


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++.+..||.+||..||.+||     +..+|..
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP-----~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRP-----SFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCC-----CHHHHHH
Confidence            8999999999999999999999     6667654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=373.95  Aligned_cols=255  Identities=28%  Similarity=0.477  Sum_probs=220.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      ..|..++.||+|+||.|+.|.++.     +++.||||.+.. ........++..+|+++|+.++|+||+.+++++..   
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~-----t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKR-----TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcC-----CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            456668999999999999999987     889999999863 23445556778899999999999999999999875   


Q ss_pred             --CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                        -..+|+|+|+| +.+|...++.+..++++.++.+++||+.||.|+|+.+|+||||||.|+|++.+..+||||||+|+.
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              45799999999 558999998888899999999999999999999999999999999999999999999999999998


Q ss_pred             cCC---CCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Q 013558          265 IDE---SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN------------  328 (441)
Q Consensus       265 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~------------  328 (441)
                      ...   ....+..+.|.+|+|||++.. ..|+..+||||+|||+.||++|++.|.+.+.-..++.|+.            
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            753   334466788999999999864 7899999999999999999999999998886655555532            


Q ss_pred             -----------ccccCC--------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 -----------EKVKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 -----------~~~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                 .....|        +..++.+.+|+.+||..||.+|+     +++|++.||||...
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi-----ta~eAL~hPYl~~~  316 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI-----TAEEALAHPYLAPY  316 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-----CHHHHhcChhhhhh
Confidence                       111111        46889999999999999999999     89999999999754

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.1e-49  Score=376.60  Aligned_cols=253  Identities=30%  Similarity=0.489  Sum_probs=214.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|+++.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC-----CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            379999999999999999999876     788999999976532 23345667889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99999999998776555555679999999999999999999999999999999999999999999999999998764322


Q ss_pred             --CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 013558          270 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  330 (441)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------------  330 (441)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....                 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence              2234679999999999999899999999999999999999999998766544333322110                 


Q ss_pred             --ccC-------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 --VKL-------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 --~~~-------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                        ..+             ...++.++++||++||++||++||     +++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~-----s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY-----LTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence              011             123688899999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-50  Score=384.65  Aligned_cols=256  Identities=34%  Similarity=0.578  Sum_probs=239.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      =|.+.+.||+|-|++|-+|++.-     +|+.||||++.|....+- ....+..|++.|+.++|||||+||++..+...+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVF-----TGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhc-----ccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            48888999999999999999875     899999999998775443 345677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~  268 (441)
                      |||+|+-++|+|++++.++ ..+.|+.++.|++||+.|+.|+|+..||||||||+||.+- .-|-|||+|||++-.+..+
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999999999776 4699999999999999999999999999999999998774 6789999999999999998


Q ss_pred             CCCccccCCCCCCCcchhcCCCCC-CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      ....+.||+..|-|||++.|..|+ +++||||||||||-|++|++||...+..+.+..|+.-++..|..++.++++||..
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence            899999999999999999999987 5789999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ||..||.+|.     ++++|..|+|++.++
T Consensus       253 MLvRdPkkRA-----slEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  253 MLVRDPKKRA-----SLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHhcCchhhc-----cHHHHhccccccCCC
Confidence            9999999998     999999999999876

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-48  Score=373.07  Aligned_cols=271  Identities=39%  Similarity=0.752  Sum_probs=238.3

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|+||+||+|.++.     +++.||+|++.+...........+..|+.+|+.++||||+++++++...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKA-----TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcC-----CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            6999999999998875     78899999998755444444556678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCcccc
Q 013558          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (441)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  275 (441)
                      ++++|.+++.+.+  .+++..++.++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            9999999998766  79999999999999999999999999999999999999999999999999998765444444567


Q ss_pred             CCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccccCCCCCcHHHHHHHHHhccc
Q 013558          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  351 (441)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  351 (441)
                      ++..|+|||++.+..++.++|||||||++|+|++|+.||.....    ..+...+......++..+++.+.++|.+||+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            88999999999888899999999999999999999999976543    34444445555667778899999999999999


Q ss_pred             CcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCC
Q 013558          352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  393 (441)
Q Consensus       352 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~  393 (441)
                      ||.+||+....++.+++.||||+.++|..+.....+|||.|+
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD  277 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence            999999887678999999999999999999988889999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.1e-48  Score=375.91  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC-----CCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            3689999999999999999999875     788999999875432  222234678999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9999999996 5777777654 5789999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc--c------------
Q 013558          268 S-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINE--K------------  330 (441)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~--~------------  330 (441)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+....+...  .            
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            2 22345678999999999875 4578899999999999999999999986432 2333222110  0            


Q ss_pred             -------cc--CC---------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          331 -------VK--LP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       331 -------~~--~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                             ..  .+         ..++.++++||.+||+.||.+||     +++++++||||+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-----s~~~~l~h~~f~~~~~  296 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-----SAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc-----CHHHHhcCcccccCCh
Confidence                   00  00         12456889999999999999999     8899999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.8e-48  Score=371.94  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=213.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.++||.|+||+||+|+++.     +++.||+|+++....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECC-----CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            4679999999999999999999876     788999999875432  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999999975 8888887654 579999999999999999999999999999999999999999999999999976533


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  330 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---------------  330 (441)
                      .. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            22 2334578999999999875 568999999999999999999999998877666555443210               


Q ss_pred             ----ccC-----------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 ----VKL-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ----~~~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                          ..+           .+.++.++++||++||+.||.+|+     +++|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~-----t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI-----SAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCCCC
Confidence                001           124688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-51  Score=385.52  Aligned_cols=256  Identities=25%  Similarity=0.486  Sum_probs=229.1

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ..|..+++||+|+||.||++.+..     +++.||+|++..+.  .+..++.+..|+.+|..++++||.++|+.|..+..
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~-----t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK-----TKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeecc-----ccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            358888999999999999999886     88999999998764  35567789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      ++++||||.||++.+.+.....+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998865443


Q ss_pred             -CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHHHH
Q 013558          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  347 (441)
                       +..+++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+...+..|-+.. +.+...+++.+++||..
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence             3478999999999999999999999999999999999999999999877754444443332 23445789999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ||++||+.||     ++.++++|+|++...
T Consensus       246 CL~k~P~~Rp-----sA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  246 CLDKNPEFRP-----SAKELLKHKFIKRAK  270 (467)
T ss_pred             HhhcCcccCc-----CHHHHhhhHHHHhcC
Confidence            9999999999     889999999998743

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-48  Score=364.61  Aligned_cols=256  Identities=29%  Similarity=0.488  Sum_probs=220.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~  188 (441)
                      ..|+.+++||+|+||+||+|+.+.     +|+.||+|+++..... +..-....+|+.+|+.++|+| ||.|++++.+..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~-----~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR-----TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec-----CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            458888899999999999999987     8899999999865432 223344578999999999999 999999999877


Q ss_pred             ------EEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          189 ------KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                            .+++|+||++. +|..++....    .++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|
T Consensus        85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence                  89999999965 8999987765    477889999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC-CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------
Q 013558          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------  329 (441)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------  329 (441)
                      ||+|+...-.. .....++|.+|+|||++.+. .|+..+||||+|||++||++++..|.+....+...+|..-       
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999876333 35677899999999999986 7999999999999999999999999998888777777531       


Q ss_pred             -----------cccCC------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          330 -----------KVKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       330 -----------~~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                 +..++            +..+++..+++.+||+.+|.+|.     +++.++.||||..+.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~-----Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI-----SAKGALTHPYFSELP  309 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc-----CHHHHhcChhhcccc
Confidence                       11122            12345899999999999999999     889999999998763

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-47  Score=369.59  Aligned_cols=285  Identities=39%  Similarity=0.732  Sum_probs=244.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||.||++.++.     +++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE-----TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC-----CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            379999999999999999999876     788999999987654444556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999998642100 


Q ss_pred             ---------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC
Q 013558          269 ---------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  333 (441)
Q Consensus       269 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~  333 (441)
                                     .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                           01123467889999999998889999999999999999999999999888888888877665444


Q ss_pred             CC---CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCc
Q 013558          334 PP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF  403 (441)
Q Consensus       334 p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~  403 (441)
                      |.   .++.++.+||.+||+.||++||++.  ++.+++.||||...+|.......  ..+.|.....++..+|
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  304 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQK--AEFIPQLESEDDTSYF  304 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhcC--CCCCCCCCCccccccC
Confidence            43   5789999999999999999999763  68999999999999999977543  3566766555444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-47  Score=377.11  Aligned_cols=259  Identities=27%  Similarity=0.450  Sum_probs=221.9

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||.||+|+++.     ++..||+|++....  .....+.+.+|+++|+.++||||+++++++..
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            345789999999999999999999886     78899999987542  23345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ++.+++||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999999998888899999999999999999999986 6999999999999999999999999999866


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------------
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------------------  327 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~------------------  327 (441)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.                  
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            432 2345679999999999999999999999999999999999999997665544332211                  


Q ss_pred             ----------------------------hc-cccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          328 ----------------------------NE-KVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       328 ----------------------------~~-~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                                  .. ....+ ..+++++++||.+||++||++||     ++++|++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~~  308 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA-----DLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC-----CHHHHhcChHHhhcc
Confidence                                        11 01111 24688999999999999999999     899999999998654


Q ss_pred             h
Q 013558          378 W  378 (441)
Q Consensus       378 ~  378 (441)
                      .
T Consensus       309 ~  309 (331)
T cd06649         309 V  309 (331)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-47  Score=393.64  Aligned_cols=252  Identities=25%  Similarity=0.427  Sum_probs=205.9

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC------CCceee
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l  180 (441)
                      +..++|+++++||+|+||+||+|.+..     +++.||||+++...    ........|+.+++.++|      .+|+++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRK-----RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcC-----CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            446789999999999999999999875     78899999996532    122345567777777754      458889


Q ss_pred             eEEEEeC-CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCC------
Q 013558          181 RYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDG------  252 (441)
Q Consensus       181 ~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~------  252 (441)
                      +++|... .++|+|||++ |++|.+++.+.+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++      
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            8888764 5799999998 77899999888899999999999999999999997 5999999999999998765      


Q ss_pred             ----------cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH
Q 013558          253 ----------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  322 (441)
Q Consensus       253 ----------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~  322 (441)
                                .+||+|||.+.....  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                      499999998865332  34467899999999999999999999999999999999999999988776554


Q ss_pred             HHHHHhccccCC------------------------------------------CCCcHHHHHHHHHhcccCcCCCCCCC
Q 013558          323 QQRIINEKVKLP------------------------------------------PFLTSEAHSLLKGLLHKDPSKRLGSG  360 (441)
Q Consensus       323 ~~~i~~~~~~~p------------------------------------------~~~s~~~~~li~~~L~~dP~~R~~~~  360 (441)
                      ...+......+|                                          ...++.+.|||.+||++||.+||   
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---  430 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL---  430 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC---
Confidence            443322110000                                          01135678999999999999999   


Q ss_pred             CCChHHhhhCcccCC
Q 013558          361 PGGVDAIKHHKWFRS  375 (441)
Q Consensus       361 ~~~~~~i~~h~~f~~  375 (441)
                        +++|+++||||..
T Consensus       431 --ta~e~L~Hp~~~~  443 (467)
T PTZ00284        431 --NARQMTTHPYVLK  443 (467)
T ss_pred             --CHHHHhcCccccc
Confidence              8999999999975

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.9e-47  Score=378.52  Aligned_cols=252  Identities=27%  Similarity=0.474  Sum_probs=210.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++....  .....+.+.+|+++|+.++|+||+++++++...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECC-----CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            4568889999999999999999875     78899999986542  2334566889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++|+|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999999999988542    34678888999999999999999999999999999999999999999999999876433


Q ss_pred             C-CCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---HHHHHH-HhccccCCCCCc
Q 013558          269 S-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---KLQQRI-INEKVKLPPFLT  338 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---~~~~~i-~~~~~~~p~~~s  338 (441)
                      . ......||..|+|||++..     ...+.++|||||||++|||++|+.||......   .....+ .......+..++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 2345679999999999853     23456899999999999999999999743322   222222 223344567789


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .++++||.+||+.||++||     +++++++||||...
T Consensus       302 ~~l~~li~~~l~~~P~~Rp-----t~~ell~hp~~~~~  334 (353)
T PLN00034        302 REFRHFISCCLQREPAKRW-----SAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHhcCcccccC
Confidence            9999999999999999999     88999999999864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-47  Score=365.05  Aligned_cols=270  Identities=38%  Similarity=0.742  Sum_probs=225.0

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh---cCCCCceeeeEEEEeCCEEEEE
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK---VTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      .||+|+||.||++.+..     +++.+|+|++.+.............+|..+++.   .+||||+.+++++...+..|+|
T Consensus         1 ~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECC-----CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            48999999999999875     788999999976544333323334445544443   4799999999999999999999


Q ss_pred             EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCcc
Q 013558          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  273 (441)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987654332 234


Q ss_pred             ccCCCCCCCcchhc-CCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccccCCCCCcHHHHHHHHHhc
Q 013558          274 MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       274 ~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  349 (441)
                      ..|+..|+|||.+. +..++.++|||||||++|+|++|..||....   ..............+|+.++.++.++|++||
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  234 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL  234 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence            57999999999986 4568999999999999999999999996532   2333333334455677889999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          350 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      ..||.+|+++...+++++++||||++++|......+..+|.+|
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence            9999999987777899999999999999988876666666555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-49  Score=381.05  Aligned_cols=255  Identities=33%  Similarity=0.562  Sum_probs=236.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||.+++++++.     .+..|++|.+.......+.. +...+|+.+++++.|||||.+++.|..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            3579999999999999999999987     67799999998876555443 36778999999999999999999999988


Q ss_pred             E-EEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          189 K-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      . ++|||+||+||+|.+.+.+..  .|+|+.+..++.||+.|+.|||++.|+|||||+.||+++.++.|||+|||+|+.+
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            8 999999999999999987654  5999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHH
Q 013558          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  343 (441)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~  343 (441)
                      .... ...+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+...+..+|.... ..+|..++.+++.
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS  236 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence            7766 6778999999999999999999999999999999999999999999999999999999887 5788899999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      +|+.||.++|..||     ++.+++.+|...
T Consensus       237 lv~~~l~~~P~~RP-----sa~~LL~~P~l~  262 (426)
T KOG0589|consen  237 LVKSMLRKNPEHRP-----SALELLRRPHLL  262 (426)
T ss_pred             HHHHHhhcCCccCC-----CHHHHhhChhhh
Confidence            99999999999999     889999998775

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-48  Score=380.87  Aligned_cols=260  Identities=32%  Similarity=0.582  Sum_probs=244.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...+.|.+.+.||+|.|++|.++++..     ++..||||++.+........ ..+.+|+++|+.++|||||+++.+.+.
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~-----t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHIL-----TGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecC-----CCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            345679999999999999999999886     88899999999877554443 348899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...+|+||||+.+|.+++++.+++++.+..++.++.|++.|++|||+++|+|||||++||||+.+.++||+|||++..+.
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      ......++||++.|.|||++.+..| ++.+|+||+|++||-|+.|.+||++.+..++..+.+.+++.+|..++.++.++|
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lL  286 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLL  286 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHH
Confidence            8888999999999999999999877 578999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +++|..+|.+|+     +.+++++|.|.....
T Consensus       287 rk~lvl~Pskr~-----~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  287 RKFLVLNPSKRG-----PCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHhhccCccccC-----CHHHhhhhcccchhh
Confidence            999999999999     889999999987543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-47  Score=375.39  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=211.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---  187 (441)
                      +|++.++||+|+||.||+|+++.     +++.||||++..... .......+.+|+.+|+.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            58999999999999999999875     788999999864321 223334678899999999999999999988643   


Q ss_pred             --CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                        ..+|+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence              35899999995 689999988888999999999999999999999999999999999999999999999999999864


Q ss_pred             CCCC----CCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------
Q 013558          266 DESS----RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------  328 (441)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~-----------  328 (441)
                      ....    .....+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3221    1234679999999999876  6789999999999999999999999987654332221110           


Q ss_pred             ----c-----------cccC-----CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          329 ----E-----------KVKL-----PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       329 ----~-----------~~~~-----p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                          .           ....     -+.+++++.+||.+||+.||++||     +++++++||||+++..
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~e~l~hp~f~~~~~  298 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP-----TAEEALADPYFKGLAK  298 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC-----CHHHHhcCchhhhcCc
Confidence                0           0000     124678899999999999999999     8899999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-47  Score=389.87  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|+++++||+|+||+||+|.++.     +++.||||++....       ....+|+.+|+.++|||||+++++|..
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICID-----TSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            345689999999999999999999875     78899999886432       123469999999999999999988753


Q ss_pred             C--------CEEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-c
Q 013558          187 R--------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-H  253 (441)
Q Consensus       187 ~--------~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~  253 (441)
                      .        ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence            2        257899999976 5655553    346799999999999999999999999999999999999999665 6


Q ss_pred             EEEEecCCccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---
Q 013558          254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---  329 (441)
                      +||+|||+|+.+.........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...++...   
T Consensus       210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999999987765555556789999999999876 46899999999999999999999999987766555444321   


Q ss_pred             --------------cc------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          330 --------------KV------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       330 --------------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                    ..            .+|...++++++||.+||++||.+||     ++.++++||||..+..
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~-----ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL-----NPIEALADPFFDDLRD  359 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc-----CHHHHhCChhHHhhhc
Confidence                          01            13445788999999999999999999     8899999999987644

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-48  Score=364.27  Aligned_cols=249  Identities=32%  Similarity=0.521  Sum_probs=214.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  188 (441)
                      .|+..+++|.|+||.||++....     +++.||||.+-.+.-.       --+|+++|+.++|||||+|..+|...  .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            48889999999999999999886     6789999998654321       12699999999999999999888642  2


Q ss_pred             ---EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEecC
Q 013558          189 ---KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFG  260 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG  260 (441)
                         .+.+|||||+. +|...++.    +..++...++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence               45689999976 88888874    5679999999999999999999999999999999999999976 999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  329 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------  329 (441)
                      .|+.+..+....++.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..++...|.+-          
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9999888877788889999999999987 57999999999999999999999999998877776666420          


Q ss_pred             -------ccc------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          330 -------KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       330 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                             ...            +...+++++.+|+.++|+++|.+|.     ++.+++.||||..+.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~-----~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL-----SALEALAHPFFDELR  313 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC-----CHHHHhcchhhHHhh
Confidence                   111            2235789999999999999999999     889999999997653

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-47  Score=368.81  Aligned_cols=277  Identities=45%  Similarity=0.811  Sum_probs=238.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|....     +++.||+|.+.+.........+.+..|+++++.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence            379999999999999999999875     788999999987655444566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .|+||||+.|++|.+++...  ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999999998764  5689999999999999999999999999999999999999999999999999875422


Q ss_pred             CC------------------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC
Q 013558          268 SS------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  317 (441)
Q Consensus       268 ~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~  317 (441)
                      ..                              ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            11                              112346899999999999988999999999999999999999999988


Q ss_pred             CHHHHHHHHHhccccCCCC--CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCC
Q 013558          318 NRQKLQQRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV  394 (441)
Q Consensus       318 ~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~  394 (441)
                      +....+..+......++..  ++.+++++|.+||+.||++||++. ..+++++.||||++++|..+..  ..||-.|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-~~~~~ll~~~~~~~~~~~~~~~--~~~~~~~~~  311 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALIRH--TTPPIIPRP  311 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch-hhHHHHHcCchhhcCChhhccc--CCCCCCCCc
Confidence            8888888877766666654  699999999999999999999321 1289999999999999988765  334444443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.9e-47  Score=364.77  Aligned_cols=253  Identities=28%  Similarity=0.408  Sum_probs=211.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEE-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-  185 (441)
                      .+|++++.||+|+||+||+|++..    .+++.||+|+++..... ......+.+|+.+++.+   +||||+++++++. 
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            369999999999999999998753    14678999998754322 22233455677777765   6999999999885 


Q ss_pred             ----eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          186 ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                          ....+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence                3457999999996 5888888654  45899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------  331 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------  331 (441)
                      |+++............||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+.....        
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            999876655445567899999999999988999999999999999999999999998877776666653210        


Q ss_pred             -------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                         .+.+.+++.+++||.+||+.||++||     ++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC-----CHHHHhcCCCC
Confidence                               01134678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.2e-47  Score=358.07  Aligned_cols=257  Identities=42%  Similarity=0.836  Sum_probs=231.1

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||.|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            6999999999999875     78899999998766555556678999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCC
Q 013558          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT  277 (441)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt  277 (441)
                      ++++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.............|+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            99999999988888999999999999999999999999999999999999999999999999999877554444456789


Q ss_pred             CCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC--HHHHHHHHH--hccccCCCCCcHHHHHHHHHhcccCc
Q 013558          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRII--NEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      ..|++||.+.+..++.++|+||||+++|+|++|..||....  ..+....+.  .....+|...+.++.++|.+||+.||
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999999988889999999999999999999999998766  666777776  45667777889999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCChh
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ++|+++....++++++||||++.+|+
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99997555569999999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-46  Score=359.98  Aligned_cols=270  Identities=38%  Similarity=0.743  Sum_probs=227.7

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH---HHHhcCCCCceeeeEEEEeCCEEEEE
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---ILTKVTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      +||+|+||.||+|.+..     +++.||+|++.+..............|..   +++...||||+.+++++...+.+|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEec-----CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            48999999999999875     78899999998754332222222333433   44456799999999999999999999


Q ss_pred             EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCcc
Q 013558          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  273 (441)
                      |||+.|++|..++.+.+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..+... ....
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence            999999999999988889999999999999999999999999999999999999999999999999998765432 2335


Q ss_pred             ccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccccCCCCCcHHHHHHHHHhc
Q 013558          274 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  349 (441)
                      .+|+..|+|||++.+. .++.++||||+||++|+|++|+.||...   ........+......+|..++.++.++|.+||
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence            6799999999999754 6899999999999999999999999865   44444455555566778888999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          350 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      ..+|.+|+.+...+++++++||||+.++|..+...+..++.+|
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  277 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP  277 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence            9999999988777899999999999999999987766655544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-47  Score=378.03  Aligned_cols=251  Identities=26%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+...+|+++++||+|+||.||+|.++.     +++.||+|....         ..+.+|+++|++++||||++++++|.
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~-----~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNK-----TCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECC-----CCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            4556789999999999999999999876     788999997532         23568999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .....++|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999999999995 689888888888999999999999999999999999999999999999999999999999999753


Q ss_pred             CCC--CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHh--------
Q 013558          266 DES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIIN--------  328 (441)
Q Consensus       266 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~-------~~~~~~~i~~--------  328 (441)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+       .......+..        
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            221  22345689999999999999999999999999999999999998774321       1111111110        


Q ss_pred             ------------------ccccCC---------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 ------------------EKVKLP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ------------------~~~~~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                        .....+         ..++.++.+||.+||+.||.+||     +++++++||||+.+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~  382 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP-----SAEALLDFAAFQDI  382 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC-----CHHHHhcChhhccC
Confidence                              000001         12467899999999999999999     89999999999764

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-46  Score=360.19  Aligned_cols=280  Identities=49%  Similarity=0.920  Sum_probs=239.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      +|++.+.||.|+||.||+|.+....  .+++.||+|++...... .....+.+.+|+++|+++ +|+||+.+++++..+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            4899999999999999999875321  26788999999764332 223345678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999875432


Q ss_pred             C--CCccccCCCCCCCcchhcCC--CCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCCCCcHH
Q 013558          269 S--RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTSE  340 (441)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~~~s~~  340 (441)
                      .  ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...    ...++...+......+|..++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  238 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence            2  22346789999999998753  4678999999999999999999999643    23445555555666677889999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      +.+|+.+||+.||++|+++++.++++++.||||..++|+.+..+..++||.|
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  290 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP  290 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence            9999999999999999988888999999999999999999887777777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-46  Score=369.05  Aligned_cols=257  Identities=29%  Similarity=0.483  Sum_probs=218.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||.||++.++.     ++..+|+|++....  .....+.+.+|+++|+.++||||++++++|.+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            345789999999999999999999876     78889999887542  23344568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .+.+|+||||+.+++|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999999999999888899999999999999999999975 7999999999999999999999999999765


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------------
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------------  326 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i-------------------  326 (441)
                      ... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......++...+                   
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            332 234567999999999999988999999999999999999999999765443332111                   


Q ss_pred             -------------------------Hhc-cccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          327 -------------------------INE-KVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       327 -------------------------~~~-~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                               ... ...++ ..++.++++||.+||++||++||     ++++++.|+||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~  305 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRS  305 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc-----CHHHHhhCHHHhcC
Confidence                                     111 11111 13678999999999999999999     89999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=373.66  Aligned_cols=249  Identities=26%  Similarity=0.447  Sum_probs=217.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+....+.+++.||+|-||.||++.+++      ...||+|.++.....    .+.+.+|+++|++|+|+|||+|++++
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~------~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~  270 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNG------STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVC  270 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcC------CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEE
Confidence            33445567778999999999999999974      345899998764332    23566899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ..++.+|||||||+.|+|.++|+.  .+.+...+...++.||++||+||+++++|||||-..||||++++.+||+|||+|
T Consensus       271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence            998899999999999999999987  467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcc--ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          263 KEIDESSRSNS--MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +..........  ..-...|.|||.+....++.++|||||||+||||+| |+.||.+.+..+..+.+..+ ++..|+.++
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP  430 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP  430 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC
Confidence            96554433222  223567999999999999999999999999999999 99999999999999988765 778899999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      +++.+++..||..+|++||     +++.+.
T Consensus       431 ~~vY~lM~~CW~~~P~~RP-----tF~~L~  455 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRP-----TFETLR  455 (468)
T ss_pred             HHHHHHHHHHhhCCcccCC-----CHHHHH
Confidence            9999999999999999999     555443

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-46  Score=373.95  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=212.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++.+.||+|+||.||+|.++.     .++.||||++.+.. ........+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC-----CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            4589999999999999999999875     77889999987543 2233445677899999999999999999987643 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ..+|+||||+++ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                 368999999976 67666643  4889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      +............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...             
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            8765554455678999999999999999999999999999999999999999887766555544321             


Q ss_pred             ---------cccC--------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ---------KVKL--------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ---------~~~~--------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                               ...+                    ....+.++++||.+||+.||.+||     +++++++||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~-----t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccc
Confidence                     0000                    011346789999999999999999     8999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-46  Score=371.90  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=210.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||++.++.     +++.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV-----LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC-----CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            3689999999999999999999875     78899999987543 22334456778999999999999999999986543


Q ss_pred             ------EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                            .+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                  57999999976 5655553  35889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------  328 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--------------  328 (441)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..              
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            876544445567899999999999999999999999999999999999999987765433222211              


Q ss_pred             --------ccccC--------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          329 --------EKVKL--------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       329 --------~~~~~--------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                              ....+                    ....++++++||.+||+.||++||     +++|++.||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI-----SVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC-----CHHHHhcCchhhh
Confidence                    11111                    112467899999999999999999     8999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=376.41  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=218.1

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      .++.+..++..+...||+|+||+||++++.+        .||||++..... ..++.+.|++|+.+|++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            4577778889999999999999999999865        599999987664 4458899999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++..... .||..+|+|.+|+.+++.. .+|.....+.|++||++|+.|||.++|||||||..||++.+++.|||+|||+
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            9998877 9999999999999999765 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccc---CCCCCCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----
Q 013558          262 AKEI---DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----  331 (441)
Q Consensus       262 a~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~----  331 (441)
                      +..-   ..........|...|||||+++.   .+|+..+||||||||+|||++|..||...+.+.+...+-.+..    
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            8753   33333455678899999999984   4689999999999999999999999997777776666655522    


Q ss_pred             -cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          332 -KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       332 -~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       ..-...++++++|+..||.+++++||     .+.+|+.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP-----~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERP-----LFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCc-----cHHHHHH
Confidence             12245678999999999999999999     6677765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-46  Score=384.79  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=223.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ..|.+.+.||+|+||.||+|....    ..++.||+|.+...   .......+.+|+.+|+.++|||||++++++...+.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~----~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGS----DPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcC----CCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            349999999999999999998764    12677888876543   23344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +|+||||++||+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            9999999999999887753    356899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHH
Q 013558          266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEA  341 (441)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~  341 (441)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..+.. .+|..++.++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            4432   23456899999999999999999999999999999999999999998888888888776544 3567889999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++||.+||+.||++||     ++++++.|+|++.+
T Consensus       300 ~~li~~~L~~dP~~Rp-----s~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRP-----TTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCc-----CHHHHHhCHHHHHH
Confidence            9999999999999999     88999999998743

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-48  Score=351.06  Aligned_cols=250  Identities=32%  Similarity=0.551  Sum_probs=220.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||+|+|+.|--|....     ++..||||++.|..   .....++.+|++++..++ |+||++|+++|+++..+||||
T Consensus        84 e~LGeGAyasVqtcv~i~-----t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ-----TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeeec-----cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            579999999999988765     88999999998863   445567889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCCccccCCC---
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDES---  268 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~---  268 (441)
                      |.|.||.|..++.++..|+|.++..++.+|+.||.|||.+||.||||||+|||.....   -||||||.++......   
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999997655   4899999987653221   


Q ss_pred             -----CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---------------HHHHH
Q 013558          269 -----SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQ  323 (441)
Q Consensus       269 -----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~---------------~~~~~  323 (441)
                           ....+.+|+..|||||++.     ...|+.++|.||||||||-||+|.+||.+.-               .+.++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                 1234678999999999975     2458999999999999999999999996431               45788


Q ss_pred             HHHHhccccCCC----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          324 QRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       324 ~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ..|..+.+.||+    .+|.+++|||+.+|.+|+.+|+     .+.++++|||++.+.-
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl-----sa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL-----SAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh-----hhhhccCCccccccch
Confidence            889999999996    5899999999999999999999     7899999999998753

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-46  Score=385.26  Aligned_cols=258  Identities=31%  Similarity=0.502  Sum_probs=225.6

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++..... .......+.+|+.+|..++|+||++++..+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS-----DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            34689999999999999999999875     788999999976543 334456678899999999999999998877543


Q ss_pred             C--------EEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEE
Q 013558          188 S--------KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       188 ~--------~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                      +        .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        478999999999999988653    4689999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCC---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-
Q 013558          256 LTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  331 (441)
Q Consensus       256 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-  331 (441)
                      |+|||+++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... 
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999865432   223457899999999999999999999999999999999999999999888888887776544 


Q ss_pred             cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+|..+++++.+||.+||+.||.+||     ++.++++|||++..
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RP-----s~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRP-----SSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHhCHHHHHh
Confidence            46788999999999999999999999     88999999998754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-46  Score=359.23  Aligned_cols=251  Identities=29%  Similarity=0.423  Sum_probs=209.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEe-
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT-  186 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-  186 (441)
                      +|++.+.||+|+||+||+|+++.     +++.||+|.+...... ......+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            58999999999999999999886     7889999998754322 12222345677777665   79999999998864 


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecC
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                          ...+++||||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence                3468999999975 788888664  348999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------  330 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------  330 (441)
                      +++............||..|+|||++.+..++.++|||||||++|+|++|.+||......+...++....          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            9987655444455678999999999999999999999999999999999999998877666555554210          


Q ss_pred             -c----------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 -V----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 -~----------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       .                .+.+.+++++.+||.+||++||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~l~hp~f  288 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-----SAFRALQHPFF  288 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC-----CHHHHhcCCCC
Confidence             0                01134678899999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-46  Score=374.22  Aligned_cols=256  Identities=26%  Similarity=0.362  Sum_probs=215.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  188 (441)
                      +|++.++||+|+||.||++.+..     +++.||||++.... ......+.+.+|+.+|+.++|+||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR-----DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC-----CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            58899999999999999999865     78899999986532 22233456788999999999999999999998776  


Q ss_pred             ---EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                         .+|+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence               8999999996 578888888888999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC--CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          266 DESS--RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       266 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...             
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            3321  22345689999999999874 5789999999999999999999999887766555444320             


Q ss_pred             ----------c---------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          330 ----------K---------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       330 ----------~---------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                .         ..+....++++.+||.+||+.||.+||     +++++++||||++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~~~  296 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-----SAADALAHPYLDEGRL  296 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc-----CHHHHhcCHhhCCCcc
Confidence                      0         122345688999999999999999999     8899999999998653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-46  Score=368.97  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=212.4

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +.+..++|++.++||+|+||.||+|.+.+..+..+++.||||++....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            456677899999999999999999987654444467789999987532  233445688999999999 89999999998


Q ss_pred             EEeC-CEEEEEEeccCCCchHHHHHHc-----------------------------------------------------
Q 013558          184 FQTR-SKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (441)
Q Consensus       184 ~~~~-~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (441)
                      +... ..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8764 4689999999999999988753                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC---CCccccCC
Q 013558          210 ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT  277 (441)
Q Consensus       210 ---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt  277 (441)
                               ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ......++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     237788899999999999999999999999999999999999999999999998653221   12233467


Q ss_pred             CCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcC
Q 013558          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+..+ ....|..+++++.+||.+||+.||.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            88999999999999999999999999999997 999998765433 33333332 3445677899999999999999999


Q ss_pred             CCCCCCCCChHHhhh
Q 013558          355 KRLGSGPGGVDAIKH  369 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~  369 (441)
                      +||     ++.++++
T Consensus       320 ~RP-----s~~el~~  329 (338)
T cd05102         320 ERP-----TFSALVE  329 (338)
T ss_pred             hCc-----CHHHHHH
Confidence            999     7788875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.9e-47  Score=375.47  Aligned_cols=249  Identities=28%  Similarity=0.460  Sum_probs=215.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-C-----CCceeeeEEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H-----PFIVQLRYSF  184 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~  184 (441)
                      +|+++++||+|+||.|-+|.+..     +++.||||++++.    +........|+.+|..|+ |     -|||+++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~-----T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK-----TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC-----CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            58999999999999999999987     8999999999864    344555677999999997 4     3899999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC--cEEEEecC
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFG  260 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkl~DFG  260 (441)
                      ...+++|||+|.+. .+|+++++.+.  .++...++.|+.||+.||.+||+.||||+|||||||||.+-+  .|||+|||
T Consensus       258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999999995 58999998774  589999999999999999999999999999999999997543  79999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN------------  328 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~------------  328 (441)
                      .|.......  .+.+.+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.+..+++..|..            
T Consensus       337 SSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  337 SSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            998766543  378899999999999999999999999999999999999999999998887777651            


Q ss_pred             ---------c-------------------------------cccCCC-----------CCcHHHHHHHHHhcccCcCCCC
Q 013558          329 ---------E-------------------------------KVKLPP-----------FLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       329 ---------~-------------------------------~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~  357 (441)
                               .                               ....|+           .-...+.|||++||..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                     0                               001120           1234678999999999999999


Q ss_pred             CCCCCChHHhhhCcccCCC
Q 013558          358 GSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       358 ~~~~~~~~~i~~h~~f~~~  376 (441)
                           +..++++||||.+.
T Consensus       495 -----tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 -----TPAQALNHPFLTGT  508 (586)
T ss_pred             -----CHHHHhcCcccccc
Confidence                 88999999999854

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.4e-46  Score=355.64  Aligned_cols=278  Identities=49%  Similarity=0.916  Sum_probs=237.7

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      +|++.+.||+|+||.||++++....  ..+..||||++++..... ....+.+.+|+.++.++ +||||+++++.+....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            4899999999999999999865422  256789999997654322 23445678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+.+++|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+...
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998765432


Q ss_pred             CC--CccccCCCCCCCcchhcCCC--CCCcchhhhHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccccCCCCCcHH
Q 013558          269 SR--SNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPPFLTSE  340 (441)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltG~~pf~~~~----~~~~~~~i~~~~~~~p~~~s~~  340 (441)
                      ..  .....|+..|+|||.+.+..  .+.++||||||+++|+|++|..||...+    ..++.+.+.......|..++.+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE  238 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence            21  23457899999999987654  7889999999999999999999996432    3444555566666777889999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      +.++|.+||+.||++||++.  ++.++++||||++++|..+.++.+.|+|.|
T Consensus       239 l~~li~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  288 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAKRIPAPFKP  288 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence            99999999999999999753  688999999999999999999999998865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=349.88  Aligned_cols=254  Identities=30%  Similarity=0.497  Sum_probs=221.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ++|++.+.||+|++|.||+|.+..     +++.||+|++......  .....+.+.+|+.++++++||||+++++++..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD-----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC-----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence            479999999999999999998765     7889999998754322  223456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..+|+|+||++|++|.+.+...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCCC----ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHH
Q 013558          268 SSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEA  341 (441)
Q Consensus       268 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~  341 (441)
                      ....    ....|+..|+|||++.+..++.++||||||+++|||++|+.||...+.......+...  ...++..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            2111    3456889999999999988999999999999999999999999876655554444433  345677889999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .+||++||..+|++||     ++.++++|+||
T Consensus       237 ~~li~~~l~~~p~~Rp-----t~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRP-----SAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCC-----CHHHHhhCCCC
Confidence            9999999999999999     89999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.3e-46  Score=360.76  Aligned_cols=255  Identities=25%  Similarity=0.460  Sum_probs=213.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+++++.     +++.||+|+++....  ......+.+|+.++++++||||+++++++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK   77 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecC-----CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence            4679999999999999999999875     778899999875432  222334668999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99999999976 787777654 4589999999999999999999999999999999999999999999999999976433


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------------
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------------  329 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------------  329 (441)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            22 2234578999999999875 46889999999999999999999999887765544443221                


Q ss_pred             ---cccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 ---KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                         ...++           +.+++++++||.+||+.||.+|+     +++++++||||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  292 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI-----SAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC-----CHHHHhcChhhhhc
Confidence               01111           24788999999999999999999     89999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.3e-46  Score=368.38  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=210.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++++.||+|+||.||+|.+..     +++.||+|++.... ........+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecC-----CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            4689999999999999999998765     78889999987543 2233445677899999999999999999988643 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ..+|+||||+++ +|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence                 357999999976 56666643  5889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      +............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...             
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            8765554455678999999999999999999999999999999999999999877654433322110             


Q ss_pred             ---------cc-----c---------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ---------KV-----K---------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ---------~~-----~---------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                               ..     .               .+...+.++++||.+||+.||++||     +++++++||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----s~~ell~hp~~~~  316 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDEALQHPYINV  316 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC-----CHHHHhcCcchhc
Confidence                     00     0               1122456789999999999999999     8999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=344.87  Aligned_cols=250  Identities=33%  Similarity=0.595  Sum_probs=222.0

Q ss_pred             CCCceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013558          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (441)
Q Consensus       109 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  186 (441)
                      .++|.+. ++||-|-.|.|..|.++.     +++.+|+|++....        ..++|+++--.. .|||||+++++|+.
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~-----T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKR-----TQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEecc-----chhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4567765 589999999999999987     88999999986432        356788776655 59999999999864


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEE
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~  257 (441)
                          ...+.+|||.|+||.|+..+..++.  |+|.++..|+.||..|+.|||+.+|.||||||+|+|...   |..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                4578999999999999999998865  999999999999999999999999999999999999964   4579999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccccC
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKL  333 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~----~~~~~~~i~~~~~~~  333 (441)
                      |||+|+.-.......+.|-|++|.|||++....|+..+|+||+||++|-|++|.+||....    ...+..+|..+.+.|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9999998776667788999999999999999999999999999999999999999998643    456889999999999


Q ss_pred             CC----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          334 PP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       334 p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |.    .+|++++|+|+++|..+|.+|+     ++++++.|||+..-
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRl-----TI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERL-----TIEEVMDHPWINQY  328 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhhe-----eHHHhhcCchhccc
Confidence            85    5899999999999999999999     99999999999753

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-46  Score=352.65  Aligned_cols=251  Identities=35%  Similarity=0.638  Sum_probs=215.9

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++.+.||+|+||+||+++++.     +++.||+|++......... .....+|+.++++++||||+++++++.....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK-----NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT-----TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC-----CCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence            7899999999999999999986     7789999999886543333 223455999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-CCCCC
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSR  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-~~~~~  270 (441)
                      +||||+.+++|.+++...+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+... .....
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999763 23334


Q ss_pred             CccccCCCCCCCcchhc-CCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccccCC----CCCcHHHH
Q 013558          271 SNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      .....++..|+|||++. +..++.++||||||+++|+|++|..||...+   ......+.........    .....++.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            45678899999999998 8889999999999999999999999999873   3333333333222211    22348999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++|.+||+.||++||     +++++++||||
T Consensus       235 ~li~~~l~~~p~~R~-----~~~~l~~~~~~  260 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRP-----SAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHSSSSGGGST-----THHHHHTSGGG
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCCCC
Confidence            999999999999999     89999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.4e-46  Score=350.80  Aligned_cols=255  Identities=41%  Similarity=0.786  Sum_probs=227.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||.|+||.||+|+++.     +++.||+|++.+.........+.+.+|++++++++||||+++++.+.+...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD-----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc-----CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence            58999999999999999999875     7889999999876655555677889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      |+|+||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999987655444


Q ss_pred             CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+   ...+.+........+|..++.++.++|.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK  235 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence            455678999999999998889999999999999999999999998766   34444444445667788899999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCccc
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ||+.||.+|+++.   +++++.||||
T Consensus       236 ~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         236 LLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             HccCChhHcCCcc---HHHHhcCCCC
Confidence            9999999999431   4999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=349.44  Aligned_cols=254  Identities=42%  Similarity=0.805  Sum_probs=220.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHH-HhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||.|+||.||+|.++.     +++.||+|++.+...........+..|..++ ...+|+||+++++++...+.+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS-----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecC-----CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            579999999999999875     7789999999765443333334445555554 4558999999999999999999999


Q ss_pred             eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccc
Q 013558          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM  274 (441)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  274 (441)
                      ||++|++|..++...+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++....   ....
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9999999999998888899999999999999999999999999999999999999999999999999876433   3345


Q ss_pred             cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHHHHHHHhcc
Q 013558          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH  350 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~  350 (441)
                      .|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.......+    ..++.++.++|.+||+
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            789999999999988899999999999999999999999998888877777766554433    3578999999999999


Q ss_pred             cCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          351 KDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       351 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      .||++||++.  ++++++.||||++++|+
T Consensus       234 ~~p~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         234 MDPAKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CCHHHccCCC--cHHHHHcChHhhcCCCC
Confidence            9999999764  78999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-45  Score=368.39  Aligned_cols=258  Identities=25%  Similarity=0.354  Sum_probs=214.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|++++.||+|+||.||+|..++.   ..+..||+|.+....        ...+|+++|+.++||||+++++++...
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            345799999999999999999986532   256789999886532        245799999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..+|+|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99999999996 58888887778899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHh----cc-------
Q 013558          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---KLQQRIIN----EK-------  330 (441)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---~~~~~i~~----~~-------  330 (441)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ..+..+..    ..       
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322   23567999999999999999999999999999999999999999764321   11111111    00       


Q ss_pred             ------------------ccCC-----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          331 ------------------VKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       331 ------------------~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                                        ...|     ..++.++.+||++||+.||++||     ++.+++.||||+...|..+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp-----sa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP-----SAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC-----CHHHHhhCchhhccchhhhc
Confidence                              0111     13467889999999999999999     88999999999988887664

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=337.44  Aligned_cols=258  Identities=29%  Similarity=0.475  Sum_probs=221.1

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  184 (441)
                      ....++.+++..||.|+.|+|++++.+.     ++.+.|||.+.+..  +.+..+++...+.++...+ +|+||+.+|+|
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs-----~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRS-----TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcc-----cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            3445677888999999999999999987     89999999998764  3555677888888877665 99999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ..+..+++.||.|.- .+..++.+ .++++|..+-.+...++.||.||.+ +||||||+||+|||+|+.|++||||||++
T Consensus       161 i~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  161 ITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             eeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence            999999999999853 44444443 4789999999999999999999985 68999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcccc-CCC--
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEKVK-LPP--  335 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~~~~~-~p~--  335 (441)
                      ..+......+.-.|.+.|||||.+.-   ..|+..+||||||++++||.||+.||.+.+ ..+.+.+++++.++ +|.  
T Consensus       240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc
Confidence            98877777777889999999999974   468999999999999999999999999854 45677777775543 332  


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+|+.+.+|+..||++|+.+||     ...++++|||+...
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP-----~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRP-----KYNKLLEHPFIKRY  355 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCc-----chHHHhcCcceeec
Confidence            4899999999999999999999     77999999999754

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=374.74  Aligned_cols=256  Identities=29%  Similarity=0.517  Sum_probs=225.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      -|+|+..||.|+||+||+|..+.     ++-.-|-|++...   ..+.++.+.-||.||..++||+||+|++.|..++.+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL  104 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL  104 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce
Confidence            48899999999999999999875     6777788887543   355667788899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc-cCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~-~~~~  268 (441)
                      +++.|||.||-...++..- ..+.++++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.. ....
T Consensus       105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999999999887776554 5799999999999999999999999999999999999999999999999998654 3333


Q ss_pred             CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc---CCCCCcHH
Q 013558          269 SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTSE  340 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~  340 (441)
                      ....++.|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...++...+-+|....++   .|...+..
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~  264 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS  264 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence            4467899999999999976     468999999999999999999999999999998888888765443   46788999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      +.||+.+||.+||..||     ++.+|++||||.++.-.
T Consensus       265 F~DfLk~cL~Knp~~Rp-----~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRP-----PAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHHhcCCccCC-----CHHHHhhCcccccCCcc
Confidence            99999999999999999     78999999999987643

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.9e-45  Score=354.45  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=216.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||++++..     ++..+|+|.+....  .......+.+|++++++++||||+++++++..++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP-----SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC-----CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence            369999999999999999999876     77889999986532  23345567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999999999999988899999999999999999999997 69999999999999999999999999998765332


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------------  329 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------------  329 (441)
                       .....+|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...                   
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             234568899999999998888999999999999999999999999765543332222110                   


Q ss_pred             ------------------cccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ------------------KVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ------------------~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                        ....| ..++.++++||.+||..||++||     +++++++||||.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~  292 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA-----DLKELTKHPFIKR  292 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhh
Confidence                              11111 13678899999999999999999     8999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-45  Score=347.02  Aligned_cols=254  Identities=46%  Similarity=0.864  Sum_probs=227.3

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||.|+||.||++.+..     +++.|++|++.+.........+.+.+|++++++++||||+++++.+......|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKS-----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            6899999999999875     68899999998765555566778899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC--------
Q 013558          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--------  269 (441)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--------  269 (441)
                      .+++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999999999888899999999999999999999999999999999999999999999999999987643321        


Q ss_pred             -CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCC--cHHHHHHHH
Q 013558          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL--TSEAHSLLK  346 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~  346 (441)
                       ......++..|+|||.+....++.++||||||+++|+|++|..||...+..+....+.......+...  +..+.+||.
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence             22345688999999999988899999999999999999999999998888888888877777766665  999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +||+.+|.+||++.  .+.++++||||++++|
T Consensus       236 ~~l~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         236 KLLVPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHhcCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence            99999999999542  5599999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-45  Score=363.74  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|++++.||+|+||.||+|+++.     +++.||+|+..+..         ...|+.++++++||||+++++++...
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeC
Confidence            34579999999999999999999876     77889999864432         24589999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...|+|||++. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       130 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        130 AITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             CeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99999999996 478777765 4679999999999999999999999999999999999999999999999999998644


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCC-CCCCCCCHH---------HHHHHHHhc----ccc
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-PPFTHANRQ---------KLQQRIINE----KVK  332 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~-~pf~~~~~~---------~~~~~i~~~----~~~  332 (441)
                      .........||+.|+|||++.+..++.++|||||||++|||+++. .+|......         .....+...    ...
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence            444445677999999999999999999999999999999999854 444432110         011111110    001


Q ss_pred             CC------------------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          333 LP------------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       333 ~p------------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++                              ..++.++.+||.+||+.||.+||     +++|+++||||+.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----ta~e~l~hp~f~~~  357 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP-----SAEEILNYPMFAQL  357 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc-----CHHHHhcCchhccC
Confidence            11                              13567788899999999999999     88999999999864

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.5e-45  Score=349.57  Aligned_cols=266  Identities=20%  Similarity=0.330  Sum_probs=223.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.++||+|+||.||+|..+....+..+..||+|.+.....  ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            456678999999999999999999876533334567899998764431  222345678999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEE
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                      +....|+||||+++|+|.+++...+          .+....+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532          346678899999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-c
Q 013558          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-K  330 (441)
Q Consensus       256 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~  330 (441)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... .
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999886432211   122345678999999998889999999999999999998 89999988887777766654 3


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh------CcccCCCCh
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH------HKWFRSINW  378 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~------h~~f~~~~~  378 (441)
                      ...+..+++.++++|.+||+.||++||     ++.++++      ||||++++|
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRP-----TFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHHhhcCCCCCCCCC
Confidence            456667889999999999999999999     6777765      999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.1e-45  Score=385.78  Aligned_cols=150  Identities=43%  Similarity=0.765  Sum_probs=139.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|.++++||+|+||+||+|.+..     +++.||||++++...........+..|+.+++.++||||+++++++....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN-----NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            4689999999999999999999875     78899999998766555666677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+|+||||+.|++|..++...+.+++..++.|+.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-44  Score=340.83  Aligned_cols=252  Identities=29%  Similarity=0.530  Sum_probs=219.7

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~  189 (441)
                      +|++++.||+|++|.||++.++.     +++.||+|.+..... .....+.+.+|++++++++|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT-----DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC-----CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48999999999999999999875     678899999875432 23345567889999999999999999998864 457


Q ss_pred             EEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +|+||||+++++|.+++...  ..+++.+++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999999999988763  4589999999999999999999999999999999999999999999999999987543


Q ss_pred             C-CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHH
Q 013558          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (441)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  345 (441)
                      . .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.. ..+..+++++.+||
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI  234 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence            2 223456789999999999999999999999999999999999999998887777666665544 45667899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .+||+.||++||     ++.++++||||
T Consensus       235 ~~~l~~~p~~Rp-----~~~~~l~~~~~  257 (257)
T cd08223         235 ATMLSKRPEKRP-----SVKSILRQPYI  257 (257)
T ss_pred             HHHhccCcccCC-----CHHHHhcCCCC
Confidence            999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-45  Score=361.58  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=210.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++++.||+|+||+||+|.+..     +++.||||++.+... .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTR-----LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-----CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            4679999999999999999999875     788999999875432 223345577899999999999999999888643 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ..+|+++|++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                 4579999998 678877664 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------  330 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------  330 (441)
                      +.....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....           
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            876442  345679999999999977 568999999999999999999999998776555444432210           


Q ss_pred             ------------ccCC--------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          331 ------------VKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       331 ------------~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                  ...+        ...++.+.+||.+||+.||.+||     ++++++.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~-----s~~ell~hp~~~~~  304 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI-----SASEALAHPYFSQY  304 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhcc
Confidence                        0011        23567789999999999999999     88999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.5e-45  Score=349.46  Aligned_cols=261  Identities=30%  Similarity=0.506  Sum_probs=223.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .+.|+++++||+|+||.||+++++.     +++.|++|++...   .....+.+.+|+.+++.++|+||+++++.+..+.
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE-----TGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC-----CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            3569999999999999999999875     7889999998653   2344566788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|+||||++|++|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999887754 45789999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCc
Q 013558          268 S-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLT  338 (441)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s  338 (441)
                      . .......++..|+|||++.     ...++.++|||||||++|+|++|..||...+......++....   ...+..++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            2 2234457899999999985     3446789999999999999999999998777665555554332   22345678


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                      .++.+||.+||..||++||     +++++++||||..++|....
T Consensus       243 ~~~~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~~~  281 (292)
T cd06644         243 MEFRDFLKTALDKHPETRP-----SAAQLLEHPFVSSVTSNRPL  281 (292)
T ss_pred             HHHHHHHHHHhcCCcccCc-----CHHHHhcCccccccccchhH
Confidence            9999999999999999999     88999999999999887643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-44  Score=344.11  Aligned_cols=253  Identities=29%  Similarity=0.506  Sum_probs=219.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------chhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +|.+.+.||+|+||.||+|.+..     +++.||+|.+......      .....+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS-----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC-----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            37788999999999999999765     6788999988654322      123446788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ......++||||+++++|..++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||+++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999999998888899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC-------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCCC
Q 013558          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF  336 (441)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~  336 (441)
                      .....       ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... ...++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN  235 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence            64211       112346889999999999888999999999999999999999999876655544444332 4456678


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++.++.++|++||+.||.+||     +++++++|+||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp-----~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRP-----TAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCc-----CHHHHhhCCCC
Confidence            899999999999999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.2e-45  Score=350.05  Aligned_cols=240  Identities=18%  Similarity=0.222  Sum_probs=211.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CCEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLY  191 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~  191 (441)
                      ..||+|++|.||++..       +++.||||.+.+.........+.+.+|+.+|++++||||+++++++.+    ...++
T Consensus        26 ~~i~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEE-------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            6799999999999987       567899999987654444446778899999999999999999999876    45789


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      +||||++||+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+...  
T Consensus        99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--  176 (283)
T PHA02988         99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--  176 (283)
T ss_pred             EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence            999999999999999988889999999999999999999998 59999999999999999999999999999865432  


Q ss_pred             CccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  346 (441)
                      .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...+..++...+...  ...+|...++++++||.
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~  256 (283)
T PHA02988        177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE  256 (283)
T ss_pred             cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence            234578999999999976  67899999999999999999999999998888888777544  44556678999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||+.||++||     +++++++
T Consensus       257 ~cl~~dp~~Rp-----s~~ell~  274 (283)
T PHA02988        257 ACTSHDSIKRP-----NIKEILY  274 (283)
T ss_pred             HHhcCCcccCc-----CHHHHHH
Confidence            99999999999     7888875

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-44  Score=343.48  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=217.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh---cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI---IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      +|++.+.||+|+||.||++...      +++.+|+|.+.....   ........+.+|+.+|+.++|+||+++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            4888999999999999999753      678899998865321   2234456688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +.+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999876421


Q ss_pred             -------CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCC
Q 013558          268 -------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFL  337 (441)
Q Consensus       268 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~  337 (441)
                             ........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+...   ...++..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence                   11123456899999999999988999999999999999999999999876655444444332   23466778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +.++.+||++||+.+|.+||     ++.+++.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp-----~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERP-----SALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence            99999999999999999999     88999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-44  Score=350.44  Aligned_cols=256  Identities=25%  Similarity=0.447  Sum_probs=213.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||.|+||.||+++++.     +++.||+|.+.....  ......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKL-----TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcC-----CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence            4679999999999999999999875     778999999875432  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          78 SLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99999999975 888877654 5689999999999999999999999999999999999999999999999999976433


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------------
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------------  329 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------------  329 (441)
                      .. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...                
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            22 2234567899999999875 45788999999999999999999999887766554443221                


Q ss_pred             ---cccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          330 ---KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       330 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                         ...++           ..++.++++||.+||+.||.+||     +++++++||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI-----SAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccccc
Confidence               01111           34788999999999999999999     889999999997653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=362.20  Aligned_cols=264  Identities=34%  Similarity=0.594  Sum_probs=231.0

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||.|.||+||-++++.     +|+.||||++.|.+...+.. ..+++|+.||+.+.||.||.|-..|++.+.+++|||
T Consensus       570 evLGSGQFG~VYgg~hRk-----tGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRK-----TGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             hhccCCcceeeecceecc-----cCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            689999999999999987     99999999999987765544 779999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCCccccCCCCCC
Q 013558          196 FINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDESSRS  271 (441)
Q Consensus       196 ~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~~~  271 (441)
                      .+.|.-|.-+|. ..+++++...++++.||+.||.|||-++|+|+||||+|||+....   ++||||||+|+.+.+....
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            997644444443 458899999999999999999999999999999999999996543   7999999999999998888


Q ss_pred             ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHHHHHHHH
Q 013558          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKG  347 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~  347 (441)
                      .+.+||+.|+|||++..++|++..|+||+|||+|--++|..||..  .+++-.+|.+..+.+|+    .+++++.|||..
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            899999999999999999999999999999999999999999954  35566677777777775    589999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCC-Chhhhhh--cccCCCCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI-NWKTLEA--REMQPKFKP  392 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~-~~~~~~~--~~~~p~~~p  392 (441)
                      +|+..-.+|.     +++..+.|||+++. .|.++..  ..+-+.|+-
T Consensus       802 LLqVkm~kRy-----svdk~lsh~Wlq~yq~w~DLRelE~~igeRyiT  844 (888)
T KOG4236|consen  802 LLQVKMRKRY-----SVDKSLSHPWLQDYQTWLDLRELEVRIGERYIT  844 (888)
T ss_pred             HHHHHHHHhc-----chHhhccchhhhcchHHHHHHHHHHhhCcceec
Confidence            9999999999     89999999999975 4766642  233344543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.6e-45  Score=386.49  Aligned_cols=261  Identities=27%  Similarity=0.481  Sum_probs=218.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      ....++|+++++||+|+||+||+|+++.     ++..||+|++..... .......+..|+.+|+.++|||||+++++|.
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~-----tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECC-----CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            3445789999999999999999999886     788999999876543 2334566888999999999999999999886


Q ss_pred             e--CCEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccccCCCceecCC--
Q 013558          186 T--RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKC-------GIVHRDLKPENILMDS--  250 (441)
Q Consensus       186 ~--~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-------~iiHrDlkp~NILl~~--  250 (441)
                      .  ...+||||||+++|+|..+|...    +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            4  45799999999999999988653    5799999999999999999999985       4999999999999964  


Q ss_pred             ---------------CCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCC
Q 013558          251 ---------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPP  313 (441)
Q Consensus       251 ---------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~p  313 (441)
                                     .+.+||+|||++..+.........+||+.|+|||++.+  ..++.++||||||||||||++|..|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                           34599999999987755544556789999999999864  4588999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhccccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          314 FTHANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       314 f~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      |...+........+.....++ ...+.++.+||..||+.+|.+||     ++.+++.|+||+.+.
T Consensus       243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP-----Sa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP-----SALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc-----CHHHHhccHHHhhcC
Confidence            976554433333333333333 45789999999999999999999     889999999998664

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.7e-44  Score=337.85  Aligned_cols=252  Identities=29%  Similarity=0.522  Sum_probs=222.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|.++.     +++.|++|.+...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC-----CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            58899999999999999999875     7889999998765433 33456688899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999999998764  57899999999999999999999999999999999999999999999999998876443


Q ss_pred             CC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHHH
Q 013558          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (441)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  346 (441)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..... .++..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence            22 2345789999999999999999999999999999999999999998887777777765543 345578899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +||+.+|++||     ++.++++|||+
T Consensus       235 ~~l~~~p~~Rp-----~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRP-----DTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCc-----CHHHHhhCCCC
Confidence            99999999999     88999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-44  Score=345.19  Aligned_cols=251  Identities=25%  Similarity=0.441  Sum_probs=212.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+.++++++||||+++++.+.....
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL-----TRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            368999999999999999999875     78899999987542  23344568889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .++||||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...... 
T Consensus        74 ~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          74 ISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             EEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999999999988543    35789999999999999999999999999999999999999999999999999875433 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcc-ccC-CCCCcHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------QKLQQRIINEK-VKL-PPFLTSE  340 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~  340 (441)
                      .....+||..|+|||++.+..++.++|||||||++|+|++|+.||.....       ....+.+.... ... ...++++
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            23456899999999999999999999999999999999999999965321       12223332222 122 2357889


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +++||.+||+.||.+||     ++++++.||||...+
T Consensus       229 ~~~li~~~l~~~P~~Rp-----~~~eil~~~~~~~~~  260 (279)
T cd06619         229 FVHFITQCMRKQPKERP-----APENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHhhCChhhCC-----CHHHHhcCccccccc
Confidence            99999999999999999     899999999998664

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.4e-44  Score=344.84  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=213.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+++++.     +++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE-----TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC-----CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            469999999999999999999875     788999999875432 22233457789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +++||||++++.|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999999998888777777789999999999999999999999999999999999999999999999999998765433


Q ss_pred             -CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 013558          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  330 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------------  330 (441)
                       ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             2334568899999999876 557889999999999999999999998766544433332100                 


Q ss_pred             --ccCC------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 --VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 --~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                        ...|            +.++..+.+||.+||+.||++||     ++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL-----SCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC-----CHHHHhcCCCC
Confidence              0011            24678899999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.4e-44  Score=361.23  Aligned_cols=247  Identities=23%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ...|.+.+.||+|+||.||+|.+..     .++.||||....         ..+.+|+++|++++|+|||++++++...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~  233 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG  233 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4579999999999999999999876     678899996432         22457999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..++|||++. ++|..++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       234 ~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        234 LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9999999995 5888887654 5699999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhccc---cC
Q 013558          268 SS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--------NRQKLQQRIINEKV---KL  333 (441)
Q Consensus       268 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~--------~~~~~~~~i~~~~~---~~  333 (441)
                      ..   .....+||..|+|||++.+..++.++|||||||+||||++|..++...        ....+.+.+.....   .+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            22   123467999999999999999999999999999999999987654321        12223322222111   01


Q ss_pred             C-------------------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          334 P-------------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       334 p-------------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +                               ..++.++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP-----sa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP-----SAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc-----CHHHHhhCcccCC
Confidence            1                               02456899999999999999999     8899999999974

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.2e-45  Score=363.59  Aligned_cols=258  Identities=22%  Similarity=0.384  Sum_probs=214.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +.+..++|++.+.||+|+||.||+|++....+..++..||+|++.....  ....+.+.+|+.+++.+ +|+||++++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            3455668999999999999999999987655555667899999975432  23456688899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc------------------------------------------------------
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~------------------------------------------------------  209 (441)
                      +...+.+|+||||+++|+|.+++...                                                      
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            99999999999999999999988643                                                      


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC---
Q 013558          210 ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---  270 (441)
Q Consensus       210 ----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  270 (441)
                                      .++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                            2478889999999999999999999999999999999999999999999999986543321   


Q ss_pred             CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~  347 (441)
                      .....++..|||||++.+..++.++|||||||++|||++ |+.||...........+...  ....|..++++++++|.+
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence            112335678999999999999999999999999999997 99999876554444444333  334566789999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhh
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ||+.||.+||     +++++.+
T Consensus       351 cl~~dp~~RP-----s~~~l~~  367 (374)
T cd05106         351 CWNLEPTERP-----TFSQISQ  367 (374)
T ss_pred             HcCCChhhCc-----CHHHHHH
Confidence            9999999999     7788765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.4e-45  Score=355.44  Aligned_cols=253  Identities=21%  Similarity=0.385  Sum_probs=207.7

Q ss_pred             EEeeEccc--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          114 IFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       114 ~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      ++++||+|  +||+||++.++.     +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++.+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecc-----cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            56789999  788999999886     889999999876532 2344567888999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999999998653  458999999999999999999999999999999999999999999999998654322111


Q ss_pred             --------CCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-------
Q 013558          270 --------RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  332 (441)
Q Consensus       270 --------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-------  332 (441)
                              ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..................       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                    1122356788999999976  46899999999999999999999999865544333322221110       


Q ss_pred             ---------------------------------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          333 ---------------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       333 ---------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                                             ....+++++.+||++||+.||++||     +++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~ell~~p~f  310 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP-----SASTLLNHSFF  310 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC-----CHHHHhcChhh
Confidence                                                   1123567899999999999999999     88999999999


Q ss_pred             CCCC
Q 013558          374 RSIN  377 (441)
Q Consensus       374 ~~~~  377 (441)
                      +.+.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=346.25  Aligned_cols=256  Identities=30%  Similarity=0.518  Sum_probs=221.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||.|+||.||++.++.     ++..+|+|++...   .....+.+..|+.++++++||||+++++.+.....
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE-----TGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC-----CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            469999999999999999999875     6789999998653   23344667889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999999988764 56999999999999999999999999999999999999999999999999998764322


Q ss_pred             -CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcH
Q 013558          269 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTS  339 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~  339 (441)
                       .......|+..|+|||++.     ...++.++|||||||++|+|++|+.||...+..+....+....   ...+..++.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS  236 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence             2234467899999999985     3456789999999999999999999998887776666665542   234567889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ++.+||.+||+.+|.+||     +++++++|+||.+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~~  270 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRP-----TAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHHHHHHhccChhhCc-----CHHHHhcChhhcccch
Confidence            999999999999999999     8899999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-44  Score=344.00  Aligned_cols=251  Identities=28%  Similarity=0.491  Sum_probs=213.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|++..     +++.||+|+++...   ......+.+|+.+++.++||||+++++.+...+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVN-----TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcC-----CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            3579999999999999999999875     78899999987542   223345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765432


Q ss_pred             C-CCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC-----CCCcH
Q 013558          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-----PFLTS  339 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p-----~~~s~  339 (441)
                      . ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+.......+     ..++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            2 233457999999999985   45688899999999999999999999976554433333332222211     24678


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcc
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  372 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  372 (441)
                      .+.+||.+||+.+|++||     ++++++.|||
T Consensus       240 ~~~~li~~~l~~~P~~R~-----~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRP-----TAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCc-----CHHHHhcCCC
Confidence            999999999999999999     8899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.9e-44  Score=339.37  Aligned_cols=254  Identities=30%  Similarity=0.501  Sum_probs=216.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      .+|++.++||+|+||.||++.++.     ++..||+|++.....  ......+.+.+|+.++++++||||+++++++.+.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD-----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC-----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            579999999999999999999875     788999999864321  2234456788999999999999999999998763


Q ss_pred             --CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                        ..+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence              578999999999999999988888999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcH
Q 013558          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (441)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~  339 (441)
                      ...    .......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...  ....|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            321    1223456899999999999888999999999999999999999999876555444444332  2345667889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      .+.++|++||. +|++||     +++++++|||++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp-----~~~~il~~~~~~  265 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRP-----SADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHhc-ChhhCC-----CHHHHhcCcccC
Confidence            99999999995 999999     899999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-44  Score=342.88  Aligned_cols=255  Identities=27%  Similarity=0.535  Sum_probs=223.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||.|+||.||++++..     +++.||+|++....  .......+.+|+++++.++|+||+++++++.++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR-----TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC-----CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence            368999999999999999999875     78899999987543  23344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|+|+||+++++|.+++... .+++..++.++.|++.||.|||+++|+||||+|+||+++.++.++|+|||+++..... 
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999999998765 8899999999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCC-CcHHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF-LTSEAHSLLK  346 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~  346 (441)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .++.. ++.++.++|.
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence            233456789999999999988899999999999999999999999987776666555554422 33444 7899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +||..+|++||     +++++++|+||.+..
T Consensus       233 ~~l~~~p~~Rp-----t~~~il~~~~~~~~~  258 (274)
T cd06609         233 LCLNKDPKERP-----SAKELLKHKFIKKAK  258 (274)
T ss_pred             HHhhCChhhCc-----CHHHHhhChhhcCCC
Confidence            99999999999     899999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-44  Score=340.44  Aligned_cols=254  Identities=29%  Similarity=0.482  Sum_probs=216.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  186 (441)
                      .+|++.+.||+|+||.||++.+..     ++..||+|++.....  ........+.+|+.+++.++||||+++++++.+ 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD-----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC-----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            379999999999999999999875     788999999875432  123345678899999999999999999998875 


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ...+++++||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence             4678999999999999999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcH
Q 013558          266 DESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (441)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~  339 (441)
                      ....    ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+...  ...+|..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence            3211    122356899999999999988999999999999999999999999876655444443322  3455677889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      .+++|| +||..+|++||     ++++|++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp-----~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRP-----SAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCc-----CHHHHhcCcccc
Confidence            999999 57778999999     899999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.8e-44  Score=343.48  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=208.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|.++.     ++..||+|++..... .....+.+.+|+.++++++||||+++++++..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK-----TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC-----CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            58999999999999999999875     788999999865432 233345678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      |+||||+. ++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            99999997 5787777543   4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------------
Q 013558          268 SSR-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------------  329 (441)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------------  329 (441)
                      ... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            221 2334678999999998754 5788999999999999999999999876544332222110                


Q ss_pred             --cc-----------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 --KV-----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 --~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                        ..           .....+++++++||++||+.||.+||     ++++|+.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI-----SAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC-----CHHHHhcCCCC
Confidence              00           01234789999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-44  Score=342.08  Aligned_cols=251  Identities=27%  Similarity=0.459  Sum_probs=212.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+++++.     +++.||+|++....   ......+.+|+.++++++||||+++++++....
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH-----TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC-----CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            4579999999999999999999875     77899999986532   233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999875432


Q ss_pred             C-CCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC-----CCCCcH
Q 013558          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----PPFLTS  339 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~-----p~~~s~  339 (441)
                      . ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||...+..+....+.......     +..++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 234467899999999985   3457889999999999999999999997654433332322222221     234688


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcc
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  372 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  372 (441)
                      .+.+||++||+.+|++||     ++++|++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp-----~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRP-----TAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCc-----CHHHHhcCCC
Confidence            999999999999999999     8899999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-44  Score=343.73  Aligned_cols=252  Identities=31%  Similarity=0.520  Sum_probs=216.7

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++.+.||+|+||.||++.+..     ++..+++|.+....   ....+.+.+|+++++.++||||+++++++......|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence            6888999999999999999875     77889999986532   334556788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-C
Q 013558          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~  269 (441)
                      +||||+++++|..++.+ .+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999999999887765 467999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             CCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHH
Q 013558          270 RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEA  341 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~  341 (441)
                      ......|+..|+|||++.     +..++.++|||||||++|+|++|+.||...+..+....+....   ...+..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            234467899999999984     3457789999999999999999999998877666665554432   23456688999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++||.+||+.||.+||     +++++++||||+..
T Consensus       239 ~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARW-----TTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhcCCCEecc
Confidence            9999999999999999     88999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-44  Score=346.32  Aligned_cols=251  Identities=25%  Similarity=0.457  Sum_probs=208.1

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|+++.     +++.||+|.+..... .......+.+|+.++++++||||+++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~-----~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC-----CCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            48999999999999999999876     788999999876432 223334577899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      |+|+||+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            999999975 77777754 5679999999999999999999999999999999999999999999999999998654332


Q ss_pred             C-CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhcc----------------
Q 013558          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEK----------------  330 (441)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf-~~~~~~~~~~~i~~~~----------------  330 (441)
                      . .....++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+....+....                
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            2 2345678999999998764 4789999999999999999988885 4444444444332110                


Q ss_pred             -------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 -------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 -------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                   ....+.+++++++||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI-----SAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC-----CHHHHhcCCCC
Confidence                         001134788999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=362.25  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=219.7

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .|++..+...-++-||.|+.|.||+++.+       ++.||||+++.-          -..+|+-|++|+||||+.+.|+
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeee
Confidence            35555555666788999999999999874       567999987532          1247888999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      |.....+|||||||..|-|+..|+....+.......+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCCCCCcHHH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTSEA  341 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~  341 (441)
                      .+........++||..|||||++.+...+.|+|||||||||||||||..||...+...+..-+-...  +..|..+++.+
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence            9887777788999999999999999999999999999999999999999999877665555544443  45668899999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCc
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  371 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  371 (441)
                      +-||+.||+-.|..||     ++.+|+.|-
T Consensus       341 klL~Kqcw~sKpRNRP-----SFrqil~Hl  365 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRP-----SFRQILLHL  365 (904)
T ss_pred             HHHHHHHHhcCCCCCc-----cHHHHHHHH
Confidence            9999999999999999     889999983

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-44  Score=337.16  Aligned_cols=251  Identities=27%  Similarity=0.501  Sum_probs=218.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||.|+||.||+|.++.     +++.+|+|++....   ....+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIA-----TGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecC-----CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            3579999999999999999999875     67789999997543   224567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|++|||+.+++|.+++... ..+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999999988776 7899999999999999999999999999999999999999999999999999987543


Q ss_pred             CC-CCccccCCCCCCCcchhcCC---CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-----CCCCCc
Q 013558          268 SS-RSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----LPPFLT  338 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-----~p~~~s  338 (441)
                      .. ......|+..|+|||++.+.   .++.++|+|||||++|+|++|+.||...+..+....+....+.     .+..++
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            32 23456789999999999876   7889999999999999999999999887665555444443222     233467


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  372 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  372 (441)
                      .++.+||++||..+|.+||     ++++++.|+|
T Consensus       234 ~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRP-----TATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCC-----CHHHHhcCCC
Confidence            8899999999999999999     8899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-43  Score=343.01  Aligned_cols=254  Identities=27%  Similarity=0.470  Sum_probs=220.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..+|++.+.||.|+||.||++.+..     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++....
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVA-----TGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcC-----CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            4579999999999999999998765     78899999986543   233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|+||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999999999888865 46899999999999999999999999999999999999999999999999998865433


Q ss_pred             CC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      .. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++..+.+|
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence            22 23457899999999999888999999999999999999999999887765554444332   223456788999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |++||..||.+||     ++.+++.||||+..
T Consensus       249 i~~~l~~dp~~Rp-----t~~~il~~~~~~~~  275 (296)
T cd06655         249 LNRCLEMDVEKRG-----SAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHhhcChhhCC-----CHHHHhhChHhhhc
Confidence            9999999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.8e-44  Score=350.21  Aligned_cols=245  Identities=29%  Similarity=0.462  Sum_probs=193.8

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l  192 (441)
                      .++||+|+||+||+|+++..   .+++.||+|.+.....     ...+.+|+.+|++++||||+++++++..  +..+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~---~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccC---CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            46899999999999987631   2567899999865422     2346689999999999999999999854  567999


Q ss_pred             EEeccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec----CCCCcEEEEec
Q 013558          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkl~DF  259 (441)
                      ||||+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9999965 787776532         258999999999999999999999999999999999999    46679999999


Q ss_pred             CCccccCCCC----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH---------HHHHHH
Q 013558          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  325 (441)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~---------~~~~~~  325 (441)
                      |+++.+....    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.....         .+...+
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            9998754321    2345678999999999987 4589999999999999999999999964331         111111


Q ss_pred             HHhc-----------cccC---------------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHh
Q 013558          326 IINE-----------KVKL---------------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI  367 (441)
Q Consensus       326 i~~~-----------~~~~---------------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i  367 (441)
                      +...           ...+                           ....+.++.+||++||+.||.+||     +++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----t~~e~  311 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----TSEQA  311 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC-----CHHHH
Confidence            1110           0000                           012356789999999999999999     89999


Q ss_pred             hhCccc
Q 013558          368 KHHKWF  373 (441)
Q Consensus       368 ~~h~~f  373 (441)
                      ++||||
T Consensus       312 l~hp~f  317 (317)
T cd07868         312 MQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.1e-44  Score=359.51  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=212.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +.+..++|++.++||+|+||+||+|.+.+.....++..||||+++...  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            344556899999999999999999987554444467789999986543  223345678899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC-----------------------------------------------------
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------  210 (441)
                      +...+..++||||++||+|.+++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999998886432                                                     


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       211 ----------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                  4678889999999999999999999999999999999999999999999999875432


Q ss_pred             CC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhc-cccCCCCCcHHHH
Q 013558          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ..   .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+..+ ....|...+.+++
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence            21   112345678999999999999999999999999999998 999998765443 33333332 2334566789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||.+||+.||++||     ++.+|++
T Consensus       348 ~li~~cl~~dP~~RP-----s~~eil~  369 (375)
T cd05104         348 DIMKSCWDADPLKRP-----TFKQIVQ  369 (375)
T ss_pred             HHHHHHccCChhHCc-----CHHHHHH
Confidence            999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.9e-44  Score=334.89  Aligned_cols=252  Identities=28%  Similarity=0.498  Sum_probs=223.1

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|..+.     +++.+|+|.+..... .....+.+.+|+.+|++++||||+++++.+...+.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC-----CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58999999999999999999875     788999999976543 233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~  267 (441)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999999999764  3589999999999999999999999999999999999998654 689999999988765


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLK  346 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  346 (441)
                      ........|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ..++..++.+++++|.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence            555556778999999999998889999999999999999999999999887777766665543 3466778999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +||..||++||     +++++++||||
T Consensus       235 ~~l~~~p~~Rp-----t~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRP-----QLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCC-----CHHHHhhCCCC
Confidence            99999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.9e-44  Score=335.76  Aligned_cols=253  Identities=32%  Similarity=0.521  Sum_probs=220.7

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +|+..+.||+|+||+||+|..+.     +++.|++|.+.....  ......+.+.+|+.+++.++|+||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD-----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC-----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            47788999999999999999875     678899999875432  22345567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|+||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccccCCCCCcHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li  345 (441)
                      .......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....++..+++++.+||
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence            4345667899999999998776 89999999999999999999999987665444444433  23446677899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++||+.+|.+||     ++++++.|||+
T Consensus       236 ~~~l~~~p~~Rp-----~~~~~l~~~~~  258 (258)
T cd06632         236 LKCLQRDPSLRP-----TAAELLEHPFV  258 (258)
T ss_pred             HHHhhcCcccCc-----CHHHHhcCCCC
Confidence            999999999999     89999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-44  Score=343.80  Aligned_cols=254  Identities=27%  Similarity=0.468  Sum_probs=218.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..+|++.+.||+|+||.||++.++.     +++.||+|.+.....   ...+.+.+|+.+++.+.|+||+++++.+....
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECC-----CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            4589999999999999999999775     788999999876432   23456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..|+||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999999998854 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      . ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++..+.+|
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence            2 223457899999999999888999999999999999999999999877664433333222   223456788999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |.+||..||++||     ++++++.|+||...
T Consensus       250 i~~~l~~~p~~Rp-----t~~eil~~~~~~~~  276 (296)
T cd06654         250 LNRCLDMDVEKRG-----SAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHCcCCcccCc-----CHHHHhhChhhhcc
Confidence            9999999999999     89999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.5e-44  Score=337.63  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=218.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||.|+||+||+|....     ++..+|+|++.......  ..+.+.+|+.+|+.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence            479999999999999999999775     67889999987544322  55678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      .|+|||++++++|.+++...   ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++..+.
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999999999764   458999999999999999999999999999999999999999999999999987754


Q ss_pred             CCCC-----CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CC-----
Q 013558          267 ESSR-----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-----  334 (441)
Q Consensus       267 ~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p-----  334 (441)
                      ....     .....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+..+...++...... ++     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccc
Confidence            3322     2345789999999998876 7899999999999999999999999887766666555543221 21     


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ..++.++.+||.+||+.||++||     ++++|+.||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp-----~~~~ll~~p~~  267 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRP-----TAEELLKHKFF  267 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCc-----CHHHHhhCCCC
Confidence            25678999999999999999999     89999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-43  Score=334.10  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=222.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|+++++||.|+||.||.++...     +++.+++|.+...... ......+.+|++++++++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE-----DDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            58999999999999999999875     7888999998765432 34455678999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ++||||+++++|.+++.+.  ..+++.++..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999999999765  46899999999999999999999999999999999999999999999999999876443


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CCCCCcHHHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK  346 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~  346 (441)
                      . ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... .+..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence            3 334567899999999999888899999999999999999999999988888888777665443 34567899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +||..+|.+||     +++++++|+|+
T Consensus       235 ~~l~~~p~~R~-----s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRP-----TADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCC-----CHHHHhhCcCC
Confidence            99999999999     88999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-44  Score=342.60  Aligned_cols=254  Identities=42%  Similarity=0.780  Sum_probs=229.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      ++|++.+.||+|+||.||++..+.     +++.||+|++.+.........+.+.+|+.+++++. |+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            379999999999999999999875     78899999998765545555577889999999998 999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..++||||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998865432


Q ss_pred             C---------------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 013558          269 S---------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  327 (441)
Q Consensus       269 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~  327 (441)
                      .                     ......|+..|+|||++.+..++.++|+||||+++++|++|+.||...+.....+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            2                     1233567899999999998889999999999999999999999999888777778887


Q ss_pred             hccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCCh----HHhhhCccc
Q 013558          328 NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV----DAIKHHKWF  373 (441)
Q Consensus       328 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~----~~i~~h~~f  373 (441)
                      .....+|..+++.+.+||.+||+.||.+||     ++    +++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL-----GVNEGYDELKAHPFF  280 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCC-----CcccCHHHHhcCCCC
Confidence            777888899999999999999999999999     67    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-43  Score=335.06  Aligned_cols=252  Identities=29%  Similarity=0.561  Sum_probs=221.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+++.+.     +++.||+|.+...... ....+.+.+|+.++++++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE-----DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC-----CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58999999999999999999875     7789999998764432 23445678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+.+++|.+++....  .+++.++..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999999887643  5899999999999999999999999999999999999999999999999999875443


Q ss_pred             CC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHHH
Q 013558          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (441)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  346 (441)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+.. ..+..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence            22 2234688999999999988899999999999999999999999998888777777765543 456778999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +||+.+|.+||     +++++++||||
T Consensus       235 ~~l~~~p~~Rp-----~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRP-----SVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCc-----CHHHHhhCcCC
Confidence            99999999999     89999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.7e-44  Score=343.38  Aligned_cols=256  Identities=21%  Similarity=0.382  Sum_probs=219.7

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||.||++.............||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345799999999999999999998764433455789999986542  233445688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      ...|++|||+++++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999765                457889999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~  327 (441)
                      +.+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998653221   1234456889999999998889999999999999999998 999999888888888776


Q ss_pred             hcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          328 NEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       328 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ... ...|..++.++.+|+.+||+.||.+||     ++++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRP-----RFKDIHTR  279 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            553 345678899999999999999999999     88888763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-44  Score=344.72  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP  175 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  175 (441)
                      +..++|++.++||+|+||.||+|.++...           ....+..||+|++....  .......+.+|+.+|.+++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            34568999999999999999999865321           11244579999987542  233456688999999999999


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 013558          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------IFREDQARFYTAEIVSAVSHLHKCGI  236 (441)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~i  236 (441)
                      ||+++++++.+.+..++||||+.+|+|.+++....                   .+++..+..++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886532                   36778899999999999999999999


Q ss_pred             cccccCCCceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc--CC
Q 013558          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQ  311 (441)
Q Consensus       237 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--G~  311 (441)
                      +||||||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986533221   223456789999999998889999999999999999986  67


Q ss_pred             CCCCCCCHHHHHHHHHh--------ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          312 PPFTHANRQKLQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       312 ~pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      .||...+..+....+..        .....++.++..+.+||.+||+.||++||     ++++|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~~i~  299 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP-----SFSDIH  299 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc-----CHHHHH
Confidence            88887666655544321        11234567889999999999999999999     778884

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-44  Score=340.11  Aligned_cols=254  Identities=26%  Similarity=0.465  Sum_probs=216.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      +|+..+.||+|+||.||++..+.     +++.||+|++......   .....+.+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC-----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence            48888999999999999998765     7889999998754321   122456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~  266 (441)
                      +.+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999999998888999999999999999999999999999999999999998776 59999999987754


Q ss_pred             CCC-----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----hccccCCCC
Q 013558          267 ESS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-----NEKVKLPPF  336 (441)
Q Consensus       267 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~-----~~~~~~p~~  336 (441)
                      ...     ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.     .....++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            321     1223568899999999998889999999999999999999999997544332222221     223446667


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      +++++.++|.+||..+|.+||     ++.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~-----~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRP-----PSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCc-----CHHHHhcCcccC
Confidence            899999999999999999999     889999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-44  Score=344.21  Aligned_cols=254  Identities=27%  Similarity=0.494  Sum_probs=216.1

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||+|.+....  .......+.+|+.++++++|+||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP-----TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            369999999999999999999875     78899999886532  23334668889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +|+||||++|++|..++...   ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999998888763   379999999999999999999996 59999999999999999999999999999765


Q ss_pred             CCCCCCccccCCCCCCCcchhcCC------CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHh-ccccCCC
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR---IIN-EKVKLPP  335 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~---i~~-~~~~~p~  335 (441)
                      ... ......|+..|+|||++.+.      .++.++|||||||++|+|++|+.||...........   +.. ....++.
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd06622         154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS  232 (286)
T ss_pred             cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence            432 23445788999999998654      347899999999999999999999976554443333   222 2345667


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+++++.+||.+||+.+|++||     ++++++.||||...
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp-----~~~~l~~~~~~~~~  268 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRP-----TYAQLLEHPWLVKY  268 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCC-----CHHHHhcChhhhhc
Confidence            7899999999999999999999     88999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.6e-44  Score=339.53  Aligned_cols=251  Identities=27%  Similarity=0.496  Sum_probs=211.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      .+.|++.+.||+|+||.||++.++.     +++.||+|++....    .....+..|+.+++++ +|+||+++++++...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcC-----CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            3568999999999999999999875     78899999987542    2234577899999998 699999999998753


Q ss_pred             ------CEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          188 ------SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       188 ------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                            ..+|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+||
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence                  4689999999999999998764  46899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC-CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--
Q 013558          260 GLAKEIDES-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--  331 (441)
Q Consensus       260 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--  331 (441)
                      |++...... .......|+..|+|||++.     +..++.++|||||||++|||++|..||...........+.....  
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            999865432 2334567999999999986     34578899999999999999999999987665544444433221  


Q ss_pred             cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ..+..++.++.+||.+||..||.+||     +++++++||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRP-----TTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCC-----CHHHHhhCCCC
Confidence            12345789999999999999999999     88999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.3e-44  Score=335.82  Aligned_cols=249  Identities=26%  Similarity=0.490  Sum_probs=217.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||.|+||.||++..+.     +++.|++|.+.....     .+.+.+|++++++++|+||+++++.+.....
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE-----TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC-----CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            579999999999999999999875     678999999875432     5678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999999999875 457899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      . ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++.++.++
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence            3 233456899999999999999999999999999999999999999876655444333222   223345678899999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      |.+||+.||++||     ++++++.||||
T Consensus       233 i~~~l~~~P~~Rp-----s~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERP-----SAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCc-----CHHHHhcCCCC
Confidence            9999999999999     88999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.3e-44  Score=338.03  Aligned_cols=253  Identities=20%  Similarity=0.298  Sum_probs=214.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|++.+.||+|+||.||++.++..  ...+..||+|.++...  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            456799999999999999999987532  1256789999987642  223345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      +..++||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999999998774 578999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          267 ESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       267 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      .....  ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....|..++..+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            22111  12345678999999999999999999999999999775 99999988887777776554 3355677899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+||+.+|.+||     ++++|++
T Consensus       239 ~li~~c~~~~p~~RP-----~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERP-----RFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCC-----CHHHHHH
Confidence            999999999999999     7778765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=345.45  Aligned_cols=252  Identities=25%  Similarity=0.466  Sum_probs=221.0

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |.++.+||+|+||.||+|.++.     +|+++|+|.+.-+     ..++.+..|+.+|++++.|++|++||.|.....++
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            7788999999999999999886     9999999988643     23456788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-C
Q 013558          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~  269 (441)
                      +|||||..|++.+.++. +.++.|+++..+++..++||+|||...-||||||..|||++.+|+.||+|||.|..+... .
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999999999875 468999999999999999999999999999999999999999999999999999876443 2


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~  346 (441)
                      ..++..||+.|||||++..-+|+.++||||||++..||..|++||....+......|-..   .++-|+..|.++.|||+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~  264 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR  264 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence            356789999999999999999999999999999999999999999876554333333222   22335568899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +||.++|++|-     ++-++++|+|.++..-
T Consensus       265 ~CLiK~PE~R~-----TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  265 SCLIKKPEERK-----TALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHhcCCHHHHH-----HHHHHhhhhhhcCCCc
Confidence            99999999998     8899999999987543

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=341.01  Aligned_cols=253  Identities=29%  Similarity=0.524  Sum_probs=215.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|+++... ......+.+.+|+++++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA-----TGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC-----CCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            379999999999999999999875     67899999986543 233445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .++||||++++.+...+.+...+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99999999987777666666779999999999999999999999999999999999999999999999999998765443


Q ss_pred             --CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------
Q 013558          270 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-----------------  329 (441)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-----------------  329 (441)
                        ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+...                 
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence              33456789999999999887 8899999999999999999999999876554433322210                 


Q ss_pred             ---------------cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 ---------------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 ---------------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                     ...++..++.++++||++||..+|++||     +++++++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL-----TCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc-----cHHHHhcCCCC
Confidence                           0013344689999999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-43  Score=339.35  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=209.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHH-HHhcCCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ++|++.+.||+|+||.||+++++.     +++.||+|.+..... ..... .+..|+.+ ++.++||||+++++++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP-----TGTIMAVKRIRATVN-SQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC-----CCcEEEEEEEecCCC-cHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            479999999999999999999886     789999999876432 12222 34445554 66778999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999997 577666653    24689999999999999999999997 99999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC----CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-H-HHHHHHHHhccccCC-CC
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTHAN-R-QKLQQRIINEKVKLP-PF  336 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvvl~elltG~~pf~~~~-~-~~~~~~i~~~~~~~p-~~  336 (441)
                      ............|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||.... . ..+...+......++ ..
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            7654433344678999999999865    456889999999999999999999997532 2 223232222233444 35


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ++.++.+||.+||..+|.+||     ++++++.||||+...+.
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~  270 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERP-----NYPELLQHPFFELHLSK  270 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCc-----CHHHHhcCchhhhcccc
Confidence            789999999999999999999     88999999999987654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.1e-44  Score=352.17  Aligned_cols=252  Identities=27%  Similarity=0.470  Sum_probs=210.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++.+.. ......+.+.+|+.++++++|+||++++++|... 
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK   88 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECC-----CCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence            3579999999999999999999876     78899999986532 2233445577899999999999999999988644 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ...|+||||+.+ +|...+...  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          89 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence                 357999999965 787777654  899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      +............|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...             
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            8765544445567899999999999999999999999999999999999999877654444333210             


Q ss_pred             ---------ccc--------------C-------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          330 ---------KVK--------------L-------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       330 ---------~~~--------------~-------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                               ...              +       +...++++++||.+||+.||++||     ++++++.||||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~eiL~~~~~~  315 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI-----SVDDALQHPYIN  315 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc-----CHHHHhcChhHh
Confidence                     000              0       112456789999999999999999     899999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.8e-44  Score=341.53  Aligned_cols=253  Identities=30%  Similarity=0.465  Sum_probs=213.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||.||+|.++.     +++.||+|++.+.... ....+.+.+|+++++.++||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE-----TGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC-----CCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            369999999999999999999875     6889999998664322 2344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .|+||||+++++|..+......+++.+++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++..+....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999999999888877766779999999999999999999999999999999999999999999999999988754322


Q ss_pred             -CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------
Q 013558          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------  329 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~------------------  329 (441)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...                  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence             2334568999999999875 44788999999999999999999999866554433333210                  


Q ss_pred             -ccc------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 -KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 -~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ...            ..+.++..+.+||.+||+.+|++||     +++++++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  286 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP-----SSSQLLHHEFF  286 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch-----hHHHHhcCCCC
Confidence             000            1235688999999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-43  Score=333.55  Aligned_cols=252  Identities=30%  Similarity=0.547  Sum_probs=221.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  188 (441)
                      +|++++.||.|+||.||+|.+..     +++.||+|++..... .....+.+..|+++++.++|+||+++++.+..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS-----DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            58999999999999999999875     778899999876543 34445678889999999999999999998764  45


Q ss_pred             EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccccCCCceecCCCCcEEEEec
Q 013558          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLH-----KCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH-----~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                      .+|++|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            78999999999999988865    367999999999999999999999     899999999999999999999999999


Q ss_pred             CCccccCCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCC
Q 013558          260 GLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL  337 (441)
Q Consensus       260 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~  337 (441)
                      |++........ .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+...+.+.+..... .++..+
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY  234 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence            99987655433 3456789999999999988899999999999999999999999998887777777766544 456788


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +.++.+++.+||+.+|++||     ++++|++|||+
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp-----~~~~il~~~~~  265 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRP-----STEELLQLPLI  265 (265)
T ss_pred             CHHHHHHHHHHccCCcccCC-----CHHHHhhCCCC
Confidence            99999999999999999999     89999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-43  Score=343.33  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=217.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||.||++.++.     +++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++...+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIA-----TGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECC-----CCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3579999999999999999999875     788999999875432   23356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999998865 56899999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      .. .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...   ....+..++..+++|
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF  248 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence            22 23457899999999999988999999999999999999999999876554332222221   122456688999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |.+||+.||++||     +++++++||||+..
T Consensus       249 i~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (297)
T cd06656         249 LNRCLEMDVDRRG-----SAKELLQHPFLKLA  275 (297)
T ss_pred             HHHHccCChhhCc-----CHHHHhcCchhccc
Confidence            9999999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-43  Score=343.98  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=210.9

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +..++|++.+.||+|+||.||+|.++.     ++.  .+|+|.+...  ........+.+|+.++.++ +|+||++++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~-----~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEcc-----CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            456789999999999999999999864     343  4577665432  2334456788899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCcee
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  247 (441)
                      +..++.+|+||||+++++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil  156 (303)
T cd05088          77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  156 (303)
T ss_pred             ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence            999999999999999999999997643                4789999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013558          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (441)
Q Consensus       248 l~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i  326 (441)
                      ++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            99999999999999875332222222334677999999988889999999999999999998 99999887777776666


Q ss_pred             Hhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          327 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       327 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ... ....+..++.++.+||.+||+.+|++||     ++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~il~~  276 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  276 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            543 2345566889999999999999999999     78888874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-43  Score=337.50  Aligned_cols=252  Identities=31%  Similarity=0.499  Sum_probs=213.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|.++.     +++.||+|++...... ....+.+.+|+.++++++||||+++++++.....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC-----CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58999999999999999999875     7889999998765422 33445688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      |+||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9999999 99999988654 569999999999999999999999999999999999999999999999999998764432


Q ss_pred             --CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------
Q 013558          270 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  330 (441)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------------  330 (441)
                        ......|+..|+|||++.+. .++.++|||||||++|||++|.++|...+.......+....                
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence              13345789999999998754 46889999999999999999999998776655544443210                


Q ss_pred             ---cc-----------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          331 ---VK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       331 ---~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                         ..           ..+..+.++.+||.+||+.||++||     +++++++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL-----SAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC-----CHHHHhhCcCcC
Confidence               00           1124578999999999999999999     889999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.3e-43  Score=337.65  Aligned_cols=252  Identities=27%  Similarity=0.481  Sum_probs=212.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      .++|++.+.||+|+||.||+|..+.     +++.+|+|++....    .....+.+|+.+++++ +||||+++++++...
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKK-----DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            5689999999999999999999875     78899999986532    2234567899999999 799999999998753


Q ss_pred             -----CEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          188 -----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                           +.+|+||||++|++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence                 468999999999999888753    35789999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC-CCccccCCCCCCCcchhcCC-----CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--
Q 013558          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  330 (441)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--  330 (441)
                      ||++....... ......|+..|+|||++...     .++.++|||||||++|||++|+.||...+.......+....  
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            99988654322 23345789999999998643     36789999999999999999999998776655555554332  


Q ss_pred             -ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          331 -VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       331 -~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                       ...+..++..+.+||.+||+.+|++||     ++.+|+.||||+
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~  291 (291)
T cd06639         252 TLLHPEKWCRSFNHFISQCLIKDFEARP-----SVTHLLEHPFIK  291 (291)
T ss_pred             CCCcccccCHHHHHHHHHHhhcChhhCc-----CHHHHhcCcccC
Confidence             223556778999999999999999999     899999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-43  Score=338.83  Aligned_cols=255  Identities=23%  Similarity=0.426  Sum_probs=217.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|.+.+.||+|+||+||++.........++..+|+|.+....   ....+.+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            3456899999999999999999986543333356779999886532   3345568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      .+.+++||||+++++|.+++...+             .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999987554             4899999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 013558          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~  329 (441)
                      +||+|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+..+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998653221   1223345778999999999999999999999999999998 99999988888777777766


Q ss_pred             c-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 K-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      . ...+..++.++.+|+.+||+.||.+||     ++++++.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~v~~  274 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRL-----NIKEIHS  274 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            5 345567899999999999999999999     7788754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.4e-43  Score=336.95  Aligned_cols=257  Identities=20%  Similarity=0.305  Sum_probs=215.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||.||++.+++......+..||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4556899999999999999999988754333456789999986432  12234457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEE
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999987532          3567889999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-c
Q 013558          257 TDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-V  331 (441)
Q Consensus       257 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~  331 (441)
                      +|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999876533221   122345788999999998889999999999999999999 799998888777776665543 3


Q ss_pred             cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       332 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ..+..++..+.++|.+||+.||++||     ++.+++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            55677899999999999999999999     78888763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-43  Score=340.71  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=217.7

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||+||++.+..     +++.||+|++....  .....+.+.+|+++++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIP-----TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcC-----CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            34679999999999999999999875     78899999986542  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ..+|+||||+++++|..++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999999999888889999999999999999999997 699999999999999999999999999987653


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHhc-cccCC
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----------KLQQRIINE-KVKLP  334 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-----------~~~~~i~~~-~~~~p  334 (441)
                      .. .....+|+..|+|||++.+..++.++|||||||++|+|++|..||......           +....+... ...++
T Consensus       156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         156 NS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             hh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            32 233567999999999998888999999999999999999999999865431           223333322 22233


Q ss_pred             C-CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 P-FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 ~-~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      . .++.++.+||.+||+.||++||     +++++++|+||..
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rp-----t~~e~~~~~~~~~  271 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERP-----TPQQLCAMPPFIQ  271 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccc
Confidence            3 3788999999999999999999     8899999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.6e-43  Score=331.37  Aligned_cols=247  Identities=31%  Similarity=0.581  Sum_probs=217.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.++||+|+||.||+++++.     +++.||+|.++...  .....+.+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN-----SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC-----CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            58999999999999999999876     78899999986543  233456678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999999888653  45899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  346 (441)
                      . ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..... .++..++..+++||.
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence            2 23346789999999999998899999999999999999999999998887777777765543 356778999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||+.||++||     ++.+++.
T Consensus       234 ~~l~~~P~~Rp-----~~~~il~  251 (255)
T cd08219         234 QMFKRNPRSRP-----SATTILS  251 (255)
T ss_pred             HHHhCCcccCC-----CHHHHhh
Confidence            99999999999     7888876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.1e-43  Score=332.84  Aligned_cols=256  Identities=29%  Similarity=0.527  Sum_probs=224.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      .+|++.+.||+|++|.||+|+++.     +++.|++|++......  ...+.+.+|+.++++++|+||+++++++.....
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP-----TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence            369999999999999999999886     7889999998765321  445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++......
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999999999999888899999999999999999999999 99999999999999999999999999999876543


Q ss_pred             CCC-ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhc-cccCCCC-CcHHHH
Q 013558          269 SRS-NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINE-KVKLPPF-LTSEAH  342 (441)
Q Consensus       269 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~  342 (441)
                      ... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...   ...+....+... ...++.. ++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            332 2567899999999999998999999999999999999999999776   444555555433 2334555 889999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ++|.+||..+|++||     ++.++++||||+.++
T Consensus       234 ~li~~~l~~~p~~R~-----~~~~ll~~~~~~~~~  263 (264)
T cd06623         234 DFISACLQKDPKKRP-----SAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHccCChhhCC-----CHHHHHhCHHHHhcc
Confidence            999999999999999     889999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-43  Score=338.44  Aligned_cols=255  Identities=23%  Similarity=0.405  Sum_probs=218.3

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|.+.+.||+|+||.||+|..........++.||+|++....  .....+.+.+|+++|+.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            346799999999999999999987654333457889999987542  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      ...++||||+++++|.+++...+              .+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              4788999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 013558          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~  329 (441)
                      +||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997643221   1223446788999999999999999999999999999998 99999888888877777766


Q ss_pred             ccc-CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 KVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 ~~~-~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ... .+..++.++.+||.+||+.||++||     ++++++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRI-----NIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            543 3557899999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-43  Score=341.62  Aligned_cols=255  Identities=26%  Similarity=0.421  Sum_probs=214.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +|++.+.||+|+||.||+|.++.     +++.||+|.+......  .......+..|+.++++++|+||+++++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE-----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC-----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence            48899999999999999999875     6889999999765433  1223445678999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|+||||+ +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999999999 889999998776 799999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------------
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------------  331 (441)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|...+..+...++.....              
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            32 2233457889999999865 4678899999999999999999988987766555544432100              


Q ss_pred             --------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                    ......+.++.+||.+||+.||++||     ++++++.|+||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~e~l~~~~~~~~  288 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI-----TARQALEHPYFSND  288 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc-----CHHHHhhCccccCC
Confidence                          01133578899999999999999999     89999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=330.85  Aligned_cols=249  Identities=56%  Similarity=1.046  Sum_probs=225.5

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|+||.||++.+..     +++.||+|++.+.........+.+..|+.+++.++|+||+++++.+..+..+|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKD-----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            6999999999999875     67899999998876655666778899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-CCCccccC
Q 013558          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCG  276 (441)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~g  276 (441)
                      .+++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... .......|
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            99999999988888999999999999999999999999999999999999999999999999999875443 23445678


Q ss_pred             CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCC
Q 013558          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  356 (441)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  356 (441)
                      +..|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+.+......++..++.++.++|++||..||++|
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999999999888899999999999999999999999988888888888888888899999999999999999999999


Q ss_pred             CCCCCCChHHhhhCccc
Q 013558          357 LGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       357 ~~~~~~~~~~i~~h~~f  373 (441)
                      |++.  .+++++.||||
T Consensus       236 ~~~~--~~~~l~~~~~f  250 (250)
T cd05123         236 LGSG--GAEEIKAHPFF  250 (250)
T ss_pred             CCcc--cHHHHHhCCCC
Confidence            9432  14999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-43  Score=334.19  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=213.3

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-------chhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      +|.+.+.||.|+||.||++..+.     +++.+|+|.++.....       .....+.+..|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT-----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecC-----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            58889999999999999998775     7889999988642211       12234567889999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +.....+++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC---CCccccCCCCCCCcchhcCCC--CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCC--
Q 013558          264 EIDESS---RSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLP--  334 (441)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p--  334 (441)
                      ......   ......|+..|+|||++....  ++.++|+||||+++|+|++|..||...+.......+...  ...++  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence            643221   123456899999999988654  789999999999999999999999765544433333222  22233  


Q ss_pred             --CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          335 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       335 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                        ..++.++.+||.+||..+|++||     +++++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~  272 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRP-----TARELLQHPFI  272 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCC-----CHHHHhhCCCC
Confidence              24688999999999999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-43  Score=332.21  Aligned_cols=246  Identities=22%  Similarity=0.412  Sum_probs=211.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||++.++      .+..+|+|.+......    .+.+.+|+.+|++++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR------AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec------cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            457999999999999999999876      3457999987654321    245778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..++||||+++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999999999988754 5689999999999999999999999999999999999999999999999999886533


Q ss_pred             CCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHH
Q 013558          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  343 (441)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~  343 (441)
                      ....  ....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+.... ...|...+.++.+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  232 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE  232 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            2211  22335668999999998889999999999999999999 999999888888877777653 3456668899999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ||.+||+.||++||     +++++++
T Consensus       233 li~~c~~~~p~~Rp-----s~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRP-----TFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCc-----CHHHHHH
Confidence            99999999999999     7788865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-44  Score=337.62  Aligned_cols=253  Identities=29%  Similarity=0.485  Sum_probs=218.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||.|+||.||+|.++.     +++.+|+|.+.....  ......+.+|++++++++||||+++++.+.....
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC-----CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            368889999999999999999876     788999999876532  2445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +++|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||.+.....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999999876 789999999999999999999999 9999999999999999999999999999876543


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhc-cccCCCC-CcHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLPPF-LTSE  340 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~  340 (441)
                      ... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...     ...+..+.+... ....+.. ++.+
T Consensus       154 ~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06605         154 SLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD  232 (265)
T ss_pred             HHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            222 2277899999999999999999999999999999999999999654     233344444433 2334444 8899


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +++||.+||..||++||     ++.+++.||||+.
T Consensus       233 ~~~li~~~l~~~p~~Rp-----t~~~ll~~~~~~~  262 (265)
T cd06605         233 FQDFVNLCLIKDPRERP-----SYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHcCCCchhCc-----CHHHHhhCchhhc
Confidence            99999999999999999     8999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-43  Score=335.62  Aligned_cols=246  Identities=29%  Similarity=0.528  Sum_probs=205.6

Q ss_pred             CCceEEeeE--cccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013558          110 GDFEIFRVV--GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  186 (441)
                      ++|++.+.+  |+|+||.||++..+.     ++..+|+|++.+.....        .|+.+...+ +||||+++++.|..
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKP-----TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcC-----CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            356676666  999999999999876     78899999987643211        122222222 79999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~  265 (441)
                      .+.+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999999998888999999999999999999999999999999999999999998 9999999998765


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhccccCCCCCcHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLPPFLTSEA  341 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~  341 (441)
                      ...   ....|+..|+|||++.+..++.++|||||||++|+|++|+.||........    ...........++.+++.+
T Consensus       161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence            432   345689999999999998999999999999999999999999975443321    1122234445566799999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+||.+||+.||.+|++    +++++++||||++
T Consensus       238 ~~li~~~l~~~p~~R~~----~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLT----NYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCc----hHHHHhcCCcccC
Confidence            99999999999999993    3699999999974

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-43  Score=348.91  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=213.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +.+..++|++.++||+|+||.||+|.+.+..+..+++.||+|+++...  .....+.+..|+.+++++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            345567899999999999999999987665555577899999986432  223345677899999999 79999999998


Q ss_pred             EEe-CCEEEEEEeccCCCchHHHHHHc-----------------------------------------------------
Q 013558          184 FQT-RSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (441)
Q Consensus       184 ~~~-~~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (441)
                      +.. +..++++|||+++++|.+.+...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            865 46789999999999999888542                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC---CccccCCC
Q 013558          210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTT  278 (441)
Q Consensus       210 --------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~  278 (441)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....   .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2578999999999999999999999999999999999999999999999999987533221   22345677


Q ss_pred             CCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHHHHHHHHhcccCcCC
Q 013558          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSK  355 (441)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~  355 (441)
                      .|+|||++.+..++.++|||||||++|||++ |..||.+....+........  ....+...++++.+++.+||+.+|++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999998 99999875544333333222  33456678899999999999999999


Q ss_pred             CCCCCCCChHHhhhC
Q 013558          356 RLGSGPGGVDAIKHH  370 (441)
Q Consensus       356 R~~~~~~~~~~i~~h  370 (441)
                      ||     +++++++|
T Consensus       320 RP-----s~~ell~~  329 (337)
T cd05054         320 RP-----TFSELVEI  329 (337)
T ss_pred             Cc-----CHHHHHHH
Confidence            99     78888874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.9e-43  Score=341.96  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||.||++.++.     +++.||+|++...... ......+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTT-----SGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            45689999999999999999999875     7889999998754322 22223456799999999999999999998765


Q ss_pred             --CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                        +.+|+||||+.+ +|.+.+... ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence              579999999975 787777653 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          265 IDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      ..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...             
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65432 2223356888999999875 56789999999999999999999999988877766655431             


Q ss_pred             ------cccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 ------KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 ------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                            ...++           ..+++++.+||.+||+.||++||     ++++++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-----TAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc-----CHHHHhcChhhccC
Confidence                  11111           13588999999999999999999     89999999999743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.5e-43  Score=330.85  Aligned_cols=252  Identities=30%  Similarity=0.532  Sum_probs=216.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||++....     +++.||+|++...... ....+.+.+|+.+++.++|+||+++++.+.....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD-----TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC-----CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58999999999999999998765     7789999999765432 45677899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      ++|+||+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999999999998887899999999999999999999999999999999999999999999999999887543322


Q ss_pred             -----CccccCCCCCCCcchhcCCC---CCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh-ccccCCCC--Cc
Q 013558          271 -----SNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN-EKVKLPPF--LT  338 (441)
Q Consensus       271 -----~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~-~~~~~p~~--~s  338 (441)
                           .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+.. ....+|..  ++
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS  234 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence                 12356889999999998766   8899999999999999999999997653 3333333332 23345554  48


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ..+.+||.+||+.+|.+||     ++++++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~-----~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRP-----TASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence            9999999999999999999     88999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-43  Score=363.64  Aligned_cols=268  Identities=22%  Similarity=0.332  Sum_probs=201.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCC----------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  178 (441)
                      .++|+++++||+|+||+||+|..+....          ...+...+.|.+.+...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3589999999999999999987653110          000111111112221112233445688999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      ++++++...+..|+|+|++.+ +|..++...     ......+++.++.||+.||.|||++|||||||||+||||+.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999954 677766543     23446778899999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC-CCCC--CHHHHHHHHHh
Q 013558          254 VMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHA--NRQKLQQRIIN  328 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p-f~~~--~~~~~~~~i~~  328 (441)
                      +||+|||+++.+....  .....+||..|+|||++.+..++.++|||||||++|||++|..+ |...  +.......+..
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999998764432  23356899999999999999999999999999999999998754 4322  22222222111


Q ss_pred             c----cccCC----------------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 E----KVKLP----------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ~----~~~~p----------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .    ...+|                            ..++.++.++|.+||+.||.+||     ++.|++.||||...
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp-----sa~elL~hp~f~~~  460 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP-----GAAELLALPLFSAE  460 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc-----CHHHHhhChhhhcC
Confidence            0    00000                            13566788899999999999999     88999999999987


Q ss_pred             Chhhhh
Q 013558          377 NWKTLE  382 (441)
Q Consensus       377 ~~~~~~  382 (441)
                      ..+.+.
T Consensus       461 ~~~~~~  466 (501)
T PHA03210        461 EEEEIL  466 (501)
T ss_pred             CchHHH
Confidence            766553

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.1e-43  Score=335.65  Aligned_cols=248  Identities=29%  Similarity=0.510  Sum_probs=206.5

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC--C
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR--S  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~  188 (441)
                      |++.++||+|+||.||++.++.     +++.||+|++.+... ..... ...+|+.++.++. |+||+++++++.+.  +
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK-----TGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcC-----CCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            6789999999999999999875     788999999875432 22222 2346888888885 99999999999987  8


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++....
T Consensus        74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99999999975 777777653 57899999999999999999999999999999999999999 9999999999987655


Q ss_pred             CCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------
Q 013558          268 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-----------------  329 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-----------------  329 (441)
                      ........++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+...                 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444455678999999998654 55788999999999999999999999887765554444321                 


Q ss_pred             -cccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 -KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ...++           ..++.++.+||.+||++||++||     ++++++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI-----TAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc-----CHHHHhhCCCC
Confidence             11111           24689999999999999999999     89999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=349.34  Aligned_cols=257  Identities=30%  Similarity=0.497  Sum_probs=211.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  184 (441)
                      .+....|+++++||+||.+.||+|..-      ..+.||+|.+.... .+...+..+.+|+.+|.+|+ |.+||+|++|-
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s------~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNS------DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecC------CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            355668999999999999999999854      45678888775433 34566778999999999995 99999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ..++.+|+||||=+ -+|..+|..... +....+++|..||+.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|.
T Consensus       430 v~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  430 VTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             ccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence            99999999999854 489999987754 4446899999999999999999999999999999998 57899999999999


Q ss_pred             ccCCCCC---CccccCCCCCCCcchhcCCC-----------CCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh
Q 013558          264 EIDESSR---SNSMCGTTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN  328 (441)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~  328 (441)
                      .+.....   ..+.+||+.||+||.+....           .++++||||||||||+|+.|++||.... ...-+..|..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            8765433   34578999999999997433           3578999999999999999999997532 3333444444


Q ss_pred             c--cccCCCCCcH-HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 E--KVKLPPFLTS-EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ~--~~~~p~~~s~-~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .  .++||..-+. ++.++++.||++||++||     ++.++|+|||+..+
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~-----si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRW-----SIPELLQHPFLQIQ  633 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCC-----CcHHHhcCcccccc
Confidence            3  3456654333 399999999999999999     88999999999763

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=358.91  Aligned_cols=247  Identities=27%  Similarity=0.495  Sum_probs=217.3

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (441)
                      +||+|+||+||.++++.     +....|||.+...   .....+.+..||.+-++|+|.|||+++|.+.+++.+-|.||-
T Consensus       582 VLGKGTYG~VYA~RD~~-----tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq  653 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD-----TQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ  653 (1226)
T ss_pred             EeecCceeEEEeecccc-----ceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence            79999999999999886     7788999998653   244566788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcEEEEecCCccccCC-CCCC
Q 013558          197 INGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDE-SSRS  271 (441)
Q Consensus       197 ~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~-~~~~  271 (441)
                      ++||+|...++.. |++  +|..+.+|.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+.. ...+
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            9999999999877 777  8899999999999999999999999999999999996 579999999999988643 4456


Q ss_pred             ccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHH--HhccccCCCCCcHHHHHHHH
Q 013558          272 NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRI--INEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i--~~~~~~~p~~~s~~~~~li~  346 (441)
                      .++.||.-|||||++..  .+|+.++|||||||++.||.||++||.... +...+-++  .+..+++|..++.+++.||.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence            78999999999999985  579999999999999999999999997543 33223222  34467788999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +|+.+||..||     ++++++..||++.-
T Consensus       814 rcFepd~~~R~-----sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  814 RCFEPDPCDRP-----SAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHcCCCcccCc-----cHHHhccCcccccC
Confidence            99999999999     78999999999864

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-43  Score=333.69  Aligned_cols=257  Identities=23%  Similarity=0.351  Sum_probs=219.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||.||++..+....+..+..||+|.+....  .......+.+|+.+|+.++|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            34567899999999999999999998765544567889999986543  2233456778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEE
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                      .....|+||||+++|+|.+++....          .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999986532          367889999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-c
Q 013558          256 LTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-K  330 (441)
Q Consensus       256 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~  330 (441)
                      |+|||+++.+....   ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+..+.+... .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            99999998654322   1233456889999999998889999999999999999998 99999988887777776644 3


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..+|..++.++.+||.+||+.+|++||     ++.+++.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~l~~  273 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRP-----TFLEIVS  273 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            456778899999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.2e-43  Score=336.28  Aligned_cols=251  Identities=30%  Similarity=0.494  Sum_probs=209.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++++.||.|++|.||+|+++.     +++.||||.+..... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC-----CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            48999999999999999999875     788999998865432 223335678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ++||||+. ++|..++...  ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++......
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999996 5788887653  56899999999999999999999999999999999999999999999999998765432


Q ss_pred             C-CCccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-----------------  329 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-----------------  329 (441)
                      . ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++...                 
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            2 223346788999999887644 688899999999999999999999876654433332211                 


Q ss_pred             -cc-----------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 -KV-----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 -~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ..           ...+.++++++++|.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI-----SAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC-----CHHHHhcCCCC
Confidence             00           11234788999999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-43  Score=338.39  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=212.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++.+.||.|+||.||+|.++.     +++.+|+|.++..... ......+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK-----TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC-----CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            479999999999999999999875     7789999999765432 23334567899999999999999999999877  


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            899999999975 8888887654 58999999999999999999999999999999999999999999999999998765


Q ss_pred             CC-CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------
Q 013558          267 ES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  330 (441)
Q Consensus       267 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--------------  330 (441)
                      .. .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+...++....              
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 223345678999999998764 46889999999999999999999998877665555443210              


Q ss_pred             -----------------ccCCCC-CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 -----------------VKLPPF-LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 -----------------~~~p~~-~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                       ..++.. +++.+.+||++||+.||++||     +++|++.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI-----SAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC-----CHHHHhcCCCC
Confidence                             112233 588999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-45  Score=354.56  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=220.2

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |.-++.||.|+||.||-|++..     +.++||||.|....-...+..+.+..|+.+|++++|||+|.+.|+|-.+...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~-----n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC-----ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            6677899999999999999886     88999999998766555666778999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      ||||||-| +-.+++.-. .++.+.++..|+.+.+.||.|||+++.||||||..|||+.+.|.|||+|||.|.....   
T Consensus       103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99999966 555666443 5799999999999999999999999999999999999999999999999999977543   


Q ss_pred             CccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCC-CCCcHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLP-PFLTSEAHSLL  345 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p-~~~s~~~~~li  345 (441)
                      .++++|||+|||||++.   .+.|+-++||||||++..||.-.++|+-..+....+.-|..+ .+.++ +..+..++.||
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            67899999999999987   467999999999999999999999998877766666666544 44444 46899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ..||++-|.+||     +.+++++|+|...
T Consensus       259 d~CLqKipqeRp-----tse~ll~H~fv~R  283 (948)
T KOG0577|consen  259 DSCLQKIPQERP-----TSEELLKHRFVLR  283 (948)
T ss_pred             HHHHhhCcccCC-----cHHHHhhcchhcc
Confidence            999999999999     7799999999864

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4e-43  Score=352.12  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=213.1

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~  182 (441)
                      .+.+..++|+++++||+|+||.||+|.+........+..||||++....  .....+.+.+|+++|+++. ||||+++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            4456677899999999999999999998654443455679999986542  2334567889999999996 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-----------------------------------------------------
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (441)
                      ++.+.+.+|+|||||++|+|.+++...                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999999888643                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          210 -------------------------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       210 -------------------------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                                                                 ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       1367788899999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~  322 (441)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986533221   223456788999999999899999999999999999997 9999987544333


Q ss_pred             -HHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 -QQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 -~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       ...+... ....+..++.++.++|.+||+.||++||     ++.+|.+
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  392 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP-----SFLHLSD  392 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc-----CHHHHHH
Confidence             3333332 3445667899999999999999999999     6666654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.6e-43  Score=335.85  Aligned_cols=255  Identities=26%  Similarity=0.491  Sum_probs=220.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+.++.||.|+||.||++.++.     ++..||+|++.....  ......+.+|+.+++.+.|+||+++++.+.++...
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc-----CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            58888999999999999999875     778999999875432  33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+||||++|++|.+++.. +.+++.++..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999999998864 578999999999999999999999999999999999999999999999999997754322 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHh
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~  348 (441)
                      ......++..|+|||++.+..++.++|+|||||++|||++|..||...+.......+... ...++..++..+.+||.+|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            223456889999999999888999999999999999999999999877766655554333 2334456788999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      |+.+|++||     +++++++|+||.....
T Consensus       237 l~~~p~~Rp-----~~~~il~~~~~~~~~~  261 (277)
T cd06640         237 LNKDPSFRP-----TAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcccCc-----CHHHHHhChHhhhcch
Confidence            999999999     8899999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=304.78  Aligned_cols=254  Identities=27%  Similarity=0.492  Sum_probs=218.3

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|...++||+|+||+||+++.+.     ++++||+|.++.+... +..-....+|+.+|+.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~-----t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE-----THEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC-----ccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            57778899999999999999876     8999999999876533 33334567899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .+|+|||.. +|..+... ++.++.+.++.++.|+++||.|+|+++++||||||.|+||+.+|.+||+|||+++.++-..
T Consensus        77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            999999965 77776654 5789999999999999999999999999999999999999999999999999999876554


Q ss_pred             C-CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-----------ccC--
Q 013558          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-----------VKL--  333 (441)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-----------~~~--  333 (441)
                      + ....+-|.+|++|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..+...+|...-           -.+  
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            3 3345679999999999874 58999999999999999988 999999999999888886410           011  


Q ss_pred             -------C---------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          334 -------P---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       334 -------p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                             |         +.++...+||+.++|.-+|.+|+     ++++.++||||.+.
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri-----saeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI-----SAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc-----CHHHHhcCcccccc
Confidence                   1         23456789999999999999999     88999999999753

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.7e-43  Score=331.36  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=215.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|.+.+.||+|+||.||+|.++.     .++.||+|++....    .....+.+|+++++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEec-----CCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            455679999999999999999999875     77889999986532    224567789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +..+++||||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+|||+++++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999998764  3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      .......  ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... ....+..++.+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK  233 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            6443221  12234568999999999999999999999999999998 99999988888777777653 45567788999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.++|.+||+.||++||     ++.++++
T Consensus       234 ~~~li~~cl~~~p~~Rp-----~~~~l~~  257 (263)
T cd05052         234 VYELMRACWQWNPSDRP-----SFAEIHQ  257 (263)
T ss_pred             HHHHHHHHccCCcccCC-----CHHHHHH
Confidence            99999999999999999     7777765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.6e-43  Score=335.23  Aligned_cols=252  Identities=28%  Similarity=0.491  Sum_probs=209.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE-
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ-  185 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-  185 (441)
                      ..++|++.+.||+|+||.||+|.++.     +++.+|+|++....    .....+.+|+.+++.+ +||||+++++++. 
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKK-----NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECC-----CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            45689999999999999999999875     77899999876432    1224577899999999 6999999999874 


Q ss_pred             ----eCCEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          186 ----TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                          .+..+|+||||++|++|.+.+..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                44679999999999999887753    3568999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCC-CCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--
Q 013558          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--  329 (441)
Q Consensus       258 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--  329 (441)
                      |||+++...... ......|+..|+|||++..     ..++.++|||||||++|||++|+.||...+.......+...  
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999998754322 2334579999999999853     45788999999999999999999999876554443333222  


Q ss_pred             -cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ....+..++.++.+||.+||+.||++||     +++++++|+||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRP-----TVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCC-----CHHHHhhcccC
Confidence             1223455788999999999999999999     89999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.1e-43  Score=334.94  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=209.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT-  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-  186 (441)
                      .+.|++.+.||.|+||.||+++++.     +++.+|+|++....    .....+..|+.+++++ +|+||+++++++.. 
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4579999999999999999999875     77899999986542    2234577899999998 69999999999853 


Q ss_pred             -----CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          187 -----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                           ...+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence                 46799999999999999988754  45889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC-CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-c
Q 013558          260 GLAKEIDES-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-K  332 (441)
Q Consensus       260 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~  332 (441)
                      |++...... .......|+..|+|||++.     ...++.++|||||||++|||++|..||...........+..... .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            998765422 2234567899999999986     34678899999999999999999999976654443333332211 1


Q ss_pred             -CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          333 -LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       333 -~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       .+..++.++.+||++||..||.+||     ++.+|++||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRP-----STEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCc-----CHHHHhcCCCC
Confidence             1235789999999999999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=365.30  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  183 (441)
                      ..++.-+++|.+.|.+|||+.||+|+...     .+..||+|.+--.   ++...+.+++|+++|+.|. |+|||.+++.
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~-----~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVK-----GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecC-----CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            44666689999999999999999999875     4588999998653   5777888999999999996 9999999993


Q ss_pred             E-Ee------CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCC
Q 013558          184 F-QT------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG  252 (441)
Q Consensus       184 ~-~~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~  252 (441)
                      . ..      .-.++|.||||.||.|.+++..+  ..|+|.++..|++|+++|+.+||.+.  |||||||-|||||+.+|
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            2 21      23689999999999999999744  56999999999999999999999998  99999999999999999


Q ss_pred             cEEEEecCCccccCCCCCC----------ccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH
Q 013558          253 HVMLTDFGLAKEIDESSRS----------NSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~  319 (441)
                      +.||||||.|.........          -...-|+-|+|||++.   +...+.|+|||+|||+||.|+....||+... 
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-  262 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-  262 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-
Confidence            9999999998753222211          1123589999999985   6788999999999999999999999998653 


Q ss_pred             HHHHHHHHhccccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          320 QKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       320 ~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                         .-.|+.+++.+|+  .++..+++||+.||+.||++||     ++-+++.+
T Consensus       263 ---~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP-----nI~Qv~~~  307 (738)
T KOG1989|consen  263 ---KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP-----NIYQVLEE  307 (738)
T ss_pred             ---ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC-----CHHHHHHH
Confidence               2467888899886  6999999999999999999999     77887753

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-42  Score=330.19  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=210.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .+++.....||+|+||.||++.++.     ++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLS-----TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence            3455556789999999999998765     67889999886542   234456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~  264 (441)
                      ..++|+||+++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999999998765 455  88899999999999999999999999999999999976 67999999999876


Q ss_pred             cCCCC-CCccccCCCCCCCcchhcCC--CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH--HHH-HHHhccccCCCCCc
Q 013558          265 IDESS-RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQK--LQQ-RIINEKVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltG~~pf~~~~~~~--~~~-~i~~~~~~~p~~~s  338 (441)
                      ..... ......|+..|+|||++.+.  .++.++||||||+++|+|++|..||...+...  ... ........+|..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence            53322 23345689999999998764  37889999999999999999999997543221  111 12233445677889


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +++++|+.+||+.+|.+||     ++++++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rp-----t~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRA-----SAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCC-----CHHHHHhCCCC
Confidence            9999999999999999999     88999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-43  Score=332.11  Aligned_cols=251  Identities=27%  Similarity=0.500  Sum_probs=211.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.+++|++.....    ..+.+.+|+.+++++ .|+||+++++++...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKK-----TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECC-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            4689999999999999999999875     678999999875432    335688999999999 699999999999764


Q ss_pred             C------EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          188 S------KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       188 ~------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      .      .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence            4      58999999999999888865    3579999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCC-CCCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Q 013558          258 DFGLAKEIDES-SRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (441)
Q Consensus       258 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~  331 (441)
                      |||++...... .......|+..|+|||++..     ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            99998765332 22334568999999999864     3467889999999999999999999987665555555544322


Q ss_pred             ---cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                         ..+..++.++++||.+||..||++||     +++++++|||+
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~ll~~~~~  275 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRP-----FMEELLEHPFI  275 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCc-----CHHHHhcCCCC
Confidence               22334778999999999999999999     89999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.6e-43  Score=339.80  Aligned_cols=251  Identities=27%  Similarity=0.497  Sum_probs=214.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |.....||+|+||.||++.+..     ++..||||.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH-----TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC-----CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            5556789999999999998865     77899999986532   233456788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-C
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-R  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  270 (441)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            99999999999887754 578999999999999999999999999999999999999999999999999987643222 2


Q ss_pred             CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~  347 (441)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...   .......++..+.++|.+
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            23457899999999999888999999999999999999999999887766655554432   222233578899999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||..||.+||     +++++++|+||+..
T Consensus       255 ~l~~~P~~Rp-----t~~~il~~~~~~~~  278 (292)
T cd06658         255 MLVREPSQRA-----TAQELLQHPFLKLA  278 (292)
T ss_pred             HccCChhHCc-----CHHHHhhChhhhcc
Confidence            9999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.3e-43  Score=341.64  Aligned_cols=245  Identities=27%  Similarity=0.452  Sum_probs=192.4

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l  192 (441)
                      ..+||+|+||+||+|+.+..   .++..||+|.+.....     ...+.+|+.+|+.++||||+++++++..  +..+|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC---CccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            35899999999999987642   2567899998865321     2346789999999999999999998853  568999


Q ss_pred             EEeccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec----CCCCcEEEEec
Q 013558          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkl~DF  259 (441)
                      ||||+.+ +|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9999965 677766422         248899999999999999999999999999999999999    56789999999


Q ss_pred             CCccccCCCC----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---------HHHHH
Q 013558          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------KLQQR  325 (441)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---------~~~~~  325 (441)
                      |+++......    ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......         .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            9998754322    2234578999999999976 45789999999999999999999999653311         00111


Q ss_pred             HHh----------------------------cc----------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHh
Q 013558          326 IIN----------------------------EK----------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI  367 (441)
Q Consensus       326 i~~----------------------------~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i  367 (441)
                      +..                            ..          .......+..+.+||.+||+.||.+||     +++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-----t~~e~  311 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI-----TSEQA  311 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc-----CHHHH
Confidence            100                            00          000112356788999999999999999     89999


Q ss_pred             hhCccc
Q 013558          368 KHHKWF  373 (441)
Q Consensus       368 ~~h~~f  373 (441)
                      ++||||
T Consensus       312 l~hp~f  317 (317)
T cd07867         312 LQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-42  Score=327.82  Aligned_cols=252  Identities=30%  Similarity=0.566  Sum_probs=218.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||++..+.     ++..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS-----DSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC-----CCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            58999999999999999999876     7788999998765432 23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc-EEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-VMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-vkl~DFG~a~~~~~  267 (441)
                      |+|+||+++++|.+++.+..  .+++..+..++.|++.||.|||+++|+|+||||+||++++++. +||+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999999999987653  4799999999999999999999999999999999999998864 69999999987644


Q ss_pred             CCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHH
Q 013558          268 SSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (441)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  345 (441)
                      ... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..... ..++.++.++.++|
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence            322 2234689999999999888899999999999999999999999988777666666554433 34567889999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .+||..+|++||     +++++++||||
T Consensus       235 ~~~l~~~p~~Rp-----t~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRP-----SITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCc-----CHHHHhhCCCC
Confidence            999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-42  Score=336.73  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=215.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ...|++.+.||+|+||+||++..+.     +++.||+|++...........+.+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            3569999999999999999999875     78899999987554444455567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99999999975 66666543 46799999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccC-CCCCcHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKL-PPFLTSEAH  342 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~  342 (441)
                         .....|+..|+|||++.   ...++.++||||||+++|||++|+.||...+.......+.... ... +..++.+++
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               23457889999999885   3567889999999999999999999998877666555444332 222 234688999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||.+||..||++||     ++.+++.|+||...
T Consensus       245 ~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  273 (307)
T cd06607         245 NFVDSCLQKIPQDRP-----SSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHhcCChhhCc-----CHHHHhcChhhccc
Confidence            999999999999999     88999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-42  Score=333.26  Aligned_cols=252  Identities=24%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|.+.+.||+|+||.||+|.++.     +++.||+|++.....  ......+.+|+.+++.++|+||+++++++..+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC-----CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            3579999999999999999999876     778999999865432  222234668999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+. ++|...+.. ...+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9999999996 566666544 35688999999999999999999999999999999999999999999999999876432


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhc--------------c
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINE--------------K  330 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~--------------~  330 (441)
                      .. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.. +....+...              .
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            21 2234567899999999876 45788999999999999999999999765432 222221100              0


Q ss_pred             cc---------CC---------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 VK---------LP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ~~---------~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ..         .+         ...+.++.+||.+||+.||.+||     ++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-----t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-----SAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc-----CHHHHhcCCCC
Confidence            00         00         01256889999999999999999     88999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=333.94  Aligned_cols=252  Identities=25%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||++.++.     +++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKL-----TGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcC-----CCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            3689999999999999999999875     678999999875432  122234567999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          77 TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             eEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99999999975 898888764 4689999999999999999999999999999999999999999999999999876432


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc---------------
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE---------------  329 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~~---------------  329 (441)
                      .. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+...               
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            21 1223457889999999875 458899999999999999999999997654 22222222110               


Q ss_pred             ----c--cc---------CCCCCc--HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 ----K--VK---------LPPFLT--SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 ----~--~~---------~p~~~s--~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                          .  ..         ....++  .++.++|.+||+.+|++||     ++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp-----s~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-----SAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc-----CHHHHhcCCCC
Confidence                0  00         001234  7889999999999999999     88999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-42  Score=329.07  Aligned_cols=249  Identities=21%  Similarity=0.381  Sum_probs=212.4

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|+++++||+|+||.||++...      .+..||+|.+.....    ..+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            355678999999999999999999865      456799998765322    2456888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ..+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999998764  568899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      .......  .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+... ....+..++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD  231 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            7643221  122345678999999998889999999999999999998 99999888777777766544 2333456889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.++|.+||..+|++||     +++++.+
T Consensus       232 ~~~~li~~~l~~~p~~Rp-----~~~~i~~  256 (261)
T cd05072         232 ELYDIMKTCWKEKAEERP-----TFDYLQS  256 (261)
T ss_pred             HHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            999999999999999999     7777754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-42  Score=332.55  Aligned_cols=255  Identities=21%  Similarity=0.355  Sum_probs=214.0

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||+||+|...... ...+..+|+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            3467999999999999999999864321 1256789999987532  233446688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG-----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      ...|+||||+++++|.+++....                 .+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            99999999999999999886432                 3788899999999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013558          251 DGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i  326 (441)
                      ++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+...+.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998653321   1233456778999999998889999999999999999998 99999887777666666


Q ss_pred             Hhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          327 INEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       327 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .... ...+..+++++.++|.+||+.||.+||     ++++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP-----RFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHH
Confidence            5443 345677899999999999999999999     77888763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=327.62  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=217.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      .+|++.+.||+|+||.||++.++.     ++..||+|.+....  .........+.+|+.++++++|+||+++++++.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD-----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC-----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            479999999999999999999875     78899999875432  12234556788999999999999999999998764


Q ss_pred             --CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                        ..+++|+||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence              568999999999999999988888999999999999999999999999999999999999999999999999999865


Q ss_pred             CCC----CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCCCCcH
Q 013558          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (441)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~  339 (441)
                      ...    .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||..........++...  ...+|..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            321    1123456899999999999888999999999999999999999999876655555554432  3456888999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++.++|.+||+ +|.+||     ++.+++.|||.
T Consensus       237 ~~~~~i~~~l~-~~~~r~-----~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRP-----TAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCc-----cHHHHhcCCCC
Confidence            99999999999 579999     88999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-42  Score=334.09  Aligned_cols=253  Identities=27%  Similarity=0.465  Sum_probs=207.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      ++|++.+.||+|+||.||++.++.     +++.||+|++.... ........+.+|+.+++.+. ||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN-----TGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC-----CCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            469999999999999999999875     78899999986543 22233456778999999995 699999999998766


Q ss_pred             E-----EEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEE
Q 013558          189 K-----LYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLT  257 (441)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~  257 (441)
                      .     +|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence            5     8999999986 787777543     35799999999999999999999999999999999999998 8999999


Q ss_pred             ecCCccccCCC-CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----
Q 013558          258 DFGLAKEIDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----  330 (441)
Q Consensus       258 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----  330 (441)
                      |||+++.+... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+....     
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999865332 12233467889999998865 457899999999999999999999998776655444433210     


Q ss_pred             ---------------c--------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          331 ---------------V--------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       331 ---------------~--------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                                     .        ...+.++.++.+||.+||..||.+||     ++++++.||||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~-----~~~eil~~~~~~  295 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI-----SAKAALTHPYFD  295 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC-----CHHHHhcCCCcC
Confidence                           0        00134788999999999999999999     889999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-42  Score=334.21  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=216.0

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|.+.+.||+|+||.||+|++...........+++|.+....   ....+.+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            346799999999999999999987654443456779999886533   23345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      ...++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997643                37899999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~  327 (441)
                      +.+||+|||++.......   ......|+..|+|||++.+..++.++|||||||++|||++ |..||...+..+..+.+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999997653321   1233456788999999999999999999999999999999 999998888777777666


Q ss_pred             hccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .... ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~v~~  277 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRL-----NIKEIYK  277 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            5543 34556789999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-42  Score=369.25  Aligned_cols=244  Identities=25%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||.||+|.+..     +++.||+|++...........+.+.+|++++++++||||+++++++.+.+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~-----tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV-----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC-----CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence            689999999999999999999875     788999999976543344455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          190 LYLILDFINGGHLFFHLYRQ-----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      .|+||||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999999999988642           2345667888999999999999999999999999999999999999999


Q ss_pred             cCCccccCCC-------------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH
Q 013558          259 FGLAKEIDES-------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (441)
Q Consensus       259 FG~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~  319 (441)
                      ||+++.....                   ......+||+.|||||++.+..++.++|||||||++|||++|..||...+.
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            9999865210                   011235799999999999999999999999999999999999999987655


Q ss_pred             HHHHHHHH-hccccC--CCCCcHHHHHHHHHhcccCcCCCCC
Q 013558          320 QKLQQRII-NEKVKL--PPFLTSEAHSLLKGLLHKDPSKRLG  358 (441)
Q Consensus       320 ~~~~~~i~-~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~~  358 (441)
                      .+...... ......  ...+++.+.+++.+||+.||++|++
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence            44332211 111111  1357889999999999999999984

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.3e-43  Score=337.78  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=212.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      ++|+..++||+|+||.||++.++.     +++.||+|.+.+....  .....+.+|+.++.++. |+||+++++++..+.
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKP-----SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECC-----CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            467788899999999999999876     7889999998754322  34456788999999996 999999999999999


Q ss_pred             EEEEEEeccCCCchHHH---HH--HcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 KLYLILDFINGGHLFFH---LY--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~---l~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ..+++|||+.+ +|.+.   +.  ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999999865 44332   22  23679999999999999999999997 49999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCC---CCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc-cccCC---
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINE-KVKLP---  334 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~-~~~~p---  334 (441)
                      +.+..........|+..|+|||++.+.   .++.++|||||||++|+|++|+.||..... .+....+... ...++   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            876544334455789999999999876   689999999999999999999999976542 1222222222 12222   


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                       ..++.++.+||.+||++||++||     ++++|+.||||+...|....
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~i~~~~~~~~~~~~~~~  279 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVD  279 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhchhhcchh
Confidence             24789999999999999999999     88999999999987766544

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-42  Score=324.56  Aligned_cols=252  Identities=33%  Similarity=0.551  Sum_probs=222.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  188 (441)
                      +|.+.+.||+|++|.||++..+.     +++.|++|++...... ....+.+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD-----TGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            48889999999999999999875     7889999998765422 45567889999999999999999999999988  8


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999887654


Q ss_pred             CC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHH--hccccCCCCCcHHHH
Q 013558          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRII--NEKVKLPPFLTSEAH  342 (441)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~  342 (441)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+.  .....+|..++..+.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence            43   445678999999999998889999999999999999999999998765 333333333  234456778899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +||.+||+.||++||     ++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp-----~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRP-----TADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCC-----CHHHHhhCCCC
Confidence            999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-44  Score=354.00  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=220.5

Q ss_pred             CCCc-eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       109 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      .++| +...+||+|+|-+||+|.+..     +|..||--.++...+. .....+++..|+.+|+.|+|||||++|++|.+
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~-----~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEE-----EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccc-----cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            3445 345689999999999998754     6767776665544432 34556889999999999999999999999987


Q ss_pred             CCE--EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCC-CCcEEEEecCC
Q 013558          187 RSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGL  261 (441)
Q Consensus       187 ~~~--~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~-~~~vkl~DFG~  261 (441)
                      ...  +.+|+|++..|+|..|+++.+.++...++.|++||++||.|||++.  |||||||.+||+|+. .|.|||+|+|+
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence            654  8999999999999999999999999999999999999999999885  999999999999985 58999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcccc--CCCCCc
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK--LPPFLT  338 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s  338 (441)
                      |....... .....|||.|||||++. ..|+..+||||||++|+||+|+.+||.. .+..++++++..+..+  +...-.
T Consensus       193 Atl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  193 ATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             HHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence            99876544 44589999999999997 7899999999999999999999999975 6788999999887543  333447


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +++++||.+||.. .+.|+     ++.|+|.|+||..-
T Consensus       271 Pevr~fIekCl~~-~~~R~-----sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  271 PEVREFIEKCLAT-KSERL-----SAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHHhcC-chhcc-----CHHHHhhChhhccc
Confidence            8999999999999 99999     88999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-43  Score=338.71  Aligned_cols=257  Identities=26%  Similarity=0.481  Sum_probs=219.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++.+.||+|+||.||++.+..     +++.||+|++....  .....+.+.+|+.++++++||||+++++++..+...
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            47778899999999999998865     67889999987543  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999999999888754 578999999999999999999999999999999999999999999999999998754332 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHh
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~  348 (441)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|..||...........+... ...++..++.++.++|.+|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            223456899999999999988999999999999999999999999876655555444333 2234456788999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                      |+.+|++||     ++.++++|+||....+..
T Consensus       237 l~~~p~~Rp-----~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         237 LNKDPRFRP-----TAKELLKHKFITRYTKKT  263 (277)
T ss_pred             ccCCcccCc-----CHHHHHHhHHHHHHhhhH
Confidence            999999999     889999999998665443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-42  Score=329.14  Aligned_cols=250  Identities=27%  Similarity=0.452  Sum_probs=212.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||.||+|+.+.     +++.||||.+.............+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC-----CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence            579999999999999999999876     788999998876544455556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .++||||+++++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999999887753    345899999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcc-ccC-CCCCcHH
Q 013558          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEK-VKL-PPFLTSE  340 (441)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~--~~~~~~~i~~~~-~~~-p~~~s~~  340 (441)
                      ..... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....  .....+.+.... ... +..++..
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            43221 234578899999999998889999999999999999999999996543  334444443322 122 2357789


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.++|.+||+.+|++||     ++.++++
T Consensus       237 ~~~li~~cl~~~p~~Rp-----~~~~vl~  260 (267)
T cd08228         237 LRELVSMCIYPDPDQRP-----DIGYVHQ  260 (267)
T ss_pred             HHHHHHHHCCCCcccCc-----CHHHHHH
Confidence            99999999999999999     8888886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=323.44  Aligned_cols=252  Identities=31%  Similarity=0.576  Sum_probs=222.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|++|.||++.++.     .++.||+|.+...... ....+.+.+|++++++++|+||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE-----TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC-----CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            58899999999999999998875     6788999999776432 34556789999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999987654332


Q ss_pred             -CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hccccCCCCCcHHHHHHHHHh
Q 013558          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~  348 (441)
                       .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+. .....++..++..+.++|.+|
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence             234578999999999988888999999999999999999999998766544444433 344556778899999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCccc
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      |..+|++||     ++.++++|+||
T Consensus       235 l~~~p~~R~-----~~~~~l~~~~~  254 (254)
T cd06627         235 FQKDPNLRP-----TAKQLLKHPWI  254 (254)
T ss_pred             HhCChhhCc-----CHHHHhcCCCC
Confidence            999999999     88999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-42  Score=335.19  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=209.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      ++|++.++||+|+||.||+|..+...   ....+++|.++..  ......+.+.+|+.++.++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            57999999999999999999876511   2234788877532  1233345678899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      .+|+||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            9999999999999999997642                478899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-c
Q 013558          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-K  330 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~  330 (441)
                      .+||+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||......+....+... .
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999999875332212222233567999999998889999999999999999997 99999988888777777654 3


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+..++.++.+||.+||+.+|.+||     +++++++
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~i~~  270 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERP-----PFAQISV  270 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            345667899999999999999999999     7788865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-42  Score=331.70  Aligned_cols=252  Identities=27%  Similarity=0.494  Sum_probs=217.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|...+.||+|++|.||++.++.     +++.+++|++....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS-----TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC-----CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            46667899999999999999775     67889999886432   23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+|+||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... 
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            999999999999998877 679999999999999999999999999999999999999999999999999887643322 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC---CCCCcHHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLLK  346 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~  346 (441)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.......   +..++..+.+||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            2234568999999999998889999999999999999999999998887777776666543222   2347889999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||+.+|++||     ++.++++|+||+..
T Consensus       251 ~~l~~~p~~Rp-----t~~~il~~~~~~~~  275 (285)
T cd06648         251 RMLVRDPAQRA-----TAAELLNHPFLAKA  275 (285)
T ss_pred             HHcccChhhCc-----CHHHHccCcccccC
Confidence            99999999999     88999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-42  Score=334.72  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=211.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|++|+||++.++.     +++.||+|.+..... .....+.+.+|++++++++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV-----TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC-----CCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            579999999999999999999875     788999999865432 22334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~  266 (441)
                      .|+||||+++ +|..++.....  +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++....
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         76 LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9999999964 78777765443  578899999999999999999999999999999999985 5679999999997653


Q ss_pred             CCC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  330 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--------------  330 (441)
                      ... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+...++....              
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            322 2234567899999999876 457899999999999999999999998776655444432110              


Q ss_pred             -------cc--------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          331 -------VK--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       331 -------~~--------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                             ..        ..+.+++++.++|.+||+.+|++||     ++++++.||||++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-----TARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc-----CHHHHhcCchHhHHh
Confidence                   00        1235788999999999999999999     889999999998654

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-42  Score=332.64  Aligned_cols=250  Identities=26%  Similarity=0.495  Sum_probs=210.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.++||.|++|.||+|+++.     +++.||+|++.....  ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT-----TGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC-----CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence            58999999999999999999875     788999999876532  22335567899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ++||||+.+ +|.+++...   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999985 788877654   3589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC-CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------
Q 013558          268 SSR-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  330 (441)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---------------  330 (441)
                      ... .....++..|++||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            221 234567899999999866 457889999999999999999999998877665555443210               


Q ss_pred             ---cc-----------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 ---VK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ---~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                         ..           +.+.++.+++++|.+||+.||.+||     +++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI-----SAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence               00           1134578899999999999999999     88999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=328.11  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=215.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||+||+|.++...  .....||+|.+....  .......+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            467999999999999999999986421  135679999886543  2334456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999999998764 5789999999999999999999999999999999999999999999999999987642


Q ss_pred             CCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+... ....+..+++.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY  238 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            111   112334678999999998899999999999999999998 99999887777777776654 3345667899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +|+.+||+.+|++||     ++++++++
T Consensus       239 ~li~~cl~~~p~~Rp-----~~~ei~~~  261 (266)
T cd05033         239 QLMLDCWQKDRNERP-----TFSQIVST  261 (266)
T ss_pred             HHHHHHcCCCcccCc-----CHHHHHHH
Confidence            999999999999999     78888763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-42  Score=330.49  Aligned_cols=255  Identities=28%  Similarity=0.433  Sum_probs=212.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  187 (441)
                      ++|+..+.||.|++|.||+|.++.     +++.+|+|.+.....  ......+.+|++++++++||||++++++|..  .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            469999999999999999999875     788999999875432  2345668889999999999999999998865  3


Q ss_pred             CEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ..+|+||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            479999999999999887653    3468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhc-cccCC---
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLP---  334 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-----~~~~~~~~i~~~-~~~~p---  334 (441)
                      ...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...     ...+....+... ...++   
T Consensus       154 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         154 ELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             cccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            654322 23456889999999999999999999999999999999999999765     223444444331 11122   


Q ss_pred             ---CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          335 ---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       335 ---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                         ...++++.+||.+||..||.+||     ++.+++.|+||++..
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~eil~~~~~~~~~  273 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRP-----TPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCC-----CHHHHHhCccccccc
Confidence               12467899999999999999999     889999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-42  Score=331.33  Aligned_cols=256  Identities=22%  Similarity=0.385  Sum_probs=214.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||.||+|.++.......+..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            446799999999999999999998753322356789999876432  223335578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEE
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLT  257 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~  257 (441)
                      ...++||||+.|++|.+++...+       .+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999987654       489999999999999999999999999999999999998765   59999


Q ss_pred             ecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-ccc
Q 013558          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK  332 (441)
Q Consensus       258 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~  332 (441)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987632211   112233567999999998899999999999999999997 99999988877776665543 445


Q ss_pred             CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       333 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .|..++..+.+++.+||+.+|++||     +++++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rp-----s~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRP-----NFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence            6778899999999999999999999     88999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.9e-42  Score=324.44  Aligned_cols=252  Identities=32%  Similarity=0.590  Sum_probs=223.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||.|+||.||++.+..     ++..||+|++..... .....+.+.+|+++++.++|+|++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS-----DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC-----CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            58999999999999999999875     678999999876442 234456688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ++|+||+++++|.+++.+.    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            9999999999999998764    679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHH
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSL  344 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l  344 (441)
                      ... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+.... ..++..++.++.++
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            433 2344578999999999998889999999999999999999999998888777777766543 34566789999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      |.+||..+|++||     ++.+++.||||
T Consensus       235 i~~~l~~~p~~Rp-----~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERP-----SIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCc-----CHHHHhcCCCC
Confidence            9999999999999     88999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-42  Score=331.31  Aligned_cols=255  Identities=23%  Similarity=0.414  Sum_probs=215.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|.+.++||+|+||.||+|..........+..+|+|.+....   ....+.+.+|+++++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            3456899999999999999999986543333456789999876532   3345578899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG---------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      .+..++||||+++++|.+++...+               .+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999987653               47899999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~  327 (441)
                      +.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            9999999999976533211   122345788999999999999999999999999999998 999998877777666665


Q ss_pred             hc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .. ....+..+++.+.+||.+||+.||.+||     ++++|++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----~~~~l~~  276 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRM-----VIKDIHS  276 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            54 3455677899999999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-43  Score=334.67  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=217.3

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|++.++||+|+||.||++.+........++.||+|++....  .....+.+.+|+.++..++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            345688999999999999999988654333456789999987542  223446688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      ...++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999888532                347888999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~  327 (441)
                      +.+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999886533221   223456789999999988889999999999999999998 999999888888888877


Q ss_pred             hccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .... .++..++..+.+|+.+||+.+|.+||     ++++|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~i~~  278 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRP-----RFKDIHS  278 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            6543 45678999999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-42  Score=336.11  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=204.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.++||+|+||.||+|.++.     +++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            4579999999999999999999876     788999999865432 2222334567999999999999999999887643


Q ss_pred             --------EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          189 --------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       189 --------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                              ..++||||+.+ +|...+... ..+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                    46999999965 787777654 37899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC-----CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---
Q 013558          260 GLAKEIDESSR-----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---  330 (441)
Q Consensus       260 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---  330 (441)
                      |++........     .....++..|+|||++.+. .++.++||||||+++|||++|..||...+.......+....   
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99986533221     2234678899999998764 47889999999999999999999998776554333322110   


Q ss_pred             ----------------ccCC-------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 ----------------VKLP-------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ----------------~~~p-------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                      ..++             ...+..+.+||.+||..||.+||     +++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~-----t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI-----DADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc-----CHHHHhcCCCC
Confidence                            0111             11356788999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-42  Score=338.73  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=210.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|++.+.||+|+||+||+|++..... .....||+|++....  .....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            345689999999999999999998764211 123358999986432  23344568889999999999999999999876


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      . ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            4 578999999999999999875 46889999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCC---ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          266 DESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       266 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      ......   ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            543322   12234678999999999999999999999999999998 99999887766655444332 33445678899


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.++|.+||..||.+||     ++.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rp-----s~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRP-----KFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            99999999999999999     78888875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-42  Score=326.88  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=206.8

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (441)
                      +||+|+||.||++.++..   .++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK---KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC---CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            689999999999976432   256789999986543 23445567889999999999999999999875 4567999999


Q ss_pred             cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC----Cc
Q 013558          197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SN  272 (441)
Q Consensus       197 ~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~----~~  272 (441)
                      +++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++.+.....    ..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            99999999998888899999999999999999999999999999999999999999999999999987543321    12


Q ss_pred             cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhcc
Q 013558          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  350 (441)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  350 (441)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||...+..++...+..+ ....|..+++++.+||.+||+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2334678999999988889999999999999999998 99999988887777777654 345677899999999999999


Q ss_pred             cCcCCCCCCCCCChHHhhh
Q 013558          351 KDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       351 ~dP~~R~~~~~~~~~~i~~  369 (441)
                      .||++||     ++++|..
T Consensus       237 ~~p~~Rp-----~~~~i~~  250 (257)
T cd05116         237 YGVDERP-----GFAVVEL  250 (257)
T ss_pred             cCchhCc-----CHHHHHH
Confidence            9999999     6666643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-42  Score=330.73  Aligned_cols=252  Identities=26%  Similarity=0.508  Sum_probs=218.8

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++++.||.|+||.||++.++.     ++..||+|++.....  ......+.+|+.++++++||||+++++++..+...|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECC-----CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            7888999999999999998765     778999999865432  334567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-C
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-R  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  270 (441)
                      +||||+++++|..++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.... .
T Consensus        79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999999999988864 578999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                      .....|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+... ...++..++.++.++|.+||
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence            23457899999999998888899999999999999999999999877766666655433 23355678899999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          350 HKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +.+|.+||     ++.++++||||...
T Consensus       238 ~~~p~~Rp-----~~~~~l~~~~~~~~  259 (277)
T cd06641         238 NKEPSFRP-----TAKELLKHKFIVRF  259 (277)
T ss_pred             cCChhhCc-----CHHHHHhCHHHhhh
Confidence            99999999     88999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-42  Score=327.55  Aligned_cols=248  Identities=21%  Similarity=0.400  Sum_probs=211.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||+||+++++      .+..+|+|.+.....    ..+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEec------CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            3467999999999999999999875      334599998875432    124578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ..+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            9999999999999999998764 468999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHH
Q 013558          267 ESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAH  342 (441)
Q Consensus       267 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~  342 (441)
                      .....  ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.... ...+...+..++
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY  231 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            32211  12335678999999998889999999999999999998 999998887777777776543 334556789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +++.+||+.||.+||     ++.+|+.+
T Consensus       232 ~li~~cl~~~p~~Rp-----~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERP-----TFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCC-----CHHHHHHh
Confidence            999999999999999     88888763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-42  Score=333.66  Aligned_cols=259  Identities=22%  Similarity=0.422  Sum_probs=219.0

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ..+..++|++.+.||+|+||.||++..+..........+|+|.+....  .......+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            445667899999999999999999998764433355789999987542  223345678899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCcee
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  247 (441)
                      +...+.+++||||+.+|+|..++...                +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998642                45889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHH
Q 013558          248 MDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ  323 (441)
Q Consensus       248 l~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~  323 (441)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987543221   122335678999999999999999999999999999998 99999988877777


Q ss_pred             HHHHhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          324 QRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       324 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+.... ...+...+.++.+|+.+||..||++||     ++++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~eil~~  287 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-----TFKQLVED  287 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHH
Confidence            7665543 345667889999999999999999999     78888763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=349.22  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=221.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      |.+..++-.+.++||+|+||.||+++.+..... ....||+|..+......+.....+.+|+++|+.++|||||++||+.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344555666779999999999999998752211 1122899998865556677888899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .....+++|||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|||+++
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999999999987 49999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccc-cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc--cccCCCCCcH
Q 013558          264 EIDESSRSNSM-CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~  339 (441)
                      ........... .-...|+|||.+....|+.++|||||||++||+++ |..||.+....++..+|...  +...|...++
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            75422222212 24578999999999999999999999999999999 89999999999999999554  3456678889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++..++.+|+..||++|+     +..++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~-----tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRP-----TMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhcc-----CHHHHHH
Confidence            999999999999999999     6666654

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=326.44  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=212.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||.||++.+.      .++.||+|.++....    ..+.+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            45678999999999999999999865      346799999875432    23457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            999999999999999999997654  689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+.......+... ....+..+++.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE  232 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            6532211  11223457999999998899999999999999999999 99999988877777766544 33455678999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+++.+||+.+|++||     +++++.+
T Consensus       233 ~~~li~~~l~~~P~~Rp-----~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRP-----TFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCC-----CHHHHHH
Confidence            99999999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-42  Score=335.49  Aligned_cols=257  Identities=22%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+..++|.+.+.||+|+||.||+|++.+....  .....+|+|.+....  .......+..|+.+++.+ +||||+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            34456899999999999999999987643221  234579999987542  223345677899999999 7999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                      ++...+.+|+||||+.+|+|.+++....                .+++.++..++.||+.||+|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999997642                478899999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~  322 (441)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..++
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999999876543211   112234578999999999889999999999999999998 9999988887777


Q ss_pred             HHHHHhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+.... ...+..++.++.+||.+||..+|.+||     +++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~  294 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  294 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            77765553 356678899999999999999999999     7788876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.2e-42  Score=325.42  Aligned_cols=242  Identities=22%  Similarity=0.422  Sum_probs=205.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||+|+++.     +++.||+|.+....  .......+.+|+++++.++||||+++++++.....+|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA-----DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEec-----CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence            369999999999999875     78899999876432  23445668899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCc--
Q 013558          196 FINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--  272 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--  272 (441)
                      |+.+++|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........  
T Consensus        74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999999999987654 68999999999999999999999999999999999999999999999999987654322111  


Q ss_pred             -cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          273 -SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       273 -~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                       ...++..|+|||.+.+..++.++|||||||++|||++ |..||...........+... ....+..++..+.+|+.+||
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence             1123456999999998889999999999999999998 99999877766655555443 34566778999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhh
Q 013558          350 HKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+|++||     +++++++
T Consensus       234 ~~~p~~Rp-----s~~~~~~  248 (252)
T cd05084         234 EYDPGQRP-----SFSTVHQ  248 (252)
T ss_pred             CCChhhCc-----CHHHHHH
Confidence            99999999     7788764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-42  Score=335.96  Aligned_cols=252  Identities=25%  Similarity=0.481  Sum_probs=215.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+....||+|+||.||++.++.     +++.||+|++.....   ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH-----SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC-----CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            35566689999999999999875     678999999865432   2345678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+||||+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999999999887654 568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLLK  346 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~  346 (441)
                      .....+|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....   ...+..++..+.++|+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            2334678999999999998889999999999999999999999998777666665554332   2233467889999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||+.+|.+||     +++++++|+||...
T Consensus       253 ~~l~~~P~~Rp-----s~~~ll~~~~~~~~  277 (297)
T cd06659         253 RMLTREPQERA-----TAQELLDHPFLLQT  277 (297)
T ss_pred             HHhcCCcccCc-----CHHHHhhChhhccC
Confidence            99999999999     89999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-42  Score=341.99  Aligned_cols=255  Identities=24%  Similarity=0.440  Sum_probs=212.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      .+|++.+.||+|+||+||++++..     +++.||||.+..... .......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSE-----TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecC-----CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            479999999999999999999875     788999999875422 233345567899999999999999999988654  


Q ss_pred             ---CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                         ..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence               35899999996 68988988888999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC-CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------
Q 013558          265 IDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------  328 (441)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--------------  328 (441)
                      .... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.......+..              
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            6443 22344578999999999875 4688999999999999999999999987654332222210              


Q ss_pred             ---------c-----c---ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 ---------E-----K---VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ---------~-----~---~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                               .     .   ....+.+++++.+||++||+.||++||     +++++++||||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----s~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI-----TVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc-----CHHHHHcCcchhhh
Confidence                     0     0   011245789999999999999999999     89999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=352.03  Aligned_cols=243  Identities=37%  Similarity=0.622  Sum_probs=213.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      ...|++...+|.|+|+.|-.+.++.     +++.+++|++.+....       ..+|+.++... +||||+++++.+.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~-----t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP-----TDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc-----cccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCC
Confidence            5678888999999999999999886     8888999999876211       23466555555 799999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec-CCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl-~~~~~vkl~DFG~a~~~~  266 (441)
                      .+.|+|||++.|+.|.+.+...+.+. .++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999999999999999888877666 8888999999999999999999999999999999 699999999999998876


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      ..  ..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||..... .++..+|..+.+.  ..+|.++++||
T Consensus       468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl  543 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL  543 (612)
T ss_pred             hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence            54  4566789999999999999999999999999999999999999976444 4666666554433  88999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++||+.||.+|+     ++++++.|+||
T Consensus       544 ~~LL~~dP~~Rl-----~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRL-----GADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCc-----ChhhhccCcch
Confidence            999999999999     88999999999

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=330.33  Aligned_cols=254  Identities=28%  Similarity=0.552  Sum_probs=215.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~  187 (441)
                      .|++.+.||+|+||.||+|.+..     +++.||+|.+....  .....+.+.+|+.+++.+.   ||||+++++++...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP-----TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC-----CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            48889999999999999999875     78899999986542  2334556788999999996   99999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ...|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999999999988865 5789999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCC-CCcHHHHH
Q 013558          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPP-FLTSEAHS  343 (441)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~  343 (441)
                      .. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.... ..++. .++.++.+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence            32 2334578999999999875 457889999999999999999999998776555444332221 22333 37889999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +|.+||+.||++||     ++.+++.|+||+...
T Consensus       234 ~i~~~l~~~p~~R~-----~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERL-----SAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCc-----CHHHHhhChHhhccc
Confidence            99999999999999     889999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=326.99  Aligned_cols=246  Identities=22%  Similarity=0.430  Sum_probs=210.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..+|++.+.||+|+||.||+++++      .+..+|+|++.+...    ..+.+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            346899999999999999999875      445799999865432    1234677999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999999999999998764 5689999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHH
Q 013558          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (441)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  343 (441)
                      ....  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... ....+..++.++.+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT  232 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            2211  11223457999999999899999999999999999999 89999887777777666544 34566778999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||..+|++||     +++++++
T Consensus       233 li~~cl~~~p~~Rp-----t~~~~l~  253 (256)
T cd05059         233 IMYSCWHEKPEDRP-----AFKKLLS  253 (256)
T ss_pred             HHHHHhcCChhhCc-----CHHHHHH
Confidence            99999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-42  Score=341.99  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=211.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++.... ........+.+|+.+|++++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR-----SGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            579999999999999999999876     78899999987543 223345567789999999999999999998763   


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ...+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence             357899999995 589899887888999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCC-----CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Q 013558          266 DESSR-----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  329 (441)
Q Consensus       266 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------  329 (441)
                      .....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     234578999999999865 46889999999999999999999999876544332222110          


Q ss_pred             ----------------ccc-----CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 ----------------KVK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 ----------------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                      ...     +.+.+++++.++|.+||+.+|++||     ++++++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~~~~~  300 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-----TVEQALQHPFLAQY  300 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc-----CHHHHHhChhhhhc
Confidence                            001     1134689999999999999999999     88999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=324.99  Aligned_cols=246  Identities=26%  Similarity=0.451  Sum_probs=215.6

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||+|......  ..+..||+|++.......  ..+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999987411  237889999987654322  46778899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          196 FINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       196 ~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      |+++++|.+++...         ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875         779999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       267 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      ...   ......++..|+|||.+....++.++|||||||++|+|++ |..||......++.+.+... ....+..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL  236 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence            432   2334567889999999998889999999999999999999 69999988888887777643 445677889999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .++|.+||+.||++||     ++++++++
T Consensus       237 ~~li~~~l~~~p~~Rp-----s~~~l~~~  260 (262)
T cd00192         237 YELMLSCWQLDPEDRP-----TFSELVER  260 (262)
T ss_pred             HHHHHHHccCCcccCc-----CHHHHHHh
Confidence            9999999999999999     88998864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.4e-42  Score=333.60  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=215.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ..+..++|++.+.||+|+||.||++.+........+..+|+|+++...  .....+.+.+|+.+++++ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            345556899999999999999999987543333456789999987542  233456788999999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +...+.+|+||||+.+|+|.+++....  .+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999987643  389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc--ccCCC
Q 013558          262 AKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK--VKLPP  335 (441)
Q Consensus       262 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~--~~~p~  335 (441)
                      ++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||......+.........  ...+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            986543221   122346788999999999999999999999999999998 999998776655544444332  23455


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..++++.+|+.+||.++|++||     ++++++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rp-----t~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRP-----TFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            6889999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-43  Score=361.00  Aligned_cols=256  Identities=25%  Similarity=0.439  Sum_probs=224.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+...+.+..+.||+|+||+||+++.-+.........||||.++...  +......|++|+++|..++|||||+|+|+|.
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            35566788899999999999999998877656677899999997653  3446678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (441)
                      .++.+|+|+|||..|||.++|....              +++..+...|+.||+.||+||-++.+|||||-++|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            9999999999999999999997542              27888999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCCCCCCc---cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESSRSN---SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~  327 (441)
                      ..|||+|||+++.+-......   ...-...|||||.+..+.++.++|||||||+|||+++ |+.||.+...++..+.|.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999999753322111   2223578999999999999999999999999999999 999999999999999998


Q ss_pred             hccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          328 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       328 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      .+++ ..|+..+.++.+|+..||+.+|.+||     ++.||-
T Consensus       720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP-----sF~eI~  756 (774)
T KOG1026|consen  720 AGQLLSCPENCPTEVYSLMLECWNENPKRRP-----SFKEIH  756 (774)
T ss_pred             cCCcccCCCCCCHHHHHHHHHHhhcCcccCC-----CHHHHH
Confidence            8765 56789999999999999999999999     566663

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-42  Score=339.66  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=211.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||.||++.+..     ++..||||++.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECC-----CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            5679999999999999999999875     78899999986532 22333456778999999999999999999987654


Q ss_pred             ------EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                            .+++||||+ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                  469999999 778877775 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------  331 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~----------  331 (441)
                      ......  .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.....          
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            865432  334578999999999876 4578899999999999999999999987765544443322110          


Q ss_pred             ---------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 ---------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                           .+.+.++.++.++|.+||+.||++||     ++.+++.||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI-----TAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC-----CHHHHhcCccHhhh
Confidence                                 11245788899999999999999999     88999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=339.85  Aligned_cols=253  Identities=26%  Similarity=0.456  Sum_probs=206.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++.++||+|+||.||++.++.     +++.||+|++....  .......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKP-----TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcC-----CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            589999999999999999999875     78899999986422  223345577899999999999999999887644  


Q ss_pred             ---CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                         ..+|+|+||+.+ +|...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        78 ~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          78 ESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             cccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence               358999999965 7877664 45799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC----CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------
Q 013558          265 IDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------  328 (441)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~-----------  328 (441)
                      ......    .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            533221    233578999999998764 5688999999999999999999999987654333222211           


Q ss_pred             ----cc-----------cc-----CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 ----EK-----------VK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ----~~-----------~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                          ..           ..     ..+.++.++.+||.+||+.||++||     ++.+++.||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~e~l~hp~~~~~  298 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI-----TVEEALAHPYLEQY  298 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-----CHHHHhcCcccccc
Confidence                00           00     1134678899999999999999999     88999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.1e-42  Score=331.41  Aligned_cols=255  Identities=23%  Similarity=0.379  Sum_probs=213.7

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCC-----------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  176 (441)
                      ..++|+++++||+|+||.||+|.......           ...+..||+|.+.....  ....+.+.+|++++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            45689999999999999999998765221           11346789999876532  345567889999999999999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      |+++++++..++..++||||+.+++|..++.+..           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999998765           68999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc--CCCCCCCCCHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ  320 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--G~~pf~~~~~~  320 (441)
                      |+++.++.++|+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998653322   1233456788999999998889999999999999999998  78899877766


Q ss_pred             HHHHHHHhc--------cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          321 KLQQRIINE--------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       321 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +....+...        ....+..++.++.+||.+||+.||.+||     ++.+|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP-----TFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC-----CHHHHHH
Confidence            665555432        1223456789999999999999999999     7888854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=329.79  Aligned_cols=250  Identities=29%  Similarity=0.485  Sum_probs=210.0

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++.+.||.|++|.||++.++.     ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL-----TGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC-----CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6788999999999999999875     788999999876432 2233355778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          192 LILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +||||++ ++|..++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999995 58988887765  78999999999999999999999999999999999999999999999999997654322


Q ss_pred             C-CccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 013558          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  330 (441)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------------  330 (441)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+......++....                 
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            2 2334578899999988764 57889999999999999999999998776654443332210                 


Q ss_pred             ------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 ------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                  ....+.++.++.++|.+||+.||.+||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI-----SAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHhcCCCC
Confidence                        011245778999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=323.14  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=213.9

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||.|+||.||++..       .++.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~-------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY-------RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ   71 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe-------cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence            4456899999999999999999976       457899999875432    45678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....|+||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            999999999999999999998765  699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ......  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..++...+... ....+..+++++.
T Consensus       152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05039         152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY  229 (256)
T ss_pred             cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHH
Confidence            643222  3345678999999988889999999999999999997 99999888877776666544 3445667899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++|.+||..+|++||     ++++++.
T Consensus       230 ~li~~~l~~~p~~Rp-----~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRP-----TFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCc-----CHHHHHH
Confidence            999999999999999     7788775

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=340.57  Aligned_cols=255  Identities=28%  Similarity=0.441  Sum_probs=218.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  188 (441)
                      +|++.+.||.|+||.||+|++..     +++.||+|++.+.. ......+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR-----TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC-----CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58999999999999999999875     68899999987542 22344567888999999999999999999988775  


Q ss_pred             ---EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                         .+|+||||+.+ +|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          75 DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence               89999999974 89888888789999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC----CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------
Q 013558          266 DESS----RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------  331 (441)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---------  331 (441)
                      ....    ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+.....         
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            5432    23445689999999999887 789999999999999999999999998877666555543110         


Q ss_pred             ----------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          332 ----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       332 ----------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                            ...+.++.++.+||.+||+.+|++||     ++++++.||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~~  296 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-----TADEALAHPYLAQLH  296 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC-----CHHHHHhCccHHhhc
Confidence                                  01234678999999999999999999     899999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-42  Score=333.48  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=215.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||++....     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.....
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA-----TGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC-----CCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            579999999999999999998765     67789999986432   2234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999999999998865 458899999999999999999999999999999999999999999999999887654322


Q ss_pred             -CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccc--cCCCCCcHHHHHHH
Q 013558          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-EKV--KLPPFLTSEAHSLL  345 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~-~~~--~~p~~~s~~~~~li  345 (441)
                       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ...  ..+..++..+++||
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence             22345689999999999988899999999999999999999999987665443333322 122  22345788999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ++||+.+|++||     ++++++.|+||+...
T Consensus       250 ~~~l~~~p~~Rp-----~~~~il~h~~~~~~~  276 (293)
T cd06647         250 NRCLEMDVEKRG-----SAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHccCChhhCc-----CHHHHhcCHHHhcCc
Confidence            999999999999     889999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-42  Score=329.75  Aligned_cols=252  Identities=22%  Similarity=0.392  Sum_probs=212.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|+||.||+|.............+|+|.+....  .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            488899999999999999987654433345679999886543  223346688899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          191 YLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                      ++||||+.+++|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478889999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~  322 (441)
                      |+++++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|||++ |..||.+....++
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999986532211   223456778999999998889999999999999999998 9999998888777


Q ss_pred             HHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+.+... ....+..++.++.+||.+||+.+|++||     +++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-----~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP-----TFADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC-----CHHHHHH
Confidence            7666543 3345667899999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.7e-42  Score=328.52  Aligned_cols=258  Identities=28%  Similarity=0.497  Sum_probs=222.7

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..+.|++.+.||+|+||.||++.+..     .+..|++|++.....    ..+.+.+|+++++.++|+||+++++.+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA-----TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34569999999999999999999875     678899999976432    345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999999998876 89999999999999999999999999999999999999999999999999887643


Q ss_pred             CCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cC--CCCCcHHHH
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL--PPFLTSEAH  342 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~--p~~~s~~~~  342 (441)
                      ... ......++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... ..  +..++.+++
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence            321 22345688999999999988899999999999999999999999988776655555543322 22  234789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      +||.+||+.+|.+||     ++.+++.|+||+...|.
T Consensus       248 ~li~~~l~~~p~~Rp-----t~~~il~~~~~~~~~~~  279 (286)
T cd06614         248 DFLNKCLVKDPEKRP-----SAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHhccChhhCc-----CHHHHhhChHhhccCch
Confidence            999999999999999     88999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.5e-42  Score=326.71  Aligned_cols=250  Identities=27%  Similarity=0.465  Sum_probs=211.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+++++.     +++.||||.+.............+.+|+.+++.++|+||+++++++..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC-----CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            479999999999999999999875     778999998876554455556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .++||||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999999988864    356899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhccc-cCC-CCCcHH
Q 013558          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRIINEKV-KLP-PFLTSE  340 (441)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~--~~~~~~i~~~~~-~~p-~~~s~~  340 (441)
                      ..... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....  ......+..... ..+ ..++++
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            43222 2345789999999999988899999999999999999999999975433  333444433221 122 357899


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++|.+||+.||++||     ++++|++
T Consensus       237 ~~~li~~~l~~~p~~Rp-----t~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRP-----DITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCC-----CHHHHHH
Confidence            99999999999999999     7776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-43  Score=342.43  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=198.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +++|.-..+||+|+||.||++...      .+..||||.+.......   ...+.+|+.+|.+++|||||+|+|+|.+.+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~------~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~  144 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLS------DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGG  144 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEEC------CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence            367888899999999999999875      44889999776543221   344999999999999999999999999998


Q ss_pred             -EEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 -KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 -~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                       ..+||+|||++|+|.++|+...  .++|.+...|+.++++||+|||...   |||||||++|||||+++++||+|||+|
T Consensus       145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa  224 (361)
T KOG1187|consen  145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA  224 (361)
T ss_pred             ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence             5999999999999999998775  8999999999999999999999753   999999999999999999999999999


Q ss_pred             cccCC-CCCCccc-cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hc----
Q 013558          263 KEIDE-SSRSNSM-CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------RQKLQQRII-NE----  329 (441)
Q Consensus       263 ~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~------~~~~~~~i~-~~----  329 (441)
                      +.... ....... .||.+|+|||++..+..+.++|||||||+|+||++|+.+.+...      ..+...... ..    
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e  304 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE  304 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence            77654 3333333 89999999999999999999999999999999999998887432      111111111 11    


Q ss_pred             --cccCC-CCCc-----HHHHHHHHHhcccCcCCCCCCCCCChHHh
Q 013558          330 --KVKLP-PFLT-----SEAHSLLKGLLHKDPSKRLGSGPGGVDAI  367 (441)
Q Consensus       330 --~~~~p-~~~s-----~~~~~li~~~L~~dP~~R~~~~~~~~~~i  367 (441)
                        ...+. ....     ..+..+..+|++.+|.+||     +..++
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP-----~m~~V  345 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP-----TMSQV  345 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc-----CHHHH
Confidence              11111 1222     2356788899999999999     55665

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-42  Score=345.11  Aligned_cols=258  Identities=23%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  183 (441)
                      +.+..++|.+.++||+|+||.||+|++++......+..||+|++....  .....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            455566899999999999999999998754333456789999997542  2233456888999999997 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC-----------------------------------------------------
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------  210 (441)
                      +...+.+++||||+.+|+|.+++++.+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986532                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          211 ---------------------------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       211 ---------------------------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                                                                   .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999998653221   1223457889999999998889999999999999999998 899998755544


Q ss_pred             HHHHHHhc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ........  ....|..++.++.+||.+||+.+|.+||     ++++|++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~  394 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP-----DFSQLVH  394 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            44333332  3445677899999999999999999999     7788876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.9e-42  Score=321.73  Aligned_cols=251  Identities=27%  Similarity=0.520  Sum_probs=221.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.++||+|+||.||+++++.     +++.+|+|.+...... ......+.+|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS-----DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC-----CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            58999999999999999998875     7789999998765432 33445677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      |+||||+++++|..++.+    ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            999999999999988866    3568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  345 (441)
                      .. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... ..+..++.+++++|
T Consensus       155 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08530         155 KN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI  233 (256)
T ss_pred             cC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence            54 33345689999999999998899999999999999999999999998888777777665543 35567889999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .+||+.+|++||     ++.++++||+.
T Consensus       234 ~~~l~~~p~~Rp-----~~~~~l~~p~~  256 (256)
T cd08530         234 RSMLQVKPKLRP-----NCDKILASPAV  256 (256)
T ss_pred             HHHcCCCcccCC-----CHHHHhcCCCC
Confidence            999999999999     88999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-41  Score=318.45  Aligned_cols=249  Identities=33%  Similarity=0.567  Sum_probs=216.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|++.+.||+|++|.||++.++.     +++.+++|++.....   ...+.+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR-----TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC-----CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            58899999999999999999875     678899999876432   3456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      ++++||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999999998776 689999999999999999999999999999999999999999999999999998765543


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCC--CCcHHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPP--FLTSEAHSLLK  346 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~li~  346 (441)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....+.  .++..+.++|.
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence            345567899999999999888999999999999999999999999877554444333322 222332  34889999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKW  372 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~  372 (441)
                      +||+.||++||     ++.+++.|||
T Consensus       233 ~~l~~~p~~R~-----t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRP-----TAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCC-----CHHHHhcCCC
Confidence            99999999999     8899999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.2e-42  Score=332.68  Aligned_cols=257  Identities=22%  Similarity=0.393  Sum_probs=215.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+..++|.+.++||+|+||.||+|+..+...  ......+|+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3445689999999999999999998754321  1245679999987532  233455688899999999 6999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                      ++...+.+|+||||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999763                2478899999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~  322 (441)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999986543211   112234567999999999899999999999999999999 9999998888887


Q ss_pred             HHHHHhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+.... ...+..++.++++||.+||..||++||     ++++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~  288 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP-----TFKQLVE  288 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            77776543 355677889999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-42  Score=327.62  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=210.8

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEeCC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRS  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~  188 (441)
                      |++.+.||+|+||.||+++++.     +++.||+|++..... .......+.+|+.+++++   +|+||+++++++....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN-----TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC-----CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            7889999999999999999875     688999999975432 222234466788877766   5999999999998877


Q ss_pred             E-----EEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          189 K-----LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      .     ++++|||+.+ +|.+++.+..  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            6     9999999975 7888887643  589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----c----
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----K----  332 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----~----  332 (441)
                      +.............++..|+|||++.+..++.++|||||||++|+|++|.+||......+...++.....     .    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            9887554444455688999999999998899999999999999999999999998877776666643110     0    


Q ss_pred             -------C-----------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          333 -------L-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       333 -------~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                             +           .+.+++.+.+||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI-----SAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC-----CHHHHhcCcCC
Confidence                   0           113567889999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=325.75  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=210.0

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE--
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK--  189 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--  189 (441)
                      |++.+.||+|+||.||+|..+..  ...+..||+|.+..... .....+.+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD--DGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC--CCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            57889999999999999987641  12457899999875432 23445678899999999999999999998866544  


Q ss_pred             ----EEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          190 ----LYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       190 ----~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                          .++||||+++|+|..++...      ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                89999999999998888543      35899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCC
Q 013558          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  334 (441)
Q Consensus       260 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p  334 (441)
                      |+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ....|
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987543221   112335678999999988899999999999999999999 99999888877777776654 44567


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..++.++.++|.+||+.||++||     ++.++++
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp-----~~~e~~~  267 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRP-----TFTKLRE  267 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            78999999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.7e-42  Score=326.56  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=210.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|+++++||+|+||+||+|++..... .....||+|++....  .......+.+|+.+++.++|+||+++++++..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            345689999999999999999998764211 012358999986542  23344568889999999999999999998875


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ...++++||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             4578999999999999998764 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCC---ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          266 DESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       266 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      ......   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            433221   12234678999999998899999999999999999998 99999877766666655443 34455678999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.++|.+||+.||++||     ++.+++.
T Consensus       240 ~~~li~~~l~~dp~~Rp-----~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRP-----RFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.3e-42  Score=323.89  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=207.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||.||+|++..      ...||+|++.+...    ..+.+.+|+++++.++||||+++++.+. 
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-   71 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence            445689999999999999999998753      34599999875332    1245788999999999999999998875 


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence            45689999999999999999764  3589999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCC--ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      +......  ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+... ....+..+++.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  231 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence            6433221  23346678999999998889999999999999999999 89999888777776666543 23445678999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+||.+||++||++||     ++++++.
T Consensus       232 l~~li~~~l~~~p~~Rp-----~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERP-----TFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCC-----CHHHHHH
Confidence            99999999999999999     6677654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4e-42  Score=339.10  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=210.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .+..++|++.++||+|+||+||+|.+.+..+..+++.||||+++...  .......+.+|+.+|.++ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            45567899999999999999999997765555578899999987543  233445678899999999 689999999987


Q ss_pred             Ee-CCEEEEEEeccCCCchHHHHHHc------------------------------------------------------
Q 013558          185 QT-RSKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (441)
Q Consensus       185 ~~-~~~~~lv~E~~~gg~L~~~l~~~------------------------------------------------------  209 (441)
                      .. +..+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            65 45689999999999999988643                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC---CCcc
Q 013558          210 -------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNS  273 (441)
Q Consensus       210 -------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~  273 (441)
                                   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         136778888999999999999999999999999999999999999999999997653221   1122


Q ss_pred             ccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHhc-cccCCCCCcHHHHHHHHHhcc
Q 013558          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ-KLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  350 (441)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  350 (441)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+..+ ....|..+++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            345678999999999999999999999999999997 99999765433 233333222 344566788999999999999


Q ss_pred             cCcCCCCCCCCCChHHhhhC
Q 013558          351 KDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       351 ~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .||++||     ++.+|++|
T Consensus       321 ~~p~~Rp-----s~~eil~~  335 (343)
T cd05103         321 GEPSQRP-----TFSELVEH  335 (343)
T ss_pred             CChhhCc-----CHHHHHHH
Confidence            9999999     88999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.2e-42  Score=326.18  Aligned_cols=256  Identities=23%  Similarity=0.409  Sum_probs=218.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||.||+|+.+...+....+.+++|.+....  .....+.+.+|++++++++|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            346899999999999999999998765444466789999886532  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG---------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      ...|+||||+++|+|.+++....         .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999998765         689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcccc--C
Q 013558          259 FGLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--L  333 (441)
Q Consensus       259 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~~--~  333 (441)
                      ||++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+......  .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            99987542211  1233456778999999988888999999999999999998 89999877777777777655433  3


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +..++..+.++|.+||+.||++||     ++.+++..
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp-----~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRP-----SFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHHH
Confidence            567889999999999999999999     78888763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.8e-41  Score=330.17  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |...++||+|+||+||+|++..     +++.|++|++.............+.+|+.+++.++||||+++++++.+....|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH-----TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC-----CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            7777889999999999999865     78899999987654444455567888999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      +||||+.+ +|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....   
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99999965 67666654 45789999999999999999999999999999999999999999999999999865322   


Q ss_pred             CccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cC-CCCCcHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSLL  345 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li  345 (441)
                      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+..... .. ...++..+++||
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            33567899999999984   35678899999999999999999999988776655555543322 22 235678899999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      .+||+++|.+||     ++.++++||||+..+-.
T Consensus       254 ~~~l~~~P~~Rp-----~~~~~l~~~~~~~~~~~  282 (313)
T cd06633         254 DYCLQKIPQERP-----ASAELLRHDFVRRDRPA  282 (313)
T ss_pred             HHHccCChhhCc-----CHHHHhcCcccCCCchh
Confidence            999999999999     88999999999876533

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-42  Score=339.25  Aligned_cols=250  Identities=21%  Similarity=0.340  Sum_probs=203.4

Q ss_pred             eeEccc--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013558          116 RVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       116 ~~lG~G--~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      ..||+|  +||+||+|+++.     +++.||+|++...... ....+.+.+|+.+++.++||||++++++|..++.+|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP-----TGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC-----CCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356666  999999999875     7899999998764322 34457888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC-
Q 013558          194 LDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-  270 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-  270 (441)
                      |||+.+++|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+........ 
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999999988765  3589999999999999999999999999999999999999999999999986543211110 


Q ss_pred             -------CccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------
Q 013558          271 -------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------  331 (441)
Q Consensus       271 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~----------  331 (441)
                             .....++..|+|||++.+  ..++.++|||||||++|+|++|..||...........+.....          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence                   111234667999999976  3478999999999999999999999987655444333322111          


Q ss_pred             -------------------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          332 -------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       332 -------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                                                           ..+..++.++.+||++||+.||++||     +++++++|+||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----ta~e~l~~~~~~  312 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP-----SASSLLSHAFFK  312 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC-----CHHHHhhCHHHH
Confidence                                                 01123567899999999999999999     899999999997


Q ss_pred             CC
Q 013558          375 SI  376 (441)
Q Consensus       375 ~~  376 (441)
                      ++
T Consensus       313 ~~  314 (328)
T cd08226         313 QV  314 (328)
T ss_pred             HH
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-42  Score=333.80  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=205.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  188 (441)
                      +|++.++||+|+||.||+|.++..   ..++.||+|.+...........+.+.+|+.+++.++||||+++++++...  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            489999999999999999998641   25789999999875433334445677899999999999999999999988  8


Q ss_pred             EEEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC----CCcEEEEec
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMLTDF  259 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~----~~~vkl~DF  259 (441)
                      .+|+||||+.+ +|...+...     ..+++..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+||
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            89999999975 666655432     36899999999999999999999999999999999999999    999999999


Q ss_pred             CCccccCCCCC----CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH---------HHHH
Q 013558          260 GLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---------LQQR  325 (441)
Q Consensus       260 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~---------~~~~  325 (441)
                      |++..+.....    ....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+...         ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987543222    234578999999998876 457899999999999999999999997544321         1111


Q ss_pred             HHh--------------------------ccccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          326 IIN--------------------------EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       326 i~~--------------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      +..                          ....++           ...+.++.++|.+||+.||++||     ++++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~eil  311 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI-----TAEEAL  311 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc-----CHHHHh
Confidence            100                          001111           14677899999999999999999     899999


Q ss_pred             hCccc
Q 013558          369 HHKWF  373 (441)
Q Consensus       369 ~h~~f  373 (441)
                      .||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-41  Score=321.64  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=213.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+|..+.     +++.||+|.++..........+.+.+|++++++++|+||+++++++...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC-----CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            579999999999999999999875     788999999876554455556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .++||||+++++|..++..    ...+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999999999988864    245899999999999999999999999999999999999999999999999998865


Q ss_pred             CCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcc-ccCCC-CCcHH
Q 013558          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEK-VKLPP-FLTSE  340 (441)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~--~~~~~~~i~~~~-~~~p~-~~s~~  340 (441)
                      .... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....  ..+....+.... ...|. .++.+
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            4322 2334578999999999998889999999999999999999999996543  334444444332 23343 67889


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.++|.+||..+|++||     ++.+|++
T Consensus       237 ~~~~i~~cl~~~p~~Rp-----~~~~il~  260 (267)
T cd08224         237 LRDLVSRCINPDPEKRP-----DISYVLQ  260 (267)
T ss_pred             HHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            99999999999999999     7777764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=380.35  Aligned_cols=254  Identities=31%  Similarity=0.535  Sum_probs=223.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +++-...||.|.||.||-|....     +|...|+|.++..... ......+.+|..+|..++|||+|++||+-...+.+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~-----tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-----TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCC-----ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            45667789999999999998775     8999999999776544 44566788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      +|.||||+||+|.+.+...+..+|...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+.... 
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999999999888888999999999999999999999999999999999999999999999999998875442 


Q ss_pred             ----CCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHH-hccccCCCCCcHH
Q 013558          270 ----RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRII-NEKVKLPPFLTSE  340 (441)
Q Consensus       270 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~-~~~~~~p~~~s~~  340 (441)
                          ......||+.|||||++.+   ++...+.||||||||+.||+||+.||...+ ...++..+- ...+.+|..++.+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence                1235689999999999985   557789999999999999999999998643 334444443 4577899999999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .++||..||+.||++|.     ++.||+.|.|=+.
T Consensus      1470 g~dFle~Cl~~dP~~Rw-----~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRW-----TASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHHhcCchhhh-----HHHHHHHhhcccc
Confidence            99999999999999999     8889999998654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.7e-42  Score=323.39  Aligned_cols=247  Identities=23%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||.||+|...      .+..+|+|.+.....    ..+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-   71 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence            45568999999999999999999865      455699999876432    1245788999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....|+||||+.+++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence            45689999999999999998764  4589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      +.....  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+... ....+...+..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS  231 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            543221  122335668999999988889999999999999999999 99999888877777776543 44566778999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+||.+||.++|++||     +++++..
T Consensus       232 ~~~li~~~l~~~p~~Rp-----t~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERP-----TFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCc-----CHHHHHH
Confidence            99999999999999999     6677653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.2e-42  Score=327.89  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=215.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||.||+|++++...+.++..||+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            446899999999999999999998754444467889999987542  223345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      ...++||||+++|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999987532                      36788899999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876432211   222344677999999998899999999999999999998 889998888888


Q ss_pred             HHHHHHhccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ....+..... ..+..++.++.+||.+||+.||.+||     +++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP-----SFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            7777765543 34667889999999999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.7e-42  Score=337.37  Aligned_cols=252  Identities=27%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++.+.||.|+||.||+|.++.     +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~-----~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC-----CCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            689999999999999999999875     78899999986543   23456678899999999999999998776543  


Q ss_pred             ------------CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcE
Q 013558          188 ------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHV  254 (441)
Q Consensus       188 ------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~v  254 (441)
                                  ..+|+||||+. ++|...+. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                        36899999997 48877775 45789999999999999999999999999999999999997 45678


Q ss_pred             EEEecCCccccCCCCC----CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Q 013558          255 MLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       255 kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~  329 (441)
                      ||+|||+++.+.....    .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986533211    123467889999998754 56888999999999999999999999877655444443221


Q ss_pred             c-------------------------c-----cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 K-------------------------V-----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 ~-------------------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .                         .     .+.+.++.++.+||.+||+.||.+||     ++++++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL-----TAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc-----CHHHHhCCCccccc
Confidence            0                         0     01235788999999999999999999     88999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-41  Score=322.31  Aligned_cols=248  Identities=21%  Similarity=0.389  Sum_probs=210.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|+++++||+|+||.||+|..+      .++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT   71 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence            345678999999999999999999865      467799999875432    2346778999999999999999998864


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                       .+.+|+||||+.+++|.+++...  ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence             56799999999999999988754  368999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      .......  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+... ....+..++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE  230 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCH
Confidence            7652221  123346778999999998889999999999999999999 99999988777776666543 3345667889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.++|.+||+.+|++||     ++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERP-----TFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=321.47  Aligned_cols=244  Identities=25%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-  185 (441)
                      +...+|++.+.||+|+||.||++..       .+..+|+|.+....     ..+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~-------~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY-------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE-------cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            4556899999999999999999976       35679999886432     2356788999999999999999998754 


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .....|+||||+++++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence            5567999999999999999987654  48899999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      ......  ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+ ....++.+++.+
T Consensus       151 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05082         151 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV  228 (256)
T ss_pred             eccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            654322  23445678999999998889999999999999999997 99999888877777766544 334566789999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++|.+||+.+|++||     +++++++
T Consensus       229 ~~li~~~l~~~p~~Rp-----t~~~l~~  251 (256)
T cd05082         229 YDVMKQCWHLDAATRP-----SFLQLRE  251 (256)
T ss_pred             HHHHHHHhcCChhhCc-----CHHHHHH
Confidence            9999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=326.53  Aligned_cols=250  Identities=29%  Similarity=0.520  Sum_probs=211.3

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK  189 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~  189 (441)
                      |++.+.||.|+||.||+|.++.     +++.+|+|.+.... ........+.+|+.+++.++|+||+++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK-----TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC-----CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            7889999999999999999875     67899999998754 2334445677899999999999999999999988  89


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .++||||+++ +|..++... ..+++..++.++.||+.||.|||++|++|+||||+||++++++.+||+|||++......
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999999975 888887665 57999999999999999999999999999999999999999999999999999876543


Q ss_pred             C--CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------------
Q 013558          269 S--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (441)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------------  331 (441)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....              
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            2  1234467889999998765 4578999999999999999999999988776655555432100              


Q ss_pred             -----------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 -----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 -----------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                       .+...+++++.++|++||..+|.+||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-----SADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc-----CHHHHhhCcCC
Confidence                             00111388999999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.6e-42  Score=325.51  Aligned_cols=247  Identities=25%  Similarity=0.396  Sum_probs=213.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..+|++.++||.|+||.||+|.++      .+..+|+|++....   ....+.+..|+.+++.++|+||+++++++....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~------~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK------NRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec------CCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            457999999999999999999986      46779999987643   223446788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999999999764  468999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHH
Q 013558          267 ESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (441)
Q Consensus       267 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  343 (441)
                      .... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ....+..+++++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK  235 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence            3221 223345678999999998889999999999999999998 89999888877777776644 34556788999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +|.+||+.||.+||     ++++|.+
T Consensus       236 ~i~~~l~~~p~~Rp-----t~~~l~~  256 (261)
T cd05148         236 IMLECWAAEPEDRP-----SFKALRE  256 (261)
T ss_pred             HHHHHcCCCchhCc-----CHHHHHH
Confidence            99999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-41  Score=329.79  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+..+.||+|+||.||++++..     ++..+|+|++.............+.+|+++++.++|||++++++++.++...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            48888999999999999999875     7789999998765444444556788899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      |+||||+.| +|.+.+.. ...+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....  
T Consensus       101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            999999975 67666654 46789999999999999999999999999999999999999999999999999875433  


Q ss_pred             CCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cC-CCCCcHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSL  344 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~l  344 (441)
                       .....|+..|+|||++.   ...++.++|||||||++|||++|+.||...+.......+..... .. +..+++.+++|
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  256 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  256 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence             33457899999999974   45688899999999999999999999988776666666654432 22 24578899999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |.+||+.+|.+||     ++.++++|+|+..
T Consensus       257 i~~~l~~~p~~Rp-----t~~~il~~~~~~~  282 (317)
T cd06635         257 VDSCLQKIPQDRP-----TSEELLKHMFVLR  282 (317)
T ss_pred             HHHHccCCcccCc-----CHHHHHhChhhhc
Confidence            9999999999999     8899999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-42  Score=325.66  Aligned_cols=249  Identities=32%  Similarity=0.531  Sum_probs=208.4

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  192 (441)
                      ++.+.||.|.||.||+|.++. .....+..|+||.+...  ......+.+.+|++++++++||||+++++++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccc
Confidence            467899999999999999984 22336788999999542  233446778899999999999999999999998888999


Q ss_pred             EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          193 ILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999887  6799999999999999999999999999999999999999999999999999987632211


Q ss_pred             ---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHH
Q 013558          271 ---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLL  345 (441)
Q Consensus       271 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  345 (441)
                         .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+.... ...+..++..+.++|
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence               223456788999999998889999999999999999999 789999888888888875543 456678999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhh
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+||..||++||     ++++|++
T Consensus       239 ~~C~~~~p~~RP-----s~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRP-----SFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS-------HHHHHH
T ss_pred             HHHcCCChhhCc-----CHHHHHh
Confidence            999999999999     7888864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.6e-42  Score=324.93  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR----  187 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----  187 (441)
                      |.+.++||+|+||.||++++....   ....+|+|.++... ......+.+.+|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            346789999999999999876411   12368999886543 2344456788899999999999999999976432    


Q ss_pred             --CEEEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                        ...++||||+.+|+|..++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence              3578999999999998877422      34889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCC
Q 013558          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLP  334 (441)
Q Consensus       260 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p  334 (441)
                      |+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......++...+.... ...+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP  236 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987543221   122346778999999999999999999999999999999 899998887777777776543 3556


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..++..+.++|.+||+.||++||     ++++|++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp-----s~~~l~~  266 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRP-----SFETLRC  266 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            77889999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-41  Score=329.53  Aligned_cols=258  Identities=21%  Similarity=0.393  Sum_probs=216.4

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCC--CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+..++|.+.+.||+|+||.||+|++....  ....+..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            3455678999999999999999999865322  11245679999986532  233456688999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +++......|+||||+.+|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997642                46778899999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987643221   223345678999999998889999999999999999998 899999888888


Q ss_pred             HHHHHHhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +...+.... ...+..++.++++||.+||..+|.+||     ++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~l~  291 (304)
T cd05101         248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP-----TFKQLVE  291 (304)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence            877776543 345667889999999999999999999     7788876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-41  Score=322.76  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=211.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|+++...  .....+|+|.+....  .....+.+.+|+.++++++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            457999999999999999999876421  134579999886532  2334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999999775 4689999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCC----ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          268 SSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       268 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      ....    ....++..|+|||.+.+..++.++|+|||||++||+++ |..||...+..+....+... ....+..+++.+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence            2211    11223568999999998889999999999999999887 99999887777766666554 233445678999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++.+||+++|.+||     ++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp-----~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERP-----KFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCC-----CHHHHHH
Confidence            9999999999999999     6777764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.1e-42  Score=321.24  Aligned_cols=234  Identities=32%  Similarity=0.567  Sum_probs=200.7

Q ss_pred             cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCC
Q 013558          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG  200 (441)
Q Consensus       121 G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg  200 (441)
                      |.||.||+|+++.     +++.||+|.+.+...        ..+|...+....||||+++++++......|+||||++||
T Consensus         4 g~~~~v~~~~~~~-----~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTR-----TQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEcc-----CCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            8999999999886     888999999976431        233555556667999999999999999999999999999


Q ss_pred             chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCC
Q 013558          201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY  280 (441)
Q Consensus       201 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y  280 (441)
                      +|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......  .....++..|
T Consensus        71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y  148 (237)
T cd05576          71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY  148 (237)
T ss_pred             CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence            99999988888999999999999999999999999999999999999999999999999988765442  2345567889


Q ss_pred             CCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCC
Q 013558          281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSG  360 (441)
Q Consensus       281 ~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~  360 (441)
                      +|||.+.+..++.++|+||+||++|||++|..||...... .   .......+|..+++.+++||.+||+.||++|++++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I---NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c---ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            9999998888999999999999999999999988643211 0   01123457788999999999999999999999887


Q ss_pred             CCChHHhhhCccc
Q 013558          361 PGGVDAIKHHKWF  373 (441)
Q Consensus       361 ~~~~~~i~~h~~f  373 (441)
                      ..+++++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence            7788999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=320.32  Aligned_cols=244  Identities=19%  Similarity=0.321  Sum_probs=206.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||.||+|.+.....  ....+|+|.+......  ...+.+.+|+.+++.+.|+||+++++++. ....++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCC--CcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            479999999999998765211  3478999998765432  34456888999999999999999999876 456899999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCC----
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----  271 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~----  271 (441)
                      |+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999876433221    


Q ss_pred             ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+... ....+..++..++++|.+||
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            11223567999999998899999999999999999998 99999888777776666544 33566778999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhh
Q 013558          350 HKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..+|++||     ++.++++
T Consensus       236 ~~~p~~Rp-----~~~~l~~  250 (257)
T cd05060         236 KYRPEDRP-----TFSELES  250 (257)
T ss_pred             cCChhhCc-----CHHHHHH
Confidence            99999999     7777764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-41  Score=334.27  Aligned_cols=259  Identities=21%  Similarity=0.396  Sum_probs=216.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+...+|++.+.||+|+||.||+|++.+....  .....||+|.+....  .....+.+.+|+++++++ +||||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            445556899999999999999999987643221  123468999886432  233456788899999999 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +++...+.+++||||+++|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987642                36778889999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543221   122334567999999999999999999999999999998 899999888888


Q ss_pred             HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          322 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       322 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ....+... ....+..++.++.+||.+||+.+|.+||     ++++++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-----TFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHHH
Confidence            87777654 3345667889999999999999999999     78888874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=320.78  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=213.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||.||+|..+      .++.+|||.+.....    ..+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~------~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN------GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc------CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            55678999999999999999999865      346799999875432    23457889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            899999999999999999997653  689999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      +.....  .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....+...+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE  232 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            643211  112234578999999998889999999999999999998 99999888877777777654 33456677899


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+++.+||+.+|++||     +++++..
T Consensus       233 ~~~~i~~~l~~~p~~Rp-----~~~~l~~  256 (261)
T cd05034         233 LYDLMLQCWDKDPEERP-----TFEYLQS  256 (261)
T ss_pred             HHHHHHHHcccCcccCC-----CHHHHHH
Confidence            99999999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-42  Score=336.48  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=209.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|.+.+.||+|+||.||+|.++.     +++.||+|++.+... .......+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKR-----TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCC-----CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            589999999999999999999875     788999999875432 223344577899999999999999999998754  


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ..+|+|+||+.+ +|..++  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence                357999999964 666554  3468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-------------  329 (441)
                      ....  ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...             
T Consensus       166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            6533  2334578899999999876 46889999999999999999999999887655444433221             


Q ss_pred             ----------cccC--------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          330 ----------KVKL--------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       330 ----------~~~~--------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                ....        .+.++.++.+||.+||+.||.+||     ++++++.||||+.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL-----TATEALEHPYFDSFRDAD  307 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc-----CHHHHhcCcchhhccccc
Confidence                      0001        124678899999999999999999     889999999999876433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-41  Score=335.90  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++.+.||+|+||.||++.++.     +++.||+|++.+... .....+.+.+|+.++++++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcC-----CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            4689999999999999999998765     788999999875321 223345677899999999999999999988643 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ...|++++++ |++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                 3478888887 7788777654 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------  330 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------  330 (441)
                      +....  ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....           
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            86543  2344678999999999876 568889999999999999999999998766544433332210           


Q ss_pred             ------------ccCC--------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          331 ------------VKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       331 ------------~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                  ...+        ...++++++||.+||+.||.+|+     ++.+++.||||..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~f~~  305 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQ  305 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC-----CHHHHhcChhhhh
Confidence                        0111        13578899999999999999999     8899999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=334.47  Aligned_cols=256  Identities=27%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             CCce-EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh-----------HHHHHHHHHHHHHhcCCCCc
Q 013558          110 GDFE-IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------HVDYMKAERDILTKVTHPFI  177 (441)
Q Consensus       110 ~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI  177 (441)
                      ++|. +.+.||.|+||+||+|.++.     .++.||||++.........           ....+.+|+.+++.++|+||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL-----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC-----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            3565 45779999999999999875     7889999998764322210           11246789999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      +++++++...+..|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            999999999999999999997 5899999888889999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCC---------------CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH
Q 013558          258 DFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQK  321 (441)
Q Consensus       258 DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~  321 (441)
                      |||++......               .......++..|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998765411               111234568899999998764 46889999999999999999999999887766


Q ss_pred             HHHHHHhccc----------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          322 LQQRIINEKV----------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       322 ~~~~i~~~~~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ....+....-                            ......+.++.+||.+||+.+|++||     ++++++.|+||
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI-----SAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc-----CHHHHhcCccc
Confidence            6555533110                            01124578899999999999999999     88999999999


Q ss_pred             CCC
Q 013558          374 RSI  376 (441)
Q Consensus       374 ~~~  376 (441)
                      +..
T Consensus       317 ~~~  319 (335)
T PTZ00024        317 KSD  319 (335)
T ss_pred             CCC
Confidence            854

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-41  Score=330.54  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=205.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++.++||+|+||.||+|.++.     +++.+|+|++....... .....+.+|+++++.++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK-----TGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            5689999999999999999999876     78889999987643222 2223466899999999999999999887543 


Q ss_pred             -------CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          188 -------SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       188 -------~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                             ..+|+||||+.+ +|...+.. ...+++..++.++.||++||.|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence                   357999999975 66666654 357999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC------------CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 013558          260 GLAKEIDESSR------------SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI  326 (441)
Q Consensus       260 G~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i  326 (441)
                      |+++.......            .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99986533211            123457889999998865 45789999999999999999999999887766555544


Q ss_pred             Hhccc-----------------------cCC-------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          327 INEKV-----------------------KLP-------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       327 ~~~~~-----------------------~~p-------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .....                       ..+       ..+++++.+||.+||+.||.+||     ++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL-----TASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc-----CHHHHhcCCCC
Confidence            32100                       000       13457889999999999999999     88999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=328.08  Aligned_cols=255  Identities=21%  Similarity=0.364  Sum_probs=208.3

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCC---------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  178 (441)
                      ...+|++.++||+|+||.||+|++.....         ......||+|.+....  .....+.+.+|++++++++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            34689999999999999999998754211         1133469999987542  233455688999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCchHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                      ++++++......++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999886542            368889999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc--CCCCCCCCCHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK  321 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--G~~pf~~~~~~~  321 (441)
                      |++.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|||||||++|+|++  |..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976533221   122345778999999998889999999999999999988  778998776666


Q ss_pred             HHHHHHh--------ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ....+..        .....++.+++.+.+||.+||+.||++||     ++++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP-----TFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            5554422        11223556789999999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-42  Score=336.38  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=212.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||++++..     +++.||+|++.... ......+.+.+|+.+++.++|+||+++++++....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTK-----TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECC-----CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            4579999999999999999999876     78899999986532 22334456778999999999999999998887655


Q ss_pred             E------EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ~------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .      +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            4      99999999 6689888765 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------  331 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~----------  331 (441)
                      ......  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....          
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            876443  344578899999999865 4678899999999999999999999987776655554433110          


Q ss_pred             ---------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 ---------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                           .....++.++.+||++||+.||.+||     ++.+|+.||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp-----t~~ell~h~~~~~~  304 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI-----TAAEALAHPYLAEY  304 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC-----CHHHHhcCCCcccc
Confidence                                 01124688999999999999999999     88999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-43  Score=321.26  Aligned_cols=259  Identities=28%  Similarity=0.450  Sum_probs=207.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~  188 (441)
                      ..|++++.||+|+||.||+|..+..++. ..+.||+|.++..... ........+|+.+++.++||||+.|..+|.+ +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3699999999999999999976654432 1347999998765321 1222345689999999999999999999887 78


Q ss_pred             EEEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC----CcEEEEec
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDF  259 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----~~vkl~DF  259 (441)
                      .+++++||++. +|...++-+     ..++...++.|+.||+.|+.|||++-|+||||||.||||..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999977 788887543     358999999999999999999999999999999999999877    89999999


Q ss_pred             CCccccCCCC----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH---------HHHHHH
Q 013558          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  325 (441)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~---------~~~~~~  325 (441)
                      |+++.+...-    .....+-|.+|+|||++.| ..|+.+.|||++|||+.||++-++.|.+...         .+...+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875432    2345678999999999987 5689999999999999999999999965321         233444


Q ss_pred             HHhc-----------cccCCC--------------------------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          326 IINE-----------KVKLPP--------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       326 i~~~-----------~~~~p~--------------------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      |+.-           -..+|+                          .-++.+.+|+.+||++||.+|+     ++++++
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI-----ta~qAl  335 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI-----TAEQAL  335 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc-----cHHHHh
Confidence            4320           001111                          1245588999999999999999     889999


Q ss_pred             hCcccCCC
Q 013558          369 HHKWFRSI  376 (441)
Q Consensus       369 ~h~~f~~~  376 (441)
                      +|+||..-
T Consensus       336 eh~yF~~d  343 (438)
T KOG0666|consen  336 EHPYFTED  343 (438)
T ss_pred             cccccccC
Confidence            99999754

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-41  Score=321.28  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|.++...  .....||||++....  .......+..|+.+++.++||||+++++++.++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCC--CCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            357999999999999999999987521  134579999986532  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..++||||+++++|.+++... +.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999999988764 5689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCcc----cc--CCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          268 SSRSNS----MC--GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       268 ~~~~~~----~~--gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......    ..  .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+... ....+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence            221111    11  2357999999999999999999999999999887 99999888777777766543 3344567889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+.+++.+||+.+|.+||     ++++|+.
T Consensus       239 ~~~~li~~~l~~~p~~Rp-----~~~~i~~  263 (269)
T cd05065         239 ALHQLMLDCWQKDRNARP-----KFGQIVS  263 (269)
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-41  Score=319.94  Aligned_cols=247  Identities=25%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||.||++.+..      +..+|+|.+.....    ..+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-   71 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence            344679999999999999999998763      34599998765432    2345778999999999999999998875 


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~  151 (260)
T cd05069          72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL  151 (260)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence            456899999999999999997643  478999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      ......  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+... ....+..++..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05069         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES  231 (260)
T ss_pred             ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            543221  122346678999999998889999999999999999999 99999988777776666544 33456678999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++|++||.+||++||     +++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp-----~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERP-----TFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCc-----CHHHHHH
Confidence            99999999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-41  Score=328.67  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||.||++.++.     +++.||+|+++.... .......+.+|++++++++||||+++++++.+.
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD-----TGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC-----CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            34689999999999999999999875     678999999876432 222334567899999999999999999998765


Q ss_pred             C----------EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEE
Q 013558          188 S----------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       188 ~----------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      .          .+|+|+||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence            4          89999999987 666666543 57999999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCC--CccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--
Q 013558          257 TDFGLAKEIDESSR--SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--  331 (441)
Q Consensus       257 ~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--  331 (441)
                      +|||++........  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+....-  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987643321  223356788999998865 4578899999999999999999999987766554444432100  


Q ss_pred             ----------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 ----------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 ----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                                  .....++..+.+||.+||+.||.+||     ++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC-----TAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC-----CHHHHhcCCCC
Confidence                                        01124688999999999999999999     88999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-41  Score=318.20  Aligned_cols=247  Identities=22%  Similarity=0.413  Sum_probs=211.7

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|++.+.||+|+||.||++.+.      .+..+|+|.+......    ...+.+|++++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTER   71 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence            3457999999999999999999875      3567999988654322    23577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...|+||||+.+++|.+++... +.++++.++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999999999999998764 568999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ....  .....++..|+|||++.+..++.++||||||+++|||++ |..||......++.+.+... ....+...+.++.
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY  231 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            3221  122335678999999998889999999999999999998 99999888877777777654 3334566789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +|+.+||+.+|++||     +++++++
T Consensus       232 ~l~~~~l~~~p~~Rp-----~~~~~l~  253 (256)
T cd05112         232 ELMQHCWKERPEDRP-----SFSLLLH  253 (256)
T ss_pred             HHHHHHcccChhhCC-----CHHHHHH
Confidence            999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=322.56  Aligned_cols=242  Identities=24%  Similarity=0.403  Sum_probs=202.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYL  192 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  192 (441)
                      +.||+|+||.||+++.+.     ++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+.+|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcC-----CCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            368999999999999875     333  46888776422  233445678899999999 79999999999999999999


Q ss_pred             EEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEE
Q 013558          193 ILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      ||||+++|+|.+++....                .+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence            999999999999987643                4788999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCC
Q 013558          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  334 (441)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p  334 (441)
                      +|||++..............+..|+|||++....++.++|||||||++|||++ |..||...+..+..+.+... ....+
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  233 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence            99999864332211222234667999999998889999999999999999997 99999888777777766553 33456


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..++.++.+|+.+||..||.+||     ++++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~  263 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERP-----SFAQILV  263 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence            67889999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-41  Score=326.85  Aligned_cols=259  Identities=31%  Similarity=0.487  Sum_probs=211.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  183 (441)
                      ..+..++|++.+.||+|+||.||+|.++.     +++.||||.+.+...  ......+..|+.++.++. |+||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKK-----TGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECC-----CCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            34566789999999999999999999875     688999999976432  222344556777666664 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +.+...+|+||||+.+ +|...+.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             eecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            9999999999999854 66666554 4678999999999999999999997 6999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCC----CCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcc-ccCCC
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEK-VKLPP  335 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~~-~~~p~  335 (441)
                      +..+..........++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+.... ...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T cd06618         162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP  241 (296)
T ss_pred             chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence            98765444444456888999999987653    78899999999999999999999976332 33444444332 22332


Q ss_pred             --CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 --FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 --~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                        .++.++.+||.+||..||.+||     ++++++.|+||...
T Consensus       242 ~~~~~~~l~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  279 (296)
T cd06618         242 NEGFSPDFCSFVDLCLTKDHRKRP-----KYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCC-----CHHHHhcChhhhcc
Confidence              4788999999999999999999     88999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-41  Score=335.35  Aligned_cols=255  Identities=31%  Similarity=0.506  Sum_probs=209.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      .++|++.+.||+|+||.||++.++.     +++.+|+|.+.+.. ........+.+|+.+++++ +||||+++++++...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR-----TKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC-----CCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            3579999999999999999999875     67899999886532 1223344567899999999 999999999998653


Q ss_pred             --CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                        ..+|+||||+.+ +|..++... .+.+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          80 NDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence              468999999974 898888665 7899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC------CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Q 013558          266 DESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------  330 (441)
Q Consensus       266 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--------  330 (441)
                      ....      ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...++....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            3321      2234578999999998765 557889999999999999999999998765544433322110        


Q ss_pred             -----------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          331 -----------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       331 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                             ....+.++.++.+||.+||+.||++||     ++.++++|+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----s~~~il~~~~~~~~  301 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL-----TAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc-----CHHHHhhChhhhhh
Confidence                                   001123688999999999999999999     88999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-41  Score=327.29  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=213.4

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |....+||+|+||.||++..+.     +++.||+|++....   ....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS-----SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW   93 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC-----CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence            3334689999999999998875     78899999875432   233456888999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-C
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-R  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  270 (441)
                      +||||+++++|.+++. .+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .
T Consensus        94 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657          94 VVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             EEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence            9999999999988764 4578999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~  347 (441)
                      .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....   ......++..+.++|.+
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            234578999999999988888999999999999999999999998877666555543322   22234578999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||+.||.+||     ++.+++.||||...
T Consensus       253 ~l~~~P~~R~-----~~~~ll~~~~~~~~  276 (292)
T cd06657         253 LLVRDPAQRA-----TAAELLKHPFLAKA  276 (292)
T ss_pred             HHhCCcccCc-----CHHHHhcChHHhcc
Confidence            9999999999     88999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.7e-41  Score=325.19  Aligned_cols=254  Identities=21%  Similarity=0.388  Sum_probs=206.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  177 (441)
                      .++|++.+.||+|+||.||+|++....           ...+...+|+|++....  .....+.+.+|+.+|+.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            457999999999999999998754311           11234579999987542  23345678899999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCchHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCce
Q 013558          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (441)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  246 (441)
                      +++++++...+..++||||+.+++|.+++....           .+++..+..++.||+.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987643           366778999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc--CCCCCCCCCHHH
Q 013558          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK  321 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--G~~pf~~~~~~~  321 (441)
                      |++.++.+||+|||+++.+.....   .....++..|+|||+..+..++.++|||||||++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986533221   122344678999999988889999999999999999998  789998766655


Q ss_pred             HHHHHHh--------ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .......        .....+..+++.+.+||.+||+.||++||     ++++|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP-----SFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            5443321        11234456789999999999999999999     6777754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.4e-41  Score=330.17  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=207.1

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC--
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR--  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--  187 (441)
                      +|++.+.||+|+||.||++++....   .+..||+|++.... ......+.+.+|+.+++++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4899999999999999999987511   27789999986432 2223345677899999999 599999999875432  


Q ss_pred             --CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                        ..+|+++||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence              46889999986 589999988888999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Q 013558          266 DESS-----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  329 (441)
Q Consensus       266 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------  329 (441)
                      ....     ......||..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...          
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321     1234578999999998765 56899999999999999999999999876644433322210          


Q ss_pred             ------------------ccc---CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ------------------KVK---LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ------------------~~~---~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                        ...   ..+.++..+.+||.+||+.||.+||     ++++++.||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~ll~~~~~~~  297 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI-----SVEEALEHPYLAI  297 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC-----CHHHHhcChhhhh
Confidence                              000   1123578999999999999999999     8999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4e-41  Score=322.23  Aligned_cols=254  Identities=19%  Similarity=0.308  Sum_probs=207.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||+||++.+...... ....+++|.+...  ........+..|+.++++++||||+++++++. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            3456899999999999999999998651110 1124777776432  12333456778888999999999999999875 


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ....++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            45678999999999999999764 57899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHH
Q 013558          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (441)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~  340 (441)
                      .....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+.+..+. ...+...+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            33221   233457788999999998889999999999999999998 999998877766655554432 3345567889


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+++.+||..||++||     ++.++++
T Consensus       240 ~~~li~~c~~~~p~~Rp-----s~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRP-----TFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            99999999999999999     7788865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-41  Score=317.79  Aligned_cols=242  Identities=22%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (441)
                      .||+|+||.||++.++..   ..+..||+|++....  .....+.+.+|+.++++++||||+++++++. ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~---~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecC---CCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence            489999999999987532   145579999986542  2344566889999999999999999999875 4578999999


Q ss_pred             cCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC----C
Q 013558          197 INGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (441)
Q Consensus       197 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~----~  271 (441)
                      +++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........    .
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999999998875 45789999999999999999999999999999999999999999999999999986543221    1


Q ss_pred             ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+... ....|...++++.++|.+||
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            11223578999999998889999999999999999996 99999988777776666553 44567788999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhh
Q 013558          350 HKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..||++||     ++.+|.+
T Consensus       236 ~~~~~~Rp-----~~~~i~~  250 (257)
T cd05115         236 IYKWEDRP-----NFAKVEE  250 (257)
T ss_pred             CCChhhCc-----CHHHHHH
Confidence            99999999     6666654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=354.05  Aligned_cols=308  Identities=47%  Similarity=0.816  Sum_probs=277.3

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEe
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++|+|+||.|++++..+-.  +.+..||+|+.++......... .-..|..++..++ ||++|+++..|+.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccc--cccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            4799999999999765433  3788999999988665444433 5566888999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCcccc
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  275 (441)
                      +..||+|+..+.....+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++|+.|||+++..-.....   |
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999876443333   9


Q ss_pred             CCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCC
Q 013558          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSK  355 (441)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~  355 (441)
                      ||..|||||++.  ++...+|+||||++++||++|..||..    ++..+|....+.+|..++.++++++..++.++|.+
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            999999999998  778889999999999999999999987    78899999999999999999999999999999999


Q ss_pred             CCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCC--CCCCcccCeeeeC
Q 013558          356 RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--TAGEHFKGYTYVA  433 (441)
Q Consensus       356 R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~f~~~~~~~  433 (441)
                      |+++++..+.++++|+||..++|..+..++.+|+|+|....+.+..+||..++...+.++|...+  .+...|+||+|++
T Consensus       229 rLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva  308 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVA  308 (612)
T ss_pred             HhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccC
Confidence            99999999999999999999999999999999999999999999999999999887777665443  3458999999998


Q ss_pred             CCc
Q 013558          434 PNP  436 (441)
Q Consensus       434 ~~~  436 (441)
                      +.+
T Consensus       309 ~~i  311 (612)
T KOG0603|consen  309 PGV  311 (612)
T ss_pred             hHH
Confidence            754

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-41  Score=321.81  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=200.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSK  189 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  189 (441)
                      |++++.||+|+||+||++..+... ...+..||+|++....  .......+.+|+++|+.++||||+++++++..  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            499999999999999988754322 2367789999987542  12334567789999999999999999998765  346


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +++||||+.+++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            89999999999999988764 69999999999999999999999999999999999999999999999999998764322


Q ss_pred             C----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH--H-------------HHHHHH-hc
Q 013558          270 R----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ--K-------------LQQRII-NE  329 (441)
Q Consensus       270 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~--~-------------~~~~i~-~~  329 (441)
                      .    .....++..|+|||.+.+..++.++||||||+++|||++|..||......  +             ..+.+. ..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence            1    12234567799999999888999999999999999999999998643211  0             011111 11


Q ss_pred             cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 ~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ....+..++.++.+++.+||+.||++||     ++++++.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~i~~  276 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRP-----TFRSLIP  276 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            2234567789999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-41  Score=327.43  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=213.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+..+.||+|+||.||+++++.     ++..+|+|.+...........+.+.+|+++++.++|+|++++++++......
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC-----CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            48888999999999999999875     7788999998754333344455677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      ++||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....  
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            99999997 477776654 45689999999999999999999999999999999999999999999999999876543  


Q ss_pred             CCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cC-CCCCcHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSL  344 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~l  344 (441)
                       .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+..... .. +..++..+++|
T Consensus       168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (308)
T cd06634         168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  246 (308)
T ss_pred             -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence             23457899999999985   34578899999999999999999999987665555444443322 22 34688899999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |++||+.+|++||     +++++++|+|+...
T Consensus       247 i~~cl~~~P~~Rp-----~~~~ll~~~~~~~~  273 (308)
T cd06634         247 VDSCLQKIPQDRP-----TSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHhhCCcccCC-----CHHHHhhCcccccc
Confidence            9999999999999     88999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=359.68  Aligned_cols=256  Identities=23%  Similarity=0.395  Sum_probs=221.8

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +.....++.+.||+|.||.||.+.............||||.+.+.  .+...+..|.+|..+|+.++|||||+++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            456778899999999999999999886543222445888888654  456677889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                      ....+|++|||.||+|..+|++.       ..++..+...++.||++|+.||+++++|||||..+|+||+....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       24889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCC-ccc--cCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHH-HHHhccccCC
Q 013558          260 GLAKEIDESSRS-NSM--CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQ-RIINEKVKLP  334 (441)
Q Consensus       260 G~a~~~~~~~~~-~~~--~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~-~i~~~~~~~p  334 (441)
                      |+|+.+...... ..-  .-...|||||.+....++.++|||||||+|||++| |..||.+.+..+++. -...+++..|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            999954322211 111  22468999999999999999999999999999999 999999988888887 4455688889


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++++.+.++|..||+.+|++||     ++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP-----~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRP-----SFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCc-----cHHHHHh
Confidence            99999999999999999999999     6677766

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.9e-41  Score=318.64  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=212.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|+..+.||+|+||.||+|..+..  +.....+|+|.+....  .....+.+..|+.+++.++|+||+++++++..
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMP--GRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecC--CCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3456799999999999999999998642  1134579999986542  22334568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .+..|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999999998764 57899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCC----ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          266 DESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       266 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......    .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  237 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS  237 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            432211    11223457999999998889999999999999999997 99999888777777777543 2233456789


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+++.+||+.+|++||     +++++++
T Consensus       238 ~~~~li~~c~~~~p~~Rp-----~~~~i~~  262 (268)
T cd05063         238 AVYQLMLQCWQQDRARRP-----RFVDIVN  262 (268)
T ss_pred             HHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            999999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=323.28  Aligned_cols=249  Identities=31%  Similarity=0.529  Sum_probs=208.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  190 (441)
                      |++.+.||+|+||+||+|....     +++.||||.+......  .......+|+..+++++ |+||+++++++..++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence            6788999999999999999875     6788999998654321  11223456899999999 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      |+||||+ +|+|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999999 779988887765  7899999999999999999999999999999999999999999999999999876654


Q ss_pred             CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------
Q 013558          269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------  329 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~------------------  329 (441)
                      .......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||...+..+...++...                  
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            44455678999999998854 55789999999999999999999999877655544433210                  


Q ss_pred             -cc-----------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          330 -KV-----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       330 -~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ..           ...+..+.++.+||++||+.||++||     ++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP-----TASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC-----CHHHHhhCCCC
Confidence             00           01122368899999999999999999     89999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=324.04  Aligned_cols=250  Identities=29%  Similarity=0.521  Sum_probs=211.4

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++.+.||.|++|.||++....     +++.+++|.+..... .......+.+|+.+|++++|+||+++++++.....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC-----CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            6778999999999999999865     788999999876432 2234566778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      +||||+.+ +|...+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... 
T Consensus        75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            99999976 787777664 689999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------------
Q 013558          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------------  330 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~------------------  330 (441)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...++....                  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            22335688899999999876 78999999999999999999999998877655544443210                  


Q ss_pred             -cc-----------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 -VK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 -~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                       ..           ..+.++.++.+||.+||+.||.+||     ++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc-----CHHHHhhCCCC
Confidence             00           1124678999999999999999999     88999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.4e-41  Score=316.43  Aligned_cols=248  Identities=22%  Similarity=0.387  Sum_probs=209.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.++||+|+||.||++...      .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            355678999999999999999999864      34569999886532    23456788999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      . ...+++|||+++++|.+++...  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence            7 7889999999999999999764  457888999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      .......  .....++..|+|||++....++.++|+|||||++|+|++ |..||...+.......+... ....+...+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE  230 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCH
Confidence            6543221  122345677999999998889999999999999999998 99999988777777666544 2334567889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+++.+||+.+|++||     +++++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERP-----TFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCc-----CHHHHHH
Confidence            999999999999999999     6676653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.7e-41  Score=317.17  Aligned_cols=244  Identities=23%  Similarity=0.391  Sum_probs=208.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|++|.||++.+...  +.....||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            4689999999999998642  123446999999875533  556778899999999999999999999988 89999999


Q ss_pred             ccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC---
Q 013558          196 FINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---  270 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  270 (441)
                      |+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.....   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999997764  689999999999999999999999999999999999999999999999999987643211   


Q ss_pred             -CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc--cccCCCCCcHHHHHHHH
Q 013558          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  346 (441)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+...  ....+..++..+.+++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence             123457789999999999899999999999999999998 99999888777777666542  23345667899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||+.+|++||     ++++++.
T Consensus       236 ~~l~~~p~~Rp-----s~~~~~~  253 (257)
T cd05040         236 QCWAHNPADRP-----TFAALRE  253 (257)
T ss_pred             HHCCCCcccCC-----CHHHHHH
Confidence            99999999999     7788765

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.3e-41  Score=329.22  Aligned_cols=245  Identities=22%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCc
Q 013558          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (441)
Q Consensus       122 ~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (441)
                      ++|.||.++.+.     +++.||||++.... ......+.+.+|+.+++.++|+||+++++++......|++|||+++++
T Consensus        12 ~~~~v~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216          12 DLMIVHLAKHKP-----TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             CCceEEEEEecC-----CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            445566666654     78899999997653 234456779999999999999999999999999999999999999999


Q ss_pred             hHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC--------CC
Q 013558          202 LFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--------RS  271 (441)
Q Consensus       202 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--------~~  271 (441)
                      |.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.+.......        ..
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            99998764  468999999999999999999999999999999999999999999999999887543211        12


Q ss_pred             ccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhc-------------------
Q 013558          272 NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINE-------------------  329 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~-~~i~~~-------------------  329 (441)
                      ....++..|+|||++.+  ..++.++|||||||++|||++|..||......... +.+...                   
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence            33457888999999876  45889999999999999999999999865543322 222100                   


Q ss_pred             --------------cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          330 --------------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       330 --------------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                    ....+..++.++.+||.+||+.||++||     +++++++||||+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~p~~~~~~  302 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP-----SASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc-----CHHHHhcCchHhhhc
Confidence                          0001123457889999999999999999     899999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-41  Score=319.46  Aligned_cols=252  Identities=28%  Similarity=0.478  Sum_probs=211.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +|.+.++||+|+||.||++++..     .+..+++|+++.....  .......+..|+.+++.++||||+++++++.+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK-----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC-----CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            58999999999999999998875     4444566665432211  1223344667999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ..++||||+++++|.+.+..    ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            99999999999999888754    356899999999999999999999999999999999999975 6799999999877


Q ss_pred             cCCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          265 IDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....+..++.++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            54322 233456899999999998888999999999999999999999999877776666666544 3345667889999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++|.+||..||++||     +++++++||||
T Consensus       235 ~li~~~l~~~p~~Rp-----~~~~il~~~~~  260 (260)
T cd08222         235 SIMQSMLNKDPSLRP-----SAAEILRNPFI  260 (260)
T ss_pred             HHHHHHhcCChhhCc-----CHHHHhhCCCC
Confidence            999999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=322.39  Aligned_cols=250  Identities=31%  Similarity=0.499  Sum_probs=211.8

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |++.+.||+|+||.||+++...     +++.||+|++.... ......+.+..|+.+++.++|+||+++++++...+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK-----TGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC-----CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            6778899999999999999875     78899999998654 22333456778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      +||||+.+ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++...... 
T Consensus        75 ~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            99999974 899999876 589999999999999999999999999999999999999999999999999998764432 


Q ss_pred             CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------c
Q 013558          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------K  330 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~------------------~  330 (441)
                      ......++..|+|||++.+. .++.++|||||||++|||++|..||...+..+...++...                  .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            22344567889999998776 7899999999999999999999999887765554444321                  0


Q ss_pred             ccC-----------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 VKL-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 ~~~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ..+           -+.++.++.++|++||..||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI-----SAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCC-----CHHHHhhCcCC
Confidence            001           123478899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.3e-41  Score=313.83  Aligned_cols=241  Identities=22%  Similarity=0.413  Sum_probs=204.8

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||.||++...      .+..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence            36999999999999854      56789999886542  22334467889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCC--c
Q 013558          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--N  272 (441)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~  272 (441)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  .
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            99999999988754 46899999999999999999999999999999999999999999999999998764332211  1


Q ss_pred             cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhcc
Q 013558          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  350 (441)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  350 (441)
                      ...++..|+|||++.+..++.++||||||+++|+|++ |..||...........+... ....+..++..+.+|+.+||.
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2234677999999998889999999999999999998 99999888777766666544 345567789999999999999


Q ss_pred             cCcCCCCCCCCCChHHhhh
Q 013558          351 KDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       351 ~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+|++||     +++++.+
T Consensus       233 ~~p~~Rp-----~~~~l~~  246 (250)
T cd05085         233 YKPENRP-----KFSELQK  246 (250)
T ss_pred             cCcccCC-----CHHHHHH
Confidence            9999999     7788865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-41  Score=319.42  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=213.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||+||++.++.... .....+|+|.+.+...  ......+.+|+.++++++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            34689999999999999999998765221 1234689998865532  3345668889999999999999999999887 


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999998775 568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCc---cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          267 ESSRSN---SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       267 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      ......   ...++..|+|||.+....++.++|+|||||++|||++ |..||......++.+.+... ....|...+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            332211   1223568999999988889999999999999999998 99999988888877777654 345566788999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++.+||..||.+||     ++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp-----~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRP-----TFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCC-----CHHHHHH
Confidence            9999999999999999     6777754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-40  Score=314.37  Aligned_cols=250  Identities=23%  Similarity=0.422  Sum_probs=213.7

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      +++.+.||.|+||.||++++..... ..+..+|+|++.....  ....+.+..|+.+++.++|+||+++++++.+.+..|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            4567899999999999999875211 2348899999865432  225567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          192 LILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      ++|||+++++|.+++.....  +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999976554  9999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc--cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHH
Q 013558          270 RSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLL  345 (441)
Q Consensus       270 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  345 (441)
                      ...  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.....+.+.... ...+..++.++.+++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            211  1236789999999988889999999999999999998 899998888887777776543 345667899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhh
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+||..||++||     ++.++++
T Consensus       238 ~~~l~~~p~~Rp-----t~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRP-----TFSELVE  256 (258)
T ss_pred             HHHCcCChhhCc-----CHHHHHh
Confidence            999999999999     7888875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-40  Score=325.96  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  186 (441)
                      ..++|++.+.||.|+||.||+|.++.     +++.||+|++.+... .....+.+..|+.+++.++||||++++++|.. 
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQL-----TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECC-----CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            34679999999999999999999876     788999998865432 23344567789999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ....|+||||+ +++|...+. ...+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++....
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            56799999999 558877765 4568999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------c-
Q 013558          267 ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---------------E-  329 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~---------------~-  329 (441)
                      .  ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..               . 
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            3  2334567899999998765 5689999999999999999999999987654322211110               0 


Q ss_pred             ----------cccC-----CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ----------KVKL-----PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ----------~~~~-----p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                ....     .+.++.++.++|.+||+.+|++||     ++++++.|+||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~ell~~~~~~~  293 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI-----SAAEALAHPYLAP  293 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCCcccc
Confidence                      0011     134678999999999999999999     8899999999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=306.84  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..++.++|.+.+.||+|||+-||+|+...     +++.||+|.+.-..   .+..+..++|++..++++||||++++++.
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            44677899999999999999999999665     88899999987643   45567788999999999999999998776


Q ss_pred             EeC-----CEEEEEEeccCCCchHHHHHHc---C-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCCc
Q 013558          185 QTR-----SKLYLILDFINGGHLFFHLYRQ---G-IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (441)
Q Consensus       185 ~~~-----~~~~lv~E~~~gg~L~~~l~~~---~-~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~  253 (441)
                      ..+     ...|+++.|...|+|.+.+.+.   + .++|.++..|+.+|++||++||+..  .+||||||.|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            433     3599999999999999988654   2 6999999999999999999999998  999999999999999999


Q ss_pred             EEEEecCCccccCCCCC----------CccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCC--
Q 013558          254 VMLTDFGLAKEIDESSR----------SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN--  318 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~--  318 (441)
                      ++|.|||.+....-.-.          ......|..|+|||++.-   ...+.++|||||||+||+|+.|..||+..-  
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            99999999876421110          112346889999999874   456889999999999999999999996321  


Q ss_pred             HHHHHHHHHhccccCCC--CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          319 RQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       319 ~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ...+.-.+....+.+|.  .+|+.+.+||+.||+.||.+||     ++.+++.+
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP-----~i~~ll~~  296 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP-----TIPELLSK  296 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC-----CHHHHHHH
Confidence            11122234445556663  4899999999999999999999     88888763

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-40  Score=318.44  Aligned_cols=255  Identities=20%  Similarity=0.346  Sum_probs=213.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||.||++.++... ...+..+++|.+...  ......+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            45678999999999999999999987421 123678999988643  234456778899999999999999999998765


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                       ....++++||+.+++|.+++...        ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             57789999999999999998664        358899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-ccc
Q 013558          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK  332 (441)
Q Consensus       258 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~  332 (441)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++||+++ |+.||...+..++...+..+ ...
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            9999986533221   123456778999999998889999999999999999999 99999988877776665543 223


Q ss_pred             CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       333 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+..+++++.+++.+||..||++||     ++.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERP-----SFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            4456789999999999999999999     7788774

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=322.11  Aligned_cols=253  Identities=28%  Similarity=0.508  Sum_probs=210.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--C----Cceee
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--P----FIVQL  180 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~l  180 (441)
                      +-..+|++++.+|+|+||.|..+.++.     ++..||||+++.-    ....+..+-|+++|+++.+  |    -+|++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~-----~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRE-----TKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecC-----CCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            446789999999999999999999886     6889999998642    2334556679999999942  3    37888


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC--------
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--------  250 (441)
                      .++|.-.+++|+|+|.+ |-++++.+..+.  +++..+++.+++|+++++.|||+.+++|-||||+|||+..        
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            89999999999999999 668999998764  6999999999999999999999999999999999999932        


Q ss_pred             ------------CCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC
Q 013558          251 ------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN  318 (441)
Q Consensus       251 ------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~  318 (441)
                                  +..|||+|||.|+.-.+.  ...++.|..|+|||++.+-+++.++||||+||||+||.+|...|...+
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                        236999999999875543  367889999999999999999999999999999999999999998655


Q ss_pred             HHH---HHHHHHhc------------------cccCCCC-------------------------CcHHHHHHHHHhcccC
Q 013558          319 RQK---LQQRIINE------------------KVKLPPF-------------------------LTSEAHSLLKGLLHKD  352 (441)
Q Consensus       319 ~~~---~~~~i~~~------------------~~~~p~~-------------------------~s~~~~~li~~~L~~d  352 (441)
                      ..+   ++++|+..                  ++..|+.                         ...++.|||++||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            433   55555421                  1111110                         1235789999999999


Q ss_pred             cCCCCCCCCCChHHhhhCcccCCC
Q 013558          353 PSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       353 P~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |.+|+     ++.|++.||||+..
T Consensus       394 P~~Ri-----Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  394 PARRI-----TLREALSHPFFARL  412 (415)
T ss_pred             ccccc-----cHHHHhcCHHhhcC
Confidence            99999     89999999999754

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=319.22  Aligned_cols=242  Identities=19%  Similarity=0.315  Sum_probs=199.9

Q ss_pred             eeEcccCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      +.||+|+||.||++.++...+.  .....+|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            3699999999999987653211  123458888875432   33445678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc--------EEEEecCCccc
Q 013558          194 LDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKE  264 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--------vkl~DFG~a~~  264 (441)
                      |||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        +|++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987765        69999999876


Q ss_pred             cCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      ...   .....++..|+|||++.+ ..++.++|||||||++|||++| ..||...+..... .+......+|...+.++.
T Consensus       158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (258)
T cd05078         158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELA  233 (258)
T ss_pred             cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHH
Confidence            432   234578899999999986 4578999999999999999998 5677665554433 344456677777889999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||.+||+.||++||     ++++|++
T Consensus       234 ~li~~~l~~~p~~Rp-----s~~~il~  255 (258)
T cd05078         234 NLINQCMDYEPDFRP-----SFRAIIR  255 (258)
T ss_pred             HHHHHHhccChhhCC-----CHHHHHH
Confidence            999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=312.38  Aligned_cols=241  Identities=24%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||.||++.+.      .++.||+|.+......  .....+.+|++++++++|+||+++++++.+....++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~------~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK------GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEe------CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence            46999999999999875      3678999998764322  345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCC---
Q 013558          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---  271 (441)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~---  271 (441)
                      |+.|++|.+++... ..+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++.........   
T Consensus        73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999999998664 56899999999999999999999999999999999999999999999999999865422111   


Q ss_pred             ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+... ....+..++.++.++|.+||
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  232 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW  232 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence            12234567999999998889999999999999999999 89999888777766666543 34456778999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhh
Q 013558          350 HKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+|++||     ++++++.
T Consensus       233 ~~~p~~Rp-----~~~ell~  247 (251)
T cd05041         233 AYDPENRP-----SFSEIYN  247 (251)
T ss_pred             ccChhhCc-----CHHHHHH
Confidence            99999999     7888875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.6e-40  Score=314.73  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=211.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +...+|.+.++||+|+||.||+|.+....  .....+|+|......  .....+.+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            34567999999999999999999876421  134568999886543  23345678899999999999999999998875


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ...|+||||+++++|.+++.+.. .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence             45789999999999999997754 5899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      .....  .....++..|+|||.+....++.++|||||||++|||++ |..||...+..+....+... ....+..++.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            43321  112234568999999988889999999999999999986 99999887777666666543 445677889999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++|.+||..+|++||     ++.+++.
T Consensus       238 ~~li~~~l~~~P~~Rp-----t~~~~~~  260 (270)
T cd05056         238 YSLMTKCWAYDPSKRP-----RFTELKA  260 (270)
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999     7777765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-40  Score=312.89  Aligned_cols=242  Identities=24%  Similarity=0.430  Sum_probs=205.5

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||.||++..       .++.||+|.+....     ..+.+.+|+.++++++||||+++++++..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            346799999999999999998763       56779999986532     234678899999999999999999998765


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence             4799999999999999997653  5899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  343 (441)
                      ...  ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+... ....+..+++.+.+
T Consensus       151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (254)
T cd05083         151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV  228 (254)
T ss_pred             ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHH
Confidence            332  222344678999999998889999999999999999997 99999988877777666544 23345678899999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +|.+||+.+|++||     ++++++.
T Consensus       229 li~~~l~~~p~~Rp-----~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRP-----SFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999     7777764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-40  Score=317.30  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  188 (441)
                      -|++++.||+|+||.||+|+.... ...++..||+|.+....  .......+.+|+.+++.++||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccC-CCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            489999999999999999986421 12367889999986542  233456788999999999999999999998875  5


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998765 3589999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---------------HHHHHHHHHh
Q 013558          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQQRIIN  328 (441)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---------------~~~~~~~i~~  328 (441)
                      ...    .....|+..|+|||++.+..++.++|||||||++|||+++..|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            221    224557778999999998889999999999999999999877653211               1111111111


Q ss_pred             -ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          329 -EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       329 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       .....+..++..+.+||.+||+.||++||     +++++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  278 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRT-----TFQNLIE  278 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCc-----CHHHHHH
Confidence             12334567899999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=312.99  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=213.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~  183 (441)
                      ..+..++.+-+..||.|+||+|++..++.     +++..|||.++....  ....++++.|.+... .-++||||++||.
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~-----sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKP-----SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCc-----cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            34555677778899999999999999886     899999999987654  233445666776654 4579999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEE
Q 013558          184 FQTRSKLYLILDFINGGHLFFHL-----YRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l-----~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      ...++.+++.||+|+- +|..+.     ..+..++|..+-.|....+.||+||-. ..|||||+||+|||++..|.||||
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence            9999999999999964 453222     234579999999999999999999985 689999999999999999999999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccccC-
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKL-  333 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~~~~~-  333 (441)
                      |||++..+...-..+.-.|...|||||.+..  .+|+.++||||||++|||+.||+.||...+. .+....+..+.++. 
T Consensus       211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL  290 (361)
T ss_pred             cccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence            9999988776655666789999999999974  5699999999999999999999999987654 34445555554432 


Q ss_pred             --CC---CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          334 --PP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       334 --p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                        +.   .++..+..||.-||.+|-+.||     ..++++++||++..
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rp-----ky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRP-----KYDDLKKFPFYRMY  333 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCc-----chhhhhcCchhhhh
Confidence              22   3789999999999999999999     78999999999743

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-40  Score=311.83  Aligned_cols=245  Identities=22%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~  194 (441)
                      +.||+|+||.||+|.+....  .....+|+|.+...  ......+.+.+|+.+++.++||||+++++++. .++..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999875321  24567999987542  22334567788999999999999999999765 456789999


Q ss_pred             eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC----
Q 013558          195 DFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----  269 (441)
Q Consensus       195 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  269 (441)
                      ||+.+|+|.+++.+. ....+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998764 456788888999999999999999999999999999999999999999999997653211    


Q ss_pred             -CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHHH
Q 013558          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLK  346 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  346 (441)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+.... ...+..+++.+.+++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML  236 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence             1123346778999999998889999999999999999999 577787777777666665543 3345667899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhh
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +||+.+|++||     ++.+++.
T Consensus       237 ~cl~~~p~~Rp-----~~~~il~  254 (262)
T cd05058         237 SCWHPKPEMRP-----TFSELVS  254 (262)
T ss_pred             HHcCCChhhCC-----CHHHHHH
Confidence            99999999999     7788875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-40  Score=315.95  Aligned_cols=242  Identities=19%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             eEcccCCeEEEEEEEcCCC-------------------CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc
Q 013558          117 VVGQGAFGKVFQVKKKGVD-------------------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~-------------------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  177 (441)
                      .||+|+||.||++......                   +......+|+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            6999999999998753211                   11123458888886532   2233557789999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----
Q 013558          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----  252 (441)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----  252 (441)
                      +++++++......++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 46789999999999999999999999999999999999997654    


Q ss_pred             ---cEEEEecCCccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHH-cCCCCCCCCCHHHHHHHHH
Q 013558          253 ---HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRII  327 (441)
Q Consensus       253 ---~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~ell-tG~~pf~~~~~~~~~~~i~  327 (441)
                         .+||+|||++.....   .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+... ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY  234 (274)
T ss_pred             ccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence               489999998865422   123457888999998875 56899999999999999995 6999998766554433 33


Q ss_pred             hccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          328 NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       328 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .....+|...++++.++|.+||+.+|++||     ++++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~il~~  272 (274)
T cd05076         235 EKKHRLPEPSCKELATLISQCLTYEPTQRP-----SFRTILRD  272 (274)
T ss_pred             HhccCCCCCCChHHHHHHHHHcccChhhCc-----CHHHHHHh
Confidence            444556666778999999999999999999     78898864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-40  Score=312.95  Aligned_cols=243  Identities=21%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             eeEcccCCeEEEEEEEcCCCC-------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          116 RVVGQGAFGKVFQVKKKGVDD-------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +.||+|+||.||++.......       ......+++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999998542111       0123358888875532   333456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc-------EEEEecC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------VMLTDFG  260 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-------vkl~DFG  260 (441)
                      ..++||||+++|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.       +|++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56999999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhc-CCCCCCcchhhhHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccccCCCCCc
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~ell-tG~~pf~~~~~~~~~~~i~~~~~~~p~~~s  338 (441)
                      ++.....   .....|+..|+|||++. +..++.++|||||||++|||+ .|..||......+.. .+...........+
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~  233 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC  233 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence            9876432   22346788999999987 567899999999999999998 599999776544432 23333333444457


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +++.+||.+||+.||.+||     ++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp-----~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRP-----FFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCc-----CHHHHHHh
Confidence            8899999999999999999     88898864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-40  Score=315.11  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=201.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  187 (441)
                      .+|++++.||+|+||.||++..+.... .++..||+|.+....   ....+.+.+|+++++.++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcC-CCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            479999999999999999998653322 267889999986532   3445678899999999999999999998754  3


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999998764 468999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCC----ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHH
Q 013558          267 ESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---------------LQQRII  327 (441)
Q Consensus       267 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~---------------~~~~i~  327 (441)
                      .....    ....++..|+|||++.+..++.++|||||||++|||++|..++.......               ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            32211    11223456999999998889999999999999999999877764322110               011112


Q ss_pred             hc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..  ....+..++.++.+||.+||..+|++||     ++++|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP-----SFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            22  2234457889999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-40  Score=312.82  Aligned_cols=243  Identities=21%  Similarity=0.340  Sum_probs=194.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||.||++.....   .....+|+|.+....  .......+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecC---CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence            3699999999999975431   245678898875432  23334567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+++|+|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999999987643     24678889999999999999999999999999999999999999999999987532221 


Q ss_pred             --CCccccCCCCCCCcchhcC-------CCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-ccc-----C
Q 013558          270 --RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK-----L  333 (441)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~-----~  333 (441)
                        ......++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+... ...     +
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence              1223346778999999753       356789999999999999999 88999877666555544332 222     3


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +..++..+.+++..|+ .||++||     ++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rp-----t~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRP-----TAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCccccc-----CHHHHHH
Confidence            3467889999999999 5999999     6677764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.9e-40  Score=313.94  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=205.9

Q ss_pred             eeEcccCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  194 (441)
                      +.||+|+||.||+++.+.... +..+..+|+|.+.+..  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            368999999999998865331 2244679999886532  1233456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-----cEEEEecCCc
Q 013558          195 DFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMLTDFGLA  262 (441)
Q Consensus       195 E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-----~vkl~DFG~a  262 (441)
                      ||+++++|.+++...       ..+++.++..++.||+.||.|||+++++|+||||+||+++.++     .+||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998653       3478899999999999999999999999999999999999887     8999999999


Q ss_pred             cccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          263 KEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       263 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      +.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            76533211   123345788999999999899999999999999999998 99999887777766665443 44566788


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +..+.+||.+||..+|.+||     +++++++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp-----~~~~i~~  265 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERP-----TFDRIQE  265 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            99999999999999999999     7788765

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.7e-40  Score=311.80  Aligned_cols=243  Identities=21%  Similarity=0.337  Sum_probs=194.5

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +.||+|+||.||++....   +.+...+|+|.++....  ......+.+|+.++++++||||+++++++.+...+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence            368999999999998653   22566799998865432  2233467889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+++|+|.+++....     ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999999987532     35677888999999999999999999999999999999999999999999987543221 


Q ss_pred             --CCccccCCCCCCCcchhcCC-------CCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH-hccccCC----
Q 013558          270 --RSNSMCGTTEYMAPEILLSK-------GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLP----  334 (441)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~-~~~~~~p----  334 (441)
                        ......|+..|+|||++.+.       .++.++|||||||++|||++ |..||......+...... .....++    
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL  235 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence              12235678899999998642       35789999999999999996 999998766555443332 2222222    


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       ...++.+.+++.+|+ .+|++||     ++++|..
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rp-----t~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRP-----SAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCC-----CHHHHHH
Confidence             246788999999999 6899999     7788764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.5e-40  Score=318.19  Aligned_cols=254  Identities=21%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||.||++.++.... .....+|+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGE-TVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCC-cceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            345689999999999999999998865211 012357888876532  22333457889999999999999999999875


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      . ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4779999999999999987654 6899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      .....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+... ....+...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            43222   222345778999999999999999999999999999997 99999877665555444332 23345567889


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+++.+||..+|++||     +++++++
T Consensus       240 ~~~li~~c~~~~p~~Rp-----~~~~l~~  263 (303)
T cd05110         240 VYMVMVKCWMIDADSRP-----KFKELAA  263 (303)
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7788776

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.8e-40  Score=310.74  Aligned_cols=250  Identities=31%  Similarity=0.552  Sum_probs=210.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------cchhHHHHHHHHHHHHHh-cCCCCceeeeE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTK-VTHPFIVQLRY  182 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~  182 (441)
                      +|++.+.||+|+||.||++.++.    ..++.+|+|.+.....       ........+..|+.++.+ ++||||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            48889999999999999999864    2467899998864321       122334556778888875 79999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEE
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      ++..++..++||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            99999999999999999999887743    3568999999999999999999996 789999999999999999999999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CC-C
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-P  335 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p-~  335 (441)
                      |||++.............|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...... .+ .
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            999998765544445667899999999999888999999999999999999999999887777666666554332 22 2


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++++.+||.+||+.||++||     ++.++..
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp-----~~~e~~~  265 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARP-----DIIQVSA  265 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCC-----CHHHHHH
Confidence            5789999999999999999999     7777765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=314.42  Aligned_cols=254  Identities=15%  Similarity=0.177  Sum_probs=192.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhH--------HHHHHHHHHHHHhcCCCCce
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------VDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv  178 (441)
                      +..++|++.++||+|+||+||+|.+....  ..+..+|+|+...........        ......+...+..+.|+||+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            44568999999999999999999986511  125667777643322110000        01112233445567899999


Q ss_pred             eeeEEEEeCC----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcE
Q 013558          179 QLRYSFQTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (441)
Q Consensus       179 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v  254 (441)
                      ++++.+....    ..++++|++.. ++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9998766543    45788888744 666666666667899999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-H-----
Q 013558          255 MLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-Q-----  320 (441)
Q Consensus       255 kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~-----  320 (441)
                      ||+|||+|+.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .     
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998753211        12235799999999999999999999999999999999999999987632 2     


Q ss_pred             ---HHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          321 ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       321 ---~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                         +...++......+ +..++++.+++..|+..+|++||     +.++|++
T Consensus       246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp-----~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKP-----DYDALIK  291 (294)
T ss_pred             hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCC-----CHHHHHH
Confidence               1223333333333 35689999999999999999999     7788764

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-40  Score=309.69  Aligned_cols=240  Identities=20%  Similarity=0.285  Sum_probs=195.0

Q ss_pred             eeEcccCCeEEEEEEEcCCCC-----CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDD-----GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +.||+|+||.||++.++....     ......+++|++.....    ....+.+|+.+|+.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            469999999999999875221     11123577777654321    14667889999999999999999999988 778


Q ss_pred             EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-------cEEEEecCCc
Q 013558          191 YLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLA  262 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-------~vkl~DFG~a  262 (441)
                      ++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 799999999999999999999999999999999999999888       8999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCC--CCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccccCCCCCcH
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTS  339 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~  339 (441)
                      .....   .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...+..+...... .....+.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence            87543   2334577889999999876  78999999999999999999 688887765443333222 22233333458


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+.++|.+||..+|.+||     ++.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rp-----t~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRP-----SFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-39  Score=310.69  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=206.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---  188 (441)
                      |++.++||+|+||.||+|.++..  ..+++.+|||++.... ......+.+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            67788999999999999987642  2257889999986543 23334566888999999999999999999886532   


Q ss_pred             ---EEEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                         ..++++||+.+|+|..++...      ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               357899999999998876532      24788999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCC
Q 013558          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  334 (441)
Q Consensus       260 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p  334 (441)
                      |+++.......   .....++..|++||.+.+..++.++|||||||++|+|++ |..||...+..+....+... ....+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99987543221   223345678999999998889999999999999999999 99999888777776666543 34455


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+..+.+++.+||+.+|++||     ++.+++.
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rp-----s~~~~~~  267 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRP-----SFQHLRD  267 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            67889999999999999999999     7788775

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=321.02  Aligned_cols=257  Identities=29%  Similarity=0.507  Sum_probs=214.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh----cchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----IKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .++|-++.+||+|||+.||+|.+..     ..+.||||+-.....    ...+..+...+|..|-+.|+||.||++|++|
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~-----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT-----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc-----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            3568899999999999999998765     678899998643322    2345566778999999999999999999999


Q ss_pred             E-eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccccCCCceecC---CCCcEEEEe
Q 013558          185 Q-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--GIVHRDLKPENILMD---SDGHVMLTD  258 (441)
Q Consensus       185 ~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~---~~~~vkl~D  258 (441)
                      . +.+.+|-|+|||+|.+|..+|+.+..++|.+++.|+.||+.||.||.+.  .|||-||||.|||+-   .-|.+||+|
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            6 4567999999999999999999999999999999999999999999976  499999999999994   457899999


Q ss_pred             cCCccccCCCCC--------CccccCCCCCCCcchhcCC----CCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHH-
Q 013558          259 FGLAKEIDESSR--------SNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQ-  324 (441)
Q Consensus       259 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~-  324 (441)
                      ||+++.++....        +....||.+|++||.+.-.    ..+.++||||+|||+|.++.|+.||..... .++++ 
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            999998755432        3456799999999987633    357899999999999999999999976532 23322 


Q ss_pred             -HHHh-ccccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          325 -RIIN-EKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       325 -~i~~-~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                       .|++ ..+.||  +.++.++++||++||++.-+.|.     ++.++..||||..
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~-----DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI-----DVQQLACDPYLLP  746 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhh-----hHHHHccCccccc
Confidence             2222 245566  47999999999999999999999     8999999999863

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.1e-41  Score=349.94  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=205.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE----
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ----  185 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----  185 (441)
                      .+|+.++.||+||||.||+|+.+-     .|+.||||.+....  .......+.+|+.+|.+|+|||||+++..|.    
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKl-----DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKL-----DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecc-----cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            478999999999999999999986     89999999998764  3445567889999999999999998653100    


Q ss_pred             --------------------------------------------------------------------------e-----
Q 013558          186 --------------------------------------------------------------------------T-----  186 (441)
Q Consensus       186 --------------------------------------------------------------------------~-----  186 (441)
                                                                                                +     
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                      0     


Q ss_pred             ----------------------------C--------CEEEEEEeccCCCchHHHHHHcCCC-CHHHHHHHHHHHHHHHH
Q 013558          187 ----------------------------R--------SKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVS  229 (441)
Q Consensus       187 ----------------------------~--------~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~i~~qi~~~L~  229 (441)
                                                  +        ..+||-||||+...|.+++.++... ....++.+++||++||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                                        0        2378999999987777777666544 57889999999999999


Q ss_pred             HHHHCCCcccccCCCceecCCCCcEEEEecCCccccC-------------------CCCCCccccCCCCCCCcchhcCC-
Q 013558          230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-------------------ESSRSNSMCGTTEYMAPEILLSK-  289 (441)
Q Consensus       230 ~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~-  289 (441)
                      |+|++|||||||||.||++++++.|||+|||+|+...                   .....++.+||.-|+|||++.+. 
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998721                   11134567899999999999865 


Q ss_pred             --CCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccccCCCC----CcHHHHHHHHHhcccCcCCCCCCCCC
Q 013558          290 --GHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKRLGSGPG  362 (441)
Q Consensus       290 --~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~~~~p~~----~s~~~~~li~~~L~~dP~~R~~~~~~  362 (441)
                        .|+.|+|+||||||++||+.   ||.. .....+..++..+.++.|..    --+.-..+|+.||+.||.+||     
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP-----  863 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP-----  863 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC-----
Confidence              49999999999999999986   4643 44556667777666666522    224567899999999999999     


Q ss_pred             ChHHhhhCcccC
Q 013558          363 GVDAIKHHKWFR  374 (441)
Q Consensus       363 ~~~~i~~h~~f~  374 (441)
                      ++.|+|++.||-
T Consensus       864 tA~eLL~s~llp  875 (1351)
T KOG1035|consen  864 TATELLNSELLP  875 (1351)
T ss_pred             CHHHHhhccCCC
Confidence            889999999997

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-39  Score=310.47  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=206.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|++.+.||+|+||.||++...... ..++..+|+|++......  ...+.+.+|+++++.+.|+||+++++++..  
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            357889999999999999999875422 225788999999765432  345678899999999999999999999887  


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ....++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            568999999999999999997754 6899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCC----ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH--------------HHHHHH
Q 013558          266 DESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK--------------LQQRII  327 (441)
Q Consensus       266 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~--------------~~~~i~  327 (441)
                      ......    ....++..|+|||.+.+..++.++||||||+++|||++|..||.......              ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            532211    12344567999999998889999999999999999999999986532211              111122


Q ss_pred             hc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..  ....+..++.++.+|+.+||+.+|.+||     ++.+|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP-----SFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            22  2233456788999999999999999999     7788875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-39  Score=306.72  Aligned_cols=242  Identities=20%  Similarity=0.331  Sum_probs=193.8

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (441)
                      .||+|+||.||+++....   .....+++|.+....  .....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD---TGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcC---CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            699999999999975431   133456777765432  123346788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC---C
Q 013558          197 INGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---S  269 (441)
Q Consensus       197 ~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~---~  269 (441)
                      +++|+|.+++.+.    ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......   .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999998764    24667788899999999999999999999999999999999999999999998642211   1


Q ss_pred             CCccccCCCCCCCcchhcC-------CCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc------ccCCC
Q 013558          270 RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK------VKLPP  335 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~------~~~p~  335 (441)
                      .....+|+..|+|||++..       ..++.++|||||||++|||++ |..||...+..+....+..+.      ..++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            2234578899999999853       245778999999999999997 688998777666666554332      22334


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++.+.+++..|| .+|++||     ++++|++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp-----~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRA-----TAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCC-----CHHHHHH
Confidence            57889999999999 6799999     7788864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-42  Score=305.60  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=209.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .+.|+.+.+||+|.||.||+|+.+.     +++.||+|++-.+.. ....-....+|+++|..++|+|++.+++.|..  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n-----~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~   89 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKN-----TGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcC-----ccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence            3468888999999999999999886     778899987654322 22333445679999999999999999887753  


Q ss_pred             ------CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                            ...+|+||++|+. +|.-.+.+. -+++..+++.++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+||
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence                  3459999999976 788888665 57999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCC-----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--c--
Q 013558          260 GLAKEIDESS-----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--E--  329 (441)
Q Consensus       260 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~--~--  329 (441)
                      |+++.+....     +.+..+-|.+|++||.+.| ..|+++.|||+-|||+.||++|.+.+.+.........|..  +  
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9998764322     2345567999999999886 6799999999999999999999999998877666555531  0  


Q ss_pred             ---------------ccc---CCC-------------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 ---------------KVK---LPP-------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ---------------~~~---~p~-------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                     .+.   +|.             .-++++.+|+.++|..||.+|+     ++++++.|.||..
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~-----~ad~alnh~~F~k  320 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI-----DADQALNHDFFWK  320 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc-----chHhhhchhhhhc
Confidence                           010   111             1245889999999999999999     8899999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=315.26  Aligned_cols=251  Identities=21%  Similarity=0.351  Sum_probs=212.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      ++..+...+.++||+|-||.|.+|...      ....||||.++...  ..+....|.+|+++|.+|+|||||.|+++|.
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve------g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE------GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec------CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            345567888999999999999999864      45789999998764  3445678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .++.+++|+|||++|+|..++.++.  .+.......|+.||+.||+||.+.+++||||.+.|+|++.++++||+|||+++
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence            9999999999999999999998873  33556667799999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCC---ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc--CCCCCCCCCHHHHHHHHHh---c-----c
Q 013558          264 EIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN---E-----K  330 (441)
Q Consensus       264 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--G~~pf~~~~~~~~~~~i~~---~-----~  330 (441)
                      .+-.....   ...+-...|||+|.+..+.++.++|+|+||+++||+++  ...||.....++..++...   .     -
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            65333221   23445688999999999999999999999999999866  8899988777766655432   1     2


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +..|..++.++.++|.+||.+|-++||     +.+++-.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RP-----sFe~lh~  799 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRP-----SFEQLHL  799 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCC-----CHHHHHH
Confidence            345678899999999999999999999     7788744

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=329.79  Aligned_cols=240  Identities=34%  Similarity=0.519  Sum_probs=199.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  188 (441)
                      .+..-+.||+|+||.||+++++.     +|+.||||.+++..  .....+...+|+++|++++|+|||+++++-++..  
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnke-----tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKE-----TGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             ceeehhhhcCCccceeeeecccc-----cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            46677899999999999999886     99999999998754  3344567788999999999999999998765543  


Q ss_pred             ----EEEEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CCC--cEEEE
Q 013558          189 ----KLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMLT  257 (441)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~~--~vkl~  257 (441)
                          .-.+|||||.||+|+..+.+.   ..++|.+...++.++..||.|||++||+||||||.||++-  .+|  ..||+
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence                568999999999999999754   4699999999999999999999999999999999999994  333  58999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhc---
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINE---  329 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~---  329 (441)
                      |||.|+.++.+....+++||..|.+||++.. +.|+..+|.|||||++|+++||..||.....    .++...+...   
T Consensus       167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            9999999999888899999999999999994 8899999999999999999999999964322    2233333321   


Q ss_pred             ------------------cccCCCCCcH----HHHHHHHHhcccCcCCCC
Q 013558          330 ------------------KVKLPPFLTS----EAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       330 ------------------~~~~p~~~s~----~~~~li~~~L~~dP~~R~  357 (441)
                                        .+++|..++.    .+-.++..+|..+|.+|.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                              1223334443    345678889999999997

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=322.00  Aligned_cols=252  Identities=23%  Similarity=0.410  Sum_probs=219.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      |..++..+.++||+|.||.|+++.|+.-  ..+.-.||||+++.+....  ....|.+|+.+|.+|+|+|+|+|||+..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~p--sgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQP--SGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCC--CCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            3344567778999999999999998762  2244569999998765432  56779999999999999999999999887


Q ss_pred             CCEEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                       ..+.+|||++++|+|.+.|++  .+.|.-..+..|+.||+.||.||..+++|||||-..||||.....|||||||+.+.
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             778999999999999999987  35688889999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccccC----CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh-ccccCCCCCc
Q 013558          265 IDESSRSNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~-~~~~~p~~~s  338 (441)
                      +..+...+.+.+    ...|+|||.+....++.++|||++||+||||++ |+.||.+.....++++|-. +++.-|+.++
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs  341 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS  341 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence            877665544333    457999999999999999999999999999999 9999999999999999864 3667788999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  368 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  368 (441)
                      +++.+++.+||..+|.+||     ++..|.
T Consensus       342 edIY~imk~cWah~paDRp-----tFsair  366 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRP-----TFSAIR  366 (1039)
T ss_pred             HHHHHHHHHhccCCccccc-----cHHHHH
Confidence            9999999999999999999     555554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=324.98  Aligned_cols=255  Identities=26%  Similarity=0.501  Sum_probs=219.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  186 (441)
                      ..+-|++.++||.|.+|.||+++.+.     +++..|+|++....    +..+.+..|.++|+.+ .|||++.+|++|..
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~-----~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVK-----TGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeee-----cCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34569999999999999999999886     88899999987643    3334577899999987 59999999999964


Q ss_pred             -----CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          187 -----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                           ++.++||||||.||+.-++++.-  .++.|+.+..|++.++.||.+||++.+||||||-.|||++.+|.|||+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence                 57899999999999998888654  57999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC-CCCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---
Q 013558          260 GLAKEIDES-SRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---  330 (441)
Q Consensus       260 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---  330 (441)
                      |++..+... .+..+.+||+.|||||++..     ..|+..+|+||||++..||.-|.+|+.+..+...+-.|-...   
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk  247 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  247 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence            999886543 34567889999999999974     347788999999999999999999998877766555554432   


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +.-|...++++.+||..||.+|-.+||     ...++++|||....
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP-----~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRP-----STEELLKHPFITEQ  288 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCc-----chhhhccCCccccc
Confidence            223566889999999999999999999     88999999999843

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-38  Score=330.29  Aligned_cols=264  Identities=19%  Similarity=0.307  Sum_probs=184.0

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ...+..++|++.++||+|+||.||+|++..... ..+..||+|.+.....     .+....|  .++...+.+++.++..
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYG  197 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHh
Confidence            344567899999999999999999999875111 1278899998754221     1111111  1122222233222221


Q ss_pred             ------EEeCCEEEEEEeccCCCchHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCc
Q 013558          184 ------FQTRSKLYLILDFINGGHLFFHLYRQGI--------------------FREDQARFYTAEIVSAVSHLHKCGIV  237 (441)
Q Consensus       184 ------~~~~~~~~lv~E~~~gg~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~L~~LH~~~ii  237 (441)
                            ...+..+++||||+.+++|.+++.....                    ..+..++.++.||+.||.|||++||+
T Consensus       198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi  277 (566)
T PLN03225        198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV  277 (566)
T ss_pred             hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence                  2456789999999999999988865421                    12345678999999999999999999


Q ss_pred             ccccCCCceecCC-CCcEEEEecCCccccCCC--CCCccccCCCCCCCcchhcCC----------------------CCC
Q 013558          238 HRDLKPENILMDS-DGHVMLTDFGLAKEIDES--SRSNSMCGTTEYMAPEILLSK----------------------GHN  292 (441)
Q Consensus       238 HrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~  292 (441)
                      ||||||+|||++. ++.+||+|||+|+.+...  ......+||+.|||||.+...                      .++
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            9999999999985 689999999999865332  223467899999999976432                      234


Q ss_pred             CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------------ccCCCCCcHHHHHHHHHhccc
Q 013558          293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------------VKLPPFLTSEAHSLLKGLLHK  351 (441)
Q Consensus       293 ~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---------------------~~~p~~~s~~~~~li~~~L~~  351 (441)
                      .++|||||||+||||+++..++... .......+....                     +.........+.+||.+||++
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            4679999999999999987765422 111111111100                     001111233456999999999


Q ss_pred             CcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       352 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      ||++||     +++++++||||.+..+..+
T Consensus       437 dP~kR~-----ta~e~L~Hpff~~~~~~~~  461 (566)
T PLN03225        437 KGRQRI-----SAKAALAHPYFDREGLLGL  461 (566)
T ss_pred             CcccCC-----CHHHHhCCcCcCCCCcccc
Confidence            999999     8999999999998877543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=298.18  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=209.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      .+|.-++.+|.|.- .|..|-+.-     .++.||+|.+... .......++..+|..++..++|+||++++.+|...  
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            47888999999998 666666543     7889999988665 33455566778899999999999999999998643  


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ..+|+|||+|.. +|...+.  -.++-+.+..++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+
T Consensus        90 l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence                368999999965 7877776  346788999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--------------  329 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--------------  329 (441)
                      .....-..+.++.|..|.|||++.+..|...+||||+||++.||++|...|.+.+..+.+.++...              
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            866655667788999999999999988999999999999999999999999988766655554310              


Q ss_pred             --------c-----c----cCCC-----------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          330 --------K-----V----KLPP-----------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       330 --------~-----~----~~p~-----------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                              .     .    .+|+           .-...+++++.+||..||++|+     +++++|+||||+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri-----sv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI-----SVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc-----cHHHHhcCCeee
Confidence                    0     0    0111           1234689999999999999999     899999999999

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=314.11  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=215.7

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      +|++...+.....+||-|.||.||.+.|+.     ..-.||||.++.+.    -.++.|..|..+|+.++|||+|+|+|+
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKk-----yslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGV  331 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV  331 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeec-----cceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhh
Confidence            344445567778899999999999999987     55579999987643    346678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      |..+..+|||.|||..|+|.++|++..  .++.-.+..++.||..||+||..+++|||||-..|+|+.++..||++|||+
T Consensus       332 CT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  332 CTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             hccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999999998764  367777888999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCc--cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          262 AKEIDESSRSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      ++.+.....+.  ...-...|.|||-+....++.++|||+|||+|||+.| |-.||.+.+....+..+.++ ++.-|..+
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC  491 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC  491 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC
Confidence            99876544322  1223578999999999999999999999999999999 99999999988888777554 67788999


Q ss_pred             cHHHHHHHHHhcccCcCCCCCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGS  359 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~  359 (441)
                      ++...+|++.||+.+|..||+.
T Consensus       492 PpkVYeLMraCW~WsPsDRPsF  513 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSF  513 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccH
Confidence            9999999999999999999944

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.7e-38  Score=290.43  Aligned_cols=240  Identities=46%  Similarity=0.809  Sum_probs=211.5

Q ss_pred             CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCc
Q 013558          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (441)
Q Consensus       122 ~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (441)
                      +||.||++....     +++.+|+|++........  .+.+.+|++++++++|+||+++++.+......++++||+.+++
T Consensus         1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECC-----CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            589999999875     678999999876543221  5678899999999999999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCC
Q 013558          202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM  281 (441)
Q Consensus       202 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~  281 (441)
                      |..++.....+++..+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||.+.............++..|+
T Consensus        74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            99999877779999999999999999999999999999999999999999999999999998876654455677899999


Q ss_pred             CcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccccCCCC---CcHHHHHHHHHhcccCcCCCC
Q 013558          282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPF---LTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       282 aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~  357 (441)
                      +||.+.+..++.++|||+||+++|+|++|..||.. .+.....+.+..........   ++.++.+++.+||..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999988899999999999999999999999987 56666666665554444333   889999999999999999999


Q ss_pred             CCCCCChHHhhhCccc
Q 013558          358 GSGPGGVDAIKHHKWF  373 (441)
Q Consensus       358 ~~~~~~~~~i~~h~~f  373 (441)
                           ++.++++||||
T Consensus       234 -----~~~~~~~~~~~  244 (244)
T smart00220      234 -----TAEEALQHPFF  244 (244)
T ss_pred             -----CHHHHhhCCCC
Confidence                 88999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=315.09  Aligned_cols=242  Identities=25%  Similarity=0.433  Sum_probs=208.9

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  193 (441)
                      +.++||.|-||.||.+......++ ..--||||..+.+..  .+..+.|..|..+|+.++|||||+|+|++.+. ..++|
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kg-e~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKG-ERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccC-cceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            356899999999999988654322 334589999877543  33467789999999999999999999998764 68999


Q ss_pred             EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCc
Q 013558          194 LDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN  272 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  272 (441)
                      ||+++-|.|..+|+.+ ..++......|++||..||.|||+..+|||||-..|||+.....|||+|||+++.+.......
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence            9999999999999876 568999999999999999999999999999999999999999999999999999987665544


Q ss_pred             cccC--CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh-ccccCCCCCcHHHHHHHHHh
Q 013558          273 SMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       273 ~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~~  348 (441)
                      .-.|  ...|||||.+.-..++.++|||.|||++||++. |..||.+....+..-.|.+ ++++.|+.+++.+..|+.+|
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc  628 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC  628 (974)
T ss_pred             ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence            3344  567999999999999999999999999999988 9999998766666655544 47889999999999999999


Q ss_pred             cccCcCCCCCC
Q 013558          349 LHKDPSKRLGS  359 (441)
Q Consensus       349 L~~dP~~R~~~  359 (441)
                      |.++|.+||..
T Consensus       629 WayeP~kRPrf  639 (974)
T KOG4257|consen  629 WAYEPSKRPRF  639 (974)
T ss_pred             hccCcccCCcH
Confidence            99999999943

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=300.35  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=199.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----C---CCce
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----H---PFIV  178 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv  178 (441)
                      +..++|.+.++||.|-|++||+|.+..     ..+.||+|+++..    +.+.+....||++|++++     |   .+||
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq-----~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQ-----NKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeecc-----CCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            344899999999999999999999986     8899999999754    445566778999999983     2   4799


Q ss_pred             eeeEEEEe----CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCC
Q 013558          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD  251 (441)
Q Consensus       179 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~  251 (441)
                      +|++.|..    +.++|+|+|++ |.+|..+|...  ..++...++.|++||+.||.|||. +||||.||||+|||+..+
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            99999974    56899999999 66888888665  469999999999999999999995 799999999999999210


Q ss_pred             --------------------------------------------------------------------------------
Q 013558          252 --------------------------------------------------------------------------------  251 (441)
Q Consensus       252 --------------------------------------------------------------------------------  251 (441)
                                                                                                      
T Consensus       225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n  304 (590)
T KOG1290|consen  225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN  304 (590)
T ss_pred             ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013558          252 --------------------------------------------------------------------------------  251 (441)
Q Consensus       252 --------------------------------------------------------------------------------  251 (441)
                                                                                                      
T Consensus       305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~  384 (590)
T KOG1290|consen  305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI  384 (590)
T ss_pred             cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence                                                                                            


Q ss_pred             ------CcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC------H
Q 013558          252 ------GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------R  319 (441)
Q Consensus       252 ------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~------~  319 (441)
                            -++||+|||-|..+..  ..+.-..|..|+|||++.+.+|+..+||||++|++|||+||...|+...      .
T Consensus       385 ~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  385 PLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             CCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence                  0145555555544322  1233356889999999999999999999999999999999999996322      1


Q ss_pred             HHHHHH------------------------------------------HHhccccCCCCCcHHHHHHHHHhcccCcCCCC
Q 013558          320 QKLQQR------------------------------------------IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       320 ~~~~~~------------------------------------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~  357 (441)
                      ++....                                          ++.+++.++..-..++.+||.-||+.+|++|+
T Consensus       463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            111111                                          11233344444456788999999999999999


Q ss_pred             CCCCCChHHhhhCcccCCC
Q 013558          358 GSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       358 ~~~~~~~~~i~~h~~f~~~  376 (441)
                           ++.++++|||++.+
T Consensus       543 -----tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  543 -----TAAQCLKHPWLNPV  556 (590)
T ss_pred             -----cHHHHhcCccccCC
Confidence                 88999999999876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-37  Score=315.61  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhcc-----------hhHHHHH
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIK-----------KNHVDYM  162 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~-----------~~~~~~~  162 (441)
                      .++..++|++.++||+|+||+||++......           +...++.||||.+.......           ....+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            3466789999999999999999998753211           12345689999986432110           0011223


Q ss_pred             HHHHHHHHhcCCCCc-----eeeeEEEEe--------CCEEEEEEeccCCCchHHHHHHcC-------------------
Q 013558          163 KAERDILTKVTHPFI-----VQLRYSFQT--------RSKLYLILDFINGGHLFFHLYRQG-------------------  210 (441)
Q Consensus       163 ~~E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-------------------  210 (441)
                      ..|+.++.+++|.++     ++++++|..        .+..++||||+.+++|.++++...                   
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            457777888876554     566676643        356899999999999998886421                   


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccc--cCCCCCCCc
Q 013558          211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--CGTTEYMAP  283 (441)
Q Consensus       211 -----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~--~gt~~y~aP  283 (441)
                           .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++............  .+|+.|+||
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                 2356778899999999999999999999999999999999999999999999765433222222  347899999


Q ss_pred             chhcCCC--------------------CC--CcchhhhHHHHHHHHHcCCC-CCCCCCHH-----------HHHHHHHhc
Q 013558          284 EILLSKG--------------------HN--KDADWWSVGILLYEMLTGQP-PFTHANRQ-----------KLQQRIINE  329 (441)
Q Consensus       284 E~~~~~~--------------------~~--~~~DvwslGvvl~elltG~~-pf~~~~~~-----------~~~~~i~~~  329 (441)
                      |++....                    |+  .+.||||+||++|+|++|.. ||......           .....+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9986432                    12  34799999999999999876 77532111           111112222


Q ss_pred             cccCC--CCCcHHHHHHHHHhcccCc---CCCCCCCCCChHHhhhCcccCC
Q 013558          330 KVKLP--PFLTSEAHSLLKGLLHKDP---SKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 ~~~~p--~~~s~~~~~li~~~L~~dP---~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+.++  +.+++.++|||.+||.++|   .+|+     +++|+++||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl-----Sa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRL-----SVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCC-----CHHHHhCCCCcCC
Confidence            33333  4678999999999999876   6899     8999999999964

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-39  Score=321.44  Aligned_cols=260  Identities=24%  Similarity=0.389  Sum_probs=226.6

Q ss_pred             HhhhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceee
Q 013558          101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL  180 (441)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  180 (441)
                      .+...++......|.++||.|-||.||+++.+.-.  .....||||.++...  .+.+...|+.|+.||-+++||||++|
T Consensus       620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrL  695 (996)
T KOG0196|consen  620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRL  695 (996)
T ss_pred             HHhhhhcChhheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEE
Confidence            34445567778899999999999999999987633  245679999997643  34455678899999999999999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                      -|+......+.||.|||++|+|..+|+.+ +.|...++..+++.|+.||.||-+.|.|||||-..||||+.+..+|++||
T Consensus       696 EGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  696 EGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             EEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence            99999999999999999999999999866 78999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCC-CC-ccccC--CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccC
Q 013558          260 GLAKEIDESS-RS-NSMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKL  333 (441)
Q Consensus       260 G~a~~~~~~~-~~-~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~  333 (441)
                      |+++.+.+.. .. ++..|  ...|.|||.+....++.++||||+||+|||.++ |..||-....++..+.|..+ +++-
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP  855 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence            9999875543 22 22333  367999999999999999999999999999888 99999999889988888765 5566


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      |..++..+.+|+..||++|-.+||     .+.+|..
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP-----~F~qiV~  886 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRP-----KFAQIVS  886 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCC-----CHHHHHH
Confidence            678999999999999999999999     7788876

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.7e-39  Score=310.94  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=212.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC------CCce
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIV  178 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv  178 (441)
                      ..+--++|.+....|+|-|++|..|++..     .+..||||+++...+..+    .-+.|++||++|+.      -|++
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~-----r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQA-----RGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccC-----CCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHH
Confidence            34455689999999999999999999875     677999999998765433    34569999999963      4899


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcE
Q 013558          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHV  254 (441)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~v  254 (441)
                      .|+-.|....++|||+|-+. -+|.++|.+.|.   +....++.|+.|++.||..|-.+||+|.||||+|||+++. ..+
T Consensus       498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence            99999999999999999984 489999987764   7888999999999999999999999999999999999875 468


Q ss_pred             EEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC
Q 013558          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (441)
Q Consensus       255 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p  334 (441)
                      ||||||.|....... .+.+.-+..|.|||++.|..|+...|+||+||+||||.||+..|.+.+...++...+.-+-+||
T Consensus       577 KLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  577 KLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             eeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            999999998876654 3344557789999999999999999999999999999999999999887766654432111111


Q ss_pred             ---------------------------------------------------------C---CCcHHHHHHHHHhcccCcC
Q 013558          335 ---------------------------------------------------------P---FLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       335 ---------------------------------------------------------~---~~s~~~~~li~~~L~~dP~  354 (441)
                                                                               .   .+-..+++||.+||..||.
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence                                                                     0   0123578999999999999


Q ss_pred             CCCCCCCCChHHhhhCcccCC
Q 013558          355 KRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       355 ~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +|+     ++.++|.||||..
T Consensus       736 KRi-----t~nqAL~HpFi~~  751 (752)
T KOG0670|consen  736 KRI-----TVNQALKHPFITE  751 (752)
T ss_pred             hcC-----CHHHHhcCCcccC
Confidence            999     8999999999964

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.2e-38  Score=277.73  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=205.6

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  186 (441)
                      ..++|++.+++|+|.|+.||.+....     +.+.++||+++.-      ..+.+.+|+.||+.|. ||||++|++...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~-----~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINIT-----NNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccC-----CCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            45789999999999999999998764     6778999988642      2345889999999997 9999999999876


Q ss_pred             C--CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEecCCcc
Q 013558          187 R--SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAK  263 (441)
Q Consensus       187 ~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG~a~  263 (441)
                      .  ....||+||+.+.+.....   ..++...++.++.|++.||.|||++||+|||+||.|++||.. ..++|+|+|+|.
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence            4  4578999999886654333   568889999999999999999999999999999999999864 579999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCC-CCCHHHHHHHHH-------------h
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRII-------------N  328 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~-~~~~~~~~~~i~-------------~  328 (441)
                      .+......+..+.+..|--||++.. ..|+...|+|||||++..|+..+.||- +.+..+.+-+|.             +
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            9888777777788999999999875 668999999999999999999888874 333333322221             1


Q ss_pred             ccccCC------------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 EKVKLP------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ~~~~~p------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ..+.++                        .-+++++.|||.++|..|-.+|+     |++|++.||||..+
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl-----TakEam~HpyF~~~  328 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL-----TAKEAMAHPYFAPV  328 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc-----chHHHhcCchHHHH
Confidence            111111                        12579999999999999999999     88999999999755

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=286.56  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=209.0

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---  188 (441)
                      .+--+-||.|+||+||.+.+-.     +++.+|+|++..- ...-...+.+.+|+++|...+|.|++..++..+...   
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df  128 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF  128 (449)
T ss_pred             CCCCCcccccceeEEEeccCCC-----CccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence            3444689999999999988654     8999999988542 223334467889999999999999999988876543   


Q ss_pred             --EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       189 --~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                        .+|+|.|+|.. +|...+.....++.+.++-+++||++||.|||+.||+||||||.|+|++.+..+||||||+|+...
T Consensus       129 FqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  129 FQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence              57889999964 888888888889999999999999999999999999999999999999999999999999999764


Q ss_pred             CCC--CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Q 013558          267 ESS--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---------------  328 (441)
Q Consensus       267 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~---------------  328 (441)
                      ...  ..+..+-|.+|+|||++.| ..|+..+||||+|||+.||+..+..|...++.+.++.|..               
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            432  2344567899999999997 5689999999999999999999999988887766665542               


Q ss_pred             --------ccccCC-----------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          329 --------EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       329 --------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                              ...+.|           ..-..+..+++.++|..||++|.     +.++.+.|+|.....
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri-----s~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI-----SVEEALQHRYLEEGR  350 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc-----cHhhhcccccccccc
Confidence                    111111           12335788999999999999999     889999999987654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=267.26  Aligned_cols=215  Identities=27%  Similarity=0.447  Sum_probs=179.6

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  186 (441)
                      ..++...+..||+|+||.|-+.++..     +|...|+|.++....  ....+.+.+|+.+..+. .+|++|.+||.+..
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~-----sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQ-----SGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeecc-----CCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            33456667889999999999999887     899999999976532  33445677788887766 69999999999999


Q ss_pred             CCEEEEEEeccCCCchHH----HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCC
Q 013558          187 RSKLYLILDFINGGHLFF----HLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~----~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++.+++.||.|+- +|..    .+.+.+.++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|+||+||||.
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999999965 5532    334557899999999999999999999964 899999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcC----CCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK  330 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~  330 (441)
                      +..+.+.-..+--.|...|||||.+..    .+|+.++||||||+++.||.+++.||.. .++.+++.+++.+.
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            988766554444678999999999863    4799999999999999999999999986 45566666666553

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=314.13  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=218.7

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCC--CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceee
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGD--SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQL  180 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  180 (441)
                      .+.+..++.++.+.||.|.||.|+++..++.....  ....||||.++....  ....+.+..|+++|+.+ .|+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            45566666778889999999999999876544321  256799999876543  35667889999999999 59999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCC
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~  244 (441)
                      ++++...+.+++|+||+..|+|..+++..+                .++..+...++.||+.|++||++.++|||||-.+
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998766                3888999999999999999999999999999999


Q ss_pred             ceecCCCCcEEEEecCCccccCCCCCCc--cccC--CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCC-
Q 013558          245 NILMDSDGHVMLTDFGLAKEIDESSRSN--SMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN-  318 (441)
Q Consensus       245 NILl~~~~~vkl~DFG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~-  318 (441)
                      ||||..+..+||+|||+|+.........  .-.|  ...|||||.+....|+.++|||||||+|||+++ |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999654433221  1222  345999999999999999999999999999999 999999865 


Q ss_pred             HHHHHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          319 RQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       319 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..++.+.+..+ +...|..++.++.++++.||+.+|++||     +..++..
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP-----~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP-----TFSECVE  574 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            66666666655 5678899999999999999999999999     6666654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=313.98  Aligned_cols=243  Identities=29%  Similarity=0.460  Sum_probs=199.3

Q ss_pred             ceEEeeEcccCCeE-EEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCE
Q 013558          112 FEIFRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (441)
Q Consensus       112 y~~~~~lG~G~~g~-V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  189 (441)
                      |.-.+++|.|+.|+ ||++..       .++.||||.+-.      +..+...+|+..|+.. +|||||++|+.-.+...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-------e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-------EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-------CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            33346799999986 788876       567899997643      3445678999999999 49999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---C--CcEEEEecC
Q 013558          190 LYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---D--GHVMLTDFG  260 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~--~~vkl~DFG  260 (441)
                      +||+.|.|.. +|.+++...+.    ......+.++.|++.||++||+.+||||||||.||||+.   +  ..++|+|||
T Consensus       578 ~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  578 LYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            9999999965 89999977421    112456889999999999999999999999999999975   3  479999999


Q ss_pred             CccccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccccCC-
Q 013558          261 LAKEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-  334 (441)
Q Consensus       261 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p-  334 (441)
                      +++.+..+..    ..+..||-+|+|||++....-+.++|||||||++|+.++ |..||...  .+...+|+.+...+- 
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~  734 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVH  734 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceee
Confidence            9998765432    345679999999999998888889999999999999999 59999643  444566777655432 


Q ss_pred             --CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                        +....++++||.+||.++|..||     ++.+++.||+|+.
T Consensus       735 L~~~~d~eA~dLI~~ml~~dP~~RP-----sa~~VL~HPlFW~  772 (903)
T KOG1027|consen  735 LEPLPDCEAKDLISRMLNPDPQLRP-----SATDVLNHPLFWD  772 (903)
T ss_pred             eccCchHHHHHHHHHhcCCCcccCC-----CHHHHhCCCccCC
Confidence              22223899999999999999999     8899999999975

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=299.01  Aligned_cols=202  Identities=32%  Similarity=0.520  Sum_probs=181.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHH-----HHHHHHHHHHhcC---CCCceee
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD-----YMKAERDILTKVT---HPFIVQL  180 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---hpnIv~l  180 (441)
                      ..+|..++.+|.|+||.|++|.++.     +...|+||.+.|.++....+++     .+-.||+||..++   |+||+++
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~-----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKE-----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             cccceeeeeccccccceEEEeeecc-----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            4579999999999999999999986     7888999999998775544433     2557999999997   9999999


Q ss_pred             eEEEEeCCEEEEEEecc-CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          181 RYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                      +++|++++.+||+||-- +|-+|++++..+..++|.+++.|++|++.|+++||+.||||||||-+||.++.+|-+||+||
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            99999999999999985 45599999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCC
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH  316 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~  316 (441)
                      |.|.....+ ....++||..|.|||++.|..| +..-|||+||++||.++....||..
T Consensus       715 gsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            998765543 4667899999999999999887 6779999999999999999999863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.7e-36  Score=332.12  Aligned_cols=235  Identities=21%  Similarity=0.282  Sum_probs=186.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|...++||+|+||.||+|+.+.     ++..||||.+.....       ....|++++++++|||||++++++.+....
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIK-----NGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECC-----CCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            46667899999999999999875     778999998864321       112468889999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH---KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      |+||||+++|+|.++++   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......
T Consensus       759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999999999999985   3789999999999999999999   6799999999999999999988876 666544322


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC-----HHHHHHHHH---------hccc--
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRII---------NEKV--  331 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~-----~~~~~~~i~---------~~~~--  331 (441)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||....     ..+..+...         ....  
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               223468999999999999999999999999999999999999995321     111111110         0000  


Q ss_pred             --cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          332 --KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       332 --~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                        ..+.....++.+++.+||+.||++||     +++++++
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~  946 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARP-----CANDVLK  946 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCc-----CHHHHHH
Confidence              01111223577899999999999999     7788876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=301.89  Aligned_cols=255  Identities=28%  Similarity=0.485  Sum_probs=220.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++.++|.|+||.||+++++.     +++..|+|+++...   .....-+..|+-+++.++|||||.+++.+-..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~-----s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~d   85 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR-----SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD   85 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc-----cCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence            4689999999999999999999987     88999999998654   333456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .++++||||.||+|.+.-+--++++|.++..++++.+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+...
T Consensus        86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998775432


Q ss_pred             -CCCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC-----CCCCcH
Q 013558          269 -SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----PPFLTS  339 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~-----p~~~s~  339 (441)
                       .+...+.||++|||||+-.   ..+|+..+|||++|++..|+---++|.-...+........+..+.-     +...++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence             2356789999999999864   5679999999999999999998888876555554444444333332     235788


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+.+|++.+|.++|++||     +++.++.|||...-
T Consensus       246 ~fh~fvK~altknpKkRp-----taeklL~h~fvs~~  277 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRP-----TAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHhcCCCccCC-----Chhhheeceeeccc
Confidence            999999999999999999     78899999998643

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=298.29  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=209.9

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      .+..++||+|+||+||++.+-... ..-+-.||+|++.....  ......+..|+-+|.+++|||+++|++++.... +-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Peg-e~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEG-ENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCC-ceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            445679999999999999886531 12345699999876543  333466888999999999999999999998776 88


Q ss_pred             EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      ||++||++|.|.++++.+ +.+.......|..||++||.|||.++++||||-.+||||..-.++||+|||+|+.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999865 5788999999999999999999999999999999999999999999999999998765544


Q ss_pred             Ccccc---CCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh-ccccCCCCCcHHHHHHH
Q 013558          271 SNSMC---GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       271 ~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li  345 (441)
                      .....   -.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+.. +++..|+..+.++..++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            33322   2567999999999999999999999999999999 9999999888888777654 46788999999999999


Q ss_pred             HHhcccCcCCCCC
Q 013558          346 KGLLHKDPSKRLG  358 (441)
Q Consensus       346 ~~~L~~dP~~R~~  358 (441)
                      .+||..|+..||+
T Consensus       934 vkCwmid~~~rp~  946 (1177)
T KOG1025|consen  934 VKCWMIDADSRPT  946 (1177)
T ss_pred             HHHhccCcccCcc
Confidence            9999999999993

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=275.85  Aligned_cols=238  Identities=24%  Similarity=0.428  Sum_probs=191.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEE
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQ  185 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~  185 (441)
                      .....+++++||+|.||.||+|+.       .++.||||++...      ..+.+.+|.+|...  ++|+||++++++-.
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL-------~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek  274 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQL-------DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEK  274 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhc-------cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence            345678889999999999999987       4589999998643      34567788888775  57999999998876


Q ss_pred             eCC----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccccCCCceecCCCC
Q 013558          186 TRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMDSDG  252 (441)
Q Consensus       186 ~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NILl~~~~  252 (441)
                      ...    .++||+||.+.|+|.++|..+ .+++.....++..|++||+|||+-         .|+|||||..||||..|+
T Consensus       275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             cCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            655    899999999999999999775 689999999999999999999952         499999999999999999


Q ss_pred             cEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCC-CC-----CcchhhhHHHHHHHHHcCCC-----------
Q 013558          253 HVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKG-HN-----KDADWWSVGILLYEMLTGQP-----------  312 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslGvvl~elltG~~-----------  312 (441)
                      ...|+|||+|..+....   .....+||..|||||++.+.- ..     .+.||||+|.|||||++...           
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            99999999999875432   234578999999999998742 22     35899999999999998543           


Q ss_pred             -CCC-----CCCHHHHHHHHHhc--cccCCCC-----CcHHHHHHHHHhcccCcCCCCCC
Q 013558          313 -PFT-----HANRQKLQQRIINE--KVKLPPF-----LTSEAHSLLKGLLHKDPSKRLGS  359 (441)
Q Consensus       313 -pf~-----~~~~~~~~~~i~~~--~~~~p~~-----~s~~~~~li~~~L~~dP~~R~~~  359 (441)
                       ||.     ....+++...++..  ++.+|..     --..+++.|..||..|++.|+++
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence             332     22344555555443  4556543     23568899999999999999954

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=263.57  Aligned_cols=260  Identities=18%  Similarity=0.294  Sum_probs=220.6

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      .+..+...+++...++-+|+||.||.+.++..++-.+.+.+.+|.++..  ..+.++..+..|..+|..+.|||+..+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3455666789999999999999999998886555445566777777544  34667888999999999999999999998


Q ss_pred             EEEe-CCEEEEEEeccCCCchHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       183 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      +..+ ....++++.++.-|+|..++...        ..++..+...++.|++.|++|||++||||.||-.+|++||+..+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence            8765 45678888999999998888732        23677888899999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 013558          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~  329 (441)
                      +||+|=.+++.+....   ...+.-....||+||.+....|+..+|+|||||+||||+| |+.||...++.++..-++++
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            9999999999764322   2233345678999999999999999999999999999999 99999999999999988876


Q ss_pred             -cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       ++..|-++++++..++..||...|++||     +.+|+..
T Consensus       515 yRlaQP~NCPDeLf~vMacCWallpeeRP-----sf~Qlv~  550 (563)
T KOG1024|consen  515 YRLAQPFNCPDELFTVMACCWALLPEERP-----SFSQLVI  550 (563)
T ss_pred             ceecCCCCCcHHHHHHHHHHHhcCcccCC-----CHHHHHH
Confidence             6778889999999999999999999999     6667643

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=266.57  Aligned_cols=234  Identities=26%  Similarity=0.430  Sum_probs=185.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~  187 (441)
                      .+..+.+.||+|.||.||+++++       |+.||||++....      .+...+|.+|.+.  |+|+||+.+++.-..+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-------Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-------GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             heeEEEEEecCccccceeecccc-------CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            46889999999999999999985       4679999986532      1345678888875  5999999999876654


Q ss_pred             C----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCCCceecCCCCcEE
Q 013558          188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       188 ~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~vk  255 (441)
                      .    .++||.+|.+.|+|+++|.+ ..++.+...+++..++.||+|||..        .|.|||||..||||..+|..-
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence            3    69999999999999999988 6789999999999999999999942        399999999999999999999


Q ss_pred             EEecCCccccCCCC-----CCccccCCCCCCCcchhcCCC----C--CCcchhhhHHHHHHHHHcC----------CCCC
Q 013558          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG----H--NKDADWWSVGILLYEMLTG----------QPPF  314 (441)
Q Consensus       256 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGvvl~elltG----------~~pf  314 (441)
                      |+|+|+|.......     ..+..+||..|||||++...-    +  =..+||||||.|+||++..          ++||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999997654432     234568999999999997532    1  1358999999999999762          5688


Q ss_pred             CCC-----CHHHHHHHHHhc--cccCCCCC--c---HHHHHHHHHhcccCcCCCC
Q 013558          315 THA-----NRQKLQQRIINE--KVKLPPFL--T---SEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       315 ~~~-----~~~~~~~~i~~~--~~~~p~~~--s---~~~~~li~~~L~~dP~~R~  357 (441)
                      .+.     +.+++..-+...  ++.+|...  .   ..+-.+++.||..||.-|+
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl  491 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL  491 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence            642     334444444333  33444432  1   3466889999999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-32  Score=249.83  Aligned_cols=214  Identities=40%  Similarity=0.663  Sum_probs=186.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      |.+.+.||.|++|.||++....     +++.+|+|.+......  ...+.+.+|+..+++++|+|++++++++......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence            5678999999999999999875     6788999999765322  24567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          192 LILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      +++|++++++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999999999988766 8999999999999999999999999999999999999999999999999998765543 


Q ss_pred             -CCccccCCCCCCCcchh-cCCCCCCcchhhhHHHHHHHHHcCCCCCCC--CCHHHHHHHHHhcccc
Q 013558          270 -RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK  332 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~elltG~~pf~~--~~~~~~~~~i~~~~~~  332 (441)
                       ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..  .+...+.+.|..+...
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence             33456788999999999 667788899999999999999999999977  4455677777766543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.4e-31  Score=242.51  Aligned_cols=211  Identities=38%  Similarity=0.675  Sum_probs=186.7

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (441)
                      ||+|++|.||++....     +++.+++|++.......  ..+.+.+|+++++.+.|++|+++++++......++++|++
T Consensus         1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecC-----CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            6899999999999864     68899999987653221  3467889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCccccCCCC-CCccc
Q 013558          198 NGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESS-RSNSM  274 (441)
Q Consensus       198 ~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~-~~~~~  274 (441)
                      .|++|..++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            999999998776 57899999999999999999999999999999999999999 8999999999998765432 13345


Q ss_pred             cCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCc
Q 013558          275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       275 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      .+...|++||.+... .++.+.|+|++|+++++|                               ..+.+++.+||+.||
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCc
Confidence            678899999999877 788999999999999999                               688999999999999


Q ss_pred             CCCCCCCCCChHHhhhCc
Q 013558          354 SKRLGSGPGGVDAIKHHK  371 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~  371 (441)
                      ++||     +++++++|+
T Consensus       203 ~~R~-----~~~~l~~~~  215 (215)
T cd00180         203 EKRP-----SAKEILEHL  215 (215)
T ss_pred             ccCc-----CHHHHhhCC
Confidence            9999     889998874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.4e-33  Score=264.37  Aligned_cols=254  Identities=23%  Similarity=0.452  Sum_probs=198.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  187 (441)
                      ...|.++++||.|+|++||++.+...  ....+.||+|.+....     ...++.+|+++|..+. +.||+++.+++..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            35699999999999999999987642  2257789999886533     3356889999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~  266 (441)
                      +...+||||++..+..++..   .++-.+++.+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|....
T Consensus       108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            99999999999877666654   3568899999999999999999999999999999999984 5678999999997210


Q ss_pred             C-------------------CC--------------------------CCccccCCCCCCCcchhcCC-CCCCcchhhhH
Q 013558          267 E-------------------SS--------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSV  300 (441)
Q Consensus       267 ~-------------------~~--------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvwsl  300 (441)
                      .                   +.                          ......||++|+|||++... ..+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0                   00                          00123599999999999864 46889999999


Q ss_pred             HHHHHHHHcCCCCCCCCC-HH-------------HHHHHH-Hhcc---------------------c-------------
Q 013558          301 GILLYEMLTGQPPFTHAN-RQ-------------KLQQRI-INEK---------------------V-------------  331 (441)
Q Consensus       301 Gvvl~elltG~~pf~~~~-~~-------------~~~~~i-~~~~---------------------~-------------  331 (441)
                      |||++.++++..||-... ..             ++.+.- ..+.                     +             
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999994321 00             000000 0000                     0             


Q ss_pred             ---cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          332 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       332 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                         ...+..+..+.+|+.+||..||.+|+     +++++|+||||...+
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRi-----tAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRI-----TAEDALKHPFFDEAD  388 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcc-----cHHHHhcCcCCcchh
Confidence               01123456899999999999999999     889999999998654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.98  E-value=6.7e-33  Score=287.69  Aligned_cols=249  Identities=40%  Similarity=0.736  Sum_probs=209.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..+|+.++.|..|+||.||+++++.     +.+.+|+|+ .++.+.-+       +   +|.....|++|          
T Consensus        82 e~df~~IklisngAygavylvrh~~-----trqrfa~ki-Nkq~lilR-------n---ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKE-----TRQRFAMKI-NKQNLILR-------N---ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccc-----cccchhhcc-cccchhhh-------c---cccccCCccee----------
Confidence            4589999999999999999999986     788899954 44332111       1   44455566665          


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                                 |+-...++.-+.++.+.        +.+++|||+.||+|||+||+|+||..=|++|++|||+++.....
T Consensus       136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       45556666666666543        88999999999999999999999999999999999998753111


Q ss_pred             ----------------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc
Q 013558          269 ----------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  332 (441)
Q Consensus       269 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~  332 (441)
                                      -.....|||+.|+|||++..++|+..+|||++|+|+||.+.|+.||.+.++++++..++...+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                            1134569999999999999999999999999999999999999999999999999999998888


Q ss_pred             CCC---CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          333 LPP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       333 ~p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +|+   .+.++++++|.++|+.+|..|.+.+  ++-++++|.||+.+||..|..++  ..|+|-....+++.+||..
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfdTR  349 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFDTR  349 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhh--ccccccccccccchhhccc
Confidence            885   4789999999999999999999875  88999999999999999998665  4599999999999999854

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=5.1e-32  Score=294.56  Aligned_cols=197  Identities=17%  Similarity=0.192  Sum_probs=148.3

Q ss_pred             hcCC-CCceeeeEEE-------EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 013558          171 KVTH-PFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDL  241 (441)
Q Consensus       171 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDl  241 (441)
                      .+.| .||++++++|       .....++++||++ +++|.+++... ..+++.+++.++.||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5788888877       2335688889988 55999999753 56999999999999999999999999999999


Q ss_pred             CCCceecCCC-------------------CcEEEEecCCccccCCCC-----------------CCccccCCCCCCCcch
Q 013558          242 KPENILMDSD-------------------GHVMLTDFGLAKEIDESS-----------------RSNSMCGTTEYMAPEI  285 (441)
Q Consensus       242 kp~NILl~~~-------------------~~vkl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~  285 (441)
                      ||+||||+..                   +.+||+|||+++......                 .....+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999654                   455666666665321100                 0112468999999999


Q ss_pred             hcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CCCCCcHHHHHHHHHhcccCcCCCCCCCCCCh
Q 013558          286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV  364 (441)
Q Consensus       286 ~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~  364 (441)
                      +.+..|+.++|||||||+||||++|..|+....  .....+...... ..........+++.+||++||.+||     ++
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp-----s~  259 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP-----SM  259 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc-----Ch
Confidence            999999999999999999999999998875422  122222211111 0111245677999999999999999     88


Q ss_pred             HHhhhCcccCC
Q 013558          365 DAIKHHKWFRS  375 (441)
Q Consensus       365 ~~i~~h~~f~~  375 (441)
                      .++++||||..
T Consensus       260 ~eil~h~~~~~  270 (793)
T PLN00181        260 SELLQSEFINE  270 (793)
T ss_pred             HHHhhchhhhh
Confidence            99999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=242.82  Aligned_cols=235  Identities=26%  Similarity=0.369  Sum_probs=184.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE-EEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY-SFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~-~~~~~  187 (441)
                      +.|.|.+.||+|.||.+.+|++++     +...+++|.+.+....    ...+.+|...--.| .|.||+.-|+ .|++.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            469999999999999999999997     8889999998765432    34466666655455 5899998765 47888


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CCCcEEEEecCCcccc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~~~vkl~DFG~a~~~  265 (441)
                      +.+++++||++.|+|...+... .+-|...+.++.|++.||.|||++++||||||.+||||-  +..+|||||||+.+..
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999999999998877553 478899999999999999999999999999999999994  3348999999998764


Q ss_pred             CCCCCCccccCCCCCCCcchhcCC-----CCCCcchhhhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhccccCCC
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANR-----QKLQQRIINEKVKLPP  335 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltG~~pf~~~~~-----~~~~~~i~~~~~~~p~  335 (441)
                      +..  ....--+..|.+||+....     ..++.+|+|.||+++|.++||++||.....     .+..+-........|.
T Consensus       174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            432  1222345679999987643     236779999999999999999999964221     1122222222334453


Q ss_pred             ---CCcHHHHHHHHHhcccCcCCC
Q 013558          336 ---FLTSEAHSLLKGLLHKDPSKR  356 (441)
Q Consensus       336 ---~~s~~~~~li~~~L~~dP~~R  356 (441)
                         .+++.+..+.++-|..++++|
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCccccc
Confidence               578999999999999999999

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.8e-29  Score=223.33  Aligned_cols=158  Identities=20%  Similarity=0.228  Sum_probs=130.7

Q ss_pred             CchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCC
Q 013558          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT  278 (441)
Q Consensus       200 g~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  278 (441)
                      |+|.+++... ..+++.+++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6899999874 56999999999999999999999999      999999999999999  9998875442    236899


Q ss_pred             CCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccccC-------CCCCcH--HHHHHHHHh
Q 013558          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKL-------PPFLTS--EAHSLLKGL  348 (441)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~li~~~  348 (441)
                      .|||||++.+..++.++|||||||++|||++|+.||..... ......+.......       +..++.  +++++|.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976543 23333333322211       122333  699999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccC
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      |..||.+||     ++.+++.|+|+.
T Consensus       149 l~~~p~~Rp-----~~~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRRE-----AANHYLAHCRAL  169 (176)
T ss_pred             Hhccccccc-----CHHHHHHHHHHH
Confidence            999999999     889999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.5e-30  Score=270.36  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=203.4

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeec---hhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ....++|.|++|.|+.+....     ....++.|..+.   ...........+..|..+-..+.|+|++..+..+.+...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~-----~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS-----DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecC-----CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            456789999999888887665     333344444331   111222222236678878888999999988777777766


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      .+-+||||++ +|+..+...+.+...++..++.|++.||.|||..||.|||||++|+++..+|.+||+|||.+..+... 
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            6667999999 99999998889999999999999999999999999999999999999999999999999999875332 


Q ss_pred             ----CCCccccCCCCCCCcchhcCCCCCC-cchhhhHHHHHHHHHcCCCCCCCCCHHHHH--H-------HHHhccccCC
Q 013558          269 ----SRSNSMCGTTEYMAPEILLSKGHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQ--Q-------RIINEKVKLP  334 (441)
Q Consensus       269 ----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvvl~elltG~~pf~~~~~~~~~--~-------~i~~~~~~~p  334 (441)
                          .....++|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+..  +       ++..+...+-
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence                2345789999999999999999976 589999999999999999999765443322  1       1111222223


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                      ..++.+.+.+|.+||+.||.+|.     ++++|++.+||+.++-..
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~-----ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRI-----TIEQILNDEWIRSIECCH  595 (601)
T ss_pred             HhchhhHHHHHHHHccCChhhee-----cHHHHhhChHhhhcceEE
Confidence            45788999999999999999999     999999999999886443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=2.6e-27  Score=228.16  Aligned_cols=250  Identities=40%  Similarity=0.657  Sum_probs=207.7

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC-CceeeeEEEEeCCEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSKL  190 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~  190 (441)
                      |.+.+.||.|+||.||++.+.        ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence            788999999999999999865        57899999876554444567788999999999988 799999999888889


Q ss_pred             EEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccccC
Q 013558          191 YLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~  266 (441)
                      +++++++.++++.+.+....   .+.+..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++.+.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999999997776665   799999999999999999999999999999999999999998 79999999998654


Q ss_pred             CCC-------CCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcccc
Q 013558          267 ESS-------RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVK  332 (441)
Q Consensus       267 ~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~  332 (441)
                      ...       .....+||..|+|||.+.+   ..+....|+|++|++++++++|..||.....    ......+......
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            432       2466789999999999987   5788899999999999999999999887653    4455555444433


Q ss_pred             -CCCCCc--------HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          333 -LPPFLT--------SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       333 -~p~~~s--------~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                       ......        ..+.+++.+++..+|..|.     +..+...++|..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~-----~~~~~~~~~~~~  279 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL-----SSSSDLSHDLLA  279 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcC-----CHHHHhhchHhh
Confidence             222211        5789999999999999999     556666655544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.2e-27  Score=234.07  Aligned_cols=168  Identities=23%  Similarity=0.234  Sum_probs=131.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCcee-eeEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQ-LRYS  183 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~  183 (441)
                      ...++|.+.++||+|+||+||+|+++.    .+++.+|||++.....  ......+.+.+|+++|++++|+||+. +++ 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            345689999999999999999998764    1466789998753311  12334566899999999999999985 443 


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc-CCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NILl~~~~~vkl~DFG~a  262 (441)
                         .+..|+||||++|++|.. +.   ...   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus        90 ---~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence               246899999999999962 21   111   1467889999999999999999999 999999999999999999999


Q ss_pred             cccCCCCC---------CccccCCCCCCCcchhcCC
Q 013558          263 KEIDESSR---------SNSMCGTTEYMAPEILLSK  289 (441)
Q Consensus       263 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~  289 (441)
                      +.+.....         ..+.++++.|+|||.+...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            97643221         1356788999999998743

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-26  Score=225.45  Aligned_cols=239  Identities=24%  Similarity=0.365  Sum_probs=188.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC----CCceeeeEEE-E
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----PFIVQLRYSF-Q  185 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~  185 (441)
                      +|++.++||+|+||.||+|.+...    ....+|+|+.........   ..+..|+.+|..+..    .++..+++.+ .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~----~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE----KNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC----CCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence            799999999999999999998751    145799998766432111   146779999998863    6899999999 5


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-----CcEEEEe
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHVMLTD  258 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-----~~vkl~D  258 (441)
                      .+..-|+||+.+ |.+|.++....  +.++..++..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|
T Consensus        92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            788899999998 77999887554  579999999999999999999999999999999999999865     4699999


Q ss_pred             cCCcc--ccC-CC------CC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 013558          259 FGLAK--EID-ES------SR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  327 (441)
Q Consensus       259 FG~a~--~~~-~~------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~  327 (441)
                      ||+++  .+. ..      ..  ...+.||..|+++.+..+...+++.|+||++.++.||+.|..||...........+.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998  321 11      11  223569999999999999999999999999999999999999997654322222222


Q ss_pred             h---c-ccc-CCCCCcHHHHHHHHHhcccCcCCCC
Q 013558          328 N---E-KVK-LPPFLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       328 ~---~-~~~-~p~~~s~~~~~li~~~L~~dP~~R~  357 (441)
                      .   . ... +....+.++.++...+-..+...+|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  285 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP  285 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence            1   1 111 2344567888888888888888888

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=199.32  Aligned_cols=268  Identities=20%  Similarity=0.284  Sum_probs=208.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~  185 (441)
                      +..++|.++++||.|+||.+|++....     +|..||||+-....- .    ..+..|..+.+.|++ ..|..+..++.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~-----~ge~VAiK~Es~~a~-h----pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISIT-----SGEEVAIKLESSKAK-H----PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeecc-----CCceEEEEeecccCC-C----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            556789999999999999999999876     889999998765431 1    235678999998875 56777777888


Q ss_pred             eCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC---CcEEEEecCC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGL  261 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkl~DFG~  261 (441)
                      +...-.+|||++ |.+|.+.+.- ...|+..++.-++-|++.-++|+|.+++|||||||+|+|+.-+   ..+.|+|||+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            888999999998 7799888754 3679999999999999999999999999999999999999643   4689999999


Q ss_pred             ccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcc
Q 013558          262 AKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEK  330 (441)
Q Consensus       262 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~  330 (441)
                      |+.+-...        ......||..|.+-....+...+...|+-|+|.+|..+..|..||.+..   ..+-+++|...+
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            98763221        2345689999999999988889999999999999999999999998743   344566676666


Q ss_pred             ccCC-----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc-------CCCChhhhhhcccC
Q 013558          331 VKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF-------RSINWKTLEAREMQ  387 (441)
Q Consensus       331 ~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f-------~~~~~~~~~~~~~~  387 (441)
                      ...|     ..++.|+.-.|.-|-..--++-|...  -+.++.+--|+       --.||..+.++.-+
T Consensus       241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~--ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q  307 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM--YLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQ  307 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH--HHHHHHHHHHhhccccCCeEeeHHHHHHHhhc
Confidence            6555     46788888888877665555555321  24444332221       12479988765544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-25  Score=204.25  Aligned_cols=207  Identities=21%  Similarity=0.357  Sum_probs=175.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  189 (441)
                      .|++.++||+|+||++++++..-     +++.||||.-...     ...-.+..|.+..+.|. .+.|..+|.+.+.+-+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~-----nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY-----NNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             cceeccccccCcceeeecccccc-----cCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            69999999999999999998765     7899999976432     22235778999999885 7999999988888889


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-----cEEEEecCCcc
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMLTDFGLAK  263 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-----~vkl~DFG~a~  263 (441)
                      -.||+|++ |-+|.+++.-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99999998 77998888655 5699999999999999999999999999999999999997543     58999999999


Q ss_pred             ccCCCCC--------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHh
Q 013558          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIIN  328 (441)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~  328 (441)
                      .+.....        ..+..||..||+-.-..+...++..|+-|||-+++.+|.|.+||.+.   +..+-+++|-.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            8643321        24567999999999999999999999999999999999999999763   44555566643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4.3e-25  Score=201.56  Aligned_cols=175  Identities=15%  Similarity=0.170  Sum_probs=136.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH------HHHHHHHHHhcCCCCceee
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTHPFIVQL  180 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpnIv~l  180 (441)
                      +-.++|+++++||.|+||.||++..       ++..+|+|+++......+.....      +.+|+..+.++.|++|..+
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            4467899999999999999998654       24469999997654444443333      5789999999999999999


Q ss_pred             eEEEEeC--------CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          181 RYSFQTR--------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       181 ~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      .+++...        +..++||||++|.+|.+..    .+++    ....+++.+|..||+.|++|||+||+||+++.+|
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence            8886643        3589999999999997763    2333    2456999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHH
Q 013558          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML  308 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ell  308 (441)
                       ++|+|||............           .++....|+.++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence             9999999887653322111           1444566778999999999876553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1e-24  Score=196.36  Aligned_cols=143  Identities=19%  Similarity=0.285  Sum_probs=112.2

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh-----------------------HHHHHHHHHHHHHh
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------------------HVDYMKAERDILTK  171 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~  171 (441)
                      ...||+|+||.||+|.+.      +|+.||||+++........                       .......|+.+|.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            467999999999999864      6789999999765321111                       01234569999999


Q ss_pred             cCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccccCCCceecCC
Q 013558          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NILl~~  250 (441)
                      +.++++.........  ..++||||++|+++.......+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ 
T Consensus        76 l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          76 LVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             HHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            988776443332222  2389999999987766555567899999999999999999999 799999999999999998 


Q ss_pred             CCcEEEEecCCccccC
Q 013558          251 DGHVMLTDFGLAKEID  266 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~  266 (441)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5889999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=4.1e-24  Score=200.82  Aligned_cols=234  Identities=24%  Similarity=0.342  Sum_probs=153.3

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC----------CCceee
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----------PFIVQL  180 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~l  180 (441)
                      .+...+.||.|+++.||.|.+..     +++.+|||+............+.+++|.-....+.+          -.++-.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~-----t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE-----TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEcc-----CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            36778899999999999999986     899999999876655556667777777655544322          122222


Q ss_pred             eEEEE---------eCC--------EEEEEEeccCCCchHHHHH---HcCCC---CHHHH-HHHHHHHHHHHHHHHHCCC
Q 013558          181 RYSFQ---------TRS--------KLYLILDFINGGHLFFHLY---RQGIF---REDQA-RFYTAEIVSAVSHLHKCGI  236 (441)
Q Consensus       181 ~~~~~---------~~~--------~~~lv~E~~~gg~L~~~l~---~~~~~---~~~~~-~~i~~qi~~~L~~LH~~~i  236 (441)
                      ++...         ...        +.+++|+-+. ++|.+.+.   .....   ....+ ..+..|+++.+++||..||
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl  166 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL  166 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence            22221         111        2467888875 47766643   33222   12223 3345899999999999999


Q ss_pred             cccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCC--------CCCCcchhhhHHHHHHHHH
Q 013558          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK--------GHNKDADWWSVGILLYEML  308 (441)
Q Consensus       237 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslGvvl~ell  308 (441)
                      +|+||||+|++++.+|.++|+||+.....+.....  ...+..|.+||.....        .++.+.|.|+||+++|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999999877664432221  3456789999987542        4678899999999999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCC
Q 013558          309 TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  356 (441)
Q Consensus       309 tG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  356 (441)
                      +|..||...........    .+..-..+++..++||+.+|++||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999986533221111    222222789999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-25  Score=230.90  Aligned_cols=235  Identities=26%  Similarity=0.407  Sum_probs=183.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-hcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~-~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +|...+.||.+.|=+|.+|++.      . ..|+||++.+.. ... ....+++ .|++ ...++|||++.+.-+..++.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~------e-G~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR------E-GLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC------C-ceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence            6888999999999999998864      3 349999987654 122 2333333 3555 66678999999988878888


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc--C
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--D  266 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~--~  266 (441)
                      ..|||-+|... +|++.+..+.-+...+.+.|+.||+.||.-+|+.||+|||||.+||||+.=+-+.|+||...+..  .
T Consensus        95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            89999999965 89999988888899999999999999999999999999999999999999999999999877642  1


Q ss_pred             C--CCCCccccCC----CCCCCcchhcCCC-----------CCCcchhhhHHHHHHHHHc-CCCCCCC-----------C
Q 013558          267 E--SSRSNSMCGT----TEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLT-GQPPFTH-----------A  317 (441)
Q Consensus       267 ~--~~~~~~~~gt----~~y~aPE~~~~~~-----------~~~~~DvwslGvvl~ellt-G~~pf~~-----------~  317 (441)
                      +  .....-+..|    ..|+|||.+....           .+++.||||+||+++||++ |++||.-           .
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            1  1111122222    4699999986422           4678999999999999999 8999952           1


Q ss_pred             CHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          318 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       318 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+..+++|          -+..++.||..|++.||++|+     ++++.|+.
T Consensus       254 ~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~Rl-----SAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKI----------EDVSLRNLILSMIQRDPSKRL-----SAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhC----------cCccHHHHHHHHHccCchhcc-----CHHHHHHh
Confidence            222223222          234789999999999999999     77888874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.4e-23  Score=187.84  Aligned_cols=188  Identities=18%  Similarity=0.230  Sum_probs=139.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-hHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  189 (441)
                      +.+...|++|+||+||++..       .+..++.+.+........ -....+.+|+++|++|. |++|.+++++    ..
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             cccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            34567899999999997653       445566665544332111 11235789999999995 5889999886    45


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc-CCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .|++|||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......
T Consensus        73 ~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             EEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            7999999999988654321      1 2357789999999999999999999 799999999999999999999865543


Q ss_pred             CCC--------------ccccCCCCCCCcchhcCC-CCC-CcchhhhHHHHHHHHHcCCCCCCCC
Q 013558          269 SRS--------------NSMCGTTEYMAPEILLSK-GHN-KDADWWSVGILLYEMLTGQPPFTHA  317 (441)
Q Consensus       269 ~~~--------------~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvvl~elltG~~pf~~~  317 (441)
                      ...              .....++.|++|+....- ..+ ...+|++.|+-+|.++|+..++-+.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            321              011358888998875432 233 4579999999999999998887543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.4e-23  Score=189.31  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=114.1

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-----------------------hHHHHHHHHHHHHHh
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----------------------NHVDYMKAERDILTK  171 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~  171 (441)
                      .+.||+|+||.||+|.+.      +|+.||||+++.......                       .....+..|...+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999999864      578999999986531100                       012234679999999


Q ss_pred             cCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCC
Q 013558          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (441)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~  250 (441)
                      +.|++|.....+....  .|+||||++|+++.........+++..+..++.|++.+|.+||. +||+||||||+|||++ 
T Consensus        76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            9999875544433332  48999999988665443345678899999999999999999999 9999999999999998 


Q ss_pred             CCcEEEEecCCccccCC
Q 013558          251 DGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~~  267 (441)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9.4e-24  Score=199.17  Aligned_cols=269  Identities=28%  Similarity=0.401  Sum_probs=184.3

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCC-----C-------------------------CCCcEEEEEEeechhhcc
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----G-------------------------DSDGIYAMKVMRKDTIIK  155 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~-------------------------~~~~~~avK~~~~~~~~~  155 (441)
                      ++..++|++...||+|....||.++.+....     +                         ...-..|||.|-.-....
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            4667889999999999999999987654110     0                         011235666654322211


Q ss_pred             --hhHHHHHHHHHH------H-----------HH-----hcCCCCceeeeEEEEe-------------------------
Q 013558          156 --KNHVDYMKAERD------I-----------LT-----KVTHPFIVQLRYSFQT-------------------------  186 (441)
Q Consensus       156 --~~~~~~~~~E~~------~-----------l~-----~l~hpnIv~l~~~~~~-------------------------  186 (441)
                        ....+.+-+|..      +           ++     .-+|||||++..+|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence              111222222221      1           11     1259999998877643                         


Q ss_pred             --CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CCC--cEEEEecC
Q 013558          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMLTDFG  260 (441)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~~--~vkl~DFG  260 (441)
                        ...+|+||...+. +|..++..+. .+....+-++.|+++|+.|||++||.|||+|.+||||.  +|+  .+.|+|||
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence              2358999998865 8888887654 46677888999999999999999999999999999994  444  58899999


Q ss_pred             CccccCC-------CCCCccccCCCCCCCcchhcCCC-----C-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHH-
Q 013558          261 LAKEIDE-------SSRSNSMCGTTEYMAPEILLSKG-----H-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-  326 (441)
Q Consensus       261 ~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i-  326 (441)
                      .+-.-+.       ....-...|....||||+....+     . -.++|.|+.|.+.||+++...||.......+..+- 
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence            8643211       11122345778899999987432     1 24799999999999999999999874432221111 


Q ss_pred             -HhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          327 -INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       327 -~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                       ...-+.+|+.+++.+++++..+|++||++|++.  .-+..+++--.|..-+|
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp--~iAANvl~LsLw~~~~~  521 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP--NIAANVLNLSLWRMGED  521 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCc--cHHHhHHHHHHhcCchH
Confidence             123355778999999999999999999999965  24556665444444444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=4.5e-24  Score=222.41  Aligned_cols=293  Identities=33%  Similarity=0.581  Sum_probs=247.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...+.+.+.+-+-+|+++.++.++..+     ++...+.|+..+.........+.+..+-.++-...+|.++.....+.-
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            456678888999999999999988765     666777777766555555555666667767666677888877666667


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ....+||++|+.|++|...++..+..+++-++.++..+..+++|||...+.|||++|.|+|+..+|+.+++|||......
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999998443221


Q ss_pred             C--------------------------------CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCC
Q 013558          267 E--------------------------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF  314 (441)
Q Consensus       267 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf  314 (441)
                      .                                ........||+.|.+||...+......+|||++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                                01123457999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccccCCC---CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCC
Q 013558          315 THANRQKLQQRIINEKVKLPP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK  391 (441)
Q Consensus       315 ~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~  391 (441)
                      ....+++.+++|.......|.   ..+.++++++.++|..+|.+|.++.  ...++..|+||+.++|..+....  ..|+
T Consensus      1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~--~~~~ 1111 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQK--AEFV 1111 (1205)
T ss_pred             CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCcccccccc--CccC
Confidence            999999999999998887764   5789999999999999999999764  56799999999999999997554  4578


Q ss_pred             CCCCCcccccCcccccC
Q 013558          392 PDVSGKDCIANFDKCWT  408 (441)
Q Consensus       392 p~~~~~~~~~~~~~~~~  408 (441)
                      |...+..+.++|...|.
T Consensus      1112 p~~~s~~dtS~~~~r~~ 1128 (1205)
T KOG0606|consen 1112 PQPESTQDTSYFESRFS 1128 (1205)
T ss_pred             CCCCCCCccchhhcccc
Confidence            88887888888877766

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-23  Score=185.72  Aligned_cols=238  Identities=21%  Similarity=0.359  Sum_probs=189.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++..++-+|.+.-.|..|++++.+       ..+++|++.-.....+. .+.+..|.-.|+-+.||||+.+++.|..
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqg-------ndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQG-------NDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccC-------cchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccC
Confidence            334456667788899999999999853       44677777654433322 2346678888888999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC-Cc-ccccCCCceecCCCCcEEEE--ecC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCG-IV-HRDLKPENILMDSDGHVMLT--DFG  260 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~-ii-HrDlkp~NILl~~~~~vkl~--DFG  260 (441)
                      ..++.++..||+.|+|+..++....  .+..++..++.+|+.|+.|||+.. +| ---|....|+||++.+.+|.  |--
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999999987643  678899999999999999999875 44 34689999999999877764  322


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCC---CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccCCC
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP  335 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~  335 (441)
                      ++.  .+    ....-.+.||+||.+..+.-+   ..+|+|||.+++|||.|...||....+.+.--+|.-+  ++.+|+
T Consensus       339 fsf--qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp  412 (448)
T KOG0195|consen  339 FSF--QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP  412 (448)
T ss_pred             eee--ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence            221  11    122346889999999877654   4689999999999999999999988877766666443  678999


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLG  358 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~  358 (441)
                      .++..+..|++-|+..||.+||.
T Consensus       413 gis~hm~klm~icmnedpgkrpk  435 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPK  435 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCC
Confidence            99999999999999999999993

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1e-21  Score=178.60  Aligned_cols=135  Identities=18%  Similarity=0.164  Sum_probs=105.7

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-----CCCCceeeeEEEEeCC
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRS  188 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~  188 (441)
                      -.+.||+|+||.||.  +..     +.. .+||++....   ....+.+.+|+.+++.+     .||||++++++++++.
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~-----~~~-k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~   74 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPE-----DAQ-RCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC   74 (210)
T ss_pred             CcceecCCCceEEEE--CCC-----CcC-eEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence            346899999999995  432     333 4799887643   22345688999999999     5799999999999873


Q ss_pred             ---EEE-EEEec--cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccccCCCceecCC----CCcEEEE
Q 013558          189 ---KLY-LILDF--INGGHLFFHLYRQGIFREDQARFYTAEIVSAV-SHLHKCGIVHRDLKPENILMDS----DGHVMLT  257 (441)
Q Consensus       189 ---~~~-lv~E~--~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~iiHrDlkp~NILl~~----~~~vkl~  257 (441)
                         .++ +|+||  +.+++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.    ++.++|+
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence               434 78999  557999999966 456666  35678888888 9999999999999999999974    3489999


Q ss_pred             ecCCc
Q 013558          258 DFGLA  262 (441)
Q Consensus       258 DFG~a  262 (441)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.9e-22  Score=211.03  Aligned_cols=197  Identities=20%  Similarity=0.379  Sum_probs=161.4

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceee
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQL  180 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l  180 (441)
                      ...+....|.|-+.||+|+||.||+|...      .++.||||+-+.....+---      -.+++.+|+   -+-|+.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHH
Confidence            33456678999999999999999999865      58999999976644332211      223444444   2345666


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-------CCc
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------DGH  253 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-------~~~  253 (441)
                      ...+.-.+..+||+||.+.|+|.+++...+.+++..+.+++.||+.-+++||..+|||+||||+|+||..       .--
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            6666677788999999999999999998889999999999999999999999999999999999999942       335


Q ss_pred             EEEEecCCcccc---CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCC
Q 013558          254 VMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP  312 (441)
Q Consensus       254 vkl~DFG~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~  312 (441)
                      ++|+|||.+-.+   .........++|-.+--+|+..|+.++..+|.|.|+.+++-||.|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999998653   34445566788999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=3.2e-21  Score=179.42  Aligned_cols=147  Identities=24%  Similarity=0.246  Sum_probs=114.9

Q ss_pred             CceEEeeEcccCCeEEEEEE-EcCCCCCCCCcEEEEEEeechhhcc---------------------hhHHHHHHHHHHH
Q 013558          111 DFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDI  168 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~~~~~~~avK~~~~~~~~~---------------------~~~~~~~~~E~~~  168 (441)
                      -|.+.+.||+|+||.||+|. +..     +++.||+|+++......                     ......+..|+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            48899999999999999998 433     78899999997543110                     0011346789999


Q ss_pred             HHhcCCCC--ceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccccCCCc
Q 013558          169 LTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPEN  245 (441)
Q Consensus       169 l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~N  245 (441)
                      ++++.+..  +.++++.    ...++||||+.|++|.........+....+..++.||+.+|.+||++| |+||||||+|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            99997532  3344432    235899999999888666544556777778899999999999999999 9999999999


Q ss_pred             eecCCCCcEEEEecCCccccCC
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      |+++ ++.++|+|||.+.....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccCC
Confidence            9999 88999999999875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6e-20  Score=168.26  Aligned_cols=137  Identities=20%  Similarity=0.326  Sum_probs=113.6

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +.||+|++|.||++.+       .+..+++|+.......     .......+.+|+.++..+.|++|.....++......
T Consensus         2 ~~l~~G~~~~vy~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee-------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            5799999999999986       3456889976532211     112234577899999999999988777777777889


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++||||++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999988865432    7888999999999999999999999999999999 88999999998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-22  Score=209.76  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=208.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  189 (441)
                      .|.+.+.||+|+|+.|-++....    .....+|+|.+.... ......+.+..|..+-+.+. |.|++.+++.....+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~----~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR----DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcC----CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            57778889999999998876543    245567777665433 33455566777888888887 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCcccccCCCceecCCCC-cEEEEecCCcccc
Q 013558          190 LYLILDFINGGHLFFHL-YRQG-IFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEI  265 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l-~~~~-~~~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~  265 (441)
                      .+++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999999888 5554 6788899999999999999999 99999999999999999999 9999999999876


Q ss_pred             CC-CC---CCccccC-CCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhc----cccCC
Q 013558          266 DE-SS---RSNSMCG-TTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINE----KVKLP  334 (441)
Q Consensus       266 ~~-~~---~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~-~~i~~~----~~~~p  334 (441)
                      .. ..   .....+| ++.|+|||...+. ......|+||.|+++.-+++|..|+......... ......    .....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            54 22   2345678 9999999999985 4567899999999999999999999765443321 111111    12333


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ..++....+++.++|..+|..|.     +++++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~-----s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRL-----SIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhcc-----ccccccccccccc
Confidence            56888999999999999999999     8899999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=5.1e-21  Score=187.62  Aligned_cols=174  Identities=25%  Similarity=0.367  Sum_probs=136.1

Q ss_pred             CEEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ..+|+.|++|...+|.+++.+..   ..+......++.|++.|++|   +|.+|||+||.||+...+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            36899999999999999997654   35667888999999999999   9999999999999999999999999999887


Q ss_pred             cCCCC-------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcccc--CC
Q 013558          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LP  334 (441)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~~--~p  334 (441)
                      .....       ..+...||..||+||.+.+..|+.++||||||++|+||++ -...|+.   ...+..+..+.++  +-
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFL  482 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHh
Confidence            65544       4456789999999999999999999999999999999998 3333321   1222333333322  11


Q ss_pred             CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       335 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      .. -++-.+|+.+||.+.|.+||     .+.+.-.|+|.
T Consensus       483 ~d-~p~e~~ll~~lls~~p~~RP-----~~~~~~~~~~~  515 (516)
T KOG1033|consen  483 QD-YPEEYTLLQQLLSPSPEERP-----SAIEVALHEFL  515 (516)
T ss_pred             hc-CcHHHHHHHHhcCCCcccCc-----hHHHHhhhhhc
Confidence            11 23456899999999999999     44555555553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.7e-19  Score=163.74  Aligned_cols=133  Identities=22%  Similarity=0.251  Sum_probs=107.2

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  191 (441)
                      .||+|+||.||++.+       .+..+++|+.......     .......+.+|+++++.+.|+++.....++......+
T Consensus         1 ~ig~G~~~~vy~~~~-------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec-------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            489999999999984       4467899986543211     1222356778999999999887665555556667789


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +||||++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||+++.
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999887755321       7889999999999999999999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.6e-19  Score=164.02  Aligned_cols=140  Identities=19%  Similarity=0.200  Sum_probs=108.8

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-------------------hHHHHHHHHHHHHHhc
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-------------------NHVDYMKAERDILTKV  172 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l  172 (441)
                      |.+.+.||+|+||.||++...      +++.+|||++........                   ........|..++..+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            788899999999999999764      678899999765321000                   0112356789999999


Q ss_pred             CCCC--ceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          173 THPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       173 ~hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      .|++  +...++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||++++
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence            8774  444443    245689999999998865432      1446678899999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccCC
Q 013558          251 DGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~~  267 (441)
                      ++.++|+|||++..+..
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=4.1e-19  Score=185.01  Aligned_cols=138  Identities=22%  Similarity=0.253  Sum_probs=111.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-----hcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-----IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .|...++||+|+||+||++.+.+       ..+++|+.....     .......+.+.+|+++++.++|++|+....++.
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            35667899999999999988643       234444332211     111223456889999999999999998877777


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .....++||||++|++|.+++.        ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            7778899999999999988875        356789999999999999999999999999999 688999999999875

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=5.1e-19  Score=176.65  Aligned_cols=196  Identities=23%  Similarity=0.331  Sum_probs=155.7

Q ss_pred             HHhcCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCC-cccccCCCce
Q 013558          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI-VHRDLKPENI  246 (441)
Q Consensus       169 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i-iHrDlkp~NI  246 (441)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... -.+++--...++++|+.||.|||+..| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45688999999999999999999999999999999999874 457777778899999999999998776 9999999999


Q ss_pred             ecCCCCcEEEEecCCccccCCC---CCCccccCCCCCCCcchhcCCC-------CCCcchhhhHHHHHHHHHcCCCCCCC
Q 013558          247 LMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTH  316 (441)
Q Consensus       247 Ll~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvvl~elltG~~pf~~  316 (441)
                      ++|....+||+|||+.......   .......-...|.|||.+.+..       .+.+.|+||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765321   1111222346699999998642       35679999999999999999999975


Q ss_pred             C----CHHHHHHHHHh-ccccCCC------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          317 A----NRQKLQQRIIN-EKVKLPP------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       317 ~----~~~~~~~~i~~-~~~~~p~------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .    +..++..++.. +...+.+      .+.+++..++++||..+|.+||     +++++..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP-----s~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP-----SIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc-----cHHHHHh
Confidence            2    33456666655 2222221      3455799999999999999999     5565543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=1.2e-18  Score=156.56  Aligned_cols=140  Identities=24%  Similarity=0.301  Sum_probs=99.8

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH---------------------HHHHHHHHHhcC
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY---------------------MKAERDILTKVT  173 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~  173 (441)
                      .+.||+|+||+||+|.+.      +++.||||+++............                     ...|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            467999999999999864      57789999987643211111111                     135666666665


Q ss_pred             CCC--ceeeeEEEEeCCEEEEEEeccCCCchHHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecC
Q 013558          174 HPF--IVQLRYSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (441)
Q Consensus       174 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~-l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~  249 (441)
                      +..  +.+.++.    ...++||||++|+.+... +... .. ...++.++.+++.++.++|. +||+||||||+||+++
T Consensus        76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            433  4444432    246899999999543221 1111 11 16788999999999999999 9999999999999999


Q ss_pred             CCCcEEEEecCCccccCC
Q 013558          250 SDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       250 ~~~~vkl~DFG~a~~~~~  267 (441)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=1.5e-17  Score=155.01  Aligned_cols=137  Identities=23%  Similarity=0.327  Sum_probs=103.9

Q ss_pred             eeEc-ccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh----c------chhHHHHHHHHHHHHHhcCCCCc--eeeeE
Q 013558          116 RVVG-QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----I------KKNHVDYMKAERDILTKVTHPFI--VQLRY  182 (441)
Q Consensus       116 ~~lG-~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~----~------~~~~~~~~~~E~~~l~~l~hpnI--v~l~~  182 (441)
                      ..|| .||.|+||.+..       .+..++||.+.....    .      .......+.+|+.++..+.|++|  +..++
T Consensus        37 ~~lg~~~g~gtv~~v~~-------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             ceeecCCCCccEEEEEe-------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            4577 788888888875       356799998864321    1      11233567889999999998775  66666


Q ss_pred             EEEeC-C---EEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          183 SFQTR-S---KLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       183 ~~~~~-~---~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      +.... .   ..++|||+++| .+|.+++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            64432 2   23599999997 688877754 4566543    5689999999999999999999999999999999999


Q ss_pred             ecCCccc
Q 013558          258 DFGLAKE  264 (441)
Q Consensus       258 DFG~a~~  264 (441)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=5.4e-17  Score=139.41  Aligned_cols=132  Identities=21%  Similarity=0.290  Sum_probs=111.3

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCCEEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY  191 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~  191 (441)
                      +++.||+|.++.||++...       +..+++|.......     ...+..|+.+++.+.|  .++.+++.++...+..+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~   69 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY   69 (155)
T ss_pred             cceecccccccceEEEEec-------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence            4578999999999999864       25799999865432     3457789999999976  58999998888888999


Q ss_pred             EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++|||+.|+.+...       +......++.+++.+|.+||..   +++|+|++|+||+++..+.++++|||.++.
T Consensus        70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99999998877443       5567778899999999999984   799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=5e-16  Score=155.40  Aligned_cols=254  Identities=23%  Similarity=0.237  Sum_probs=191.8

Q ss_pred             CceEEeeEcc--cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013558          111 DFEIFRVVGQ--GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (441)
Q Consensus       111 ~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  187 (441)
                      .|.+.+.+|.  |.+|.||.++...   ...+..+|+|.-+...- .......=.+|....+.++ |+|.++.+..++..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence            4677888999  9999999988721   12778899997432211 1111112234666666664 99999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHCCCcccccCCCceecCCC-CcEEEEecCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVS----AVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGL  261 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~----~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG~  261 (441)
                      +..|+-+|++. .+|..+...... +++..++.+..+...    ||.++|..+++|-|+||.||++..+ ...+++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            99999999995 678777766554 889999999999999    9999999999999999999999999 8899999999


Q ss_pred             ccccCCCCCC------ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhccccC
Q 013558          262 AKEIDESSRS------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--NRQKLQQRIINEKVKL  333 (441)
Q Consensus       262 a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~--~~~~~~~~i~~~~~~~  333 (441)
                      ...+......      ....|...|++||+..+. ++...|+|++|.++.+..+|..+....  +.......+. ...++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~  347 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEF  347 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhh
Confidence            9887554422      223578889999998654 788899999999999999987766433  1111111111 11222


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      -...+.++...+..|++.+|..|+     +.+.++.|++....
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~-----~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRL-----TAQILTALNVIHSK  385 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhh-----HHHHHhccccccch
Confidence            334566777799999999999999     78999999998744

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.60  E-value=9.9e-16  Score=156.84  Aligned_cols=144  Identities=18%  Similarity=0.344  Sum_probs=97.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-------------------------------hhHH
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHV  159 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~  159 (441)
                      +|+. +.||.|++|.||+|+.+.     +|+.||||+.++.....                               .+..
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            4666 789999999999999874     58999999997542100                               1222


Q ss_pred             HHHHHHHHHHHhc----------CCCCceeeeEEEEe-CCEEEEEEeccCCCchHHH--HHHcC----CCCHHHHHHHHH
Q 013558          160 DYMKAERDILTKV----------THPFIVQLRYSFQT-RSKLYLILDFINGGHLFFH--LYRQG----IFREDQARFYTA  222 (441)
Q Consensus       160 ~~~~~E~~~l~~l----------~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~----~~~~~~~~~i~~  222 (441)
                      +.+.+|+.+++..          .+.+.+.+-.++.+ ....+|||||++|+.+.+.  +...+    .+.+..+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            3344444444433          12222322222222 3456799999999999764  33333    244555555555


Q ss_pred             HHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCccccCC
Q 013558          223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDE  267 (441)
Q Consensus       223 qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a~~~~~  267 (441)
                      |++       ..|++|+|+||.||+++.+|    .++++|||++..++.
T Consensus       275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            554       58999999999999999988    999999999987654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=1.2e-14  Score=147.06  Aligned_cols=142  Identities=18%  Similarity=0.301  Sum_probs=97.2

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-------------------------------hhHHH----
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVD----  160 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~~----  160 (441)
                      +.||.|++|.||+|+.+      +|+.||||+.+......                               .+...    
T Consensus       123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            56999999999999976      67899999986532100                               00001    


Q ss_pred             --HHHHHHHHHHhc----C-CCCceeeeEEE-EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHH-HHHH
Q 013558          161 --YMKAERDILTKV----T-HPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVS-AVSH  230 (441)
Q Consensus       161 --~~~~E~~~l~~l----~-hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~-~L~~  230 (441)
                        .+.+|...+.++    . +++|. +-.++ ......++||||++|++|.+..... ...   ....++.+++. .+..
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQ  272 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHH
Confidence              133455545444    2 33332 22222 2244579999999999997766432 122   23445566655 4678


Q ss_pred             HHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       231 LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +|..|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.57  E-value=5.4e-14  Score=142.23  Aligned_cols=215  Identities=18%  Similarity=0.241  Sum_probs=150.8

Q ss_pred             CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHH
Q 013558          139 SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR  218 (441)
Q Consensus       139 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~  218 (441)
                      .+..+.|.+.+...   ....+.+.+-++-|+.++||||+++++.++.++.+|+|+|-+.  -|..++.+.+   ...+.
T Consensus        36 ~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence            56677777775543   2445667788899999999999999999999999999999985  5677776654   67777


Q ss_pred             HHHHHHHHHHHHHH-HCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC-CccccCCCCCCCcchhcCCCCCCcch
Q 013558          219 FYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDAD  296 (441)
Q Consensus       219 ~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~D  296 (441)
                      .-+.||+.||.||| +++++|++|....|+|+..|..||++|-++........ .....--..|..|+.+....  -..|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            88899999999998 67899999999999999999999999988765433221 11111222356666554333  3479


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh-CcccCC
Q 013558          297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH-HKWFRS  375 (441)
Q Consensus       297 vwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~-h~~f~~  375 (441)
                      .|.|||+++|++.|..+-  .           .....+..+++....+-.+.+.-.+..|+.. ..-+.+++. |.||++
T Consensus       186 ~~~Lg~li~el~ng~~~~--~-----------~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~-~~~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  186 SWGLGCLIEELFNGSLLT--K-----------TDLSNTGKIPKALIELYCKKLGATELKRPNK-LRFILECRLLGGFFRN  251 (690)
T ss_pred             hhhHHHHHHHHhCcccCc--c-----------hhhhccCccchhHHHHHHHHhccccccccch-hhHHHHHHhccccccc
Confidence            999999999999993321  1           1112223344455555556666666666652 223344444 888876


Q ss_pred             CC
Q 013558          376 IN  377 (441)
Q Consensus       376 ~~  377 (441)
                      .-
T Consensus       252 ~f  253 (690)
T KOG1243|consen  252 DF  253 (690)
T ss_pred             hH
Confidence            43

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.7e-15  Score=151.69  Aligned_cols=251  Identities=26%  Similarity=0.308  Sum_probs=189.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  186 (441)
                      ...+|..+..||.|.|+.|+.+..+.    .++..|++|...+........+.. ..|+.+...+ .|.+++.++..|..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~----~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRP----EGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecC----CCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccc
Confidence            34578999999999999999887542    267789999887655444333333 3466666666 48999999889988


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG~a~~~  265 (441)
                      .+..|+-.|||+++++...+...-.+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+..+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence            88999999999999887777555678899999999999999999999999999999999999876 78899999988652


Q ss_pred             CCCCCCccccCCCCCC--CcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          266 DESSRSNSMCGTTEYM--APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      .-.  .....+.-.++  +++......+..+.|+++||..+.+.++|...-...   .....|..+.....+....++..
T Consensus       418 ~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  418 AFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             cee--cccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHhhhh
Confidence            211  11122333344  555556677889999999999999999986543221   12344555555555555688999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +.+.++..++..|+     .+.++..|.=|
T Consensus       493 ~~kv~~~~~~~~~~-----l~~~l~~~~~~  517 (524)
T KOG0601|consen  493 LLKVMINPDRKRRP-----SAVELSLHSEF  517 (524)
T ss_pred             hhhhhcCCccccch-----hhhhhcccchh
Confidence            99999999999998     55666655543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.1e-14  Score=135.17  Aligned_cols=205  Identities=17%  Similarity=0.289  Sum_probs=150.0

Q ss_pred             HHHhcCCCCceeeeEEEEeC-----CEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 013558          168 ILTKVTHPFIVQLRYSFQTR-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--I  236 (441)
Q Consensus       168 ~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--i  236 (441)
                      -|-.+.|.|||+++.++.+.     ....++.|||..|+|..+|++.    ..+.....++++-||+.||.|||+..  |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34556799999999988653     4588999999999998888754    45888999999999999999999875  9


Q ss_pred             cccccCCCceecCCCCcEEEEecCCccccCC------CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC
Q 013558          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG  310 (441)
Q Consensus       237 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG  310 (441)
                      +|+++..+-|++..+|-+|+.--.-.. ...      ........|-++|.+||.=.....+..+|||+||+..+||..|
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999988875322111 100      0011223467899999987777777889999999999999887


Q ss_pred             CCCC-CCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          311 QPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       311 ~~pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      ..-- ...........|..-.+-+..   .--+++|.+||+..|..||     ++.+++.||-.-++....+
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~eP~~rp-----~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEGEPNGRP-----DARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeeccC---ccccCcCcccccCCCCCCc-----chhhhhcCceeeecchHHH
Confidence            6542 222222222222222222221   2236789999999999999     8899999999877765543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=7.2e-14  Score=123.18  Aligned_cols=128  Identities=23%  Similarity=0.299  Sum_probs=95.0

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCEEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLI  193 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv  193 (441)
                      ++.|+.|.++.||+++.       .++.|++|+......    ....+..|+.+++.+.+.+++ +++...  ....++|
T Consensus         3 ~~~l~~G~~~~vy~~~~-------~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-------ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEE-------CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence            46788999999999885       356799998754321    112356799999988665544 444433  2345799


Q ss_pred             EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccccCCCceecCCCCcEEEEecCCccc
Q 013558          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI-----VHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-----iHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      |||++|.++...        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++|+|||.+..
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999999887542        11123456799999999999985     9999999999998 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=4.3e-13  Score=120.09  Aligned_cols=148  Identities=19%  Similarity=0.258  Sum_probs=104.2

Q ss_pred             EeeEcccCCeEEEEEEEcCCC-CCCCCcEEEEEEeechhh--------c-----------chhHHHHHH----HHHHHHH
Q 013558          115 FRVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTI--------I-----------KKNHVDYMK----AERDILT  170 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~-~~~~~~~~avK~~~~~~~--------~-----------~~~~~~~~~----~E~~~l~  170 (441)
                      ...||.|--+.||.|....-. ....+..+|||+.+-...        .           ..+....+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357899999999999743100 000246899998764211        0           012233333    8999999


Q ss_pred             hcCC--CCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccccCCCcee
Q 013558          171 KVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENIL  247 (441)
Q Consensus       171 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NIL  247 (441)
                      ++..  -++...+++    ..-++||||+.++.+.....+...+++.++..+..+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9853  455556554    46789999997754533222334566677788889999999998 8999999999999999


Q ss_pred             cCCCCcEEEEecCCccccCC
Q 013558          248 MDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       248 l~~~~~vkl~DFG~a~~~~~  267 (441)
                      ++ ++.+.|+|||.+.....
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            96 57899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=5.5e-12  Score=109.44  Aligned_cols=134  Identities=23%  Similarity=0.250  Sum_probs=99.0

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeec-----hhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-----DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      ..|++|+-+.+|.+.+.+       ..+++|.-.+     ..+..+-..++..+|..+|.++.--.|.--+-++.+....
T Consensus         2 ~~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            357899999999886642       2356665332     2233333445677899999988755555444555677788


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .|+|||++|..|.+.+...       .-.++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            8999999998888888665       144566666777789999999999999999996555 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=1.9e-11  Score=105.62  Aligned_cols=144  Identities=25%  Similarity=0.277  Sum_probs=106.5

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEe-----echhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .+..|-+|+-+.|+++.+       .|+.+.||.-     +...+..+-...+.++|+++|.++.--.|.--.-+|.+..
T Consensus        11 ~l~likQGAEArv~~~~~-------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc-------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            567888999999999886       4566777753     2333334444567788999999886545444444566666


Q ss_pred             EEEEEEeccCC-CchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCCc
Q 013558          189 KLYLILDFING-GHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLA  262 (441)
Q Consensus       189 ~~~lv~E~~~g-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a  262 (441)
                      .-.|+|||++| .++.+++....  .........++.+|-..+.-||.++|||+||.++||++..+|   .+.|+|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            77899999988 36677765542  233333478888999999999999999999999999997665   3589999988


Q ss_pred             cc
Q 013558          263 KE  264 (441)
Q Consensus       263 ~~  264 (441)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            54

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=1.5e-11  Score=113.03  Aligned_cols=140  Identities=15%  Similarity=0.234  Sum_probs=103.8

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeC---CEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTR---SKL  190 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~  190 (441)
                      +.||.|..+.||++...      .++.|++|+.......  .....+..|..+++.+.+  .++.+++.+....   +..
T Consensus         4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~   75 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP   75 (223)
T ss_pred             eecCCCccceEEEEEec------CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence            56899999999999863      3467999997654321  123457889999999975  3456676666553   367


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-------------------------------------  233 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------------  233 (441)
                      ++||||++|.++...+.. ..+++.+...++.+++.+|..||+                                     
T Consensus        76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            899999999887654422 356667777777777777777773                                     


Q ss_pred             -------------------CCCcccccCCCceecCC--CCcEEEEecCCccc
Q 013558          234 -------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKE  264 (441)
Q Consensus       234 -------------------~~iiHrDlkp~NILl~~--~~~vkl~DFG~a~~  264 (441)
                                         ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               23589999999999998  67789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=5.2e-12  Score=128.51  Aligned_cols=155  Identities=22%  Similarity=0.366  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCCCCCC----------ccccCCCCCCCcchhcCCCC
Q 013558          223 EIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----------NSMCGTTEYMAPEILLSKGH  291 (441)
Q Consensus       223 qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~  291 (441)
                      +++.||.|+|+ .++||+.|.|++|.++.+|.+||+.|+++.........          .-..-...|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            45599999996 58999999999999999999999999987654331110          01123567999999999888


Q ss_pred             CCcchhhhHHHHHHHHH-cCCCCCCCCCHHHHHHHHH----hccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHH
Q 013558          292 NKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRII----NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA  366 (441)
Q Consensus       292 ~~~~DvwslGvvl~ell-tG~~pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~  366 (441)
                      +.++|+||+||++|.+. .|+..+...+....+..-.    .....++..++.++++-|.++|..++..||     ++..
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp-----~~~~  261 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP-----TLDL  261 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc-----chhh
Confidence            99999999999999999 5776665543322222111    123345678999999999999999999999     8899


Q ss_pred             hhhCcccCCCChhhhh
Q 013558          367 IKHHKWFRSINWKTLE  382 (441)
Q Consensus       367 i~~h~~f~~~~~~~~~  382 (441)
                      ++..+||.+..-..|.
T Consensus       262 l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  262 LLSIPFFSDPGLKALR  277 (700)
T ss_pred             hhcccccCCchhhhhh
Confidence            9999999987655553

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=3.9e-10  Score=111.36  Aligned_cols=218  Identities=17%  Similarity=0.269  Sum_probs=157.4

Q ss_pred             CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CCEEEEEEecc
Q 013558          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLYLILDFI  197 (441)
Q Consensus       122 ~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~~  197 (441)
                      --.+.|+|..+.     +|..|++|.+..++....+   ....-+++++++.|+|||++.++|.+    +..+++|++|.
T Consensus       288 ~~~Ttyk~~s~~-----DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  288 FSITTYKATSNV-----DGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             ccceeEeeeecc-----CCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            345788888775     7889999998543322221   12235678999999999999998873    45799999998


Q ss_pred             CCC-chHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          198 NGG-HLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       198 ~gg-~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++. +|.++-...               ...+|..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+.+++|...|.
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence            864 676654322               2467899999999999999999999999999999999999998999998888


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC-CCCCCHHHH-HHHHHhccccCCCCCcH
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHANRQKL-QQRIINEKVKLPPFLTS  339 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p-f~~~~~~~~-~~~i~~~~~~~p~~~s~  339 (441)
                      ...+.....             |-+.   --.+-|.=.||.+++.|.||..- +......+. ...|       -..++.
T Consensus       440 ~Dvl~~d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~  496 (655)
T KOG3741|consen  440 MDVLQEDPT-------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYST  496 (655)
T ss_pred             eeeecCCCC-------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhH
Confidence            776554330             1111   12346888999999999998543 111112222 2222       245788


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhC---cccCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH---KWFRSI  376 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h---~~f~~~  376 (441)
                      +++++|.-+...++++|      ++++++.+   .||..+
T Consensus       497 D~rn~v~yl~s~~~~~k------sI~~llp~~~~~ff~vm  530 (655)
T KOG3741|consen  497 DLRNVVEYLESLNFREK------SIQDLLPMIGSRFFTVM  530 (655)
T ss_pred             HHHHHHHHHHhcCcccc------cHHHHHHHHHHHHHHHH
Confidence            99999999999999864      56888765   455443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=8.2e-10  Score=104.36  Aligned_cols=126  Identities=16%  Similarity=0.059  Sum_probs=89.6

Q ss_pred             CCcEEEEEEeechhhc---ch-----hHHHHHHHHHHHHHhcCCCC--ceeeeEEEEe-----CCEEEEEEeccCCC-ch
Q 013558          139 SDGIYAMKVMRKDTII---KK-----NHVDYMKAERDILTKVTHPF--IVQLRYSFQT-----RSKLYLILDFINGG-HL  202 (441)
Q Consensus       139 ~~~~~avK~~~~~~~~---~~-----~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~-----~~~~~lv~E~~~gg-~L  202 (441)
                      .|+.|.||........   ..     .-.....+|...+.+|..-+  ...++++++.     ...-+||+|++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            4567888866432211   00     11113668888888874322  2233444432     23578999999886 78


Q ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-------CCcEEEEecCCccc
Q 013558          203 FFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------DGHVMLTDFGLAKE  264 (441)
Q Consensus       203 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-------~~~vkl~DFG~a~~  264 (441)
                      .+++..  ....++.....++.+++..+.-||..||+|+|+++.|||++.       ++.+.|+||+.++.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            888753  345667788899999999999999999999999999999975       46899999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=8.6e-10  Score=98.44  Aligned_cols=128  Identities=24%  Similarity=0.319  Sum_probs=81.9

Q ss_pred             EEEEEEcCCCCCCCCcEEEEEEeechhh-----------------------cchhHHHHHHHHHHHHHhcCCC--Cceee
Q 013558          126 VFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------------IKKNHVDYMKAERDILTKVTHP--FIVQL  180 (441)
Q Consensus       126 V~~~~~~~~~~~~~~~~~avK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~hp--nIv~l  180 (441)
                      ||.|...      .+..+|||+.+....                       .......+..+|.+.|.++..-  ++.++
T Consensus         2 Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p   75 (188)
T PF01163_consen    2 VYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP   75 (188)
T ss_dssp             EEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E
T ss_pred             EEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE
Confidence            7877754      567899998765211                       0111234577899999999765  45556


Q ss_pred             eEEEEeCCEEEEEEeccC--CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccccCCCceecCCCCcEEEE
Q 013558          181 RYSFQTRSKLYLILDFIN--GGHLFFHLYRQGIFREDQARFYTAEIVSAVSH-LHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~--gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      +++.    .-+|||||++  |..+.. +... .++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|+
T Consensus        76 ~~~~----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   76 YDYN----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             EEEE----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             EEEe----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence            5442    3469999998  555533 3222 12245567777888885555 579999999999999999877 99999


Q ss_pred             ecCCccccC
Q 013558          258 DFGLAKEID  266 (441)
Q Consensus       258 DFG~a~~~~  266 (441)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.97  E-value=2e-08  Score=91.61  Aligned_cols=105  Identities=26%  Similarity=0.300  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHhcCCC--CceeeeEEEEeC----CEEEEEEeccCCC-chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 013558          160 DYMKAERDILTKVTHP--FIVQLRYSFQTR----SKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH  232 (441)
Q Consensus       160 ~~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH  232 (441)
                      ....+|...+..|..-  .+.+.+++.+..    ...++|+|++++. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            3466788887777432  233444554432    2468999999885 78888877555778888999999999999999


Q ss_pred             HCCCcccccCCCceecCCCC---cEEEEecCCccc
Q 013558          233 KCGIVHRDLKPENILMDSDG---HVMLTDFGLAKE  264 (441)
Q Consensus       233 ~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a~~  264 (441)
                      .+||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.92  E-value=2.5e-08  Score=89.74  Aligned_cols=139  Identities=9%  Similarity=0.129  Sum_probs=100.8

Q ss_pred             cccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcCCC--CceeeeEEEEe----CCE
Q 013558          119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHP--FIVQLRYSFQT----RSK  189 (441)
Q Consensus       119 G~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~----~~~  189 (441)
                      |+||.+.|+.....       |+.|-+|.........   ..-...+.+|...|++|..-  .+.+.......    ...
T Consensus        27 ~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~r   99 (216)
T PRK09902         27 RRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWR   99 (216)
T ss_pred             CCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceE
Confidence            57999999988764       3468888764211111   33446788999999988532  24444422111    224


Q ss_pred             EEEEEeccCC-CchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc--EEEEecCCccc
Q 013558          190 LYLILDFING-GHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKE  264 (441)
Q Consensus       190 ~~lv~E~~~g-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkl~DFG~a~~  264 (441)
                      -+||+|-+.| .+|.+++...  .+.++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|.  ++++||--++.
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7899998764 3787777653  34577778899999999999999999999999999999987777  99999986653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=1.3e-08  Score=98.45  Aligned_cols=230  Identities=17%  Similarity=0.277  Sum_probs=151.8

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCcee--------eeEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQ--------LRYSFQ  185 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~--------l~~~~~  185 (441)
                      .+.||+|+-+.+|-+-.-        .--+-|++.+.......      ..+..|... .||-+-.        |+|- .
T Consensus        16 gr~LgqGgea~ly~l~e~--------~d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~   80 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--------RDQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-R   80 (637)
T ss_pred             CccccCCccceeeecchh--------hchhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-C
Confidence            467999999999965422        22455777654321111      122233333 4654332        1221 1


Q ss_pred             eCCEEEEEEeccCCCchHHHHH----Hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          186 TRSKLYLILDFINGGHLFFHLY----RQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~----~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      ....+.++|..+.|..--..+.    ++   ....++-+...++.|+.+...||+.|-+-+|+.++|+|+.+++.|.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence            2223788899887753212221    11   3477888999999999999999999999999999999999999999998


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcC-CCCCCCCC-----HHHHHHHHH
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTG-QPPFTHAN-----RQKLQQRII  327 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG-~~pf~~~~-----~~~~~~~i~  327 (441)
                      -..-....++......+|...|.+||...     +..-+...|.|.||+++++|+.| +.||.+..     +......|.
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            66544444444455678999999999876     33446779999999999999985 99997532     111222333


Q ss_pred             hcccc-----------CC-----CCCcHHHHHHHHHhcccC--cCCCCCC
Q 013558          328 NEKVK-----------LP-----PFLTSEAHSLLKGLLHKD--PSKRLGS  359 (441)
Q Consensus       328 ~~~~~-----------~p-----~~~s~~~~~li~~~L~~d--P~~R~~~  359 (441)
                      .+.+.           -|     ..+++.+..|..+|+..-  +.-||++
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a  290 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA  290 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence            22221           11     236788999999998753  5678854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.86  E-value=3.9e-10  Score=113.84  Aligned_cols=242  Identities=19%  Similarity=0.199  Sum_probs=168.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~  188 (441)
                      ..+..+..+++|+++++++.+...     + +....+.+...        ....-++++|.+++||| .+..++.++.++
T Consensus       242 kws~~fh~fvK~altknpKkRpta-----e-klL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTA-----E-KLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCCh-----h-hheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            346777889999999999866432     2 22224544322        23456899999999999 777777778888


Q ss_pred             EEEEEEeccCCC-c-hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          189 KLYLILDFINGG-H-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       189 ~~~lv~E~~~gg-~-L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ..+++++++.++ + ........-.+.+-+...+.+.-+++|++||+.-=+|||    ||+..+ +..|..||+....+.
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence            999999999887 2 211111112344455556677778899999998778999    887754 789999999998887


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC--CCCcH-HH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFLTS-EA  341 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p--~~~s~-~~  341 (441)
                      ......+..+|+.++|||+.....+....|.|++|+--.+|.-|.+|-...  ......+-.+.  ..+-  ...+. .-
T Consensus       383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccc
Confidence            766677789999999999999999999999999998777888887775431  00000000000  0000  00011 11


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      .++...|+..-|..|+     ....+..|.+|++..
T Consensus       461 ~~~~~~~~~g~P~~pk-----v~mgacfsKvfngCp  491 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPK-----VHMGACFSKVFNGCP  491 (829)
T ss_pred             cCCcccccCCCCCCCc-----chhhHHHHHHhccCc
Confidence            2477788988998888     667888888888753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=3.2e-08  Score=91.23  Aligned_cols=140  Identities=20%  Similarity=0.219  Sum_probs=101.7

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh------------cc-------hhHHHHHHHHHHHHHhc
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------------IK-------KNHVDYMKAERDILTKV  172 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~------------~~-------~~~~~~~~~E~~~l~~l  172 (441)
                      +.+...||-|--+.||.|...      .+..+|||.=+....            ..       .-.....++|.++|++|
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            446689999999999999864      678899996443210            00       01123456799999998


Q ss_pred             CCC--CceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          173 THP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       173 ~hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      ...  .|.+.+++    +...+||||++|-.|...     ++..+.+..++..|++-+.-+-..||||+|+.+-|||+++
T Consensus       167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             hhcCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            644  56655543    567899999999766322     2235556667777777777777999999999999999999


Q ss_pred             CCcEEEEecCCccccC
Q 013558          251 DGHVMLTDFGLAKEID  266 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~  266 (441)
                      +|.+.++||-.+....
T Consensus       238 dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         238 DGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCCEEEEeCcccccCC
Confidence            9999999998765443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.83  E-value=9.5e-08  Score=86.35  Aligned_cols=144  Identities=20%  Similarity=0.240  Sum_probs=94.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH------HHHHHHHHHhc---CCC
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKV---THP  175 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~~l~~l---~hp  175 (441)
                      ..+..++|++.+++-......|.+..-       .++.|++|..+......+.....      ..+++..+.++   ..-
T Consensus        26 ~~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   26 EKILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            345567899999999888888888765       56789999987543222211111      12233333333   223


Q ss_pred             CceeeeEEEEe-----CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          176 FIVQLRYSFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       176 nIv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      .++.++.+.+.     ....++||||++|..|.+...    +.+    .+...+.+++.-||+.|++|+|..|.|++++.
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN  170 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence            33333333222     235678999999988755432    232    24456778889999999999999999999985


Q ss_pred             CCcEEEEecCCccc
Q 013558          251 DGHVMLTDFGLAKE  264 (441)
Q Consensus       251 ~~~vkl~DFG~a~~  264 (441)
                      ++ ++++||+..+.
T Consensus       171 ~~-i~iID~~~k~~  183 (229)
T PF06176_consen  171 NG-IRIIDTQGKRM  183 (229)
T ss_pred             Cc-EEEEECccccc
Confidence            55 99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.71  E-value=1.1e-07  Score=102.51  Aligned_cols=204  Identities=21%  Similarity=0.251  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE----EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 013558          158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (441)
Q Consensus       158 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~  233 (441)
                      .......|+..+..+.|+|++.++.+-.....    +.+..|++.+-++...+..-+.++...++.+..++++||.|+|+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34445567788889999999999887654432    34456788888999999999999999999999999999999999


Q ss_pred             CCCcccccCCC---ceecCCCCcEEEE--ecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCc--chhhhHHHHHHH
Q 013558          234 CGIVHRDLKPE---NILMDSDGHVMLT--DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKD--ADWWSVGILLYE  306 (441)
Q Consensus       234 ~~iiHrDlkp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslGvvl~e  306 (441)
                      ....|.-+...   +-.++.++.+.++  ||+..+.+..........-+..+.++|......+..+  .|+|.+|..+..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            97766666555   5555667778877  9999888776665555566777888998877666544  799999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          307 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       307 lltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +..|..+-...   .....++      +.....+..+++.+|+..++++|+     .+.+++.|+|.+.
T Consensus       385 ~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl-----~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  385 LSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERL-----SALELLTHPFLRF  439 (1351)
T ss_pred             hhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhcc-----chhhhhhchhccc
Confidence            99876543211   1111111      111122778999999999999999     7799999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=5.3e-07  Score=82.44  Aligned_cols=141  Identities=23%  Similarity=0.256  Sum_probs=96.8

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---------------------hhHHHHHHHHHHHHHhcC
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDILTKVT  173 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  173 (441)
                      ...|..|--+.||+|...      .+..+|+|+++.....-                     .....+..+|..-|+++.
T Consensus        53 ~g~istGKEA~Vy~a~~~------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~  126 (268)
T COG1718          53 VGCISTGKEANVYLAETG------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY  126 (268)
T ss_pred             EeeecCCcceEEEeeccC------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            346778888899998753      57889999987543211                     111234556777777774


Q ss_pred             --CCCceeeeEEEEeCCEEEEEEeccCCCch-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecC
Q 013558          174 --HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (441)
Q Consensus       174 --hpnIv~l~~~~~~~~~~~lv~E~~~gg~L-~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~  249 (441)
                        +-.+.+-+++.    .-.|||||+....+ .-.| +.-.+..+++..+..++++.+.-|-. .|+||+||..=|||+.
T Consensus       127 eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         127 EAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             HcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence              33444444433    35799999854311 1111 11223344788888899999988876 9999999999999998


Q ss_pred             CCCcEEEEecCCccccCC
Q 013558          250 SDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       250 ~~~~vkl~DFG~a~~~~~  267 (441)
                       ++.+.|+|||.|....+
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             89999999998876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=4.2e-07  Score=93.08  Aligned_cols=142  Identities=21%  Similarity=0.320  Sum_probs=91.3

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-------------------------------hhHHHHHH-
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVDYMK-  163 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~~~~~-  163 (441)
                      .-|+.++-|.||+|+.+      +|+.||||+.+..-...                               .+..+.+. 
T Consensus       131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            56899999999999987      68999999987632100                               01111222 


Q ss_pred             -----HHHHHHHhcC-----CCCceeeeEEEEeCCEEEEEEeccCCCchHHHH--HHcCCCCHHHHHHHHHHHHHH-HHH
Q 013558          164 -----AERDILTKVT-----HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQGIFREDQARFYTAEIVSA-VSH  230 (441)
Q Consensus       164 -----~E~~~l~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l--~~~~~~~~~~~~~i~~qi~~~-L~~  230 (441)
                           +|..-+.+++     .++|.--.-+++-.+.-.|+|||++|-.+.+..  .. ..++...   ++..++.+ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence                 2333333331     233332222333455678999999998887663  33 3344222   22222222 223


Q ss_pred             HHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       231 LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +-..|++|.|.+|.||+++.+|++.+.|||+...++.
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3458999999999999999999999999999887654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=1.2e-06  Score=80.93  Aligned_cols=134  Identities=16%  Similarity=0.165  Sum_probs=82.5

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEEEEeCCEEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv  193 (441)
                      ..||+|..+.||+.         .+..+++|......     ....+.+|.++++.+..-.  +.+.+++....+...+|
T Consensus         7 ~~i~~G~t~~~y~~---------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv   72 (226)
T TIGR02172         7 TQTGEGGNGESYTH---------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI   72 (226)
T ss_pred             eeecCCCCcceeEe---------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence            57899999999973         23347888876422     2234678999999886433  45667777777888999


Q ss_pred             EeccCCCc-hH--------------HHH-------HHc--CCCCHHH-HHHHHH----------HHHH-HHHHHH----H
Q 013558          194 LDFINGGH-LF--------------FHL-------YRQ--GIFREDQ-ARFYTA----------EIVS-AVSHLH----K  233 (441)
Q Consensus       194 ~E~~~gg~-L~--------------~~l-------~~~--~~~~~~~-~~~i~~----------qi~~-~L~~LH----~  233 (441)
                      ||+++|.. +.              ..+       +..  ....... ...+..          .+.. ...+|.    .
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            99999963 11              111       110  0011000 001100          0111 122222    1


Q ss_pred             CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ..++|+|+.|.||++++++ +.|+||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            2468999999999999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.50  E-value=1.7e-06  Score=77.31  Aligned_cols=128  Identities=25%  Similarity=0.369  Sum_probs=91.4

Q ss_pred             CCceEEeeEcccCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhcc------------------hhHHHHHHHHHHHHH
Q 013558          110 GDFEIFRVVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------------------KNHVDYMKAERDILT  170 (441)
Q Consensus       110 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~------------------~~~~~~~~~E~~~l~  170 (441)
                      .+++.++.||.|.- |.||+++.       .|+.||||+.+.-....                  ....+.+..|.+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg  109 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG  109 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence            57999999999999 99999987       56799999933211100                  023345667777766


Q ss_pred             hcC---CCCc--eeeeEEEEeC------------------CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHH
Q 013558          171 KVT---HPFI--VQLRYSFQTR------------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA  227 (441)
Q Consensus       171 ~l~---hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~  227 (441)
                      +|+   +.++  |+++||..-.                  ....||.||++...         .+...    -+.+|++-
T Consensus       110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~d  176 (207)
T PF13095_consen  110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRD  176 (207)
T ss_pred             HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHH
Confidence            664   5566  8999987321                  13577888877643         22222    34567777


Q ss_pred             HHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       228 L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      |..+|..||+-+|+++.|..   +  -||+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence            88899999999999999987   3  389999864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=2.5e-06  Score=78.70  Aligned_cols=138  Identities=25%  Similarity=0.354  Sum_probs=81.7

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEEEE---eCCE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQ---TRSK  189 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~---~~~~  189 (441)
                      ++.|+.|..+.||++...      + +.+++|.....     .....+..|..+++.+...  -+.+++....   ....
T Consensus         2 i~~l~~G~~n~~~~v~~~------~-~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD------D-GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEET------T-SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             CccCCCCCeeeEEEEEEC------C-cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            567999999999999864      2 58999997553     2345677888888888533  2445555432   3446


Q ss_pred             EEEEEeccCCCchHH----------------HH---HHc----CCCCHHH------HHHH---------------HHHHH
Q 013558          190 LYLILDFINGGHLFF----------------HL---YRQ----GIFREDQ------ARFY---------------TAEIV  225 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~----------------~l---~~~----~~~~~~~------~~~i---------------~~qi~  225 (441)
                      .+++|++++|..+..                .+   +..    ..+....      ...+               ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            899999999987766                11   111    0111000      0000               11122


Q ss_pred             H-HHHHHHH-------CCCcccccCCCceecC-CCCcEEEEecCCccc
Q 013558          226 S-AVSHLHK-------CGIVHRDLKPENILMD-SDGHVMLTDFGLAKE  264 (441)
Q Consensus       226 ~-~L~~LH~-------~~iiHrDlkp~NILl~-~~~~vkl~DFG~a~~  264 (441)
                      . .+..+++       ..++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 2333332       3599999999999999 667778999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=3.6e-06  Score=78.75  Aligned_cols=134  Identities=15%  Similarity=0.118  Sum_probs=80.8

Q ss_pred             EcccCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEe
Q 013558          118 VGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       118 lG~G~~-g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      |-.|.. ..||++...       +..+.||+.....      ...+.+|+++++.+. +--+.+++++....+..++|||
T Consensus         6 ~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           6 VTEGQSGATVYRLDGK-------NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             cCCCCCcCeEEEEcCC-------CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            344555 789988642       3468888875432      224567898988884 3345567777777677899999


Q ss_pred             ccCCCchHHHH-------------------HHcC----CCCHH------HHHHHHH----------------HHHHHHHH
Q 013558          196 FINGGHLFFHL-------------------YRQG----IFRED------QARFYTA----------------EIVSAVSH  230 (441)
Q Consensus       196 ~~~gg~L~~~l-------------------~~~~----~~~~~------~~~~i~~----------------qi~~~L~~  230 (441)
                      +++|..|....                   +...    .+...      .....+.                .+...+..
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99997765321                   1000    11100      0000000                01111222


Q ss_pred             HH-------HCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          231 LH-------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       231 LH-------~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      |-       ...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            21       23489999999999999988889999997743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.28  E-value=5.6e-06  Score=71.85  Aligned_cols=130  Identities=20%  Similarity=0.271  Sum_probs=90.5

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCcee-eeEEEEeCCEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSKL  190 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~~  190 (441)
                      .++.+.||+|++|.||++.++       +..+|+|+-+.+.     ....+..|.++|..+.--++.. +|.+.    ..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-------~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-------GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----ED   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-------CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence            445678999999999999985       3479999876543     2345788999999998766654 33332    23


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccC-CCceecCCCCcEEEEecCCccc
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK-PENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk-p~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++.|||+.|-.|.......   +    +.-+..+++.-.-|-..||-|+.|. |..++|-.++.+.|+||..|+.
T Consensus        88 ~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            4559999998875544321   1    2223345566556778899999886 4445555566999999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=3.3e-05  Score=69.60  Aligned_cols=130  Identities=25%  Similarity=0.266  Sum_probs=91.7

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------------cchhHHHHHHHHHHHHHhcC------CCC
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------------IKKNHVDYMKAERDILTKVT------HPF  176 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------hpn  176 (441)
                      ..||+|+.=.||.--        .....+||++.....             ......+...+|+.....+.      +.+
T Consensus         7 ~~i~~G~~R~cy~HP--------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~   78 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP--------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH   78 (199)
T ss_pred             cccccCCCceEEECC--------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence            579999999999522        344588999877550             00112344556776666655      788


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCC------CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          177 IVQLRYSFQTRSKLYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~g------g~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      |.+++|+.+++--..+|+|.+..      -+|.+++.. +.+++ ....   .+-+-..||-+++|+.+||+|.||++..
T Consensus        79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            99999999999999999998643      267777744 44665 3333   3344456889999999999999999953


Q ss_pred             CC----cEEEEe
Q 013558          251 DG----HVMLTD  258 (441)
Q Consensus       251 ~~----~vkl~D  258 (441)
                      ..    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=1.4e-05  Score=81.94  Aligned_cols=140  Identities=19%  Similarity=0.297  Sum_probs=87.1

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc----------------------------hhHHHHHHHHHH
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------------------------KNHVDYMKAERD  167 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~----------------------------~~~~~~~~~E~~  167 (441)
                      +.||..+.|.||+|+.+      .|+.||||+-+..-...                            .+..+.+..|+.
T Consensus       167 ~piaaASlaQVhrA~L~------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             chhhhcchhheEEEEec------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            57999999999999987      58899999976532100                            111122223333


Q ss_pred             HHH----------hcCCCC------ceeeeEEEEeCCEEEEEEeccCCCchH--HHHHHcCCCCHHHHHHHHHHHHHHHH
Q 013558          168 ILT----------KVTHPF------IVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSAVS  229 (441)
Q Consensus       168 ~l~----------~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~--~~l~~~~~~~~~~~~~i~~qi~~~L~  229 (441)
                      .++          .+.|-+      |.++|-  .-...-.|+||||+|..+.  +.+.+.+ ++...+.   ..+.++..
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~---~~l~~~~~  314 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDIL---NKLVEAYL  314 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHH---HHHHHHHH
Confidence            322          223434      223322  2234678999999998654  4455544 3433332   23333211


Q ss_pred             -HHHHCCCcccccCCCceecCC----CCcEEEEecCCccccCC
Q 013558          230 -HLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       230 -~LH~~~iiHrDlkp~NILl~~----~~~vkl~DFG~a~~~~~  267 (441)
                       -|=..|++|.|-+|.||++..    ++.+.+-|||+...+..
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence             223578999999999999984    67899999999887654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=2e-05  Score=86.64  Aligned_cols=83  Identities=13%  Similarity=0.278  Sum_probs=56.4

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCc--eeeeEEEEeC---
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFI--VQLRYSFQTR---  187 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---  187 (441)
                      .++.|+.|.++.+|++....   +.....+++|+........  ....+.+|.++|+.+. |.+|  .+++.++.+.   
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~---~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGN---GGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             eEEEeCCCCcCceEEEEECC---CCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            35778999999999987642   1112457777754332111  1235778999999995 6664  6777777654   


Q ss_pred             CEEEEEEeccCCCc
Q 013558          188 SKLYLILDFINGGH  201 (441)
Q Consensus       188 ~~~~lv~E~~~gg~  201 (441)
                      +..|+||||++|..
T Consensus       117 G~~flVME~v~G~~  130 (822)
T PLN02876        117 GTAFYIMEYLEGRI  130 (822)
T ss_pred             CCceEEEEecCCcc
Confidence            46789999998864

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.09  E-value=3.8e-06  Score=61.07  Aligned_cols=59  Identities=34%  Similarity=0.727  Sum_probs=47.0

Q ss_pred             CCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCCC----CCCcccCeeee
Q 013558          374 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPT----AGEHFKGYTYV  432 (441)
Q Consensus       374 ~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~f~~~~~~  432 (441)
                      ++++|+.+..++++|||+|.+.+..+.++|+..++......++.....    .+..|.||+|+
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~   63 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYV   63 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCccc
Confidence            478999999999999999999999999999988877655555433221    14789999996

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.99  E-value=3.4e-05  Score=71.81  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.4

Q ss_pred             CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +++|+|+.+.|||++.++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998766567999997743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=2.8e-05  Score=69.67  Aligned_cols=98  Identities=16%  Similarity=0.157  Sum_probs=78.2

Q ss_pred             HHHHHHHhcCC-CCceeeeEEEEeCCEEEEEEeccCCCchHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 013558          164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHK---CGI  236 (441)
Q Consensus       164 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~i  236 (441)
                      .|.-+|+.+.+ +++.+++|+|-    .++|.||...+++...   +..-...++..+..|+.++++.+++|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888898876 69999999983    3568899987665321   1222346899999999999999999997   347


Q ss_pred             cccccCCCceecCCCCcEEEEecCCcccc
Q 013558          237 VHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       237 iHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .-.|++++|+-++++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.88  E-value=0.00019  Score=69.20  Aligned_cols=79  Identities=9%  Similarity=0.080  Sum_probs=55.3

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC---CCceeeeEEEEe--
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT--  186 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~--  186 (441)
                      -.-.+.||.|..+.||.....       +..+.+|..+..     .....+..|...|+.+.-   -.+.++++++..  
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-------~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-------QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-------CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            444678999999999988642       234777774321     112467889999998853   356777877654  


Q ss_pred             -CCEEEEEEeccCCCch
Q 013558          187 -RSKLYLILDFINGGHL  202 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L  202 (441)
                       .+..+||||+++|+++
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence             3678999999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00018  Score=66.81  Aligned_cols=76  Identities=25%  Similarity=0.275  Sum_probs=46.7

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCEEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKLYLI  193 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv  193 (441)
                      ++.|..|-...+|++....    ..++.|++|+.......   . -...+|..+++.+.... ..++++.+. .   .+|
T Consensus         3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~~---~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTEL---I-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCccc---e-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence            4567788888999986431    01467889976542211   1 12346888888885333 344444332 2   379


Q ss_pred             EeccCCCch
Q 013558          194 LDFINGGHL  202 (441)
Q Consensus       194 ~E~~~gg~L  202 (441)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.83  E-value=1.2e-06  Score=96.45  Aligned_cols=253  Identities=15%  Similarity=0.068  Sum_probs=154.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-  185 (441)
                      ...+++.--+|-|.+++--..+.+.       .-+.+|+.+.-..  ..+-..+....|...++...|+++...+.-.. 
T Consensus      1228 ~e~~EV~l~i~~~~~~R~k~Lr~ki-------d~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~p 1300 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKI-------DWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPP 1300 (2724)
T ss_pred             hhhhheeeecccceeeccchHhhhh-------ceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCC
Confidence            4456666666666554432221111       1245555433211  11223344555666677778998876654443 


Q ss_pred             -eCCEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccccCCCceecCCCCcEE
Q 013558          186 -TRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       186 -~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vk  255 (441)
                       +....|.+++|+.+|.++..+-+.    ..+.+.-+.....+.+.+..-+|+..     .+|+++|+-|.+|..+.++|
T Consensus      1301 s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~ 1380 (2724)
T KOG1826|consen 1301 SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVK 1380 (2724)
T ss_pred             CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccc
Confidence             244678999999999999998664    22333333333334466777767532     68999999999999999999


Q ss_pred             EEecCCccccCC-CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccC
Q 013558          256 LTDFGLAKEIDE-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKL  333 (441)
Q Consensus       256 l~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~  333 (441)
                      ++++|+.+...+ ........+++.|+.|++...-.++.++|+|..|+-+|++..|..+|..-....+...+.+.. ..+
T Consensus      1381 ~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sI 1460 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSI 1460 (2724)
T ss_pred             ccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccc
Confidence            999999983322 223345677889999999988888888999999999999999988874321111111111111 122


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +...+.++......+|-..-..||     ....++.-+.|
T Consensus      1461 e~l~pgdaNve~~~~Ll~K~~~rp-----~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1461 EKLKPGDANVEALHRLLWKYMERP-----GQYISLSRDHF 1495 (2724)
T ss_pred             cccCCCcccHHHHHHHHHHhhhcc-----hhhhhcccccc
Confidence            222233444444444445556777     44555555555

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.79  E-value=0.00043  Score=67.11  Aligned_cols=142  Identities=20%  Similarity=0.275  Sum_probs=82.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEE----
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS----  183 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~----  183 (441)
                      +....++.++.|....+|++...       +..+++|+.....     ..+.+..|.+++..|....  +.+++..    
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t~-------~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~   89 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTTD-------VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGR   89 (307)
T ss_pred             CCceeccccCCccccceEEEEeC-------CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence            44556778888888899988642       3358889875421     1223455677777764211  3333321    


Q ss_pred             --EEeCCEEEEEEeccCCCchH----H----------HHHHc-CCC--------CHHHH-----H----------HHHHH
Q 013558          184 --FQTRSKLYLILDFINGGHLF----F----------HLYRQ-GIF--------REDQA-----R----------FYTAE  223 (441)
Q Consensus       184 --~~~~~~~~lv~E~~~gg~L~----~----------~l~~~-~~~--------~~~~~-----~----------~i~~q  223 (441)
                        ....+..++++||++|..+.    .          .++.. ..+        .....     .          .....
T Consensus        90 ~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~  169 (307)
T TIGR00938        90 QLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAE  169 (307)
T ss_pred             eehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHH
Confidence              12246789999999985431    1          11110 001        00000     0          01112


Q ss_pred             HHHHHHHHHH-------CCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       224 i~~~L~~LH~-------~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +...++++..       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       170 LDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3334555542       679999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.72  E-value=0.00074  Score=67.44  Aligned_cols=80  Identities=13%  Similarity=0.149  Sum_probs=53.6

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-c-c--hhHHHHHHHHHHHHHhcC---CCCceeeeEEEEe
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-I-K--KNHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~-~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~  186 (441)
                      -.+.||.|.+..||++....     .++.++||.-..... . .  ....++...|.+.|+.+.   -.++.+++.+  +
T Consensus        30 ~~~elggGn~N~VyrV~~~~-----g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTE-----GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCC-----CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            35789999999999998752     335799998532110 0 1  123456777888888763   2456667665  4


Q ss_pred             CCEEEEEEeccCCC
Q 013558          187 RSKLYLILDFINGG  200 (441)
Q Consensus       187 ~~~~~lv~E~~~gg  200 (441)
                      ....++||||+++.
T Consensus       103 ~~~~~lVME~L~~~  116 (401)
T PRK09550        103 EELAVTVMEDLSDH  116 (401)
T ss_pred             CCCCEEEEecCCCc
Confidence            46688999999864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.62  E-value=6.2e-05  Score=71.48  Aligned_cols=137  Identities=15%  Similarity=0.232  Sum_probs=93.7

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------ch-----------hHH--HHHHHHHHHHHhc
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------KK-----------NHV--DYMKAERDILTKV  172 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~-----------~~~--~~~~~E~~~l~~l  172 (441)
                      +.+...||-|--+.||.+.+.      .|..+++|.-+.....      ..           ..+  -...+|...|+.|
T Consensus        94 ~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL  167 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL  167 (465)
T ss_pred             hhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence            567889999999999998865      6778888864332110      00           001  1234688888887


Q ss_pred             C-CCCce-eeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          173 T-HPFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       173 ~-hpnIv-~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      . |.+=| +.+    +....++|||++.|-.|...-+-      ..+..+...+..-+--|.++|+||+|..--||+|++
T Consensus       168 ~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  168 YERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             HHcCCCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            4 43322 233    34578899999998777443211      123334445555566788999999999999999999


Q ss_pred             CCcEEEEecCCccc
Q 013558          251 DGHVMLTDFGLAKE  264 (441)
Q Consensus       251 ~~~vkl~DFG~a~~  264 (441)
                      ++.++++||-.+..
T Consensus       238 d~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVS  251 (465)
T ss_pred             CCCEEEeechHhhc
Confidence            99999999976544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00027  Score=66.63  Aligned_cols=132  Identities=14%  Similarity=0.210  Sum_probs=74.5

Q ss_pred             EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCEEEEEEec
Q 013558          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDF  196 (441)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~  196 (441)
                      +..|-.+.+|++..       .++.+++|.......  .-.. ...+|..+++.+..-.++ +++...  .  -++||||
T Consensus         4 ~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~   69 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-------PGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEW   69 (256)
T ss_pred             CCCcCcCCeEEEEe-------CCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEe
Confidence            45677888998863       455688887543211  1001 135688888888643332 333332  2  2689999


Q ss_pred             cCCCchHH--------------HH---HHcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCc
Q 013558          197 INGGHLFF--------------HL---YRQG----IFRE-DQARFYTAEI---------VSAVSHLHK--------CGIV  237 (441)
Q Consensus       197 ~~gg~L~~--------------~l---~~~~----~~~~-~~~~~i~~qi---------~~~L~~LH~--------~~ii  237 (441)
                      ++|..+..              .+   +...    +++. ..+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            99865421              11   1111    1111 1122222111         111222222        2489


Q ss_pred             ccccCCCceecCCCCcEEEEecCCccc
Q 013558          238 HRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       238 HrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      |+|+.|.||++++++ +.|+||..|..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999997754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0017  Score=63.29  Aligned_cols=30  Identities=33%  Similarity=0.521  Sum_probs=25.9

Q ss_pred             CCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .|+||+|+.+.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999866556899999774

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.00086  Score=64.54  Aligned_cols=140  Identities=19%  Similarity=0.226  Sum_probs=83.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeE------
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY------  182 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~------  182 (441)
                      +..-++.|..|....+|++..       .+..+++|+....      ..+.+..|+.++..+.+..  +.+++.      
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~-------~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~   81 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTT-------DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEY   81 (296)
T ss_pred             chhheecccCccccceEEEEe-------CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence            344466788888889998864       2346899987541      1234666888888774322  334332      


Q ss_pred             EEEeCCEEEEEEeccCCCchHH--------------HHHHc-CCC----------CHHH--HH--------HHHHHHHHH
Q 013558          183 SFQTRSKLYLILDFINGGHLFF--------------HLYRQ-GIF----------REDQ--AR--------FYTAEIVSA  227 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~--------------~l~~~-~~~----------~~~~--~~--------~i~~qi~~~  227 (441)
                      +....+..++|+++++|..+..              .++.. ..+          .+..  ..        .....+..+
T Consensus        82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  161 (296)
T cd05153          82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE  161 (296)
T ss_pred             eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence            1233556789999999876421              01110 000          0000  00        011122334


Q ss_pred             HHHHHH-------CCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          228 VSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       228 L~~LH~-------~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +.++.+       .+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            444443       469999999999999988778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.55  E-value=0.00062  Score=65.80  Aligned_cols=80  Identities=15%  Similarity=0.144  Sum_probs=47.3

Q ss_pred             EeeEcccCCeEEEEEEEcCC-CCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL  192 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~-~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  192 (441)
                      ++.|..|-...||++..... .....++.|++|+.....    .......+|..+++.+....+ .++++.+. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            34566677779998874320 001125779999975432    111235678888888853333 34555443 2   35


Q ss_pred             EEeccCCCch
Q 013558          193 ILDFINGGHL  202 (441)
Q Consensus       193 v~E~~~gg~L  202 (441)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.41  E-value=0.0017  Score=62.89  Aligned_cols=146  Identities=20%  Similarity=0.320  Sum_probs=97.7

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----------------------chhHHHHHHHHHHHH
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----------------------KKNHVDYMKAERDIL  169 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----------------------~~~~~~~~~~E~~~l  169 (441)
                      ++-..|..|--+.||.|...      .|..+|||+++-.-+.                       .+--.-+...|++-|
T Consensus       147 ~inGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             ecccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            34467888999999998754      6777999988642211                       011112455688888


Q ss_pred             HhcCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccccCCCceec
Q 013558          170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILM  248 (441)
Q Consensus       170 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NILl  248 (441)
                      ++|+...|..---..  -....|||+++.+.....-..+...++...+..+-.|++.-+.-| |.+++||.||.--|+|+
T Consensus       221 kRl~~aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  221 KRLNNAGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY  298 (520)
T ss_pred             HHHHhcCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence            888654432111000  023578999996433322223445677788888888888877776 46899999999999999


Q ss_pred             CCCCcEEEEecCCccccCC
Q 013558          249 DSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       249 ~~~~~vkl~DFG~a~~~~~  267 (441)
                       .+|.+.|+|.+.+.....
T Consensus       299 -hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             -ECCEEEEEEccccccCCC
Confidence             678999999987765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.0031  Score=60.12  Aligned_cols=30  Identities=43%  Similarity=0.605  Sum_probs=25.2

Q ss_pred             CCcccccCCCceecCCCCc-EEEEecCCccc
Q 013558          235 GIVHRDLKPENILMDSDGH-VMLTDFGLAKE  264 (441)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~-vkl~DFG~a~~  264 (441)
                      .++|+|+++.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997565 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.10  E-value=0.0051  Score=60.32  Aligned_cols=76  Identities=16%  Similarity=0.175  Sum_probs=48.3

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc----chhHHHHHHHHHHHHHhcC--CC-CceeeeEEEEeCCE
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----KKNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRSK  189 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~  189 (441)
                      .||.|....||++....     .++.++||.-......    -+-..++..-|...|+...  .| .+.++|.  .+...
T Consensus         2 EigdGnlN~VfrV~~~~-----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE-----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCC-----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc
Confidence            58999999999998532     3357999875422111    1233455667888887764  34 4444533  45556


Q ss_pred             EEEEEeccCC
Q 013558          190 LYLILDFING  199 (441)
Q Consensus       190 ~~lv~E~~~g  199 (441)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            7799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.07  E-value=0.0019  Score=65.13  Aligned_cols=160  Identities=16%  Similarity=0.205  Sum_probs=102.4

Q ss_pred             HHHHHHHHHHhcCCCCceeeeEEEEe-CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 013558          161 YMKAERDILTKVTHPFIVQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (441)
Q Consensus       161 ~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHr  239 (441)
                      .+.-..++++.+.|+|+...+++-.. .....+|||++ +.+|.+.+..+. +......              .+|+.|-
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee
Confidence            35557788999999999998887654 34588899999 558888887654 2221111              2232222


Q ss_pred             ccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH
Q 013558          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (441)
Q Consensus       240 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~  319 (441)
                           |       .++++| .++.   .   .....|                +++|||++|.++.++.-|...+.....
T Consensus        92 -----~-------~~~~td-~~~t---~---~~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~~  136 (725)
T KOG1093|consen   92 -----N-------IIYITD-HFLT---K---YPSPIG----------------PKSDVWSLGFIILELYLGISLEAELTE  136 (725)
T ss_pred             -----h-------hhhccc-cccc---c---CCCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence                 1       223333 1110   0   011111                489999999999999999887765554


Q ss_pred             HHHHHHHHhccc------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          320 QKLQQRIINEKV------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       320 ~~~~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+....+..-..            .+--.+++...+++.+|+-..|..||     ...++.+++-|..+
T Consensus       137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~-----l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP-----LPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc-----chhHHhcCccHHHH
Confidence            444433332110            01123566778899999999999999     67889999988765

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.07  E-value=0.0088  Score=57.90  Aligned_cols=29  Identities=31%  Similarity=0.549  Sum_probs=25.5

Q ss_pred             CCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.02  E-value=0.0055  Score=60.43  Aligned_cols=143  Identities=18%  Similarity=0.242  Sum_probs=80.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~  189 (441)
                      ...+ ..|-.|-...+|++...... ...++.|++|+.....   ...+++ .+|..+++.+..-++. ++++.+.. + 
T Consensus        38 ~~~i-~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g-  109 (344)
T PLN02236         38 ALQV-IPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G-  109 (344)
T ss_pred             cEEE-EEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence            3444 45545888899998753211 1134679999876532   222222 5688888888644433 45555533 2 


Q ss_pred             EEEEEeccCCCchHHH--------------H---HHcC------CCCHHHHHHHHHHH-----------------HHHHH
Q 013558          190 LYLILDFINGGHLFFH--------------L---YRQG------IFREDQARFYTAEI-----------------VSAVS  229 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~--------------l---~~~~------~~~~~~~~~i~~qi-----------------~~~L~  229 (441)
                        .|+||++|.+|...              +   +...      .....++..+..++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              58999987665311              1   1111      01122232332211                 11111


Q ss_pred             HH----H----HCCCcccccCCCceecCC-CCcEEEEecCCcc
Q 013558          230 HL----H----KCGIVHRDLKPENILMDS-DGHVMLTDFGLAK  263 (441)
Q Consensus       230 ~L----H----~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~  263 (441)
                      .|    .    ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22    1    225899999999999986 4789999998775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.68  E-value=0.014  Score=57.25  Aligned_cols=144  Identities=17%  Similarity=0.240  Sum_probs=79.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~  188 (441)
                      ++.++..+. .|-...+|++...+..  ..+..|++|+.....   ...++ -.+|..+++.+..-++. ++++++. .+
T Consensus        15 ~~i~i~~l~-gGlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G   86 (330)
T PLN02421         15 SDFSVERIS-GGITNLLLKVSVKEEN--GNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG   86 (330)
T ss_pred             CceEEEEeC-CcccceEEEEEecCCC--CCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc
Confidence            345554444 4777889988754311  123478899875432   11122 24688888888654443 4555553 33


Q ss_pred             EEEEEEeccCCCchHH--------------HH---HHcC-C----C-CHHHHHHHHHHH---------------------
Q 013558          189 KLYLILDFINGGHLFF--------------HL---YRQG-I----F-REDQARFYTAEI---------------------  224 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~--------------~l---~~~~-~----~-~~~~~~~i~~qi---------------------  224 (441)
                         +|.+|++|..|..              .+   +... +    . -...+..+..++                     
T Consensus        87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~  163 (330)
T PLN02421         87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE  163 (330)
T ss_pred             ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence               5899998765421              11   1111 0    1 122222222221                     


Q ss_pred             -HHHHHHHH----HCC----CcccccCCCceecCC-CCcEEEEecCCccc
Q 013558          225 -VSAVSHLH----KCG----IVHRDLKPENILMDS-DGHVMLTDFGLAKE  264 (441)
Q Consensus       225 -~~~L~~LH----~~~----iiHrDlkp~NILl~~-~~~vkl~DFG~a~~  264 (441)
                       ..-+..+.    ..+    ++|.|+.+.|||+++ ++.++++||..|..
T Consensus       164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             11122221    222    699999999999975 57899999987743

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.48  E-value=0.029  Score=56.11  Aligned_cols=77  Identities=13%  Similarity=0.131  Sum_probs=50.2

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cch---hHHHHHHHHHHHHHhcC---CCCceeeeEEEEe
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKK---NHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~  186 (441)
                      ..+.||.|....||++...       ++.++||.-..... ...   ....+...|...|+.+.   ..++.+++.++. 
T Consensus        36 ~~~eiggGn~N~VyrV~~~-------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4678899999999998752       23588987542211 111   12344455677777664   246777877665 


Q ss_pred             CCEEEEEEeccCC
Q 013558          187 RSKLYLILDFING  199 (441)
Q Consensus       187 ~~~~~lv~E~~~g  199 (441)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             456788999977

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.47  E-value=0.064  Score=52.01  Aligned_cols=30  Identities=23%  Similarity=0.243  Sum_probs=27.3

Q ss_pred             CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +++|+|+.+.|||++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999987653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.46  E-value=0.015  Score=56.58  Aligned_cols=72  Identities=29%  Similarity=0.380  Sum_probs=53.8

Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ....|++|++- |+.|. .+   ......++..|+.+.+.-++-+..+ ..-|||+...||||+ +|+|.|+||-+++.
T Consensus       298 ~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            34577888875 44442 11   2235677778888877777666643 589999999999999 99999999999984

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.35  E-value=0.03  Score=55.68  Aligned_cols=78  Identities=15%  Similarity=0.230  Sum_probs=51.4

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcC--CC-CceeeeEEEEeCC
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRS  188 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~  188 (441)
                      .+.||.|.-..||++....     .++.++||.-.......   +-..++..-|...|+...  .| ++.++|.  .+..
T Consensus        34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH
Confidence            6789999999999998742     24568888753221111   233566777888888764  34 4555543  4556


Q ss_pred             EEEEEEeccCC
Q 013558          189 KLYLILDFING  199 (441)
Q Consensus       189 ~~~lv~E~~~g  199 (441)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            67789999854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.16  E-value=0.072  Score=51.56  Aligned_cols=148  Identities=16%  Similarity=0.188  Sum_probs=83.5

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~  188 (441)
                      ...+++.+-.|..-.+|....       +++.++|. ... ............+|..+++.+.-  --+...++.+.++.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~-------~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~   96 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGD-------TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY   96 (321)
T ss_pred             CCceeeeccCCcccceEEEec-------CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC
Confidence            345555553444444554432       35678887 321 12223344556778888888753  12233455665554


Q ss_pred             --EEEEEEeccCCCch---------H---------HHHHHc-----------C---CCCHHHHHHHHHHH----------
Q 013558          189 --KLYLILDFINGGHL---------F---------FHLYRQ-----------G---IFREDQARFYTAEI----------  224 (441)
Q Consensus       189 --~~~lv~E~~~gg~L---------~---------~~l~~~-----------~---~~~~~~~~~i~~qi----------  224 (441)
                        ..|.||+|++|..+         .         +.|..-           +   .+...++..+..+.          
T Consensus        97 ~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173          97 LGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             CCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence              67999999998322         1         111100           0   01111222222222          


Q ss_pred             ----HHHHHHHHHC--------CCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          225 ----VSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       225 ----~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                          ..-..+|+.+        .++|+|+.+.||+|+.++-+=|.||+++..-+.
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                2234455533        389999999999999999999999999876443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.07  E-value=0.11  Score=49.80  Aligned_cols=76  Identities=17%  Similarity=0.285  Sum_probs=47.4

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~  188 (441)
                      .+-.+.|+.|.-..+|++.  .     .++.|.||+-...      ....+..|..-|+.|.   --.+.+++++....+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~-----~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--T-----DGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--T-----TS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eeeeEecCCCChhheEEEE--C-----CCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            4456778889999999887  2     6778999987632      1235677888888883   345778888888777


Q ss_pred             EEEEEEeccCCC
Q 013558          189 KLYLILDFINGG  200 (441)
Q Consensus       189 ~~~lv~E~~~gg  200 (441)
                      .-||||||++.+
T Consensus        86 ~~fLlle~l~~~   97 (288)
T PF03881_consen   86 DAFLLLEFLEMG   97 (288)
T ss_dssp             CCEEEEE-----
T ss_pred             CceEEEEeecCC
Confidence            789999998776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.04  E-value=0.21  Score=48.79  Aligned_cols=71  Identities=10%  Similarity=0.082  Sum_probs=42.3

Q ss_pred             cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--Ccee---eeE--EEEeCCEEEEE
Q 013558          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQ---LRY--SFQTRSKLYLI  193 (441)
Q Consensus       121 G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~---l~~--~~~~~~~~~lv  193 (441)
                      +.-..||++...      .+..|++|+.+...    .....+..|..++..|...  .++.   .-|  ....++..+.|
T Consensus        36 s~eN~vy~v~~~------~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l  105 (325)
T PRK11768         36 SYENRVYQFGDE------DGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFAL  105 (325)
T ss_pred             cccceEEEEecC------CCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEE
Confidence            455678988743      45679999876432    1234466677777766321  1222   111  22335678889


Q ss_pred             EeccCCCc
Q 013558          194 LDFINGGH  201 (441)
Q Consensus       194 ~E~~~gg~  201 (441)
                      +++++|..
T Consensus       106 ~~~~~G~~  113 (325)
T PRK11768        106 FPRRGGRA  113 (325)
T ss_pred             EeeeCCCC
Confidence            99998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.96  E-value=0.015  Score=53.08  Aligned_cols=30  Identities=47%  Similarity=0.706  Sum_probs=21.4

Q ss_pred             CCcccccCCCceec-CCCCcEEEEecCCccc
Q 013558          235 GIVHRDLKPENILM-DSDGHVMLTDFGLAKE  264 (441)
Q Consensus       235 ~iiHrDlkp~NILl-~~~~~vkl~DFG~a~~  264 (441)
                      -++|+|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47999999999999 8899999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=95.93  E-value=0.054  Score=54.11  Aligned_cols=83  Identities=14%  Similarity=0.163  Sum_probs=44.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~  188 (441)
                      +.++ +.|..|-...+|++....... ....+.|.+++....   ....++ -.+|+++++.+...++. ++++.+..  
T Consensus        52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~--  124 (383)
T PTZ00384         52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD--  124 (383)
T ss_pred             cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence            3444 455558888999987532100 000122444432111   111111 24688999998655444 45555532  


Q ss_pred             EEEEEEeccCCCch
Q 013558          189 KLYLILDFINGGHL  202 (441)
Q Consensus       189 ~~~lv~E~~~gg~L  202 (441)
                        ++|.||++|..|
T Consensus       125 --g~l~efIeGr~l  136 (383)
T PTZ00384        125 --FTIQEWVEGNTM  136 (383)
T ss_pred             --EEEEEEeccccC
Confidence              599999998765

>PRK06148 hypothetical protein; Provisional

Probab=95.90  E-value=0.17  Score=57.11  Aligned_cols=31  Identities=39%  Similarity=0.624  Sum_probs=26.5

Q ss_pred             CCCcccccCCCceecCCCC--cEE-EEecCCccc
Q 013558          234 CGIVHRDLKPENILMDSDG--HVM-LTDFGLAKE  264 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~--~vk-l~DFG~a~~  264 (441)
                      .++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  565 999998754

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=95.89  E-value=0.0036  Score=42.50  Aligned_cols=41  Identities=37%  Similarity=0.686  Sum_probs=27.3

Q ss_pred             CCCcccccCcccccCCCCCCCCCC-C----CCCCCCcccCeeeeCC
Q 013558          394 VSGKDCIANFDKCWTTMPADDSPA-P----TPTAGEHFKGYTYVAP  434 (441)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~f~~~~~~~~  434 (441)
                      +.+..+++|||.+++.++...++. .    ....+..|.||+|+++
T Consensus         2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~   47 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNP   47 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETC
T ss_pred             CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCC
Confidence            456778999999999988777664 1    2245567999999986

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.42  E-value=0.13  Score=47.18  Aligned_cols=74  Identities=18%  Similarity=0.336  Sum_probs=50.4

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCCEEEE
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRSKLYL  192 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l  192 (441)
                      +.+.-|---..|.+.+       ....|.||+-.      ......+..|+.=|..|.   --.+.+++.+....++.|+
T Consensus        22 ~~v~gG~inea~~v~d-------g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl   88 (286)
T COG3001          22 EEVSGGDINEAWRLRD-------GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL   88 (286)
T ss_pred             cccCCccccceeEeec-------CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence            3444444445565553       44668888743      344556777877777664   3457778888889999999


Q ss_pred             EEeccCCCch
Q 013558          193 ILDFINGGHL  202 (441)
Q Consensus       193 v~E~~~gg~L  202 (441)
                      ||||++-+.+
T Consensus        89 Vle~L~~~~~   98 (286)
T COG3001          89 VLEYLPTGPL   98 (286)
T ss_pred             EEeeccCCCC
Confidence            9999987654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.12  E-value=0.075  Score=48.35  Aligned_cols=85  Identities=18%  Similarity=0.218  Sum_probs=58.6

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--CCCc
Q 013558          160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--CGIV  237 (441)
Q Consensus       160 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ii  237 (441)
                      ..+..+.+++.++.  .|++|..-  ..-.+.+++|+|-....            .. ..++.-=+.+|.-.|+  .+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~-~N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF-SNFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch-hHHHHHhHHHHHHhhccCCCee
Confidence            34567788888765  37777632  44568899999854211            01 1122222466777884  4699


Q ss_pred             ccccCCCceecCCCCcEEEEecCC
Q 013558          238 HRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       238 HrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      |+|..|+||+-|..|.+||.|=+.
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhh
Confidence            999999999999999999999764

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	441
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-83
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-83
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-80
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-80
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-80
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-79
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-74
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-71
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-71
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-71
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-70
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-70
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-70
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-70
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-70
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-68
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-68
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-68
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-67
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-67
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-67
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-65
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-65
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-65
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-65
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-65
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-65
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-65
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-65
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-65
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-65
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-65
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-65
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-65
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-65
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-65
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-65
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-65
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-65
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-65
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-65
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-65
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-65
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-65
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-65
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-65
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-65
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-65
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-65
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-65
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-65
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-65
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-65
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-65
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-65
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-65
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-64
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-64
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-64
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-64
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-64
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-64
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-64
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-64
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-64
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-64
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-64
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-64
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-64
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-64
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-64
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-64
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-64
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-64
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-64
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-64
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-63
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-63
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-63
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-63
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-63
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-57
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-56
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-55
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-55
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-55
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-55
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-54
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-54
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-54
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-54
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-54
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-54
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-54
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-54
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-54
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-54
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-54
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-54
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-54
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-54
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-54
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-53
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-53
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-49
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-49
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-49
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-49
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-49
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-49
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-47
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-47
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-47
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-47
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-47
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-46
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-46
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-46
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-46
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-45
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-45
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-44
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-44
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-39
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-39
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-39
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-37
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-37
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-37
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-37
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-37
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-37
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-37
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-37
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-36
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-36
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-36
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-36
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-36
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-36
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-36
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-36
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-36
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-36
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-36
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-36
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-36
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-36
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-36
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-36
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-35
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-35
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-35
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-34
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-33
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-33
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-33
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-33
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-32
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-32
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-32
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-32
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-32
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-31
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-31
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-31
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-31
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-31
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-31
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-31
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-31
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-31
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-31
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-31
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-31
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-31
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-31
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-31
3soa_A	444	Full-Length Human Camkii Length = 444		6e-31
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-31
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-31
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-31
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-30
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-30
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-30
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-30
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-30
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-30
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-30
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-30
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-30
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-30
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-29
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-29
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-29
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-29
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-28
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-28
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-28
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-28
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-27
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-27
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-27
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-27
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-27
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-26
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-26
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-26
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-26
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-26
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-26
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-26
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-26
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-26
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-25
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-25
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-25
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-25
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-25
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-24
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-24
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-24
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-24
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-23
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-23
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-23
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-23
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-22
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-22
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-22
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-22
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-22
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-22
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-22
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-22
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-22
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-22
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-22
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-22
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-22
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-22
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-22
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-22
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-22
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-22
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-22
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-22
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-22
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-22
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-22
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-22
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-22
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-22
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-22
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-21
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-21
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-21
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-21
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-21
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-20
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-20
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-20
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-20
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-19
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-19
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-15
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-12
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-12
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-12
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		9e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		9e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  306 bits (785), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 149/301 (49%), Positives = 205/301 (68%), Gaps = 4/301 (1%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
Query: 404 D 404
           D
Sbjct: 311 D 311

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  305 bits (782), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 149/301 (49%), Positives = 204/301 (67%), Gaps = 4/301 (1%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + ++  CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
Query: 404 D 404
           D
Sbjct: 311 D 311

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  295 bits (754), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 143/304 (47%), Positives = 197/304 (64%), Gaps = 4/304 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP     +  
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDT 312
Query: 401 ANFD 404
             FD
Sbjct: 313 FYFD 316

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  294 bits (753), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 194/292 (66%), Gaps = 4/292 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 17  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 73
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 74  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 254 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  294 bits (753), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 194/292 (66%), Gaps = 4/292 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  292 bits (748), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 144/307 (46%), Positives = 202/307 (65%), Gaps = 5/307 (1%)
Query: 99  LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNH 158
           ++A SE K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ 
Sbjct: 18  VKAGSE-KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH--LYAMKVLKKATLKVRDR 74
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           V   K ERDIL  V HPF+V+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +
Sbjct: 75  VR-TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGT 277
           FY AE+   + HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            EYMAPE++  +GH+  ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253
Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
           ++EA SLL+ L  ++P+ RLGSGP G + IK H ++ +I+W  L  RE++P FKP V+  
Sbjct: 254 STEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQP 313
Query: 398 DCIANFD 404
           D    FD
Sbjct: 314 DDTFYFD 320

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  275 bits (704), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 137/298 (45%), Positives = 197/298 (66%), Gaps = 8/298 (2%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P DF   +V+G+G+F                   YA+KV++K  I+KK    ++ +ER++
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L K V HPF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEIL 286
           + +LH   IV+RDLKPENIL+DS GH++LTDFGL KE I+ +S +++ CGT EY+APE+L
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
             + +++  DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271
Query: 347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           GLL KD +KRLG+    ++ IK H +F  INW  L  +++ P F P+VSG + + +FD
Sbjct: 272 GLLQKDRTKRLGAKDDFME-IKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFD 328

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  264 bits (675), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 189/300 (63%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  264 bits (675), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 189/300 (63%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 238
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 239 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 298

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  264 bits (675), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 189/300 (63%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  263 bits (673), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 143/328 (43%), Positives = 208/328 (63%), Gaps = 14/328 (4%)
Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAM 145
           Q+  ++HE   A L   +E K+G  +FE+ +V+G GA+                  +YAM
Sbjct: 31  QLLTVKHELRTANLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK--LYAM 87
Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 264 EI--DESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFT---H 316
           E   DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267
Query: 317 ANRQ-KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
            N Q ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ 
Sbjct: 268 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
Query: 376 INWKTLEAREMQPKFKPDVSGKDCIANF 403
           INW  L A+++   FKP +  +  ++NF
Sbjct: 328 INWDDLAAKKVPAPFKPVIRDELDVSNF 355

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  263 bits (673), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 188/300 (62%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  263 bits (672), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 188/300 (62%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  263 bits (672), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 188/300 (62%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  263 bits (672), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 188/300 (62%), Gaps = 6/300 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 240
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 241 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 300

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  254 bits (650), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 121/307 (39%), Positives = 190/307 (61%), Gaps = 7/307 (2%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 142 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 196
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 376
Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
            EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ + 
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSET 436
Query: 399 CIANFDK 405
               FD+
Sbjct: 437 DTRYFDE 443

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  254 bits (650), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 124/297 (41%), Positives = 184/297 (61%), Gaps = 8/297 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            +  P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LHK GI++RDLK +N+++DS+GH+ + DFG+ KE + +   +   CGT +Y+APEI+  
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 254
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
           + K P+KRLG GP G   ++ H +FR I+W+ LE RE+QP FKP V GK    NFDK
Sbjct: 255 MTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGA-ENFDK 310

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  254 bits (650), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 121/307 (39%), Positives = 190/307 (61%), Gaps = 7/307 (2%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 193
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
            EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ + 
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSET 433
Query: 399 CIANFDK 405
               FD+
Sbjct: 434 DTRYFDE 440

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 186/302 (61%), Gaps = 7/302 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 59
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 239
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 240 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 299
Query: 404 DK 405
           D+
Sbjct: 300 DE 301

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  253 bits (646), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 186/302 (61%), Gaps = 7/302 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 240
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 241 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 300
Query: 404 DK 405
           D+
Sbjct: 301 DE 302

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  253 bits (646), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 186/302 (61%), Gaps = 7/302 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 59  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 238
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 239 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 298
Query: 404 DK 405
           D+
Sbjct: 299 DE 300

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 171/262 (65%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 327
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 328 QRKVEAPFIPKFKGPGDTSNFD 349

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+ P GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +N D
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNAD 328

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 56  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 116 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA 175
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 176 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 233
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 234 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 293
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 294 QRKVEAPFIPKFKGPGDTSNFD 315

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 64  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 123
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 124 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 183
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 184 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 241
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 242 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 301
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 302 QRKVEAPFIPKFKGPGDTSNFD 323

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  245 bits (626), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 171/262 (65%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 55  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 114
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 115 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 175 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 232
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 233 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIY 292
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 293 QRKVEAPFIPKFKGPGDTSNFD 314

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 239
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 299
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 300 QRKVEAPFIPKFKGPGDTSNFD 321

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 327
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 328 QRKVEAPFIPKFKGPGDTSNFD 349

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 239
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 299
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 300 QRKVEAPFIPKFKGPGDTSNFD 321

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  244 bits (624), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+Y+M  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  244 bits (623), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 171/262 (65%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +  ++ +  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRVKGATWT--LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 327
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 328 QRKVEAPFIPKFKGPGDTSNFD 349

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  244 bits (623), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  244 bits (623), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 108/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI++SKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  244 bits (622), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 121/305 (39%), Positives = 186/305 (60%), Gaps = 8/305 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S  ++G  +FE  RV+G+G+F                  +YA+KV++KD I++ + V+  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD-----LYAVKVLKKDVILQDDDVECT 70
Query: 163 KAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I     + + CGT +Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N++V  P +L  +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 341 AHSLLKGLLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 399
           A  +LK  + K+P+ RLGS   GG  AI  H +F+ I+W  L  R+++P F+P +  ++ 
Sbjct: 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSRED 310
Query: 400 IANFD 404
           ++NFD
Sbjct: 311 VSNFD 315

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  244 bits (622), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+AP I+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  244 bits (622), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  243 bits (621), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +K  G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ I +HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 114/293 (38%), Positives = 177/293 (60%), Gaps = 7/293 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  243 bits (619), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  243 bits (619), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  242 bits (618), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  242 bits (618), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  242 bits (617), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 114/293 (38%), Positives = 177/293 (60%), Gaps = 7/293 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  241 bits (616), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 114/293 (38%), Positives = 177/293 (60%), Gaps = 7/293 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  241 bits (616), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 169/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  241 bits (614), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 119/329 (36%), Positives = 204/329 (62%), Gaps = 20/329 (6%)
Query: 91  LEHENDAELEAESER---KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           +E E +A    ES +    +G  DF++ RV+G+G++                  IYAM+V
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMRV 84
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++K+ +     +D+++ E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF---------TH 316
                +++ CGT  Y+APEIL  + +    DWW++G+L++EM+ G+ PF           
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRS 375
                L Q I+ +++++P  L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 376 INWKTLEAREMQPKFKPDVSGKDCIANFD 404
           ++W  +E +++ P FKP++SG+  + NFD
Sbjct: 325 VDWDMMEQKQVVPPFKPNISGEFGLDNFD 353

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  241 bits (614), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 108/262 (41%), Positives = 168/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  241 bits (614), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 108/262 (41%), Positives = 168/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  240 bits (613), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 108/262 (41%), Positives = 168/262 (64%), Gaps = 2/262 (0%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
            ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 307
Query: 383 AREMQPKFKPDVSGKDCIANFD 404
            R+++  F P   G    +NFD
Sbjct: 308 QRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  240 bits (613), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 179/297 (60%), Gaps = 8/297 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP  SG++   NFD+
Sbjct: 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNA-ENFDR 632

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  240 bits (613), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 115/293 (39%), Positives = 175/293 (59%), Gaps = 7/293 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  R +G G+F                   YAMK++ K  ++K   +++   E+ I   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++L++  GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 276
Query: 352 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 113/296 (38%), Positives = 184/296 (62%), Gaps = 8/296 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+F                   YAMKV++K+ +++   V++   ER +L+
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + + +    +CGT +Y+APE++ +K 
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKP 179
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL  L+ 
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDK 405
           +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FDK
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK 295

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 115/310 (37%), Positives = 195/310 (62%), Gaps = 17/310 (5%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 56
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 394
            L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 296
Query: 395 SGKDCIANFD 404
           SG+  + NFD
Sbjct: 297 SGEFGLDNFD 306

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/310 (37%), Positives = 195/310 (62%), Gaps = 17/310 (5%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 394
            L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 300
Query: 395 SGKDCIANFD 404
           SG+  + NFD
Sbjct: 301 SGEFGLDNFD 310

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 114/310 (36%), Positives = 195/310 (62%), Gaps = 17/310 (5%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 251
Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 394
            ++ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 311
Query: 395 SGKDCIANFD 404
           SG+  + NFD
Sbjct: 312 SGEFGLDNFD 321

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 116/297 (39%), Positives = 178/297 (59%), Gaps = 8/297 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 405
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G++   NFD+
Sbjct: 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNA-ENFDR 311

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  218 bits (555), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 174/302 (57%), Gaps = 11/302 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DFE+ +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 68
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAP 188
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NF
Sbjct: 249 LLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 304
Query: 404 DK 405
           DK
Sbjct: 305 DK 306

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  215 bits (547), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 173/302 (57%), Gaps = 11/302 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF + +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 67
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NF
Sbjct: 248 LLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 303
Query: 404 DK 405
           DK
Sbjct: 304 DK 305

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 109/281 (38%), Positives = 164/281 (58%), Gaps = 9/281 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 58
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 238
Query: 342 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 239 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 109/281 (38%), Positives = 164/281 (58%), Gaps = 9/281 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 59
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 239
Query: 342 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 240 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 108/281 (38%), Positives = 165/281 (58%), Gaps = 9/281 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 342 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 109/281 (38%), Positives = 164/281 (58%), Gaps = 9/281 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 56
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 236
Query: 342 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 237 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 162/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K  +K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 163/275 (59%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 162/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N+  GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 90
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEK 270
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 271 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 162/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  208 bits (529), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 161/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 160/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L + FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 272
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 273 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 162/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 69
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 249
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 250 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 162/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 160/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 160/275 (58%), Gaps = 9/275 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 348 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 381
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  192 bits (489), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 165/291 (56%), Gaps = 14/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  192 bits (489), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 165/291 (56%), Gaps = 14/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 165/291 (56%), Gaps = 14/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 165/291 (56%), Gaps = 14/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 160/300 (53%), Gaps = 13/300 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AHSL 344
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE     A SL
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
              LL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    D
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLD 479

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 160/300 (53%), Gaps = 13/300 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AHSL 344
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE     A SL
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
              LL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    D
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLD 479

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/308 (35%), Positives = 171/308 (55%), Gaps = 20/308 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC 399
           SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D 
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 482
Query: 400 --IANFDK 405
             I +FD+
Sbjct: 483 FDIGSFDE 490

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/308 (35%), Positives = 171/308 (55%), Gaps = 20/308 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC 399
           SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D 
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 482
Query: 400 --IANFDK 405
             I +FD+
Sbjct: 483 FDIGSFDE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/308 (35%), Positives = 171/308 (55%), Gaps = 20/308 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC 399
           SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D 
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 482
Query: 400 --IANFDK 405
             I +FD+
Sbjct: 483 FDIGSFDE 490

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/308 (35%), Positives = 171/308 (55%), Gaps = 20/308 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 361
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC 399
           SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D 
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 481
Query: 400 --IANFDK 405
             I +FD+
Sbjct: 482 FDIGSFDE 489

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  184 bits (467), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 106/304 (34%), Positives = 167/304 (54%), Gaps = 19/304 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 304 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 360
Query: 401 ANFD 404
           +NFD
Sbjct: 361 SNFD 364

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 106/304 (34%), Positives = 167/304 (54%), Gaps = 19/304 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 309 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 365
Query: 401 ANFD 404
           +NFD
Sbjct: 366 SNFD 369

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 106/304 (34%), Positives = 167/304 (54%), Gaps = 19/304 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 309 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 365
Query: 401 ANFD 404
           +NFD
Sbjct: 366 SNFD 369

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/314 (34%), Positives = 171/314 (54%), Gaps = 23/314 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 122
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           E+V A+  +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 281 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 333
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 302
Query: 334 PPFLTS---EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 390
           P  +T    EA  L++ L+    S+    G  G++  K H +F  +NW+ +  R ++  +
Sbjct: 303 PSHVTDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPY 357
Query: 391 KPDVSGKDCIANFD 404
            PDVS     +NFD
Sbjct: 358 IPDVSSPSDTSNFD 371

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/314 (34%), Positives = 171/314 (54%), Gaps = 23/314 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 138
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           E+V A+  +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y
Sbjct: 199 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 281 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 333
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 318
Query: 334 PPFLT---SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 390
           P  +T    EA  L++ L+    S+    G  G++  K H +F  +NW+ +  R ++  +
Sbjct: 319 PSHVTDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPY 373
Query: 391 KPDVSGKDCIANFD 404
            PDVS     +NFD
Sbjct: 374 IPDVSSPSDTSNFD 387

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/316 (35%), Positives = 164/316 (51%), Gaps = 25/316 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  +YAMK+M K  ++K+  V   +
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ-----VYAMKIMNKWDMLKRGEVSCFR 109
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTA 222
            ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY A
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           EIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG  L    D + RS    GT +Y
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 281 MAPEILLS-------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKV 331
           ++PEIL +         +  + DWW++G+  YEM  GQ PF   +  +   +I++  E +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 332 KLPPF---LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 388
            LP     +  EA   ++ LL   P  RLG   GG    + H +F  ++W  L  R+  P
Sbjct: 290 SLPLVDEGVPEEARDFIQRLLCP-PETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSVP 344
Query: 389 KFKPDVSGKDCIANFD 404
            F PD  G     NFD
Sbjct: 345 PFTPDFEGATDTCNFD 360

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 158/299 (52%), Gaps = 15/299 (5%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FEI R +G+G+F                  +YAMK M K   +++N V  +  E  I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKK-----MYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + +  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-- 289
               I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YMAPE+  S+  
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 290 -GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
            G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P   + E  SLL
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
Query: 346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           K LL  +P +R       +  +++  +   INW  +  + + P F P+    +C   F+
Sbjct: 252 KKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE 306

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 111/341 (32%), Positives = 177/341 (51%), Gaps = 28/341 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  ++AMK++ K  ++K+      + ERD+L 
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY AE+V A+ 
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTS- 339
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 340 --EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
              A  L++ L+    S+    G  G++  K H +F  I+W  +  R  +  + P+VS  
Sbjct: 310 SENAKDLIRRLI---CSREHRLGQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSP 364
Query: 398 DCIANF---DKCWXXXXXXXXXXXXXXXGEH--FKGYTYVA 433
              +NF   D C                G H  F G+TY +
Sbjct: 365 TDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTS 405

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 101/304 (33%), Positives = 166/304 (54%), Gaps = 19/304 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+     ++  GT +Y++PE+L S
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFLTSE 340
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L       ++  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKH 309
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A +L+   L  D   RLG    GV+ IK H +F++  W     RE      P++S     
Sbjct: 310 AKNLICAFL-TDREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDS 366
Query: 401 ANFD 404
           +NFD
Sbjct: 367 SNFD 370

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 145/278 (52%), Gaps = 11/278 (3%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 62
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPP 181
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
           L+  LL   P +RL      +  +  H W ++ + + L
Sbjct: 242 LISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 274

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 145/278 (52%), Gaps = 11/278 (3%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 63
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 242
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
           L+  LL   P +RL      +  +  H W ++ + + L
Sbjct: 243 LISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 143/265 (53%), Gaps = 18/265 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 F---LTSEAHSLLKGLLHKDPSKRL 357
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 143/265 (53%), Gaps = 18/265 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 F---LTSEAHSLLKGLLHKDPSKRL 357
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 160/290 (55%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 143/265 (53%), Gaps = 18/265 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 F---LTSEAHSLLKGLLHKDPSKRL 357
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 160/290 (55%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 60
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 240
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 241 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 281

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 150/265 (56%), Gaps = 12/265 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWF 373
           L  +PSKR     G ++ I   +W 
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWM 267

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 159/290 (54%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG+  Y APE+   K
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 245
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 246 LVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 286

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 159/290 (54%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 142/265 (53%), Gaps = 18/265 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K  +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKKALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 F---LTSEAHSLLKGLLHKDPSKRL 357
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 160/290 (55%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 158/290 (54%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG   Y APE+   K
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 249 LVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 289

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 147/284 (51%), Gaps = 10/284 (3%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG +     SSR  ++CGT +Y+ PE++  + H++  D WS+G+L YE L G+P
Sbjct: 172 ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 313 PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           PF     Q+  +RI   +   P F+T  A  L+  LL  +PS+R
Sbjct: 231 PFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 147/284 (51%), Gaps = 10/284 (3%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG +     SSR + +CGT +Y+ PE++  + H++  D WS+G+L YE L G+P
Sbjct: 172 ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 313 PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           PF     Q+  +RI   +   P F+T  A  L+  LL  +PS+R
Sbjct: 231 PFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 138/257 (53%), Gaps = 6/257 (2%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           E   +R+    DFEI R +G+G F                  I A+KV+ K  + K    
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVE 69
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLD 188
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           Y+ PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T 
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 248
Query: 340 EAHSLLKGLLHKDPSKR 356
            A  L+  LL  +PS+R
Sbjct: 249 GARDLISRLLKHNPSQR 265

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 159/290 (54%), Gaps = 16/290 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ +  CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 241 LISRLLKHNPSQR 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 138/254 (54%), Gaps = 6/254 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGLLHKDPSKR 356
            L+  LL  +PS+R
Sbjct: 239 DLISRLLKHNPSQR 252

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 138/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR +++CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDTLCGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 237 LISRLLKHNPSQR 249

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 241 LISRLLKHNPSQR 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 136/252 (53%), Gaps = 6/252 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R+    DFEI R +G+G F                  I A+KV+ K  + K      ++ 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 345 LKGLLHKDPSKR 356
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 239 LISRLLKHNPSQR 251

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E +  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 241 LISRLLKHNPSQR 253

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 137/256 (53%), Gaps = 6/256 (2%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A   R+    DFEI R +G+G F                  I A+KV+ K  + K     
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEH 56
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDY 175
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           + PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 235
Query: 341 AHSLLKGLLHKDPSKR 356
           A  L+  LL  +PS+R
Sbjct: 236 ARDLISRLLKHNPSQR 251

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 135/252 (53%), Gaps = 6/252 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R+    DFEI R +G+G F                  I A+KV+ K  + K      ++ 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTELCGTLDYLPPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 345 LKGLLHKDPSKR 356
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 143/264 (54%), Gaps = 18/264 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  +KI    FE    +G GAF                  ++A+K + K  +  K   
Sbjct: 16  QAEDIKKI----FEFKETLGTGAFSEVVLAEEKATGK-----LFAVKCIPKKAL--KGKE 64
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E  +L K+ H  IV L   +++ + LYL++  ++GG LF  +  +G + E  A  
Sbjct: 65  SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST 124
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH+ GIVHRDLKPEN+L    D +  +M++DFGL+K   +    ++ CG
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244
Query: 336 F---LTSEAHSLLKGLLHKDPSKR 356
           +   ++  A   ++ L+ KDP+KR
Sbjct: 245 YWDDISDSAKDFIRNLMEKDPNKR 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 138/254 (54%), Gaps = 6/254 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A 
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 343 SLLKGLLHKDPSKR 356
            L+  LL  +PS+R
Sbjct: 235 DLISRLLKHNPSQR 248

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 55
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 116 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 174
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 235 LISRLLKHNPSQR 247

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 237 LISRLLKHNPSQR 249

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 241 LISRLLKHNPSQR 253

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 6/246 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR + +CGT +Y+ PE++  + 
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRM 185
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 351 KDPSKR 356
            +PS+R
Sbjct: 246 HNPSQR 251

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 239 LISRLLKHNPSQR 251

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 137/254 (53%), Gaps = 6/254 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q   +RI   +   P F+T  A 
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGAR 234
Query: 343 SLLKGLLHKDPSKR 356
            L+  LL  +PS+R
Sbjct: 235 DLISRLLKHNPSQR 248

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 146/264 (55%), Gaps = 12/264 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIX 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL+ ++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P + +++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKF 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKW 372
           L  +PSKR     G ++ I   +W
Sbjct: 248 LILNPSKR-----GTLEQIXKDRW 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 177
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 238 LISRLLKHNPSQR 250

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 6/246 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 179
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL 
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 239
Query: 351 KDPSKR 356
            +PS+R
Sbjct: 240 HNPSQR 245

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTXLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 145/273 (53%), Gaps = 11/273 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR +++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRDTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
            L+  LL  + S+RL      +  +  H W ++
Sbjct: 239 DLISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPP 177
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 238 LISRLLKHNPSQR 250

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 144/273 (52%), Gaps = 11/273 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
            L+  LL  + S+RL      +  +  H W ++
Sbjct: 239 DLISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 239 LISRLLKHNPSQR 251

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 137/253 (54%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 239 LISRLLKHNPSQR 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 136/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++ GT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP-SSRRTTLSGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 237 LISRLLKHNPSQR 249

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 135/253 (53%), Gaps = 6/253 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   + GT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLXGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGLLHKDPSKR 356
           L+  LL  +PS+R
Sbjct: 241 LISRLLKHNPSQR 253

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 142/277 (51%), Gaps = 11/277 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  I K+     ++ E +I  
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHF-----IVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F  R ++YLIL++   G L+  L +   F E +      E+  A+ +
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+   G + + DFG +     S R  +MCGT +Y+ PE++  + 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP-SLRRKTMCGTLDYLPPEMIEGRM 197
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           HN+  D W +G+L YE+L G PPF  A+  +  +RI+   +K P  + + A  L+  LL 
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLR 257
Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 387
            +PS+RL      +  +  H W R+ + + L    +Q
Sbjct: 258 HNPSERL-----PLAQVSAHPWVRANSRRVLPPSALQ 289

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F    V+G GAF                  ++A+K ++K    + +    ++ E  +L K
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSS---LENEIAVLKK 62
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 232 HKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPF---LTSEAHSL 344
           K ++K  D WS+G++ Y +L G PPF      KL ++I     +   PF   ++  A   
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 345 LKGLLHKDPSKR 356
           +  LL KDP++R
Sbjct: 242 ICHLLEKDPNER 253

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 157/285 (55%), Gaps = 16/285 (5%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREV-----AVKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK L
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKL 248
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           L  +P KR     G ++ I   +W    +    E  E++P  +PD
Sbjct: 249 LVLNPIKR-----GSLEQIMKDRWMNVGH----EEEELKPYTEPD 284

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/225 (36%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV++K T+ KK     ++ E  +L +++HP I++L+  F+T +++ L+L+ + GG L
Sbjct: 81  YALKVLKK-TVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  +  +G + E  A     +I+ AV++LH+ GIVHRDLKPEN+L  +   D  + + DF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 318
           GL+K ++      ++CGT  Y APEIL    +  + D WSVGI+ Y +L G  PF     
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 319 RQKLQQRIIN-EKVKLPPF---LTSEAHSLLKGLLHKDPSKRLGS 359
            Q + +RI+N E   + P+   ++  A  L++ L+  DP KRL +
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT 300

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 69/170 (40%), Positives = 103/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +  S+CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/248 (33%), Positives = 137/248 (55%), Gaps = 21/248 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT----LEAREM 386
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K     L + E 
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKRKFQDLLSEEN 295
Query: 387 QPKFKPDV 394
           +   KP V
Sbjct: 296 ESTAKPQV 303

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 130/229 (56%), Gaps = 17/229 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 130/229 (56%), Gaps = 17/229 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 239
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 240 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 283

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 130/229 (56%), Gaps = 17/229 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 82/245 (33%), Positives = 137/245 (55%), Gaps = 25/245 (10%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 379
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 390
           P + +E    A  L+K LL  DP  R  +     +    H W        L+  +M+ KF
Sbjct: 380 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPW--------LQDEDMKRKF 426
Query: 391 KPDVS 395
           +  +S
Sbjct: 427 QDLLS 431

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 130/229 (56%), Gaps = 17/229 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 246
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 247 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 290

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 77/219 (35%), Positives = 129/219 (58%), Gaps = 16/219 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
Query: 335 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           P + +E    A  L+K LL  DP  R  +     +A++H
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTE----EALRH 400

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 68/170 (40%), Positives = 102/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 68/170 (40%), Positives = 102/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 132/266 (49%), Gaps = 18/266 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++F  +G+GAF                   YA K++    +  ++H   ++ E  I   
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQE-----YAAKIINTKKLSARDH-QKLEREARICRL 77
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 232 HKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
           H+ G+VHRDLKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS 343
              + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA  
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKH 369
           L+  +L  +PSKR+ +     +A+KH
Sbjct: 258 LINKMLTINPSKRITAA----EALKH 279

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 126/232 (54%), Gaps = 6/232 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  ++ E   L    HP I++L     T S +++++++++GG LF
Sbjct: 45  AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELF 104
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E ++R    +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 105 DYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +       CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 165 MMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            ++I +     P +L     SLLK +L  DP KR       +  I+ H+WF+
Sbjct: 225 FKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKR-----ATIKDIREHEWFK 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 126/232 (54%), Gaps = 6/232 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +     + CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            ++I      +P +L     +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 116/209 (55%), Gaps = 9/209 (4%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 335 P----FLTSEAHSLLKGLLHKDPSKRLGS 359
                 +T EA SL+  +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 116/209 (55%), Gaps = 9/209 (4%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 47  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 107 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 226
Query: 335 P----FLTSEAHSLLKGLLHKDPSKRLGS 359
                 +T EA SL+  +L  +P KR+ +
Sbjct: 227 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 255

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 116/209 (55%), Gaps = 9/209 (4%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 335 P----FLTSEAHSLLKGLLHKDPSKRLGS 359
                 +T EA SL+  +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 120/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/207 (36%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250
Query: 335 P----FLTSEAHSLLKGLLHKDPSKRL 357
                 +T EA SL+  +L  +P KR+
Sbjct: 251 SPEWDTVTPEAKSLIDSMLTVNPKKRI 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 125/232 (53%), Gaps = 6/232 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +       CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            ++I      +P +L     +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 125/223 (56%), Gaps = 8/223 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 50  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 109
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 228
Query: 321 KLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGS 359
           ++ +R+   K    P     ++ EA  L+K +L  +PSKR+ +
Sbjct: 229 EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 271

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 135/249 (54%), Gaps = 7/249 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  ++G+G+F                    A+K++ K  + K   V  ++ E  I  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEV-----AIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVS 229
           ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEILLS 288
           +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI   
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
             H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+  L
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 349 LHKDPSKRL 357
           L ++P+ RL
Sbjct: 247 LRRNPADRL 255

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 108 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 168 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 227
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 228 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 263

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 125/223 (56%), Gaps = 8/223 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 33  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 92
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 93  DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 211
Query: 321 KLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGS 359
           ++ +R+   K    P     ++ EA  L+K +L  +PSKR+ +
Sbjct: 212 EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 254

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 232
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 233 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 268

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 119/216 (55%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 118/216 (54%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 248 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQE-----YAAMIINTKKLSARDH-QKLEREARICR 65
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            L+  +L  +PSKR+ +     +A+KH
Sbjct: 246 DLINKMLTINPSKRITAA----EALKH 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 145/276 (52%), Gaps = 18/276 (6%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+F                    + ++++K  +       
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM------- 52
Query: 161 YMKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           +M+ ER+I  L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R
Sbjct: 53  HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+ 
Sbjct: 112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            Y APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231
Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +  A SL++ ++  DP +R+      +  I+   WF
Sbjct: 232 SPGAQSLIRRMIVADPMQRI-----TIQEIRRDPWF 262

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 118/216 (54%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 126 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 186 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 245
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 246 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 281

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 118/216 (54%), Gaps = 1/216 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 222 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 76/209 (36%), Positives = 114/209 (54%), Gaps = 13/209 (6%)
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E  IL +V  HP I+ L  S+++ S ++L+ D +  G LF +L  +    E + R   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
             ++ AVS LH   IVHRDLKPENIL+D +  + L+DFG +  ++   +   +CGT  Y+
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 282 APEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVK 332
           APEIL         G+ K+ D W+ G++L+ +L G PPF H  RQ L  R+I E   +  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFS 325
Query: 333 LPPF--LTSEAHSLLKGLLHKDPSKRLGS 359
            P +   +S    L+  LL  DP  RL +
Sbjct: 326 SPEWDDRSSTVKDLISRLLQVDPEARLTA 354

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 122/216 (56%), Gaps = 20/216 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 234 CGIVHRDLKPENILMDSDG---HVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSK 289
            G+VHRDLKPEN+L   +     + + DFG A+ +  ++    + C T  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPF---------LT 338
           G+++  D WS+G++LY ML+GQ PF   +R       +   +K+K   F         ++
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            EA  L++GLL  DP+KRL      +  +++++W +
Sbjct: 245 QEAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQ 275

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 139/273 (50%), Gaps = 27/273 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 68
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 340
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 248
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 249 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 276

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQE-----YAAKIINTKKLSARDH-QKLEREARICR 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNH 145
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +H+  IVHRDLKPEN+L+ S      V L DFGLA E+  E        GT  Y++PE+L
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 265
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           +L+  +L  +P+KR+ +      A+KH
Sbjct: 266 NLINQMLTINPAKRITAD----QALKH 288

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 DLINKMLTINPAKRITAS----EALKH 261

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 138/273 (50%), Gaps = 27/273 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I  N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIAAN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 340
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 139/273 (50%), Gaps = 27/273 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 340
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 DLINKMLTINPAKRITAS----EALKH 261

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 134/267 (50%), Gaps = 18/267 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +++++  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H+ G+VHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
             + + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           +L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 NLINQMLTINPAKRITAH----EALKH 261

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 247
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFR 374
           L  +P  R+      +  I    WF+
Sbjct: 248 LIVNPLNRI-----SIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFR 374
           L  +P  R+      +  I    WF+
Sbjct: 247 LIVNPLNRI-----SIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 58
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 237
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFR 374
           L  +P  R+      +  I    WF+
Sbjct: 238 LIVNPLNRI-----SIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 62
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 241
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFR 374
           L  +P  R+      +  I    WF+
Sbjct: 242 LIVNPLNRI-----SIHEIMQDDWFK 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 121/222 (54%), Gaps = 13/222 (5%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 50  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 109
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 170 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228
Query: 336 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
                ++ +A SL++ LL K P +R+ S    + A++ H+WF
Sbjct: 229 KDWLNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWF 265

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 138/273 (50%), Gaps = 27/273 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 340
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 121/222 (54%), Gaps = 13/222 (5%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 67  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 126
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 187 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245
Query: 336 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
                ++ +A SL++ LL K P +R+ S    + A++ H+WF
Sbjct: 246 KDWLNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWF 282

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 55  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 228
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 288
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L   PS R+ +     DA+  H+W ++
Sbjct: 289 LTYVPSMRISA----RDAL-DHEWIQT 310

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 56  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 229
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 289
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L   PS R+ +     DA+  H+W ++
Sbjct: 290 LTYVPSMRISA----RDAL-DHEWIQT 311

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 38  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 211
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 271
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L   PS R+ +     DA+  H+W ++
Sbjct: 272 LTYVPSMRISAR----DAL-DHEWIQT 293

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 205
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 265
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L   PS R+ +     DA+  H+W ++
Sbjct: 266 LTYVPSMRISAR----DAL-DHEWIQT 287

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 27/273 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+     GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 340
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 128/243 (52%), Gaps = 22/243 (9%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFING 199
           + A+K + +   I +N       +R+I+    + HP IV+ +    T + L +I+++ +G
Sbjct: 47  LVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLT 257
           G L+  +   G F ED+ARF+  +++S VS+ H   I HRDLK EN L+D      + + 
Sbjct: 101 GELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTH 316
           DFG +K     S+  S  GT  Y+APE+LL + ++ K AD WS G+ LY ML G  PF  
Sbjct: 161 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
Query: 317 A----NRQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
                + +K  QRI++ K  +P    ++ E   L+  +   DP+ R+      +  IK H
Sbjct: 221 PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI-----SIPEIKTH 275
Query: 371 KWF 373
            WF
Sbjct: 276 SWF 278

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 139/267 (52%), Gaps = 18/267 (6%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I +L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++ HK  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YD 205
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKX 265
Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L   PS R+ +     DA+  H+W ++
Sbjct: 266 LTYVPSXRISAR----DAL-DHEWIQT 287

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 111/200 (55%), Gaps = 8/200 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  +  Q   +F+EDQ   +
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTE 279
             +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ ++ +      C GT  
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 336
           Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  +II+     PP    
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFPPVSLH 248
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
            + +  SL+  L  ++P  R
Sbjct: 249 YSYDLRSLVSQLFKRNPRDR 268

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 126/224 (56%), Gaps = 9/224 (4%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRLGS 359
             + +R+   K    LP +  ++ +A  L++ +L   PS R+ +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 126/224 (56%), Gaps = 9/224 (4%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRLGS 359
             + +R+   K    LP +  ++ +A  L++ +L   PS R+ +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 125/222 (56%), Gaps = 9/222 (4%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
             + +R+   K    LP +  ++ +A  L++ +L   PS R+
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 125/223 (56%), Gaps = 9/223 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++RK ++   ++   ++ E  +L  + HP I++L   F+ +   YL+++   GG LF
Sbjct: 66  AIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S V++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS+G++L+ +L G PPF     Q
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243
Query: 321 KLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGS 359
           ++ +++   K     P +  ++  A  L+K +L  D  +R+ +
Sbjct: 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 24/270 (8%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E KIG   F++ R +G GA+                    A+KV++K    K  + D  K
Sbjct: 31  EGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEK-----AIKVIKKSQFDKGRYSDDNK 84
Query: 164 A----------ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
                      E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F 
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDESSR 270
           E  A     +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    +  +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
                GT  Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++   K
Sbjct: 205 LRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 331 VKLP----PFLTSEAHSLLKGLLHKDPSKR 356
                     ++ EA  L+K +L  D +KR
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKR 293

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 19/252 (7%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ + + GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEI-DE 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQ 324
           +    + C T  ++APE+L  +G++   D WS+G+LLY MLTG  PF +      +++  
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 325 RIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 380
           RI + K  L       ++  A  L+  +LH DP +RL +       +  H W   ++W  
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA-----LVLRHPWI--VHWDQ 286
Query: 381 LEAREMQPKFKP 392
           L   ++  +  P
Sbjct: 287 LPQYQLNRQDAP 298

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/227 (34%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G  PF + 
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
Query: 318 ---NRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRL 357
                +++  RI + K  L       ++  A  L+  +LH DP +RL
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 123/242 (50%), Gaps = 23/242 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G  PF + 
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
Query: 318 ---NRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
                +++  RI + K  L       ++  A  L+  +LH DP +RL +       +  H
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTA-----KQVLQH 283
Query: 371 KW 372
            W
Sbjct: 284 PW 285

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM--RKDTIIKKNHVDYMKAERDIL 169
           +E+  V+G+GAF                   +A+K++   K T       + +K E  I 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQ-----FAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNSMCGTTEYM 281
            A+ + H   I+HRD+KPEN+L+ S  +   V L DFG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FL 337
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+ P     +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHI 259
Query: 338 TSEAHSLLKGLLHKDPSKRL 357
           +  A  L++ +L  DP++R+
Sbjct: 260 SESAKDLVRRMLMLDPAERI 279

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 152/316 (48%), Gaps = 32/316 (10%)
Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXX 140
           SS + L  + L  ++  E   E   ++G G F I R   Q                    
Sbjct: 8   SSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKE-------------- 53
Query: 141 XIYAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197
             YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ +
Sbjct: 54  --YAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 111
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---H 253
           +GG LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D +     
Sbjct: 112 SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 313
           + L DFG+A +I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  P
Sbjct: 172 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
Query: 314 FTHANRQKLQQRI--INEKVKLPPFL-TSE-AHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           F    +Q+    I  +N       F  TSE A   ++ LL KDP +R+      +     
Sbjct: 232 FLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM-----XIAQSLE 286
Query: 370 HKWFRSINWKTLEARE 385
           H W ++I  + +   +
Sbjct: 287 HSWIKAIRRRNVRGED 302

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 123/227 (54%), Gaps = 18/227 (7%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++AE ++L  + HP I+++   F+    +Y++++   GG L   +       +  + 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 219 FYTAEIV----SAVSHLHKCGIVHRDLKPENILM-DSDGH--VMLTDFGLAKEIDESSRS 271
            Y AE++    +A+++ H   +VH+DLKPENIL  D+  H  + + DFGLA+       S
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII---- 327
            +  GT  YMAPE+   +      D WS G+++Y +LTG  PFT  + +++QQ+      
Sbjct: 184 TNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 328 NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           N  V+  P LT +A  LLK +L KDP +R    P     + HH+WF+
Sbjct: 243 NYAVECRP-LTPQAVDLLKQMLTKDPERR----PSAAQVL-HHEWFK 283

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V +LH   I H DLKPENI L+D +     + L DFG+A +I+  +   ++ GT
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPP 335
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I  +N       
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 336 FL-TSE-AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 385
           F  TSE A   ++ LL KDP +R+      +     H W ++I  + +   +
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRRNVRGED 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 113/204 (55%), Gaps = 8/204 (3%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  IL +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  + 
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V++LH   I H DLKPENI L+D +    H+ L DFGLA EI++     ++ GT
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 338 TSE----AHSLLKGLLHKDPSKRL 357
            S+    A   ++ LL K+  KRL
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRL 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 116/204 (56%), Gaps = 8/204 (3%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V +LH   I H DLKPENI L+D +     + L DFG+A +I+  +   ++ GT
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPP 335
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I  +N       
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 336 FL-TSE-AHSLLKGLLHKDPSKRL 357
           F  TSE A   ++ LL KDP +R+
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRM 265

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 123/252 (48%), Gaps = 19/252 (7%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ +   GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEI-DE 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQ 324
           +    + C T  ++APE+L  +G++   D WS+G+LLY  LTG  PF +      +++  
Sbjct: 174 NGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILA 233
Query: 325 RIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 380
           RI + K  L       ++  A  L+   LH DP +RL +       +  H W   ++W  
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAA-----LVLRHPWI--VHWDQ 286
Query: 381 LEAREMQPKFKP 392
           L   ++  +  P
Sbjct: 287 LPQYQLNRQDAP 298

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/226 (33%), Positives = 124/226 (54%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 357
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 125/226 (55%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/226 (33%), Positives = 124/226 (54%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 357
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/226 (33%), Positives = 124/226 (54%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 357
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 122/226 (53%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSE----AHSLLKGLLHKDPSKRL 357
              +Q+    I            S+    A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 122/226 (53%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSE----AHSLLKGLLHKDPSKRL 357
              +Q+    I            S+    A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 124/226 (54%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT  ++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 124/226 (54%), Gaps = 11/226 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LI + + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 39/262 (14%)
Query: 143 YAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTKVTHPFIVQ 179
           YAMKV+ K  +I+                       +  ++ +  E  IL K+ HP +V+
Sbjct: 41  YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK 100
Query: 180 LRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L           LY++ + +N G +   +       EDQARFY  +++  + +LH   I+
Sbjct: 101 LVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII 159
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTTEYMAPEILLSKGH---N 292
           HRD+KP N+L+  DGH+ + DFG++ E   S    SN++ GT  +MAPE L         
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSG 218
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLH 350
           K  D W++G+ LY  + GQ PF       L  +I ++ ++ P  P +  +   L+  +L 
Sbjct: 219 KALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLD 278
Query: 351 KDPSKRLGSGPGGVDAIKHHKW 372
           K+P  R+      V  IK H W
Sbjct: 279 KNPESRI-----VVPEIKLHPW 295

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 115/208 (55%), Gaps = 13/208 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 253
Query: 334 PP----FLTSEAHSLLKGLLHKDPSKRL 357
            P     ++  A  L++ +L  DP++R+
Sbjct: 254 NPRQWSHISESAKDLVRRMLMLDPAERI 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 115/208 (55%), Gaps = 13/208 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 251
Query: 334 PP----FLTSEAHSLLKGLLHKDPSKRL 357
            P     ++  A  L++ +L  DP++R+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERI 279

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 282 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 L------TSEAHSLLKGLLHKDPSKR 356
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 282 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 L------TSEAHSLLKGLLHKDPSKR 356
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 90/147 (61%), Gaps = 2/147 (1%)
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
            +  ++  D +S+GI+LYEML G+PPF
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 125/266 (46%), Gaps = 25/266 (9%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +   GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 282 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 L------TSEAHSLLKGLLHKDPSKR 356
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 52/306 (16%)
Query: 109 PGDFEIF-----RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           PG FE        ++G+GA+                   YA+K++ K     ++ V   +
Sbjct: 7   PGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKE-----YAVKIIEKQAGHSRSRV--FR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
               +     +  I++L   F+  ++ YL+ + + GG +  H+ +Q  F E +A     +
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM------ 274
           + +A+  LH  GI HRDLKPENIL +S      V + DF L   +  ++    +      
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 275 --CGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFT------------ 315
             CG+ EYMAPE++      +  ++K  D WS+G++LY ML+G PPF             
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRG 239
Query: 316 ---HANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 368
                 + KL + I   K + P      ++SEA  L+  LL +D  +RL +       + 
Sbjct: 240 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAA-----QVL 294
Query: 369 HHKWFR 374
            H W +
Sbjct: 295 QHPWVQ 300

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 239
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 240 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 300 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 360 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 392

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 119/216 (55%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V +  S+    +L+++++F+ GG L   + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT-DIV 133
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++  
Sbjct: 134 THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 193
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  +   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP +    +  S+L+G    +L ++PS+R
Sbjct: 254 ---RDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQR 286

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 125/258 (48%), Gaps = 18/258 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F                  +   KV   D +  K   D +K E D+L
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVP----VALKKVQIFDLMDAKARADCIK-EIDLL 86
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----LT 338
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP      +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 264
Query: 339 SEAHSLLKGLLHKDPSKR 356
            E   L+   ++ DP KR
Sbjct: 265 EELRQLVNMCINPDPEKR 282

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 162
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 223 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 283 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 315

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 87/152 (57%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 117
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 178 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 238 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 270

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 119
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 180 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 240 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 272

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINA 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 108
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 109 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 169 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 229 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 261

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 112
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 113 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 172
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 173 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
Query: 327 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 356
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 233 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 265

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 10/211 (4%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHS 343
             K +    D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++    
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            L   L  D  KR     G    +  H++ +
Sbjct: 249 FLNRCLEMDVEKR-----GSAKELLQHQFLK 274

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 238 ALLHKILVENPSARI-----TIPDIKKDRWY 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 157
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 218 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 277
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 278 TEPTQRM-----TITEFMNHPWI 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 86/152 (56%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 14/232 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++    ++ +   S+   SKL++I++++ GG     L R G F E Q      EI
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEI 129
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAP
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL----TS 339
           E++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L    T 
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLVGDFTK 246
Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
                +   L+KDPS R    P   + +K HK+    + KT    E+  +FK
Sbjct: 247 SFKEFIDACLNKDPSFR----PTAKELLK-HKFIVKNSKKTSYLTELIDRFK 293

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 10/211 (4%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 129
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHS 343
             K +    D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++    
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 249
Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            L   L  D  KR     G    +  H++ +
Sbjct: 250 FLNRCLEMDVEKR-----GSAKELIQHQFLK 275

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 147
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 208 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 267
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 268 TEPTQRM-----TITEFMNHPWI 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 148
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 209 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 268
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 269 TEPTQRM-----TITEFMNHPWI 286

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 149
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 210 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 269
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 270 TEPTQRM-----TITEFMNHPWI 287

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 142
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 203 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 262
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 263 TEPTQRM-----TITEFMNHPWI 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 262 TEPTQRM-----TITEFMNHPWI 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 264 TEPTQRM-----TITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 193
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 254 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 313
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 314 TEPTQRM-----TITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 308 TEPTQRM-----TITEFMNHPWI 325

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 264 TEPTQRM-----TITEFMNHPWI 281

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +     C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 351 KDPSKRLGSGPGGVDAIKHHKWF 373
            +P++R+      +    +H W 
Sbjct: 262 TEPTQRM-----TITEFMNHPWI 279

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHS 135
Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHN 292
             ++HR++K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K + 
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 195
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKGLL 349
              D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++     L   L
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 255
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFR 374
             D  KR     G    +  H++ +
Sbjct: 256 EMDVEKR-----GSAKELIQHQFLK 275

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 102/182 (56%), Gaps = 16/182 (8%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 305 YEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSK 355
           Y +L G PPF ++N  +     +  +++L  +         ++ +A  L++ LL  DP++
Sbjct: 201 YILLCGFPPF-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 356 RL 357
           RL
Sbjct: 260 RL 261

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 102/182 (56%), Gaps = 16/182 (8%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 305 YEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSK 355
           Y +L G PPF ++N  +     +  +++L  +         ++ +A  L++ LL  DP++
Sbjct: 220 YILLCGFPPF-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 356 RL 357
           RL
Sbjct: 279 RL 280

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 116/220 (52%), Gaps = 14/220 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           +K E  I   + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGT 277
             ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT
Sbjct: 111 H-QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 278 TEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPP 335
             Y+APE+L  +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 229
Query: 336 F--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +  + S   +LL  +L ++PS R+      +  IK  +W+
Sbjct: 230 WKKIDSAPLALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  I+ ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTT 278
             +    + H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T 
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 336
           E+ APEI+  +      D W++G+L Y +L+G  PF   +  +  Q +   + +     F
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 337 --LTSEAHSLLKGLLHKDPSKRL 357
             ++ EA   +K LL K+P KRL
Sbjct: 275 SSVSPEAKDFIKNLLQKEPRKRL 297

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 127/230 (55%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NIL+ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVV 158
Query: 258 DFGLAKEIDESSRS----NSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S  S     ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVXQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 129/230 (56%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPDSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 129/230 (56%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 13  RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 64
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 239
Query: 335 PFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           P L +      E    LK  L K+P  R    P     ++H
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 5   RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 114
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 231
Query: 335 PFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           P L +      E    LK  L K+P  R    P     ++H
Sbjct: 232 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 268

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 112/206 (54%), Gaps = 5/206 (2%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNE 140
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNS 273
           +Q       ++ A+++LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +   
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---K 330
           + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +    K
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 260
Query: 331 VKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +K    ++      L+ +L +DP +R
Sbjct: 261 LKNSHKVSPVLRDFLERMLVRDPQER 286

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 7/203 (3%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLP 334
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + +     N      
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380
Query: 335 PFLTSEAHSLLKGLLHKDPSKRL 357
             ++ +    ++ LL  DP+ R+
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRM 403

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 131
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +M
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L    
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNY 248
Query: 342 HSLLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
              LK      L+K+PS R    P   + +KH    R+
Sbjct: 249 SKPLKEFVEACLNKEPSFR----PTAKELLKHKFILRN 282

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 129/230 (56%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 14/232 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 344 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 129/230 (56%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 120/233 (51%), Gaps = 14/233 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A K+++   +  K  V   K E  ++ ++ H  ++QL  +F++++ + L++++++GG LF
Sbjct: 118 AAKIIKTRGMKDKEEV---KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 204 FHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDG-HVMLTDFG 260
             +  +     E     +  +I   + H+H+  I+H DLKPENIL ++ D   + + DFG
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           LA+      +     GT E++APE++     +   D WSVG++ Y +L+G  PF   N  
Sbjct: 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 321 KLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
           +    I+  +  L       ++ EA   +  LL K+ S R+ +     +A+KH
Sbjct: 295 ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISAS----EALKH 343

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 7/203 (3%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLP 334
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + +     N      
Sbjct: 215 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 274
Query: 335 PFLTSEAHSLLKGLLHKDPSKRL 357
             ++ +    ++ LL  DP+ R+
Sbjct: 275 SGISEDGKDFIRKLLLADPNTRM 297

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 14/232 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +MAP
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 245
Query: 344 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 246 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 292

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 13/186 (6%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++ + ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G++ Y +L G PPF      A     + RI   + + P      ++ E   L++ LL 
Sbjct: 248 SLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLK 307
Query: 351 KDPSKR 356
            +P++R
Sbjct: 308 TEPTQR 313

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 14/232 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 344 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 129/230 (56%), Gaps = 22/230 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 58  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 116 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 175
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 312 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 356
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 234 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+ +     LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 236
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 237 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DFGL   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLP--- 334
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              ++  A  L+  LL +D  +RL +       +  H W +
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 15/269 (5%)
Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK 150
           +E E  A  E E  +K     +     +G GAF                      + + +
Sbjct: 10  VELEGLAACEGEYSQK-----YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQ 209
           D  I+   +  +  E  IL++V H  I+++   F+ +    L+++    G  LF  + R 
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
               E  A +   ++VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++   
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
              + CGT EY APE+L+   +   + + WS+G+ LY ++  + PF      +L++ +  
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-----ELEETV-- 237
Query: 329 EKVKLPPFLTS-EAHSLLKGLLHKDPSKR 356
           E    PP+L S E  SL+ GLL   P +R
Sbjct: 238 EAAIHPPYLVSKELMSLVSGLLQPVPERR 266

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 251
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 252 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 252
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 253 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 236
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 237 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 238 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 238 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 279
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 280 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 238 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 264
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 265 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 279
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 280 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 217
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 271
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 272 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 300

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 265
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 266 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 264
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 265 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 265
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 266 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 264
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 265 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 17/223 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDF-INGGHLFFHLYRQGIFREDQAR 218
           +K E  +L ++ H  ++QL      + + K+Y+++++ + G         +  F   QA 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DESSRSNS 273
            Y  +++  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +     D++ R++ 
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 274 MCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
             G+  +  PEI   L        D WS G+ LY + TG  PF   N  KL + I     
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            +P         LLKG+L  +P+KR       +  I+ H WFR
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFR 268

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH 232
           P ++ L   ++  S++ LIL++  GG +F     +   +  E+       +I+  V +LH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 233 KCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           +  IVH DLKP+NIL+ S    G + + DFG++++I  +     + GT EY+APEIL   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF--LTSEAHSLL 345
                 D W++GI+ Y +LT   PF   + Q+    I  +N       F  ++  A   +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268
Query: 346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
           + LL K+P KR    P   +    H W +  +++ L
Sbjct: 269 QSLLVKNPEKR----PTA-EICLSHSWLQQWDFENL 299

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 232
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 233 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 181
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 235
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 236 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 232
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 233 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DF L   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLP--- 334
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              ++  A  L+  LL +D  +RL +       +  H W +
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 251
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 252 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 252
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 253 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 106/190 (55%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 106/190 (55%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 265
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 266 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 264
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 265 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 265
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 266 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 279
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 280 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 171
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 230
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 284
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 285 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 313

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 146
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 147 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 205
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 206 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 259
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 260 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 288

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 10/195 (5%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 341
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 342 HSLLKGLLHKDPSKR 356
            + +      DP KR
Sbjct: 256 KAFILKCFEPDPDKR 270

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 115/235 (48%), Gaps = 16/235 (6%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P+I +   S+   +KL++I++++ GG     L + G   E        
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILR 123
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +M
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L  + 
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQ- 239
Query: 342 HS-----LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
           HS      ++  L+KDP  R    P   + +K HK+      KT    E+  ++K
Sbjct: 240 HSKPFKEFVEACLNKDPRFR----PTAKELLK-HKFITRYTKKTSFLTELIDRYK 289

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 10/195 (5%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 181
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 341
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 241
Query: 342 HSLLKGLLHKDPSKR 356
            + +      DP KR
Sbjct: 242 KAFILKCFEPDPDKR 256

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 64/289 (22%)
Query: 142 IYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           I A+K+M K+ I  I    V+ +K E  ++ K+ HP I +L   ++    + L+++  +G
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 200 GHLF-------------------------------------FHLYRQG---IFREDQARF 219
           GHL                                       H +R+    + RE     
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEI-----DESSRSN 272
              +I SA+ +LH  GI HRD+KPEN L  ++    + L DFGL+KE       E     
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 273 SMCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           +  GT  ++APE+L   ++ +    D WS G+LL+ +L G  PF   N      +++N+K
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 331 VKL--PPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK--HHKWF 373
           +    P +  L+  A  LL  LL+++  +R        DA++   H W 
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERF-------DAMRALQHPWI 334

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 252
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   P  R        + I++H W + +
Sbjct: 253 HLIRWCLALRPXDR-----PTFEEIQNHPWMQDV 281

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 11/217 (5%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 123 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 182
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 183 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302
Query: 326 IINEK---VKLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
           I +E     ++PP         ++  L K+P  R+ +
Sbjct: 303 IASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSA 339

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 84/153 (54%), Gaps = 2/153 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ +   P +V+   S+   + L++++++   G +   +  R     ED+       
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMA 282
            +  + +LH    +HRD+K  NIL++++GH  L DFG+A ++ D  ++ N + GT  +MA
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           PE++   G+N  AD WS+GI   EM  G+PP+ 
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 42/306 (13%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 64
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------EIDESSRSN 272
               E++  + +LHK G +HRD+K  NIL+  DG V + DFG++       +I  +    
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 332 KLPPFLTSEAH-------------SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 378
             PP L +                 ++   L KDP KR    P   + ++H  + ++ N 
Sbjct: 244 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLRHKFFQKAKNK 297
Query: 379 KTLEAR 384
           + L+ +
Sbjct: 298 EFLQEK 303

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 43/296 (14%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 60  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 119
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------EIDESSRSN 272
               E++  + +LHK G +HRD+K  NIL+  DG V + DFG++       +I  +    
Sbjct: 120 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 238
Query: 332 KLPPFLTSEAH-------------SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
             PP L +                 ++   L KDP KR    P   + ++ HK+F+
Sbjct: 239 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLR-HKFFQ 287

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 103/190 (54%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ +   
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           +    GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 47/284 (16%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++ +++   G L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMER 234
Query: 320 QKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 359
             + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 104 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
             +       GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283
Query: 326 IINEK---VKLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
           I +E     ++PP         ++  L K+P  R+ +
Sbjct: 284 IASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSA 320

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 17/228 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           + A+K MR+    ++N    M  +  +L     P+IVQ   +F T + +++ ++ +    
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA 110
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFG 260
                  QG   E      T  IV A+ +L  K G++HRD+KP NIL+D  G + L DFG
Sbjct: 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           ++  + +    +   G   YMAPE +         ++  AD WS+GI L E+ TGQ P+ 
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 316 HANRQ-KLQQRIINEKVKLPPFL------TSEAHSLLKGLLHKDPSKR 356
           +     ++  +++ E+   PP L      + +  S +K  L KD  KR
Sbjct: 231 NCKTDFEVLTKVLQEE---PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 2/152 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           ++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 2/152 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           ++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 96/186 (51%), Gaps = 10/186 (5%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP +++L   F+T+    L+L+  +    LF ++  +G   E  +R +  ++V+A+ H H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 233 KCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKG 290
             G+VHRD+K ENIL+D   G   L DFG    + +   ++   GT  Y  PE I   + 
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRHQY 215
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H   A  WS+GILLY+M+ G  PF         Q I+  ++  P  ++ +  +L++  L 
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALIRRCLA 269
Query: 351 KDPSKR 356
             PS R
Sbjct: 270 PKPSSR 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +                  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMD----VTGDEEEEIKQEINML 74
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 195 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 191
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLPPFLTS 339
           E L    ++  +D WS+G+ L EM  G+ P    +      +L   I+NE    PP L S
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEP---PPKLPS 248
Query: 340 EAHSL-----LKGLLHKDPSKR 356
              SL     +   L K+P++R
Sbjct: 249 GVFSLEFQDFVNKCLIKNPAER 270

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ + IDE   +N   GT  YM+
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE--MANEFVGTRSYMS 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE L    ++  +D WS+G+ L EM  G+ P       +L   I+NE    PP L S   
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP---PPKLPSAVF 231
Query: 343 SL-----LKGLLHKDPSKR 356
           SL     +   L K+P++R
Sbjct: 232 SLEFQDFVNKCLIKNPAER 250

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H  G++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 232
Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            L++  L   PS R        + I++H W + +
Sbjct: 233 HLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------KLQQRIINEKVKL 333
           E L    ++  +D WS+G+ L EM  G+ P    + +          +L   I+NE    
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEP--- 229
Query: 334 PPFLTSEAHSL-----LKGLLHKDPSKR 356
           PP L S   SL     +   L K+P++R
Sbjct: 230 PPKLPSGVFSLEFQDFVNKCLIKNPAER 257

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 47/285 (16%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLL 56
Query: 170 TKVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RE 214
             + H ++V+       R +F       + +S L++ +++     L+  ++ + +   R+
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------ 268
           +  R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S      
Sbjct: 117 EYWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 269 -------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHAN 318
                  S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 319 RQKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 359
           R  + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 234
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 274

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++ E  +   + HP I+ LR        L L+++F  GG L   L  + I   D   
Sbjct: 50  IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILV 108
Query: 219 FYTAEIVSAVSHLHKCGIV---HRDLKPENILMD--------SDGHVMLTDFGLAKEIDE 267
            +  +I   +++LH   IV   HRDLK  NIL+         S+  + +TDFGLA+E   
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +++  S  G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   + 
Sbjct: 169 TTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227
Query: 328 NEKVKLP-PFLTSEAHS-LLKGLLHKDPSKR 356
             K+ LP P    E  + L++   + DP  R
Sbjct: 228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 199
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 109/200 (54%), Gaps = 8/200 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTT 278
            ++   +++LH     IVHR+LK  N+L+D    V + DFGL++ +      S S  GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 336
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
           L  +  ++++G    +P KR
Sbjct: 264 LNPQVAAIIEGCWTNEPWKR 283

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 108/200 (54%), Gaps = 8/200 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTT 278
            ++   +++LH     IVHRDLK  N+L+D    V + DFGL++ +      S    GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 336
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
           L  +  ++++G    +P KR
Sbjct: 264 LNPQVAAIIEGCWTNEPWKR 283

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 133/305 (43%), Gaps = 46/305 (15%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 331
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
                              K+ P L  +  SLL  +LH DP+KR+ +      A   H +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPF 289
Query: 373 FRSIN 377
           F+ + 
Sbjct: 290 FQDVT 294

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 133/284 (46%), Gaps = 47/284 (16%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVXLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++  ++     L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HR+LKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +E +   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXER 234
Query: 320 QKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 359
             + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGA 278

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 98/185 (52%), Gaps = 24/185 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS       G TEY+      APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQPPF 314
            +P F
Sbjct: 219 RRPIF 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +   RDIL   T           +    +Y++ D +     
Sbjct: 84  YCQRTLREIQILLRFRHENVIGIRDILRAST----------LEAMRDVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 132 LYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA 191
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    E D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 192 RIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 331
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 21/191 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +  S+ GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQPPF 314
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  +S  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQG--IFREDQ------ARFYTAEIVSAVSHLHKCGIVHRDLKP 243
           L+LD++        +YR      R  Q       + Y  ++  +++++H  GI HRD+KP
Sbjct: 96  LVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150
Query: 244 ENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVG 301
           +N+L+D D  V+ L DFG AK++     + S   +  Y APE++  +  +    D WS G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 302 ILLYEMLTGQPPF 314
            +L E+L GQP F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 97/185 (52%), Gaps = 24/185 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTE------YMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS       G TE      Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQPPF 314
            +P F
Sbjct: 219 RRPIF 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 123/262 (46%), Gaps = 48/262 (18%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LY 207
           D +IKK  +  ++    +L ++ HP +V L   F+ + +L+L+ ++ +  H   H    Y
Sbjct: 42  DPVIKKIALREIR----MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD--HTVLHELDRY 95
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
           ++G+  E   +  T + + AV+  HK   +HRD+KPENIL+     + L DFG A+ +  
Sbjct: 96  QRGV-PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
Query: 267 ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF--------THA 317
            S   +    T  Y +PE+L+    +    D W++G +  E+L+G P +         + 
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
Query: 318 NRQKLQQRIINEK-----------VKLP------------PFLTSEAHSLLKGLLHKDPS 354
            R+ L   I   +           VK+P            P ++  A  LLKG LH DP+
Sbjct: 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT 274
Query: 355 KRLGSGPGGVDAIKHHKWFRSI 376
           +RL       + + HH +F +I
Sbjct: 275 ERLTC-----EQLLHHPYFENI 291

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 273 HYDPNKRISA 282

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 44/277 (15%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ 209
           D ++KK  +  +K    +L ++ H  +V L    + + + YL+ +F++   L    L+  
Sbjct: 64  DKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN 119
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           G+  +   + Y  +I++ +   H   I+HRD+KPENIL+   G V L DFG A+ +    
Sbjct: 120 GLDYQVVQK-YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 270 RS-NSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF------------- 314
              +    T  Y APE+L+    + K  D W++G L+ EM  G+P F             
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238
Query: 315 -THANRQKLQQRIINEK-----VKLP------------PFLTSEAHSLLKGLLHKDPSKR 356
               N     Q + N+      V+LP            P L+     L K  LH DP KR
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 357 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
               P   + + HH +F+   +    ++E+Q K + D
Sbjct: 299 ----PFCAELL-HHDFFQMDGFAERFSQELQLKVQKD 330

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 147
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 208 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 157
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 218 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 155
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 216 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 89  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 178 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 236 DQLKRIME 243

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 124
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 185 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 198
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 259 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 127
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 187
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 188 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 34/260 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 10  EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 53
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 54  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 169
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 336
           +MAPE+     +++  D +S GI+L+E++T + PF        +          PP    
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 229
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
           L     SL+     KDPS+R
Sbjct: 230 LPKPIESLMTRCWSKDPSQR 249

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 138
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 198
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 199 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 95/185 (51%), Gaps = 24/185 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----------MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS              T  Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQPPF 314
            +P F
Sbjct: 219 RRPIF 223

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 272 HYDPNKRISA 281

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 120
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 180
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 123
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 183
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 184 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 132
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 193 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 89/160 (55%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YMAP
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELE 222

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 34/260 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 9   EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 52
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 53  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 168
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 336
           +MAPE+     +++  D +S GI+L+E++T + PF        +          PP    
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
           L     SL+     KDPS+R
Sbjct: 229 LPKPIESLMTRCWSKDPSQR 248

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 273 HYDPNKRISA-----KAALAHPFFQDVT 295

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 21/191 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +   + GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQPPF 314
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 118 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 178 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 236 DQLKRIME 243

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           H DP+KR+ +      A   H +F+ + 
Sbjct: 271 HYDPNKRISA-----KAALAHPFFQDVT 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 48  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 49  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 108
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 109 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 165
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 166 TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 239 ESLHDLMCQCWRKEPEER 256

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 331
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 239 ESLHDLMCQCWRKEPEER 256

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 331
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ + ++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 331
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKIRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 39/238 (16%)
Query: 156 KNHVDYMKAERDI--LTKVT-HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQG 210
           +N  D  +  R+I  LT+++ H  IV L    +  +   +YL+ D++        + R  
Sbjct: 47  QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRAN 104
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------- 263
           I      ++   +++  + +LH  G++HRD+KP NIL++++ HV + DFGL++       
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 264 -------EIDESSRS--------NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEM 307
                   I+E++ +             T  Y APEILL S  + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 308 LTGQPPFTHANRQKLQQRII-------NEKVK--LPPFLTSEAHSLLKGLLHKDPSKR 356
           L G+P F  ++     +RII       NE V+    PF  +   SL + +  +  +KR
Sbjct: 225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 88/168 (52%), Gaps = 12/168 (7%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           +  YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ 
Sbjct: 103 TDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYE 306
           ++ D  + + DFGLA++ D  S       T  Y APE++L+   + +  D WSVG ++ E
Sbjct: 161 VNEDCELKILDFGLARQAD--SEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 307 MLTGQPPFTHANRQKLQQRIINEKVKLPP------FLTSEAHSLLKGL 348
           M+TG+  F  ++    Q + I +    PP        + EA + +KGL
Sbjct: 219 MITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 61  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 109
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 110 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 169
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 170 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 227
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 228 DQLKRIME 235

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 24/232 (10%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R  + + +     +  + D++ + +  P+IVQ   +       ++ ++ ++     
Sbjct: 50  MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDK 109
Query: 204 FHLYRQGIFR----EDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTD 258
           F+ Y   +      E+     T   V A++HL +   I+HRD+KP NIL+D  G++ L D
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169
Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPF 314
           FG++ ++ +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 315 THANR--QKLQQRIINEKVKLPPFLTSEAH--------SLLKGLLHKDPSKR 356
              N    +L Q +  +    PP L++           + +   L KD SKR
Sbjct: 230 PKWNSVFDQLTQVVKGD----PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 54  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 232
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 233 ESLHDLMCQCWRKDPEER 250

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 85/330 (25%), Positives = 138/330 (41%), Gaps = 62/330 (18%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK--------------DTIIK 155
            D+ I R + QG F                   YA+K   K              D I  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFRE 214
           K+  D  K E  I+T + + + +          ++Y+I +++ N   L F  Y   +  +
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF-FVLDK 142
Query: 215 DQARFYTAEIVSAV--------SHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +   F   +++  +        S++H +  I HRD+KP NILMD +G V L+DFG ++ +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFT-HANRQKL 322
            +     S  GT E+M PE   ++     A  D WS+GI LY M     PF+   +  +L
Sbjct: 203 VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 323 QQRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGG 363
              I  + ++ P                    FL++E    LK  L K+P++R+ S    
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE--- 318
Query: 364 VDAIKHHKWFRSINWKTLE--AREMQPKFK 391
            DA+KH  W    N + L   ++E+  K K
Sbjct: 319 -DALKHE-WLADTNIEDLREFSKELYKKRK 346

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 62  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 115
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 116 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G   F   +      ++
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235
Query: 327 INE 329
           I +
Sbjct: 236 IEQ 238

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 52  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 230
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 231 ESLHDLMCQCWRKDPEER 248

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 106 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 162
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 163 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD--EMTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ + ++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 349
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 350 HKDPSKRLGS 359
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD--EMTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 63/104 (60%), Gaps = 3/104 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 180
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 63/104 (60%), Gaps = 3/104 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 198
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 179
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 180
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 238

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 191
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 249

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 52  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 112 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 168
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 169 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 88  VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
Query: 326 IIN 328
           I +
Sbjct: 268 IAS 270

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--G 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--G 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 312 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 491 ESLHDLMCQCWRKEPEER 508

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 102 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 161
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 162 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281
Query: 326 IIN 328
           I +
Sbjct: 282 IAS 284

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL   NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 104 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283
Query: 326 IIN 328
           I +
Sbjct: 284 IAS 286

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMXG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 17/182 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 41  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  + 
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 217
Query: 313 PF 314
            F
Sbjct: 218 LF 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 99  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 156
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 157 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 216
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 217 WSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 100 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 157
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 158 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 217
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 218 WSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 91  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 148
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 149 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 208
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 209 WSVGCILAEMLSNRPIF 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 132 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 191
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 192 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 56  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 234
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 235 ESLHDLMCQCWRKEPEER 252

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 102 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 159
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 160 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 219
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 220 WSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 69  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 116
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 117 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 176
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 177 RVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 2/150 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +++HP I+ L  +F  +S + L+ DF+             +      + Y    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+      T  Y AP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQP 312
           E+L  ++ +    D W+VG +L E+L   P
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 230 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGL + I+++  +         ++
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 408
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     KDP +R
Sbjct: 409 ESLHDLMCQCWRKDPEER 426

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 34/187 (18%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE            TT          + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKE------------TT---------GEKYDKSCDMW 182
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 350
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 242
Query: 351 KDPSKRL 357
            +P++R+
Sbjct: 243 TEPTQRM 249

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 79/149 (53%), Gaps = 8/149 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  + +YL+   +  G    ++ +     +D  +F   +I+  + ++H   I+HRDLK
Sbjct: 95  SLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 152
Query: 243 PENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVG 301
           P N+ ++ D  + + DFGL +  D+         T  Y APEI+L+  H N+  D WSVG
Sbjct: 153 PSNLAVNEDSELKILDFGLCRHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 302 ILLYEMLTGQ---PPFTHANRQKLQQRII 327
            ++ E+LTG+   P   H ++ KL  R++
Sbjct: 211 CIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 17/182 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  + 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI 223
Query: 313 PF 314
            F
Sbjct: 224 LF 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D+GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 50/252 (19%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR------QGIFREDQAR 218
           E  ++ ++ H  IV+L     T +KL L+ +F++     +   R      +G+   +  +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVK 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGT 277
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       + +S   T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 278 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------NE 329
             Y AP++L+ S+ ++   D WS G +L EM+TG+P F   N ++ Q ++I       NE
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNE 230
Query: 330 KV-----KLPPF-----------------------LTSEAHSLLKGLLHKDPSKRLGSGP 361
            +     KLP +                       L       L GLL  +P  RL +  
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-- 288
Query: 362 GGVDAIKHHKWF 373
                  HH WF
Sbjct: 289 ---KQALHHPWF 297

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 2/164 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRI 213

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 64  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 117
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 118 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            +        T  Y APE++L  G+  + D WSVG ++ E++ G   F   +      ++
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKV 237
Query: 327 INE 329
           I +
Sbjct: 238 IEQ 240

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +YL+   +  G   + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 232 WSVGCILAEMLSNRPIF 248

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 2/164 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 2/164 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  IL    H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++  A+  LH   I H D++PENI+  +     + + +FG A+++        +    
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPF 336
           EY APE+      +   D WS+G L+Y +L+G  PF     Q++ + I+N +       F
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 337 --LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             ++ EA   +  LL K+   R+ +     +A++H
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTAS----EALQH 258

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 352
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
            APE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P    
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412
Query: 339 SEAHSLLKGLLHKDPSKR 356
              + ++K   H D + R
Sbjct: 413 PAVYDVMKNCWHLDAATR 430

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 59/113 (52%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+        + +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 72  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 56  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 180
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
            APE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P    
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240
Query: 339 SEAHSLLKGLLHKDPSKR 356
              + ++K   H D + R
Sbjct: 241 PAVYEVMKNCWHLDAAMR 258

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 239

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 165
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
            APE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P    
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225
Query: 339 SEAHSLLKGLLHKDPSKR 356
              + ++K   H D + R
Sbjct: 226 PAVYEVMKNCWHLDAAMR 243

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 153 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 210
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N   D WSVG ++ E+LTG+  F   +     Q+I+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 4/153 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T   L L+ ++++     +      I      + +  ++
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMA 282
           +  +++ H+  ++HRDLKP+N+L++  G + L DFGL  AK I   +  N +  T  Y  
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           P+ILL S  ++   D W VG + YEM TG+P F
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 12/191 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILL 287
           +L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 346 KGLLHKDPSKR 356
                 DPS+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + +  FGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 226
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 227 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 265

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 230
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 231 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 269

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DF LA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
            APE L     +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P    
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 231
Query: 339 SEAHSLLKGLLHKDPSKR 356
              + ++K   H D + R
Sbjct: 232 PAVYEVMKNCWHLDAAMR 249

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   + ++ ++++ G L   L  +     R  Q     A
Sbjct: 53  EAQVMKKLRHEKLVQL-YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 231
Query: 339 SEAHSLLKGLLHKDPSKR 356
              H L+     K+P +R
Sbjct: 232 ESLHDLMCQCWRKEPEER 249

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
           + E  +L K  H  I+ L   + T+  L ++  +  G  L+ HL+ Q   F+  Q     
Sbjct: 80  RNEVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTT 278
            +    + +LH   I+HRD+K  NI +     V + DFGLA      S S  +    G+ 
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  + +N     +D +S GI+LYE++TG+ P++H N +
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG F                    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSV-----AIKKVIQDPRFRNRELQIMQD----LAV 75
Query: 172 VTHPFIVQLRYSFQT-----RSKLYL--ILDFINGGHLFFHLYRQGIFREDQA------R 218
           + HP IVQL+  F T     R  +YL  +++++       H   +  +R   A      +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIK 132
Query: 219 FYTAEIVSAVSHLH--KCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEIDESSRSNSMC 275
            +  +++ ++  LH     + HRD+KP N+L+ ++DG + L DFG AK++  S  + +  
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 276 GTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHAN 318
            +  Y APE++    H   A D WSVG +  EM+ G+P F   N
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 6/188 (3%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 75  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 253
Query: 349 LHKDPSKR 356
              DPS+R
Sbjct: 254 WAYDPSRR 261

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLH 232
           HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  + + A++HLH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAPE LL   + 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYG 233
Query: 293 KDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKG 347
             AD +S+G+ + E+    + P      Q+L+Q        LPP     L+SE  S+L  
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVM 287
Query: 348 LLHKDPSKR 356
           +L  DP  R
Sbjct: 288 MLEPDPKLR 296

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 6/188 (3%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 98  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 276
Query: 349 LHKDPSKR 356
              DPS+R
Sbjct: 277 WAYDPSRR 284

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 6/188 (3%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 349 LHKDPSKR 356
              DPS+R
Sbjct: 249 WAYDPSRR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 344 LLKGLLHKDPSKR 356
           L+      DPS+R
Sbjct: 241 LMTKCWAYDPSRR 253

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 245
Query: 344 LLKGLLHKDPSKR 356
           L+      DPS+R
Sbjct: 246 LMTKCWAYDPSRR 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 246
Query: 344 LLKGLLHKDPSKR 356
           L+      DPS+R
Sbjct: 247 LMTKCWAYDPSRR 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 6/188 (3%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 349 LHKDPSKR 356
              DPS+R
Sbjct: 249 WAYDPSRR 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 341 AHSLLKGLLHKDPSKR 356
            +SL+      DPS+R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  G   YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 54  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 113 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 3/166 (1%)
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++  P +V +    +   +LY+    ING  L   L RQG     +A     +I SA+  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--SRSNSMCGTTEYMAPEILLS 288
            H  G  HRD+KPENIL+ +D    L DFG+A    +   ++  +  GT  Y APE    
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
                 AD +++  +LYE LTG PP+   ++  +    IN+ +  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPY-QGDQLSVXGAHINQAIPRP 254

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SN 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++         +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 79  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 137
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/218 (20%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 38  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 94  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 214 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 251

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 110/225 (48%), Gaps = 23/225 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K ++  T+  ++ ++    E  I+ K+ H  +VQL Y+  +   +Y++ +++N G L 
Sbjct: 37  AIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL-YAVVSEEPIYIVTEYMNKGSLL 91
Query: 204 FHLYRQGIFREDQARFY--------TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
             L      ++ + R           A++ + ++++ +   +HRDL+  NIL+ +     
Sbjct: 92  DFL------KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 256 LTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 312
           + DFGLA+ I+++  +         ++ APE  L       +D WS GILL E++T G+ 
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205
Query: 313 PFTHA-NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           P+    NR+ L+Q     ++  P       H L+     KDP +R
Sbjct: 206 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEER 250

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/218 (20%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 211 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 248

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 12/191 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILL 287
           +L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 346 KGLLHKDPSKR 356
                 DPS+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 158 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 217
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 218 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 257

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/218 (20%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 211 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 248

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/218 (20%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 33  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 89  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 209 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 221
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 214
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 215 DPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/218 (20%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 36  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 92  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 212 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 249

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 341 AHSLLKGLLHKDPSKR 356
            +SL+      DPS+R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+R++T  K N    +  E  ++  V  P++ +L       S + L+   +  G L 
Sbjct: 50  AIKVLRENTSPKANK--EILDEAYVMAGVGSPYVSRL-LGICLTSTVQLVTQLMPYGCLL 106
Query: 204 FHLYRQGIFREDQARF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            H+      RE++ R        +  +I   +S+L    +VHRDL   N+L+ S  HV +
Sbjct: 107 DHV------RENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKI 160
Query: 257 TDFGLAK--EIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 312
           TDFGLA+  +IDE+   ++      ++MA E +L +     +D WS G+ ++E++T G  
Sbjct: 161 TDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 313 PFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
           P+     +++   +   E++  PP  T + + ++
Sbjct: 221 PYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM 254

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 162 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 221
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 50/223 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTI-IKKNHVD--YMKAERDILTKV 172
           +V+G G+F                  ++  K++  D + IKK   D  +   E  I+  V
Sbjct: 46  KVIGNGSFGV----------------VFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIV 89
Query: 173 THPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ---------- 216
            HP +V L+  F +         L L+L+++           + ++R  +          
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMP 139
Query: 217 ---ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSN 272
               + Y  +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + 
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 273 SMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           S   +  Y APE++  +  +  + D WS G ++ E++ GQP F
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 108 GPGDFEIF--------RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           GPGD  +F        R +G+G F                  + A+K ++ D      H 
Sbjct: 21  GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKADA--GPQHR 77
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              K E DIL  + H  I++ +   +    + L L+++++  G L  +L R  I    Q 
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QL 136
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +  +I   +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +   
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 278 TE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +    + APE L        +D WS G+ LYE+LT
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           +E  I+ +  HP I++L         + ++ +F+  G L  F     G F   Q      
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT- 277
            I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G  
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP 334
              + APE +  +     +D WS GI+++E+++ G+ P+   + Q +   I  + ++  P
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPP 245
Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
           P   +  H L+     KD + R
Sbjct: 246 PDCPTSLHQLMLDCWQKDRNAR 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 159 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 218
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 219 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 221
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 221
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 158 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 217
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 218 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 257

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 46  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 102 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 221
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           +E  I+ +  HP I++L         + ++ +F+  G L  F  L   G F   Q     
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGML 122
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT 277
             I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G 
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKL 333
               + APE +  +     +D WS GI+++E+++ G+ P+   + Q +   I  + ++  
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPP 242
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           PP   +  H L+     KD + R
Sbjct: 243 PPDCPTSLHQLMLDCWQKDRNAR 265

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 218
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 219 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/218 (19%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++ ++ + + ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 55  AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 111 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 170
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+   +N
Sbjct: 171 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 230
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            + ++      ++  P   ++  + ++     + P  R
Sbjct: 231 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 268

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 214
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 215 DPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 218
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 219 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 55  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 111 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 169
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 170 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 229
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 230 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 269

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 79  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 136
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPP 313
           DFG++  + +S       G   YMAPE     L  KG++  +D WS+GI + E+   + P
Sbjct: 197 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256
Query: 314 FTHANR--QKLQQRIINEKVKLP 334
           +       Q+L+Q +     +LP
Sbjct: 257 YDSWGTPFQQLKQVVEEPSPQLP 279

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGLA+  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             + ++E  +LPP +   A  + L+     KD + R
Sbjct: 260 -IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 288 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 344 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 402
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 403 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 462
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 463 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 502

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 249 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 305 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 424 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+   
Sbjct: 155 LSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 214
Query: 318 NRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 215 DPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 125/278 (44%), Gaps = 25/278 (8%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 125/278 (44%), Gaps = 25/278 (8%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 62/111 (55%), Gaps = 2/111 (1%)
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGT 277
            Y  ++  AV  +H  GI HRD+KP+N+L++S D  + L DFG AK++  S  S +   +
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICS 204
Query: 278 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
             Y APE++L +  +    D WS+G +  E++ G+P F+         RII
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 22/263 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G F                    A+K+++ D I   +  ++++ E   + +
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 172 VTHPFIVQLR-YSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP + +L   S ++R+K  L     IL F+  G  H F    R G     +  +   R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I   + +L     +HRDL   N ++  D  V + DFGL+++I         C + 
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKL 333
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           PP    E + L+      DP +R
Sbjct: 261 PPECMEEVYDLMYQCWSADPKQR 283

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 125/278 (44%), Gaps = 25/278 (8%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 82
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 83  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 135
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 255
Query: 321 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 256 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 292

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             + ++E  +LPP +   A  + L+     KD + R
Sbjct: 260 -IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R +L L+++++  G L   L R    R D +R   Y
Sbjct: 58  EIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTT 278
           +++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G +
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 279 E--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 327
              + APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCR 236
Query: 328 -------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                   +++  PP   +E H L+K      P  R
Sbjct: 237 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 272

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 100 DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 215
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +MAPE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 82/151 (54%), Gaps = 8/151 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S    + +Y++ +++       ++  QG   E+ AR +  +++  + ++H   ++HRDLK
Sbjct: 90  SLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147
Query: 243 PENILMDSDGHVM-LTDFGLAKEIDE--SSRSNSMCG--TTEYMAPEILLS-KGHNKDAD 296
           P N+ ++++  V+ + DFGLA+ +D   S + +   G  T  Y +P +LLS   + K  D
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207
Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
            W+ G +  EMLTG+  F  A+  +  Q I+
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 116
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMC 275
             Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 276 GTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 327
           G +   + APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPA 236
Query: 328 ----------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                      +++  PP   +E H L+K      P  R
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 275

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E  +++   +  I +VVG G F                    A+K + K    +K   D+
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVGYTEKQRRDF 93
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+ +  HP I++L         + ++ +++  G L          R+  A+F  
Sbjct: 94  L-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTV 146
Query: 222 AEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
            ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 273 SMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +  + ++E
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDE 265
Query: 330 KVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             +LPP +   A  + L+     KD + R
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 61  DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 176
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +MAPE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E  +++   +  I +VVG G F                    A+K + K    +K   D+
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTL-KVGYTEKQRRDF 93
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+ +  HP I++L         + ++ +++  G L          R+  A+F  
Sbjct: 94  L-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTV 146
Query: 222 AEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
            ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 273 SMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +  + ++E
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDE 265
Query: 330 KVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             +LPP +   A  + L+     KD + R
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230
Query: 323 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             + ++E  +LPP +   A  + L+     KD + R
Sbjct: 231 -IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 233 --KCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 213
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 259

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 106/218 (48%), Gaps = 26/218 (11%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 75  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 127
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++ +++
Sbjct: 128 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 268 ------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
                 ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 188 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 245
Query: 321 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 246 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 282

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 26/164 (15%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-------------S 269
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+              +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIIN 328
           R     GT  YM+PE +    ++   D +S+G++L+E+L    PF T   R +    + N
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242
Query: 329 EKVKLPPFLTSE---AHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             +K PP  T +    + +++ +L   P +R    P  ++ I++
Sbjct: 243 --LKFPPLFTQKYPCEYVMVQDMLSPSPMER----PEAINIIEN 280

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL +  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             + ++E  +LPP +   A  + L+     KD + R
Sbjct: 260 -IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 117
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMC 275
             Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 276 GTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 327
           G +   + APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 237
Query: 328 ----------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                      +++  PP   +E H L+K      P  R
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 276

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 310 GQPPFTHA 317
            + PF H 
Sbjct: 229 RREPFFHG 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 35  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 92
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 93  DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPP 313
           DFG++  + +    +   G   YMAPE     L  KG++  +D WS+GI + E+   + P
Sbjct: 153 DFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 314 FTHANR--QKLQQRIINEKVKLP 334
           +       Q+L+Q +     +LP
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLP 235

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R   Y
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTT 278
           +++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G +
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 279 E--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 327
              + APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 328 -------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                   +++  PP   +E H L+K      P  R
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 63  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 122 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 181
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 292

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 310 GQPPFTHA 317
            + PF H 
Sbjct: 234 RREPFFHG 241

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKEIDE-SSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++I+      N+  G    ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 66  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 125 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 184
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 245 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 295

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 61  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 120 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTE 179
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 240 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 290

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRSKLYLILDFI 197
           YA+KV+R    IKK +    K E DIL K+      +  IV+    F     + LI + +
Sbjct: 63  YAVKVVRN---IKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118
Query: 198 NGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------ 249
            G  L+  + R     F  +  + Y  EI+ A+++L K  + H DLKPENIL+D      
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 250 --------SDGH-----------VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
                   +DG            + L DFG A    +S    S+  T +Y APE++L+ G
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG 235
Query: 291 HNKDADWWSVGILLYEMLTGQPPF-THANRQKL 322
            +  +D WS G +L E+ TG   F TH + + L
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 243 PHLASEKVYTIMYSCWHEKADER 265

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 25/278 (8%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ + +  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 120 MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 299 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 113/232 (48%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 -----------YRQGIFREDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                      Y      E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 119/269 (44%), Gaps = 26/269 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAF                  + A+K ++  T+  +   D+ + E ++LT
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQAR-------- 218
            + H  IV+          L ++ +++  G L   L   G    I  + Q R        
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                  ++I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 191
Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN 328
            G T     +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++     
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 251
Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
             ++ P     E + ++ G   ++P +RL
Sbjct: 252 RVLERPRVCPKEVYDVMLGCWQREPQQRL 280

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AKEI-DESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 315
           ++ + D+   + +  G      + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 316 HANRQKLQQRIINEKVKLP-PFLTSEA-HSLLKGLLHKDPSKR 356
             NR  +    + E  +LP P     A H L+    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 228 PHLASEKVYTIMYSCWHEKADER 250

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 243 PHLASEKVYTIMYSCWHEKADER 265

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           +K   D++  E  I+ +  HP +V L         + ++++F+  G L   L +  G F 
Sbjct: 85  EKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-- 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++ I++   +  
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
            +  G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I 
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIE 262
Query: 329 EKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
           E  +LP  +   A  H L+     K+ ++R
Sbjct: 263 EGYRLPAPMDCPAGLHQLMLDCWQKERAER 292

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AKEI-DESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 315
           ++ + D+   + +  G      + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 316 HANRQKLQQRIINEKVKLP-PFLTSEA-HSLLKGLLHKDPSKR 356
             NR  +    + E  +LP P     A H L+    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E  +++   +  I +VVG G F                    A+K + K    +K   D+
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTL-KVGYTEKQRRDF 93
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+ +  HP I++L         + ++ + +  G L          R+  A+F  
Sbjct: 94  L-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTV 146
Query: 222 AEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
            ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 273 SMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +  + ++E
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDE 265
Query: 330 KVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             +LPP +   A  + L+     KD + R
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 130/293 (44%), Gaps = 27/293 (9%)
Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXX 139
           ++  + + I     E+  E   E  ++I     +I +V+G G F                
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 62
Query: 140 XXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
               A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  
Sbjct: 63  --FVAIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 118
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDG 252
           G L          R++  +F   ++V       + + +L     VHRDL   NIL++S+ 
Sbjct: 119 GSL------DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL 172
Query: 253 HVMLTDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYE 306
              ++DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 232
Query: 307 MLT-GQPPFTHANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKR 356
           +++ G+ P+     Q +    I +  +LPP +   S  H L+     KD + R
Sbjct: 233 VMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 284

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 61  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 113
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 173
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 233
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 234 PHLASEKVYTIMYSCWHEKADER 256

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 41  AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 97
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHRDL   N+L+ +  +  ++DF
Sbjct: 98  KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 315 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                 ++   I   ++++ PP    E ++L+
Sbjct: 215 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 246

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
           +    +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 53
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 54  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 106
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 166
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 226
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 227 PHLASEKVYTIMYSCWHEKADER 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230
Query: 323 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 356
             + ++E  +LPP +   A  + L+     KD + R
Sbjct: 231 -IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+L+D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 33/241 (13%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAER--DILTKVTHPFIVQL-RYSFQTRS---KLYLILDF 196
           YA+K      I+     D  +A+R  D+     HP I++L  Y  + R    + +L+L F
Sbjct: 57  YALK-----RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 197 INGGHLFFHLYR---QGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
              G L+  + R   +G F  EDQ  +    I   +  +H  G  HRDLKP NIL+  +G
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171
Query: 253 HVMLTDFGLAKEID---ESSR--------SNSMCGTTEYMAPEILLSKGH---NKDADWW 298
             +L D G   +     E SR        +   C T  Y APE+   + H   ++  D W
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVW 230
Query: 299 SVGILLYEMLTGQPPFTHANRQKLQQRI-INEKVKLP--PFLTSEAHSLLKGLLHKDPSK 355
           S+G +LY M+ G+ P+    ++     + +  ++ +P  P  +S    LL  ++  DP +
Sbjct: 231 SLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290
Query: 356 R 356
           R
Sbjct: 291 R 291

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +++  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEEDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 29/263 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 335 PFLTSE-AHSLLKGLLHKDPSKR 356
           P L SE  ++++    H+   +R
Sbjct: 228 PHLASEKVYTIMYSCWHEKADER 250

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 367 AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 423
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHR+L   N+L+ +  +  ++DF
Sbjct: 424 KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 315 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                 ++   I   ++++ PP    E ++L+
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 572

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 28/165 (16%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-------- 274
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 275 -----CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
                 GT  YM+PE +    ++   D +S+G++L+E+L         + Q  + RII +
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVRIITD 285
Query: 330 --KVKLPPFLTS---EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
              +K P   T    + H +++ +L   P++R    P   D I++
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER----PEATDIIEN 326

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 72  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 124
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 185 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 242
Query: 322 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 356
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 243 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 278

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 150 KDTIIKKNHVDYMKAERDI--LTKVTHPFIVQ-------LRYSFQTRSK---------LY 191
           K  +IK+   +  KAER++  L K+ H  IV          Y  +T SK         L+
Sbjct: 37  KTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ--ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           + ++F + G L   + ++   + D+  A     +I   V ++H   +++RDLKP NI + 
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML- 308
               V + DFGL   +    +     GT  YM+PE + S+ + K+ D +++G++L E+L 
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 309 TGQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                F T      L+  II++          +  +LL+ LL K P  R
Sbjct: 217 VCDTAFETSKFFTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDR 259

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Y++ I  ED    Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQP-PFTHANR 319
            ++    R        ++MAPE +  K ++  +D WS G+LL+E+  L G P P    + 
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
               +     +++ P + T E + ++    H+DP +R
Sbjct: 310 DFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER 346

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 57  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 109
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 110 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227
Query: 322 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 356
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 228 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 263

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/262 (22%), Positives = 119/262 (45%), Gaps = 29/262 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G F                    A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE-- 223
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T +  
Sbjct: 51  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLL 103
Query: 224 -----IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCG 276
                +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S     
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
              +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        P
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 336 FLTSE-AHSLLKGLLHKDPSKR 356
            L SE  ++++    H+   +R
Sbjct: 224 HLASEKVYTIMYSCWHEKADER 245

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 51  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 103
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 164 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 221
Query: 322 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 356
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 222 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 257

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPF---------TH 316
           +    +    + APE L+       +D WS G+ L+E+LT       P          TH
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 317 ANRQKLQQRIIN-----EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
              Q    R++N     +++  PP    E + L++      PS R
Sbjct: 245 G--QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 139 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 198
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 199 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 53  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 112
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPF---------TH 316
           +    +    + APE L+       +D WS G+ L+E+LT       P          TH
Sbjct: 173 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 232
Query: 317 ANRQKLQQRIIN-----EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
              Q    R++N     +++  PP    E + L++      PS R
Sbjct: 233 G--QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 275

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 39/180 (21%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 316
            S     N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 317 ANRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            ++   +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 98  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 148
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 149 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 316
           + +  S             T  Y APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266
Query: 317 AN 318
            N
Sbjct: 267 KN 268

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +I   V ++H   ++HRDLKP NI +     V + DFGL   +    +     GT  YM+
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEML-TGQPPF-THANRQKLQQRIINEKVKLPPFLTSE 340
           PE + S+ + K+ D +++G++L E+L      F T      L+  II++          +
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD------IFDKK 257
Query: 341 AHSLLKGLLHKDPSKR 356
             +LL+ LL K P  R
Sbjct: 258 EKTLLQKLLSKKPEDR 273

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 174 HPFIVQL-------RYSFQTRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAE 223
           HP IVQ        +    T    +L+L  +  G L   L +   +G    D       +
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 224 IVSAVSHLH--KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE------SSRSNSMC 275
              AV H+H  K  I+HRDLK EN+L+ + G + L DFG A  I        S++  ++ 
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 276 -------GTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
                   T  Y  PEI+    +    +  D W++G +LY +   Q PF    +     R
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LR 260
Query: 326 IINEKVKLPPFLTSEA--HSLLKGLLHKDPSKRL 357
           I+N K  +PP  T     HSL++ +L  +P +RL
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVXAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PF 336
           ++ APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPE 338
Query: 337 LTSEA-HSLLKGLLHKDPSKR 356
           L  +A   L++     +P +R
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQR 359

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 35/176 (19%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 321 KLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 35/176 (19%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 321 KLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
             +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 147
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 148 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 316
           + +  S             T  Y APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265
Query: 317 AN 318
            N
Sbjct: 266 KN 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 80
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKV 331
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    ++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260
Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKR 356
           + P     E + L++    + P +R
Sbjct: 261 EKPLNCDDEVYDLMRQCWREKPYER 285

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 56  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 173
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 174 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 233
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 234 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 288

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 70
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKV 331
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    ++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 250
Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKR 356
           + P     E + L++    + P +R
Sbjct: 251 EKPLNCDDEVYDLMRQCWREKPYER 275

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 53  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 170
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 171 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 230
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 231 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 285

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQARFYTAE 223
           E   + K++HP +V+          +Y++ ++I+ G L  +L   G   E  Q      +
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           +   ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+ GT    ++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE+     ++  +D W+ GIL++E+ + G+ P+  + N + + +     ++  P   +
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231
Query: 339 SEAHSLLKGLLHKDPSKR 356
              + ++    H+ P KR
Sbjct: 232 DTIYQIMYSCWHELPEKR 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PF 336
           ++ APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPE 338
Query: 337 LTSEA-HSLLKGLLHKDPSKR 356
           L  +A   L++     +P +R
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQR 359

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 105 AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 283 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 44/298 (14%)
Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKD 151
           E+E D + E   E      + E  +V+G GAF                    A+K++++ 
Sbjct: 33  EYEYDLKWEFPRE------NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 152 TIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQ 209
                +  + + +E  ++T++ +H  IV L  +      +YLI ++   G L  +L  ++
Sbjct: 87  A--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 210 GIFREDQARF----------------------YTAEIVSAVSHLHKCGIVHRDLKPENIL 247
             F ED+  +                      +  ++   +  L     VHRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 248 MDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           +     V + DFGLA++I   S    R N+     ++MAPE L    +   +D WS GIL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 304 LYEMLT-GQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ + G  P+      AN  KL Q     K+  P + T E + +++     D  KR
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 57  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 174
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 175 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 234
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 235 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 289

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 2/153 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             +K ++   D WS G +  E+     P    N
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF----- 219
           E  ++  + HP +++         +L  I ++I GG L      +GI +   +++     
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQR 110
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESS------- 269
             +  +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+  +DE +       
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 270 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
                  +  ++ G   +MAPE++  + +++  D +S GI+L E++
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
           +    +LH   I+HRD+K  NIL+D +    +TDFG++K   E+ ++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 49  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 39/180 (21%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 316
                  N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 317 ANRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 369
            ++   +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFH 205
           +D  + K+     K E + L  + HP IV+   S+++  K    + L+ +    G L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLA 262
           L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D GLA
Sbjct: 120 LKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQK 321
             +  +S + ++ GT E+ APE    K +++  D ++ G    E  T + P++   N  +
Sbjct: 180 T-LKRASFAKAVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237
Query: 322 LQQRIIN-------EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           + +R+ +       +KV +P     E   +++G + ++  +R
Sbjct: 238 IYRRVTSGVKPASFDKVAIP-----EVKEIIEGCIRQNKDER 274

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFR 213
           +K  VD++  E  I+ + +H  I++L         + +I +++  G L  F   + G F 
Sbjct: 87  EKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSN 272
             Q       I + + +L     VHRDL   NIL++S+    ++DFGL++ + D+   + 
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 273 SMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
           +  G      + APE +  +     +D WS GI+++E++T G+ P+   +  ++  + IN
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAIN 264
Query: 329 EKVKLP 334
           +  +LP
Sbjct: 265 DGFRLP 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 47/238 (19%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +EI  ++G G++                  +   K++R    + ++ +D  +  R+I
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRV----VAIKKILR----VFEDLIDCKRILREI 103
Query: 169 --LTKVTHPFIVQ-----LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF-REDQARFY 220
             L ++ H  +V+     +    +   +LY++L+  +    F  L+R  ++  E   +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTL 161
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS------- 273
              ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS       
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 274 ------------------MCG---TTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                             + G   T  Y APE ILL + + +  D WS+G +  E+L 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 119/236 (50%), Gaps = 26/236 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHLYRQ---GI------FREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L  +   G+          + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 109/229 (47%), Gaps = 25/229 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  G L 
Sbjct: 39  AIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL- 95
Query: 204 FHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
                    R++  +F   ++V       + + +L     VHR L   NIL++S+    +
Sbjct: 96  -----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKV 150
Query: 257 TDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT- 309
           +DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E+++ 
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 310 GQPPFTHANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKR 356
           G+ P+     Q +    I +  +LPP +   S  H L+     KD + R
Sbjct: 211 GERPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 258

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  +   +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 315
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 316 PDYTTPEMYQTMLDCWHGEPSQR 338

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 322
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 323 PDYTTPEMYQTMLDCWHGEPSQR 345

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  +   +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 318 PDYTTPEMYQTMLDCWHGEPSQR 340

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 324
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 325 PDYTTPEMYQTMLDCWHGEPSQR 347

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y++ +++  G+L 
Sbjct: 61  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+    E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 117 DYL-RECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFG 175
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 176 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 77
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HR+L   NIL+  +    + DFGL++  +   +   
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKV 331
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    ++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 257
Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKR 356
           + P     E + L++    + P +R
Sbjct: 258 EKPLNCDDEVYDLMRQCWREKPYER 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 274
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 275 PDYTTPEMYQTMLDCWHGEPSQR 297

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 309
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 310 PDYTTPEMYQTMLDCWHGEPSQR 332

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P + T E +  +    H +PS+R
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 8/218 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 56  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 112
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I++    +++      ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 173 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  +      +++  P       ++L+      DPS R
Sbjct: 233 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 114/242 (47%), Gaps = 12/242 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + +  +V+G GAF                  + A+K++ + T  K N V++M  E  I+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD-EALIMA 95
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            + HP +V+L         + L+   +  G L  + H ++  I  +     +  +I   +
Sbjct: 96  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGM 153
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEI 285
            +L +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E 
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHS 343
           +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + 
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 273
Query: 344 LL 345
           ++
Sbjct: 274 VM 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++F+ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEFLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 43  AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 97
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+ I+++  +         ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 158 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 37/193 (19%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I   +++R+ TI+ +   DY+    D++          +        +LY++L+  +   
Sbjct: 67  IDCKRILREITILNRLKSDYIIRLYDLI----------IPDDLLKFDELYIVLEIADSD- 115
Query: 202 LFFHLYRQGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
               L++  IF  E+  +     ++   + +H+ GI+HRDLKP N L++ D  V + DFG
Sbjct: 116 -LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174
Query: 261 LAKEIDESSRSNSMCGTTE-----------------------YMAPE-ILLSKGHNKDAD 296
           LA+ I+    +N +    E                       Y APE ILL + + K  D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 297 WWSVGILLYEMLT 309
            WS G +  E+L 
Sbjct: 235 IWSTGCIFAELLN 247

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIIN-----------EKVKL 333
             +K ++   D WS G +  E+   G+P F   +     +RI                KL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 334 P------------------PFLTSEAHSLLKGLLHKDPSKRLGS 359
           P                  P L +    LL+ LL  +P +R+ +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 247 IDVYMIMVKCWMIDADSR 264

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 8/218 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 40  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 96
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 263 KEI-DESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 157 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  +      +++  P       ++L+      DPS R
Sbjct: 217 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 254

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + +++     D   R
Sbjct: 249 IDVYMIMRKCWMIDADSR 266

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 250 IDVYMIMVKCWMIDADSR 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 8/218 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 44  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 100
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 263 KEI-DESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  +      +++  P       ++L+      DPS R
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 248 IDVYMIMVKCWMIDADSR 265

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 270
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+ I+++  +         ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 118/259 (45%), Gaps = 12/259 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   + +  +V+G GAF                  + A+K++ + T  K N V++M  
Sbjct: 10  RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD- 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  I+  + HP +V+L         + L+   +  G L  + H ++  I  +     +  
Sbjct: 67  EALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCV 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTE 279
           +I   + +L +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     +
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 337
           +MA E +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 244
Query: 338 TSEAHSLLKGLLHKDPSKR 356
           T + + ++      D   R
Sbjct: 245 TIDVYMVMVKCWMIDADSR 263

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 20  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 76
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 77  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 135
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 136 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 255
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + +++     D   R
Sbjct: 256 IDVYMIMRKCWMIDADSR 273

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 249 IDVYMIMVKCWMIDADSR 266

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 247 IDVYMIMVKCWMIDADSR 264

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + +++     D   R
Sbjct: 246 IDVYMIMRKCWMIDADSR 263

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R      +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 92/187 (49%), Gaps = 30/187 (16%)
Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA 217
           M A R+I  L ++ HP ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY--AEHDLWHIIK--FHRASKA 118
Query: 218 ------------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGL 261
                       +    +I+  + +LH   ++HRDLKP NIL+  +    G V + D G 
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 262 AKEIDESSRS----NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH 316
           A+  +   +     + +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-H 237
Query: 317 ANRQKLQ 323
             ++ ++
Sbjct: 238 CRQEDIK 244

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 65/128 (50%), Gaps = 7/128 (5%)
Query: 214 EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           ED        IV A+ HLH K  ++HRD+KP N+L+++ G V   DFG++  + +    +
Sbjct: 135 EDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD 194
Query: 273 SMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRI 326
              G   Y APE     L  KG++  +D WS+GI   E+   + P+       Q+L+Q +
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254
Query: 327 INEKVKLP 334
                +LP
Sbjct: 255 EEPSPQLP 262

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFR 213
           +K   D++  E  I+ +  HP I+ L         + ++ +++  G L   L +  G F 
Sbjct: 64  EKQRRDFL-GEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRS 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +  
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
            +  G     + APE +  +     +D WS GI+++E+++ G+ P+     Q +  + + 
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-IKAVE 241
Query: 329 EKVKLP 334
           E  +LP
Sbjct: 242 EGYRLP 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 72  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 127
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 128 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 113/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + +++     D   R
Sbjct: 248 IDVYMIMRKCWMIDADSR 265

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 46  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 101
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 102 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 160
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 39  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 94
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 95  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 153
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 48  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 103
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 104 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 162
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 45  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 100
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 101 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 159
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 47  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 102
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 103 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 161
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 40  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 95
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 96  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 154
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 169
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 73/139 (52%), Gaps = 20/139 (14%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHR 239
           ++LYLI D+   G L+ +L    +  +   +   +  VS + HLH        K  I HR
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHR 166
Query: 240 DLKPENILMDSDGHVMLTDFGLA-KEIDESSRS----NSMCGTTEYMAPEIL---LSKGH 291
           DLK +NIL+  +G   + D GLA K I +++      N+  GT  YM PE+L   L++ H
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 292 NKD---ADWWSVGILLYEM 307
            +    AD +S G++L+E+
Sbjct: 227 FQSYIMADMYSFGLILWEV 245

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 73  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 131
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 192 KHFESFKRADIYAMGLVFWEI 212

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 16  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 72
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 73  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 132 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 251
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 252 IDVYMIMVKCWMIDADSR 269

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 120
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 121 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 240
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDR 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 119
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 120 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 239
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDR 262

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 98  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 156
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 217 KHFESFKRADIYAMGLVFWEI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 75  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 133
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 194 KHFESFKRADIYAMGLVFWEI 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDR 260

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 130
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 191 KHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 78  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 136
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 197 KHFESFKRADIYAMGLVFWEI 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 249 IDVYMIMVKCWMIDADSR 266

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 249 IDVYMIMVKCWMIDADSR 266

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 35  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 91
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 92  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 150
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 151 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 270
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 271 IDVYMIMVKCWMIDADSR 288

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 253 IDVYMIMVKCWMIDADSR 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 248 IDVYMIMVKCWMIDADSR 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 113
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 114 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 233
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDR 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 54  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 113 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 232
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDR 255

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L      R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 121
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 122 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 241
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDR 264

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 7   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 63
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 64  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 123 IAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 242
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 243 IDVYMIMVKCWMIDADSR 260

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 114/260 (43%), Gaps = 25/260 (9%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 105
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---- 278
           ++ + + +L     VHRDL   N L+     V + DFG++++I  S+    + G T    
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPI 224
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPF 336
            +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P  
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
              E +++++G   ++P +R
Sbjct: 285 CPPEVYAIMRGCWQREPQQR 304

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 116
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 117 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 236
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDR 259

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDR 260

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 60
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 61  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 240 IDVYMIMVKCWMIDADSR 257

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/276 (21%), Positives = 119/276 (43%), Gaps = 43/276 (15%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L   +    +++ P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E +++  + H  +V+L Y+  TR + +Y+I +++  G L  F      G     +   ++
Sbjct: 58  EANLMKTLQHDKLVRL-YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TE 279
           A+I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         +
Sbjct: 117 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 176
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + APE +        +D WS GILLYE++T G+ P+
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +
Sbjct: 58  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLF 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    + 
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 280 ---YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFT-------HANRQKLQQR 325
              + APE L        +D WS G+ LYE+LT     Q P T       H   Q    R
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 236
Query: 326 II-----NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +       E++  P     E + L+K     + S R
Sbjct: 237 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFR 272

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +
Sbjct: 59  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLF 117
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    + 
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 280 ---YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFT-------HANRQKLQQR 325
              + APE L        +D WS G+ LYE+LT     Q P T       H   Q    R
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 237
Query: 326 II-----NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +       E++  P     E + L+K     + S R
Sbjct: 238 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFR 273

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 114/260 (43%), Gaps = 25/260 (9%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 76
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---- 278
           ++ + + +L     VHRDL   N L+     V + DFG++++I  S+    + G T    
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPI 195
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPF 336
            +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P  
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 255
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
              E +++++G   ++P +R
Sbjct: 256 CPPEVYAIMRGCWQREPQQR 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 48  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 107 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 226
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDR 249

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 114/260 (43%), Gaps = 25/260 (9%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 82
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---- 278
           ++ + + +L     VHRDL   N L+     V + DFG++++I  S+    + G T    
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPI 201
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPF 336
            +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P  
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 261
Query: 337 LTSEAHSLLKGLLHKDPSKR 356
              E +++++G   ++P +R
Sbjct: 262 CPPEVYAIMRGCWQREPQQR 281

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + +++     D   R
Sbjct: 248 IDVYMIMRKCWMIDADSR 265

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/276 (21%), Positives = 119/276 (43%), Gaps = 43/276 (15%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L   +    +++ P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 248 IDVYMIMVKCWMIDADSR 265

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/276 (21%), Positives = 119/276 (43%), Gaps = 43/276 (15%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           L   +    +++ P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 253 IDVYMIMVKCWMIDADSR 270

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 250 IDVYMIMVKCWMIDADSR 267

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 130 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 189
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 238

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 149 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 208
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 257

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 69/217 (31%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH------------------VML 256
           Q R    ++  AV  LH   + H DLKPENIL ++SD                    V +
Sbjct: 138 QVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-T 315
            DFG A   D    S ++  T  Y APE++L  G ++  D WS+G +++E   G   F T
Sbjct: 198 VDFGSAT-FDHEHHS-TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQT 255
Query: 316 HANRQKLQQ------------------------------------RIINEKVK-LPPFLT 338
           H NR+ L                                      R + E  K L  +LT
Sbjct: 256 HDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLT 315
Query: 339 SEAHS------LLKGLLHKDPSKRLGSGPGGVDAIKH 369
           SEA        L++ +L  +P+KRL  G    +A++H
Sbjct: 316 SEAEEHHQLFDLIESMLEYEPAKRLTLG----EALQH 348

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + ++ +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILL-SKGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 296 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           D W  G ++ EM T + P    N ++ Q  +I++
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 24/138 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG A   DE    +++  T  Y APE++L+ G ++  D WS+G +L E   G  
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 313 PF-THANRQKL--QQRII 327
            F TH +++ L   +RI+
Sbjct: 233 VFPTHDSKEHLAMMERIL 250

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 269 SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 328 NE 329
           ++
Sbjct: 243 SQ 244

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 77/155 (49%), Gaps = 5/155 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E +++  + H  +V+L         +Y+I +F+  G L  F      G     +   ++A
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         ++
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE +        ++ WS GILLYE++T G+ P+
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  +  M+ +R+ T  K N    +  
Sbjct: 44  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIME-LREATSPKANK--EILD 100
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 101 EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 159
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 160 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 279
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 280 IDVYMIMVKCWMIDADSR 297

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 318
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 319 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTA 290

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 328 NE 329
           ++
Sbjct: 243 SQ 244

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 318
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 319 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 359
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTA 290

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 154
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 283 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 318
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 274
Query: 319 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL
Sbjct: 275 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARL 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 269 SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 241
Query: 328 NE 329
           ++
Sbjct: 242 SQ 243

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 42  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 97
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HR+L   NIL++++  V +
Sbjct: 98  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKI 156
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 49  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HR+L+  NIL+       + DFGLA+ I+++  +      
Sbjct: 108 LDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 333
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 227
Query: 334 PPFLTSEAHSLLKGLLHKDPSKR 356
           P     E + L++    + P  R
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDR 250

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 57/90 (63%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++   + + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 593
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 594 PAGCPREMYDLMNLCWTYDVENRPG 618

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 594
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 595 PAGCPREMYDLMNLCWTYDVENRPG 619

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 253 IDVYMIMVKCWMIDADSR 270

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 10/258 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLLKGLLHKDPSKR 356
            + + ++      D   R
Sbjct: 253 IDVYMIMVKCWMIDADSR 270

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/262 (22%), Positives = 111/262 (42%), Gaps = 27/262 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAF                  + A+K ++   D   K  H      E ++LT + 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 73
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I + + +L     VHRDL   N L+  +  V + DFG+++++  S+    + G T  
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTML 192
Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLP 334
              +M PE ++ +    ++D WS+G++L+E+ T G+ P+   +  ++ + I   +V + P
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 252
Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
                E + L+ G   ++P  R
Sbjct: 253 RTCPQEVYELMLGCWQREPHMR 274

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 249
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 250 PAGCPREMYDLMNLCWTYDVENRPG 274

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRPG 260

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 56/90 (62%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++     + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 94/238 (39%), Gaps = 49/238 (20%)
Query: 109 PGDFEIFRVVGQGAF---------XXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           P ++EI  ++G+G++                           I   +++R+ TI+ +   
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 86
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           DY+    D++          +        +LY++L+  +       L++  IF  +Q  +
Sbjct: 87  DYIIRLHDLI----------IPEDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVK 134
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---------- 268
                ++     +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+            
Sbjct: 135 TILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 269 ----------------SRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                            +  S   T  Y APE ILL + +    D WS G +  E+L 
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRPG 276

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRPG 276

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEID--ESSRSNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D  +     ++ GT  ++APE L +   ++
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSE 222
Query: 294 DADWWSVGILLYEMLTGQPPFTHA 317
             D +  G++L E++TGQ  F  A
Sbjct: 223 KTDVFGYGVMLLELITGQRAFDLA 246

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRPG 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   ++ L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++ 
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 291
Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    +E + ++K     DP KR
Sbjct: 292 SPEHAPAEMYDIMKTCWDADPLKR 315

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 229
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 230 PAGCPREMYDLMNLCWTYDVENRPG 254

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
           R  L +V HP IVQ+ ++F   +        Y++++++ G  L     ++    E  A  
Sbjct: 130 RQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-- 186
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  EI+ A+S+LH  G+V+ DLKPENI++ ++  + L D G    I+       + GT  
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINS---FGYLYGTPG 242
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           + APEI+ + G     D ++VG  L  +    P
Sbjct: 243 FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLP 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   ++ L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++ 
Sbjct: 228 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 286
Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    +E + ++K     DP KR
Sbjct: 287 SPEHAPAEMYDIMKTCWDADPLKR 310

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   ++ L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++ 
Sbjct: 210 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 268
Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    +E + ++K     DP KR
Sbjct: 269 SPEHAPAEMYDIMKTCWDADPLKR 292

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++      + GTT YMA
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 198 PEALRGEITPK-SDIYSFGVVLLEIITGLP 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   ++ L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++ 
Sbjct: 226 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 284
Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    +E + ++K     DP KR
Sbjct: 285 SPEHAPAEMYDIMKTCWDADPLKR 308

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 33/193 (17%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---DSDGHV--MLTDFGLAKEIDES----SRSNS 273
           +  S ++HLH   IVHRDLKP NIL+   ++ G +  M++DFGL K++       SR + 
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 274 MCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           + GT  ++APE+L     +      D +S G + Y +++ G  PF  + ++  Q  I+  
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLG 243
Query: 330 KVKLPPFLTSE-----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
              L      +     A  L++ ++  DP KR    P     +K H +F S+        
Sbjct: 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKR----PSAKHVLK-HPFFWSL-------- 290
Query: 385 EMQPKFKPDVSGK 397
           E Q +F  DVS +
Sbjct: 291 EKQLQFFQDVSDR 303

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPG 266

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 9/101 (8%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           +  T EY +PE+LL       AD WS   L++E++TG   F
Sbjct: 196 I-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 96/205 (46%), Gaps = 7/205 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 333
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 334 PPFLTSEAHSLLKGLLHKDPSKRLG 358
           P     E + L+      D   R G
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPG 256

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 9/101 (8%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           +  T EY +PE+LL       AD WS   L++E++TG   F
Sbjct: 196 I-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 74/141 (52%), Gaps = 5/141 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
            A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  +     +  +   
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 335
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 253
Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
              +  ++L+    ++ PS+R
Sbjct: 254 DCPAWVYALMIECWNEFPSRR 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 210 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 264
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 324
Query: 262 AKEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+            G     ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 325 AR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 64/138 (46%), Gaps = 24/138 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG A   DE    +++     Y APE++L+ G ++  D WS+G +L E   G  
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 313 PF-THANRQKL--QQRII 327
            F TH +++ L   +RI+
Sbjct: 233 VFPTHDSKEHLAMMERIL 250

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   ++ L     +HRDL   NIL+       + DFGLA+ I   S    + N+  
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++ 
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 291
Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P    +E + ++K     DP KR
Sbjct: 292 SPEHAPAEMYDIMKTCWDADPLKR 315

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 74/141 (52%), Gaps = 5/141 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
            A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  +     +  +   
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 335
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 270
Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
              +  ++L+    ++ PS+R
Sbjct: 271 DCPAWVYALMIECWNEFPSRR 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++    + + GTT Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 195 PEALRGEITPK-SDIYSFGVVLLEIITGLP 223

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 50/84 (59%), Gaps = 2/84 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEID--ESSRSNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D  +     ++ G   ++APE L +   ++
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSE 214
Query: 294 DADWWSVGILLYEMLTGQPPFTHA 317
             D +  G++L E++TGQ  F  A
Sbjct: 215 KTDVFGYGVMLLELITGQRAFDLA 238

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 334 PP 335
            P
Sbjct: 258 QP 259

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 35/198 (17%)
Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +I  +H   + AE   LT       ++ ++Y F+    + + + ++     F  +     
Sbjct: 57  LIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLS 115
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAK------- 263
           F+E   R Y   +  A+  +H+ GIVHRD+KP N L +       L DFGLA+       
Sbjct: 116 FQE--VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173
Query: 264 --------EIDESSRSNSMC--------------GTTEYMAPEILLSKGHNKDA-DWWSV 300
                   E  +   S + C              GT  + APE+L    +   A D WS 
Sbjct: 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233
Query: 301 GILLYEMLTGQPPFTHAN 318
           G++   +L+G+ PF  A+
Sbjct: 234 GVIFLSLLSGRYPFYKAS 251

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 258
Query: 334 PP 335
            P
Sbjct: 259 QP 260
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	441
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	0.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	0.0
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	0.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	0.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	0.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	0.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	0.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	0.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	0.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-177
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-176
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-174
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-171
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-171
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-171
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-170
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-170
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-168
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-167
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-167
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-167
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-164
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-117
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-113
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-88
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-87
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-86
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-82
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-80
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-78
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-78
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-78
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-77
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-76
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-76
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-75
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-75
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-75
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-75
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-74
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-74
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-73
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-73
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-73
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-73
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-72
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-72
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-72
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-72
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-72
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-72
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-72
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-72
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-72
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-72
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-72
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-72
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-72
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-71
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-71
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-71
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-70
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-70
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-70
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-70
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-70
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-70
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-70
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-69
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-69
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-69
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-69
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-68
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-68
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-68
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-68
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-68
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-67
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-67
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-67
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-66
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-66
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-65
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-65
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-64
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-64
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-64
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-62
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-62
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-59
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-55
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-54
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-51
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-50
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-49
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-47
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-47
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-46
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-44
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-43
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-43
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-42
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-42
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-38
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-37
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-37
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-36
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-36
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-35
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-35
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-35
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-35
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-34
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-33
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-33
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-32
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-30
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-30
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-28
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-27
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-26
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-25
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	4e-04

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  532 bits (1374), Expect = 0.0
 Identities = 160/320 (50%), Positives = 221/320 (69%), Gaps = 4/320 (1%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVD 160
               KI P  FE+ RV+G+G +GKVFQV+K      ++  I+AMKV++K  I++      
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
            AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT E
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           YMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 399
           EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ 
Sbjct: 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEED 306

Query: 400 IANFDKCWTTMPADDSPAPT 419
           ++ FD  +T     DSP  +
Sbjct: 307 VSQFDSKFTRQTPVDSPDDS 326

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  530 bits (1368), Expect = 0.0
 Identities = 154/375 (41%), Positives = 219/375 (58%), Gaps = 18/375 (4%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           G S                       L   S     P DF   +V+G+G+FGKV   + K
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLY 191
                  +  YA+KV++K  I+KK    ++ +ER++L K V HPF+V L +SFQT  KLY
Sbjct: 61  -----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
            +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH   IV+RDLKPENIL+DS 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175

Query: 252 GHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GH++LTDFGL KE I+ +S +++ CGT EY+APE+L  + +++  DWW +G +LYEML G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

Query: 311 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
            PPF   N  ++   I+N+ ++L P +T+ A  LL+GLL KD +KRLG+       IK H
Sbjct: 236 LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSH 294

Query: 371 KWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---------- 420
            +F  INW  L  +++ P F P+VSG + + +FD  +T  P  ++    P          
Sbjct: 295 VFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVK 354

Query: 421 TAGEHFKGYTYVAPN 435
            A E F G++Y  P 
Sbjct: 355 EAAEAFLGFSYAPPT 369

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  524 bits (1352), Expect = 0.0
 Identities = 152/324 (46%), Positives = 210/324 (64%), Gaps = 4/324 (1%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
            ++         E   K  P  FE+ +V+GQG+FGKVF VKK      D+  +YAMKV++
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLK 61

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           K T+  ++ V   K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++
Sbjct: 62  KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDES 268
            +F E+  +FY AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID  
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            ++ S CGT EYMAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+ 
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

Query: 329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 388
            K+ +P FL+ EA SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P
Sbjct: 241 AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHP 300

Query: 389 KFKPDVSGKDCIANFDKCWTTMPA 412
            FKP     +    FD  +T    
Sbjct: 301 PFKPATGRPEDTFYFDPEFTAKTP 324

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  523 bits (1349), Expect = 0.0
 Identities = 127/339 (37%), Positives = 202/339 (59%), Gaps = 12/339 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+++KD +I+ + V+  
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECT 67

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY 
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   + + CGT +Y
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A ++ KGL+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G++  
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRN-A 306

Query: 401 ANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 435
            NFD+ +T  P   +P             F+G+++V   
Sbjct: 307 ENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 345

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  521 bits (1343), Expect = 0.0
 Identities = 132/340 (38%), Positives = 208/340 (61%), Gaps = 17/340 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

Query: 405 KCWTTMPADDSPAPTP-----------TAGEHFKGYTYVA 433
             +T      +P                  E F+ + Y+A
Sbjct: 296 DEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  521 bits (1343), Expect = 0.0
 Identities = 130/351 (37%), Positives = 206/351 (58%), Gaps = 12/351 (3%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
             +    +   S  ++G  +FE  RV+G+G+FGKV   + K     ++  +YA+KV++KD
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKD 59

Query: 152 TIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            I++ + V+    E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +  
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESS 269
            F E +ARFY AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I    
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
            + + CGT +Y+APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N+
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 330 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQP 388
           +V  P +L  +A  +LK  + K+P+ RLGS   GG  AI  H +F+ I+W  L  R+++P
Sbjct: 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299

Query: 389 KFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 435
            F+P +  ++ ++NFD  +       +P           + F+ + YV+P 
Sbjct: 300 PFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  514 bits (1327), Expect = 0.0
 Identities = 117/324 (36%), Positives = 198/324 (61%), Gaps = 9/324 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K    DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   E
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           R +L+ VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+ 
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
            A+ +LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV 174

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
           + +K +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234

Query: 346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFD 404
             L+ +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FD
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 294

Query: 405 KCWTTMPADDSPAPTPTAGEHFKG 428
           K +     +          + F+ 
Sbjct: 295 K-YPEEDINYGVQGEDPYADLFRD 317

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  514 bits (1326), Expect = 0.0
 Identities = 131/388 (33%), Positives = 230/388 (59%), Gaps = 22/388 (5%)

Query: 65  HNRSHSFVGPSP-RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           H+  H +  P+        ++   I+E +   +     ++   +G  DF++ RV+G+G++
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182
            KV  V+ K      +D IYAM+V++K+ +     +D+++ E+ +  + + HPF+V L  
Sbjct: 66  AKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120

Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
            FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180

Query: 243 PENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
            +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +    DWW++G
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 302 ILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 352
           +L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+LK  L+KD
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD 300

Query: 353 PSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP 411
           P +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+  + NFD  +T  P
Sbjct: 301 PKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEP 360

Query: 412 ADDSPAPTP----TAGEHFKGYTYVAPN 435
              +P             F+G+ Y+ P 
Sbjct: 361 VQLTPDDDDIVRKIDQSEFEGFEYINPL 388

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  511 bits (1319), Expect = 0.0
 Identities = 127/348 (36%), Positives = 216/348 (62%), Gaps = 21/348 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +G  DF++ RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D++
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWV 56

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKV 331
           +APEIL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKF 390
           ++P  L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P F
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 296

Query: 391 KPDVSGKDCIANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAP 434
           KP++SG+  + NFD  +T  P   +P             F+G+ Y+ P
Sbjct: 297 KPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  497 bits (1282), Expect = e-177
 Identities = 145/327 (44%), Positives = 212/327 (64%), Gaps = 12/327 (3%)

Query: 87  QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           Q+  ++HE           K+G  +FE+ +V+G GA+GKVF V+K      D+  +YAMK
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMK 88

Query: 147 VMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           V++K TI+ K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF 
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208

Query: 265 --IDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFT----H 316
              DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT     
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
            ++ ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ I
Sbjct: 269 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

Query: 377 NWKTLEAREMQPKFKPDVSGKDCIANF 403
           NW  L A+++   FKP +  +  ++NF
Sbjct: 329 NWDDLAAKKVPAPFKPVIRDELDVSNF 355

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  495 bits (1276), Expect = e-176
 Identities = 125/357 (35%), Positives = 204/357 (57%), Gaps = 10/357 (2%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
              + + +   S+   + + + +   + E  S+       F+  + +G G+FG+V  VK 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
           K     +S   YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY
Sbjct: 63  K-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           ++++++ GG +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G++ +TDFG AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G 
Sbjct: 178 GYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
           PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HK
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 372 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKG 428
           WF + +W  +  R+++  F P   G    +NFD  +       S       G+ F  
Sbjct: 296 WFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKEFTE 349

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  503 bits (1297), Expect = e-174
 Identities = 134/414 (32%), Positives = 218/414 (52%), Gaps = 13/414 (3%)

Query: 29  SPDFDFTEVFGPLTPCRHNNQSPASTSA-SLGDPQVIHNRSHSFVGPSPRYALSSSLPLQ 87
           S  F  +E+            S       ++  P      +        R  +       
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
            ++  +         +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKI 373

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++KD +I+ + V+    E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            + G F+E  A FY AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            +   + + CGT +Y+APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q 
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553

Query: 326 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 385
           I+   V  P  ++ EA ++ KGL+ K P KRLG GP G   IK H +FR I+W+ LE +E
Sbjct: 554 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613

Query: 386 MQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 435
           +QP +KP  SG++   NFD+ +T  P   +P             F+G+++V   
Sbjct: 614 IQPPYKPKASGRN-AENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 666

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  484 bits (1247), Expect = e-171
 Identities = 121/339 (35%), Positives = 193/339 (56%), Gaps = 15/339 (4%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + K+   DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECT 64

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N+ CGT +Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 400
           A  LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      
Sbjct: 245 AKDLLVKLFVREPEKRLGVRG----DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 300

Query: 401 ANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAPN 435
           +NFDK +       S A            F+ ++++ P 
Sbjct: 301 SNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPG 339

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  492 bits (1269), Expect = e-171
 Identities = 129/436 (29%), Positives = 204/436 (46%), Gaps = 29/436 (6%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
              + LT    S + PD         +T C    +            ++ H   +  V P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE--YLSVAP 157

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
              Y  S      +Q    E          + +    F  +RV+G+G FG+V   + +  
Sbjct: 158 FADYLDSIYFNRFLQWKWLER---------QPVTKNTFRQYRVLGKGGFGEVCACQVR-- 206

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194
               +  +YA K + K  I K+        E+ IL KV   F+V L Y+++T+  L L+L
Sbjct: 207 ---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 195 DFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
             +NGG L FH+Y  G   F E +A FY AEI   +  LH+  IV+RDLKPENIL+D  G
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           H+ ++D GLA  + E        GT  YMAPE++ ++ +    DWW++G LLYEM+ GQ 
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 313 PFTHANRQ----KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 368
           PF    ++    ++++ +     +     + +A SL   LL KDP++RLG   G    +K
Sbjct: 384 PFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443

Query: 369 HHKWFRSINWKTLEAREMQPKFKPDVSGKDC--IANFDKCWTTMPADDSPAPTPTAGEHF 426
            H  F+ +N+K L A  ++P FKPD     C  + + ++  T           PT  + +
Sbjct: 444 EHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKG----VELEPTDQDFY 499

Query: 427 KGYTYVA-PNPWLSSV 441
           + +   + P PW + +
Sbjct: 500 QKFATGSVPIPWQNEM 515

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  484 bits (1247), Expect = e-171
 Identities = 119/351 (33%), Positives = 192/351 (54%), Gaps = 22/351 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   + 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERDI+     P++VQL Y+FQ    LY++++++ GG L   +       E  ARFYTA
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 175

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEY 280
           E+V A+  +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 281 MAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-- 334
           ++PE+L S+G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L   
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295

Query: 335 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
               ++ EA +L+   L  D   RLG    GV+ IK H +F++  W     R+      P
Sbjct: 296 DDNDISKEAKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352

Query: 393 DVSGKDCIANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTYVAPNPWLSS 440
           D+S     +NFD        +++ P P    G    F G+TY +   +LSS
Sbjct: 353 DLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSS 403

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  485 bits (1249), Expect = e-170
 Identities = 129/322 (40%), Positives = 201/322 (62%), Gaps = 7/322 (2%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
                E      A+ + ++   +FE  +++G+G FGKV  VK+K      +   YAMK++
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKIL 181

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
           +K+ I+ K+ V +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 209 QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-ID 266
           + +F ED+ARFY AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I 
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           + +   + CGT EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

Query: 327 INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM 386
           + E+++ P  L  EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++
Sbjct: 362 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421

Query: 387 QPKFKPDVSGKDCIANFDKCWT 408
            P FKP V+ +     FD+ +T
Sbjct: 422 SPPFKPQVTSETDTRYFDEEFT 443

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  493 bits (1270), Expect = e-170
 Identities = 115/352 (32%), Positives = 181/352 (51%), Gaps = 23/352 (6%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E    +   DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETL 235

Query: 162 MKAERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ER +L+ V     PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   R
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           FY AEI+  + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT 
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTH 354

Query: 279 EYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLP 334
            YMAPE+L     ++  ADW+S+G +L+++L G  PF       + ++ +  +   V+LP
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

Query: 335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 394
              + E  SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P  
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474

Query: 395 SGKDC-----IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 441
              +      I +FD+  T               E ++ +       W   V
Sbjct: 475 GEVNAADAFDIGSFDEEDTKGIKLLDS-----DQELYRNFPLTISERWQQEV 521

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  475 bits (1225), Expect = e-168
 Identities = 102/321 (31%), Positives = 171/321 (53%), Gaps = 17/321 (5%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +    +    FEI R +G+G+FGKV  V+K      D+  +YAMK M K   +++N V  
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRN 61

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+  + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + + 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            E+V A+ +L    I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YM
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 282 APEILLSK---GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPP 335
           APE+  S+   G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241

Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 395
             + E  SLLK LL  +P +R       +  +++  +   INW  +  + + P F P+  
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRF----SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297

Query: 396 GKDCIANFDKCWTTMPADDSP 416
             +C   F+     M  +  P
Sbjct: 298 RLNCDPTFE--LEEMILESKP 316

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  471 bits (1215), Expect = e-167
 Identities = 112/293 (38%), Positives = 173/293 (59%), Gaps = 10/293 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYV 77

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTA
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTE 279
           EIVSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           Y++PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 257

Query: 340 EAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
           +A  L++ LL  D +KRLG     G   +K H +F S+ W+ L  +   PK  
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT-PPKLT 309

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  475 bits (1225), Expect = e-167
 Identities = 122/364 (33%), Positives = 181/364 (49%), Gaps = 35/364 (9%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            E ++   DFEI +V+G+GAF +V  VK K      +  +YAMK+M K  ++K+  V   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
           + ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY 
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AEIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG   ++  D + RS    GT +
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 280 YMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 332
           Y++PEIL + G       +  + DWW++G+  YEM  GQ PF   +  +   +I++ K  
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288

Query: 333 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 387
           L        +  EA   ++ LL   P  RLG   GG    + H +F  ++W  L  R+  
Sbjct: 289 LSLPLVDEGVPEEARDFIQRLL-CPPETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSV 343

Query: 388 PKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----------EHFKGYTYVAPNPW 437
           P F PD  G     NFD     + A  S      +             F GY+Y      
Sbjct: 344 PPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALR 403

Query: 438 LSSV 441
            S V
Sbjct: 404 DSEV 407

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  480 bits (1237), Expect = e-167
 Identities = 117/343 (34%), Positives = 183/343 (53%), Gaps = 17/343 (4%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           + +G   F  FRV+G+G FG+VF  + K      +  +YA K + K  + K+        
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFY 220
           E+ IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
           TA+IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E     +++    GT  
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP 335
           +MAPE+LL + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414

Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 395
             +  +    + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD  
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474

Query: 396 GKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAP-NPW 437
                   D    +       A      E F+ +       PW
Sbjct: 475 TVYAKNIQDVGAFS--TVKGVAFEKADTEFFQEFASGTCPIPW 515

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  468 bits (1207), Expect = e-164
 Identities = 116/351 (33%), Positives = 188/351 (53%), Gaps = 28/351 (7%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACF 121

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           + ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY 
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AE+V A+  +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           Y++PEIL +       +  + DWWS+G+ +YEML G+ PF   +  +   +I+N K +  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 335 -----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 389
                  ++  A  L++ L+      RLG    G++  K H +F  I+W  +  R  +  
Sbjct: 302 FPTQVTDVSENAKDLIRRLI-CSREHRLGQ--NGIEDFKKHPFFSGIDWDNI--RNCEAP 356

Query: 390 FKPDVSGKDCIANFDK---CWTTMPADDSPAPTPTAGEH--FKGYTYVAPN 435
           + P+VS     +NFD    C         P  T  +G H  F G+TY +  
Sbjct: 357 YIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSC 407

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  342 bits (880), Expect = e-117
 Identities = 93/299 (31%), Positives = 155/299 (51%), Gaps = 17/299 (5%)

Query: 99  LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           L    +RK    DF+I R +G+G FG V+  ++K      +  I A+KV+ K  + K+  
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGV 57

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ++ E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++ 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  E+  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R  +MCGT 
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMCGTL 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           +Y+ PE++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236

Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 397
             +  L+  LL   P +RL      +  +  H W +        +R + P        K
Sbjct: 237 DGSKDLISKLLRYHPPQRL-----PLKGVMEHPWVK------ANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  333 bits (855), Expect = e-113
 Identities = 90/282 (31%), Positives = 151/282 (53%), Gaps = 11/282 (3%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 176

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 385
           L+  LL  +PS+R       +  +  H W  + + K    + 
Sbjct: 237 LISRLLKHNPSQRP-----MLREVLEHPWITANSSKPSNCQN 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  294 bits (754), Expect = 1e-97
 Identities = 82/332 (24%), Positives = 132/332 (39%), Gaps = 28/332 (8%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +         S     PR      +  + +  E       +     
Sbjct: 3   HHHHHSSGVDLGTENLYF-----QSMHQLQPR-----RVSFRGEASETLQSPGYDPSRPE 52

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 F+    +G G++G+VF+V+ K  +DG    +YA+K         K+    +  E
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGR---LYAVKRSMSPFRGPKDRARKLA-E 106

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
                KV  HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRD 165

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
            + A++HLH  G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAP
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+ L   +   AD +S+G+ + E+      P      Q+L+Q  +    +    L+SE  
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--PPEFTAGLSSELR 282

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           S+L  +L  DP  R        +A+      R
Sbjct: 283 SVLVMMLEPDPKLRA-----TAEALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  286 bits (734), Expect = 4e-94
 Identities = 76/337 (22%), Positives = 135/337 (40%), Gaps = 60/337 (17%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----- 156
             E+     D+ I R + QG F K+   +K           YA+K   K  + KK     
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYEKSLLEKKRDFTK 75

Query: 157 ---------NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
                    +  D  K E  I+T + + + +          ++Y+I +++    +     
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 208 RQGI--------FREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
              +              +     ++++ S++H +  I HRD+KP NILMD +G V L+D
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTH 316
           FG ++ + +        GT E+M PE   ++   +    D WS+GI LY M     PF+ 
Sbjct: 196 FGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 317 -ANRQKLQQRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKR 356
             +  +L   I  + ++ P                    FL++E    LK  L K+P++R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 357 LGSGPGGVDAIKHHKWFRSINWKTLE--AREMQPKFK 391
           +       +    H+W    N + L   ++E+  K K
Sbjct: 315 I-----TSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  269 bits (689), Expect = 3e-88
 Identities = 74/267 (27%), Positives = 145/267 (54%), Gaps = 12/267 (4%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF++  ++G+G+F  V++ +        +    A+K++ K  + K   V  ++ E  I 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAV 228
            ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
            +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
              H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+  
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245

Query: 348 LLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           LL ++P+ RL      + ++  H +  
Sbjct: 246 LLRRNPADRL-----SLSSVLDHPFMS 267

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  267 bits (685), Expect = 7e-87
 Identities = 82/307 (26%), Positives = 151/307 (49%), Gaps = 14/307 (4%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP---GDFEIFRVVGQGAFGKVFQV 129
           GP+P     + +P              +   E  + P     +   R +G+G F K F++
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60

Query: 130 KKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                 D D+  ++A K++ K  ++K +  + M  E  I   + H  +V     F+    
Sbjct: 61  S-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           ++++L+      L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 250 SDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            D  V + DFGLA +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 309 TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 368
            G+PPF  +  ++   RI   +  +P  +   A SL++ +L  DP+ R       ++ + 
Sbjct: 236 VGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP-----TINELL 290

Query: 369 HHKWFRS 375
           + ++F S
Sbjct: 291 NDEFFTS 297

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  265 bits (680), Expect = 1e-86
 Identities = 79/291 (27%), Positives = 147/291 (50%), Gaps = 16/291 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +   R +G+G F K F++      D D+  ++A K++ K  ++K +  + M  E  I 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V     F+    ++++L+      L     R+    E +AR+Y  +IV    
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLS 288
           +LH+  ++HRDLK  N+ ++ D  V + DFGLA +++ +  R   +CGT  Y+APE+L  
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           KGH+ + D WS+G ++Y +L G+PPF  +  ++   RI   +  +P  +   A SL++ +
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWK----TLEAREMQPKFKPDVS 395
           L  DP+ R       ++ + + ++F S  +      +    + P+F    S
Sbjct: 250 LQTDPTARP-----TINELLNDEFFTS-GYIPARLPITCLTIPPRFSIAPS 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  255 bits (653), Expect = 1e-82
 Identities = 76/306 (24%), Positives = 140/306 (45%), Gaps = 52/306 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DFE   V+GQGAFG+V + +         D   YA+K +R      +  +  + +E  +L
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRH----TEEKLSTILSEVMLL 56

Query: 170 TKVTHPFIVQLRYSFQ-------------TRSKLYLILDFINGGHLFFHLYRQGIF-RED 215
             + H ++V+   ++               +S L++ +++   G L+  ++ + +  + D
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---- 271
           +      +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 272 -----------NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                       S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234

Query: 320 QKLQQRIINEKVKLPPFL----TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
             + +++ +  ++ PP            +++ L+  DP+KR      G   + +  W   
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPV 289

Query: 376 INWKTL 381
            +   +
Sbjct: 290 KHQDEV 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  250 bits (641), Expect = 4e-80
 Identities = 86/314 (27%), Positives = 150/314 (47%), Gaps = 17/314 (5%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKV 147
               H +  +L  E+        +   + +G+G+FGK   VK         DG  Y +K 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST------EDGRQYVIKE 56

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           +    +  K   +  + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  + 
Sbjct: 57  INISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115

Query: 208 RQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Q   +F+EDQ   +  +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ +
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 266 DES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           + +   + +  GT  Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 325 RIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 383
           +II+     +    + +  SL+  L  ++P  R       V++I    +      K L  
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP-----SVNSILEKGFIAKRIEKFLSP 290

Query: 384 REMQPKFKPDVSGK 397
           + +  +F      K
Sbjct: 291 QLIAEEFCLKTFSK 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  246 bits (629), Expect = 1e-78
 Identities = 74/317 (23%), Positives = 122/317 (38%), Gaps = 58/317 (18%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 321
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 322 LQQRIINEKV-------------------------KLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  +II  K                           L   L      +L  +L  D  K 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 357 LGSGPGGVDAIKHHKWF 373
                 G D        
Sbjct: 295 W-----GFDQFFAETSD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  248 bits (635), Expect = 1e-78
 Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 53/302 (17%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 321
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 322 LQQRIINEKV-------------------------KLPPFLTSEAHSLLKGLLHKDPSKR 356
           +  +II  K                           L   L      +L  +L  D  K 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 357 LG 358
            G
Sbjct: 295 WG 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  244 bits (625), Expect = 4e-78
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 33/288 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 76

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 281 MAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN 328
           M PE +                +  +D WS+G +LY M  G+ PF    N+      II+
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

Query: 329 --EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              +++ P     +   +LK  L +DP +R+      +  +  H + +
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  242 bits (620), Expect = 4e-77
 Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 33/288 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 57

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 281 MAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN 328
           M PE +     +++           +D WS+G +LY M  G+ PF    N+      II+
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

Query: 329 --EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              +++ P     +   +LK  L +DP +R+      +  +  H + +
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  241 bits (615), Expect = 4e-76
 Identities = 44/306 (14%), Positives = 115/306 (37%), Gaps = 39/306 (12%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN 157
            ++ ++E ++G     +  ++G+GAF +V++  +  ++D  +   + +KV +     +  
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-----YRQGIF 212
                    + L        ++   +   ++   L+ +  + G L   +       + + 
Sbjct: 113 I---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----------DSDGHVMLTDFGL 261
            +     +   ++  +  +H C I+H D+KP+N ++           D    + L D G 
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 262 AKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           + ++    + +   + C T+ +   E+L +K  N   D++ V   +Y ML G        
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 319 RQKLQQR--------------IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 364
             + +                  +  + +P      +  LL+  L K   +   +    +
Sbjct: 290 GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN---KI 346

Query: 365 DAIKHH 370
            A+++ 
Sbjct: 347 RALRNR 352

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  237 bits (607), Expect = 8e-76
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 18/271 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++   +G+GAF  V +   K      +   +A K++    +  ++    ++ E  I  K
Sbjct: 8   YDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQK-LEREARICRK 61

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A     +I+ ++++ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +   GT  Y++PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             ++K  D W+ G++LY +L G PPF   ++ +L  +I       P      +T EA SL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           +  +L  +P KR+ +      A+K   W  +
Sbjct: 242 IDSMLTVNPKKRITA----DQALK-VPWICN 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  240 bits (615), Expect = 1e-75
 Identities = 80/339 (23%), Positives = 139/339 (41%), Gaps = 43/339 (12%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERK----------IGPGDFEI 114
           H+  H   G  PR +          E +H +  +L  + + K          +    + I
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
            + +G G   KVFQV  +         IYA+K +  +    +    Y   E   L K+  
Sbjct: 61  LKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQ 113

Query: 175 P--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
               I++L     T   +Y++++      L   L ++      + + Y   ++ AV  +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSK 289
           + GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  G   YM PE +   
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 290 G-----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN--EKVKLPP 335
                        +  +D WS+G +LY M  G+ PF    N+      II+   +++ P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291

Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
               +   +LK  L +DP +R+      +  +  H + +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 325

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  242 bits (620), Expect = 2e-75
 Identities = 84/303 (27%), Positives = 151/303 (49%), Gaps = 23/303 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  RV+G+G+FG+V   K K      +    A+KV+ K  + +K   + +  E  +L 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HP I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +HK  IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+ L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-L 200

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
              +++  D WS G++LY +L+G PPF  AN   + +++   K          ++  A  
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           L++ +L   PS R+ +     DA+  H+W ++         ++        +    I  F
Sbjct: 261 LIRKMLTYVPSMRISA----RDALD-HEWIQTYT-----KEQISVDVPSLDNAILNIRQF 310

Query: 404 DKC 406
              
Sbjct: 311 QGT 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  242 bits (620), Expect = 2e-75
 Identities = 81/303 (26%), Positives = 151/303 (49%), Gaps = 20/303 (6%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +        +       + I  ++G+G+FG+V + K +      +   YA+KV+ K 
Sbjct: 5   HHHSSGRENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKA 58

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +   K+    +  E ++L K+ HP I++L    +  S  Y++ +   GG LF  + ++  
Sbjct: 59  SAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDES 268
           F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DFGL+    ++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
           ++     GT  Y+APE+ L   +++  D WS G++LY +L+G PPF   N   + +R+  
Sbjct: 178 TKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236

Query: 329 EKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 384
            K          ++ +A  L++ +L   PS R+ +       ++ H W +  + +T    
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQKYSSETPTIS 291

Query: 385 EMQ 387
           ++ 
Sbjct: 292 DLP 294

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  238 bits (609), Expect = 3e-75
 Identities = 86/310 (27%), Positives = 144/310 (46%), Gaps = 27/310 (8%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           GP            +  E       +             +++   +G+GAF  V +   K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHK 51

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                 +   +A K++    +  ++    ++ E  I  K+ HP IV+L  S Q  S  YL
Sbjct: 52  -----TTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYL 105

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-- 250
           + D + GG LF  +  +  + E  A     +I+ ++++ H  GIVHR+LKPEN+L+ S  
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165

Query: 251 -DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               V L DFGLA E+++S   +   GT  Y++PE+L    ++K  D W+ G++LY +L 
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 310 GQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 365
           G PPF   ++ +L  +I       P      +T EA SL+  +L  +P KR+ +      
Sbjct: 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA----DQ 281

Query: 366 AIKHHKWFRS 375
           A+K   W  +
Sbjct: 282 ALK-VPWICN 290

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  236 bits (602), Expect = 5e-74
 Identities = 56/380 (14%), Positives = 106/380 (27%), Gaps = 66/380 (17%)

Query: 46  HNNQSPASTSASLGDP-----QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE 100
           H++ S    +     P     + + NR       +    + S+    +            
Sbjct: 4   HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 63

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            ESE    P       V+GQ       +   +  + G+    + + V         N + 
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQ--ETGE---SFEVHVPYFTERPPSNAIK 118

Query: 161 YMKAER-------------------------DILTKVTHPFIVQLRYSFQTRSKLYLIL- 194
            MK E                          D++       ++++R   +    L     
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 195 -------DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                      G  L  H               T +++  ++ LH  G+VH  L+P +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-----------HNKDAD 296
           +D  G V LT F                 +  +  PE+   +                 D
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            W++G+++Y +     P T        + I      +P        +LL+G L      R
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDR 351

Query: 357 LGSGPGGVDAIKHHKWFRSI 376
           L               +  +
Sbjct: 352 L-----LPLQAMETPEYEQL 366

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  238 bits (610), Expect = 8e-74
 Identities = 79/284 (27%), Positives = 146/284 (51%), Gaps = 19/284 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  + +G GA+G+V   + K      +    A+K++RK ++   ++   +  E  +L 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSK-LLEEVAVLK 91

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F+ +   YL+++   GG LF  +  +  F E  A     +++S V++
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LHK  IVHRDLKPEN+L++S   D  + + DFGL+   +   +     GT  Y+APE+ L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-L 210

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K +++  D WS+G++L+ +L G PPF     Q++ +++   K          ++  A  
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 387
           L+K +L  D  +R+ +      A++ H W + +  K     E+ 
Sbjct: 271 LIKQMLQFDSQRRISAQ----QALE-HPWIKEMCSKKESGIELP 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  230 bits (589), Expect = 3e-73
 Identities = 68/260 (26%), Positives = 134/260 (51%), Gaps = 21/260 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G G++G+  ++++K      SDG I   K +   ++ +      + +E ++L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59

Query: 170 TKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE 223
            ++ HP IV+       R+   LY+++++  GG L   + +         E+       +
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGT 277
           +  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 336
             YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P  
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239

Query: 337 LTSEAHSLLKGLLHKDPSKR 356
            + E + ++  +L+     R
Sbjct: 240 YSDELNEIITRMLNLKDYHR 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  231 bits (591), Expect = 3e-73
 Identities = 83/254 (32%), Positives = 144/254 (56%), Gaps = 16/254 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F    V+G GAF +VF VK++      +  ++A+K ++K    + + +   + E  +L 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPAFRDSSL---ENEIAVLK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLA 180

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K ++K  D WS+G++ Y +L G PPF      KL ++I     +        ++  A  
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240

Query: 344 LLKGLLHKDPSKRL 357
            +  LL KDP++R 
Sbjct: 241 FICHLLEKDPNERY 254

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  230 bits (589), Expect = 4e-73
 Identities = 79/270 (29%), Positives = 143/270 (52%), Gaps = 19/270 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I  ++G+G+FG+V + K +      +   YA+KV+ K +   K+    +  E ++L K
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLKK 77

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L    +  S  Y++ +   GG LF  + ++  F E  A     ++ S ++++
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  IVHRDLKPENIL++S   D  + + DFGL+    ++++     GT  Y+APE+ L 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LR 196

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             +++  D WS G++LY +L+G PPF   N   + +R+   K          ++ +A  L
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           ++ +L   PS R+ +       ++ H W +
Sbjct: 257 IRKMLTFHPSLRITA----TQCLE-HPWIQ 281

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  230 bits (588), Expect = 7e-73
 Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 27/288 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E   ++G+G    V +   K      +   YA+K++        +  +  +        
Sbjct: 19  YEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 168 --ILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             IL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+APE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 285 IL------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---- 334
           I+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +      
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 382
              +     L+   L   P KR        +    H +F+    + + 
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR 296

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  229 bits (585), Expect = 1e-72
 Identities = 82/276 (29%), Positives = 142/276 (51%), Gaps = 13/276 (4%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G        + A+K++ +  I   + V
Sbjct: 3   KHDGRVKIGH--YVLGDTLGVGTFGKV----KIGEHQLTGHKV-AVKILNRQKIRSLDVV 55

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             +K E   L    HP I++L     T +  ++++++++GG LF ++ + G   E +AR 
Sbjct: 56  GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           Y APE++  +     + D WS G++LY +L G  PF   +   L ++I      +P +L 
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
               +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 236 RSVATLLMHMLQVDPLKRA-----TIKDIREHEWFK 266

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  229 bits (586), Expect = 1e-72
 Identities = 79/296 (26%), Positives = 145/296 (48%), Gaps = 30/296 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           +E+   +G G F  V + ++K      +   YA K ++K  +         + ++ E +I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  +  +I+  V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++      +  + L DFG+A +I+  +   ++ GT E++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I               +  
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 396
           A   ++ LL KDP +R+        +++ H W ++I  + +         + + SG
Sbjct: 242 AKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNV---------RGEDSG 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  229 bits (585), Expect = 1e-72
 Identities = 79/271 (29%), Positives = 135/271 (49%), Gaps = 21/271 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + +   +G+G++G+V    +KG     +    A K + K        VD  K E +I+  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKY---FVEDVDRFKQEIEIMKS 62

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A     +++SAV++ 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  + HRDLKPEN L  +   D  + L DFGLA          +  GT  Y++P++ L 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LE 181

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             +  + D WS G+++Y +L G PPF+     ++  +I       P      ++ +A SL
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           ++ LL K P +R+ S          H+WF  
Sbjct: 242 IRRLLTKSPKQRITS-----LQALEHEWFEK 267

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  231 bits (591), Expect = 1e-72
 Identities = 90/320 (28%), Positives = 153/320 (47%), Gaps = 32/320 (10%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +       S +        +L     +     +  +D         
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD--------- 53

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 FE+   +G+GA   V++ K+KG     +   YA+KV     + K      ++ E
Sbjct: 54  -----FFEVESELGRGATSIVYRCKQKG-----TQKPYALKV-----LKKTVDKKIVRTE 98

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L +++HP I++L+  F+T +++ L+L+ + GG LF  +  +G + E  A     +I+
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 226 SAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV++LH+ GIVHRDLKPEN+L      D  + + DFGL+K ++      ++CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP----PFL 337
           PEIL    +  + D WSVGI+ Y +L G  PF      Q + +RI+N +          +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 338 TSEAHSLLKGLLHKDPSKRL 357
           +  A  L++ L+  DP KRL
Sbjct: 279 SLNAKDLVRKLIVLDPKKRL 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  230 bits (589), Expect = 1e-72
 Identities = 92/303 (30%), Positives = 162/303 (53%), Gaps = 26/303 (8%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG--VDDGDSDGIYAMKVMRKDTIIKKNH 158
           A+ +  IG   + + + +G+G F KV    K    +  G      A+K++ K    + N 
Sbjct: 8   ADEQPHIGN--YRLLKTIGKGNFAKV----KLARHILTGRE---VAIKIIDKT---QLNP 55

Query: 159 VDYMKAER--DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ 216
               K  R   I+  + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           AR    +IVSAV + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175

Query: 277 TTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
              Y APE+   K ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P 
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235

Query: 336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 395
           +++++  +LLK  L  +P KR       ++ I   +W         E  E++P  +P++ 
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRG-----TLEQIMKDRWIN----AGHEEDELKPFVEPELD 286

Query: 396 GKD 398
             D
Sbjct: 287 ISD 289

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  230 bits (589), Expect = 3e-72
 Identities = 80/275 (29%), Positives = 136/275 (49%), Gaps = 21/275 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I               +  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           A   ++ LL K+  KRL       +A++ H W   
Sbjct: 249 AKDFIRKLLVKETRKRLTI----QEALR-HPWITP 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  229 bits (586), Expect = 3e-72
 Identities = 75/287 (26%), Positives = 141/287 (49%), Gaps = 21/287 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++    +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 13  YDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +         ++ 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 387
           A   ++ LL KDP KR+       D+++ H W +  + +   +R+  
Sbjct: 248 AKDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKAS 289

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  229 bits (586), Expect = 3e-72
 Identities = 83/276 (30%), Positives = 142/276 (51%), Gaps = 32/276 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           + +G+G+F    +   K      S+  +A+K      II K      + E   L     H
Sbjct: 17  KPLGEGSFSICRKCVHK-----KSNQAFAVK------IISKRMEANTQKEITALKLCEGH 65

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H  
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 235 GIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKG 290
           G+VHRDLKPEN+L    + +  + + DFG A+     ++   + C T  Y APE+L   G
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQ-------KLQQRIINEKVKLP----PFLTS 339
           +++  D WS+G++LY ML+GQ PF   +R        ++ ++I              ++ 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           EA  L++GLL  DP+KRL      +  +++++W + 
Sbjct: 246 EAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQD 276

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  229 bits (585), Expect = 3e-72
 Identities = 75/257 (29%), Positives = 130/257 (50%), Gaps = 16/257 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V H  ++ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I +             +  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 341 AHSLLKGLLHKDPSKRL 357
           A   ++ LL K+  KRL
Sbjct: 249 AKDFIRKLLVKETRKRL 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  228 bits (583), Expect = 5e-72
 Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 20/286 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F I + +G+G F +V++           DG   A+K ++   ++          E D+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G L   +        +  E     Y  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAP 283
            SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK-LPP-FLTS 339
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I       LP    + 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 385
           E   L+   ++ DP KR    P         K   +    +LE   
Sbjct: 266 ELRQLVNMCINPDPEKR----PDVTYVYDVAKRMHACTASSLEHHH 307

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  227 bits (581), Expect = 6e-72
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 23/273 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G GAFG V  V+++      S     +K + KD    +  ++ ++AE ++L  
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQARFYTAEIVSA 227
           + HP I+++   F+    +Y++++   GG L         R     E        ++++A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 228 VSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +++ H   +VH+DLKPENIL         + + DFGLA+       S +  GT  YMAPE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP---FLTSEA 341
           +   +      D WS G+++Y +LTG  PFT  + +++QQ+   ++         LT +A
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
             LLK +L KDP +R          + HH+WF+
Sbjct: 256 VDLLKQMLTKDPERRP-----SAAQVLHHEWFK 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  232 bits (594), Expect = 7e-72
 Identities = 87/273 (31%), Positives = 137/273 (50%), Gaps = 19/273 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF  V +  K       +   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSARDHQK-LEREARICR 65

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
            L+  +L  +PSKR+ +     +A+K H W   
Sbjct: 246 DLINKMLTINPSKRITA----AEALK-HPWISH 273

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  233 bits (597), Expect = 8e-72
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 28/284 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVD 160
            +   R +G GA+G+V   K+K           A+KV++K    K          +   +
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            +  E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F E  A   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    +  +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--- 334
             Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++   K       
Sbjct: 212 AYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270

Query: 335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
              ++ EA  L+K +L  D +KR  +     +A+   +W +   
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAE----EALN-SRWIKKYA 309

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  226 bits (577), Expect = 2e-71
 Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 45/285 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DF+   ++G G FG+VF+ K +       DG  Y +K ++ +           KAER   
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN---------EKAEREVK 56

Query: 168 ILTKVTHPFIVQLRYSFQ----------------TRSKLYLILDFINGGHLFFHL--YRQ 209
            L K+ H  IV     +                     L++ ++F + G L   +   R 
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
               +  A     +I   V ++H   +++RDLKP NI +     V + DFGL   +    
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           +     GT  YM+PE + S+ + K+ D +++G++L E+L            K    +   
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLR-- 232

Query: 330 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              +      +  +LL+ LL K P  R          I       
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTVW 272

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  227 bits (581), Expect = 3e-71
 Identities = 71/277 (25%), Positives = 139/277 (50%), Gaps = 25/277 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DIL 169
           +E+  V+G+G F  V +   +     ++   +A+K++          +     +R   I 
Sbjct: 26  YELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESS-RSNSMCGTTEYM 281
            A+ + H   I+HRD+KP  +L+ S      V L  FG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL 337
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+       +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHI 259

Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           +  A  L++ +L  DP++R+       +A+  H W +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVY----EALN-HPWLK 291

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  227 bits (580), Expect = 4e-71
 Identities = 77/319 (24%), Positives = 130/319 (40%), Gaps = 65/319 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DI 168
            + +   +GQG++G V    +       +  I A+K+M K+ I + N  D  + +    +
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------------ 210
           + K+ HP I +L   ++    + L+++  +GGHL   L                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
                                 + RE        +I SA+ +LH  GI HRD+KPEN L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 249 DSDG--HVMLTDFGLAKEID-----ESSRSNSMCGTTEYMAPEIL--LSKGHNKDADWWS 299
            ++    + L DFGL+KE       E     +  GT  ++APE+L   ++ +    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 300 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSK 355
            G+LL+ +L G  PF   N      +++N+K+         L+  A  LL  LL+++  +
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321

Query: 356 RLGSGPGGVDAIKHHKWFR 374
           R             H W  
Sbjct: 322 RF-----DAMRALQHPWIS 335

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  224 bits (572), Expect = 2e-70
 Identities = 76/299 (25%), Positives = 140/299 (46%), Gaps = 25/299 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-MKAERDI 168
           G + +  ++G+G++GKV     K V D ++    A+K+++K  + +  + +  +K E  +
Sbjct: 5   GKYLMGDLLGEGSYGKV-----KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59

Query: 169 LTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGH--LFFHLYRQGIFREDQARFYTAEI 224
           L ++ H  ++QL      + + K+Y+++++   G   +   +  +  F   QA  Y  ++
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTTEYM 281
           +  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +   +  ++     G+  + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 282 APEILL-SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
            PEI            D WS G+ LY + TG  PF   N  KL + I      +P     
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 398
               LLKG+L  +P+KR       +  I+ H WFR    K     E      P    KD
Sbjct: 239 PLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFR----KKHPPAEAPVPIPPSPDTKD 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  234 bits (597), Expect = 2e-70
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 48/304 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G +E+   +G G FG V +   +     D+    A+K  R++   K  + +    E  I+
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPK--NRERWCLEIQIM 66

Query: 170 TKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLY---RQGIFREDQARFY 220
            K+ HP +V  R       KL       L +++  GG L  +L         +E   R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSMCGT 277
            ++I SA+ +LH+  I+HRDLKPENI++          + D G AKE+D+        GT
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------ 331
            +Y+APE+L  K +    D+WS G L +E +TG  PF    +       + EK       
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 332 ------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 373
                              L   L  +    L+ +L     +R     G      +   F
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDPQNPNVGCF 301

Query: 374 RSIN 377
           ++++
Sbjct: 302 QALD 305

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  223 bits (571), Expect = 5e-70
 Identities = 83/281 (29%), Positives = 146/281 (51%), Gaps = 27/281 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---- 166
           ++ + + +G GA G+V    ++      +    A+K++ K      +  +   A      
Sbjct: 11  EYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 167 -DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y  +++
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT  Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 283 PEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP---- 334
           PE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K        
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 335 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
             ++ +A  L+K LL  DP  R        +    H W + 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQD 280

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  223 bits (571), Expect = 5e-70
 Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 21/271 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKV----KGTDQVLVKKEISILNI 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             H  I+ L  SF++  +L +I +FI+G  +F           E +   Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPF--LTSEAHSL 344
              +   D WS+G L+Y +L+G  PF     Q++ + I+N +       F  ++ EA   
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           +  LL K+   R+ +     +A++ H W + 
Sbjct: 238 VDRLLVKERKSRMTA----SEALQ-HPWLKQ 263

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  226 bits (579), Expect = 5e-70
 Identities = 83/296 (28%), Positives = 148/296 (50%), Gaps = 31/296 (10%)

Query: 100 EAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
               ++ + P        + + +G GA G+V    ++      +    A++++ K     
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAI 175

Query: 156 KNHVDYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            +  +   A       +IL K+ HP I++++  F      Y++L+ + GG LF  +    
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK 234

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDE 267
             +E   + Y  +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 268 SSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ 323
           +S   ++CGT  Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354

Query: 324 QRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
            +I + K          ++ +A  L+K LL  DP  R        +    H W + 
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQD 405

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  224 bits (573), Expect = 8e-70
 Identities = 87/353 (24%), Positives = 146/353 (41%), Gaps = 28/353 (7%)

Query: 26  SASSPDFDFT-EVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSL 84
            +S  D  F  E        RH          +            + +    +    +  
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK--LNDA 64

Query: 85  PLQIQELEHENDAELEAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             +  E  +      E E        +F    +   V+G+G    V +   +      + 
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----ATG 119

Query: 141 GIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194
             +A+K+M                +  + E  IL +V  HP I+ L  S+++ S ++L+ 
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
           D +  G LF +L  +    E + R     ++ AVS LH   IVHRDLKPENIL+D +  +
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239

Query: 255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEML 308
            L+DFG +  ++   +   +CGT  Y+APEIL         G+ K+ D W+ G++L+ +L
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

Query: 309 TGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRL 357
            G PPF H  +  + + I+  + +         +S    L+  LL  DP  RL
Sbjct: 300 AGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  222 bits (569), Expect = 2e-69
 Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 30/277 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E+   +G G++    +   K      ++  +A+K      II K+  D    E +IL 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVK------IIDKSKRD-PTEEIEILL 70

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +   HP I+ L+  +     +Y++ + + GG L   + RQ  F E +A      I   V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           +LH  G+VHRDLKP NIL   +      + + DFG AK++  E+    + C T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLP----PFL 337
           +L  +G++   D WS+G+LLY MLTG  PF +      +++  RI + K  L       +
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           +  A  L+  +LH DP +RL         +  H W  
Sbjct: 251 SDTAKDLVSKMLHVDPHQRL-----TAALVLRHPWIV 282

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (568), Expect = 2e-69
 Identities = 83/275 (30%), Positives = 147/275 (53%), Gaps = 14/275 (5%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+FGKV    K          + A+K + +  + K +   
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKV----KLATHYKTQQKV-ALKFISRQLLKKSDMHM 54

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E   L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R +
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+  Y
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173

Query: 281 MAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
            APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL+ 
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            A SL++ ++  DP +R+      +  I+   WF 
Sbjct: 234 GAQSLIRRMIVADPMQRI-----TIQEIRRDPWFN 263

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  221 bits (566), Expect = 3e-69
 Identities = 78/309 (25%), Positives = 135/309 (43%), Gaps = 26/309 (8%)

Query: 92  EHENDAELEAESERKIGPGDFEIF-----RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
            H +  +L  E+       +F  F     + +G+G F  V Q   K      +   YA K
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAK 60

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            ++K    +    + +  E  +L      P ++ L   ++  S++ LIL++  GG +F  
Sbjct: 61  FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 206 LY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFG 260
                  +  E+       +I+  V +LH+  IVH DLKP+NIL+      G + + DFG
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           ++++I  +     + GT EY+APEIL         D W++GI+ Y +LT   PF   + Q
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 321 KLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
           +    I    V         ++  A   ++ LL K+P KR  +       +  H W +  
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA----EICLS-HSWLQQW 294

Query: 377 NWKTLEARE 385
           +++ L   E
Sbjct: 295 DFENLFHPE 303

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  218 bits (559), Expect = 8e-69
 Identities = 79/293 (26%), Positives = 147/293 (50%), Gaps = 25/293 (8%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 336
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 337 -LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 388
            + S   +LL  +L ++PS R+      +  IK  +W+     K L+    +P
Sbjct: 233 KIDSAPLALLHKILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRP 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  221 bits (566), Expect = 1e-68
 Identities = 75/270 (27%), Positives = 132/270 (48%), Gaps = 20/270 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+ +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLDKYTV---KNEISIMNQ 104

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSH 230
           + HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    + H
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+  
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
           +      D W++G+L Y +L+G  PF   +  +  Q +     +        ++ EA   
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           +K LL K+P KRL       DA++ H W +
Sbjct: 285 IKNLLQKEPRKRLTV----HDALE-HPWLK 309

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  219 bits (560), Expect = 2e-68
 Identities = 81/331 (24%), Positives = 156/331 (47%), Gaps = 25/331 (7%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 336
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 337 -LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 395
            + S   +LL  +L ++PS R+      +  IK  +W+     K L+    +P+      
Sbjct: 233 KIDSAPLALLHKILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRPRVTSGGV 283

Query: 396 GKDCIANFDKCWTTMPADDSPAPTPTAGEHF 426
            +          + +      + + T G  +
Sbjct: 284 SESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  219 bits (560), Expect = 3e-68
 Identities = 73/292 (25%), Positives = 134/292 (45%), Gaps = 24/292 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--- 166
             +     +G GAFG V       VD   +  +  +K ++K+ +++   ++  K  +   
Sbjct: 24  QKYSTMSPLGSGAFGFV----WTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 167 --DILTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAE 223
              IL++V H  I+++   F+ +    L+++   +G  LF  + R     E  A +   +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++      + CGT EY AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 284 EILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+L+   +   + + WS+G+ LY ++  + PF         +  +   +  P  ++ E  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELM 252

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR-SINWKTLEAREMQPKFKPD 393
           SL+ GLL   P +R       ++ +    W    +N       E+    KP+
Sbjct: 253 SLVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  222 bits (568), Expect = 8e-68
 Identities = 82/276 (29%), Positives = 145/276 (52%), Gaps = 13/276 (4%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G  +     + A+K++ +  I   + V
Sbjct: 8   KHDGRVKIGH--YILGDTLGVGTFGKV----KVGKHELTGHKV-AVKILNRQKIRSLDVV 60

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E   L    HP I++L     T S +++++++++GG LF ++ + G   E ++R 
Sbjct: 61  GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180

Query: 280 YMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           Y APE++  + +   + D WS G++LY +L G  PF   +   L ++I +     P +L 
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
               SLLK +L  DP KR       +  I+ H+WF+
Sbjct: 241 PSVISLLKHMLQVDPMKRA-----TIKDIREHEWFK 271

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  219 bits (559), Expect = 8e-68
 Identities = 84/274 (30%), Positives = 137/274 (50%), Gaps = 23/274 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++  + +G G FG       + + D  +  + A+K + +   I +N    ++ E    
Sbjct: 20  DRYDFVKDIGSGNFGVA-----RLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +I+++ +GG L+  +   G F ED+ARF+  +++S VS
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   I HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPP--FLTSE 340
            + ++ K AD WS G+ LY ML G  PF         +K  QRI++ K  +P    ++ E
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              L+  +   DP+ R+      +  IK H WF 
Sbjct: 251 CCHLISRIFVADPATRI-----SIPEIKTHSWFL 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  216 bits (553), Expect = 2e-67
 Identities = 88/337 (26%), Positives = 147/337 (43%), Gaps = 32/337 (9%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H   G  PR +  +            +  +L    E++     +++  ++G G FG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCN-------DLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM---KAERDILTKVTH--PFIVQ 179
            V+   +  V D       A+K + KD I     +        E  +L KV+     +++
Sbjct: 58  SVYSGIR--VSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           L   F+      LIL+       LF  +  +G  +E+ AR +  +++ AV H H CG++H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 239 RDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDAD 296
           RD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  PE +     H + A 
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVYSPPEWIRYHRYHGRSAA 231

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            WS+GILLY+M+ G  PF H       + II  +V     ++SE   L++  L   PS R
Sbjct: 232 VWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 285

Query: 357 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
                   + I++H W + +      A        P 
Sbjct: 286 P-----TFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  223 bits (571), Expect = 3e-67
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 20/273 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++ 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTP---HESDKETVRKEIQTMSV 210

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP +V L  +F+  +++ +I +F++GG LF           ED+A  Y  ++   + H
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
           K      D WSVG+L Y +L+G  PF   N  +  + + +    +       ++ +    
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
           ++ LL  DP+ R+        A++ H W    N
Sbjct: 391 IRKLLLADPNTRMTI----HQALE-HPWLTPGN 418

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  214 bits (548), Expect = 6e-67
 Identities = 80/304 (26%), Positives = 136/304 (44%), Gaps = 44/304 (14%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               ++    + +   +G+G++G V    K   ++ D+   YAMKV+ K  +I++     
Sbjct: 7   GDCVQLNQ--YTLKDEIGKGSYGVV----KLAYNENDNT-YYAMKVLSKKKLIRQAGFPR 59

Query: 162 MKAERD-----------------------ILTKVTHPFIVQLR--YSFQTRSKLYLILDF 196
               R                        IL K+ HP +V+L           LY++ + 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
           +N G +   +       EDQARFY  +++  + +LH   I+HRD+KP N+L+  DGH+ +
Sbjct: 120 VNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 257 TDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQP 312
            DFG++ E     +  ++  GT  +MAPE L         K  D W++G+ LY  + GQ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 313 PFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
           PF       L  +I ++ ++ P  P +  +   L+  +L K+P  R+      V  IK H
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLH 293

Query: 371 KWFR 374
            W  
Sbjct: 294 PWVT 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  218 bits (555), Expect = 1e-66
 Identities = 60/399 (15%), Positives = 105/399 (26%), Gaps = 65/399 (16%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           + NR       +    + S+    +             ESE    P       V+GQ   
Sbjct: 32  LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER----------------- 166
               +       D ++   + + V         N +  MK E                  
Sbjct: 92  YAYLEAT-----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 167 --------DILTKVTHPFIVQLRYSFQTRSKLYLILDFIN--------GGHLFFHLYRQG 210
                   D++       ++++R   +    L     +          G  L  H     
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS- 269
                     T +++  ++ LH  G+VH  L+P +I++D  G V LT F        S+ 
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKD-----ADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
                     E  A  +L    H+        D W++G+ +Y +     P T        
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 324 QRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 383
           + I      +P        +LL+G L      RL               +  +       
Sbjct: 327 EWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL------- 370

Query: 384 REMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTA 422
           R       P                  P   +  P    
Sbjct: 371 RTELSAALPLYQTDGEPTREG----GAPPSGTSQPDEAG 405

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  216 bits (553), Expect = 1e-66
 Identities = 63/254 (24%), Positives = 123/254 (48%), Gaps = 15/254 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
                 ++G G FG+V + ++       +    A K+++          + +K E  ++ 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTR---GMKDKEEVKNEISVMN 141

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
           ++ H  ++QL  +F++++ + L++++++GG LF  +  +     E     +  +I   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 230 HLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+  I+H DLKPENIL  +     + + DFGLA+      +     GT E++APE++ 
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
               +   D WSVG++ Y +L+G  PF   N  +    I+  +  L       ++ EA  
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 344 LLKGLLHKDPSKRL 357
            +  LL K+ S R+
Sbjct: 322 FISKLLIKEKSWRI 335

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  212 bits (541), Expect = 1e-65
 Identities = 80/318 (25%), Positives = 141/318 (44%), Gaps = 31/318 (9%)

Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             + PLQ                +R+    ++ +  ++G+G FG VF   +  + D    
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHR--LTDRLQ- 58

Query: 141 GIYAMKVMRKDTIIKKNHVDYM---KAERDILTKV----THPFIVQLRYSFQTRSKLYLI 193
              A+KV+ ++ ++  + +        E  +L KV     HP +++L   F+T+    L+
Sbjct: 59  --VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116

Query: 194 LDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           L+  +    LF ++  +G   E  +R +  ++V+A+ H H  G+VHRD+K ENIL+D   
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           G   L DFG    + +   ++   GT  Y  PE +     H   A  WS+GILLY+M+ G
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

Query: 311 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
             PF         Q I+  ++  P  ++ +  +L++  L   PS R       ++ I   
Sbjct: 236 DIPFER------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP-----SLEEILLD 284

Query: 371 KWFRSINWKTLEAREMQP 388
            W +       E   + P
Sbjct: 285 PWMQ----TPAEDVPLNP 298

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  211 bits (538), Expect = 3e-65
 Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 32/276 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            I    +   + +G+G F  V  V+            YA+K +      ++   +  + E
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQRE 76

Query: 166 RDILTKVTHPFIVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ----GIFREDQA 217
            D+     HP I++L            + +L+L F   G L+  + R         EDQ 
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--- 274
            +    I   +  +H  G  HRDLKP NIL+  +G  +L D G   +       +     
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 275 -------CGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQ 323
                    T  Y APE+   + H   ++  D WS+G +LY M+ G+ P+    ++    
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 324 QRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 357
              +  ++ +P     +S    LL  ++  DP +R 
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  212 bits (541), Expect = 1e-64
 Identities = 81/346 (23%), Positives = 155/346 (44%), Gaps = 41/346 (11%)

Query: 48  NQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKI 107
           + S   +            +  +   P P        P Q  +   ++  +++  +    
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61

Query: 108 GPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
              D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E 
Sbjct: 62  ---DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EV 105

Query: 167 DILTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARF 219
           ++  + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A  
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCG 276
               I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C 
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ----RIINEKVK 332
           T  Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +   +      RI   + +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285

Query: 333 LP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            P      ++ E   L++ LL  +P++R+      +    +H W  
Sbjct: 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 326

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  207 bits (530), Expect = 3e-64
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 49/299 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DFE  + +G+G FG VF+ K K       D   YA+K +R    +    +   K  R   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNK------VDDCNYAIKRIR----LPNRELAREKVMREVK 55

Query: 168 ILTKVTHPFIVQLRYSF------------QTRSKLYLILDFINGGHLFFHLYRQG---IF 212
            L K+ HP IV+   ++              +  LY+ +      +L   +  +      
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---- 268
                     +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 269 ---------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                    +R     GT  YM+PE +    ++   D +S+G++L+E+L   P  T   R
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMER 233

Query: 320 QKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
            +    + N K   L        + +++ +L   P +R    P     I  +  F  ++
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER----P-EAINIIENAVFEDLD 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  208 bits (532), Expect = 3e-64
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 49/294 (16%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G+GA  +V            +   YA+K++ K      +    +  E ++L +   H 
Sbjct: 20  VLGEGAHARVQTCINLI-----TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHR 71

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            +++L   F+   + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  G
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 236 IVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPE 284
           I HRDLKPENIL    +    V + DF L   I  +   + +        CG+ EYMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 285 IL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---------------QKLQQ 324
           ++      +  ++K  D WS+G++LY +L+G PPF                      L +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 325 RIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            I   K + P      ++  A  L+  LL +D  +RL         +  H W +
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQ 300

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  208 bits (532), Expect = 4e-64
 Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 37/276 (13%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G G  GKV +   +      +    A+K++      ++        E D   + +  P
Sbjct: 36  VLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGP 82

Query: 176 FIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
            IV +   ++     +  L +I++ + GG LF  +  +G   F E +A     +I +A+ 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 230 HLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            LH   I HRD+KPEN+L    + D  + LTDFG AKE  +++   + C T  Y+APE+L
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAPEVL 201

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLP----PFLT 338
             + ++K  D WS+G+++Y +L G PPF     Q +     +RI   +   P      ++
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261

Query: 339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
            +A  L++ LL  DP++RL      +    +H W  
Sbjct: 262 EDAKQLIRLLLKTDPTERL-----TITQFMNHPWIN 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  206 bits (524), Expect = 1e-62
 Identities = 46/324 (14%), Positives = 94/324 (29%), Gaps = 55/324 (16%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           +AE   +S    G    ++   +  G    VF V+       +    +A+KV        
Sbjct: 48  NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENS 102

Query: 156 KNHVDYMKAERDILTKVTHPFIVQLR--------------------------YSFQTRSK 189
           ++ ++ +        ++      + R                                + 
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 190 LYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243
             L++   +         L F    +G          TA+++   ++L   G+VH    P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222

Query: 244 ENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVG 301
           +N+ +  DG +ML D     ++    R  +      Y   E L +         + W +G
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 302 ILLYEMLTGQPPFTHAN--RQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKD 352
           + +Y +     PF       +   +R                  L     +L+   L+ D
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 353 PSKRLGSGPGGVDAIKHHKWFRSI 376
             +RL               F  +
Sbjct: 341 RRRRL-----LPLEAMETPEFLQL 359

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  207 bits (528), Expect = 2e-62
 Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 44/320 (13%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E D   E  S   +G   F    V+G GA G +     +G+ D       A+K       
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV---YRGMFDNRD---VAVK------R 55

Query: 154 IKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI- 211
           I      +   E  +L +   HP +++   + + R   Y+ ++      L  ++ ++   
Sbjct: 56  ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEID 266
               +      +  S ++HLH   IVHRDLKP NIL+           M++DFGL K++ 
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 267 ESSRS----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 318
               S    + + GT  ++APE+L     +      D +S G + Y +++ G  PF  + 
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 319 RQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           +++    +    +            A  L++ ++  DP KR          +  H +F S
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWS 289

Query: 376 INWKTLEAREMQPKFKPDVS 395
                    E Q +F  DVS
Sbjct: 290 --------LEKQLQFFQDVS 301

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  202 bits (515), Expect = 3e-62
 Identities = 58/294 (19%), Positives = 113/294 (38%), Gaps = 41/294 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F     +G G FG VF+  K+   DG    IYA+K  +K      +  + ++       
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKR--LDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG----HLFFHLYRQGIFREDQARFYTAEIVS 226
              H  +V+   ++     + +  ++ NGG     +  +      F+E + +    ++  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVM-------------------LTDFGLAKEIDE 267
            + ++H   +VH D+KP NI +                          + D G    I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            S      G + ++A E+L  +  H   AD +++ + +      +P   + +       I
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240

Query: 327 INEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 379
              ++ ++P  L+ E   LLK ++H DP +R    P    A+  H    S + K
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERR----P-SAMALVKHSVLLSASRK 289

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  201 bits (512), Expect = 4e-60
 Identities = 75/325 (23%), Positives = 128/325 (39%), Gaps = 69/325 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
               +++G G+ G V     +G   G      A+K       +  +  D    E  +LT+
Sbjct: 17  VVSEKILGYGSSGTV---VFQGSFQGRP---VAVK------RMLIDFCDIALMEIKLLTE 64

Query: 172 VT-HPFIVQLRYSFQTRSKLYLILDFINGGHLF-------FHLYRQGIFREDQARFYTAE 223
              HP +++   S  T   LY+ L+  N   L               + +E        +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHVMLTDFGLAKEIDE--- 267
           I S V+HLH   I+HRDLKP+NIL+ +             +  ++++DFGL K++D    
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 268 --SSRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
              +  N+  GT+ + APE+L         +   +  D +S+G + Y +L+ G+ PF   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 318 NRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
             +  +  II     L          L +EA  L+  ++  DP KR          +  H
Sbjct: 244 YSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP-----TAMKVLRH 296

Query: 371 KWFRSINWKTLEAREMQPKFKPDVS 395
             F          +  + +F   VS
Sbjct: 297 PLFWP--------KSKKLEFLLKVS 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  196 bits (500), Expect = 2e-59
 Identities = 71/315 (22%), Positives = 129/315 (40%), Gaps = 24/315 (7%)

Query: 52  ASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD 111
            S S S G    + + + ++   S +            E     +     + E +     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETED-NEGVLLTEKLKPVDYEYREEVHW 59

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
                 VG+G+FG+V     +  D   +    A+K +R +    +        E      
Sbjct: 60  MTHQPRVGRGSFGEVH----RMKD-KQTGFQCAVKKVRLEVFRVE--------ELVACAG 106

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++ P IV L  + +    + + ++ + GG L   + + G   ED+A +Y  + +  + +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166

Query: 232 HKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS------NSMCGTTEYMAPE 284
           H   I+H D+K +N+L+ SDG    L DFG A  +            + + GT  +MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEA 341
           +++ K  +   D WS   ++  ML G  P+T   R  L  +I +E     ++PP      
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286

Query: 342 HSLLKGLLHKDPSKR 356
              ++  L K+P  R
Sbjct: 287 AQAIQEGLRKEPVHR 301

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  184 bits (470), Expect = 2e-55
 Identities = 75/272 (27%), Positives = 130/272 (47%), Gaps = 23/272 (8%)

Query: 100 EAESERKIGPGDFEIFR-----VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           E + E  +   D+E        V+G+G +G V+     G D   +    A+K + +    
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY----AGRD-LSNQVRIAIKEIPER--- 58

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGI 211
              +   +  E  +   + H  IVQ   SF     + + ++ + GG    L    +    
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI-DESS 269
             E    FYT +I+  + +LH   IVHRD+K +N+L+++  G + ++DFG +K +   + 
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178

Query: 270 RSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI 326
            + +  GT +YMAPEI+    +G+ K AD WS+G  + EM TG+PPF      Q    ++
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238

Query: 327 INEKV--KLPPFLTSEAHSLLKGLLHKDPSKR 356
              KV  ++P  +++EA + +      DP KR
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  182 bits (463), Expect = 5e-54
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 43/283 (15%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G     + RV+ +G F  V++ +     D  S   YA+K +  +   ++     +  E
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSN---EEEKNRAIIQE 75

Query: 166 RDILTKVT-HPFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYR---QGIFRE 214
              + K++ HP IVQ   +         T    +L+L  +  G L   L +   +G    
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 215 DQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           D       +   AV H+H+    I+HRDLK EN+L+ + G + L DFG A  I      +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 273 S-------------MCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTH 316
                            T  Y  PEI+    +    +  D W++G +LY +   Q PF  
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

Query: 317 ANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKRL 357
                 + RI+N K  +PP  T  +  HSL++ +L  +P +RL
Sbjct: 256 GA----KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  179 bits (456), Expect = 3e-53
 Identities = 67/266 (25%), Positives = 125/266 (46%), Gaps = 53/266 (19%)

Query: 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++ 
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EVELH 64

Query: 170 TKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTA 222
            + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A     
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE               
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------------- 170

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLP- 334
                    + ++K  D WS+G+++Y +L G PPF   +       ++ RI   + + P 
Sbjct: 171 -------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 335 ---PFLTSEAHSLLKGLLHKDPSKRL 357
                ++ E   L++ LL  +P++R+
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRM 249

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  176 bits (447), Expect = 1e-51
 Identities = 64/333 (19%), Positives = 112/333 (33%), Gaps = 74/333 (22%)

Query: 111 DFEIFRVVGQGAFGKVFQVK----------KK---------------------------- 132
           DFE  + +G+G FG VF+ K          K+                            
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 133 ------------GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
                            + D I+         +   + +D    +   +   +    V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIV 237
                 +  LY+ +      +L   + R+                +I  AV  LH  G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCGTTEYMAPE 284
           HRDLKP NI    D  V + DFGL   +D+                     GT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHS 343
            +    ++   D +S+G++L+E+L      T   R ++   + N K   L      + H 
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM 304

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
           +++ +L   P++R    P     I  +  F ++
Sbjct: 305 MVQDMLSPSPTER----P-EATDIIENAIFENL 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  174 bits (444), Expect = 1e-51
 Identities = 72/271 (26%), Positives = 136/271 (50%), Gaps = 17/271 (6%)

Query: 92  EHENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
                + L      K  P + F     +G+G+FG+VF    KG+D+  +  + A+K++  
Sbjct: 3   HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKIIDL 57

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
           +    ++ ++ ++ E  +L++   P++ +   S+   +KL++I++++ GG     L   G
Sbjct: 58  EEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG 114

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S 269
              E Q      EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ ++  
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + N+  GT  +MAPE++    ++  AD WS+GI   E+  G+PP +  +  K+   I   
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234

Query: 330 KVKLPPFL----TSEAHSLLKGLLHKDPSKR 356
               PP L    +      ++  L+K+PS R
Sbjct: 235 N---PPTLEGNYSKPLKEFVEACLNKEPSFR 262

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  171 bits (435), Expect = 2e-50
 Identities = 67/280 (23%), Positives = 128/280 (45%), Gaps = 19/280 (6%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +  + ++  ELE ++      G F  F   +G+G+F  V+    KG+D   +    A   
Sbjct: 4   RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVY----KGLDTETTV-EVAWCE 58

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF----QTRSKLYLILDFINGGHLF 203
           + +D  + K+     K E ++L  + HP IV+   S+    + +  + L+ + +  G L 
Sbjct: 59  L-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFG 260
            +L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D G
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           LA     S    ++ GT E+MAPE +  + +++  D ++ G+ + EM T + P++     
Sbjct: 178 LATLKRASFAK-AVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235

Query: 321 KLQQRIINEKVK---LPPFLTSEAHSLLKGLLHKDPSKRL 357
               R +   VK          E   +++G + ++  +R 
Sbjct: 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  170 bits (432), Expect = 2e-49
 Identities = 76/307 (24%), Positives = 149/307 (48%), Gaps = 35/307 (11%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD----FEIFRVVG 119
           +H+  H   G       + +L  Q   + HE   + +A     +  GD     + +  +G
Sbjct: 1   MHHHHHHSSGVDLG---TENLYFQSGVVTHE---QFKAALRMVVDQGDPRLLLDSYVKIG 54

Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVM------RKDTIIKKNHVDYMKAERDILTKVT 173
           +G+ G V   ++K      S    A+K+M      R++ +           E  I+    
Sbjct: 55  EGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQRRELLFN---------EVVIMRDYQ 100

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q       ++ A+++LH 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
            G++HRD+K ++IL+  DG V L+DFG   +I  +  +  S+ GT  +MAPE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKGLL 349
            + D WS+GI++ EM+ G+PP+   +  +  +R+ +    K+K    ++      L+ +L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279

Query: 350 HKDPSKR 356
            +DP +R
Sbjct: 280 VRDPQER 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  168 bits (427), Expect = 4e-49
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 29/276 (10%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-- 148
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 149 ----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
               +K+ II          E  ++ +  +P IV    S+    +L+++++++ GG L  
Sbjct: 56  QQQPKKELIIN---------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT- 105

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
            +  +    E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165

Query: 265 I-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           I  E S+ ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +  
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

Query: 324 QRIINE---KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
             I      +++ P  L++     L   L  D  KR
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  164 bits (418), Expect = 1e-47
 Identities = 69/302 (22%), Positives = 140/302 (46%), Gaps = 31/302 (10%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H    P   Y + ++  L  Q     +  +++      I   D  I   +G G+FG
Sbjct: 3   HHHHHH---PMSDYDIPTTENLYFQGAM--DGDDMD------IPWCDLNIKEKIGAGSFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184
            V + +  G D        A+K++ +     +   ++++ E  I+ ++ HP IV    + 
Sbjct: 52  TVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHPNIVLFMGAV 103

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLHKCG--IVHR 239
                L ++ ++++ G L+  L++ G   +    +      ++   +++LH     IVHR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKGHNKDADWW 298
           +LK  N+L+D    V + DFGL++    +  S  S  GT E+MAPE+L  +  N+ +D +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223

Query: 299 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL----HKDPS 354
           S G++L+E+ T Q P+ + N  ++   +  +  +L   +    +  +  ++      +P 
Sbjct: 224 SFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPW 281

Query: 355 KR 356
           KR
Sbjct: 282 KR 283

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  164 bits (416), Expect = 3e-47
 Identities = 67/280 (23%), Positives = 136/280 (48%), Gaps = 15/280 (5%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
           S   +Q++        +L+ +S  K     F++   +G+G++G V++   K     ++  
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQ 55

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+K +  ++ +++     +  E  I+ +   P +V+   S+   + L++++++   G 
Sbjct: 56  IVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 202 LF-FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
           +      R     ED+        +  + +LH    +HRD+K  NIL++++GH  L DFG
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170

Query: 261 LAKEIDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           +A ++ ++ ++ N++ GT  +MAPE++   G+N  AD WS+GI   EM  G+PP+   + 
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

Query: 320 QKLQQRIINE---KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            +    I        + P   +      +K  L K P +R
Sbjct: 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  162 bits (413), Expect = 9e-47
 Identities = 73/270 (27%), Positives = 125/270 (46%), Gaps = 26/270 (9%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               +    D E    +G G  G+V++++ +      +  + A+K MR+     K     
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRS--GNKEENKR 69

Query: 162 MKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +  + D++ K    P+IVQ   +F T + +++ ++ +           QG   E      
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129

Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D  G + L DFG++  + +    +   G   
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 280 YMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVK 332
           YMAPE +         ++  AD WS+GI L E+ TGQ P+     + + L + ++ E+  
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-VLQEE-- 246

Query: 333 LPPFL------TSEAHSLLKGLLHKDPSKR 356
            PP L      + +  S +K  L KD  KR
Sbjct: 247 -PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  162 bits (412), Expect = 2e-46
 Identities = 63/253 (24%), Positives = 106/253 (41%), Gaps = 19/253 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+       D   +  + A+K M             +  E   L K
Sbjct: 56  FSDLREIGHGSFGAVY----FARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +   + +NS  GT  +MAPE++L+   
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDE 227

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-----TSEAHS 343
             ++   D WS+GI   E+   +PP  + N       I   +    P L     +    +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPALQSGHWSEYFRN 284

Query: 344 LLKGLLHKDPSKR 356
            +   L K P  R
Sbjct: 285 FVDSCLQKIPQDR 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (405), Expect = 8e-46
 Identities = 73/266 (27%), Positives = 125/266 (46%), Gaps = 30/266 (11%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S   I   + E+  VVG+GAFG V + K +  D        A+K +  ++  K     ++
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERK----AFI 49

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E   L++V HP IV+L  +    + + L++++  GG L+  L+         A    +
Sbjct: 50  V-ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 223 ---EIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC 275
              +    V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I       +  
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNK 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-----NEK 330
           G+  +MAPE+     +++  D +S GI+L+E++T + PF          RI+       +
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTR 222

Query: 331 VKLPPFLTSEAHSLLKGLLHKDPSKR 356
             L   L     SL+     KDPS+R
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQR 248

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  159 bits (403), Expect = 2e-45
 Identities = 75/255 (29%), Positives = 128/255 (50%), Gaps = 18/255 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G GAFGKV++ K K     ++  + A KV+       +  ++    E +IL  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVI---ETKSEEELEDYIVEIEILAT 72

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             HP+IV+L  ++    KL+++++F  GG +    L       E Q +    +++ A++ 
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLS- 288
           LH   I+HRDLK  N+LM  +G + L DFG++ +  ++  + +S  GT  +MAPE+++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 289 ----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEA 341
                 ++  AD WS+GI L EM   +PP    N  ++  +I       +  P   + E 
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252

Query: 342 HSLLKGLLHKDPSKR 356
              LK  L K+P  R
Sbjct: 253 RDFLKIALDKNPETR 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  159 bits (403), Expect = 2e-45
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 38/288 (13%)

Query: 97  AELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK 156
           +E  +     I   D+E+  V+G GA   V                 A+K +  +    +
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCA-PKKEKVAIKRINLEKC--Q 54

Query: 157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQ---- 209
             +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+  +    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
            G+  E        E++  + +LHK G +HRD+K  NIL+  DG V + DFG++  +   
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

Query: 269 ------SRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
                     +  GT  +MAPE +   +G++  AD WS GI   E+ TG  P+      K
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234

Query: 322 LQQRIINEKVKLPPFLTSEA-------------HSLLKGLLHKDPSKR 356
           +    +      PP L +                 ++   L KDP KR
Sbjct: 235 VLMLTLQND---PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  158 bits (401), Expect = 6e-45
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 31/286 (10%)

Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +E     ++  E        D +    +G+GA+G V ++  K      S  I A+K +R 
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRS 57

Query: 151 DTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF----H 205
              + +     +  + D++ +    P+IVQ   +       ++ ++ ++     F    +
Sbjct: 58  T--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                +  E+     T   V A++HL     I+HRD+KP NIL+D  G++ L DFG++ +
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 265 IDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFT--HAN 318
           + +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+   ++ 
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 319 RQKLQQRIINEKVKLPPFL--------TSEAHSLLKGLLHKDPSKR 356
             +L Q ++      PP L        +    + +   L KD SKR
Sbjct: 236 FDQLTQ-VVKGD---PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  156 bits (396), Expect = 1e-44
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 31/282 (10%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +    +A  + +I  G   + + +G G+FG V+    KG   GD     A+K++   
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY----KGKWHGD----VAVKMLNVT 57

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
               +    + K E  +L K  H  I+     + T  +L ++  +  G  L+ HL+    
Sbjct: 58  APTPQQLQAF-KNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASET 115

Query: 212 -FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
            F   +      +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S 
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 271 SNSM---CGTTEYMAPEILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHAN------ 318
           S+      G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N      
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

Query: 319 ----RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
               R  L   +   +   P  +      L+   L K   +R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRM----KRLMAECLKKKRDER 273

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  156 bits (396), Expect = 1e-44
 Identities = 60/263 (22%), Positives = 118/263 (44%), Gaps = 19/263 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   D E    +G+GA+G V +++        S  I A+K +R    +       +  +
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRAT--VNSQEQKRLLMD 55

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYT 221
            DI  +    PF V    +      +++ ++ ++     F    + +     ED      
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 222 AEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             IV A+ HLH K  ++HRD+KP N+L+++ G V + DFG++  + +    +   G   Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175

Query: 281 MAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKV-KLP 334
           MAPE +  + + K     +D WS+GI + E+   + P+ +     +  ++++ E   +LP
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235

Query: 335 P-FLTSEAHSLLKGLLHKDPSKR 356
               ++E        L K+  +R
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKER 258

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (397), Expect = 4e-44
 Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 16/283 (5%)

Query: 87  QIQELEHENDAELEAESERKIG-------PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           +++ELE +       E+              DFE    +G G  G VF+V  K      S
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----S 57

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
             + A K++  +  IK    + +  E  +L +   P+IV    +F +  ++ + ++ ++G
Sbjct: 58  GLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
           G L   L + G   E      +  ++  +++L  K  I+HRD+KP NIL++S G + L D
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           FG++ ++   S +NS  GT  YM+PE L    ++  +D WS+G+ L EM  G+ P    +
Sbjct: 176 FGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP 361
            ++L+     +             +  + L       R     
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  154 bits (392), Expect = 1e-43
 Identities = 70/267 (26%), Positives = 126/267 (47%), Gaps = 32/267 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+    KG     +  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVY----KGRHV-KTGQLAAIKVMD----VTGDEEEEIKQEINML 74

Query: 170 TKV-THPFIVQLRYSF------QTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K   H  I     +F          +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE++         ++  +D WS+GI   EM  G PP    +  +    I        
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---A 251

Query: 335 PFL-----TSEAHSLLKGLLHKDPSKR 356
           P L     + +  S ++  L K+ S+R
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQR 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  160 bits (405), Expect = 3e-43
 Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 39/270 (14%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           ++ PGD     +E+   +  G  G ++      +D   +     +K +           +
Sbjct: 71  QLNPGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHS-----GDAE 121

Query: 161 YMK---AERDILTKVTHPFIVQLRYSF------QTRSKLYLILDFINGGHLFFHLYRQGI 211
                 AER  L +V HP IVQ+ ++F            Y++++++ G  L     +   
Sbjct: 122 AQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQK 178

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               +A  Y  EI+ A+S+LH  G+V+ DLKPENI++  +  + L D G    I+     
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN---SF 234

Query: 272 NSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
             + GT  + APEI+  +     A D ++VG  L  +    P         L +      
Sbjct: 235 GYLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PV 290

Query: 331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSG 360
           +K           LL+  +  DP +R  + 
Sbjct: 291 LKTYDSY----GRLLRRAIDPDPRQRFTTA 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  150 bits (380), Expect = 2e-42
 Identities = 59/286 (20%), Positives = 119/286 (41%), Gaps = 41/286 (14%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-------AMKVM 148
            +E        +   + E  + +G+G FG V +            G         A+K +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHK------------GRLVKDKSVVAIKSL 52

Query: 149 RKDTIIKKNHVDYM----KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
                  +  +       + E  I++ + HP IV+L       +   ++++F+  G L+ 
Sbjct: 53  ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYH 110

Query: 205 HLYRQGIFREDQARFYTA-EIVSAVSHLHKCG--IVHRDLKPENILMDSDG-----HVML 256
            L  +    +   +     +I   + ++      IVHRDL+  NI + S          +
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPF 314
            DFGL+++   S   + + G  ++MAPE + ++   + + AD +S  ++LY +LTG+ PF
Sbjct: 171 ADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

Query: 315 THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL----HKDPSKR 356
              +  K++   +  +  L P +  +    L+ ++      DP KR
Sbjct: 229 DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  152 bits (386), Expect = 3e-42
 Identities = 57/313 (18%), Positives = 110/313 (35%), Gaps = 23/313 (7%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGA--FGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           H  +   +  S      G +E+  V+G+G      V   + K      +     ++ +  
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINL 62

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYR 208
           +       V +++ E  +     HP IV  R +F   ++L+++  F+  G        + 
Sbjct: 63  EAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                E    +    ++ A+ ++H  G VHR +K  +IL+  DG V L+       +   
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 269 -SRSNSMC-------GTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             R   +            +++PE+L    +G++  +D +SVGI   E+  G  PF    
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 378
             ++    +N      P L   +    + L          SG          +     + 
Sbjct: 242 ATQMLLEKLNGT---VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298

Query: 379 KTLEAREMQPKFK 391
                R   P F 
Sbjct: 299 SHPYHRTFSPHFH 311

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  148 bits (375), Expect = 9e-42
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 23/264 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAE 165
           I   +  +  ++G G FGKV++    G +        A+K  R D        ++ ++ E
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +   + HP I+ LR        L L+++F  GG L   L  + I   D    +  +I 
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIA 115

Query: 226 SAVSHLHKCG---IVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNSM 274
             +++LH      I+HRDLK  NIL+             + +TDFGLA+E   +++  S 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SA 174

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL- 333
            G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   +   K+ L 
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234

Query: 334 -PPFLTSEAHSLLKGLLHKDPSKR 356
            P         L++   + DP  R
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSR 258

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (377), Expect = 1e-41
 Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 20/261 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + + R+VG+G  G V++ +     D   + I A+K+M +           M+ E    
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88

Query: 170 TKVTHPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
            ++  P +V + + F +   +LY+ +  ING  L   L RQG     +A     +I SA+
Sbjct: 89  GRLQEPHVVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEIL 286
              H  G  HRD+KPENIL+ +D    L DFG+A    +    +  +  GT  YMAPE  
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
                   AD +++  +LYE LTG PP+       +   I        P  ++    +  
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPSTVRPGIPV 263

Query: 347 GL-------LHKDPSKRLGSG 360
                    + K+P  R  + 
Sbjct: 264 AFDAVIARGMAKNPEDRYVTC 284

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  148 bits (375), Expect = 2e-41
 Identities = 70/256 (27%), Positives = 125/256 (48%), Gaps = 16/256 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G G    V+  +     D   +   A+K +      K+  +   + E    
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183

Query: 288 SKGHNKDA--DWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRIINEKVKLPPFLTSE 340
           +KG   D   D +S+GI+LYEML G+PPF          + +Q  + N    +   +   
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243

Query: 341 AHSLLKGLLHKDPSKR 356
             +++     KD + R
Sbjct: 244 LSNVILRATEKDKANR 259

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (372), Expect = 6e-41
 Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 32/270 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     EI  ++G+G FG+V+     G   G+     A++++  +   +     + K E 
Sbjct: 30  IPFEQLEIGELIGKGRFGQVY----HGRWHGE----VAIRLIDIERDNEDQLKAF-KREV 80

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIV 225
               +  H  +V    +  +   L +I     G  L+  +    I    ++ R    EIV
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSM---CGTTE 279
             + +LH  GI+H+DLK +N+  D +G V++TDFGL           R + +    G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 280 YMAPEIL---------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           ++APEI+              +K +D +++G + YE+   + PF     + +  ++    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GT 257

Query: 331 VKLPPFLTSEAHSLLKGLL----HKDPSKR 356
              P          +  +L      +  +R
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEER 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  145 bits (367), Expect = 1e-40
 Identities = 51/261 (19%), Positives = 107/261 (40%), Gaps = 23/261 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          + +   G++++ + +G D         +KV++      +   D+ + E 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 167 DILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED--QARFYTA 222
             L   +HP ++ +             LI  ++  G L+  L+    F  D  QA  +  
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 223 EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           ++   ++ LH     I    L   ++++D D    ++   +        R         +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAW 174

Query: 281 MAPEILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP 335
           +APE L  K  + +   AD WS  +LL+E++T + PF   +  ++  ++  E     +PP
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
            ++     L+K  +++DP+KR
Sbjct: 235 GISPHVSKLMKICMNEDPAKR 255

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  144 bits (366), Expect = 5e-40
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 31/275 (11%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             R   P D     V+G+G FG+  +V  +      +  +  MK + +     +      
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTF 54

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
             E  ++  + HP +++         +L  I ++I GG L   +      +   Q   + 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------------ 269
            +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+ + +              
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 270 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQR 325
              +  ++ G   +MAPE++  + +++  D +S GI+L E++           R      
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDF 232

Query: 326 IINEKVKLPPFLTSEAHSLLKGLL----HKDPSKR 356
            +N +  L  +           +       DP KR
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  142 bits (359), Expect = 3e-39
 Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 61/294 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
           D  +   VG+G +G+V++   +G +        A+K      I           E ++  
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGEN-------VAVK------IFSSRDEKSWFRETELYN 55

Query: 169 LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
              + H  I+        S  + ++L+LI  +   G L+ +L    +      R     I
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSI 114

Query: 225 VSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RS 271
            S ++HLH        K  I HRDLK +NIL+  +G   + D GLA    +S+      +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 272 NSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEMLTG----------QPPF- 314
           N   GT  YMAPE+L            K  D W+ G++L+E+             +PPF 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 315 ----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 357
                  + + +++ +  ++ +      + +    + L  L+    +++PS RL
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  141 bits (358), Expect = 7e-39
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 25/267 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +     D       A+KV+R D     +     + E    
Sbjct: 12  DRYELGEILGFGGMSEVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66

Query: 170 TKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +              Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S     ++ ++ GT +Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 282 APEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFTHANRQK--LQQRIINEKVKLP--- 334
           +PE   ++G + DA  D +S+G +LYE+LTG+PPFT  +      Q   + E    P   
Sbjct: 187 SPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIPPSAR 242

Query: 335 -PFLTSEAHSLLKGLLHKDPSKRLGSG 360
              L+++  +++   L K+P  R  + 
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTA 269

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  140 bits (356), Expect = 2e-38
 Identities = 78/322 (24%), Positives = 133/322 (41%), Gaps = 56/322 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E   +VG+G++G V + + K     D+  I A+K   +      + +    A R+I  
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLES---DDDKMVKKIAMREIKL 77

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ H  +V L    + + + YL+ +F++   L               + Y  +I++ +
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
              H   I+HRD+KPENIL+   G V L DFG A+ +  ++         E     Y AP
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY--DDEVATRWYRAP 193

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV----- 331
           E+L+    + K  D W++G L+ EM  G+P F   +       I+        +      
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 332 KLP--------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
           K P                    P L+     L K  LH DP KR        + + HH 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC----AELL-HHD 308

Query: 372 WFRSINWKTLEAREMQPKFKPD 393
           +F+   +    ++E+Q K + D
Sbjct: 309 FFQMDGFAERFSQELQLKVQKD 330

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  138 bits (349), Expect = 1e-37
 Identities = 76/317 (23%), Positives = 133/317 (41%), Gaps = 56/317 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+G++G VF+ + +     D+  I A+K   +    + + V    A R+I  
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLES---EDDPVIKKIALREIRM 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP +V L   F+ + +L+L+ ++ +   L      Q    E   +  T + + AV
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
           +  HK   +HRD+KPENIL+     + L DFG A+ +   S         E     Y +P
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSP 171

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF---------------------------- 314
           E+L+    +    D W++G +  E+L+G P +                            
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 315 THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
           T+     ++     +   L    P ++  A  LLKG LH DP++RL         +  H 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH-HP 286

Query: 372 WFRSINWKTLEAREMQP 388
           +F +I      A+E   
Sbjct: 287 YFENIREIEDLAKEHDK 303

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  138 bits (350), Expect = 1e-37
 Identities = 62/298 (20%), Positives = 117/298 (39%), Gaps = 61/298 (20%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                 ++ + +G+G +G+V+  K +G          A+K      +           E 
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVK------VFFTTEEASWFRET 80

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           + ++LYLI D+   G L+ +L    +  +   +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL- 139

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
               VS + HLH        K  I HRDLK +NIL+  +G   + D GLA +    +   
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 271 ---SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------Q 311
               N+  GT  YM PE+L    +         AD +S G++L+E+             Q
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 312 PPF-----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 357
            P+     +  + + +++ +  +K++      + + E    +  L+      +P+ RL
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  138 bits (349), Expect = 3e-37
 Identities = 65/298 (21%), Positives = 122/298 (40%), Gaps = 61/298 (20%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                  +   +G+G FG+V++ K +G +        A+K      I           E 
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWRGEE-------VAVK------IFSSREERSWFREA 85

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           T ++L+L+ D+   G LF +L R  +  E   +  
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL- 144

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
                S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++   
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 271 ---SNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------Q 311
               N   GT  YMAPE+L            K AD +++G++ +E+             Q
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 312 PPF-----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 357
            P+     +  + +++++ +  +K++      + + EA  ++  ++    + + + RL
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  137 bits (346), Expect = 4e-37
 Identities = 57/318 (17%), Positives = 117/318 (36%), Gaps = 62/318 (19%)

Query: 88  IQELEHENDAELEAESER-KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           +    H + + ++  +E         ++  V  +G FG V++ +             A+K
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVK 53

Query: 147 VMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGG 200
           +               + E ++  L  + H  I+Q     +        L+LI  F   G
Sbjct: 54  IF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107

Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH----------KCGIVHRDLKPENILMDS 250
            L   L    +   +        +   +++LH          K  I HRD+K +N+L+ +
Sbjct: 108 SLSDFLKANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

Query: 251 DGHVMLTDFGLAKEIDESSRSNSM---CGTTEYMAPEIL-----LSKGHNKDADWWSVGI 302
           +    + DFGLA + +    +       GT  YMAPE+L       +      D +++G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 303 LLYEMLTG-----------QPPF-----THANRQKLQQRIINEKVKLPP---FLTSEAHS 343
           +L+E+ +              PF      H + + +Q+ ++++K +      +      +
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286

Query: 344 LLKGLL----HKDPSKRL 357
           +L   +      D   RL
Sbjct: 287 MLCETIEECWDHDAEARL 304

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  135 bits (342), Expect = 9e-37
 Identities = 72/318 (22%), Positives = 132/318 (41%), Gaps = 83/318 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G V++ +            +A+K +R            ++ E +   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIR------------LEKEDEGIP 44

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   IL ++ H  IV+L     T+ +L L+ + ++      L      +G      
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVT 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           A+ +  ++++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R      
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---- 157

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII- 327
           T E     Y AP++L+ SK ++   D WSVG +  EM+ G P F      +  Q  RI  
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFR 215

Query: 328 -----NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGS 359
                N K      +LP                    L      LL  +L  DP++R+ +
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

Query: 360 GPGGVDAIKHHKWFRSIN 377
                 A++ H +F+  N
Sbjct: 276 ----KQALE-HAYFKENN 288

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  135 bits (341), Expect = 3e-36
 Identities = 74/321 (23%), Positives = 126/321 (39%), Gaps = 54/321 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T   +  +  +   R++  
Sbjct: 12  QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVAV 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L            +KL L+ + ++       +     +     +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTYLDKVPEPGVPTETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 331
             Y APE+LL   +    D WSVG +  EM   +P F  ++      +I+       E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

Query: 332 -----KLP----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
                 LP                  +      LL   L  +P+KR+ +      A+  H
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA----YSALS-H 297

Query: 371 KWFRSINWKTLEAREMQPKFK 391
            +F+ +           P  +
Sbjct: 298 PYFQDLERCKENLDSHLPPSQ 318

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  134 bits (340), Expect = 3e-36
 Identities = 83/319 (26%), Positives = 138/319 (43%), Gaps = 84/319 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            ++    VG+G +G V++ K           I A+K +R            + AE +   
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIR------------LDAEDEGIP 63

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ HP IV L     +   L L+ +F+       L  +   +   ++ Q
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQ 120

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + Y  +++  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS     
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY---- 176

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII- 327
           T E     Y AP++L+ SK ++   D WS+G +  EM+TG+P F         Q  +I  
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF--PGVTDDDQLPKIFS 234

Query: 328 -----NEKV-----KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLG 358
                N +      +LP                   P    E   LL  +L  DP+KR+ 
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294

Query: 359 SGPGGVDAIKHHKWFRSIN 377
           +     DA+  H +F+ ++
Sbjct: 295 A----RDAMN-HPYFKDLD 308

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  135 bits (341), Expect = 3e-36
 Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 74/317 (23%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
            A SE  +   + ++  ++G+G +G V++        G  D    A+KV          +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK--------GSLDERPVAVKVF------SFAN 48

Query: 159 VDYMKAERDI--LTKVTHPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
                 E++I  +  + H  I +      R +   R +  L++++   G L  +L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108

Query: 212 FREDQARFYTAEIVSAVSHLH---------KCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
                 R     +   +++LH         K  I HRDL   N+L+ +DG  +++DFGL+
Sbjct: 109 DWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 263 KEIDESSR---------SNSMCGTTEYMAPEIL-------LSKGHNKDADWWSVGILLYE 306
             +  +           + S  GT  YMAPE+L         +   K  D +++G++ +E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 307 MLTG-------------QPPF-----THANRQKLQQRIINEKV--KLPP--FLTSEAHSL 344
           +                Q  F      H   + +Q  +  EK   K P      S A   
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 345 LKGLL----HKDPSKRL 357
           LK  +     +D   RL
Sbjct: 288 LKETIEDCWDQDAEARL 304

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  133 bits (337), Expect = 7e-36
 Identities = 66/338 (19%), Positives = 125/338 (36%), Gaps = 83/338 (24%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            F+    +G G +  V++       +  +    A+K ++ D       T I+        
Sbjct: 6   QFKQLEKLGNGTYATVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIR-------- 52

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHL--FFHLYRQGIFREDQAR 218
            E  ++ ++ H  IV+L     T +KL L+ +F++     ++              +  +
Sbjct: 53  -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       +     ++
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF----SS 167

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQP-------------------- 312
           E     Y AP++L+ S+ ++   D WS G +L EM+TG+P                    
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 313 -----------------PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSK 355
                                   + L+Q +          L       L GLL  +P  
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDM 284

Query: 356 RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
           RL +      A+  H WF         +          
Sbjct: 285 RLSAK----QALH-HPWFAEYYHHA--SMGGSRSHHHH 315

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  132 bits (335), Expect = 1e-35
 Identities = 71/306 (23%), Positives = 112/306 (36%), Gaps = 52/306 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G GA+G V++ +     D  S    A+K +R            +   R++  
Sbjct: 10  RYEPVAEIGVGAYGTVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L             K+ L+ + ++       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 331
             Y APE+LL   +    D WSVG +  EM   +P F   +      +I        E  
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242

Query: 332 -----KLP----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
                 LP                P +      LL  +L  +P KR+ +      A++ H
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA----FRALQ-H 297

Query: 371 KWFRSI 376
            +    
Sbjct: 298 SYLHKD 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  130 bits (330), Expect = 5e-35
 Identities = 67/317 (21%), Positives = 126/317 (39%), Gaps = 79/317 (24%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +G+G +G VF+ K     + ++  I A+K +R            +  + +   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAK-----NRETHEIVALKRVR------------LDDDDEGVP 45

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ H  IV+L     +  KL L+ +F +     +        G    + 
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEI 102

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + +  +++  +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R      
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---- 158

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRII-- 327
           + E     Y  P++L  +K ++   D WS G +  E+     P    N    Q +RI   
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

Query: 328 ----NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGSG 360
                E+      KLP                  P L +    LL+ LL  +P +R+ + 
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA- 277

Query: 361 PGGVDAIKHHKWFRSIN 377
               +A++ H +F    
Sbjct: 278 ---EEALQ-HPYFSDFC 290

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  131 bits (333), Expect = 6e-35
 Identities = 80/311 (25%), Positives = 132/311 (42%), Gaps = 70/311 (22%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
            +E    +G+G F  V++ + K     +++ I A+K   K   IK  H    K      A
Sbjct: 11  RYEKLDFLGEGQFATVYKARDK-----NTNQIVAIK---K---IKLGHRSEAKDGINRTA 59

Query: 165 ERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGI-FREDQARFY 220
            R+I  L +++HP I+ L  +F  +S + L+ DF+     L   +    +       + Y
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAY 117

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
               +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+     T + 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQV 173

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII----- 327
               Y APE+L  ++ +    D W+VG +L E+L   P         L Q  RI      
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGT 231

Query: 328 -NEKV-----KLP-----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 364
             E+       LP                      +   L++GL   +P  R+ +     
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA----T 287

Query: 365 DAIKHHKWFRS 375
            A+K  K+F +
Sbjct: 288 QALK-MKYFSN 297

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  131 bits (331), Expect = 8e-35
 Identities = 64/319 (20%), Positives = 120/319 (37%), Gaps = 81/319 (25%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G+V++          ++   A+K +R            ++ E +   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIR------------LEHEEEGVP 77

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQAR 218
                   +L ++ H  I++L+       +L+LI ++    + L  ++ +         +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESSRSNS 273
            +  ++++ V+  H    +HRDLKP+N+L+          + + DFGLA+      R   
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF- 194

Query: 274 MCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT------------ 315
              T E     Y  PEILL S+ ++   D WS+  +  EML   P F             
Sbjct: 195 ---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251

Query: 316 ------------------HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
                                +   + R    K  L   L  E   LL  +L  DP KR+
Sbjct: 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311

Query: 358 GSGPGGVDAIKHHKWFRSI 376
            +     +A++ H +F   
Sbjct: 312 SA----KNALE-HPYFSHN 325

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  130 bits (329), Expect = 1e-34
 Identities = 74/328 (22%), Positives = 131/328 (39%), Gaps = 76/328 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            +     +G+G +  V++ K K      +D + A+K +R +       T I+        
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIR-------- 49

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFY 220
            E  +L  + H  IV L     T   L L+ ++++     +L        I      + +
Sbjct: 50  -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +++  +++ H+  ++HRDLKP+N+L++  G + L DFGLA+     +++       E 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY----DNEV 161

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII----- 327
               Y  P+ILL S  ++   D W VG + YEM TG+P F        +Q   I      
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF--PGSTVEEQLHFIFRILGT 219

Query: 328 -NEKV-----KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPG 362
             E+                            P L S+   LL  LL  +   R+ +   
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA--- 276

Query: 363 GVDAIKHHKWFRSINWKTLEAREMQPKF 390
             DA+K H +F S+  +  +  +    F
Sbjct: 277 -EDAMK-HPFFLSLGERIHKLPDTTSIF 302

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  127 bits (322), Expect = 2e-33
 Identities = 70/326 (21%), Positives = 121/326 (37%), Gaps = 87/326 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +GQG FG+VF+ +        +    A+K +             M+ E++   
Sbjct: 18  KYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVL------------MENEKEGFP 60

Query: 168 --------ILTKVTHPFIVQLR--------YSFQTRSKLYLILDFIN---GGHLFFHLYR 208
                   IL  + H  +V L            + +  +YL+ DF      G L      
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNV 117

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
              F   + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    +
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177

Query: 269 SRSNSMCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT------- 315
             S     T       Y  PE+LL  + +    D W  G ++ EM T  P          
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237

Query: 316 -----------------------HANRQKLQQ---RIINEKVKLPPFLTSEAHSLLKGLL 349
                                     + +L +   R + +++K        A  L+  LL
Sbjct: 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLL 296

Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRS 375
             DP++R+ S     DA+  H +F S
Sbjct: 297 VLDPAQRIDS----DDALN-HDFFWS 317

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  127 bits (322), Expect = 5e-33
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 52/286 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG V+Q K       DS  + A+K + +D         +   E  I+ K
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQDK-------RFKNRELQIMRK 103

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFINGG-HLFFHLYRQG--IFREDQARFYTA 222
           + H  IV+LRY F +         L L+LD++    +     Y +          + Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------------------------- 314
           APE++  +  +    D WS G +L E+L GQP F                          
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283

Query: 315 --THANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
              +    K  Q           P    EA +L   LL   P+ RL
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  125 bits (315), Expect = 4e-32
 Identities = 74/322 (22%), Positives = 128/322 (39%), Gaps = 61/322 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG VFQ K             A+K + +D         +   E  I+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLV------ESDEVAIKKVLQDK-------RFKNRELQIMRI 88

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFING---GHLFFHLYRQGIFREDQARFYTA 222
           V HP +V L+  F +         L L+L+++          +   +        + Y  
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + S   +  Y 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------------------------- 314
           APE++  +  +  + D WS G ++ E++ GQP F                          
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268

Query: 315 --THANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 371
              +    K  Q           P    +A  L+  LL   PS R       ++A+ H  
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR----LTAIEALCHP- 323

Query: 372 WF---RSINWKTLEAREMQPKF 390
           +F   R+   +    RE+ P F
Sbjct: 324 FFDELRTGEARMPNGRELPPLF 345

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  118 bits (298), Expect = 8e-30
 Identities = 78/327 (23%), Positives = 129/327 (39%), Gaps = 85/327 (25%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 29  VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHP 78

Query: 176 FIVQLR--YSFQTRSKLYLILDF--------INGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++ L+  +      K++L+ D+        I          +         +    +I+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRSNSMCGTTE-- 279
             + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +  +        
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPVVV 197

Query: 280 ---YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------THANRQKLQQ--RI 326
              Y APE+LL ++ + K  D W++G +  E+LT +P F         +N     Q  RI
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 327 I------NEKV-----KLP---------------------------PFLTSEAHSLLKGL 348
                   +K      K+P                               S+A  LL+ L
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           L  DP KR+ S      A++   +F  
Sbjct: 318 LTMDPIKRITS----EQAMQ-DPYFLE 339

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  117 bits (296), Expect = 9e-30
 Identities = 65/296 (21%), Positives = 120/296 (40%), Gaps = 63/296 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG FG V   K     +  +    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGK-----EKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAV 75

Query: 172 VTHPFIVQLRYSFQTRSK-------LYLILDFING---GHLFFHLYRQGIFREDQARFYT 221
           + HP IVQL+  F T  +       L ++++++          +  RQ        + + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 222 AEIVSAVSHLHKC--GIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ ++  LH     + HRD+KP N+L++ +DG + L DFG AK++  S  + +   + 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 279 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQP------------------------- 312
            Y APE++  ++ +    D WSVG +  EM+ G+P                         
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 313 -----------PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
                         ++          +  +K       EA+ LL  LL   P +R+
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK----EAYDLLSALLQYLPEERM 307

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  115 bits (289), Expect = 1e-28
 Identities = 62/301 (20%), Positives = 109/301 (36%), Gaps = 64/301 (21%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKDTIIKKNHVDY 161
              + + R +  G++G V           DS+G       ++      +   I  +    
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYR-----Q 209
            +  R+I  L    HP I+ LR     +      KLYL+ + +        L +     +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
            +      +++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 270 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ-- 323
                     Y APE+++  KG  K  D WS G ++ EM   +  F   T  N+      
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248

Query: 324 ----------QRIINEKVK------LP-----------PFLTSEAHSLLKGLLHKDPSKR 356
                         +   +      L            P     A  L+  +L  +P +R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 357 L 357
           +
Sbjct: 309 I 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  113 bits (286), Expect = 2e-28
 Identities = 70/306 (22%), Positives = 129/306 (42%), Gaps = 74/306 (24%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
             DF++  ++G+GA+G V            +  I A         IKK       +  ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT-----HKPTGEIVA---------IKKIEPFDKPLFALR 55

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L    H  I+ +    +  S      +Y+I + +    H    +    +  +D
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDD 112

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGLA+ IDES+  NS  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 276 GT-----TEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THAN-- 318
                   E++      APE++L+   +++  D WS G +L E+   +P F    + +  
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232

Query: 319 -----------RQKLQQRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHK 351
                           + I + + +     LP           P +  +   LL+ +L  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 352 DPSKRL 357
           DP+KR+
Sbjct: 293 DPAKRI 298

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (288), Expect = 3e-28
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 47/246 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +E+ +V+G+G+FG+V +       D       A+K++R       N   + +    E  I
Sbjct: 99  YEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVR-------NEKRFHRQAAEEIRI 146

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQAR 218
           L  +       T   ++ +  +F  R+ + +   F       + L ++  F+       R
Sbjct: 147 LEHLRKQDKDNTM-NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVR 203

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDE------SSR 270
            +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG +    +       SR
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINE 329
                    Y APE++L   +    D WS+G +L E+LTG P         +L    + E
Sbjct: 264 F--------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL--ACMIE 313

Query: 330 KVKLPP 335
            + +P 
Sbjct: 314 LLGMPS 319

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  111 bits (281), Expect = 6e-28
 Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 64/301 (21%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + +G G  G VF        D D D   A+K   K  I+  +      A R+I
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV-----DNDCDKRVAIK---K--IVLTDPQSVKHALREI 59

Query: 169 --LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLY--------RQGIFRE 214
             + ++ H  IV++      S    +     L  +N  ++              QG   E
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNS 273
           + AR +  +++  + ++H   ++HRDLKP N+ +++ D  + + DFGLA+ +D       
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF------------ 314
               +E +      +P +LLS   + K  D W+ G +  EMLTG+  F            
Sbjct: 180 H--LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 315 ---------------THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKR 356
                                 ++  +      L    P ++ EA   L+ +L   P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 357 L 357
           L
Sbjct: 298 L 298

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  111 bits (279), Expect = 3e-27
 Identities = 68/318 (21%), Positives = 120/318 (37%), Gaps = 84/318 (26%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +G G+FG V +V      D +S   +A+K   K     +    Y   E DI+  
Sbjct: 9   YSLGKTLGTGSFGIVCEVF-----DIESGKRFALK---KVLQDPR----YKNRELDIMKV 56

Query: 172 VTHPFIVQLRYSFQTRSK--------------------------------------LYLI 193
           + H  I++L   F T                                         L +I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 194 LDFINGG-HLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
           ++++    H     + +       +    Y  ++  AV  +H  GI HRD+KP+N+L++S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 251 DGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML 308
             + + L DFG AK++  S  S +   +  Y APE++L +  +    D WS+G +  E++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 309 TGQPPF----------------------------THANRQKLQQRI-INEKVKLPPFLTS 339
            G+P F                             H    +       + +  LP    S
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 340 EAHSLLKGLLHKDPSKRL 357
            A  LL+ +L  +P  R+
Sbjct: 297 LAIDLLEQILRYEPDLRI 314

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  111 bits (280), Expect = 4e-27
 Identities = 65/299 (21%), Positives = 118/299 (39%), Gaps = 61/299 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   D   A+K   K +   +N     +A R++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY-----DAVLDRNVAIK---KLSRPFQNQTHAKRAYREL 112

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        + +    +YL+++ +        + +  +   ++  + 
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYL 169

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------- 326
            APE++L  G+ ++ D WSVG ++ EM+  +  F   +      ++              
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 327 INEKVK----------------------------LPPFLTSEAHSLLKGLLHKDPSKRL 357
           +   V+                                  S+A  LL  +L  DP+KR+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 7e-27
 Identities = 64/261 (24%), Positives = 121/261 (46%), Gaps = 16/261 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      +        E++  PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
             T + + +++     D   R
Sbjct: 243 ICTIDVYMIMRKCWMIDADSR 263

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  112 bits (282), Expect = 7e-27
 Identities = 67/296 (22%), Positives = 132/296 (44%), Gaps = 14/296 (4%)

Query: 68  SHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVF 127
           ++   G        S      + ++ E+   + +  + +I     E+ R +G+G FG V 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVH 407

Query: 128 QVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185
               +G+     +     A+K  +  T        +++ E   + +  HP IV+L     
Sbjct: 408 ----QGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQ-EALTMRQFDHPHIVKL-IGVI 460

Query: 186 TRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
           T + +++I++    G L   L  R+          Y  ++ +A+++L     VHRD+   
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGI 302
           N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  +     +D W  G+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580

Query: 303 LLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            ++E+L  G  PF    N   + +    E++ +PP      +SL+      DPS+R
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  109 bits (274), Expect = 8e-27
 Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 60/258 (23%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
               GD     +EI   +G+GAFGKV +      D        A+K+++       N   
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECI----DHKAGGRHVAVKIVK-------NVDR 53

Query: 161 YMKA---ERDILTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-- 207
           Y +A   E  +L  +             VQ+   F+    + ++ +      L    Y  
Sbjct: 54  YCEAARSEIQVLEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFEL-----LGLSTYDF 106

Query: 208 -----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
                    FR D  R    +I  +V+ LH   + H DLKPENIL     +    +  + 
Sbjct: 107 IKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165

Query: 263 KEIDESSRSN-------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLY 305
           ++       +       S     E+           APE++L+ G ++  D WS+G +L 
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225

Query: 306 EMLTGQPPF-THANRQKL 322
           E   G   F TH +++ L
Sbjct: 226 EYYLGFTVFPTHDSKEHL 243

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  109 bits (274), Expect = 1e-26
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 70/300 (23%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
              +     +G+GA+G V         D  +    A         IKK     +     +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVA---------IKKISPFEHQTYCQR 71

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L +  H  I+ +    +  +      +Y++ D +    +    L +      D
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSND 128

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
              ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA+  D         
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF- 187

Query: 276 GTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR--------- 319
             TEY+      APEI+L+ KG+ K  D WSVG +L EML+ +P F   +          
Sbjct: 188 -LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

Query: 320 ------QKLQQRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 357
                 Q+    IIN K +     LP           P   S+A  LL  +L  +P KR+
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  108 bits (273), Expect = 1e-26
 Identities = 58/253 (22%), Positives = 92/253 (36%), Gaps = 67/253 (26%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +EI   +G+G FGKV +      D        A+K++R       N   Y +A   E ++
Sbjct: 21  YEIVGNLGEGTFGKVVECL----DHARGKSQVALKIIR-------NVGKYREAARLEINV 69

Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLF----------FHLYRQG 210
           L K+             V +   F               GH+           F   ++ 
Sbjct: 70  LKKIKEKDKENKFL--CVLMSDWFNFH------------GHMCIAFELLGKNTFEFLKEN 115

Query: 211 IFR---EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
            F+       R    ++  A+  LH+  + H DLKPENIL  +     L +   + E   
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 268 SSRSN-------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLYEMLTG 310
              ++       S     E+            PE++L  G  +  D WS+G +L+E   G
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 311 QPPF-THANRQKL 322
              F TH NR+ L
Sbjct: 236 FTLFQTHENREHL 248

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  108 bits (273), Expect = 1e-26
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 66/296 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K   K     ++ +   +A R++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARF 219
             L  + H  ++ L        +    +  YL++ F+         L +     ED+ +F
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQF 132

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D     + M   T 
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEM---TG 184

Query: 280 YM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ------ 323
           Y+      APE++L+   + +  D WSVG ++ EM+TG+  F    H ++ K        
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 324 ------QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 357
                 QR+ +++ K     LP              +  A +LL+ +L  D  +R+
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  107 bits (270), Expect = 2e-26
 Identities = 62/297 (20%), Positives = 118/297 (39%), Gaps = 67/297 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             D+++ R +G+G + +VF+       +  ++    +K+++         V   K +R+I
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKP--------VKKKKIKREI 81

Query: 169 --LTKVT-HPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             L  +   P I+ L    +        L+ + +N          Q    +   RFY  E
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQ-TLTDYDIRFYMYE 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMA 282
           I+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN----------------------- 318
           PE+L+  + ++   D WS+G +L  M+  + PF H +                       
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258

Query: 319 ------------------RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 357
                             R++ ++ + +E       ++ EA   L  LL  D   RL
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQ---HLVSPEALDFLDKLLRYDHQSRL 312

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (268), Expect = 2e-26
 Identities = 33/254 (12%), Positives = 76/254 (29%), Gaps = 40/254 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + +    G     + +Q       D   D   A+  +    ++  + +    +    L
Sbjct: 31  GRYRLLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +++  P + ++     TR+   ++ ++I GG L   +          A      + +A  
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSP-SPVGAIRAMQSLAAAAD 143

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
             H+ G+      P  + +  DG V+L       + +                       
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD-------------------- 183

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLP----PFLTSEAH 342
                 D   +G  LY +L  + P       +     +R    +   P      +  +  
Sbjct: 184 ------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237

Query: 343 SLLKGLLHKDPSKR 356
           ++    +  D   R
Sbjct: 238 AVAARSVQGDGGIR 251

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 2e-26
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 65/295 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +     VG GA+G V         D  S    A+K   K +   ++ +   +A R++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74

Query: 169 --LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L   F   S        YL++ F+    L         F E++ ++ 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL--QKIMGLKFSEEKIQYL 131

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D           T Y
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--------TGY 183

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ------- 323
           +      APE++LS   +N+  D WSVG ++ EMLTG+  F    + ++           
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 324 -----QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 357
                Q++ ++  K     LP           P  + +A  LL+ +L  D  KRL
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  107 bits (270), Expect = 3e-26
 Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 61/299 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   +   A+K   K +   +N     +A R++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAIK---KLSRPFQNQTHAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        S +    +Y++++ +        + +  +   ++  + 
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYL 132

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------- 326
            APE++L  G+ ++ D WSVG ++ EM+ G   F   +      ++              
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 327 INEKVK----------------------------LPPFLTSEAHSLLKGLLHKDPSKRL 357
           +   V+                                  S+A  LL  +L  D SKR+
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  107 bits (269), Expect = 6e-26
 Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 68/243 (27%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           + + R +G G F  V+  K     D  ++   AMK++R           Y +A   E  +
Sbjct: 21  YILVRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR-------GDKVYTEAAEDEIKL 68

Query: 169 LTKVT-----------HPFIVQLRYSFQTRSKLYLILDFINGGHL-------------FF 204
           L +V               I++L   F  +          NG H+               
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGP--------NGVHVVMVFEVLGENLLALI 120

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD------SDGHVMLT 257
             Y          +  + +++  + ++H+ CGI+H D+KPEN+LM+      +   + + 
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180

Query: 258 DFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           D G A   DE       +R        EY +PE+LL       AD WS   L++E++TG 
Sbjct: 181 DLGNACWYDEHYTNSIQTR--------EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

Query: 312 PPF 314
             F
Sbjct: 233 FLF 235

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  105 bits (263), Expect = 1e-25
 Identities = 51/275 (18%), Positives = 104/275 (37%), Gaps = 36/275 (13%)

Query: 101 AESERKIGPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
              E  +      +  + +G G FG V     KG           A+K+++ +       
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVK----KGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            + +  E +++ ++ +P+IV++           L+++    G L  +L +    ++    
Sbjct: 63  DELLA-EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +             
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------N 172

Query: 279 EY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQK 321
            Y             APE +    + K    +D WS G+L++E  + GQ P+      + 
Sbjct: 173 YYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                  E++  P     E + L+      D   R
Sbjct: 230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (267), Expect = 1e-25
 Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 60/273 (21%)

Query: 95  NDAELEAESERKIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           ND   +   +  +  G+     +EI  ++G+G+FG+V +       D       A+K+++
Sbjct: 34  NDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIK 88

Query: 150 KDTIIKKNHVDYMKA---ERDILTKVTHP------FIVQLRYSFQTRSKLYLILDFINGG 200
                  N   ++     E  +L  +         +IV L+  F  R+ L L+ +     
Sbjct: 89  -------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----- 136

Query: 201 HLFFHLY-------RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDSD 251
            L ++LY        +G    +  R +  ++ +A+  L   +  I+H DLKPENIL+ + 
Sbjct: 137 MLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 252 GH--VMLTDFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
               + + DFG + ++ +       SR         Y +PE+LL   ++   D WS+G +
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCI 247

Query: 304 LYEMLTGQPPF-THANRQKLQQRIINEKVKLPP 335
           L EM TG+P F       ++    I E + +PP
Sbjct: 248 LVEMHTGEPLFSGANEVDQM--NKIVEVLGIPP 278

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (262), Expect = 1e-25
 Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 21/266 (7%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
              IG  D  +   +G G+FG V     +G  D  S      A+K ++ D + +   +D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVR----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
              E + +  + H  +++L Y       + ++ +    G L   L   QG F       Y
Sbjct: 68  FIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++   + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    + 
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 281 ----MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 332
                APE L           +D W  G+ L+EM T GQ P+   N  ++  +I  E  +
Sbjct: 187 PFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243

Query: 333 L--PPFLTSEAHSLLKGLLHKDPSKR 356
           L  P     + ++++       P  R
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDR 269

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  106 bits (266), Expect = 1e-25
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 64/295 (21%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V         D  +    A+K   K +   ++ +   +  R++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVK---KLSRPFQSIIHAKRTYREL 79

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L        S +  + +YL+   +  G    ++ +     +D  +F 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+        + M   T Y
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEM---TGY 189

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-------------- 319
           +      APEI+L+   +N+  D WSVG ++ E+LTG+  F   +               
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 320 -QKLQQRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 357
             +L ++I +E  +     L                  A  LL+ +L  D  KR+
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 2e-25
 Identities = 64/261 (24%), Positives = 120/261 (45%), Gaps = 16/261 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      +        E++  PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
             T + + ++      D   R
Sbjct: 243 ICTIDVYMIMVKCWMIDADSR 263

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  103 bits (260), Expect = 2e-25
 Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 34/270 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
           + +I     E+ R +G+G FG V     +G+     +     A+K  +  T        +
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTS-DSVREKF 63

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           ++ E   + +  HP IV+L     T + +++I++    G L   L  R+          Y
Sbjct: 64  LQ-EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++ +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S           Y
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----------TY 171

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 326
                       MAPE +  +     +D W  G+ ++E+L  G  PF    N   + +  
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 327 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
             E++ +PP      +SL+      DPS+R
Sbjct: 232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (262), Expect = 5e-25
 Identities = 69/260 (26%), Positives = 103/260 (39%), Gaps = 77/260 (29%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           F + R +G G FG+V   +       D+   YA+KV+R       N   Y ++   E DI
Sbjct: 37  FLVIRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVR-------NIKKYTRSAKIEADI 84

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFRE 214
           L K+        +  IV+    F     + LI +      L   LY         G F  
Sbjct: 85  LKKIQNDDINNNN--IVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNG-FHI 136

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT----------------- 257
           +  + Y  EI+ A+++L K  + H DLKPENIL+D                         
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 258 --------DFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                   DFG A    +      ++R         Y APE++L+ G +  +D WS G +
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCV 248

Query: 304 LYEMLTGQPPF-THANRQKL 322
           L E+ TG   F TH + + L
Sbjct: 249 LAELYTGSLLFRTHEHMEHL 268

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (256), Expect = 1e-24
 Identities = 57/261 (21%), Positives = 108/261 (41%), Gaps = 16/261 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R     +    +V+G G FG V     KGV   +G+S  I   +KV+   +  +++    
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVH----KGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAV 62

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
                  +  + H  IV+L       S L L+  ++  G L  H+   +G         +
Sbjct: 63  TD-HMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   + +L + G+VHR+L   N+L+ S   V + DFG+A  +    +          
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPP 335
            ++MA E +    +   +D WS G+ ++E++T G  P+      +        E++  P 
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
             T + + ++      D + R
Sbjct: 241 ICTIDVYMVMVKCWMIDENIR 261

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (253), Expect = 2e-24
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 34/267 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKA 164
           I   D  + R++G+G FG+V+    +GV           A+K  +KD     N   +M  
Sbjct: 9   IAREDVVLNRILGEGFFGEVY----EGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS- 62

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+  + HP IV+L          ++I++    G L  +L   +   +      Y+ +
Sbjct: 63  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           I  A+++L     VHRD+   NIL+ S   V L DFGL++ I++           +Y   
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----------DYYKA 171

Query: 281 ---------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINE 329
                    M+PE +  +     +D W   + ++E+L+ G+ PF    N+  +      +
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231

Query: 330 KVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           ++  P       ++L+      DPS R
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDR 258

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  101 bits (254), Expect = 3e-24
 Identities = 69/310 (22%), Positives = 125/310 (40%), Gaps = 29/310 (9%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEA--ESERKIGPGDFEIFRVVGQG 121
           +H+  H   G    Y        Q     H  +    A     R+I      I +++G G
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 122 AFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
             G+V      G            A+K ++     ++   D++  E  I+ +  HP I++
Sbjct: 61  DSGEVC----YGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLS-EASIMGQFDHPNIIR 114

Query: 180 LRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L     TR +   ++ +++  G L   L    G F   Q       + + + +L   G V
Sbjct: 115 L-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK 293
           HRDL   N+L+DS+    ++DFGL++ +++   +       +      APE +       
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA---FRT 230

Query: 294 ---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
               +D WS G++++E+L  G+ P+    NR  +    + E  +L  P       H L+ 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEGYRLPAPMGCPHALHQLML 288

Query: 347 GLLHKDPSKR 356
              HKD ++R
Sbjct: 289 DCWHKDRAQR 298

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 3e-24
 Identities = 57/244 (23%), Positives = 109/244 (44%), Gaps = 19/244 (7%)

Query: 77  RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD 136
            +        +    +    +  E     +      +  + +G+G FG V   +   + D
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67

Query: 137 GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLI 193
              + + A+K ++  T  +++  D+ + E +IL  + H  IV+ +   YS   R+ L LI
Sbjct: 68  NTGEVV-AVKKLQHST--EEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLI 122

Query: 194 LDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++++  G L  +L + +      +   YT++I   + +L     +HRDL   NIL++++ 
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK---DADWWSVGILLY 305
            V + DFGL K + +      +    E      APE L     +K    +D WS G++LY
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 239

Query: 306 EMLT 309
           E+ T
Sbjct: 240 ELFT 243

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  103 bits (258), Expect = 3e-24
 Identities = 73/310 (23%), Positives = 137/310 (44%), Gaps = 41/310 (13%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 143 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 194

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 195 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 244

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 245 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTH-ANRQKLQQRIINEKVKLP-PFLTSEA-HSLLK 346
               +D WS GILL E+ T G+ P+    NR+ L Q  +    ++P P    E+ H L+ 
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VERGYRMPCPPECPESLHDLMC 415

Query: 347 GLLHKDPSKR 356
               K+P +R
Sbjct: 416 QCWRKEPEER 425

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (252), Expect = 4e-24
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 19/220 (8%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
                +      +  + +G+G FG V   +   + D   + + A+K ++  T  +++  D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHST--EEHLRD 57

Query: 161 YMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQ 216
           + + E +IL  + H  IV+ +   YS   R+ L LI++++  G L  +L + +      +
Sbjct: 58  FER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              YT++I   + +L     +HRDL   NIL++++  V + DFGL K + +      +  
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 277 TTEY----MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
             E      APE L     +K    +D WS G++LYE+ T
Sbjct: 176 PGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFT 212

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.8 bits (247), Expect = 9e-24
 Identities = 52/259 (20%), Positives = 124/259 (47%), Gaps = 23/259 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V        D        A+K +R+  + ++   D+++ E 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE---DFIE-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
           +++ K++HP +VQL Y        + L+ +F+  G L  +L  ++G+F  +       ++
Sbjct: 55  EVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              +++L +  ++HRDL   N L+  +  + ++DFG+ + + +   ++S       ++ +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFL 337
           PE+      ++    +D WS G+L++E+ + G+ P+   +N + ++      ++  P   
Sbjct: 174 PEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230

Query: 338 TSEAHSLLKGLLHKDPSKR 356
           ++  + ++     + P  R
Sbjct: 231 STHVYQIMNHCWRERPEDR 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (250), Expect = 1e-23
 Identities = 62/273 (22%), Positives = 124/273 (45%), Gaps = 32/273 (11%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNH 158
           +   +I P      +V+G G FG+V+    KG+     G  +   A+K ++     +K  
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYT-EKQR 90

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
           VD++  E  I+ + +H  I++L     ++ K + +I +++  G L   L  + G F   Q
Sbjct: 91  VDFLG-EAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
                  I + + +L     VHRDL   NIL++S+    ++DFGL++ +++         
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE------ 202

Query: 277 TTEY-----------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQ 323
              Y            APE +  +     +D WS GI+++E++T G+ P+   +N + ++
Sbjct: 203 -ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261

Query: 324 QRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                 ++  P    S  + L+     ++ ++R
Sbjct: 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 72/303 (23%), Positives = 114/303 (37%), Gaps = 58/303 (19%)

Query: 93  HENDAELEAESERK-IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVM 148
           H + A+L A  +         +    +G+G FG V         D   D      A+K +
Sbjct: 5   HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVE----LCRYDPLGDNTGALVAVKQL 60

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFH 205
           +     ++   D+ + E  IL  +   FIV+ R   Y    +S L L+++++  G L   
Sbjct: 61  QHSGPDQQR--DFQR-EIQILKALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDF 116

Query: 206 LYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           L R +      +   Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK 
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

Query: 265 IDESSRSNSMCGTTEY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
           +              Y             APE L     N     +D WS G++LYE+ T
Sbjct: 177 LPLDK--------DYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLYELFT 225

Query: 310 -GQPPFTHANRQKLQQRIINEKVKL---------------PPFLTSEAHSLLKGLLHKDP 353
                 + +           +   L               PP   +E H L+K      P
Sbjct: 226 YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285

Query: 354 SKR 356
             R
Sbjct: 286 QDR 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 38/274 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D  +DG     A+K ++ D    ++   + + E D
Sbjct: 32  YLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EID 85

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           IL  + H  I++ +        + L L+++++  G L  +L R  I       F   +I 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQIC 144

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----M 281
             +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +    +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 282 APEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKL-----QQRIINEKV- 331
           APE L      K    +D WS G+ LYE+LT      +   +        Q ++   ++ 
Sbjct: 205 APECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 332 ---------KLPPFLTSEAHSLLKGLLHKDPSKR 356
                      P    +E + L+K     + S R
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (250), Expect = 2e-23
 Identities = 58/258 (22%), Positives = 112/258 (43%), Gaps = 17/258 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G+G FG+VF     G    D+  + A+K  R+          +++ E 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLV-AVKSCRETLP-PDLKAKFLQ-EA 163

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            IL + +HP IV+L     T+ + +Y++++ + GG     L       R         + 
Sbjct: 164 RILKQYSHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
            + + +L     +HRDL   N L+     + ++DFG+++E  +     +  G  +     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKW 281

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE L    ++ ++D WS GILL+E  + G  P+   +N+Q  +      ++  P    
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341

Query: 339 SEAHSLLKGLLHKDPSKR 356
                L++     +P +R
Sbjct: 342 DAVFRLMEQCWAYEPGQR 359

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (252), Expect = 3e-23
 Identities = 73/310 (23%), Positives = 137/310 (44%), Gaps = 41/310 (13%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 226 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 277

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 278 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 327

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 328 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTH-ANRQKLQQRIINEKVKLP-PFLTSEA-HSLLK 346
               +D WS GILL E+ T G+ P+    NR+ L Q  +    ++P P    E+ H L+ 
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VERGYRMPCPPECPESLHDLMC 498

Query: 347 GLLHKDPSKR 356
               K+P +R
Sbjct: 499 QCWRKEPEER 508

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 55/273 (20%), Positives = 109/273 (39%), Gaps = 38/273 (13%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMK 163
           KI   D      +GQG F K+F+  ++ V D          +KV+ K      N+ +   
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFF 60

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
               +++K++H  +V   Y          L+ +F+  G L  +L + +            
Sbjct: 61  EAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNS 273
            ++ +A+  L +  ++H ++  +NIL+  +          + L+D G++  +        
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----- 174

Query: 274 MCGTTEY-------MAPE-ILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQ 323
                +        + PE I   K  N   D WS G  L+E+ + G  P     +++KLQ
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

Query: 324 QRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                ++ +LP    +E  +L+   +  +P  R
Sbjct: 230 F--YEDRHQLPAPKAAELANLINNCMDYEPDHR 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 65/273 (23%), Positives = 127/273 (46%), Gaps = 17/273 (6%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E+  +   E  +++   +  I +VVG G FG+V   + K     +     A+K ++    
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYT 86

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGI 211
            +K   D++  E  I+ +  HP I++L     T+SK + ++ +++  G L   L      
Sbjct: 87  -EKQRRDFLG-EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F   Q       I S + +L   G VHRDL   NIL++S+    ++DFGL + +++   +
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203

Query: 272 NSMCGTTEY----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQR 325
                  +      +PE +  +     +D WS GI+L+E+++ G+ P+   +N+  ++  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA- 262

Query: 326 IINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
            ++E  +L  P    +  + L+     KD + R
Sbjct: 263 -VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 42/278 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I    F + R++G+G FG V + + K  D        A+K+++ D I   +  ++++ E 
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDIEEFLR-EA 76

Query: 167 DILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
             + +  HP + +L        +        +IL F+  G L   L       E+     
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLP 135

Query: 220 ------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
                 +  +I   + +L     +HRDL   N ++  D  V + DFGL+++I        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----- 190

Query: 274 MCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 318
                +Y             +A E L    +   +D W+ G+ ++E++T GQ P+    N
Sbjct: 191 -----DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            +     I   ++K PP    E + L+      DP +R
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 59/270 (21%), Positives = 111/270 (41%), Gaps = 38/270 (14%)

Query: 107 IGPGDFEIFRVV-GQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNHVDYMKA 164
           +   +  I  +  G G FG V     +GV       I  A+KV+++ T  K +  + M+ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVR----QGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR- 59

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ ++ +P+IV+L         L L+++   GG L   L  ++             +
Sbjct: 60  EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           +   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +            + Y   
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--------SYYTAR 170

Query: 281 ---------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 326
                     APE +      K    +D WS G+ ++E L+ GQ P+      + +    
Sbjct: 171 SAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

Query: 327 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
             ++++ PP    E ++L+          R
Sbjct: 228 QGKRMECPPECPPELYALMSDCWIYKWEDR 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 58/268 (21%), Positives = 127/268 (47%), Gaps = 41/268 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +    ++++ E 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSED---EFIE-EA 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L   +  F+  Q      ++
Sbjct: 71  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
             A+ +L     +HRDL   N L++  G V ++DFGL++ + +           EY    
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------DEYTSSV 179

Query: 281 --------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEK 330
                     PE+L+    +  +D W+ G+L++E+ + G+ P+    N +  +   I + 
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQG 237

Query: 331 VKL--PPFLTSEAHSLLKGLLHKDPSKR 356
           ++L  P   + + ++++    H+   +R
Sbjct: 238 LRLYRPHLASEKVYTIMYSCWHEKADER 265

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 38/275 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D + D      A+K ++ ++    +  D  K E +
Sbjct: 22  FLKRIRDLGEGHFGKVE----LCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIE 75

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEI 224
           IL  + H  IV+ +   +    + + LI++F+  G L  +L + +      Q   Y  +I
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
              + +L     VHRDL   N+L++S+  V + DFGL K I+      ++    +     
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 281 MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKLQQR-----IINEKV 331
            APE L+    +K    +D WS G+ L+E+LT      +               +   ++
Sbjct: 196 YAPECLM---QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 332 --KL--------PPFLTSEAHSLLKGLLHKDPSKR 356
              L        PP    E + L++      PS R
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 55/300 (18%)

Query: 50  SPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP 109
           S  + +A   +    H  S S      R    SS P           +     S+ +I  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTA---------SMPRPHSDWQIPD 53

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             +EI  ++G G++G V +       D     + A+K   K   + ++ +D  +  R+I 
Sbjct: 54  -RYEIRHLIGTGSYGHVCEAY-----DKLEKRVVAIK---KILRVFEDLIDCKRILREIA 104

Query: 169 -LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            L ++ H  +V++         +   +LY++L+                  E   +    
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT----- 277
            ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS         
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 278 -----------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPP 313
                            T ++      APE++L  + + +  D WS+G +  E+L     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 59/280 (21%), Positives = 110/280 (39%), Gaps = 26/280 (9%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKV 147
           EL       +   S   +         V+G+G FG V+     G   D+       A+K 
Sbjct: 10  ELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKS 60

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FF 204
           +            ++  E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 61  L-NRITDIGEVSQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                    +D   F   ++   + +L     VHRDL   N ++D    V + DFGLA++
Sbjct: 119 RNETHNPTVKDLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 265 IDESSRSNSMCGTTE------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
           + +     S+   T       +MA E L ++     +D WS G+LL+E++T G PP+   
Sbjct: 178 MYDKE-YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

Query: 318 NRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           N   +   ++   ++  P +     + ++    H     R
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 58/261 (22%), Positives = 127/261 (48%), Gaps = 27/261 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   +  + + +G G FG V   K KG  D       A+K++++ ++ +    ++ + E 
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYD------VAVKMIKEGSMSED---EFFQ-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
             + K++HP +V+  Y   ++   +Y++ ++I+ G L  +L          Q      ++
Sbjct: 55  QTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+      ++ A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLP-PF 336
           PE+     + K    +D W+ GIL++E+ + G+ P+  + N + + +  +++  +L  P 
Sbjct: 174 PEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--VSQGHRLYRPH 228

Query: 337 LTSEA-HSLLKGLLHKDPSKR 356
           L S+  + ++    H+ P KR
Sbjct: 229 LASDTIYQIMYSCWHELPEKR 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 63/322 (19%), Positives = 120/322 (37%), Gaps = 21/322 (6%)

Query: 49  QSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIG 108
             P  +    G   +    +  +                  +L   N   ++A     IG
Sbjct: 26  LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85

Query: 109 PGDFEI--FRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           P    +    V+G+G FG V+     G   D+       A+K +            ++  
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT- 139

Query: 165 ERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E  I+   +HP ++ L     ++     ++L ++  G L  F          +D   F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-G 198

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
            ++   +  L     VHRDL   N ++D    V + DFGLA+++ +    +    T    
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 334
             ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++   ++  P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318

Query: 335 PFLTSEAHSLLKGLLHKDPSKR 356
            +     + ++    H     R
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMR 340

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 38/234 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +E+ + +G+GA+G V++       D  +  + A+K   K     +N  D  +  R+I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSI-----DRRTGEVVAVK---KIFDAFQNSTDAQRTFREI 59

Query: 169 --LTK-VTHPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             LT+   H  IV L    +  +   +YL+ D++        + R  I      ++   +
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT------ 277
           ++  + +LH  G++HRD+KP NIL++++ HV + DFGL++      R  +          
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 278 ----------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
                     T+Y+      APEILL S  + K  D WS+G +L E+L G+P F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 60/306 (19%), Positives = 121/306 (39%), Gaps = 51/306 (16%)

Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           ++S  P      +     E E      +      + R +GQG+FG V++   KGV   + 
Sbjct: 1   MASVNPEYFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEP 54

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFIN 198
           +   A+K + +     +  ++++  E  ++ +     +V+L     ++ +   +I++ + 
Sbjct: 55  ETRVAIKTVNEAAS-MRERIEFLN-EASVMKEFNCHHVVRL-LGVVSQGQPTLVIMELMT 111

Query: 199 GGHL--FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILM 248
            G L  +    R  +         +         EI   +++L+    VHRDL   N ++
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171

Query: 249 DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDA 295
             D  V + DFG+ ++I E          T+Y             M+PE L        +
Sbjct: 172 AEDFTVKIGDFGMTRDIYE----------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221

Query: 296 DWWSVGILLYEMLT-GQPPF-THANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           D WS G++L+E+ T  + P+   +N Q    + +  + +K   P         L++    
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQ 278

Query: 351 KDPSKR 356
            +P  R
Sbjct: 279 YNPKMR 284

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.5 bits (245), Expect = 3e-22
 Identities = 67/358 (18%), Positives = 137/358 (38%), Gaps = 38/358 (10%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
             LK+      ++++       +    +   H  +   + ++    P+     S     P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
            P   + +S+         E   +        +   D E+    G G FG V     +GV
Sbjct: 308 MP---MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR----QGV 356

Query: 135 DDGDSDGIY-AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193
                  I  A+KV+++ T  K +  + M+ E  I+ ++ +P+IV+L         L L+
Sbjct: 357 YRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIVRL-IGVCQAEALMLV 413

Query: 194 LDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++   GG L   L  ++             ++   + +L +   VHR+L   N+L+ +  
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSV 300
           +  ++DFGL+K +            + Y             APE +  +  +  +D WS 
Sbjct: 474 YAKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525

Query: 301 GILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           G+ ++E L+ GQ P+      + +      ++++ PP    E ++L+          R
Sbjct: 526 GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAERDILTKVTH 174
            +G+G FG V+    KG  +       A+K +     I        +   E  ++ K  H
Sbjct: 38  KMGEGGFGVVY----KGYVNN---TTVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQH 89

Query: 175 PFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA------RFYTAE-IVS 226
             +V+L  +S        L+  ++  G L   L       +         R   A+   +
Sbjct: 90  ENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAAN 144

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAP 283
            ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++   ++ + GTT YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

Query: 284 EILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
           E L  +G     +D +S G++L E++TG P  
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLPAV 234

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 55/256 (21%), Positives = 115/256 (44%), Gaps = 17/256 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++       ++  E 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMSPD---AFLA-EA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F           ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSE 340
           PE +        +D WS GILL E++T G+ P+    N + +Q      ++  P     E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 341 AHSLLKGLLHKDPSKR 356
            + L++    + P  R
Sbjct: 239 LYQLMRLCWKERPEDR 254

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 55/264 (20%), Positives = 120/264 (45%), Gaps = 21/264 (7%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            +   +I     ++ + +G G FG+V+                A+K M+  ++  +    
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVE---A 229

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR 218
           ++  E +++  + H  +V+L ++  T+  +Y+I +F+  G L  F            +  
Sbjct: 230 FLA-EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCG 276
            ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGLA+ I+++          
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLP 334
             ++ APE +        +D WS GILL E++T G+ P+   +N + ++   +    ++P
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--LERGYRMP 405

Query: 335 -PFLTSEA-HSLLKGLLHKDPSKR 356
            P    E  ++++       P +R
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEER 429

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 60/257 (23%), Positives = 119/257 (46%), Gaps = 17/257 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 217 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 267

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 268 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--M 281
           I SA+ +L K   +HR+L   N L+  +  V + DFGL++ +   + +            
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTS 339
           APE L     +  +D W+ G+LL+E+ T G  P+      Q  +    + +++ P     
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 446

Query: 340 EAHSLLKGLLHKDPSKR 356
           + + L++     +PS R
Sbjct: 447 KVYELMRACWQWNPSDR 463

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 58/259 (22%), Positives = 113/259 (43%), Gaps = 27/259 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +     ++  E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EA 65

Query: 167 DILTKVTHPFIVQLRYSFQTRSK--LYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
            ++T++ H  +VQL        K  LY++ +++  G L  +     + +   D    ++ 
Sbjct: 66  SVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TE 279
           ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +             +
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVK 179

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFL 337
           + APE L  K  +  +D WS GILL+E+ + G+ P+     +  + +     K+  P   
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239

Query: 338 TSEAHSLLKGLLHKDPSKR 356
               + ++K   H D + R
Sbjct: 240 PPAVYEVMKNCWHLDAAMR 258

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 53/244 (21%), Positives = 105/244 (43%), Gaps = 40/244 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++ I  ++G+G++G V+        D +++   A+K   K   + ++ +D  +  R+I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAY-----DKNTEKNVAIK---KVNRMFEDLIDCKRILREI 76

Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             L ++   +I++L             +LY++L+      L           E+  +   
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---- 277
             ++   + +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+    +N +       
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 278 -------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
                        T ++      APE++L  + + K  D WS G +  E+L       + 
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 318 NRQK 321
              +
Sbjct: 256 PTNR 259

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 66/310 (21%), Positives = 108/310 (34%), Gaps = 59/310 (19%)

Query: 85  PLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYA 144
            + I   +   D + E               + +G GAFGKV +    G+   D+    A
Sbjct: 4   YVYIDPTQLPYDHKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K M K +         M  E  +L+ +  H  IV L     T      +I ++   G L
Sbjct: 58  VK-MLKPSAHLTEREALMS-ELKVLSYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDL 114

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                     F          ED               ++   ++ L     +HRDL   
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           NIL+       + DFGLA++I   S          Y            MAPE + +  + 
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 293 KDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLK 346
            ++D WS GI L+E+ +    P P    + +    +++         P    +E + ++K
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAEMYDIMK 282

Query: 347 GLLHKDPSKR 356
                DP KR
Sbjct: 283 TCWDADPLKR 292

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 61/257 (23%), Positives = 121/257 (47%), Gaps = 17/257 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 10  MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 61  AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYM 281
           I SA+ +L K   +HRDL   N L+  +  V + DFGL++ +   + +         ++ 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTS 339
           APE L     +  +D W+ G+LL+E+ T G  P+      Q  +    + +++ P     
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239

Query: 340 EAHSLLKGLLHKDPSKR 356
           + + L++     +PS R
Sbjct: 240 KVYELMRACWQWNPSDR 256

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 57/270 (21%), Positives = 105/270 (38%), Gaps = 39/270 (14%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            + +++G+G FG V +   K  D        A+K M+ D   ++   +++  E   +   
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLS-EAACMKDF 93

Query: 173 THPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           +HP +++L       S Q   K  +IL F+  G L  +L                    +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKF 152

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I   + +L     +HRDL   N ++  D  V + DFGL+K+I              Y
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---------YY 203

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 326
                       +A E L  + +   +D W+ G+ ++E+ T G  P+    N +     +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

Query: 327 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
              ++K P     E + ++      DP  R
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 54/255 (21%), Positives = 105/255 (41%), Gaps = 17/255 (6%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
              RV+G+G FG V+  +             A+K + + T   +    +++ E  ++  +
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRITE-MQQVEAFLR-EGLLMRGL 79

Query: 173 THPFIVQLRY--SFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            HP ++ L            +++L ++  G L  F    ++    +D   F   ++   +
Sbjct: 80  NHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
            +L +   VHRDL   N ++D    V + DFGLA++I +    +            + A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEA 341
           E L +      +D WS G+LL+E+LT G PP+                ++  P +     
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257

Query: 342 HSLLKGLLHKDPSKR 356
           + +++     DP+ R
Sbjct: 258 YQVMQQCWEADPAVR 272

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 36/220 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYM------K 163
           +F+   ++G G FGKV+    KGV  DG        KV      +K+   +        +
Sbjct: 40  NFDHKFLIGHGVFGKVY----KGVLRDG-------AKVA-----LKRRTPESSQGIEEFE 83

Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARF 219
            E + L+   HP +V L  +  + R+++ LI  ++  G+L  HLY   +       + R 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 220 YTAEIVSA--VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSM 274
               I +A  + +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++  S  +
Sbjct: 143 EIC-IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPP 313
            GT  Y+ PE  +  G   + +D +S G++L+E+L  +  
Sbjct: 202 KGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSA 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 69/316 (21%), Positives = 129/316 (40%), Gaps = 55/316 (17%)

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
           SP     S L   I E    N           I   D  +   +G+GAFGKVF  +   +
Sbjct: 10  SPTEGKGSGLQGHIIE----NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLI 193
                  + A+K +++ +  +    D+ + E ++LT + H  IV+  +   T  + L ++
Sbjct: 66  LPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHIVRF-FGVCTEGRPLLMV 121

Query: 194 LDFINGGHLFFHLYRQGIFREDQARFYT---------------AEIVSAVSHLHKCGIVH 238
            +++  G L   L   G   +  A                   +++ + + +L     VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEI 285
           RDL   N L+     V + DFG++++I            T+Y             M PE 
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPES 231

Query: 286 LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSE 340
           +L +    ++D WS G++L+E+ T   QP +  +N +    + Q    E+   P     E
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER---PRACPPE 288

Query: 341 AHSLLKGLLHKDPSKR 356
            +++++G   ++P +R
Sbjct: 289 VYAIMRGCWQREPQQR 304

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 51/318 (16%)

Query: 75  SPRYALSSSLPLQIQ--ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
            P+Y +   +    +       +  +L    + +    + +  + +G GAFGKV +    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-L 190
           G+   D+    A+K M K T         M  E  I++ +  H  IV L     T    +
Sbjct: 69  GLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIMSHLGQHENIVNL-LGACTHGGPV 125

Query: 191 YLILDFINGGHLFFHLYRQGIFREDQARFYT--------------AEIVSAVSHLHKCGI 236
            +I ++   G L   L R+    E    F                +++   ++ L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPE 284
           +HRD+   N+L+ +     + DFGLA++I   S          Y            MAPE
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAPE 236

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLT 338
            +    +   +D WS GILL+E+ +    P P    N +    ++      +   P F  
Sbjct: 237 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ---PAFAP 293

Query: 339 SEAHSLLKGLLHKDPSKR 356
              +S+++     +P+ R
Sbjct: 294 KNIYSIMQACWALEPTHR 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 63/235 (26%), Positives = 118/235 (50%), Gaps = 23/235 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F    ++G+G FGKV+    KG   DG    + A+K + K+   +   + + + E ++
Sbjct: 30  DNFSNKNILGRGGFGKVY----KGRLADGT---LVAVKRL-KEERTQGGELQF-QTEVEM 80

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARFYTAEIV 225
           ++   H  +++LR    T ++  L+  ++  G +   L  +   +       R   A + 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LG 139

Query: 226 SA--VSHLH-KCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTT 278
           SA  +++LH  C   I+HRD+K  NIL+D +   ++ DFGLAK +D      + ++ GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 332
            ++APE L + G  ++  D +  G++L E++TGQ  F  A        ++ + VK
Sbjct: 200 GHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 70/315 (22%), Positives = 124/315 (39%), Gaps = 63/315 (20%)

Query: 82  SSLPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
             LPL    + L ++   + E            ++ + +G+GAFG+V +    G+D   +
Sbjct: 4   DELPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY--SFQTRSKLYLILDF 196
               A+K M K+      H   M  E  IL  +  H  +V L      +    L +I++F
Sbjct: 57  CRTVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEF 113

Query: 197 INGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
              G+L                    LY+  +  E    + + ++   +  L     +HR
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHR 172

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILL 287
           DL   NIL+     V + DFGLA++I +           +Y            MAPE + 
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDP---------DYVRKGDARLPLKWMAPETIF 223

Query: 288 SKGHNKDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEA 341
            + +   +D WS G+LL+E+ +    P P    + +   +L++         P + T E 
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEM 280

Query: 342 HSLLKGLLHKDPSKR 356
           +  +    H +PS+R
Sbjct: 281 YQTMLDCWHGEPSQR 295

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 56/280 (20%), Positives = 113/280 (40%), Gaps = 41/280 (14%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +   +++ +D++ 
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM 82

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT- 221
            E  I++K  H  IV+       +S   +++++ + GG L   L R+   R  Q      
Sbjct: 83  -EALIISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139

Query: 222 -------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRS 271
                   +I     +L +   +HRD+   N L+   G      + DFG+A++I      
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---- 195

Query: 272 NSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
                   Y             M PE  +        D WS G+LL+E+ +    P  + 
Sbjct: 196 ------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +N++ L+      ++  P       + ++       P  R
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 70/331 (21%), Positives = 131/331 (39%), Gaps = 54/331 (16%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
               H+  H +  P+        +   + E E   D   E      +      + + +G+
Sbjct: 26  GYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGE 79

Query: 121 GAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFI 177
           GAFG+V   +  G+D    + +   A+K M K    +K+  D +  E +++  +  H  I
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLIS-EMEMMKMIGKHKNI 137

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARF 219
           + L     T+   LY+I+++ + G+L                   H   + +  +D    
Sbjct: 138 INL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              ++   + +L     +HRDL   N+L+  D  + + DFGLA++I              
Sbjct: 197 -AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------Y 246

Query: 280 Y------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQR 325
           Y            MAPE L  + +   +D WS G+LL+E+ T  G P       +  +  
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 326 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
               ++  P   T+E + +++   H  PS+R
Sbjct: 307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 72/324 (22%), Positives = 135/324 (41%), Gaps = 60/324 (18%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
           +G S  +   S  P+     E+E   + + E  R        + + +G+GAFG+V   + 
Sbjct: 1   MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRD----KLTLGKPLGEGAFGQVVMAEA 56

Query: 132 KGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187
            G+D        A+ V   M KD   +K+  D +  E +++  +  H  I+ L     T+
Sbjct: 57  VGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNIINL-LGACTQ 112

Query: 188 SK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVS 229
              LY+I+++ + G+L                    +  + +  +D     T ++   + 
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC-TYQLARGME 171

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--------- 280
           +L     +HRDL   N+L+  +  + + DFGLA++I+             Y         
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLP 222

Query: 281 ---MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVK 332
              MAPE L  + +   +D WS G+L++E+ T  G P       +    L++    +K  
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-- 280

Query: 333 LPPFLTSEAHSLLKGLLHKDPSKR 356
            P   T+E + +++   H  PS+R
Sbjct: 281 -PANCTNELYMMMRDCWHAVPSQR 303

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 52/288 (18%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            + I   D  + R +G+GAFGKVF  +   +       + A+K ++  T       D+ +
Sbjct: 9   VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQR 66

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------FFHLYRQGIFR 213
            E ++LT + H  IV+  Y        L ++ +++  G L            +   G  R
Sbjct: 67  -EAELLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 214 EDQARFYT-------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
           + +            ++I S + +L     VHRDL   N L+ ++  V + DFG+++++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 267 ESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQ 311
                      T+Y             M PE ++ +    ++D WS G++L+E+ T   Q
Sbjct: 185 S----------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 312 PPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           P F  +N +    + Q  + E+   P     E + ++ G   ++P +R
Sbjct: 235 PWFQLSNTEVIECITQGRVLER---PRVCPKEVYDVMLGCWQREPQQR 279

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 56/260 (21%), Positives = 115/260 (44%), Gaps = 28/260 (10%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++ + +    G   R      +   +   +    +         +   + ++ + +G+
Sbjct: 150 MQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA------LNMKELKLLQTIGK 203

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG V     +G          A+K ++ D   +     ++  E  ++T++ H  +VQL
Sbjct: 204 GEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EASVMTQLRHSNLVQL 251

Query: 181 RY--SFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCG 235
                 + +  LY++ +++  G L  +L    R  +  +   +F + ++  A+ +L    
Sbjct: 252 -LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNN 309

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
            VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++ APE L  K  +  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 367

Query: 296 DWWSVGILLYEMLT-GQPPF 314
           D WS GILL+E+ + G+ P+
Sbjct: 368 DVWSFGILLWEIYSFGRVPY 387

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 75/351 (21%), Positives = 139/351 (39%), Gaps = 69/351 (19%)

Query: 45  RHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESE 104
           +    + +S+S +   P V      S    +P  A  S       E E   D + E    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-------EYELPEDPKWE---- 77

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDY 161
                    + + +G+G FG+V   +  G+D        A+ V   M KD   +K+  D 
Sbjct: 78  --FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDL 133

Query: 162 MKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----------------- 202
           +  E +++  +  H  I+ L     T+   LY+I+++ + G+L                 
Sbjct: 134 VS-EMEMMKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
              +  + +  +D     T ++   + +L     +HRDL   N+L+  +  + + DFGLA
Sbjct: 192 INRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 263 KEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT- 309
           ++I+             Y            MAPE L  + +   +D WS G+L++E+ T 
Sbjct: 251 RDINNID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301

Query: 310 -GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
            G P       +    L++    +K   P   T+E + +++   H  PS+R
Sbjct: 302 GGSPYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQR 349

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 57/283 (20%), Positives = 115/283 (40%), Gaps = 47/283 (16%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          +G+  FGKV++    G   G+     A+K ++          ++   E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRH-EA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT---- 221
            +  ++ HP +V L     T+ + L +I  + + G L   L  +    +  +        
Sbjct: 64  MLRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 222 ------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
                       A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 270 RSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFT 315
                     Y            MAPE ++    + D+D WS G++L+E+ +   QP   
Sbjct: 183 ---------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233

Query: 316 HANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
           ++N+  ++   I  +  L  P    +  ++L+    ++ PS+R
Sbjct: 234 YSNQDVVEM--IRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 57/290 (19%), Positives = 113/290 (38%), Gaps = 41/290 (14%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
                      +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +  
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVC 113

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIF 212
            +++ +D++  E  I++K  H  IV+       +S   +++L+ + GG L   L R+   
Sbjct: 114 SEQDELDFLM-EALIISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFL-RETRP 170

Query: 213 REDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL 261
           R  Q              +I     +L +   +HRD+   N L+   G      + DFG+
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

Query: 262 AKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEML 308
           A++I              Y             M PE  +        D WS G+LL+E+ 
Sbjct: 231 ARDIYR----------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

Query: 309 T--GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
           +    P  + +N++ L+      ++  P       + ++       P  R
Sbjct: 281 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 72/310 (23%), Positives = 118/310 (38%), Gaps = 58/310 (18%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K M 
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-ML 83

Query: 150 KDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----- 202
           K+          M  E  ++T++ +H  IV L     T S  +YLI ++   G L     
Sbjct: 84  KEKADSSEREALMS-ELKMMTQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                       +  ++ +  E+     T         ++   +  L     VHRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           N+L+     V + DFGLA++I   S          Y            MAPE L    + 
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYT 252

Query: 293 KDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLK 346
             +D WS GILL+E+ +    P P    +      +Q     ++   P + T E + +++
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQ 309

Query: 347 GLLHKDPSKR 356
                D  KR
Sbjct: 310 SCWAFDSRKR 319

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 61/312 (19%), Positives = 102/312 (32%), Gaps = 101/312 (32%)

Query: 85  PLQIQELEHENDAELEAESERKIG------PGD-----FEIFRVVGQGAFGKVFQVKKKG 133
           P Q +E+   +D E E  ++   G       GD     + + R +G G F  V+      
Sbjct: 1   PEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW--- 57

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THP---FIVQLRYSFQ 185
             D       AMKV++      +++ +    E  +L  V       P    +VQL   F+
Sbjct: 58  --DIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111

Query: 186 TRSKLYLILDFINGGHL-------------FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
                       NG H+             +              +    +++  + +LH
Sbjct: 112 ISGV--------NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 233 -KCGIVHRDLKPENILM------------------------------------------- 248
            KC I+H D+KPENIL+                                           
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223

Query: 249 ------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                      V + D G A  + +    +    T +Y + E+L+  G+N  AD WS   
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYRSLEVLIGSGYNTPADIWSTAC 281

Query: 303 LLYEMLTGQPPF 314
           + +E+ TG   F
Sbjct: 282 MAFELATGDYLF 293

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 59/306 (19%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
            +  ++  + + +    +  + + +G+G FGKV +     +         A+K M K+  
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENA 65

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------- 202
                 D +  E ++L +V HP +++L Y   ++   L LI+++   G L          
Sbjct: 66  SPSELRDLLS-EFNVLKQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 203 ---------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                            H   + +   D   F   +I   + +L +  +VHRDL   NIL
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDA 295
           +     + ++DFGL++++ E            Y            MA E L    +   +
Sbjct: 183 VAEGRKMKISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQS 233

Query: 296 DWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           D WS G+LL+E++T  G P       +    L+     E+   P   + E + L+     
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWK 290

Query: 351 KDPSKR 356
           ++P KR
Sbjct: 291 QEPDKR 296

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 66/326 (20%), Positives = 125/326 (38%), Gaps = 72/326 (22%)

Query: 74  PSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG 133
           P+P Y     L L  + L  E                + E  R +G+GAFG+VFQ +  G
Sbjct: 24  PNPMYQ-RMPLLLNPKLLSLE------------YPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYL 192
           +   +   + A+K M K+        D+ + E  ++ +  +P IV+L        K + L
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKL-LGVCAVGKPMCL 127

Query: 193 ILDFINGGHL----------------FFHLYRQGIFREDQARFYT--------AEIVSAV 228
           + +++  G L                   L  +           +         ++ + +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------- 280
           ++L +   VHRDL   N L+  +  V + DFGL++ I             +Y        
Sbjct: 188 AYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----------ADYYKADGNDA 237

Query: 281 -----MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEK 330
                M PE +    +  ++D W+ G++L+E+ +   QP +  A+ +    ++   I   
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 297

Query: 331 VKLPPFLTSEAHSLLKGLLHKDPSKR 356
              P     E ++L++    K P+ R
Sbjct: 298 ---PENCPLELYNLMRLCWSKLPADR 320

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 49/265 (18%), Positives = 101/265 (38%), Gaps = 38/265 (14%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G   +++ R +G+G+FG +F+       +  ++   A+K   + +      +   
Sbjct: 4   QNNVVG-VHYKVGRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRS--DAPQLRD- 54

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E      +     I  + Y  Q      L++D +  +   L     R+  F       
Sbjct: 55  --EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAM 110

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-IDESSRS-- 271
              ++++ V  +H+  +V+RD+KP+N L+          + + DFG+ K   D  ++   
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

Query: 272 -----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQ 323
                 ++ GT  YM+    L +  ++  D  ++G +    L G  P      A  ++  
Sbjct: 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230

Query: 324 QRIINEKVKLPPFLTSEAHSLLKGL 348
           +RI  +K   P         L  G 
Sbjct: 231 ERIGEKKQSTPL------RELCAGF 249

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 60/307 (19%)

Query: 88  IQELEHENDAELEAESERK--IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-A 144
           +++  H +  +   +      +   D +   V+G+G FG+V     K     D   +  A
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRMDAA 56

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K   K+   K +H D+   E ++L K+  HP I+ L          LYL +++   G+L
Sbjct: 57  IK-RMKEYASKDDHRDFAG-ELEVLCKLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNL 113

Query: 203 FFHLYRQGIFREDQARFYT----------------AEIVSAVSHLHKCGIVHRDLKPENI 246
              L +  +   D A                    A++   + +L +   +HRDL   NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKD 294
           L+  +    + DFGL++  +             Y            MA E L    +  +
Sbjct: 174 LVGENYVAKIADFGLSRGQE------------VYVKKTMGRLPVRWMAIESLNYSVYTTN 221

Query: 295 ADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLL 349
           +D WS G+LL+E+++  G P       +   KL Q    EK   P     E + L++   
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK---PLNCDDEVYDLMRQCW 278

Query: 350 HKDPSKR 356
            + P +R
Sbjct: 279 REKPYER 285

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 55/272 (20%), Positives = 106/272 (38%), Gaps = 52/272 (19%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  +F + + +G G FG++   K     +  ++   A+K+        K+    +
Sbjct: 3   GVLMVG-PNFRVGKKIGCGNFGELRLGK-----NLYTNEYVAIKLEPM-----KSRAPQL 51

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E     ++     I Q+ Y         ++L+ +  +   LF    R          F
Sbjct: 52  HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR---------TF 102

Query: 220 --YTA-----EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-ID 266
              T      +++S + ++H   +++RD+KPEN L+   G+     + + DF LAKE ID
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162

Query: 267 ESSRS-------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--- 316
             ++         S+ GT  YM+    L K  ++  D  ++G +    L G  P+     
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222

Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
              ++  Q+I + K   P         L +  
Sbjct: 223 DTLKERYQKIGDTKRATPI------EVLCENF 248

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 36/262 (13%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++        D  +    A+K+    T  K   +    
Sbjct: 4   ELRVG-NRYRLGRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKT--KHPQLHI-- 53

Query: 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         ++++ +  +   LF    R+  F        
Sbjct: 54  -ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLL 110

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  D  +       
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQQRI 326
              ++ GT  Y +    L    ++  D  S+G +L     G  P      A +++  +RI
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

Query: 327 INEKVKLPPFLTSEAHSLLKGL 348
             +K+  P         L KG 
Sbjct: 231 SEKKMSTPI------EVLCKGY 246

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 36/262 (13%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   F + R +G G+FG+++        +  ++   A+K+    T  K   + Y  
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKT--KHPQLLY-- 51

Query: 164 AERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         L++D +  +   LF    R+           
Sbjct: 52  -ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             ++++ V  +H    +HRD+KP+N LM        V + DFGLAK+  D S+       
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRI 326
              ++ GT  Y +    L    ++  D  S+G +L   L G  P+       +++  ++I
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

Query: 327 INEKVKLPPFLTSEAHSLLKGL 348
             +KV           +L +G 
Sbjct: 229 SEKKVATSI------EALCRGY 244

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 46/259 (17%), Positives = 92/259 (35%), Gaps = 40/259 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDY 161
             +++   +GQG FG ++       +   SD    +KV   D           ++     
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 162 MKAERDILTKVTHPFIVQLRYS----FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              +     K+ +  + +   S       +S  ++I+D   G  L      Q I+  +  
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAK 147

Query: 218 RF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAK----- 263
           RF        +  I+  + ++H+   VH D+K  N+L++  +   V L D+GLA      
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 264 ----EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                     +     GT E+ + +       ++  D   +G  + + LTG  P+    +
Sbjct: 208 GVHKAYAADPKR-CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266

Query: 320 QKLQQRI--INEKVKLPPF 336
                R   I  +  +   
Sbjct: 267 DPKYVRDSKIRYRENIASL 285

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 41/252 (16%), Positives = 86/252 (34%), Gaps = 26/252 (10%)

Query: 112 FEIFRVVGQGAFGKVF---QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD- 167
           +++     +   G ++          D G     +++K+  KD  +      + +A +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 168 ------ILTKVTHPFIVQLRYSFQTRSKL-YLILDFINGGHL--FFHLYRQGIFREDQAR 218
                  L       I         + K  +L+L  + G  L     +  + +  E    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKE-IDESS------ 269
                ++ A+  LH+   VH ++  ENI +D +    V L  +G A              
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-- 326
              +   G  E+++ ++    G ++ +D  S+G  + + L G  P+T+            
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK 282

Query: 327 INEKVKLPPFLT 338
                K  PF+ 
Sbjct: 283 QKFVDKPGPFVG 294

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 44/300 (14%), Positives = 103/300 (34%), Gaps = 47/300 (15%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+ S   +G    Y  S   P              E +    +    + + + +G G FG
Sbjct: 6   HHSSGVDLGTENLYFQSMPFP--------------EGKVLDDMEGNQWVLGKKIGSGGFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDYMKAERDILTKVTHPF 176
            ++       +  + D  + +KV  ++           ++        +     ++ +  
Sbjct: 52  LIYLAFP--TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109

Query: 177 IVQLRYS--FQTRSKLY--LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           I     S   + + + Y  ++++ + G  L     + G F++         ++  + ++H
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH 168

Query: 233 KCGIVHRDLKPENILMD--SDGHVMLTDFGLAK---------EIDESSRSNSMCGTTEYM 281
           +   VH D+K  N+L+   +   V L D+GL+          +  E+ R     GT E+ 
Sbjct: 169 ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR-KGHNGTIEFT 227

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPP------FTHANRQKLQQRIINEKVKLPP 335
           + +       ++ +D   +G  +   L G+ P         A +      +      +  
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLK 287

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.0 bits (165), Expect = 8e-13
 Identities = 32/202 (15%), Positives = 59/202 (29%), Gaps = 55/202 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
             +    +G+G FG+VFQ               A+K++  +     N   + K   +IL 
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVN-GSHQKTFEEILP 72

Query: 171 KVT---------------HP--------FIVQLRY----------------------SFQ 185
           ++                            VQ  Y                       F 
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE 244
              +L+++L+F  GG       R  +     A+    ++ ++++         HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 245 NILMDSDGHVMLTDFGLAKEID 266
           N+L+       L      K   
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 25/168 (14%)

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
             LY+  +  E    + + ++   +  L     +HRDL   NIL+     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 264 EIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT-- 309
           +I +           +Y            MAPE +  + +   +D WS G+LL+E+ +  
Sbjct: 242 DIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 310 GQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
             P P    + +  ++     +++ P + T E +  +    H +PS+R
Sbjct: 293 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 38/190 (20%), Positives = 69/190 (36%), Gaps = 16/190 (8%)

Query: 109 PGDFEIFR-------VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
              +E  R        +G+GAFG+V +    G+D   +    A+K M K+      H   
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRAL 72

Query: 162 MKAERDILTKV-THPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           M  E  IL  +  H  +V  L    +    L +I++F   G+L  +L      + ++   
Sbjct: 73  MS-ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVP 127

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-T 278
           Y  +           G +  DLK     + S      + F   K + +     +      
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 279 EYMAPEILLS 288
           +++  E L+ 
Sbjct: 188 DFLTLEHLIC 197

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 2e-08
 Identities = 54/388 (13%), Positives = 110/388 (28%), Gaps = 101/388 (26%)

Query: 30  PDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQ 89
            ++ F      ++P +   + P+  +    +     +R ++      +Y +S        
Sbjct: 89  INYKFL-----MSPIKTEQRQPSMMTRMYIEQ---RDRLYNDNQVFAKYNVSR--LQPYL 138

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGK---VFQV-KKKGVDDGDSDGIYAM 145
           +L     A LE    + +         + G    GK      V     V       I+ +
Sbjct: 139 KLR---QALLELRPAKNVL--------IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 146 KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            +   ++         ++  + +L ++   +  +  +S   + +++ I   +    L   
Sbjct: 188 NLKNCNS-----PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKS 240

Query: 206 -LYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGL 261
             Y     +          A+  +A +    C           IL+ +    V  TDF  
Sbjct: 241 KPYENCLLVLLN----VQNAKAWNAFN--LSC----------KILLTTRFKQV--TDFLS 282

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP--------- 312
           A      S  +     T      +LL     +  D      L  E+LT  P         
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD------LPREVLTTNPRRLSIIAES 336

Query: 313 ---------PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKD---PSKRLGS 359
                     + H N  KL   II   +  L P    +    L  +       P+  L  
Sbjct: 337 IRDGLATWDNWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRL-SVFPPSAHIPTILL-- 392

Query: 360 GPGGVDAIKHHKWFRSINWKTLEAREMQ 387
                          S+ W  +   ++ 
Sbjct: 393 ---------------SLIWFDVIKSDVM 405

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 2/45 (4%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
           +I   V  LHK  ++H DL   N + D D  + + DFGL K  + 
Sbjct: 439 KIGEIVGKLHKNDVIHNDLTTSNFIFDKD--LYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	441
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.31
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.71
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.21
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.07
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.65
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.02
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.33
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	82.19
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.05

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.5e-73  Score=544.81  Aligned_cols=283  Identities=51%  Similarity=0.949  Sum_probs=253.8

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|+++++||+|+||+||+|++...  ..+++.||||++.+....... ...+.+|+.+|++++|||||+++++|++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4456899999999999999999997542  237889999999876543322 2357789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ++.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998653


Q ss_pred             -CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          267 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       267 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                       ......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|....+.+|..+|+++++||
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence             3344567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      ++||++||++||++...+++|+++||||++++|+.+..++++|||+|
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            99999999999988777899999999999999999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-72  Score=537.73  Aligned_cols=275  Identities=39%  Similarity=0.741  Sum_probs=252.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++|++++|||||+++++|++++
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3579999999999999999999986     88999999999887766777788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|||||+||+|.+++.+.+.++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999986432


Q ss_pred             ---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          269 ---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                         ....+.|||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++++|....+.+|..+++++++||
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence               33567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCC
Q 013558          346 KGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKF  390 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~  390 (441)
                      .+||++||++||++.. ....+|++||||++++|+.+.++  +||.
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~--~pP~  309 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPK  309 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC--CCCC
Confidence            9999999999995422 12345799999999999999654  3543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5e-72  Score=582.91  Aligned_cols=330  Identities=32%  Similarity=0.633  Sum_probs=285.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHH---HHHHHhcCCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~l~  181 (441)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++.+..+........+.+|   +.+++.++|||||+++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~-----tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            35778899999999999999999999986     899999999998776555555555555   4555667899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++|++.+.+|||||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhc-CCCCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccccCCCCC
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~~~~~~p~~~  337 (441)
                      |+.+... ...+.|||+.|||||++. +..|+.++|||||||+||||++|.+||.+.   +..++...+....+.+|..+
T Consensus       339 A~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~  417 (689)
T 3v5w_A          339 ACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  417 (689)
T ss_dssp             CEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             eeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence            9987554 356789999999999997 468999999999999999999999999753   45567788888899999999


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA  417 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  417 (441)
                      |+++++||.+||++||.+|+++...++++|++||||++++|+.+..+++.|||+|.....++..+||....+........
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~~~~  497 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIK  497 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC---------CCCC
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccCCCC
Confidence            99999999999999999999987778999999999999999999999999999999888877777764322211111122


Q ss_pred             CCCCCCCcccCeeeeCCCccccC
Q 013558          418 PTPTAGEHFKGYTYVAPNPWLSS  440 (441)
Q Consensus       418 ~~~~~~~~f~~~~~~~~~~~~~~  440 (441)
                      ..+.+++.|++|+|..+..|++.
T Consensus       498 ~~~~d~~~f~~Fs~~~~~~~q~e  520 (689)
T 3v5w_A          498 LLDSDQELYRNFPLTISERWQQE  520 (689)
T ss_dssp             CCHHHHTTTTTCCEECHHHHHHH
T ss_pred             CCchHHHHHhCCCccCccchhhh
Confidence            23346789999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-67  Score=497.75  Aligned_cols=255  Identities=31%  Similarity=0.590  Sum_probs=220.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||+++++|.+++
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTT-----TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTT-----TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            3689999999999999999999876     88999999998876666666778999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999999999 6799999999999999999999999999999999999999999999999999999999999999987766


Q ss_pred             CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      ....+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+..++.+++....+.+|..+++++++||.+
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  245 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR  245 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            66677899999999999998876 57999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ||++||++||     +++|+++||||+
T Consensus       246 ~L~~dP~~R~-----s~~eil~hpw~k  267 (275)
T 3hyh_A          246 MLIVNPLNRI-----SIHEIMQDDWFK  267 (275)
T ss_dssp             HSCSSGGGSC-----CHHHHHHCHHHH
T ss_pred             HccCChhHCc-----CHHHHHcCcccc
Confidence            9999999999     899999999996

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.8e-66  Score=507.31  Aligned_cols=323  Identities=40%  Similarity=0.807  Sum_probs=291.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            445789999999999999999999876     789999999988766566667788899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-  265 (441)
                      .+.+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. 
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999999999999999899999999999999999999999999999999999999999999999999999864 


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..+++++++||
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            33344567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC------
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT------  419 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  419 (441)
                      .+||++||.+||++++.+++++++||||++++|..+..+++.|||+|...+..+..+||..++..+...++...      
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~  316 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGL  316 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------------
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccc
Confidence            99999999999998878999999999999999999999999999999999999999999887765443332211      


Q ss_pred             -C----CCCCcccCeeeeCC
Q 013558          420 -P----TAGEHFKGYTYVAP  434 (441)
Q Consensus       420 -~----~~~~~f~~~~~~~~  434 (441)
                       .    ..+..|.||+|+++
T Consensus       317 ~~~~~~~~~~~f~~f~~~~~  336 (337)
T 1o6l_A          317 LELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------CCTTTTCCEECC
T ss_pred             cccccccccccCCCceecCC
Confidence             0    14589999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-66  Score=518.12  Aligned_cols=326  Identities=39%  Similarity=0.821  Sum_probs=287.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|..+|.++ +||||++++++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            34566789999999999999999999986     7899999999987666666666788999999887 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      |.+.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             c-cCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhccccC
Q 013558          264 E-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKL  333 (441)
Q Consensus       264 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---------~~~~~~~~i~~~~~~~  333 (441)
                      . ..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...         ....+.+.+....+.+
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  281 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  281 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred             ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence            6 33444566789999999999999999999999999999999999999999632         3455778888889999


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCC
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA  412 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~  412 (441)
                      |..+++++++||++||++||.+||++.+ .++++|++||||++++|+.+..+++.|||+|.+.+..++.+||..++..+.
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~  361 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV  361 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCC
Confidence            9999999999999999999999998642 257999999999999999999999999999999999999999999888766


Q ss_pred             CCCCCCC----CCCCCcccCeeeeCCC
Q 013558          413 DDSPAPT----PTAGEHFKGYTYVAPN  435 (441)
Q Consensus       413 ~~~~~~~----~~~~~~f~~~~~~~~~  435 (441)
                      ..++...    ...+..|.||+|+++.
T Consensus       362 ~~~~~~~~~~~~~~~~~f~~f~~~~~~  388 (396)
T 4dc2_A          362 QLTPDDDDIVRKIDQSEFEGFEYINPL  388 (396)
T ss_dssp             CCCCCCHHHHTTSCGGGGTTCCEECC-
T ss_pred             ccCCCcchhhccccccccCCcEeECcc
Confidence            5554321    2346789999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.4e-66  Score=508.91  Aligned_cols=324  Identities=40%  Similarity=0.796  Sum_probs=285.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.+ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKE-----TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcC-----CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            3556799999999999999999999886     7899999999987666666778888999999998 699999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      .. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|......+|..+++++++
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  253 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG  253 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            43 33345567999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCCC-CCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCC--
Q 013558          344 LLKGLLHKDPSKRLGSG-PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--  420 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~-~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  420 (441)
                      ||++||++||.+||++. ..++++|++||||++++|..+..++++|||+|...+..+..+||..++..+...++....  
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~  333 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHL  333 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSG
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCcccccc
Confidence            99999999999999652 235599999999999999999999999999999999999999999887765544443221  


Q ss_pred             --CCCCcccCeeeeCC
Q 013558          421 --TAGEHFKGYTYVAP  434 (441)
Q Consensus       421 --~~~~~f~~~~~~~~  434 (441)
                        ..+..|.||+|+++
T Consensus       334 ~~~~~~~f~~f~~~~~  349 (353)
T 3txo_A          334 PMINQDEFRNFEYVSP  349 (353)
T ss_dssp             GGSCGGGGTTCCEECC
T ss_pred             CcccccccCCceeeCc
Confidence              23578999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.5e-66  Score=507.53  Aligned_cols=326  Identities=39%  Similarity=0.794  Sum_probs=291.5

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+..|..+|..+ +||||+++++++
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            4567899999999999999999999886     7889999999987665666677888999999988 799999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      .. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|......+|..+++++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            43 33345678999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCC---
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---  420 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  420 (441)
                      ||.+||++||.+||++...++++|++||||++++|+.+..++++|||+|...+. +..+||..++..+...++....   
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~~~~~~  329 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIR  329 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCCHHHHH
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCccccccc
Confidence            999999999999999877789999999999999999999999999999999888 8899998776655444332211   


Q ss_pred             -CCCCcccCeeeeCCCcc
Q 013558          421 -TAGEHFKGYTYVAPNPW  437 (441)
Q Consensus       421 -~~~~~f~~~~~~~~~~~  437 (441)
                       ..+..|.||+|+++..+
T Consensus       330 ~~~~~~f~~f~~~~~~~~  347 (353)
T 2i0e_A          330 NIDQSEFEGFSFVNSEFL  347 (353)
T ss_dssp             HSCTTTTCSCCEECTTCC
T ss_pred             cccccccCCCeeeCcccc
Confidence             35678999999997654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.2e-66  Score=503.22  Aligned_cols=253  Identities=26%  Similarity=0.467  Sum_probs=230.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|+++++||+|+||+||+|+++.     +++.||||++.+....   ..+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC-----CCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999986     8899999999865432   23457889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... 
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999999999998865 67999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---cCCCCCcHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLL  345 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li  345 (441)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|.....   ..+..+++++++||
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            345678999999999999999999999999999999999999999999999999888876532   33456899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+||++||++||     +++|+++||||+..
T Consensus       305 ~~~L~~dP~~R~-----ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          305 DRLLVRDPAQRA-----TAAELLKHPFLAKA  330 (346)
T ss_dssp             HHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHcCCChhHCc-----CHHHHhcCHhhcCC
Confidence            999999999999     89999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-65  Score=511.50  Aligned_cols=253  Identities=26%  Similarity=0.472  Sum_probs=230.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|+++++||+|+||+||+|+++.     +++.||||++.+....   ..+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  222 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC-----CCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence            569999999999999999999986     8899999999865432   23457899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... 
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999999999998865 57999999999999999999999999999999999999999999999999999986543 


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLL  345 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li  345 (441)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|....   ...+..+++++++||
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            34567899999999999999999999999999999999999999999999999988887653   334567999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+||++||++||     +++|+++||||+..
T Consensus       382 ~~~L~~dP~~R~-----ta~ell~Hp~~~~~  407 (423)
T 4fie_A          382 DRLLVRDPAQRA-----TAAELLKHPFLAKA  407 (423)
T ss_dssp             HHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHcCCChhHCc-----CHHHHhcCHHhcCC
Confidence            999999999999     89999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.4e-66  Score=504.50  Aligned_cols=256  Identities=30%  Similarity=0.539  Sum_probs=228.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.... ....+.+.+|+++|++++|||||+++++|++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTE-----DGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETT-----TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4689999999999999999999986     8899999999876543 345677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      .+|||||||+||+|.+++...  ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999999999765  357999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCCCcHHHHHH
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL  344 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l  344 (441)
                      ... ...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.+|..+.+ .++..+++++++|
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            322 23457899999999999999999999999999999999999999999999999999988765 4667899999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |.+||++||++||     +++|+++||||+.
T Consensus       257 i~~~L~~dP~~R~-----s~~e~l~hp~~~~  282 (350)
T 4b9d_A          257 VSQLFKRNPRDRP-----SVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHTSHHHHT
T ss_pred             HHHHccCChhHCc-----CHHHHhcCHHhhc
Confidence            9999999999999     8999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-64  Score=502.97  Aligned_cols=322  Identities=46%  Similarity=0.854  Sum_probs=253.3

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHH-HHhcCCCCceeeeEEEEe
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~  186 (441)
                      ..++|+++++||+|+||+||+|+++.     +++.||||++.+...........+..|..+ ++.++||||++++++|.+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETT-----TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            44689999999999999999999886     788999999998776555566667778777 577899999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc-
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~-  265 (441)
                      .+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.. 
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999999999999899999999999999999999999999999999999999999999999999999863 


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++.++|......+++.++.++++||
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            33445667899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC------
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT------  419 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  419 (441)
                      .+||++||.+||++. ..++++++||||++++|+.+..+++.|||+|...+..+..+||..++..+...+....      
T Consensus       271 ~~lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~  349 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLV  349 (373)
T ss_dssp             HHHTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-----------------------------
T ss_pred             HHHcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCcccccc
Confidence            999999999999874 4689999999999999999999999999999999999999999888776543222111      


Q ss_pred             ----CCCCCcccCeeeeCCC
Q 013558          420 ----PTAGEHFKGYTYVAPN  435 (441)
Q Consensus       420 ----~~~~~~f~~~~~~~~~  435 (441)
                          ......|.||+|+++.
T Consensus       350 ~~~~~~~~~~f~~f~~~~~~  369 (373)
T 2r5t_A          350 TASVKEAAEAFLGFSYAPPT  369 (373)
T ss_dssp             --------------------
T ss_pred             ccccccccccCCCCcccCch
Confidence                1235679999998864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.5e-64  Score=495.91  Aligned_cols=319  Identities=38%  Similarity=0.748  Sum_probs=260.4

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .+..++|++.++||+|+||+||+|+++.     +++.||||++.+.........+.+..|..+|+.+ +||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            4567899999999999999999999986     7899999999887655556667788899999987 899999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      .. ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+......+|..+++++++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            43 23345678999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChH-HhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC---
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVD-AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  419 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~-~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  419 (441)
                      ||.+||+.||.+||     ++. +|++||||++++|+.+..+++.|||+|...+..+..+||..++......++...   
T Consensus       248 li~~lL~~dp~~R~-----~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~  322 (345)
T 1xjd_A          248 LLVKLFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALI  322 (345)
T ss_dssp             HHHHHSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC----------------------------------
T ss_pred             HHHHHhcCCHhHcC-----CChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCccccccc
Confidence            99999999999999     445 999999999999999999999999999999999999999888765443332211   


Q ss_pred             -CCCCCcccCeeeeCC
Q 013558          420 -PTAGEHFKGYTYVAP  434 (441)
Q Consensus       420 -~~~~~~f~~~~~~~~  434 (441)
                       ...+..|.||+|+++
T Consensus       323 ~~~~~~~f~~f~~~~~  338 (345)
T 1xjd_A          323 NSMDQNMFRNFSFMNP  338 (345)
T ss_dssp             ----CCTTTTCCC---
T ss_pred             ccccccccCCCeeeCh
Confidence             135678999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.9e-64  Score=491.92  Aligned_cols=323  Identities=39%  Similarity=0.824  Sum_probs=286.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  185 (441)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+++ +||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            455789999999999999999999886     7899999999987766666778889999999988 8999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +...+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999999863


Q ss_pred             -CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHhccccCCC
Q 013558          266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLPP  335 (441)
Q Consensus       266 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~---------~~~~~~~~~i~~~~~~~p~  335 (441)
                       .........+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|.
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  240 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  240 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence             333445678999999999999999999999999999999999999999975         3455677888888889999


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD  414 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~  414 (441)
                      .++.++++||.+||++||.+||++.+ .+++++++||||++++|+.+..+++.|||+|...+..+..+|+..++..+...
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~  320 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQL  320 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccC
Confidence            99999999999999999999997632 24799999999999999999999999999999999999999998776655433


Q ss_pred             CCCCC----CCCCCcccCeeeeCC
Q 013558          415 SPAPT----PTAGEHFKGYTYVAP  434 (441)
Q Consensus       415 ~~~~~----~~~~~~f~~~~~~~~  434 (441)
                      ++...    ...+..|.||+|+++
T Consensus       321 ~~~~~~~~~~~~~~~f~~f~~~~~  344 (345)
T 3a8x_A          321 TPDDDDIVRKIDQSEFEGFEYINP  344 (345)
T ss_dssp             CCCCHHHHTTSCGGGGTTCCEECC
T ss_pred             CCccccccccccccccCCCEeeCC
Confidence            33221    134678999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.4e-64  Score=503.50  Aligned_cols=328  Identities=35%  Similarity=0.669  Sum_probs=281.9

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++||||+++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC-----CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456778899999999999999999999986     78999999998866555555566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +|.+...+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999999998865 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC--CCccccCCCCCCCcchhcCCC----CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCC
Q 013558          263 KEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  334 (441)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p  334 (441)
                      +......  ...+.+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.+.+..++..+|....  +.+|
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            8765443  234678999999999998765    7899999999999999999999999999999999998753  4555


Q ss_pred             C--CCcHHHHHHHHHhcccCcCC--CCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCC
Q 013558          335 P--FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  410 (441)
Q Consensus       335 ~--~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~  410 (441)
                      .  .+++++++||++||+.+|.+  |+     ++++|++||||++++|..+..+++.|||+|.+.+..+.++||......
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~-----~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~  370 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRN-----GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDK  370 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSS-----CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCC
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCC-----CHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccc
Confidence            4  69999999999999988877  77     899999999999999999999999999999999999999999876554


Q ss_pred             CCCCC-CCC--CCCCCCcccCeeeeCCCccccCC
Q 013558          411 PADDS-PAP--TPTAGEHFKGYTYVAPNPWLSSV  441 (441)
Q Consensus       411 ~~~~~-~~~--~~~~~~~f~~~~~~~~~~~~~~~  441 (441)
                      ..... +.+  ....+..|.||+|++++.|++++
T Consensus       371 ~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~  404 (410)
T 3v8s_A          371 GEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSA  404 (410)
T ss_dssp             SCCCCCCCCSSCCCTTGGGTTCCEECC-------
T ss_pred             cccccCCCchhhcccccccccceEeCcccccccC
Confidence            33222 111  11357889999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.1e-64  Score=534.99  Aligned_cols=331  Identities=39%  Similarity=0.781  Sum_probs=297.7

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+..|..+|..+ +||||++++++
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESS-----SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECC-----CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            34567899999999999999999999986     7889999999987665666677788899999987 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      |++.+.+|+||||++||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999999999999998999999999999999999999999999999999999999999999999999998


Q ss_pred             cc-CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          264 EI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       264 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      .. .........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..++++.|....+.+|..++++++
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  570 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV  570 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred             ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            63 33344567899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCC---
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  419 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  419 (441)
                      +||++||++||.+||++...++++|++||||++++|+.+..++++|||+|...+ .+..+||..++..+...++...   
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~~~~  649 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQEVI  649 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCHHHH
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCchhhh
Confidence            999999999999999887777899999999999999999999999999999988 7889999998887655554321   


Q ss_pred             -CCCCCcccCeeeeCCCccccCC
Q 013558          420 -PTAGEHFKGYTYVAPNPWLSSV  441 (441)
Q Consensus       420 -~~~~~~f~~~~~~~~~~~~~~~  441 (441)
                       ..++..|.||+|+++..+..+|
T Consensus       650 ~~~~~~~f~~f~~~~~~~~~~~~  672 (674)
T 3pfq_A          650 RNIDQSEFEGFSFVNSEFLKPEV  672 (674)
T ss_dssp             TTCCGGGGTTCCEECSSCCCC--
T ss_pred             hcccccccCCCcccChhhhchhh
Confidence             2356789999999998877653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-63  Score=481.93  Aligned_cols=315  Identities=37%  Similarity=0.758  Sum_probs=272.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            345689999999999999999999876     789999999988765555667788899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+...++......+|..+++++++||.
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            4  34567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCC-CcccccCcccccCCCCCCCCCCCCCCCCCc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS-GKDCIANFDKCWTTMPADDSPAPTPTAGEH  425 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (441)
                      +||+.||.+||++...+++++++||||++++|..+..++++|||.|... +..+..+||.. .+................
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~-~~~~~~~~~~~~~~~~~~  314 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY-PEEDINYGVQGEDPYADL  314 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSCCTTGGG
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC-CccccccCccCCchhhhh
Confidence            9999999999988777899999999999999999999999999999987 47888999863 332222222223344567


Q ss_pred             ccCe
Q 013558          426 FKGY  429 (441)
Q Consensus       426 f~~~  429 (441)
                      |.||
T Consensus       315 f~~f  318 (318)
T 1fot_A          315 FRDF  318 (318)
T ss_dssp             SCCC
T ss_pred             ccCC
Confidence            8876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-63  Score=474.09  Aligned_cols=254  Identities=24%  Similarity=0.440  Sum_probs=222.0

Q ss_pred             CCCc-eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013558          109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (441)
Q Consensus       109 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  186 (441)
                      .++| ++.++||+|+||+||+|.++.     +++.||+|++.+... .....+.+.+|+.+|++++|||||+++++|.+ 
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            3455 778899999999999999986     888999999987653 34456778999999999999999999999975 


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecC-CCCcEEEEecC
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFG  260 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkl~DFG  260 (441)
                         +..+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+ .+|.+||+|||
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence               3568999999999999999999999999999999999999999999998  99999999999998 48999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccc--cCCCCC
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKV--KLPPFL  337 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-~~~~~~~~i~~~~~--~~p~~~  337 (441)
                      +|+.... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+. +...+...+..+..  .++..+
T Consensus       178 la~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  255 (290)
T 3fpq_A          178 LATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             CCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence            9986433 34567899999999999875 5999999999999999999999999764 45556666655432  355678


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ++++++||.+||++||++||     +++++++||||+.
T Consensus       256 ~~~~~~li~~~L~~dP~~R~-----s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhHCc-----CHHHHhcCccccC
Confidence            89999999999999999999     8999999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-62  Score=484.43  Aligned_cols=314  Identities=39%  Similarity=0.766  Sum_probs=285.1

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      ....++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4566799999999999999999999886     78899999998876656666778899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++..++..+...+|..+++++++||
T Consensus       192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            54  2456789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCCCCCCc
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH  425 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (441)
                      .+||+.||.+||++...++++|++||||++++|..+..+++.|||+|...+..+..+|| .+++.+...+  ........
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~~~~~~--~~~~~~~~  346 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEEEIRVS--INEKCGKE  346 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCCCCCCC--SSCCSTTT
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-cccccccccC--CCcchhhh
Confidence            99999999999987666799999999999999999999999999999999999999998 4554433222  12234567


Q ss_pred             ccCe
Q 013558          426 FKGY  429 (441)
Q Consensus       426 f~~~  429 (441)
                      |.||
T Consensus       347 f~~f  350 (350)
T 1rdq_E          347 FTEF  350 (350)
T ss_dssp             TTTC
T ss_pred             cCCC
Confidence            8776

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-63  Score=484.01  Aligned_cols=244  Identities=27%  Similarity=0.414  Sum_probs=219.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..+.|++.++||+|+||+||+|+++.     +++.||||+++++..        ..+|+.+|+.++|||||+++++|.++
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~-----~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~  122 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQ-----TGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREG  122 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred             chhheEeCcEeccCCCeEEEEEEECC-----CCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34579999999999999999999986     889999999986532        23699999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~  266 (441)
                      +.+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.
T Consensus       123 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999988 69999999998765


Q ss_pred             CCC------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---cCCCCC
Q 013558          267 ESS------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFL  337 (441)
Q Consensus       267 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~  337 (441)
                      ...      ....++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|.....   .+|+.+
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence            432      12346899999999999999999999999999999999999999998888888888887654   467889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++++||.+||++||.+||     +++|+++
T Consensus       283 s~~~~~li~~~L~~dP~~R~-----sa~el~~  309 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRA-----SAMELRR  309 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCc-----CHHHHHH
Confidence            99999999999999999999     7888754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-62  Score=495.43  Aligned_cols=325  Identities=34%  Similarity=0.649  Sum_probs=277.1

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|..++||||+++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3456778899999999999999999999986     78999999998765555555556889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +|.+.+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999999987 47899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccc
Q 013558          262 AKEIDESSR--SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVK  332 (441)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~  332 (441)
                      |+.......  ....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.+..+.+.+|...  .+.
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            987644332  34478999999999997     567899999999999999999999999999999999998764  355


Q ss_pred             CCC---CCcHHHHHHHHHhcccCcCC--CCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccccc
Q 013558          333 LPP---FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  407 (441)
Q Consensus       333 ~p~---~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~  407 (441)
                      +|.   .+++++++||++||+.+|++  |+     +++++++||||++++|+.+  ++++|||+|.+.+..+..+||..+
T Consensus       302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~-----~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~  374 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRRLICSREHRLGQN-----GIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDD  374 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHTTSSCGGGCTTTT-----TTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC-
T ss_pred             CCcccccCCHHHHHHHHHHhcccccccCCC-----CHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcc
Confidence            564   48999999999999998877  77     8899999999999999999  578999999999999999999876


Q ss_pred             CCCCCCCCCCC-----CCCCCCcccCeeeeCCCcccc
Q 013558          408 TTMPADDSPAP-----TPTAGEHFKGYTYVAPNPWLS  439 (441)
Q Consensus       408 ~~~~~~~~~~~-----~~~~~~~f~~~~~~~~~~~~~  439 (441)
                      +......+..+     .......|.||+|+++....+
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~  411 (437)
T 4aw2_A          375 DCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLSD  411 (437)
T ss_dssp             -----------------CCTTGGGTTCCEESSCTTST
T ss_pred             cccccccCCCCCccccccccCccccCCCcCCchhhcc
Confidence            54433222221     113456899999999877654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-61  Score=483.06  Aligned_cols=323  Identities=36%  Similarity=0.665  Sum_probs=270.2

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      .+..+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|..++||||+++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~-----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-----TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            3456778899999999999999999999986     88999999998766555555667889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +|++.+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            9999999999999999999999998764 799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CccccCCCCCCCcchhc-------CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--
Q 013558          262 AKEIDESSR--SNSMCGTTEYMAPEILL-------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  330 (441)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--  330 (441)
                      ++.......  ....+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.+.+..+++.+|....  
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987654332  34578999999999997       3568999999999999999999999999999999998887643  


Q ss_pred             ccCC---CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccccc
Q 013558          331 VKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  407 (441)
Q Consensus       331 ~~~p---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~  407 (441)
                      ..+|   ..+++++++||++||+ +|.+|++.  .++++|++||||++++|+.+.  ...|||+|...+..+..+||...
T Consensus       289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~  363 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTCNFDLVE  363 (412)
T ss_dssp             CCCC----CCCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCSSCC--C
T ss_pred             cCCCccccCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCcccccccCccc
Confidence            4444   5799999999999999 99999864  389999999999999999984  57899999999999999998753


Q ss_pred             CCCCCC-------CCCC--C-CCCCCCcccCeeeeCCC
Q 013558          408 TTMPAD-------DSPA--P-TPTAGEHFKGYTYVAPN  435 (441)
Q Consensus       408 ~~~~~~-------~~~~--~-~~~~~~~f~~~~~~~~~  435 (441)
                      ......       .+..  . .......|.||+|++..
T Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~  401 (412)
T 2vd5_A          364 DGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA  401 (412)
T ss_dssp             CCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCC
T ss_pred             ccccccccccCCCcccccCCCccccCCCCCCCcccCcc
Confidence            221110       0100  0 11245679999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-61  Score=477.46  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=224.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+... .....+.+.+|+++|+.++|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~-----t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL-----TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            579999999999999999999986     889999999976542 33445678899999999999999999998764   


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                         .+.+|||||||+ |+|.+++.+.+.+++.+++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence               367999999996 6899999988999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCC-----CCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC----
Q 013558          264 EIDE-----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----  333 (441)
Q Consensus       264 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~----  333 (441)
                      .+..     .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+++..|.......    
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7532     2234568999999999998875 56999999999999999999999999999988888886432111    


Q ss_pred             ---------------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          334 ---------------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       334 ---------------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                                 .+.+++++++||.+||++||++||     +++|+++||||+...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI-----SAAAALRHPFLAKYH  352 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCHhhCcCC
Confidence                                       134789999999999999999999     899999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-60  Score=485.27  Aligned_cols=301  Identities=42%  Similarity=0.820  Sum_probs=261.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcC-----CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            34556789999999999999999999886     7899999999887655566667788899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            9999999999999999999999998999999999999999999999998 999999999999999999999999999998


Q ss_pred             ccC-CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          264 EID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       264 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      ... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+...+......+|..+++++.
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  377 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK  377 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            643 3334456889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  410 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~  410 (441)
                      +||.+||++||.+||+++.++++++++||||++++|+.+..+++.|||+|......+..+||+.++.+
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence            99999999999999988888999999999999999999999999999999999999999999988763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-61  Score=462.01  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=202.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++....  .....+.+.+|+.+|++++|||||+++++|.+.+ 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT-----TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            369999999999999999999986     88999999997643  2344567889999999999999999999997544 


Q ss_pred             -----------EEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcE
Q 013558          189 -----------KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (441)
Q Consensus       189 -----------~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v  254 (441)
                                 .+|+|||||+||+|.+++...+.   ..+..++.|+.||+.||+|||++|||||||||+||||+.+|.+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       47999999999999999987765   3456789999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCCC-------------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-H
Q 013558          255 MLTDFGLAKEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-Q  320 (441)
Q Consensus       255 kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~  320 (441)
                      ||+|||+|+.+....             ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||..... .
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            999999998764432             1234689999999999999999999999999999999996   7764321 1


Q ss_pred             HHHHHHHhccccCCC---CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          321 KLQQRIINEKVKLPP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       321 ~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      .....+..  ..+|+   ..++.+.+||.+||++||.+||     ++.|+++||||++++|.
T Consensus       235 ~~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          235 RTLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERP-----EAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGCCC---
T ss_pred             HHHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCc-----CHHHHhcCHhhCCCCCC
Confidence            22233332  33332   3567789999999999999999     88999999999999984

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-59  Score=458.90  Aligned_cols=304  Identities=51%  Similarity=0.936  Sum_probs=249.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .+..++|+++++||+|+||.||+|++...  ..+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            35567899999999999999999997531  1278899999998754322 23345678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ...+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999986


Q ss_pred             cCC-CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          265 IDE-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       265 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      ... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++.++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            432 2334567899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP  411 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~  411 (441)
                      ||.+||+.||.+||++.+.+++++++||||++++|..+..+++.|||+|......+..+|+..++...
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~  318 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQT  318 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC------------------
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhccc
Confidence            99999999999999987779999999999999999999999999999999998888999987766543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.9e-60  Score=489.45  Aligned_cols=324  Identities=36%  Similarity=0.685  Sum_probs=280.7

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++||||++++++|
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-----TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            44677899999999999999999999876     7899999999887766666677888999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecC
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                      .+...+|+||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            9999999999999999999999764    369999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCC
Q 013558          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPP  335 (441)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~  335 (441)
                      +++.+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...    ...++.+.+......+|.
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            9987654433 34569999999999999999999999999999999999999999865    457788888888889999


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCC-----cccccCcccccCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-----KDCIANFDKCWTTM  410 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~-----~~~~~~~~~~~~~~  410 (441)
                      .+++++++||++||++||.+||++...++++|++||||++++|..+..+.+.|||+|....     ..+..+|+..    
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~~~----  490 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTV----  490 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC------
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcccc----
Confidence            9999999999999999999999887667899999999999999999999999999998753     2233444421    


Q ss_pred             CCCCCCCCCCCCCCcccCeeeeC-CCccccC
Q 013558          411 PADDSPAPTPTAGEHFKGYTYVA-PNPWLSS  440 (441)
Q Consensus       411 ~~~~~~~~~~~~~~~f~~~~~~~-~~~~~~~  440 (441)
                      .   .....+.+...|.+|++.+ +.+||+.
T Consensus       491 ~---~~~~~~~~~~~f~~f~~~~~~~~~~~~  518 (543)
T 3c4z_A          491 K---GVAFEKADTEFFQEFASGTCPIPWQEE  518 (543)
T ss_dssp             ----CCCCCHHHHHHHHHHCCEECHHHHHHH
T ss_pred             C---CCCCCcchhhHhhcCCCCCCChhHHHh
Confidence            1   1112224568899999976 5678864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-59  Score=465.95  Aligned_cols=291  Identities=34%  Similarity=0.693  Sum_probs=266.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++++.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++|||||+++++|
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKND-----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34566789999999999999999999886     7899999999887766667778899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+...+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            99999999999999999999999988999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhccccCCCCCc
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~---~~~~~~~~~i~~~~~~~p~~~s  338 (441)
                      +.........+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..   ....++...+......+|..++
T Consensus       165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s  244 (384)
T 4fr4_A          165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS  244 (384)
T ss_dssp             CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence            776666778899999999999974   4689999999999999999999999974   4456677777788888999999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  404 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~  404 (441)
                      .++.+||.+||+.||.+||+    +++++++||||++++|..+..+++.|||+|.....++...|+
T Consensus       245 ~~~~~li~~lL~~dP~~R~s----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~  306 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE  306 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCC----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred             HHHHHHHHHHhcCCHhHhcc----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence            99999999999999999994    389999999999999999999999999999987766666665

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.5e-60  Score=460.43  Aligned_cols=256  Identities=22%  Similarity=0.399  Sum_probs=220.5

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|.+.++||+|+||+||+|+++......+++.||||+++..   .....+.+.+|+++|++++|||||+++++|.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4556789999999999999999999876555557889999999753   2445567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~  250 (441)
                      +.+.+|||||||++|+|.++++..               +++++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999754               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013558          251 DGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i  326 (441)
                      ++.+||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   2345689999999999999999999999999999999999 99999999998888888


Q ss_pred             Hhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          327 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       327 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..+ .+..|..+++++.+||.+||+.||++||     ++++|++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~  312 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRH-----SIKDVHA  312 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCc-----CHHHHHH
Confidence            765 5678889999999999999999999999     8899876

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-60  Score=455.59  Aligned_cols=259  Identities=22%  Similarity=0.416  Sum_probs=225.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|.+.++||+|+||+||+|+++......++..||||+++..   .....+.+.+|+++|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3556789999999999999999999876554457889999999753   2344567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      +++.+|||||||+||+|.++|...+             .+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            9999999999999999999997643             699999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 013558          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~  328 (441)
                      .+||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987543221   234579999999999999999999999999999999999 9999999999999988887


Q ss_pred             cc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          329 EK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       329 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      +. ...|..+++++.+||.+||+.||++||     ++++|.  +|++
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~~i~--~~L~  285 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRK-----NIKGIH--TLLQ  285 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHH--HHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHH--HHHH
Confidence            64 567889999999999999999999999     888984  4554

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-59  Score=486.86  Aligned_cols=323  Identities=36%  Similarity=0.672  Sum_probs=276.7

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            44777899999999999999999999886     8899999999887665566667788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+.+.+|+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence            999999999999999999999987654  999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCCCCc
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~~~s  338 (441)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|..||...    ....+...+......++..++
T Consensus       334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s  413 (576)
T 2acx_A          334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS  413 (576)
T ss_dssp             EECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             eecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC
Confidence            9876655556679999999999999999999999999999999999999999875    356677778777888899999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCc-----ccccCcccccCCCCCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK-----DCIANFDKCWTTMPAD  413 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~-----~~~~~~~~~~~~~~~~  413 (441)
                      +++++||++||++||.+||++...++++|++||||++++|..+..+.+.|||+|.....     .+..+|+..       
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~~-------  486 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTV-------  486 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC-------------------
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhcccc-------
Confidence            99999999999999999998877789999999999999999999999999999976532     223334321       


Q ss_pred             CCCCCCCCCCCcccCeeee-CCCcccc
Q 013558          414 DSPAPTPTAGEHFKGYTYV-APNPWLS  439 (441)
Q Consensus       414 ~~~~~~~~~~~~f~~~~~~-~~~~~~~  439 (441)
                      ......+.+...|.+|... .+.+|++
T Consensus       487 ~~~~~~~~~~~~f~~f~~~~~~~~~~~  513 (576)
T 2acx_A          487 KGVELEPTDQDFYQKFATGSVPIPWQN  513 (576)
T ss_dssp             -----CHHHHHHHHHHCCEECHHHHHH
T ss_pred             CCCCCCccHHHHHhhhccCCCCcccch
Confidence            1111223456778888775 3456764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-59  Score=451.76  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=223.9

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++++++++||+|+||+||+|++.+..+..+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            35567899999999999999999998765555578899999997542  2334567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~  249 (441)
                      +++.+|||||||++|+|.++|...                ..+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999753                3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCCC---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 013558          250 SDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  325 (441)
Q Consensus       250 ~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~  325 (441)
                      +++.+||+|||+|+.+...   ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999875332   23445789999999999999999999999999999999998 9999999999999888


Q ss_pred             HHhcc-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          326 IINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       326 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +..+. .+.|+.+++++.+||.+||+.||++||     ++++|+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-----s~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP-----RFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            87654 567889999999999999999999999     78888763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.4e-59  Score=458.23  Aligned_cols=253  Identities=24%  Similarity=0.437  Sum_probs=210.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      ++|++.++||+|+||+||+|+++..  ..+++.||+|++.+..     ....+.+|+++|+.+ +|||||+++++|++.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            5799999999999999999987631  1267889999986542     234577899999998 6999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~  267 (441)
                      ++|+|||||+||+|.+++   +.+++.+++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999999988   469999999999999999999999999999999999999876 8999999999986432


Q ss_pred             CC-----------------------------CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCC-
Q 013558          268 SS-----------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-  316 (441)
Q Consensus       268 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~-  316 (441)
                      ..                             ...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.. 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            21                             12346899999999999875 589999999999999999999999954 


Q ss_pred             CCHHHHHHHHHhc--------------------------------------c----------------ccCCCCCcHHHH
Q 013558          317 ANRQKLQQRIINE--------------------------------------K----------------VKLPPFLTSEAH  342 (441)
Q Consensus       317 ~~~~~~~~~i~~~--------------------------------------~----------------~~~p~~~s~~~~  342 (441)
                      .+..+.+..|..-                                      .                ......++++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            4444444433210                                      0                011235789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      |||++||++||++|+     +++|+++||||++++
T Consensus       331 DLl~~lL~~dP~~R~-----ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          331 DLLDKLLDLNPASRI-----TAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHTCSCTTTSC-----CHHHHHTSGGGTTC-
T ss_pred             HHHHHHCcCChhHCc-----CHHHHhcCcccCCCC
Confidence            999999999999999     899999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-59  Score=487.24  Aligned_cols=258  Identities=27%  Similarity=0.527  Sum_probs=237.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||+|++.+..   ....+.+.+|+.+|+.++|||||+++++|.+...
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~-----tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            589999999999999999999986     88999999997643   2334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC--CcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~vkl~DFG~a~~~~  266 (441)
                      +|||||||+||+|.+++.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+  |.+||+|||+|+.+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999999864 4689999999999999999999999999999999999999854  899999999999987


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+++.+|......++    ..++++++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76666778999999999999999999999999999999999999999999999999999998877665    46899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                      +||++||++||.+||     +++|+++||||+..+|..
T Consensus       389 dli~~~L~~dp~~R~-----t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          389 DFIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCcCcCCCCCCC
Confidence            999999999999999     899999999999887754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=443.96  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=210.5

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+++..+++++.++||+|+||+||+|+++        ..||||+++... ......+.+.+|+.+|++++|||||+++++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH--------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS--------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC--------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            46788889999999999999999999854        248999987543 334556789999999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +. ++.+|||||||+||+|.+++... +.+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|
T Consensus       101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            75 46789999999999999999765 67999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC---CCCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----
Q 013558          263 KEIDES---SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----  331 (441)
Q Consensus       263 ~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----  331 (441)
                      +.....   ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+.......+.....     
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            875432   23456789999999999974   3589999999999999999999999988665544444443322     


Q ss_pred             -cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          332 -KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       332 -~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       .++..+++++.+||.+||+.||++||     ++.+|++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ei~~  293 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERP-----LFPQILS  293 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSC-----CHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence             24467899999999999999999999     7787765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.9e-58  Score=450.38  Aligned_cols=261  Identities=23%  Similarity=0.425  Sum_probs=226.2

Q ss_pred             hhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeee
Q 013558          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLR  181 (441)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~  181 (441)
                      ..+++..++|++.++||+|+||+||+|++++.....+++.||||.+....  .....+.+.+|+.+|+++.| ||||+++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            34677888999999999999999999999876665677899999997643  23345678899999999965 9999999


Q ss_pred             EEEEe-CCEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCC
Q 013558          182 YSFQT-RSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (441)
Q Consensus       182 ~~~~~-~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~  244 (441)
                      ++|.+ ++.+|+|||||++|+|.++|+..                ..+++.++..|+.||+.||+|||+++||||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            99876 45799999999999999999763                34899999999999999999999999999999999


Q ss_pred             ceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHH
Q 013558          245 NILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ  320 (441)
Q Consensus       245 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~  320 (441)
                      ||||+.++.+||+|||+|+.+.....   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997644332   345689999999999999999999999999999999998 99999886644


Q ss_pred             -HHHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          321 -KLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       321 -~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                       .+...+..+ ++..|+.+++++.+||.+||+.||++||     ++++|++|
T Consensus       295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-----t~~eil~~  341 (353)
T 4ase_A          295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  341 (353)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-----CHHHHHHH
Confidence             444444443 5678889999999999999999999999     88999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.6e-56  Score=432.71  Aligned_cols=259  Identities=31%  Similarity=0.606  Sum_probs=241.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||.||+|+++.     +++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL-----TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            35689999999999999999999876     889999999987543 344556788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999999999999989999999999999999999999999999999999999999999999999999988776


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCC-CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++..++..+...+|..+++++.+||+
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK  246 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            6666778999999999999988875 789999999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +||+.||.+||     +++++++||||+...
T Consensus       247 ~~L~~dP~~R~-----t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          247 RFLVLNPIKRG-----TLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHCCSSTTTSC-----CHHHHTTCTTTTTTC
T ss_pred             HHCCCChhHCc-----CHHHHhcCHhhcCCC
Confidence            99999999999     899999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.7e-55  Score=432.45  Aligned_cols=265  Identities=30%  Similarity=0.519  Sum_probs=242.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ++|++.+.||+|+||+||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||++++++|.+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hceEEeeEEeeCcCEEEEEEEECC-----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            479999999999999999999886     789999999987543221   234678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a  262 (441)
                      ...+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    7999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCc
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s  338 (441)
                      +...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            987766666678999999999999999999999999999999999999999999999999999988877665    5789


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  384 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  384 (441)
                      +++++||.+||.+||.+||     +++++++||||++++|.....+
T Consensus       247 ~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~~~~~~~~~  287 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRL-----TIQEALRHPWITPVDTQQAMVR  287 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTSCSSHHHHHHH
T ss_pred             HHHHHHHHHHCCCChhHCc-----CHHHHhcCcCcCCCchhhhhhc
Confidence            9999999999999999999     8899999999999999776543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-55  Score=434.04  Aligned_cols=295  Identities=47%  Similarity=0.872  Sum_probs=252.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      +..++|+++++||+|+||+||+|++...  ..+++.||||++.+.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            4456899999999999999999998531  237889999998764322 122234466799999999 699999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .....+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             cCCC--CCCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccccCCCC
Q 013558          265 IDES--SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPF  336 (441)
Q Consensus       265 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~~~p~~  336 (441)
                      +...  ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...    ....+...+......++..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            5322  22345689999999999986  34789999999999999999999999743    3456667777777888899


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF  403 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~  403 (441)
                      ++..+++||.+||+.||.+||++...+++++++|+||+.++|..+..+++.+||.|...+..+.++|
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence            9999999999999999999998888899999999999999999999999999999988777666655

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-54  Score=424.78  Aligned_cols=256  Identities=30%  Similarity=0.565  Sum_probs=233.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||+||+|.++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK-----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            4689999999999999999999876     78899999998765544455567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999999999 7799999988899999999999999999999999999999999999999999999999999999887666


Q ss_pred             CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......+...+......+|..+++++.+||++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            66677899999999999998776 68999999999999999999999887766666666666777888999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ||+.||.+||     +++++++||||+.
T Consensus       242 ~L~~dP~~Rp-----t~~eil~hp~~~~  264 (336)
T 3h4j_B          242 MIVADPMQRI-----TIQEIRRDPWFNV  264 (336)
T ss_dssp             TSCSSGGGSC-----CHHHHTTCHHHHT
T ss_pred             HcCCChhHCc-----CHHHHHhChhhcc
Confidence            9999999999     8999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-53  Score=411.01  Aligned_cols=264  Identities=28%  Similarity=0.505  Sum_probs=239.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ceEeceEEeeCCCeEEEEEEECC-----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            59999999999999999999876     788999999986543221   2356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a~  263 (441)
                      ..+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999999998888999999999999999999999999999999999999999888    89999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  339 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~  339 (441)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ..++.
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence            87655556677899999999999999999999999999999999999999999988888888877666555    46899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhc
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  384 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  384 (441)
                      ++++||.+||+.||.+||     +++++++||||+..+|.....+
T Consensus       247 ~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~~~~~  286 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSR  286 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSC-----CHHHHHHSTTTSCCSHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCC-----CHHHHhcCCCccCCcchhhhhh
Confidence            999999999999999999     8999999999999998766543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.9e-53  Score=417.38  Aligned_cols=255  Identities=32%  Similarity=0.586  Sum_probs=233.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            369999999999999999999876     788999999987543 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~  266 (441)
                      .|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999999998888999999999999999999999999999999999999998654   59999999998877


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  342 (441)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+..+...++.    .++++++
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            665566789999999999999999999999999999999999999999999999999999888777663    5799999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +||.+||+.||.+||     +++++++||||..
T Consensus       263 ~li~~~L~~dP~~R~-----t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRI-----TADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSC-----CHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCc-----CHHHHhcCcccCC
Confidence            999999999999999     8999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-53  Score=433.36  Aligned_cols=260  Identities=30%  Similarity=0.582  Sum_probs=241.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|.+.+.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHEL-----TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETT-----TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4456789999999999999999999876     78999999998766555556678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+..++..+....|..+++++.+|
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence            66666667899999999999998776 68999999999999999999999999989999999999888999999999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |++||+.||.+||     +++++++||||+.
T Consensus       247 i~~~L~~dP~~Rp-----t~~eil~hp~~~~  272 (476)
T 2y94_A          247 LKHMLQVDPMKRA-----TIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHHTCSSTTTSC-----CHHHHHTCHHHHT
T ss_pred             HHHHcCCCchhCc-----CHHHHHhCHHhhh
Confidence            9999999999999     8999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.9e-52  Score=424.54  Aligned_cols=255  Identities=32%  Similarity=0.584  Sum_probs=230.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|.++.     +++.||+|++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~-----~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETT-----TTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECC-----CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            369999999999999999999886     8899999999875532 3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC---CCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~  266 (441)
                      +|+||||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999999999999999999999999999999999999999999999999998   56889999999998765


Q ss_pred             CCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHH
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  341 (441)
                      ... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+..+...++.    .+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            433 235678999999999999999999999999999999999999999999999999999988777663    689999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ++||.+||+.||.+||     +++++++||||+.
T Consensus       245 ~~li~~~L~~dP~~Rp-----ta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDLINKMLTINPSKRI-----TAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHHHSCTTHH
T ss_pred             HHHHHHHcCCChhHCC-----CHHHHhcCccccC
Confidence            9999999999999999     8999999999964

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-53  Score=419.77  Aligned_cols=279  Identities=29%  Similarity=0.531  Sum_probs=240.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      ++|++.+.||+|+||+||+|.++.     +++.||||++.+....       ..+|+++|.++ +||||+++++++.+..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            369999999999999999999886     7899999999765421       34588888887 7999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC----CcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----~~vkl~DFG~a~~  264 (441)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999999999998999999999999999999999999999999999999998433    3599999999987


Q ss_pred             cCCC-CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhccccCC----CC
Q 013558          265 IDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLP----PF  336 (441)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~---~~~~~~~~~i~~~~~~~p----~~  336 (441)
                      .... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||..   .+..++...+..+.+.++    ..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 334567899999999999988899999999999999999999999985   466778888888777655    46


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCccccc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  407 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~  407 (441)
                      +++++++||++||+.||++||     +++++++||||.  +|..+...++.+++.|........++|+...
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  313 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRL-----TAALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALN  313 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSC-----CHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCc-----CHHHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhc
Confidence            899999999999999999999     889999999995  6888888888888887544333334454443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-53  Score=409.87  Aligned_cols=254  Identities=26%  Similarity=0.456  Sum_probs=232.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||+||+|.++.     +++.||+|++....    .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence            4689999999999999999999886     78999999987532    23456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC--CCcEEEEecCCcccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkl~DFG~a~~~  265 (441)
                      .+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999999999999765 47999999999999999999999999999999999999987  789999999999987


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEA  341 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  341 (441)
                      .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+......++    ..++.++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            665555667899999999999998899999999999999999999999999999999999988877766    4789999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++||.+||+.||.+||     +++++++||||+..
T Consensus       235 ~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  264 (321)
T 1tki_A          235 MDFVDRLLVKERKSRM-----TASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSC-----CHHHHHHSHHHHSC
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHhcChhhccC
Confidence            9999999999999999     89999999999754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.4e-52  Score=401.15  Aligned_cols=254  Identities=27%  Similarity=0.469  Sum_probs=226.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC-----CCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            4579999999999999999999775     788999999976542   23456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999999998764 6899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                      . .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+...   ....+..+++.+.+|
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence            2 344578999999999999999999999999999999999999999988877766666543   234466789999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      |.+||+.||.+||     +++++++||||+..
T Consensus       250 i~~~l~~dp~~Rp-----s~~ell~h~~~~~~  276 (297)
T 3fxz_A          250 LNRCLEMDVEKRG-----SAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHHccCChhHCc-----CHHHHhhChhhccc
Confidence            9999999999999     89999999999854

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-52  Score=398.44  Aligned_cols=259  Identities=34%  Similarity=0.688  Sum_probs=238.4

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            4556789999999999999999999875     78899999998765544555667889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +.+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      ... .....+|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+|..++.++++||
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence            432 2445689999999999999999999999999999999999999999999888888998888889999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+||+.||.+||     +++++++||||+.
T Consensus       244 ~~~l~~~p~~Rp-----s~~~ll~h~~~~~  268 (284)
T 2vgo_A          244 SKLLRYHPPQRL-----PLKGVMEHPWVKA  268 (284)
T ss_dssp             HHHSCSSGGGSC-----CHHHHHTCHHHHH
T ss_pred             HHHhhcCHhhCC-----CHHHHhhCHHHHh
Confidence            999999999999     8999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-52  Score=397.52  Aligned_cols=259  Identities=34%  Similarity=0.631  Sum_probs=235.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||+||+|.++.     +++.||+|++.+...........+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            4566789999999999999999999886     78899999998766555555677889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      +....++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+|..+++++.+||
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          160 PSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             Ccc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            433 2345689999999999999999999999999999999999999999999999999999888899999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+||+.||.+||     +++++++||||+.
T Consensus       239 ~~~l~~~p~~Rp-----s~~e~l~h~~~~~  263 (279)
T 3fdn_A          239 SRLLKHNPSQRP-----MLREVLEHPWITA  263 (279)
T ss_dssp             HHHCCSSGGGSC-----CHHHHHHCHHHHH
T ss_pred             HHHhccChhhCC-----CHHHHhhCccccC
Confidence            999999999999     8999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.2e-52  Score=403.52  Aligned_cols=266  Identities=29%  Similarity=0.511  Sum_probs=240.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccEEEeeEeeecCCEEEEEEEECC-----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            369999999999999999999876     788999999987543221   135678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a  262 (441)
                      ...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999999999888999999999999999999999999999999999999999888    8999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCc
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s  338 (441)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            887665555677899999999999999999999999999999999999999999998888888887766555    5689


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  385 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~  385 (441)
                      +++.+||.+||+.||++||     +++++++||||..++|.....+.
T Consensus       247 ~~~~~li~~~l~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~~~~  288 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRR  288 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSC-----CHHHHHHSTTTSCSSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCc-----CHHHHhcCccccCCCcccccccc
Confidence            9999999999999999999     89999999999999998766543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-52  Score=403.68  Aligned_cols=258  Identities=29%  Similarity=0.488  Sum_probs=217.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++      +++.||+|++.... ......+.+.+|+.+|++++||||+++++++.+..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            468999999999999999999975      57899999997653 23344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 787777665 4599999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------------
Q 013558          268 S-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (441)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------------  331 (441)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....              
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            3 23345689999999999976 5689999999999999999999999988776666655543110              


Q ss_pred             ----------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          332 ----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       332 ----------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                                      .+.+.+++++.+||.+||+.||++||     +++++++||||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI-----SARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTSCTT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC-----CHHHHhcCcccccCCcc
Confidence                            01234788999999999999999999     89999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7e-53  Score=406.80  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      .+|.+.++||+|+||+||+|++       +++.||||++.....    .......|+..+.+++|||||++++++.+++ 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-------~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            3689999999999999999987       467899999875431    1122345676777899999999999998654 


Q ss_pred             ---EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCCCceecCCCCcEEEE
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                         .+|||||||+||+|.+++++ ..++++.+..++.|++.||.|||++        +||||||||+||||+.++++||+
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence               68999999999999999976 4689999999999999999999987        99999999999999999999999


Q ss_pred             ecCCccccCCCCC-----CccccCCCCCCCcchhcCC------CCCCcchhhhHHHHHHHHHcCCCCCCCC---------
Q 013558          258 DFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHA---------  317 (441)
Q Consensus       258 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltG~~pf~~~---------  317 (441)
                      |||+|+.......     ....+||+.|||||++.+.      .|+.++|||||||+||||+||..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654322     2346899999999999765      3567899999999999999997765321         


Q ss_pred             ------CHHHHHHHHHhccc--cCCCC-----CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          318 ------NRQKLQQRIINEKV--KLPPF-----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       318 ------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                            ....+...+.....  .+|..     .++.+.+||.+||+.||++||     ++.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                  22344444444332  33332     235788999999999999999     7888876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-51  Score=396.22  Aligned_cols=256  Identities=24%  Similarity=0.438  Sum_probs=218.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC-----CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            579999999999999999999886     788999999986542 34445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      +|+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9999999987444444444678999999999999999999999999999999999999999999999999999876533 


Q ss_pred             CCCccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhccc---------------
Q 013558          269 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPP-FTHANRQKLQQRIINEKV---------------  331 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~p-f~~~~~~~~~~~i~~~~~---------------  331 (441)
                      ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.....               
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2344568999999999998765 89999999999999999987777 566666666666643211               


Q ss_pred             --------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                    ...+.+++++++||.+||+.||++||     +++|+++||||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC-----CHHHHhcCcccccC
Confidence                          11235789999999999999999999     89999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-52  Score=410.64  Aligned_cols=258  Identities=28%  Similarity=0.555  Sum_probs=225.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch--hHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ++|++.+.||+|+||+||+|.++.     +++.||||++........  ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            369999999999999999999876     789999999976543221  2356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc---EEEEecC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFG  260 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkl~DFG  260 (441)
                      +.+|+||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998877543    35899999999999999999999999999999999999987655   9999999


Q ss_pred             CccccCCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----C
Q 013558          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----P  335 (441)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~  335 (441)
                      +++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..++...+......++    .
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9987655432 44578999999999999999999999999999999999999999874 4566777777666554    4


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      .+++++++||.+||+.||++||     +++++++||||+..++
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~-----s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERI-----TVYEALNHPWLKERDR  295 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHTHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCc-----CHHHHhcChhhcCCcc
Confidence            6899999999999999999999     8999999999987543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-52  Score=424.74  Aligned_cols=272  Identities=25%  Similarity=0.400  Sum_probs=211.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++|||||++++++..  
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL-----EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC-----CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4689999999999999999999886     78999999996542 334455678899999999999999999999843  


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                         ...+|+||||+ +++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence               35799999998 46899999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC----------------------------CCccccCCCCCCCcchh-cCCCCCCcchhhhHHHHHHHHHc-----
Q 013558          264 EIDESS----------------------------RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLT-----  309 (441)
Q Consensus       264 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~ellt-----  309 (441)
                      ......                            .....+||+.|+|||++ .+..|+.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            764221                            23456889999999986 46679999999999999999999     


Q ss_pred             ------CCCCCCCCCH--------------------HHHHHHHHhc-------------------------------ccc
Q 013558          310 ------GQPPFTHANR--------------------QKLQQRIINE-------------------------------KVK  332 (441)
Q Consensus       310 ------G~~pf~~~~~--------------------~~~~~~i~~~-------------------------------~~~  332 (441)
                            |+++|.+.+.                    .+....|...                               ...
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  7777766431                    1222222110                               001


Q ss_pred             CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       333 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      ..+.+++++.+||++||+.||.+||     +++|+++||||+++.|...+.....+.+.|
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~-----t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~  419 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRI-----TINECLAHPFFKEVRIAEVETNATEKVRLP  419 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred             HCCCCCHHHHHHHHHHhccCccccC-----CHHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence            1235689999999999999999999     899999999999999998876555554444

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.1e-51  Score=392.09  Aligned_cols=262  Identities=31%  Similarity=0.564  Sum_probs=237.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC-----CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            4689999999999999999999876     788999999976553 3444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc---EEEEecCCcccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEI  265 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkl~DFG~a~~~  265 (441)
                      ..|+||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999999999998899999999999999999999999999999999999999987665   999999999887


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEA  341 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  341 (441)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+......++    ..+++++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            766556667899999999999999999999999999999999999999999999998888888776655    3689999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      .+||.+||+.||++||     +++++++||||++..+...
T Consensus       239 ~~li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRI-----TADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTSHHHHSCCCGGG
T ss_pred             HHHHHHHcccChhhCC-----CHHHHhcCccccCChhHHh
Confidence            9999999999999999     8999999999988765443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.3e-52  Score=416.26  Aligned_cols=263  Identities=21%  Similarity=0.381  Sum_probs=221.2

Q ss_pred             cCCCCceEEeeEccc--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          107 IGPGDFEIFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ...++|+++++||+|  +||+||+|+++.     +++.||||++..... .....+.+.+|+.+|+.++|||||++++++
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcC-----CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            345689999999999  999999999986     789999999987543 345567788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+.+.+|+||||+++|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999999999999876  67999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCC--------CCCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-
Q 013558          263 KEIDES--------SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  331 (441)
Q Consensus       263 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-  331 (441)
                      ......        ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..+....+..+.. 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            653211        12233579999999999987  6789999999999999999999999987655444433322111 


Q ss_pred             ---------------------------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHH
Q 013558          332 ---------------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA  366 (441)
Q Consensus       332 ---------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~  366 (441)
                                                                   .++..+++++++||++||+.||.+||     ++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e  330 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP-----SAST  330 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSC-----CHHH
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC-----CHHH
Confidence                                                         23456889999999999999999999     8999


Q ss_pred             hhhCcccCCCChhh
Q 013558          367 IKHHKWFRSINWKT  380 (441)
Q Consensus       367 i~~h~~f~~~~~~~  380 (441)
                      +++||||+.+.|..
T Consensus       331 ll~hp~f~~~~~~~  344 (389)
T 3gni_B          331 LLNHSFFKQIKRRA  344 (389)
T ss_dssp             HTTSGGGGGC---C
T ss_pred             HhcCHHHHHHhhcc
Confidence            99999999887654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.1e-52  Score=409.58  Aligned_cols=253  Identities=32%  Similarity=0.580  Sum_probs=213.1

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+.....    +.+.+|+.+++.++||||+++++++.+.
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKL-----TKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETT-----TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            34689999999999999999999886     78899999997643322    4577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc--EEEEecCCcccc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEI  265 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkl~DFG~a~~~  265 (441)
                      ..+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999998899999999999999999999999999999999999999987765  999999999865


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCc-chhhhHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccccCCC--CCc
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKD-ADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP--FLT  338 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvvl~elltG~~pf~~~~----~~~~~~~i~~~~~~~p~--~~s  338 (441)
                      .........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+    .....+.+......+|.  .++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            54445566789999999999998887655 899999999999999999998643    34566666666666665  589


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      +++++||.+||+.||.+||     +++++++||||.
T Consensus       249 ~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~  279 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRI-----SIPEIKTHSWFL  279 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSC-----CHHHHHTSHHHH
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHHhCcchh
Confidence            9999999999999999999     899999999994

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=397.63  Aligned_cols=269  Identities=27%  Similarity=0.420  Sum_probs=219.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.... ......+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRD-----TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            3689999999999999999999875     78899999986643 23344566789999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..++||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999999999998888888999999999999999999999999999999999999999999999999999876532


Q ss_pred             -CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Q 013558          269 -SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---------------  331 (441)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....               
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             22345689999999999986 6689999999999999999999999998887766555432110               


Q ss_pred             ----cCC------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCC
Q 013558          332 ----KLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP  388 (441)
Q Consensus       332 ----~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p  388 (441)
                          ..+            +.+++++.+||++||+.||.+||     +++++++||||+++.+.....+..+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~  303 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-----TCEQLLHHPYFENIREIEDLAKEHDK  303 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHTSGGGTTCC-----------
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC-----CHHHHhcChHHHhccCHHHHHHhhcc
Confidence                111            35788999999999999999999     89999999999999877665555443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-52  Score=413.47  Aligned_cols=270  Identities=26%  Similarity=0.434  Sum_probs=215.1

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      ++|++++.||+|+||+||+|.++.     +++.||||++.+.. ......+.+.+|+.+|+.+. ||||+++++++...+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRR-----TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETT-----TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             CceEEEEEeeeCCCeEEEEEEECC-----CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            589999999999999999999886     78999999986542 23444566778999999997 999999999998654


Q ss_pred             --EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       189 --~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                        .+|+|||||. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              7999999997 588888866 579999999999999999999999999999999999999999999999999998653


Q ss_pred             CC----------------------CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH
Q 013558          267 ES----------------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ  323 (441)
Q Consensus       267 ~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~  323 (441)
                      ..                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                      12344689999999999987 67899999999999999999999999998888777


Q ss_pred             HHHHhccc-----------------------------------------------cCCCCCcHHHHHHHHHhcccCcCCC
Q 013558          324 QRIINEKV-----------------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKR  356 (441)
Q Consensus       324 ~~i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R  356 (441)
                      ..|....-                                               ..+..+++++.+||++||+.||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            77652100                                               0112678999999999999999999


Q ss_pred             CCCCCCChHHhhhCcccCCC---ChhhhhhcccCCCCCC
Q 013558          357 LGSGPGGVDAIKHHKWFRSI---NWKTLEAREMQPKFKP  392 (441)
Q Consensus       357 ~~~~~~~~~~i~~h~~f~~~---~~~~~~~~~~~p~~~p  392 (441)
                      |     +++++++||||+.+   +|.....+.+.+||.+
T Consensus       321 ~-----t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~  354 (388)
T 3oz6_A          321 I-----SANDALKHPFVSIFHNPNEEPNCDHIITIPIND  354 (388)
T ss_dssp             C-----CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---
T ss_pred             C-----CHHHHhCCHHHHHhcCCccCCCCCCCCCCCccc
Confidence            9     89999999998754   3444444445555554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-51  Score=391.43  Aligned_cols=261  Identities=30%  Similarity=0.570  Sum_probs=229.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||.||+|.++.     +++.||||++...........+.+.+|+.+++.++||||+++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL-----TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECC-----CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34556789999999999999999999875     7889999999876555555667889999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ...+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      ..........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+.+......+|..++.++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT  240 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence            765554556789999999999988765 6899999999999999999999999988888888888888889999999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ||.+||+.||.+||     +++++++||||+.
T Consensus       241 li~~~l~~~p~~Rp-----s~~~~l~h~~~~~  267 (276)
T 2h6d_A          241 LLMHMLQVDPLKRA-----TIKDIREHEWFKQ  267 (276)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             HHHHHccCChhhCC-----CHHHHHhChhhcc
Confidence            99999999999999     8999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-51  Score=410.76  Aligned_cols=256  Identities=28%  Similarity=0.521  Sum_probs=230.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|.++.     +++.||+|++.....   .....+.+|+.+|+.++||||+++++++.+...
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCEEEEEEEECC-----CCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            579999999999999999999886     788999999976432   233468899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC--CCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~  266 (441)
                      +|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999999987654 7999999999999999999999999999999999999974  5789999999999876


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++    ..++++++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            65555567899999999999999999999999999999999999999999988888888877665544    46899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +||.+||+.||.+||     +++++++||||++..+
T Consensus       283 ~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DFIKNLLQKEPRKRL-----TVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHTSTTTSSCCT
T ss_pred             HHHHHHcCCChhHCc-----CHHHHhhCccccCCcc
Confidence            999999999999999     8999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.9e-51  Score=391.82  Aligned_cols=258  Identities=29%  Similarity=0.565  Sum_probs=238.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC-----CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            4579999999999999999999876     78899999998776555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..+++++.+||.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  248 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence             2344567999999999999999999999999999999999999999999988888888888888999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||+.||++||     +++++++||||.+.
T Consensus       249 ~l~~~p~~Rp-----s~~~ll~~~~~~~~  272 (294)
T 2rku_A          249 MLQTDPTARP-----TINELLNDEFFTSG  272 (294)
T ss_dssp             HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             HcccChhhCc-----CHHHHhhChheecC
Confidence            9999999999     88999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.6e-51  Score=400.69  Aligned_cols=258  Identities=29%  Similarity=0.565  Sum_probs=238.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3579999999999999999999876     78899999998776555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..+++++.+||.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence             2344568999999999999999999999999999999999999999999888888888888888999999999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||+.||++||     +++++++|+||...
T Consensus       275 ~l~~dp~~Rp-----s~~ell~~~~~~~~  298 (335)
T 2owb_A          275 MLQTDPTARP-----TINELLNDEFFTSG  298 (335)
T ss_dssp             HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             HccCChhHCc-----CHHHHhcCccccCC
Confidence            9999999999     88999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-51  Score=400.07  Aligned_cols=259  Identities=26%  Similarity=0.460  Sum_probs=208.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|.++.     +++.||+|++....  .....+.+.+|+.+|++++||||+++++++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECSS-----SCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            4589999999999999999999875     78899999997653  2223356778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+|+||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999999998 4898888654      35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Q 013558          263 KEIDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------  330 (441)
Q Consensus       263 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------  330 (441)
                      +..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....          
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            876533 23345689999999999986 468999999999999999999999999988887777665321          


Q ss_pred             ------------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          331 ------------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       331 ------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                              ...+..++.++.+||.+||+.||++||     +++++++||||++..|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL-----SAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCC--
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC-----CHHHHhCChhhhcccchh
Confidence                                    011235788999999999999999999     899999999999876654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-51  Score=403.13  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=215.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3579999999999999999999876     789999999976532 2333456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec-----CCCCcEEEEecCCcc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----DSDGHVMLTDFGLAK  263 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl-----~~~~~vkl~DFG~a~  263 (441)
                      .+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+     +.++.+||+|||+++
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999985 999999999899999999999999999999999999999999999999     455569999999998


Q ss_pred             ccCCC-CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc---------
Q 013558          264 EIDES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------  332 (441)
Q Consensus       264 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~---------  332 (441)
                      ..... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+......         
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            76432 233456789999999999874 5899999999999999999999999998887777776543110         


Q ss_pred             ---------C------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          333 ---------L------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       333 ---------~------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                               +            +..+++++.+||.+||+.||.+||     +++++++||||++++|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI-----SAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC-----CHHHHhCCcccCCCCCC
Confidence                     0            011678999999999999999999     89999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=404.76  Aligned_cols=255  Identities=34%  Similarity=0.592  Sum_probs=210.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....     ..+.+.+|+.+|++++||||+++++++.+..
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKG-----TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECC-----CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            3579999999999999999999886     78899999997643     2345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEEecCCcccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~DFG~a~~~  265 (441)
                      .+|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999975   889999999999877


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccccCC----CCCcHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP----PFLTSE  340 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~  340 (441)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+...+......++    ..++.+
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            6555556678999999999999999999999999999999999999999765544 46667766655433    468999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +++||++||+.||++||     +++++++||||.+..+
T Consensus       282 ~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRL-----TTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHHHTTSCSSGGGSC-----CHHHHHHSTTTTSTTC
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHhcCcccCCCcc
Confidence            99999999999999999     8999999999987643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6e-51  Score=387.66  Aligned_cols=252  Identities=31%  Similarity=0.581  Sum_probs=231.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|.++.     ++..+|+|++.+...   ...+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCC-----CCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            369999999999999999999886     788999999976532   234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~  266 (441)
                      .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988999999999999999999999999999999999999999   788999999999998877


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  342 (441)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+......++.    .+++++.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            66666677899999999998765 899999999999999999999999999999999998888777774    6899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +||.+||+.||.+||     ++.++++||||++
T Consensus       240 ~li~~~l~~dp~~R~-----s~~~~l~h~~~~~  267 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRI-----TSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHHTCSSTTTSC-----CHHHHTTSHHHHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCHHHhc
Confidence            999999999999999     8899999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-51  Score=391.79  Aligned_cols=255  Identities=25%  Similarity=0.436  Sum_probs=215.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|++.      +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999874      678899999976542 22334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9999999986 888888764 67999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Q 013558          269 -SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---------------  331 (441)
                       ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....               
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             22345679999999999976 4589999999999999999999999998887777666643100               


Q ss_pred             --------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          332 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       332 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                    .+...+++++.+||.+||+.||++||     +++++++||||++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKENN  288 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC--
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhcC
Confidence                          11245789999999999999999999     899999999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-51  Score=418.27  Aligned_cols=253  Identities=27%  Similarity=0.445  Sum_probs=212.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            4689999999999999999999886     78899999998653 3344566788999999999999999999999654 


Q ss_pred             -----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                           ..+|+||||++++ |...+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus       135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence                 4689999999764 656653  35999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----------  331 (441)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...+|....-           
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            987766556678999999999999999999999999999999999999999999888777776654210           


Q ss_pred             -----------c---------CCCC-----------CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          332 -----------K---------LPPF-----------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       332 -----------~---------~p~~-----------~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                 .         +|..           .++++++||++||+.||++||     +++|+++||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGG
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC-----CHHHHhcChhhhh
Confidence                       0         0100           156799999999999999999     8999999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-51  Score=393.32  Aligned_cols=259  Identities=27%  Similarity=0.378  Sum_probs=218.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhc---CCCCceeee
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKV---THPFIVQLR  181 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l---~hpnIv~l~  181 (441)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++......  .......+.+|+.+++.+   +||||++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT-----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            345789999999999999999999875     7889999999754321  111123455677777766   499999999


Q ss_pred             EEEEeCC-----EEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcE
Q 013558          182 YSFQTRS-----KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (441)
Q Consensus       182 ~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v  254 (441)
                      +++....     .+++||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            9998765     6899999997 599999987654  9999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc--
Q 013558          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--  332 (441)
Q Consensus       255 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~--  332 (441)
                      ||+|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......  
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999998877666667789999999999999999999999999999999999999999999888887777542111  


Q ss_pred             -------------------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          333 -------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       333 -------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                               ..+.+++++.+||.+||+.||++||     +++++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~h~~~~~~  303 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI-----SAFRALQHSYLHKD  303 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSTTC---
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC-----CHHHHhcCccccCC
Confidence                                     1135789999999999999999999     89999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.5e-52  Score=425.48  Aligned_cols=258  Identities=31%  Similarity=0.558  Sum_probs=236.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECC-----CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            369999999999999999999886     788999999987765555566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~  266 (441)
                      +|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999999998999999999999999999999999999999999999999   567899999999998877


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+......++    ..++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            6665667789999999999976 699999999999999999999999999999999999988766554    36899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +||++||+.||.+||     +++++++||||+...+
T Consensus       260 ~li~~~L~~dp~~R~-----s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRI-----SARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHTSHHHHHHTC
T ss_pred             HHHHHHCCCChhHCc-----CHHHHhhChhhccccc
Confidence            999999999999999     8999999999986544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.8e-51  Score=411.65  Aligned_cols=263  Identities=26%  Similarity=0.445  Sum_probs=216.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN-----TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4689999999999999999999886     78999999997542 3344556788999999999999999999999776 


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence                57999999996 5999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-----------------------CCccccCCCCCCCcchh-cCCCCCCcchhhhHHHHHHHHHcC---------
Q 013558          264 EIDESS-----------------------RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTG---------  310 (441)
Q Consensus       264 ~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~elltG---------  310 (441)
                      ......                       .....+||+.|+|||++ ....|+.++|||||||++|||++|         
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            764322                       23567899999999986 456799999999999999999984         


Q ss_pred             --CCCCCCCCH-----------------HHHHHHHHh------------------------ccccC-------CCCCcHH
Q 013558          311 --QPPFTHANR-----------------QKLQQRIIN------------------------EKVKL-------PPFLTSE  340 (441)
Q Consensus       311 --~~pf~~~~~-----------------~~~~~~i~~------------------------~~~~~-------p~~~s~~  340 (441)
                        .++|.+.+.                 .+....|..                        .....       .+.++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence              444444321                 112222211                        00111       1458999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  383 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  383 (441)
                      +.+||++||+.||.+||     +++++++||||+++.|...+.
T Consensus       338 ~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRI-----TIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHHHHHHSCSSTTTSC-----CHHHHHTCGGGTTTCCTTTC-
T ss_pred             HHHHHHHHhcCCcccCC-----CHHHHhcChhhhhccCcccCc
Confidence            99999999999999999     899999999999999987764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=393.85  Aligned_cols=256  Identities=31%  Similarity=0.592  Sum_probs=219.6

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----------------------hhHHHHHHH
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKA  164 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~  164 (441)
                      ..++|++.+.||+|+||.||+|+++.     +++.||||++.+.....                       ....+.+.+
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            34689999999999999999999876     78899999997654321                       122356889


Q ss_pred             HHHHHHhcCCCCceeeeEEEEe--CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccC
Q 013558          165 ERDILTKVTHPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK  242 (441)
Q Consensus       165 E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk  242 (441)
                      |+.+|++++||||+++++++.+  ...+|+||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  164 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK  164 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999999999999987  67899999999999997754 34679999999999999999999999999999999


Q ss_pred             CCceecCCCCcEEEEecCCccccCCCC-CCccccCCCCCCCcchhcCCC---CCCcchhhhHHHHHHHHHcCCCCCCCCC
Q 013558          243 PENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN  318 (441)
Q Consensus       243 p~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltG~~pf~~~~  318 (441)
                      |+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...+
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999998765432 234568999999999998765   3778999999999999999999999988


Q ss_pred             HHHHHHHHHhccccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          319 RQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       319 ~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      .......+......++  ..+++++.+||.+||+.||++||     +++++++||||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~-----s~~e~l~hp~~~  297 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC-----CHHHHTTCHHHH
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCC-----CHHHHhcCcccc
Confidence            8888888877766655  46899999999999999999999     899999999995

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.1e-51  Score=407.04  Aligned_cols=257  Identities=25%  Similarity=0.485  Sum_probs=225.9

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  192 (441)
                      ...+.||+|+||.||+|+++.     +++.||+|++.....   ...+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEEECC-----CEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcC-----CCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            346789999999999999876     788999999976432   334568899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec--CCCCcEEEEecCCccccCCCC
Q 013558          193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM--DSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl--~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      ||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++......
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            99999999999888765 469999999999999999999999999999999999999  677899999999999877666


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLL  345 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  345 (441)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++    ..+++++++||
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            66667899999999999999999999999999999999999999999999888888887766554    46899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                      .+||+.||.+||     +++++++||||++..|....
T Consensus       324 ~~~L~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~  355 (373)
T 2x4f_A          324 SKLLIKEKSWRI-----SASEALKHPWLSDHKLHSRL  355 (373)
T ss_dssp             HTTSCSSGGGSC-----CHHHHHHSHHHHCHHHHHHH
T ss_pred             HHHcCCChhhCC-----CHHHHhcCcCcCCCchhhhh
Confidence            999999999999     89999999999988765543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-51  Score=411.39  Aligned_cols=249  Identities=31%  Similarity=0.573  Sum_probs=209.5

Q ss_pred             CCCceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEEEEe
Q 013558          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQT  186 (441)
Q Consensus       109 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~  186 (441)
                      .++|.+. ++||+|+||+||+|.++.     +++.||||++...        ..+.+|+.++. ..+||||++++++|..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECC-----CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            3578887 789999999999999886     7899999998643        23567888874 4589999999999876


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEE
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~  257 (441)
                          ...+|+|||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence                567999999999999999998754  5999999999999999999999999999999999999997   7899999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhccccC
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKL  333 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~----~~~~~i~~~~~~~  333 (441)
                      |||+++...........+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..    .+...+..+...+
T Consensus       207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999999876555556789999999999999999999999999999999999999999765432    2556666666665


Q ss_pred             C----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          334 P----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       334 p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +    ..+++++++||++||+.||.+||     +++++++||||..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~  327 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  327 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccC
Confidence            5    46899999999999999999999     8999999999974

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=390.04  Aligned_cols=258  Identities=28%  Similarity=0.588  Sum_probs=206.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|++..     +++.||||++.+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH-----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEcc-----CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            3579999999999999999999875     78899999998765555555677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999999875 6799999999999999999999999999999999999999999999999999987643


Q ss_pred             C-CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      . ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+......+|..++.++.+||.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence            2 223456799999999999998999999999999999999999999988776666666666677788889999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||+.||.+||     +++++++||||...
T Consensus       245 ~~l~~dp~~Rp-----s~~~~l~h~~~~~~  269 (278)
T 3cok_A          245 QLLRRNPADRL-----SLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHSCSSGGGSC-----CHHHHTTSTTTC--
T ss_pred             HHcccCHhhCC-----CHHHHhcCccccCC
Confidence            99999999999     89999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.8e-51  Score=419.25  Aligned_cols=256  Identities=31%  Similarity=0.552  Sum_probs=229.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch----------hHHHHHHHHHHHHHhcCCCCcee
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----------NHVDYMKAERDILTKVTHPFIVQ  179 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~  179 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||+|++.+......          ...+.+.+|+.+|++++||||++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cceEEEeEecccCCeEEEEEEECC-----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            579999999999999999999886     788999999987543321          34567889999999999999999


Q ss_pred             eeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEE
Q 013558          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVML  256 (441)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl  256 (441)
                      +++++.+...+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999999999999889999999999999999999999999999999999999998776   6999


Q ss_pred             EecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC--
Q 013558          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--  334 (441)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p--  334 (441)
                      +|||+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+..+...++  
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            99999998776666667889999999999874 689999999999999999999999999999999999988877665  


Q ss_pred             --CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          335 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       335 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                        ..+++++++||++||+.||.+||     +++++++||||+..
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRC-----TAEEALNSRWIKKY  308 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCC-----CHHHHhcCHhhhhc
Confidence              57899999999999999999999     89999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.4e-51  Score=400.03  Aligned_cols=256  Identities=29%  Similarity=0.498  Sum_probs=218.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC-----CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4689999999999999999999886     788999999975432  222356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999865322


Q ss_pred             ---CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccccCC--CCCcHHH
Q 013558          269 ---SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP--PFLTSEA  341 (441)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~  341 (441)
                         ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.. .....+.......+  ..+++++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence               22346789999999999988775 77899999999999999999999875543 33333333333222  4689999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+||.+||+.||.+||     +++|+++||||+..
T Consensus       239 ~~li~~~L~~dP~~R~-----t~~eil~h~~~~~~  268 (323)
T 3tki_A          239 LALLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhhChhhccc
Confidence            9999999999999999     89999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-50  Score=386.69  Aligned_cols=252  Identities=31%  Similarity=0.556  Sum_probs=218.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|.+.+.||+|+||+||+|+++.     ++..+|+|++.+..  .....+.+.+|+++|++++||||+++++++.+...+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             heeecceeccCCCeEEEEEEEcc-----CCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            69999999999999999999876     78899999998754  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCcc
Q 013558          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~  263 (441)
                      |+||||+++|+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999888543    679999999999999999999999999999999999999   456889999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC---CCCcHH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---PFLTSE  340 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p---~~~s~~  340 (441)
                      ...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+......++   ..++++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            776655566778999999999986 5688999999999999999999999999988888877766555443   347899


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +.+||.+||+.||++||     +++++++||||+.
T Consensus       255 ~~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRP-----SAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSC-----CHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHhcCHHhhc
Confidence            99999999999999999     8999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-50  Score=386.91  Aligned_cols=264  Identities=30%  Similarity=0.535  Sum_probs=233.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh------cchhHHHHHHHHHHHHHhcC-CCCceeee
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------IKKNHVDYMKAERDILTKVT-HPFIVQLR  181 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-hpnIv~l~  181 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.||||++.....      ......+.+.+|+.+|+++. ||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            4689999999999999999999876     788999999975431      11233466789999999995 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +++......|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            99999999999999999999999999888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhc------CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC-
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-  334 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p-  334 (441)
                      +............+||+.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+......++ 
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            98876665566778999999999985      45688999999999999999999999999888888888887766554 


Q ss_pred             ---CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          335 ---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       335 ---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                         ..++.++.+||.+||+.||.+||     +++++++||||++..++.+.
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCTTC-----
T ss_pred             ccccccCHHHHHHHHHHccCCcccCC-----CHHHHHhChHhhhccchhhc
Confidence               35789999999999999999999     89999999999998876653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.1e-51  Score=418.96  Aligned_cols=255  Identities=30%  Similarity=0.584  Sum_probs=228.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|+++++||+|+||+||+|+++.     +++.||||++.+.... ......+.+|+.+|++++||||+++++++.+...+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETT-----TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            69999999999999999999876     7889999999875433 23356788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC---CCCcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~  267 (441)
                      |+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999889999999999999999999999999999999999999995   456899999999988766


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS  343 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  343 (441)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+......++    ..+++++++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            666667789999999999976 489999999999999999999999999999999999988766544    358999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ||++||+.||.+||     ++.++++||||+...
T Consensus       256 li~~~L~~dp~~R~-----t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRI-----TATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCc-----CHHHHhcCHhhccCc
Confidence            99999999999999     899999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.7e-51  Score=397.41  Aligned_cols=266  Identities=28%  Similarity=0.473  Sum_probs=227.4

Q ss_pred             CceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      +|.+. +.||+|+||+||+|+++.     +++.||+|++.+.... ......+.+|+.+++.+. ||||+++++++...+
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKS-----TGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEeeccceeCCCCCeEEEEEEECC-----CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            47777 899999999999999876     7899999999865432 334566888999999995 699999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEEecCCcc
Q 013558          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAK  263 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~DFG~a~  263 (441)
                      .+|+||||+.||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            999999999999999988553  67999999999999999999999999999999999999987   7899999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  339 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~  339 (441)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......++    ..+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            87665555667899999999999999999999999999999999999999999988888888776655443    46899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  387 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~  387 (441)
                      .+.+||.+||+.||.+||     +++++++||||++++|..+......
T Consensus       263 ~~~~li~~~L~~dP~~Rp-----t~~~ll~h~~~~~~~~~~~~~~~~~  305 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRP-----TAEICLSHSWLQQWDFENLFHPEET  305 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSC-----CHHHHTTCGGGCCCCTTCC------
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHhCCHhhcccccccccCccCC
Confidence            999999999999999999     8999999999999999877544433

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.6e-51  Score=388.00  Aligned_cols=260  Identities=30%  Similarity=0.556  Sum_probs=229.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++........   ...+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG-----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC-----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            369999999999999999999886     788999999987543221   235678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a  262 (441)
                      ....++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    8999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCc
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s  338 (441)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......++    ..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence            887655555567899999999999999999999999999999999999999999988888888877665544    5689


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      +.+.+||.+||+.||.+||     +++++++||||+.+.+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSC-----CHHHHHHCHHHHHHHHC
T ss_pred             HHHHHHHHHHccCCHhHCc-----CHHHHHhCHHHHHHHHH
Confidence            9999999999999999999     89999999999876554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-50  Score=392.54  Aligned_cols=257  Identities=30%  Similarity=0.541  Sum_probs=216.3

Q ss_pred             CCceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      +.|++. ++||+|+||+||+|+++.     +++.||||++.+..   ....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            579985 789999999999999775     78899999997643   23345688999999985 799999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc---EEEEecCCccc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE  264 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkl~DFG~a~~  264 (441)
                      +.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999999998889999999999999999999999999999999999999998776   99999999876


Q ss_pred             cCCCC--------CCccccCCCCCCCcchhcC-----CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-------------
Q 013558          265 IDESS--------RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHAN-------------  318 (441)
Q Consensus       265 ~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltG~~pf~~~~-------------  318 (441)
                      .....        .....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||....             
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            53211        1234579999999999975     457899999999999999999999997654             


Q ss_pred             --HHHHHHHHHhccccCC----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          319 --RQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       319 --~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                        ...+...+......+|    ..+++++++||.+||+.||.+||     +++++++||||++..+.
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSTTCC-----
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC-----CHHHHhcChhhcCCCCc
Confidence              2446667777777666    46899999999999999999999     89999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-50  Score=397.44  Aligned_cols=255  Identities=31%  Similarity=0.569  Sum_probs=229.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----cchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++.....     ......+.+.+|+.+++++ +||||++++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRA-----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            469999999999999999999875     788999999876431     1123346678999999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +......|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC------CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC---
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---  334 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p---  334 (441)
                      .+.........+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+.......+......++   
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8776666667899999999999863      3578899999999999999999999999888888888877766554   


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                       ..++.++.+||.+||+.||++||     +++++++||||+
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~  364 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARL-----TAEQALQHPFFE  364 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCc-----CHHHHhcCcccC
Confidence             46889999999999999999999     899999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-50  Score=415.80  Aligned_cols=255  Identities=29%  Similarity=0.564  Sum_probs=226.4

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +|+++++||+|+||+||+|+++.     ++..||+|++.+..... .....+.+|+.+|+.++||||++++++|.+...+
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETT-----TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECC-----CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            59999999999999999999886     78899999998754322 2345688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC---CcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~  267 (441)
                      |+|||||.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++....
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999999999988999999999999999999999999999999999999999764   4599999999998776


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS  343 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  343 (441)
                      .......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..++...+......++    ..+++++++
T Consensus       192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence            66666788999999999986 4699999999999999999999999999999999999988877655    368999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ||++||+.||.+||     +++++++||||+...
T Consensus       271 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          271 LIKQMLQFDSQRRI-----SAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHTCHHHHHHH
T ss_pred             HHHHHCCCChhhCc-----cHHHHhcCcccccCc
Confidence            99999999999999     899999999998653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=401.58  Aligned_cols=257  Identities=27%  Similarity=0.514  Sum_probs=225.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-----hHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+......     ...+.+.+|+.+|++++||||+++++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKE-----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETT-----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceEEEeEEEecCCEEEEEEEECC-----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            469999999999999999999876     789999999987643221     1233466799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCC-chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+.+.+++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999999776 999999988899999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  342 (441)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...      ..........|..+++++.
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG------GGGTTTCCCCSSCCCHHHH
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH------HHHHhhccCCCcccCHHHH
Confidence            8776666667889999999999998876 78899999999999999999999753      2233444556778999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCC------CChhhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS------INWKTLE  382 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~------~~~~~~~  382 (441)
                      +||.+||+.||.+||     +++++++||||+.      .+|+.+.
T Consensus       253 ~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~~~~~~~~~~~~  293 (335)
T 3dls_A          253 SLVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVF  293 (335)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHCTTTTCCCCGGGCCHHHHC
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCccccCCccccccCHHHHh
Confidence            999999999999999     8999999999965      4555554

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-50  Score=395.26  Aligned_cols=250  Identities=32%  Similarity=0.621  Sum_probs=202.1

Q ss_pred             CceEE---eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013558          111 DFEIF---RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (441)
Q Consensus       111 ~y~~~---~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  186 (441)
                      +|++.   +.||+|+||+||+|.++.     +++.||||++.+.      ....+.+|+.+++.+. ||||+++++++.+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKK-----SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETT-----TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECC-----CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            46664   789999999999999886     7899999999753      2345678999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCCcc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAK  263 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~a~  263 (441)
                      ....|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999999999999999999999999999999999999999999999999998766   89999999998


Q ss_pred             ccCCC-CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhccccCCC
Q 013558          264 EIDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIINEKVKLPP  335 (441)
Q Consensus       264 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~-------~~~~~~~i~~~~~~~p~  335 (441)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+       ..++...+..+...++.
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            65433 23456789999999999999999999999999999999999999997643       35677777777766653


Q ss_pred             ----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 ----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                          .+++++++||.+||+.||.+||     +++++++||||++.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~ell~h~w~~~~  277 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCC-----CTTTSTTCGGGCTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCC-----CHHHHhcChhhccC
Confidence                5899999999999999999999     78999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.4e-50  Score=400.46  Aligned_cols=270  Identities=27%  Similarity=0.452  Sum_probs=215.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|.++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC-----CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            3689999999999999999999876     78899999997643 23445567889999999999999999999998665


Q ss_pred             ------EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                            .+|+||||+++ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                  89999999975 7877775  46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----------  331 (441)
                      +...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....           
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            877655445567899999999999999999999999999999999999999999888777766654211           


Q ss_pred             -----------cC--------------CC------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          332 -----------KL--------------PP------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       332 -----------~~--------------p~------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                 .+              |.      ..+.++++||++||+.||.+||     +++++++||||+.  |..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~--~~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV--WYD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHT--TCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC-----CHHHHhCCcchhh--hcC
Confidence                       00              10      0156899999999999999999     8999999999984  333


Q ss_pred             hhhcccCCCCCCCC
Q 013558          381 LEAREMQPKFKPDV  394 (441)
Q Consensus       381 ~~~~~~~p~~~p~~  394 (441)
                      .......||+.|..
T Consensus       328 ~~~~~~~~~~~~~~  341 (371)
T 2xrw_A          328 PSEAEAPPPKIPDK  341 (371)
T ss_dssp             HHHHTCCCCCCCTT
T ss_pred             ccccCCCCCCCCCh
Confidence            33344555665543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.3e-51  Score=410.23  Aligned_cols=263  Identities=31%  Similarity=0.589  Sum_probs=216.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ++|++.+.||+|+||+||+|.++.     +++.||||++.+.....     ......+.+|+.+|++++||||+++++++
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECC-----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            579999999999999999999886     78899999998754321     12223477899999999999999999997


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEEEEecCC
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGL  261 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkl~DFG~  261 (441)
                      . ...+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+
T Consensus       210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5 456899999999999999998888999999999999999999999999999999999999997544   599999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccccCC---
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLP---  334 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~~~~~~p---  334 (441)
                      ++...........+||+.|+|||++.+   ..++.++|||||||++|+|++|..||..... ..+...+......++   
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            998776665667899999999999864   5678899999999999999999999976543 344555555554443   


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhh
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  383 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  383 (441)
                       ..+++++.+||.+||+.||.+||     +++++++||||++.+|.....
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~~~~~  413 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQ  413 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGCCHHHHHHHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCc-----CHHHHhCCcccCChhHHHHHH
Confidence             46899999999999999999999     899999999999988876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-51  Score=398.74  Aligned_cols=258  Identities=30%  Similarity=0.515  Sum_probs=222.8

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      +|++.+.||+|+||+||+|.++.     +++.||+|++.+....  .....+.+.+|+.+|++++||||+++++++.+.+
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQ-----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             heeecceeeecCCeEEEEEEECC-----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            69999999999999999999876     7889999999876432  3455677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 013558          189 KLYLILDFINGGHLFFHLYR----------------------------------------QGIFREDQARFYTAEIVSAV  228 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~L  228 (441)
                      .+|+||||++||+|.+++..                                        ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999988842                                        11246788999999999999


Q ss_pred             HHHHHCCCcccccCCCceecCCCC--cEEEEecCCccccCCCC-----CCccccCCCCCCCcchhcC--CCCCCcchhhh
Q 013558          229 SHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLS--KGHNKDADWWS  299 (441)
Q Consensus       229 ~~LH~~~iiHrDlkp~NILl~~~~--~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws  299 (441)
                      .|||++||+||||||+|||++.++  .+||+|||+++.+....     ......||+.|+|||++.+  ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998777  89999999998653221     2345679999999999975  67899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          300 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       300 lGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |||++|||++|+.||.+.+..+....+......++.    .+++++.+||.+||+.||.+||     +++++++||||++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~hp~~~~  336 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF-----DAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC-----CHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC-----CHHHHhcChhhcc
Confidence            999999999999999999988888888877665543    4789999999999999999999     8999999999987


Q ss_pred             CCh
Q 013558          376 INW  378 (441)
Q Consensus       376 ~~~  378 (441)
                      +.|
T Consensus       337 ~~~  339 (345)
T 3hko_A          337 FSD  339 (345)
T ss_dssp             TSS
T ss_pred             ChH
Confidence            754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-50  Score=398.40  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=215.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++++.||+|+||.||+|.++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ceEEEeEEeeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            579999999999999999999876     78999999986543 2344556788999999999999999999999865  


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence                3569999999 7899888876 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----------  331 (441)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.....           
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            7654  2455789999999999987 7799999999999999999999999999887777666643210           


Q ss_pred             --------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          332 --------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       332 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                          .+.+.+++++.+||.+||+.||.+||     +++++++||||+.+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~-----t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC---
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC-----CHHHHhcChHHHhhcCCc
Confidence                                12346789999999999999999999     899999999999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-50  Score=394.66  Aligned_cols=268  Identities=28%  Similarity=0.425  Sum_probs=226.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD-----TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT-----TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC-----CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            4579999999999999999999875     78899999987653 23444566789999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999999999888887788999999999999999999999999999999999999999999999999999875432


Q ss_pred             -CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------
Q 013558          269 -SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  330 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------------  330 (441)
                       ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+....                
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             233456799999999999875 78999999999999999999999999888776665554211                


Q ss_pred             ---ccC------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccC
Q 013558          331 ---VKL------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  387 (441)
Q Consensus       331 ---~~~------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~  387 (441)
                         ..+            .+.+++++.+||.+||+.||.+||     +++++++||||+...+.....++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~  324 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-----FCAELLHHDFFQMDGFAERFSQELQ  324 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CGGGGGGSHHHHGGGHHHHHHHHHH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC-----CHHHHhcCchhccCChhhhhhHHHh
Confidence               011            135789999999999999999999     8899999999998888776655443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.7e-50  Score=396.21  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=218.4

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceee
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQL  180 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l  180 (441)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++...    ....+.+..|+.+++.+.     ||||+++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHID-----NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECC-----CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445789999999999999999999876     7889999999743    233445678999999996     9999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC--------
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--------  250 (441)
                      ++++...+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.        
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            99999999999999999 889999998764  5999999999999999999999999999999999999975        


Q ss_pred             -----------------CCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC
Q 013558          251 -----------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (441)
Q Consensus       251 -----------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p  313 (441)
                                       ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence                             78999999999987543  23457899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhccccCC--------------------------C--------------------CCcHHHHHHHHH
Q 013558          314 FTHANRQKLQQRIINEKVKLP--------------------------P--------------------FLTSEAHSLLKG  347 (441)
Q Consensus       314 f~~~~~~~~~~~i~~~~~~~p--------------------------~--------------------~~s~~~~~li~~  347 (441)
                      |...+..+....+......+|                          .                    ..++.+.+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            998887776666544322222                          1                    123778899999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ||+.||.+||     +++++++||||+
T Consensus       339 ~L~~dP~~Rp-----ta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRP-----SPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSC-----CHHHHTTSGGGC
T ss_pred             HhcCChhhCC-----CHHHHhcCcccC
Confidence            9999999999     899999999995

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-49  Score=387.58  Aligned_cols=253  Identities=25%  Similarity=0.463  Sum_probs=224.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|+..+.||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.++++++||||+++++++...+..
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~-----~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH-----SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhhccEEeccCCCeEEEEEEECC-----CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            38888999999999999999875     78899999997643   23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            999999999999988754 579999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc---CCCCCcHHHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTSEAHSLLK  346 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~  346 (441)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......   .+..+++++.+||.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            345678999999999999999999999999999999999999999988888777777654322   23457899999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +||+.||++||     +++++++||||....
T Consensus       277 ~~l~~dp~~Rp-----s~~ell~hp~~~~~~  302 (321)
T 2c30_A          277 RMLVRDPQERA-----TAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHSCSSTTTSC-----CHHHHHTSGGGGGCC
T ss_pred             HHccCChhhCc-----CHHHHhcChhhccCC
Confidence            99999999999     899999999997543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-50  Score=399.81  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=216.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|++.+.||+|+||+||+|+++.     +++.||||++..+...       ..+|+.+|+.++||||++++++|..
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~   71 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIE-----SGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYT   71 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETT-----TCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeee
Confidence            345689999999999999999999876     7899999998754321       2369999999999999999999854


Q ss_pred             --------------------------------------CCEEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHH
Q 013558          187 --------------------------------------RSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEI  224 (441)
Q Consensus       187 --------------------------------------~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi  224 (441)
                                                            ...+++||||+++ +|.+.+.    ..+.+++..++.++.||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi  150 (383)
T 3eb0_A           72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL  150 (383)
T ss_dssp             C-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence                                                  3458999999985 7666554    45789999999999999


Q ss_pred             HHHHHHHHHCCCcccccCCCceecC-CCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHH
Q 013558          225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGI  302 (441)
Q Consensus       225 ~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv  302 (441)
                      +.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.........+||+.|+|||++.+. .++.++|||||||
T Consensus       151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9999999999999999999999998 6899999999999987666666677899999999998875 4899999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------------------cccCCCCCcHHHHHHHHHhcccCc
Q 013558          303 LLYEMLTGQPPFTHANRQKLQQRIINE-----------------------------KVKLPPFLTSEAHSLLKGLLHKDP  353 (441)
Q Consensus       303 vl~elltG~~pf~~~~~~~~~~~i~~~-----------------------------~~~~p~~~s~~~~~li~~~L~~dP  353 (441)
                      ++|||++|+.||.+.+..+....+...                             ...++..+++++.+||.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999998887777766531                             011455689999999999999999


Q ss_pred             CCCCCCCCCChHHhhhCcccCCCC
Q 013558          354 SKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       354 ~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      .+||     +++++++||||+.+.
T Consensus       311 ~~R~-----t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          311 DLRI-----NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GGSC-----CHHHHHTSGGGHHHH
T ss_pred             hhCC-----CHHHHhcCHHHHHHH
Confidence            9999     899999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.1e-51  Score=393.51  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=220.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.............+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            4589999999999999999999876     78999999998766555666778899999999999999999999987643


Q ss_pred             ----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                          ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                4599999999999999999889999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC----CCC
Q 013558          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPF  336 (441)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~----p~~  336 (441)
                      +....    .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......    +..
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            54322    2334679999999999999999999999999999999999999999988887777766554433    246


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +++++.+||.+||+.||.+||     +..+++.|+|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~-----~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRY-----QTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC-----SSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhCh-----hhHHHHHHHHHHH
Confidence            899999999999999999999     6788999999863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-50  Score=389.03  Aligned_cols=250  Identities=28%  Similarity=0.393  Sum_probs=206.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh-cCCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~  188 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++...........+ ...|+..+.+ .+||||+++++++.+.+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE-----DGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECC-----CCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            369999999999999999999886     7889999998654333333333 3445555544 48999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      .+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 66888887665 4699999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--ccCCCCCcHHHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTSEAHSLL  345 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  345 (441)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|..|+....   ....+....  ..++..+++++.+||
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHH
Confidence            655666789999999999886 68999999999999999999977665432   223333322  123467899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+||+.||++||     +++++++||||+.
T Consensus       286 ~~~L~~dP~~Rp-----t~~ell~hp~~~~  310 (311)
T 3p1a_A          286 VMMLEPDPKLRA-----TAEALLALPVLRQ  310 (311)
T ss_dssp             HHHSCSSTTTSC-----CHHHHHTSGGGSC
T ss_pred             HHHcCCChhhCc-----CHHHHHhCccccC
Confidence            999999999999     8999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-50  Score=395.84  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=218.5

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++...... ......+.+|+.+|+.++||||+++++++..  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT-----TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC-----CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3579999999999999999999876     7889999998765432 2333456789999999999999999999987  


Q ss_pred             ------CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                            .+.+|+||||+.+ +|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence                  4579999999986 676666554 67999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCC-----CCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC
Q 013558          260 GLAKEIDE-----SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  333 (441)
Q Consensus       260 G~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~  333 (441)
                      |+++.+..     .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99987542     222345678999999999976 558999999999999999999999999988888777776533222


Q ss_pred             CCC--------------------------------CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          334 PPF--------------------------------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       334 p~~--------------------------------~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ++.                                .++++.+||.+||+.||.+||     +++|+++||||++..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGSSSC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC-----CHHHHhCCCCcCCCCC
Confidence            221                                267899999999999999999     8999999999987544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-49  Score=382.29  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=215.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.++++++||||+++++++.+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTI-----LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETT-----TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECC-----CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            335689999999999999999999876     788999999976655556667789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      .+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----cCCCCCcH
Q 013558          267 ESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----KLPPFLTS  339 (441)
Q Consensus       267 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----~~p~~~s~  339 (441)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+......     ..+..+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            432  23446799999999999999999999999999999999999999999887776666554432     24567899


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLG  358 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~  358 (441)
                      .+.++|.+||++||.+||+
T Consensus       243 ~l~~li~~~l~~dp~~R~~  261 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCS
T ss_pred             HHHHHHHHHhcCCHhHccc
Confidence            9999999999999999993

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.2e-50  Score=384.97  Aligned_cols=253  Identities=34%  Similarity=0.640  Sum_probs=226.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL-----TGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeccCCCCceEEEEEECC-----CCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            369999999999999999999875     788999999976432   223457889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~  266 (441)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999888899999999999999999999999999999999999999   788999999999997644


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      .. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+......++    ..+++++.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            32 23456799999999999999999999999999999999999999999988888888887765443    56899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||.+||+.||++||     +++++++||||++.
T Consensus       240 ~li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~  268 (304)
T 2jam_A          240 DFICHLLEKDPNERY-----TCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHHCSSTTTSC-----CHHHHHTSHHHHSS
T ss_pred             HHHHHHcCCChhHCc-----CHHHHhcCccccCC
Confidence            999999999999999     89999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-49  Score=387.19  Aligned_cols=252  Identities=25%  Similarity=0.441  Sum_probs=214.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~-  186 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++....      .+.+.+|+.+|+++. ||||+++++++.+ 
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCceEEEEEecccCCeEEEEEEECC-----CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            4689999999999999999999876     78899999986432      346789999999997 9999999999998 


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccc
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~  264 (441)
                       ....++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence             678999999999999988774   489999999999999999999999999999999999999777 899999999998


Q ss_pred             cCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCC-CHHHHHHHHH-------------hc
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRII-------------NE  329 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~-~~~~~~~~i~-------------~~  329 (441)
                      ..........+||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+.             ..
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            766666667789999999999987 67899999999999999999999999543 3222222221             11


Q ss_pred             cccC------------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          330 KVKL------------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       330 ~~~~------------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ...+                        +..+++++.+||.+||+.||.+||     +++++++||||+++.|+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSGGGTTCC--
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC-----CHHHHhcCccHhhhccC
Confidence            1111                        122789999999999999999999     89999999999998765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=393.76  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=212.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++......  .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL-----TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC-----CCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            579999999999999999999876     7889999998754321  111134469999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999999975 888888765 45999999999999999999999999999999999999999999999999999865432


Q ss_pred             -CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Q 013558          269 -SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---------------  331 (441)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....               
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22345678999999999986 5689999999999999999999999999888877776654211               


Q ss_pred             ---------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          332 ---------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       332 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                     ...+.+++++.+||.+||+.||.+||     +++|+++||||.++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI-----SAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC-----CHHHHhcChhhhhccc
Confidence                           01235788999999999999999999     8999999999987653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-49  Score=389.86  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=222.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++++.||+|+||+||+|++..     +++.||||++...........+.+.+|+.+|++++||||+++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             heeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            59999999999999999999875     7899999999865444455567788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          191 YLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      |+||||+.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       130 ~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          130 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            999999974 7777775 456899999999999999999999999999999999999999999999999999987643  


Q ss_pred             CCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc--CCCCCcHHHHHH
Q 013558          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLTSEAHSL  344 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~l  344 (441)
                       ....+||+.|+|||++.   ...++.++|||||||++|||++|+.||...+.......+......  .+..+++.+++|
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence             34568999999999985   567899999999999999999999999988877766666654332  245789999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      |.+||+.||++||     +++++++||||....
T Consensus       286 i~~~l~~dP~~Rp-----s~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          286 VDSCLQKIPQDRP-----TSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHTTCHHHHSCC
T ss_pred             HHHHcccChhhCc-----CHHHHhhChhhhccC
Confidence            9999999999999     899999999997543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-50  Score=390.69  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=209.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||||++....  .....+.+.+|+.+|++++||||++++++|.+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT-----TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC-----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            469999999999999999999886     78899999997643  3345567889999999999999999999986543 


Q ss_pred             --------------------------------------------------------EEEEEEeccCCCchHHHHHHcCC-
Q 013558          189 --------------------------------------------------------KLYLILDFINGGHLFFHLYRQGI-  211 (441)
Q Consensus       189 --------------------------------------------------------~~~lv~E~~~gg~L~~~l~~~~~-  211 (441)
                                                                              .+|+||||++|++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999987643 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-------------CCccccC
Q 013558          212 --FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCG  276 (441)
Q Consensus       212 --~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~g  276 (441)
                        ..+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......             .....+|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              5666789999999999999999999999999999999999999999999998765432             2344679


Q ss_pred             CCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-CCCCCcHHHHHHHHHhcccCcCC
Q 013558          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSK  355 (441)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~  355 (441)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+..  .......+...... .+...++++.+||.+||+.||.+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            9999999999999999999999999999999998776521  12222223222111 11245678899999999999999


Q ss_pred             CCCCCCCChHHhhhCcccCCC
Q 013558          356 RLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       356 R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||     +++++++||||+++
T Consensus       317 Rp-----s~~~~l~~~~f~~~  332 (332)
T 3qd2_B          317 RP-----EATDIIENAIFENL  332 (332)
T ss_dssp             SC-----CHHHHHHSTTCCCC
T ss_pred             CC-----CHHHHhhchhhhcC
Confidence            99     89999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-50  Score=396.43  Aligned_cols=265  Identities=28%  Similarity=0.471  Sum_probs=227.2

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ...+..++|++++.||+|+||+||+|+++.     +++.||+|++....  .....+.+.+|+.+|+.++||||++++++
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   99 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGA   99 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECC-----CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence            345667899999999999999999999876     78899999997642  34455678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +...+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999999999999999999988999999999999999999999986 9999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHH-----------------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR-----------------  325 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~-----------------  325 (441)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...                 
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            765332 23456899999999999999999999999999999999999999987765543322                 


Q ss_pred             -------------------------HHhcc-ccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          326 -------------------------IINEK-VKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       326 -------------------------i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                               +.... ...+ ..++.++.+||.+||+.||.+||     +++++++||||+..+|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSHHHHHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC-----CHHHHhhChHhhcchH
Confidence                                     11111 1122 34789999999999999999999     8999999999987766


Q ss_pred             hhh
Q 013558          379 KTL  381 (441)
Q Consensus       379 ~~~  381 (441)
                      ..+
T Consensus       334 ~~~  336 (360)
T 3eqc_A          334 EEV  336 (360)
T ss_dssp             SCC
T ss_pred             hhh
Confidence            554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-49  Score=380.33  Aligned_cols=257  Identities=30%  Similarity=0.580  Sum_probs=230.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+... .....+.+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcC-----CCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            469999999999999999999875     788999999976543 23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC---CcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkl~DFG~a~~~~  266 (441)
                      +|+||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888899999999999999999999999999999999999999764   479999999998776


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..++...+..+...++    ..+++++.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            65555566799999999998764 89999999999999999999999999998888888877765443    46899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +||.+||+.||.+||     +++++++||||+...|
T Consensus       255 ~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~  285 (287)
T 2wei_A          255 DLIRKMLTFHPSLRI-----TATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHSHHHHHHCC
T ss_pred             HHHHHHcccChhhCc-----CHHHHhcCHHHhcccc
Confidence            999999999999999     8999999999986554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-49  Score=399.80  Aligned_cols=252  Identities=30%  Similarity=0.470  Sum_probs=213.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---  187 (441)
                      +|+++++||+|+||+||+|+++.     +++.||||++.....       ...+|+++|+.++|||||+++++|...   
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             eEEeeeEEeeCCCEEEEEEEECC-----CCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            69999999999999999999875     788999999875431       123699999999999999999998542   


Q ss_pred             ---CEEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-CcEEEEec
Q 013558          188 ---SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDF  259 (441)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkl~DF  259 (441)
                         ..+++||||+++ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+||
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence               247899999986 5655543    34679999999999999999999999999999999999999965 67899999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------  329 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---------  329 (441)
                      |+++.+.........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...         
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987665556677899999999999765 7999999999999999999999999998877666665431         


Q ss_pred             --------ccc------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          330 --------KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       330 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                              .+.            +++.+++++++||.+||++||.+||     +++++++||||+++.+..
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGGGCTT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC-----CHHHHhCCHhhccccccc
Confidence                    111            2346789999999999999999999     899999999998765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=388.38  Aligned_cols=255  Identities=27%  Similarity=0.489  Sum_probs=215.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSF  184 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~  184 (441)
                      +..++|++++.||+|+||+||+|.+.      +++.||||++.... ......+.+.+|+.+|+.++|  |||+++++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            45668999999999999999999864      67889999997654 234455778899999999986  9999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+...+|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus        79 ~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           79 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             ECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             eeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            999999999995 5789999999999999999999999999999999999999999999999996 68899999999987


Q ss_pred             cCCCCC---CccccCCCCCCCcchhcC-----------CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh-
Q 013558          265 IDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN-  328 (441)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~-  328 (441)
                      ......   ....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+.. 
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            643322   335689999999999975           678889999999999999999999998643 3334444443 


Q ss_pred             -ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          329 -EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       329 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                       ....+|...+.++.+||.+||+.||.+||     +++++++||||+.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~  279 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQI  279 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHS
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCC-----CHHHHHhCccccc
Confidence             24456778889999999999999999999     8999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-49  Score=396.71  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=213.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      .+|++.++||+|+||+||+|+++.     ++ .+|+|++......       ..+|+++|+.++||||++++++|...+ 
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~-----~~-~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE-----SD-EVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT-----TE-EEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC-----CC-eEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            469999999999999999999874     34 4888887654321       236999999999999999999996543 


Q ss_pred             -----EEEEEEeccCCCchHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcEEEEec
Q 013558          189 -----KLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDF  259 (441)
Q Consensus       189 -----~~~lv~E~~~gg~L~~~l---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~DF  259 (441)
                           .+|+||||++++.+....   .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                 389999999875433222   2356799999999999999999999999999999999999999 7999999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------  330 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--------  330 (441)
                      |+|+.+.........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+....        
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987666666678899999999999765 58999999999999999999999999988777666664310        


Q ss_pred             ---------c------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          331 ---------V------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       331 ---------~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                               .            .++..+++++.+||.+||+.||.+||     ++.++++||||+++.|...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL-----TAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGSTTTSSCC
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC-----CHHHHhcChhhhhhccccc
Confidence                     0            13345889999999999999999999     8999999999999877543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.3e-50  Score=393.16  Aligned_cols=264  Identities=28%  Similarity=0.507  Sum_probs=233.3

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhH--------------HHHHHHHHHHHHhc
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------------VDYMKAERDILTKV  172 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l  172 (441)
                      ...++|++.+.||+|+||.||+|++       +++.||||++..........              .+.+.+|+.+++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            3457899999999999999999987       56889999998765432221              26788999999999


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCchHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCC
Q 013558          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH------LYR--QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKP  243 (441)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------l~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp  243 (441)
                      +||||+++++++.+.+.+|+||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus       101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            999999999999999999999999999999888      655  5679999999999999999999999 9999999999


Q ss_pred             CceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCC-CCCC-cchhhhHHHHHHHHHcCCCCCCCCCH-H
Q 013558          244 ENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNK-DADWWSVGILLYEMLTGQPPFTHANR-Q  320 (441)
Q Consensus       244 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvvl~elltG~~pf~~~~~-~  320 (441)
                      +|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||...+. .
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             HhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999999999999999876443 34556899999999999887 6666 89999999999999999999988776 7


Q ss_pred             HHHHHHHhccccCC-------------------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          321 KLQQRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       321 ~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      ++...+......+|                   ..++.++.+||.+||+.||.+||     +++++++||||++.+|..+
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~~~~~~~  334 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDALKHEWLADTNIEDL  334 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC-----CHHHHhcCccccCCCHHHH
Confidence            78888877777777                   67899999999999999999999     8999999999999999886


Q ss_pred             hh
Q 013558          382 EA  383 (441)
Q Consensus       382 ~~  383 (441)
                      ..
T Consensus       335 ~~  336 (348)
T 2pml_X          335 RE  336 (348)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.2e-49  Score=375.24  Aligned_cols=255  Identities=22%  Similarity=0.414  Sum_probs=220.0

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  186 (441)
                      ....|++.+.||+|+||+||+|.+..     ++..||+|++..... .....+.+.+|+.+|+.++||||+++++++.. 
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecC-----CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            34458999999999999999999876     788999999986543 34456778899999999999999999999875 


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecC-CCCcEEEEecC
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFG  260 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkl~DFG  260 (441)
                         ...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence               4579999999999999999998889999999999999999999999999  99999999999998 78999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcc--ccCCCCC
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEK--VKLPPFL  337 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~~~--~~~p~~~  337 (441)
                      ++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+....  ..++...
T Consensus       178 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T 1t4h_A          178 LATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             GGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             Cccccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence            99764433 3445689999999998874 58999999999999999999999998744 444444444432  2345567


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ++++.+||.+||+.||.+||     +++++++||||++
T Consensus       256 ~~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~f~~  288 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhhCC-----CHHHHhhCccccc
Confidence            89999999999999999999     8999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.8e-49  Score=382.10  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ...+..++|++.+.||+|+||+||+|++       .++.||||++..... .....+.+.+|+.+|++++||||++++++
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-------HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-------CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3456677899999999999999999986       456799999876543 34455678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCCcEEEEe
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      +.+...+++||||+++|+|.+++...+.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence            9999999999999999999999987654   999999999999999999999999  99999999999999999999999


Q ss_pred             cCCccccCCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hccccCCC
Q 013558          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPP  335 (441)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~  335 (441)
                      ||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.  .....+|.
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            99998644322 2345689999999999999999999999999999999999999999988888777764  34556788


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++++.+||.+||+.||.+||     +++++++
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~  291 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRP-----SFATIMD  291 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999999999     7888876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=382.24  Aligned_cols=259  Identities=27%  Similarity=0.484  Sum_probs=225.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEEE--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ--  185 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  185 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.  
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            3689999999999999999999875     78899999998754322 345567889999999999999999999984  


Q ss_pred             eCCEEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +...+|+||||+.++ |.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            456899999999886 7677665  3579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC---CCCccccCCCCCCCcchhcCCCC--CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCc
Q 013558          264 EIDES---SRSNSMCGTTEYMAPEILLSKGH--NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (441)
Q Consensus       264 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s  338 (441)
                      .....   .......||+.|+|||++.+...  +.++|||||||++|+|++|..||...+..+....+......++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence            76432   22345679999999999986543  77899999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      +++.+||.+||+.||.+||     +++++++||||+....
T Consensus       238 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHHHHccCChhhCC-----CHHHHhcCcccccCCC
Confidence            9999999999999999999     8999999999986543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-49  Score=389.23  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=217.1

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||||++....  .....+.+.+|+.+|++++||||+++++++...  
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            579999999999999999999876     78899999997532  334456788999999999999999999999764  


Q ss_pred             ---CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                         ..+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence               479999999975 89888865 5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Q 013558          265 IDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------  331 (441)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------  331 (441)
                      .....    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....        
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            54322    1345689999999998764 5589999999999999999999999998877766666542100        


Q ss_pred             -----------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 -----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 -----------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                             .+.+.+++++.+||.+||+.||.+||     +++++++||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  320 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhhc
Confidence                                   11245789999999999999999999     89999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9e-50  Score=388.29  Aligned_cols=261  Identities=31%  Similarity=0.613  Sum_probs=219.4

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ++|++.+.||+|+||.||+|.++.     +++.||||++.+....     .......+.+|+.+|+.++||||+++++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            369999999999999999999876     7889999999765321     122334578899999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc---EEEEecCC
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL  261 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkl~DFG~  261 (441)
                      ..+. +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7665 8999999999999999988889999999999999999999999999999999999999987665   99999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccccCC---
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP---  334 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~~~~p---  334 (441)
                      ++...........+||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .+...+......+.   
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98776544344567999999999974   467899999999999999999999999765432 34445555444332   


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                       ..+++++.+||.+||+.||.+||     +++++++||||++.+|...
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rp-----s~~~~l~h~~~~~~~~~~~  286 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRK  286 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGCCHHHHHH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCC-----CHHHHhhCcCcCCHHHHHH
Confidence             46899999999999999999999     8899999999998877543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.1e-49  Score=392.36  Aligned_cols=258  Identities=22%  Similarity=0.402  Sum_probs=224.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+..++|++.+.||+|+||+||+|++.+...  ...+..||||++....  .....+.+.+|+.+|+.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            34556789999999999999999999864322  2356789999997642  344566788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +++.+.+.+|+||||++||+|.+++...+                .+++.++..++.||+.||.|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998753                47899999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      |||+.+|.+||+|||+++.+....   ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999998764432   2334567889999999999999999999999999999999 999999988888


Q ss_pred             HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +...+... ....|..++.++.+||.+||+.||.+||     +++++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~  357 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  357 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            88777665 3557778999999999999999999999     8888886

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2e-49  Score=393.26  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  187 (441)
                      ++|++++.||+|+||.||+|.++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            589999999999999999999876     78999999986543 2334556788999999999999999999999754  


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                5689999999 6799888865 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------  330 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~------------  330 (441)
                      .....  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....            
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            75432  345689999999999987 678999999999999999999999999988777766664310            


Q ss_pred             -----------cc--------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          331 -----------VK--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       331 -----------~~--------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                 ..        ....+++++.+||.+||+.||.+||     +++++++||||+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc-----CHHHHhcChhhhhccC
Confidence                       00        1134688999999999999999999     8999999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-49  Score=389.59  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=216.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.......  ....+.+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            4689999999999999999999875     78899999997543221  1122457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .+.+++||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999999986 788887655 46899999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc-----------
Q 013558          266 DES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----------  332 (441)
Q Consensus       266 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~-----------  332 (441)
                      ... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+...++......           
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            432 234557899999999999764 5899999999999999999999999998888877777643110           


Q ss_pred             -----------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          333 -----------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       333 -----------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                                       +...++.++++||.+||+.||.+||     +++|+++||||++..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSSSCC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC-----CHHHHhcChhhhcCCCC
Confidence                             0134678999999999999999999     89999999999876543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-49  Score=378.03  Aligned_cols=258  Identities=23%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++++.||+|+||+||+|+++.     +++.||+|++..... .....+.+.++..+++.++||||+++++++.
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            3556789999999999999999999876     789999999976432 2333444555666688889999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecC
Q 013558          186 TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                      +.+..|+||||++| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence            99999999999975 77666643    46899999999999999999999998 99999999999999999999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchh----cCCCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHH-HhccccCC
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI-INEKVKLP  334 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i-~~~~~~~p  334 (441)
                      +++............||+.|+|||++    .+..++.++|||||||++|+|++|+.||.. .........+ .......+
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP  235 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred             CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence            99887665555566899999999996    456788999999999999999999999986 3333333333 33333333


Q ss_pred             -CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                       ..+++++.+||.+||+.||++||     +++++++||||+.
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp-----t~~e~l~hp~f~~  272 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERP-----TYPELMQHPFFTL  272 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCc-----CHHHHHhCccccc
Confidence             46899999999999999999999     8999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.6e-49  Score=393.19  Aligned_cols=255  Identities=27%  Similarity=0.475  Sum_probs=216.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--CCCceeeeEEEE
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQ  185 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~  185 (441)
                      ...+|++++.||+|+||+||+|.+.      .++.||||++..... .....+.+.+|+.+|+.+.  ||||+++++++.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            3456999999999999999999864      578899999976543 3445677899999999996  599999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ..+.+|+||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9999999999 56789999999989999999999999999999999999999999999999995 689999999999876


Q ss_pred             CCCC---CCccccCCCCCCCcchhcC-----------CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc-
Q 013558          266 DESS---RSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE-  329 (441)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~~-  329 (441)
                      ....   .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+... 
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            4332   2345689999999999975           368889999999999999999999998653 33445555543 


Q ss_pred             -cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                       ...+|...+.++.+||.+||+.||.+||     +++++++||||+..
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~  327 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHSC
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCC-----CHHHHhhCcCcccc
Confidence             3456777899999999999999999999     89999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.5e-49  Score=383.23  Aligned_cols=273  Identities=23%  Similarity=0.346  Sum_probs=206.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||+||+|+++...  .....||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            4466778999999999999999999876511  1224799999976543 334466788999999999999999999999


Q ss_pred             EeCCEE------EEEEeccCCCchHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          185 QTRSKL------YLILDFINGGHLFFHLYRQG------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       185 ~~~~~~------~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      ......      ++||||+.+|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            887665      99999999999999986543      599999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 013558          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~  328 (441)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            999999999987644322   223456788999999999999999999999999999999 9999999888888877766


Q ss_pred             c-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCC-------hHHhhhCcccCCCChhhhhhcc
Q 013558          329 E-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGG-------VDAIKHHKWFRSINWKTLEARE  385 (441)
Q Consensus       329 ~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~-------~~~i~~h~~f~~~~~~~~~~~~  385 (441)
                      . ....+..+++++.+||.+||+.||.+||     +       +++++.|+|+....+..+....
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRP-----SFTCLRMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHHHHHHC---------------
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            5 4567788999999999999999999999     6       8889999999877666555433

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.4e-49  Score=381.49  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=221.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEE-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-  185 (441)
                      ++|++.+.||+|+||.||+|++..    .+++.||+|++....... .....+.+|+.+++.+   +||||+++++++. 
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             hceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            579999999999999999999852    267899999997643221 1122355677777766   8999999999987 


Q ss_pred             ----eCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEec
Q 013558          186 ----TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (441)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DF  259 (441)
                          ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                5668999999998 59999998754  4999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------  330 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---------  330 (441)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....         
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            99987654444556789999999999999999999999999999999999999999988877777765321         


Q ss_pred             ------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          331 ------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       331 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                        ..+...+++++++||.+||+.||.+||     ++.++++||||+++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC-----CHHHHhcCccccccchhh
Confidence                              113356889999999999999999999     899999999999887643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=384.50  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=215.9

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+++|++++||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence            34679999999999999999999886     788999999976543  23356678899999999999999999999876


Q ss_pred             C--EEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec----CCCCcEEEEe
Q 013558          188 S--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTD  258 (441)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkl~D  258 (441)
                      .  .+|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            5  88999999999999999986543   9999999999999999999999999999999999999    8888999999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhc--------CCCCCCcchhhhHHHHHHHHHcCCCCCCCCC----HHHHHHHH
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILL--------SKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRI  326 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvvl~elltG~~pf~~~~----~~~~~~~i  326 (441)
                      ||+++...........+||+.|+|||++.        +..++.++|||||||++|||++|+.||....    ..+...++
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            99999877666666778999999999986        5778999999999999999999999997432    34455555


Q ss_pred             Hhccc-------------------c------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCc
Q 013558          327 INEKV-------------------K------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  371 (441)
Q Consensus       327 ~~~~~-------------------~------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  371 (441)
                      ..+.+                   .      ++..+++.+.+||++||+.||++||     +++|+++||
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~-----s~~ell~h~  304 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFAET  304 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc-----cHHHhhhcc
Confidence            54432                   1      1123456889999999999999999     899999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-49  Score=373.49  Aligned_cols=255  Identities=29%  Similarity=0.502  Sum_probs=220.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECC-----CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            469999999999999999999875     788999999976542  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC-
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  268 (441)
                      .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999999999987778999999999999999999999999999999999999999999999999999865322 


Q ss_pred             --CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccccCC--CCCcHHHH
Q 013558          269 --SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP--PFLTSEAH  342 (441)
Q Consensus       269 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~  342 (441)
                        ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.. .....+.......+  ..+++++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              22345689999999999987765 77899999999999999999999875543 33333433332222  46899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||.+||+.||.+||     +++++++||||+..
T Consensus       240 ~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  268 (276)
T 2yex_A          240 ALLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             HHHHHHCCCCchhCC-----CHHHHhcCccccCh
Confidence            999999999999999     89999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-48  Score=388.71  Aligned_cols=255  Identities=28%  Similarity=0.424  Sum_probs=216.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|.+.+.||+|+||+||+|.++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            589999999999999999999876     78999999997643 234455678899999999999999999999987765


Q ss_pred             E------EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          190 L------YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       190 ~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .      |+||||+. ++|...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            4      99999997 5787766  3459999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-----------  331 (441)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....           
T Consensus       193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            7543  2445689999999999987 7789999999999999999999999999887777666643110           


Q ss_pred             --------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          332 --------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       332 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                                          .+++.+++++.+||.+||+.||.+||     +++++++||||+.+....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC-----CHHHHhcCcccccCCCcc
Confidence                                11245789999999999999999999     899999999999876544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5e-51  Score=406.16  Aligned_cols=251  Identities=18%  Similarity=0.212  Sum_probs=209.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHH---HHHHhcCCCCceeee----
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---DILTKVTHPFIVQLR----  181 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~l~----  181 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+   ++|++++|||||+++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C-----CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEECC-----CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            5679999999999999999999865     7889999999876555566677889999   455566899999998    


Q ss_pred             ---EEEEeCCE-----------------EEEEEeccCCCchHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHC
Q 013558          182 ---YSFQTRSK-----------------LYLILDFINGGHLFFHLYRQGIFRE-------DQARFYTAEIVSAVSHLHKC  234 (441)
Q Consensus       182 ---~~~~~~~~-----------------~~lv~E~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qi~~~L~~LH~~  234 (441)
                         +++.+.+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               77766542                 89999999 6799999987665665       77888999999999999999


Q ss_pred             CCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCC-----------CCCCcchhhhHHHH
Q 013558          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-----------GHNKDADWWSVGIL  303 (441)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGvv  303 (441)
                      ||+||||||+||||+.+|.+||+|||+++....  .....+| +.|+|||++.+.           .++.++|||||||+
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999986433  3456678 999999999987           89999999999999


Q ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          304 LYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       304 l~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +|||++|+.||...+.......+    ...+..+++++.+||.+||+.||.+||     ++.++++||||+++.
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~  367 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCC-----CHHHHHTSHHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCC-----CHHHHhhChHHHHHH
Confidence            99999999999765544333322    233467899999999999999999999     899999999998653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-48  Score=371.78  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=213.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      ++|++++.||+|+||+||+|.++.     +++.||+|++...... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRL-----DGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             chhhhhhhhcCCCceEEEEEEEcC-----CCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            369999999999999999999876     7889999999865432 23345677899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC-------------
Q 013558          189 KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------  251 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-------------  251 (441)
                      .+++||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999999765    679999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHH
Q 013558          252 ------GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ  324 (441)
Q Consensus       252 ------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~  324 (441)
                            ..+||+|||++......   ....||+.|+|||++.+. .++.++|||||||++|+|++|..++....   ...
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHH
T ss_pred             cccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHH
Confidence                  47999999999876543   334699999999999876 56689999999999999999998875442   233


Q ss_pred             HHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          325 RIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       325 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+... ...+|..+++++.+||.+||+.||.+||     +++++++||||.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP-----SAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSC-----CHHHHHTCTTC---
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCC-----CHHHHhhChHhhhh
Confidence            44443 3456778999999999999999999999     89999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-48  Score=395.53  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=215.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc------CCCCceeeeE
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV------THPFIVQLRY  182 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~  182 (441)
                      ..+|+++++||+|+||+||+|.++.     +++.||||++....    ...+.+.+|+.+++.+      +|+||+++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK-----VHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC-----CCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4579999999999999999999876     78999999997542    2334567788888877      5779999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc--EEEEe
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTD  258 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkl~D  258 (441)
                      ++.....+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence            9999999999999996 58988887764  4999999999999999999999999999999999999999987  99999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-------
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------  331 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-------  331 (441)
                      ||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....-       
T Consensus       246 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          246 FGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            999976543  34467899999999999999999999999999999999999999999888777666543100       


Q ss_pred             ----------------------------------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCC
Q 013558          332 ----------------------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS  359 (441)
Q Consensus       332 ----------------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~  359 (441)
                                                                          .++...++++.+||++||+.||++||  
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp--  401 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM--  401 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC--
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC--
Confidence                                                                01123478899999999999999999  


Q ss_pred             CCCChHHhhhCcccCCC
Q 013558          360 GPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       360 ~~~~~~~i~~h~~f~~~  376 (441)
                         +++|+++||||+..
T Consensus       402 ---ta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          402 ---TPGQALRHPWLRRR  415 (429)
T ss_dssp             ---CHHHHHTSTTTC--
T ss_pred             ---CHHHHhCChhhccC
Confidence               89999999999853

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.7e-49  Score=379.83  Aligned_cols=260  Identities=30%  Similarity=0.496  Sum_probs=221.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETT-----TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             cceeecceeccCCCeEEEEEEEcC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            579999999999999999999875     78899999987543   3345678889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC-
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-  267 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  267 (441)
                      +|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999988876 46799999999999999999999999999999999999999999999999998754311 


Q ss_pred             CCCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc---CCCCCcH
Q 013558          268 SSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTS  339 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~  339 (441)
                      ........||+.|+|||++.     +..++.++|||||||++|+|++|..||...+.......+......   .+..++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence            11233467999999999984     677899999999999999999999999998887777776655432   3456889


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                      ++.+||.+||+.||.+||     +++++++||||+++.|....
T Consensus       251 ~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  288 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRP-----SAAQLLEHPFVSSITSNKAL  288 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSC-----CHHHHTTSTTTTTCCCCHHH
T ss_pred             HHHHHHHHHcccChhhCC-----CHHHHhcChHHhhhccchhH
Confidence            999999999999999999     89999999999999876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-48  Score=386.87  Aligned_cols=259  Identities=24%  Similarity=0.401  Sum_probs=210.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--------cchhHHHHHHHHHHHHHhcCCCCce
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--------IKKNHVDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv  178 (441)
                      ...++|++.+.||+|+||.||+|.+.      .++.||||++.....        ......+.+.+|+.+|++++||||+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34578999999999999999999864      578899999865322        1233346788999999999999999


Q ss_pred             eeeEEEEe-----CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          179 QLRYSFQT-----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       179 ~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      ++++++..     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN  171 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence            99999854     347999999998 4787777654 4799999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-
Q 013558          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-  330 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-  330 (441)
                      .+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... 
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            999999999987665555666789999999999987 678999999999999999999999999988777776664311 


Q ss_pred             -------------------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          331 -------------------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       331 -------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                                                     ...++.+++.+.+||.+||+.||.+||     +++++++||||+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  324 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI-----STEQALRHPYFESLF  324 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGTTTC
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC-----CHHHHHcCchhhhcc
Confidence                                           012245688999999999999999999     899999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-49  Score=386.34  Aligned_cols=251  Identities=20%  Similarity=0.321  Sum_probs=212.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcE----EEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI----YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      +..++|+++++||+|+||+||+|+++.     +++.    ||+|.+....  .....+.+.+|+.+++.++||||+++++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIP-----EGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLG   82 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECC-----TTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcC-----CCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            456789999999999999999999875     4443    6777765432  1222234667999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++. ....++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence            886 45689999999999999999775 5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCC
Q 013558          262 AKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  336 (441)
Q Consensus       262 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~  336 (441)
                      ++.+....   ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... ....+..
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI  241 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence            98764432   2344568889999999999999999999999999999999 99999988877777777665 4566778


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ++.++.+||.+||+.||.+||     +++++++|
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rp-----s~~el~~~  270 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRP-----TFKELANE  270 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSC-----CHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            899999999999999999999     77888764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-49  Score=382.01  Aligned_cols=266  Identities=26%  Similarity=0.444  Sum_probs=200.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||+||+|.+..     +++.||||++.....  ....+.+.+|+.++++++||||+++++++
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAP-----KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECC-----CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            45667899999999999999999998765     778999999865432  23345678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEE
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYR--------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      ...+..|+||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            999999999999999999999874        456999999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCC------CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Q 013558          257 TDFGLAKEIDESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       257 ~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~  329 (441)
                      +|||++.......      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+...........
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            9999987654321      1234679999999999976 56899999999999999999999999887766555544433


Q ss_pred             cc----------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhh
Q 013558          330 KV----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  382 (441)
Q Consensus       330 ~~----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  382 (441)
                      ..          .....+++++.+||.+||+.||.+||     +++++++||||+...++.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  300 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP-----TAAELLRHKFFQKAKNKEFL  300 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSTTC---------
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc-----CHHHHhhChhhhcCCCCccc
Confidence            22          12346789999999999999999999     89999999999987766544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=376.85  Aligned_cols=261  Identities=25%  Similarity=0.467  Sum_probs=223.1

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||.||+|.++.     +++.||||++....     ..+.+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE-----TGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT-----TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC-----CCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            45689999999999999999999875     78899999997642     234578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      +.+|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999999999987 45689999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHHH
Q 013558          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAH  342 (441)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~  342 (441)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+....   ...+..++.++.
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence            432 2345679999999999999999999999999999999999999999877766555554432   233456789999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  383 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  383 (441)
                      +||.+||..||.+||     +++++++||||++..+.....
T Consensus       257 ~li~~~l~~dp~~Rp-----t~~~ll~~~~~~~~~~~~~~~  292 (314)
T 3com_A          257 DFVKQCLVKSPEQRA-----TATQLLQHPFVRSAKGVSILR  292 (314)
T ss_dssp             HHHHHHTCSCTTTSC-----CHHHHTTSHHHHTCCCGGGGH
T ss_pred             HHHHHHccCChhhCc-----CHHHHHhCHHHhcCCcchHHH
Confidence            999999999999999     899999999999887665543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-49  Score=373.21  Aligned_cols=256  Identities=25%  Similarity=0.506  Sum_probs=224.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.++++++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC-----CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            3579999999999999999999876     788999999986543 33456678899999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccccCCCceecCCCCcEEEE
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      ...+|+||||+++++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            67899999999999999998754    34999999999999999999999999     9999999999999999999999


Q ss_pred             ecCCccccCCCCC-CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCC
Q 013558          258 DFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPP  335 (441)
Q Consensus       258 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~  335 (441)
                      |||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..++...+..+.. .++.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9999987644321 2345799999999999999999999999999999999999999999888888888877655 5677


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+++++.+||.+||+.||.+||     +++++++|+|+.+
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRP-----SVEEILENPLILE  273 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTCCG
T ss_pred             ccCHHHHHHHHHHcCCCcccCC-----CHHHHHhChhhhh
Confidence            8999999999999999999999     8999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-48  Score=383.27  Aligned_cols=264  Identities=22%  Similarity=0.395  Sum_probs=218.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC------ceeeeE
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLRY  182 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~  182 (441)
                      .++|++.+.||+|+||+||+|.++.    ..++.||+|++....    ...+.+.+|+.+++.+.|++      ++.+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHA----RGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecC----CCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4689999999999999999999875    133689999997532    33456778999999987655      899999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec------------
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM------------  248 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl------------  248 (441)
                      ++...+.+|+||||+ +++|.+.+....  .+++.+++.++.||+.||.|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 567777776653  69999999999999999999999999999999999999            


Q ss_pred             -------CCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH
Q 013558          249 -------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK  321 (441)
Q Consensus       249 -------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~  321 (441)
                             +.++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                   5678999999999987543  2345689999999999999999999999999999999999999999887766


Q ss_pred             HHHHHHhccccCC--------------------------------------------CCCcHHHHHHHHHhcccCcCCCC
Q 013558          322 LQQRIINEKVKLP--------------------------------------------PFLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       322 ~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~dP~~R~  357 (441)
                      ....+......+|                                            ...+.++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            5554433211111                                            11245789999999999999999


Q ss_pred             CCCCCChHHhhhCcccCCCChhhhhhcccCC
Q 013558          358 GSGPGGVDAIKHHKWFRSINWKTLEAREMQP  388 (441)
Q Consensus       358 ~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p  388 (441)
                           +++++++||||++++|+....+..+.
T Consensus       327 -----t~~e~l~hp~f~~~~~~~~~~~~~~~  352 (355)
T 2eu9_A          327 -----TLAEALLHPFFAGLTPEERSFHTSRN  352 (355)
T ss_dssp             -----CHHHHTTSGGGGGCCHHHHC------
T ss_pred             -----CHHHHhcChhhcCCChhhccccccCC
Confidence                 89999999999999998776555443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-49  Score=389.96  Aligned_cols=262  Identities=20%  Similarity=0.323  Sum_probs=225.3

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|+++++||+|+||+||+|++.+..+..+++.||||++....  .......+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35567899999999999999999997765444578899999986532  2334456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC---cEE
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM  255 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vk  255 (441)
                      .....|+||||++||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+||||+.+|   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999999655   599


Q ss_pred             EEecCCccccC---CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-
Q 013558          256 LTDFGLAKEID---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  330 (441)
Q Consensus       256 l~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-  330 (441)
                      |+|||+++...   .........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+.... 
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998642   2223345678999999999999999999999999999999998 999999999888888887654 


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ...+..++.++.+||.+||+.||.+||     ++++|++|.++-
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~l~~~  343 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYC  343 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHHHH
Confidence            456778999999999999999999999     889999987764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.6e-48  Score=372.15  Aligned_cols=253  Identities=26%  Similarity=0.499  Sum_probs=225.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|++++.||+|+||.||+|.++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC-----CCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            369999999999999999999875     788999999976542  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999999988854 679999999999999999999999999999999999999999999999999998765432


Q ss_pred             -CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHHHHHHHH
Q 013558          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  347 (441)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... ..++..++.++.+||.+
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence             2345679999999999999999999999999999999999999999888777776665443 34567889999999999


Q ss_pred             hcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          348 LLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ||+.||.+||     +++++++||||..
T Consensus       254 ~l~~dp~~Rp-----s~~~ll~~~~~~~  276 (303)
T 3a7i_A          254 CLNKEPSFRP-----TAKELLKHKFILR  276 (303)
T ss_dssp             HCCSSGGGSC-----CHHHHTTCHHHHH
T ss_pred             HcCCChhhCc-----CHHHHhhChhhhc
Confidence            9999999999     8999999999964

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-48  Score=379.05  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=216.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC------Cceee
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP------FIVQL  180 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l  180 (441)
                      +..++|++.+.||+|+||+||+|.+..    .+++.||||++...    ....+.+.+|+.+++.++|+      +|+++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            335689999999999999999998742    26789999998753    23445678899999988765      49999


Q ss_pred             eEEEEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC--------
Q 013558          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (441)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--------  250 (441)
                      ++++...+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998775  6899999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH
Q 013558          251 -----------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (441)
Q Consensus       251 -----------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~  319 (441)
                                 ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       67899999999987543  23456899999999999999999999999999999999999999998877


Q ss_pred             HHHHHHHHhccccC--------------------------------------------CCCCcHHHHHHHHHhcccCcCC
Q 013558          320 QKLQQRIINEKVKL--------------------------------------------PPFLTSEAHSLLKGLLHKDPSK  355 (441)
Q Consensus       320 ~~~~~~i~~~~~~~--------------------------------------------p~~~s~~~~~li~~~L~~dP~~  355 (441)
                      .+....+......+                                            +...++++.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            66555443221111                                            1123577899999999999999


Q ss_pred             CCCCCCCChHHhhhCcccCCCC
Q 013558          356 RLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       356 R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ||     +++++++||||+.+.
T Consensus       320 Rp-----t~~ell~hp~f~~~~  336 (339)
T 1z57_A          320 RI-----TLREALKHPFFDLLK  336 (339)
T ss_dssp             SC-----CHHHHTTSGGGGGGG
T ss_pred             cc-----CHHHHhcCHHHHHHh
Confidence            99     899999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=375.45  Aligned_cols=261  Identities=26%  Similarity=0.466  Sum_probs=218.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  185 (441)
                      ...++|++.+.||+|+||.||+|++..     +++.||||++....    ...+.+.+|+.+++++ +||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC-----CCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            345789999999999999999999875     78899999987543    2235678899999999 7999999999998


Q ss_pred             e------CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEE
Q 013558          186 T------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       186 ~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                      .      ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence            7      56899999999999999999865  579999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCC-CCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Q 013558          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (441)
Q Consensus       258 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~  331 (441)
                      |||++....... ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...+.......+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            999998764322 234567999999999997     56688999999999999999999999998887776666654432


Q ss_pred             c--CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          332 K--LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       332 ~--~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      .  .+..++..+.+||.+||..||.+||     +++++++||||++..+...
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~  298 (326)
T 2x7f_A          252 PRLKSKKWSKKFQSFIESCLVKNHSQRP-----ATEQLMKHPFIRDQPNERQ  298 (326)
T ss_dssp             CCCSCSCSCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSHHHHCCTTHHH
T ss_pred             ccCCccccCHHHHHHHHHHhccChhhCC-----CHHHHhhChHHhhCccccc
Confidence            2  2356899999999999999999999     8999999999998876553

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-49  Score=381.80  Aligned_cols=271  Identities=29%  Similarity=0.477  Sum_probs=227.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcC--CCCcee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQ  179 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpnIv~  179 (441)
                      .....++|++.+.||+|+||.||+|+++.     +++.||||++........   ...+.+.+|+.+++++.  |+||++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            33456789999999999999999999876     789999999987643321   11234567999999996  599999


Q ss_pred             eeEEEEeCCEEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcEEEE
Q 013558          180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLT  257 (441)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~  257 (441)
                      +++++...+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999999999976 89999999889999999999999999999999999999999999999999 78999999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCC
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF  336 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~  336 (441)
                      |||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..
T Consensus       193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~  265 (320)
T 3a99_A          193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR  265 (320)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSC
T ss_pred             eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhccccccccc
Confidence            99999876543 3445679999999999987665 67899999999999999999999753      2345566677888


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      +++++.+||.+||+.||.+||     +++++++||||+++.+...........+.|
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~~~~~~~~~~~p  316 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDVLLPQETAEIHLHSLSP  316 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSCCCHHHHHHHHTC----
T ss_pred             CCHHHHHHHHHHccCChhhCc-----CHHHHhcCHhhcCccCccccccccccccCC
Confidence            999999999999999999999     899999999999887655444333333333

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.9e-48  Score=384.37  Aligned_cols=254  Identities=28%  Similarity=0.411  Sum_probs=204.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++.......    ....+|++.++.++||||++++++|...+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKS-----TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             TTEEEC----------CEEEEETT-----TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            589999999999999999999876     78899999986643222    234567888899999999999999976433


Q ss_pred             -------EEEEEeccCCCchHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccccCCCceecCC-CCcEE
Q 013558          190 -------LYLILDFINGGHLFFHL----YRQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS-DGHVM  255 (441)
Q Consensus       190 -------~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~-~~~vk  255 (441)
                             +++||||+.++ |...+    .....+++..++.++.||+.||.|||  ++||+||||||+||||+. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                   89999999874 44433    34567999999999999999999999  999999999999999996 89999


Q ss_pred             EEecCCccccCCCCCCccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----
Q 013558          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----  330 (441)
Q Consensus       256 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----  330 (441)
                      |+|||+++...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....    
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99999999877666666778999999999997654 8999999999999999999999999988877777665321    


Q ss_pred             ----------------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          331 ----------------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       331 ----------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                                  ...+...++++.+||.+||+.||.+||     +++++++||||+++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM-----KPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC-----CHHHHTTSGGGGGGGC
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC-----CHHHHhcCccccccCC
Confidence                                        011223678999999999999999999     8999999999987643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-48  Score=385.90  Aligned_cols=260  Identities=23%  Similarity=0.414  Sum_probs=221.4

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+..++|++.+.||+|+||.||+|++.+..+..+++.||||++....  .....+.+.+|+.+|+++ +||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            4456778999999999999999999998765555578999999997643  234456788999999999 7999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCchHHHHHHcCC--------------------------------------------------
Q 013558          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--------------------------------------------------  211 (441)
Q Consensus       183 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--------------------------------------------------  211 (441)
                      ++...+ .+++||||++||+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998755 49999999999999999976543                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC---CCc
Q 013558          212 ----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSN  272 (441)
Q Consensus       212 ----------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~  272 (441)
                                      +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......   ...
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            8999999999999999999999999999999999999999999999999998754332   233


Q ss_pred             cccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh--ccccCCCCCcHHHHHHHHHhc
Q 013558          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN--EKVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L  349 (441)
                      ...||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.......  .....|..+++++.+||.+||
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  333 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  333 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            4678999999999999999999999999999999998 9999988764444333333  245677889999999999999


Q ss_pred             ccCcCCCCCCCCCChHHhhhC
Q 013558          350 HKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.||.+||     +++++++|
T Consensus       334 ~~dP~~Rp-----s~~ell~~  349 (359)
T 3vhe_A          334 HGEPSQRP-----TFSELVEH  349 (359)
T ss_dssp             CSSGGGSC-----CHHHHHHH
T ss_pred             cCChhhCC-----CHHHHHHH
Confidence            99999999     88999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-48  Score=380.43  Aligned_cols=258  Identities=21%  Similarity=0.358  Sum_probs=226.0

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||.||+|++++.....+++.||||++....  .....+.+.+|+.++++++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456677999999999999999999999864444467899999997643  334556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrD  240 (441)
                      .+.+.+|+||||+++|+|.+++...                        ..+++.+++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999874                        5689999999999999999999999999999


Q ss_pred             cCCCceecCCCCcEEEEecCCccccCCC---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCC
Q 013558          241 LKPENILMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  316 (441)
Q Consensus       241 lkp~NILl~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~  316 (441)
                      |||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999999865332   12334568999999999999999999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          317 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       317 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+..+....+..... .+|..+++++.+||.+||+.||.+||     ++.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            988888888876654 56788999999999999999999999     7888875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.9e-48  Score=379.86  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=217.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....  .......+.+|+.+|+.++||||+++++++... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            4689999999999999999999875     78899999986432  334455678899999999999999999988754 


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence                67999999997 589888866 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-----------CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-
Q 013558          264 EIDESS-----------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-  330 (441)
Q Consensus       264 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-  330 (441)
                      ......           .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            764321           1234578999999998765 678999999999999999999999999887766555443210 


Q ss_pred             -----------------------c--------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          331 -----------------------V--------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       331 -----------------------~--------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                                             .        ...+.+++++.+||.+||+.||.+||     +++++++||||+...+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI-----TAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCCT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccccCCc
Confidence                                   0        01246889999999999999999999     89999999999987654


Q ss_pred             h
Q 013558          380 T  380 (441)
Q Consensus       380 ~  380 (441)
                      .
T Consensus       316 ~  316 (353)
T 2b9h_A          316 N  316 (353)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=378.57  Aligned_cols=255  Identities=22%  Similarity=0.354  Sum_probs=220.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||+||+|+++...  ..+..||||++....  .....+.+.+|+.+|++++||||+++++++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            455678999999999999999999987522  245679999997542  3444567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999755 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      ......    .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....+..++
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            644321    223346778999999999999999999999999999999 99999999888888887765 456677899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+||.+||+.||.+||     ++++|++
T Consensus       281 ~~l~~li~~~l~~dp~~Rp-----s~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRP-----RFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999999     7888876

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.7e-50  Score=397.61  Aligned_cols=259  Identities=15%  Similarity=0.210  Sum_probs=201.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc--CCCCceeee------
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLR------  181 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~------  181 (441)
                      .+|++.+.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+++.+  +||||++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE-----RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC-----CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence            459999999999999999999876     7889999999886654556667788886555555  699988754      


Q ss_pred             -EEEEeC-----------------CEEEEEEeccCCCchHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHCCC
Q 013558          182 -YSFQTR-----------------SKLYLILDFINGGHLFFHLYRQ-GIFREDQA------RFYTAEIVSAVSHLHKCGI  236 (441)
Q Consensus       182 -~~~~~~-----------------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~------~~i~~qi~~~L~~LH~~~i  236 (441)
                       +++...                 ..+|+||||++ |+|.+++... ..+.+...      ..++.||+.||.|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             555443                 34899999998 7999999864 33444444      5677999999999999999


Q ss_pred             cccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCC
Q 013558          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF  314 (441)
Q Consensus       237 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf  314 (441)
                      +||||||+||||+.+|.+||+|||+++.....  .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999876432  224567799999999987  77999999999999999999999999


Q ss_pred             CCCCHHHH--HHH-----HHhccccCC--CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          315 THANRQKL--QQR-----IINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       315 ~~~~~~~~--~~~-----i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                      ........  ...     .......++  ..+++++.+||.+||+.||++||     +++++++||||+++.|...
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL-----LPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC-----CHHHHTTSHHHHHHHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCHHHHHHHHHHh
Confidence            87633211  000     011122233  47899999999999999999999     8999999999998887643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-48  Score=367.04  Aligned_cols=251  Identities=20%  Similarity=0.399  Sum_probs=221.7

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||+||+|++.      .++.||+|++......    .+.+.+|+.++++++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   74 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566778999999999999999999976      4667999999765322    24578899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+...+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999999764 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+... ....|..+++
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  234 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence            654321  2234557888999999999999999999999999999999 99999999988888888766 4456677899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ++.+||.+||+.||.+||     +++++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rp-----s~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRP-----AFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCc-----CHHHHHHH
Confidence            999999999999999999     88998874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.3e-48  Score=376.69  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=210.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  187 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++.....     .+.+.+|+.+++.+ +||||+++++++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            4689999999999999999999875     789999999875432     12477899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc-----EEEEecCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGL  261 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-----vkl~DFG~  261 (441)
                      ...|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999999999 99999999874 68999999999999999999999999999999999999999887     99999999


Q ss_pred             ccccCCCCC--------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcc
Q 013558          262 AKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEK  330 (441)
Q Consensus       262 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~~~  330 (441)
                      ++.+.....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+....+....
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            987643322        24678999999999999999999999999999999999999999874   4455566665544


Q ss_pred             ccCC-----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          331 VKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       331 ~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+     ..++ ++.+||..||+.||.+||     ++++|.+
T Consensus       237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP-----~~~~l~~  274 (330)
T 2izr_A          237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKP-----DYDYLRK  274 (330)
T ss_dssp             HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC-----CHHHHHH
T ss_pred             ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC-----CHHHHHH
Confidence            4433     2355 999999999999999999     6666654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-48  Score=383.65  Aligned_cols=259  Identities=22%  Similarity=0.403  Sum_probs=226.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+..++|++.++||+|+||+||+|++.+...  ...+..||||++....  .....+.+.+|+++++++ +||||++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            34556789999999999999999999865432  2345679999997642  344556788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +++...+.+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998754                49999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      |||+.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998764432   2334567889999999999999999999999999999999 999999999888


Q ss_pred             HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          322 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       322 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +...+... ....+..+++++.+||.+||+.||++||     ++++++++
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVED  346 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            88887765 4556778999999999999999999999     88999873

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-48  Score=373.90  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=212.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE---
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ---  185 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---  185 (441)
                      .++|++++.||+|+||.||+|.++.     +++.||+|++...   .....+.+.+|+.++++++||||+++++++.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            4689999999999999999999875     7899999998754   2445567889999999999999999999873   


Q ss_pred             -----------eCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCc
Q 013558          186 -----------TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGH  253 (441)
Q Consensus       186 -----------~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~  253 (441)
                                 ....+|+||||+. |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                       4478999999997 58988885 46799999999999999999999999999999999999997 5679


Q ss_pred             EEEEecCCccccCCC----CCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 013558          254 VMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN  328 (441)
Q Consensus       254 vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~  328 (441)
                      +||+|||+++.....    .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999875432    22344568999999999875 6789999999999999999999999998887776666654


Q ss_pred             ccc------------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          329 EKV------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       329 ~~~------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ...                              .+++.++.++++||.+||+.||.+||     +++++++||||+...|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL-----TAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSHHHHTTCC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC-----CHHHHhCCcccccccC
Confidence            321                              12246899999999999999999999     8999999999998776


Q ss_pred             hh
Q 013558          379 KT  380 (441)
Q Consensus       379 ~~  380 (441)
                      ..
T Consensus       315 p~  316 (320)
T 2i6l_A          315 PM  316 (320)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-48  Score=389.97  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=208.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--------CCCcee
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--------HPFIVQ  179 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~  179 (441)
                      ..++|++.++||+|+||+||+|++..     +++.||||++...    ....+.+.+|+.+|+.+.        |+||++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            34789999999999999999999875     7899999999753    234456788999999985        788999


Q ss_pred             eeEEEE----eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCC
Q 013558          180 LRYSFQ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG  252 (441)
Q Consensus       180 l~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~  252 (441)
                      +++++.    ....+|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999998    556899999999 55666666554  5699999999999999999999998 999999999999999776


Q ss_pred             -------------------------------------------------cEEEEecCCccccCCCCCCccccCCCCCCCc
Q 013558          253 -------------------------------------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (441)
Q Consensus       253 -------------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aP  283 (441)
                                                                       .+||+|||+++.....  ....+||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                             7999999999876542  4456899999999


Q ss_pred             chhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc----------------------------
Q 013558          284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------RQKLQQRIINE----------------------------  329 (441)
Q Consensus       284 E~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~------~~~~~~~i~~~----------------------------  329 (441)
                      |++.+..++.++|||||||++|||++|+.||...+      .......+...                            
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99999999999999999999999999999997644      22222222211                            


Q ss_pred             --------------cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          330 --------------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       330 --------------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                    ...++...+.++.+||.+||+.||.+||     +++++++||||++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA-----TAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC-----CHHHHHTSGGGGC
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC-----CHHHHhhCccccC
Confidence                          1112233456789999999999999999     8999999999963

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.1e-48  Score=379.81  Aligned_cols=254  Identities=28%  Similarity=0.423  Sum_probs=214.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|.+.+.||+|+||.||+|.++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            579999999999999999999876     78999999997643 234455678899999999999999999999987654


Q ss_pred             ------EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          190 ------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       190 ------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                            +|+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence                  599999997 58877663  359999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------  330 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~------------  330 (441)
                      .....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....            
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            75432  345689999999999987 678999999999999999999999999888776666554310            


Q ss_pred             -------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          331 -------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       331 -------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                                         ...++.+++++.+||.+||+.||++||     +++++++||||+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCG
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhccCc
Confidence                               112346789999999999999999999     89999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-48  Score=373.44  Aligned_cols=248  Identities=22%  Similarity=0.374  Sum_probs=212.9

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.++||+|+||+||+|.++.     +++.||+|++...   .....+.+.+|+.+|++++||||+++++++.+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECC-----CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            445789999999999999999999876     7889999988543   34456678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ++..++||||++||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999999999999987 467999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCC---------------ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH-----HHHH
Q 013558          266 DESSRS---------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----LQQR  325 (441)
Q Consensus       266 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~-----~~~~  325 (441)
                      ......               ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......     ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            432211               25689999999999999999999999999999999999999986532211     0111


Q ss_pred             HHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          326 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       326 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..  ....+..+++++.+||.+||+.||++||     +++++++
T Consensus       239 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~l~~  275 (310)
T 3s95_A          239 FL--DRYCPPNCPPSFFPITVRCCDLDPEKRP-----SFVKLEH  275 (310)
T ss_dssp             HH--HHTCCTTCCTTHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cc--cccCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            11  1235678899999999999999999999     7888876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.1e-48  Score=374.41  Aligned_cols=260  Identities=22%  Similarity=0.370  Sum_probs=226.5

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+.+..++|++.+.||+|+||.||+|.+.......+++.||+|++....  .....+.+.+|+.+|+.++||||++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3456677899999999999999999998654433467899999997543  34455778899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGI------------------------FREDQARFYTAEIVSAVSHLHKCGIVHR  239 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~L~~LH~~~iiHr  239 (441)
                      +.+.+.+|+||||+++++|.+++.....                        +++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999987543                        8999999999999999999999999999


Q ss_pred             ccCCCceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCC
Q 013558          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT  315 (441)
Q Consensus       240 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~  315 (441)
                      ||||+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987643322   234467889999999999889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          316 HANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       316 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+...+...+... ....+..+++++.+||.+||+.||.+||     ++++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-----VFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            98888877777655 3456778999999999999999999999     88888873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-48  Score=378.15  Aligned_cols=259  Identities=20%  Similarity=0.309  Sum_probs=223.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||.||+|.++......+++.||||++....  .......+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            345567899999999999999999988743333367889999997543  233445688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcE
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v  254 (441)
                      .+.+..|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999999998753          457999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc
Q 013558          255 MLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  330 (441)
Q Consensus       255 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~  330 (441)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  257 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  257 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence            999999998654322   1233467889999999999999999999999999999999 999999988888888777654


Q ss_pred             -ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          331 -VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       331 -~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                       ...+..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~e~l~~  293 (322)
T 1p4o_A          258 LLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISS  293 (322)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence             356778999999999999999999999     88888875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-47  Score=382.34  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=214.1

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CC-----Cceeee
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP-----FIVQLR  181 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~  181 (441)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++...    ....+.+..|+.+++.+. |+     +|++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            35689999999999999999999876     7889999999753    233456778899988885 55     499999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccccCCCceecC--CCCcEE
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMD--SDGHVM  255 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~--~~~~vk  255 (441)
                      +++...+.+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+||||+  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            999999999999999965 999998876  46999999999999999999999  57999999999999994  578899


Q ss_pred             EEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC--
Q 013558          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--  333 (441)
Q Consensus       256 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~--  333 (441)
                      |+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......  
T Consensus       202 L~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          202 IVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             ECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999999987654  2446789999999999999999999999999999999999999999988887777765421100  


Q ss_pred             ----------------CCC----------------------------------------------CcHHHHHHHHHhccc
Q 013558          334 ----------------PPF----------------------------------------------LTSEAHSLLKGLLHK  351 (441)
Q Consensus       334 ----------------p~~----------------------------------------------~s~~~~~li~~~L~~  351 (441)
                                      |..                                              ..+++++||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                            000                                              013789999999999


Q ss_pred             CcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          352 DPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       352 dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                      ||++||     +++|+++||||+...+
T Consensus       360 dP~~Rp-----ta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          360 DPKTRI-----QPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CTTTSC-----CHHHHTTSGGGCC---
T ss_pred             ChhhCC-----CHHHHhcCcccccCCC
Confidence            999999     8999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-47  Score=368.61  Aligned_cols=258  Identities=28%  Similarity=0.522  Sum_probs=213.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      ++|++++.||+|+||.||+|+++.     +++.||||++...    ....+.+.+|+.+++.++||||+++++++.+   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNAL-----DSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcC-----CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            369999999999999999999875     7889999999653    3345678899999999999999999998865   


Q ss_pred             ----------CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEE
Q 013558          187 ----------RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       187 ----------~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                                ...+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      457899999999999999998654 588999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCC---------------CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCC-CC
Q 013558          256 LTDFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-AN  318 (441)
Q Consensus       256 l~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~-~~  318 (441)
                      |+|||++......               .......||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999865422               123456799999999999865 68999999999999999998   5543 33


Q ss_pred             HHHHHHHHHhccccCC----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhc
Q 013558          319 RQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  384 (441)
Q Consensus       319 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  384 (441)
                      .......+......+|    ...++.+++||.+||+.||.+||     +++++++||||....++.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~~~  298 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQDEVIKE  298 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC-----CHHHHHHSSCSCCCCHHHHHHH
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc-----CHHHHhCCCCcCCCChHHHHHH
Confidence            4455556655554444    45667899999999999999999     8999999999998888776544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-47  Score=362.44  Aligned_cols=250  Identities=21%  Similarity=0.363  Sum_probs=219.5

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++++.||+|+||.||+|+++      ++..||+|++......    .+.+.+|+.++++++||||+++++++.
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCS   73 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             EechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            455678999999999999999999876      5667999999765422    245788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +....|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999999998764 599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHH
Q 013558          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~  340 (441)
                      ......  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.... ...|..++++
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT  233 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence            644322  223456778999999999899999999999999999999 999999988888887776654 3456678999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+||.+||+.||.+||     +++++++|
T Consensus       234 l~~li~~~l~~~p~~Rp-----s~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRP-----TFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            99999999999999999     88999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-47  Score=366.06  Aligned_cols=251  Identities=21%  Similarity=0.396  Sum_probs=218.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++++.||+|+||+||++.++      ++..||+|++......    .+.+.+|+.++++++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   88 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVC   88 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            3456678999999999999999999876      5667999999765322    24578899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence            999999999999999999999976 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ....+..+++
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  248 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence            654321  1233456788999999999999999999999999999998 99999999888888888766 3445677899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .+.+||.+||+.||.+||     +++++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rp-----s~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERP-----TFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCc-----CHHHHHHH
Confidence            999999999999999999     88999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-48  Score=386.07  Aligned_cols=255  Identities=28%  Similarity=0.433  Sum_probs=194.7

Q ss_pred             CceE-EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013558          111 DFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (441)
Q Consensus       111 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  187 (441)
                      .|++ .++||+|+||+||+|+++..   .+++.||||++.....     ...+.+|+.+|+.++||||+++++++..  .
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            4776 45899999999999997632   2578899999975432     2346789999999999999999999965  6


Q ss_pred             CEEEEEEeccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec----CCCCcE
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHV  254 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~v  254 (441)
                      ..+|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            789999999975 787777532         249999999999999999999999999999999999999    778999


Q ss_pred             EEEecCCccccCCC----CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---------
Q 013558          255 MLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------  320 (441)
Q Consensus       255 kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~---------  320 (441)
                      ||+|||+++.+...    ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876432    223457899999999999874 5899999999999999999999999765432         


Q ss_pred             HHHHHHHhccc--------------------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCC
Q 013558          321 KLQQRIINEKV--------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPG  362 (441)
Q Consensus       321 ~~~~~i~~~~~--------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~  362 (441)
                      +....+....-                                      ......++++.+||.+||+.||.+||     
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~-----  326 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----  326 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC-----
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC-----
Confidence            33333322100                                      00112377899999999999999999     


Q ss_pred             ChHHhhhCcccCCCChh
Q 013558          363 GVDAIKHHKWFRSINWK  379 (441)
Q Consensus       363 ~~~~i~~h~~f~~~~~~  379 (441)
                      +++++++||||.+..+.
T Consensus       327 ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             CHHHHHTSGGGTSSSCC
T ss_pred             CHHHHhcChhhccCCCC
Confidence            89999999999876554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-47  Score=380.07  Aligned_cols=252  Identities=26%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----------CCC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPF  176 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn  176 (441)
                      ..++|++.+.||+|+||+||+|+++.     +++.||||++....    ...+.+.+|+.+++++.           |||
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            45689999999999999999999875     78899999997543    23456778999999886           899


Q ss_pred             ceeeeEEEEeCC----EEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecC
Q 013558          177 IVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMD  249 (441)
Q Consensus       177 Iv~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~  249 (441)
                      |+++++++...+    .+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+||||+
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            999999998654    899999999 88999999764  4599999999999999999999998 999999999999994


Q ss_pred             ------CCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH----
Q 013558          250 ------SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----  319 (441)
Q Consensus       250 ------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~----  319 (441)
                            ..+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.    
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                  4458999999999876542  3456899999999999999999999999999999999999999986542    


Q ss_pred             --HHHHHHHH------------------------------------------hccccCCCCCcHHHHHHHHHhcccCcCC
Q 013558          320 --QKLQQRII------------------------------------------NEKVKLPPFLTSEAHSLLKGLLHKDPSK  355 (441)
Q Consensus       320 --~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~  355 (441)
                        ......+.                                          .....++..+++++.+||.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence              22222221                                          2223344556788999999999999999


Q ss_pred             CCCCCCCChHHhhhCcccCCC
Q 013558          356 RLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       356 R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ||     +++++++||||++.
T Consensus       325 Rp-----t~~ell~hp~f~~~  340 (373)
T 1q8y_A          325 RA-----DAGGLVNHPWLKDT  340 (373)
T ss_dssp             CB-----CHHHHHTCGGGTTC
T ss_pred             cC-----CHHHHhhChhhhcc
Confidence            99     89999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-47  Score=365.80  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=209.7

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||.||+|.+....  ..+..||+|++....  .....+.+.+|+.++++++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            3455678999999999999999999986522  246679999986532  334456788999999999999999999997


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                       .++..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             -CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             -ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence             4567899999999999999998664 69999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ...++..+++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            7644322  233456789999999999999999999999999999997 99999988888877777664 3567788999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||.+||+.||.+||     +++++++
T Consensus       245 ~l~~li~~~l~~~p~~Rp-----s~~~l~~  269 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRP-----RFTELKA  269 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            999999999999999999     7888876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.1e-47  Score=366.39  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=210.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.++++++||||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            4689999999999999999999875     78899999998765555556678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999875443


Q ss_pred             C--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---ccCCCCCcHHHHH
Q 013558          269 S--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHS  343 (441)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~  343 (441)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+....   ...++.+++++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence            2  2335679999999999999999999999999999999999999998876665444443322   2345678999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ||.+||+.||++||+    +++++++
T Consensus       268 li~~~l~~dP~~Rp~----s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYV----TCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCS----SHHHHHH
T ss_pred             HHHHhccCCHHHHHH----hHHHHHH
Confidence            999999999999994    4666664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-47  Score=369.47  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=222.2

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +.+..++|++.+.||+|+||.||+|.+.+..+..+++.||||++....  .....+.+.+|+.+|+++ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            456667899999999999999999998654444578899999997643  233456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +...+..++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  48999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654332   234567889999999999999999999999999999999 999998876555


Q ss_pred             HHHHHHhcc--ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINEK--VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ....+....  ...+..++.++.+||.+||+.||.+||     +++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  300 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQ  300 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            444444433  334667899999999999999999999     7888886

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-47  Score=360.21  Aligned_cols=251  Identities=28%  Similarity=0.461  Sum_probs=206.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .+..++|++.+.||+|+||.||+|.+       .++.||||++....... ....+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW-------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC   75 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE-------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE-------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            35567999999999999999999986       45789999987653322 33456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccccCCCceecCC--------CCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDS--------DGH  253 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~--------~~~  253 (441)
                      .+.+..|+||||++|++|.+++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           76 LKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             CCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             ecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999999988874 568999999999999999999999999   899999999999986        778


Q ss_pred             EEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--c
Q 013558          254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--V  331 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~--~  331 (441)
                      +||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+....  .
T Consensus       155 ~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL  233 (271)
T ss_dssp             EEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred             eEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence            9999999998765433 335679999999999999999999999999999999999999999988877777776554  3


Q ss_pred             cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       332 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .++..+++++.+||.+||+.||.+||     +++++++|
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  267 (271)
T 3dtc_A          234 PIPSTCPEPFAKLMEDCWNPDPHSRP-----SFTNILDQ  267 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCc-----CHHHHHHH
Confidence            45678999999999999999999999     88898864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=376.67  Aligned_cols=260  Identities=24%  Similarity=0.394  Sum_probs=220.2

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+..++|++.+.||+|+||+||+|.+.......++..||||++....  .....+.+.+|+.+|+++ +||||+++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3556778999999999999999999998654444467789999997543  233446788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHr  239 (441)
                      ++...+.+|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999999999997653                       37999999999999999999999999999


Q ss_pred             ccCCCceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCC
Q 013558          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT  315 (441)
Q Consensus       240 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~  315 (441)
                      ||||+||||+.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987643322   234567889999999999999999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          316 HANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       316 ~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.........+...  ....+..+++++.+||.+||+.||.+||     +++++++|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~  328 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  328 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHH
Confidence            87655555554443  3445678899999999999999999999     88999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=365.79  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=214.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|....+||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLS-----NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETT-----TCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECC-----CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            3455566699999999999999876     78899999987643   334566889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a~~  264 (441)
                      .+++||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            9999999999999999998752   4679999999999999999999999999999999999987 89999999999987


Q ss_pred             cCCC-CCCccccCCCCCCCcchhcCCC--CCCcchhhhHHHHHHHHHcCCCCCCCCCHHH-HHHH--HHhccccCCCCCc
Q 013558          265 IDES-SRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQR--IINEKVKLPPFLT  338 (441)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltG~~pf~~~~~~~-~~~~--i~~~~~~~p~~~s  338 (441)
                      .... .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...+... ....  .......++..++
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS  252 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence            6432 2234567999999999997643  8899999999999999999999997543222 2211  2233456778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +++.+||.+||+.||++||     +++++++||||+...
T Consensus       253 ~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~  286 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRA-----CANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSC-----CHHHHHTSGGGCC--
T ss_pred             HHHHHHHHHHccCChhhCC-----CHHHHhcChhhhhcc
Confidence            9999999999999999999     899999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.3e-48  Score=384.41  Aligned_cols=253  Identities=22%  Similarity=0.405  Sum_probs=220.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||.||+|+++.     +++.||||++....  .....+.+.+|+.+|++++||||+++++++
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEec-----CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            44666789999999999999999999875     78899999987542  233445678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ...+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999999998654 69999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          264 EIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       264 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      ........   ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+ ....|..++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP  341 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            65432111   12235778999999998889999999999999999998 99999998888777766554 456778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+||.+||+.||++||     ++++|++
T Consensus       342 ~~l~~li~~cl~~dP~~Rp-----s~~~i~~  367 (377)
T 3cbl_A          342 DAVFRLMEQCWAYEPGQRP-----SFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            9999999999999999999     7888875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-47  Score=366.58  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=213.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ++..++|++.+.||+|+||+||+|+++...+  ...+..||+|++.+..   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            3556789999999999999999999875211  0012569999986543   3445678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc--------E
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------V  254 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--------v  254 (441)
                      +.+.+..|+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998887        9


Q ss_pred             EEEecCCccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhcccc
Q 013558          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVK  332 (441)
Q Consensus       255 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG-~~pf~~~~~~~~~~~i~~~~~~  332 (441)
                      ||+|||++.....   .....||+.|+|||++.+ ..++.++|||||||++|||++| .+||...+... ...+......
T Consensus       161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCC
T ss_pred             eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCC
Confidence            9999999876533   234568999999999987 7789999999999999999995 55555544443 4444556667


Q ss_pred             CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       333 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ++...++++.+||.+||+.||.+||     +++++++|
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  269 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRP-----SFRAIIRD  269 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            7888899999999999999999999     88999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.7e-46  Score=358.95  Aligned_cols=247  Identities=19%  Similarity=0.278  Sum_probs=212.3

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  185 (441)
                      +..++|++.+.||+|+||+||+|++..     +++.||||++.....     .+.+.+|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            445689999999999999999999875     789999999865432     12467899999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc-----EEEEec
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDF  259 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-----vkl~DF  259 (441)
                      .....|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+||
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999999 999999998764 5999999999999999999999999999999999999988776     999999


Q ss_pred             CCccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC---CHHHHHHHHHh
Q 013558          260 GLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIIN  328 (441)
Q Consensus       260 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~---~~~~~~~~i~~  328 (441)
                      |+++......        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            9998765432        234567999999999999999999999999999999999999999874   34455555544


Q ss_pred             cccc-----CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          329 EKVK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       329 ~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ....     +...+++++.+||.+||+.||.+||     ++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP-----~~~~l~~  276 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQG  276 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC-----CHHHHHH
Confidence            3322     2357899999999999999999999     7788765

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=366.59  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+..+..+++.++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETT-----TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhccccccceeeecCCeeEEEEEEec-----CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            345689999999999999999999876     788999999976542 22333445556667888899999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+.+|+||||+ ++.+...... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 5555555443 47899999999999999999999995 999999999999999999999999999987


Q ss_pred             cCCCCCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcccc-CC--C
Q 013558          265 IDESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK-LP--P  335 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~~~~-~p--~  335 (441)
                      ...........||+.|+|||++.     ...++.++|||||||++|+|++|+.||.. ....+....+...... ++  .
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            66555555678999999999995     45688999999999999999999999987 4455556666554332 33  3


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .+++++.+||.+||+.||.+||     +++++++||||++.
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  290 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSC-----CHHHHTTSHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCc-----CHHHHhhCHHHHhc
Confidence            5899999999999999999999     89999999999754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-47  Score=372.19  Aligned_cols=252  Identities=24%  Similarity=0.393  Sum_probs=216.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcE--EEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +..++|++.+.||+|+||.||+|+++.     ++..  +|+|.+....  .....+.+.+|+.+|+++ +||||++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            445689999999999999999999875     5554  4999886532  233445688999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCcee
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  247 (441)
                      +.+.+.+|+||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  174 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence            999999999999999999999997654                6999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013558          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (441)
Q Consensus       248 l~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i  326 (441)
                      ++.++.+||+|||+++............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+
T Consensus       175 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            99999999999999986443333445567899999999998889999999999999999998 99999999888888777


Q ss_pred             Hhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          327 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       327 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ... ....+..+++++.+||.+||+.||.+||     ++++++++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  294 (327)
T 1fvr_A          255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  294 (327)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            655 3456678899999999999999999999     88999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=370.93  Aligned_cols=252  Identities=29%  Similarity=0.516  Sum_probs=212.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhc----CCCCceeee
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKV----THPFIVQLR  181 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hpnIv~l~  181 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++........   .....+.+|+.+++++    +||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLT-----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTT-----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEcc-----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4689999999999999999998775     788999999976543221   1223355799999998    899999999


Q ss_pred             EEEEeCCEEEEEEec-cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC-CCCcEEEEec
Q 013558          182 YSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDF  259 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkl~DF  259 (441)
                      +++...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999999999999999 78999999999888999999999999999999999999999999999999999 8999999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCCC-CcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCc
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s  338 (441)
                      |+++..... ......||..|+|||++.+..+. .++|||||||++|+|++|+.||...      ..+......++..++
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~  257 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVS  257 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSC
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCC
Confidence            999876543 34456799999999999876664 5899999999999999999999753      345556777888999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      .++.+||.+||+.||++||     +++++++||||+...
T Consensus       258 ~~~~~li~~~l~~~p~~Rp-----s~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRP-----SLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHhcChhhcCch
Confidence            9999999999999999999     899999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.1e-47  Score=384.52  Aligned_cols=249  Identities=24%  Similarity=0.425  Sum_probs=217.7

Q ss_pred             hhhcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeee
Q 013558          102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR  181 (441)
Q Consensus       102 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  181 (441)
                      ...+.+..++|++.+.||+|+||.||++.++       ++.||||+++...     ..+.+.+|+.+|++++||||++++
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~  252 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLL  252 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEE
Confidence            3456778889999999999999999999874       4689999997543     335688999999999999999999


Q ss_pred             EEEEeCC-EEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          182 YSFQTRS-KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       182 ~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      +++.... .+|+||||+++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       253 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             EEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEee
Confidence            9987765 79999999999999999987654  79999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCC
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  336 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~  336 (441)
                      ||+++.....  .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+ ....|..
T Consensus       333 fG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~  410 (450)
T 1k9a_A          333 FGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  410 (450)
T ss_dssp             CTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred             CCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            9999865432  223467899999999999999999999999999999998 99999988777777777654 5667888


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++++.+||.+||+.||.+||     ++.+++.
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rp-----t~~~l~~  438 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRP-----TFLQLRE  438 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999999     7788765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.4e-48  Score=374.73  Aligned_cols=263  Identities=25%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~  182 (441)
                      .+.+..++|++++.||+|+||.||+|.++.     +++.||||++.....  ......+..|+. +++.++||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            455677899999999999999999999876     788999999976431  222334445555 777789999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCCCceecCCCCcEEE
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      ++...+..|+||||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            99999999999999986 77777653     56799999999999999999999998 9999999999999999999999


Q ss_pred             EecCCccccCCCCCCccccCCCCCCCcchh----cCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhcc-
Q 013558          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEK-  330 (441)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~-  330 (441)
                      +|||+++............||+.|+|||++    .+..++.++|||||||++|+|++|+.||...+.. +....+.... 
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            999999877655445556899999999998    4567899999999999999999999999864322 2222222221 


Q ss_pred             ccCC----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          331 VKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       331 ~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ..++    ..+++++.+||.+||+.||.+||     +++++++||||...++.
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHHHS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCc-----CHHHHHhChHHHHhHhh
Confidence            1222    35889999999999999999999     89999999999765443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6e-47  Score=370.36  Aligned_cols=258  Identities=22%  Similarity=0.399  Sum_probs=223.0

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+..++|++.+.||+|+||+||+|++.....  ..++..||||++....  .....+.+.+|+.+++++ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            45666789999999999999999999864321  2357789999997543  334456788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      +++...+.+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987654322   234467889999999998889999999999999999999 999999988888


Q ss_pred             HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +...+... ....+..++.++.+||.+||+.||.+||     +++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  311 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  311 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            88777655 3556778999999999999999999999     8889887

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.8e-47  Score=370.16  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=211.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|+++++||+|+||+||+|+++.... .....||+|.+....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            345689999999999999999999875211 012235777775432  23345678899999999999999999999987


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .. .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            65 78999999999999999874 67999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... ....+..++.+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            44332   223456889999999999999999999999999999999 99999988887777766554 35567789999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+||.+||+.||.+||     ++.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rp-----s~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRP-----KFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCC-----CHHHHHHH
Confidence            99999999999999999     88898874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-47  Score=356.61  Aligned_cols=250  Identities=20%  Similarity=0.394  Sum_probs=220.4

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||.||+|.+.      +++.||+|++......    .+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999986      4668999999765422    24678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+.+.+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999999999999875 568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......  ......|+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+... ....+..++.
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  232 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  232 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcH
Confidence            653321  1234567889999999999999999999999999999999 99999998888888888765 3445677899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||.+||+.||.+||     +++++++
T Consensus       233 ~l~~li~~~l~~~p~~Rp-----s~~~ll~  257 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRP-----AFSRLLR  257 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            999999999999999999     7888886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-47  Score=373.57  Aligned_cols=248  Identities=31%  Similarity=0.563  Sum_probs=183.1

Q ss_pred             CCceEEe-eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          110 GDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       110 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      ++|++.+ +||+|+||+||+|+++.     +++.||||++.....       ........++.+.||||+++++++..  
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECC-----CCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            5799965 69999999999999986     788999999865321       12223344677799999999999976  


Q ss_pred             --CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEEec
Q 013558          187 --RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF  259 (441)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~DF  259 (441)
                        ...+++||||++||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998764  6999999999999999999999999999999999999976   455999999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhccccCC-
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLP-  334 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~----~~~i~~~~~~~p-  334 (441)
                      |+++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........    ...+......++ 
T Consensus       176 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          176 GFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            999876533 34456899999999999888899999999999999999999999977654433    233333333333 


Q ss_pred             ---CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 ---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 ---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                         ..+++++++||.+||+.||.+||     +++++++||||+.
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  293 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERL-----TITQFMNHPWINQ  293 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccc
Confidence               46899999999999999999999     8999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5e-47  Score=362.46  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=222.8

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+.+..++|++.+.||+|+||+||+|.++.     ++..||+|++...    ....+.+.+|+.++++++||||++++++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~   77 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGV   77 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGG-----GTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecC-----CCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            345667789999999999999999999985     7889999998753    2345668899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +.+...+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence            99999999999999999999999874  4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          262 AKEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      +........  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... ....+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC  237 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCC
Confidence            987654322  233457889999999999999999999999999999999 99999988888777777655 45667789


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||..||.+||     +++++++
T Consensus       238 ~~~l~~li~~~l~~dp~~Rp-----s~~~~~~  264 (288)
T 3kfa_A          238 PEKVYELMRACWQWNPSDRP-----SFAEIHQ  264 (288)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHhCCChhhCc-----CHHHHHH
Confidence            99999999999999999999     7888875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-47  Score=367.39  Aligned_cols=260  Identities=23%  Similarity=0.419  Sum_probs=221.1

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+..++|++.+.||+|+||+||+|++.+..+..+++.||||++....  .....+.+.+|+.+++++ +||||+++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            3456677999999999999999999998765555578999999997643  233456788999999999 6999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCchHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       183 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      ++...+ .+|+||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987754 59999999999999999987654                8999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999987644322   234567899999999999999999999999999999998 999998765433


Q ss_pred             -HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          322 -LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       322 -~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                       ....+... ....+..+++++.++|.+||+.||.+||     +++++++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence             33333333 4556778999999999999999999999     88999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.2e-47  Score=376.03  Aligned_cols=257  Identities=18%  Similarity=0.188  Sum_probs=203.2

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHH--------HHHHHHHHHHHhcCCCCce
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hpnIv  178 (441)
                      +..++|++.++||+|+||+||+|.++.......++.||||++...........        ..+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34568999999999999999999987643333468899999876432111111        1233456667778899999


Q ss_pred             eeeEEEEeC----CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CC
Q 013558          179 QLRYSFQTR----SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SD  251 (441)
Q Consensus       179 ~l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~  251 (441)
                      ++++++...    ..+|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CcEEEEecCCccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH
Q 013558          252 GHVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ  323 (441)
Q Consensus       252 ~~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~  323 (441)
                      +.+||+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998653221        123456999999999999999999999999999999999999999853222211


Q ss_pred             HHHHh----cc-------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          324 QRIIN----EK-------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       324 ~~i~~----~~-------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .....    ..       ...+..+++++.+||..||..||.+||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP-----LYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC-----CHHHHHH
Confidence            11111    00       011256799999999999999999999     6777764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-46  Score=364.44  Aligned_cols=257  Identities=27%  Similarity=0.480  Sum_probs=213.7

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--CCCceeeeEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYS  183 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~  183 (441)
                      .+..++|++++.||+|+||.||+|.++      +++.||||++..... .....+.+.+|+.+++++.  ||||++++++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            345567999999999999999999864      578899999976542 3445677889999999997  5999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +.....+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~  174 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  174 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence            999999999999 55789999999989999999999999999999999999999999999999996 5899999999998


Q ss_pred             ccCCCCC---CccccCCCCCCCcchhcC-----------CCCCCcchhhhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh
Q 013558          264 EIDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN  328 (441)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltG~~pf~~~~-~~~~~~~i~~  328 (441)
                      .......   ....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            7643321   234579999999999976           467889999999999999999999997653 3333444443


Q ss_pred             c--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          329 E--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       329 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      .  ...++...++++.+||.+||+.||.+||     +++++++||||+..
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~  299 (313)
T 3cek_A          255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQ  299 (313)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHCC
T ss_pred             cccccCCcccchHHHHHHHHHHccCCcccCc-----CHHHHhcCccccCC
Confidence            3  3456777899999999999999999999     89999999999753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.6e-47  Score=376.47  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=209.5

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||.||+|+++..  ...+..||||++....  .....+.+.+|+.+|++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45566899999999999999999987631  1257789999997542  3344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +...+|+||||+++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999998764 699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      ......    .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+..++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            643321    122345778999999999999999999999999999998 99999998888888777655 345566789


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++.+||.+||+.||.+||     +++++++
T Consensus       277 ~~l~~li~~cl~~dp~~RP-----s~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRP-----KFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCc-----CHHHHHH
Confidence            9999999999999999999     7788875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.3e-47  Score=363.37  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=209.2

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++++.||+|+||+||+|++..... .+++.||||++...   .....+.+.+|+.+|++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCS-SCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccC-CCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4556789999999999999999998653222 37889999998753   3445567889999999999999999999986


Q ss_pred             e--CCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          186 T--RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       186 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .  ...+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            5  356999999999999999998764 5999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH----------------HH
Q 013558          263 KEIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  322 (441)
Q Consensus       263 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~----------------~~  322 (441)
                      +......    ......|+..|+|||++.+..++.++|||||||++|||++|..||......                ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            8764332    123345778899999999999999999999999999999999998643211                11


Q ss_pred             HHHHH-hccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRII-NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+. ......|..+++++.+||.+||+.||++||     +++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            22222 224556778999999999999999999999     7888875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.3e-47  Score=368.46  Aligned_cols=258  Identities=21%  Similarity=0.380  Sum_probs=221.4

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      ..+..++|++.+.||+|+||.||+|.+...........||+|++....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            456678999999999999999999998875444455689999997643  234456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ--------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~  249 (441)
                      +...+.+|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 013558          250 SDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  325 (441)
Q Consensus       250 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~  325 (441)
                      .++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999986543322   234567889999999999999999999999999999999 9999988766555555


Q ss_pred             HHhcc--ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          326 IINEK--VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       326 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +....  ...+..+++++.+||.+||+.||.+||     +++++++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  319 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP-----TFQQICS  319 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc-----CHHHHHH
Confidence            54443  345677899999999999999999999     8889886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-46  Score=365.09  Aligned_cols=257  Identities=22%  Similarity=0.358  Sum_probs=216.3

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||+||+|.++... +..+..||||++....  .......+.+|+.+++.++||||+++++++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4567789999999999999999999987521 1134569999987543  234455688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ...+.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999765 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      .......    .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+... ....+..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            7643221    122346788999999999999999999999999999999 99999998888888877665 45566789


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||+.||.+||     ++.++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  302 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRP-----KFADIVS  302 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999999     7788876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2e-46  Score=359.38  Aligned_cols=255  Identities=19%  Similarity=0.301  Sum_probs=218.3

Q ss_pred             cCcCCCCceEEe-eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          105 RKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       105 ~~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ..+..++|++.+ .||+|+||+||+|.+...   ..++.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345567899998 999999999999976431   267889999997653 234446678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      + ..+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            9 567789999999999999999998889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      .......    .....|++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ...++..+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  245 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            7644322    122346788999999998889999999999999999999 99999998888887777655 35567889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||+.||.+||     ++.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRP-----GFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999999     7788775

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=359.15  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=219.7

Q ss_pred             CcCCCCceEEe-eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .+..++|.+.+ .||+|+||.||+|.++..   .++..||||++....  .....+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccC---CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            34566888887 999999999999986532   256789999997642  344567788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                       ..+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence             456799999999999999998654 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      .......    .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ...+|..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  238 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  238 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence            7643322    223456889999999998889999999999999999998 99999988888877777665 35677889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCc
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  371 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  371 (441)
                      ++++.+||.+||+.||.+||     +++++++|.
T Consensus       239 ~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l  267 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRP-----DFLTVEQRM  267 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence            99999999999999999999     889998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-46  Score=355.19  Aligned_cols=248  Identities=20%  Similarity=0.327  Sum_probs=216.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||+||+|+++       ++.||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            3456678999999999999999999973       56799999976542 334456788999999999999999999999


Q ss_pred             EeC--CEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCCcEEEEe
Q 013558          185 QTR--SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       185 ~~~--~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      .+.  ..+++||||+++|+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence            887  78999999999999999998765  4899999999999999999999999  99999999999999999999999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhcCCCCCC---cchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cccC
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKL  333 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~--~~~~  333 (441)
                      ||++....    .....||+.|+|||++.+..++.   ++|||||||++|||++|+.||...+..+....+...  ...+
T Consensus       157 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          157 ADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI  232 (271)
T ss_dssp             GGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             ccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence            98875432    33457899999999998766554   799999999999999999999998888777776654  4456


Q ss_pred             CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          334 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       334 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +..+++++.+||.+||+.||++||     +++++++
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~  263 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRP-----KFDMIVP  263 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            788999999999999999999999     7888875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-46  Score=363.28  Aligned_cols=258  Identities=21%  Similarity=0.335  Sum_probs=211.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||.||+|.....  ..++..||+|++..... .....+.+.+|+.++++++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            345667899999999999999999987642  22567899999876432 334456788999999999999999999999


Q ss_pred             EeCC-----EEEEEEeccCCCchHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          185 QTRS-----KLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       185 ~~~~-----~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      ....     ..++||||+.+++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            8755     35999999999999999853      356999999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 013558          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~  329 (441)
                      +||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            9999999998754332   1233467889999999999999999999999999999999 99999988888777777665


Q ss_pred             -cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       330 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                       ....+..+++++.+||.+||..||.+||     ++++++++
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~  302 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRP-----TFSVLRLQ  302 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence             4566788999999999999999999999     88888863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-46  Score=356.60  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=216.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||+||+|.+....  ..+..||+|++.+..  .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            455678999999999999999999876421  245679999987653  2344567889999999999999999999986


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      + +..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5 4578999999999999999765 4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHH
Q 013558          265 IDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  340 (441)
                      .....  ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ....+..+++.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence            64432  1234567889999999999999999999999999999998 99999887777766666544 45567789999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+||.+||..||.+||     ++++++++
T Consensus       243 l~~li~~~l~~~p~~Rp-----s~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRP-----RFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHccCCchhCc-----CHHHHHHH
Confidence            99999999999999999     88888864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.4e-47  Score=368.53  Aligned_cols=261  Identities=20%  Similarity=0.328  Sum_probs=218.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||.||+|++....+..+++.||||++....  .......+.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4456899999999999999999986543333478899999996432  23344568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEE
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVML  256 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl  256 (441)
                      ....|+||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998763       4899999999999999999999999999999999999984   446999


Q ss_pred             EecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cc
Q 013558          257 TDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV  331 (441)
Q Consensus       257 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~  331 (441)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999997643322   2334568999999999999999999999999999999998 99999998888888777665 44


Q ss_pred             cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          332 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       332 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ..+..++..+.+||.+||+.||.+||     +++++++|.|+-
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHH
Confidence            56678999999999999999999999     899999988763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-46  Score=382.99  Aligned_cols=250  Identities=22%  Similarity=0.387  Sum_probs=218.2

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+.+..++|++.+.||+|+||+||+|.++      .+..||||+++...    ...+.+.+|+.+|+.++||||++++++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            35667788999999999999999999986      46679999997643    235678899999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +. ...+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            86 66799999999999999999754  3689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      ++......  ......++..|+|||++....++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..+
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  410 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC  410 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTS
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            98764321  1223456788999999998999999999999999999999 99999998888888777654 45567789


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||+.||++||     ++++|+.
T Consensus       411 ~~~l~~li~~cl~~dp~~RP-----t~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERP-----TFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCc-----CHHHHHH
Confidence            99999999999999999999     7788765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.4e-46  Score=355.89  Aligned_cols=249  Identities=23%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhH----HHHHHHHHHHHHhcCCCCceeeeE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH----VDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      +..++|++.+.||+|+||+||+|+++.     +++.||+|++..........    .+.+.+|+.++++++||||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVK-----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG   90 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETT-----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhhccceehhccccCCceeEEEEEEcC-----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence            456789999999999999999999876     78899999987644322221    257889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCCc-----E
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH-----V  254 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~-----v  254 (441)
                      ++.+..  ++||||+++|+|.+.+... ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +
T Consensus        91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           91 LMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             EETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             eecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            987665  6999999999998888655 47999999999999999999999999  999999999999988876     9


Q ss_pred             EEEecCCccccCCCCCCccccCCCCCCCcchhc--CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhc-
Q 013558          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL--QQRIINE-  329 (441)
Q Consensus       255 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~--~~~i~~~-  329 (441)
                      ||+|||+++....  ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...+....  ...+... 
T Consensus       169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             EeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            9999999986443  344578999999999984  45578899999999999999999999987554333  3333332 


Q ss_pred             -cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                       ...++..+++++.+||.+||+.||.+||     +++++++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  282 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIELCWSGDPKKRP-----HFSYIVK  282 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence             3456778999999999999999999999     7888875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-46  Score=387.67  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=220.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+...+|++.++||+|+||.||++.++.     ++..||||++....    ...+.+.+|+.+|++++||||+++++++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGG-----GTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcC-----CCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            44566789999999999999999999885     67899999997643    2345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .....+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999999999864  45899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +.......  .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+... ....|..++
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87643321  223456788999999999999999999999999999999 99999998887777776554 455678899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+||.+||+.||.+||     ++++|++
T Consensus       446 ~~l~~li~~cl~~dP~~RP-----s~~el~~  471 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRP-----SFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCc-----CHHHHHH
Confidence            9999999999999999999     7788865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.4e-46  Score=358.08  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=204.9

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|.++.     +++.||||++...........+.+.+|+.++++++||||+++++++...+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT-----TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC-----CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3579999999999999999999875     78899999998655455566677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+++||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999988864    45699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcccc-C-CCCCcH
Q 013558          265 IDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--NRQKLQQRIINEKVK-L-PPFLTS  339 (441)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~--~~~~~~~~i~~~~~~-~-p~~~s~  339 (441)
                      ..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.  +.......+...... . +..+++
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            54332 234567999999999999999999999999999999999999999754  334455555444322 2 256899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||.+||..||.+||     +++++++
T Consensus       266 ~l~~li~~~l~~dp~~Rp-----s~~~il~  290 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRP-----DVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            999999999999999999     8888886

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=364.48  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=209.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcE----EEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI----YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  182 (441)
                      +..++|+++++||+|+||+||+|+++.     +++.    ||+|.+....  .....+.+.+|+.+++.++||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   84 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIP-----EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC-----TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcC-----CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence            456789999999999999999999875     4444    4666654322  2344567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      ++.... .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            998765 88999999999999999874 5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCC
Q 013558          262 AKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  336 (441)
Q Consensus       262 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~  336 (441)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... ....+..
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  243 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            987643322   223456788999999999999999999999999999999 99999998888777777654 3566778


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.++.+||.+||+.||.+||     +++++++
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRP-----KFRELII  271 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999999     8889886

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.6e-46  Score=354.35  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=217.4

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ++.+..++|++++.||+|+||.||+|.++      .+..||+|++.....    ..+.+.+|+++|+.++||||++++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            45667789999999999999999999875      466799999875432    24568899999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +. .+..++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence            76 456899999999999999986543  799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          262 AKEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      +........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+... ....+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence            987654322  233457889999999998889999999999999999999 99999998888888777655 34566789


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||..||++||     +++++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRP-----TFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            99999999999999999999     7788875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=383.96  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=202.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  184 (441)
                      .+...+|++.++||+|+||+|+.....      +++.||||++......      .+.+|+.+|+.+ +|||||++++++
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~------~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMF------DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEES------SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEe------CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence            455567999999999999997643332      6789999998754321      245799999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-----CCcEEEEe
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTD  258 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-----~~~vkl~D  258 (441)
                      .+...+|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+||||+.     ...+||+|
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99999999999996 59999987654 4666678899999999999999999999999999999953     23688999


Q ss_pred             cCCccccCCC----CCCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc
Q 013558          259 FGLAKEIDES----SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  330 (441)
Q Consensus       259 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~  330 (441)
                      ||+|+.....    ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||...........+....
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  246 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS  246 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC
Confidence            9999876533    2234578999999999998   4567889999999999999999 999997654443332222111


Q ss_pred             cc---CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          331 VK---LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       331 ~~---~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ..   .+...+..+++||.+||+.||.+||     +++++++||||++++|.
T Consensus       247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~evl~hp~f~~~~~~  293 (432)
T 3p23_A          247 LDCLHPEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWSLEKQ  293 (432)
T ss_dssp             CTTSCTTCHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHTSTTTCCHHHH
T ss_pred             ccccCccccccHHHHHHHHHHHhCCHhhCC-----CHHHHHhCccccChHHH
Confidence            11   1123456789999999999999999     89999999999998884

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-45  Score=378.44  Aligned_cols=268  Identities=21%  Similarity=0.305  Sum_probs=218.1

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~  187 (441)
                      .++|+++++||+|+||.||+|+++.     +++.||||++......     ..+..|+.+++.+.| ++|..+..++...
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT-----TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC-----CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            4689999999999999999999875     7889999988754322     236789999999987 5666666777788


Q ss_pred             CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~  263 (441)
                      ...|+||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            8999999999 8999999975 4679999999999999999999999999999999999999   688999999999998


Q ss_pred             ccCCCCC--------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccc-
Q 013558          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKV-  331 (441)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~~-  331 (441)
                      .+.....        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..   ..+.+..+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            7654322        236789999999999999999999999999999999999999998643   3344444443332 


Q ss_pred             ----cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhh----------hCcccCCCChhhhhhcccCCCCCC
Q 013558          332 ----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK----------HHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       332 ----~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~----------~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                          .++..+++++.+||.+||+.||++||     ++++|+          .++|+..++|..+..++.+++..|
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RP-----s~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p  304 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAP  304 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC---------
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCC
Confidence                23367899999999999999999999     555543          378999999999987766665544

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.5e-46  Score=356.05  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=200.5

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ..++..++|++.++||+|+||+||+++++        ..+|+|++.... ......+.+.+|+.+|+.++||||++++++
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            45677889999999999999999999743        349999987543 234556778899999999999999999995


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                       .....+++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           89 -STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             -ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             -ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence             4566789999999999999998644 56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCC---CCCCccccCCCCCCCcchhc---CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcccc---
Q 013558          263 KEIDE---SSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVK---  332 (441)
Q Consensus       263 ~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~-~~~~i~~~~~~---  332 (441)
                      +....   ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||...+..+ +...+......   
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            86543   22234567999999999997   5678889999999999999999999998755444 44444333222   


Q ss_pred             --CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          333 --LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       333 --~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                        ++..+++++.+||.+||+.||.+||     +++++++
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~  281 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERP-----SFPRILA  281 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence              2346889999999999999999999     7888875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-46  Score=358.87  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||+||+|++....  ..+..||||++...........+.+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34568999999999999999999875311  1334699999987655455667788999999999999999999999987


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .. .++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999998765 67999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc--ccCCCCCc
Q 013558          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK--VKLPPFLT  338 (441)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s  338 (441)
                      .....    .....+|..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+....  ...+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            54322    233467889999999998889999999999999999999 999999999888888887654  34556899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++.++|.+||..||.+||     +++++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rp-----s~~~l~~  277 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRP-----TFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            9999999999999999999     8889886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.4e-46  Score=354.16  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=212.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----  186 (441)
                      +|++++.||+|+||.||+|+++.     +++.||+|++....       +.+.+|+.++++++||||+++++++..    
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRI-----DGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETT-----TCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             ccceeeeeccCCceEEEEEEEcC-----CCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            69999999999999999999875     78899999997543       235679999999999999999998864    


Q ss_pred             ------------CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          187 ------------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       187 ------------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                                  ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        45689999999999999999765  6799999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc
Q 013558          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  332 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~  332 (441)
                      .+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||..  .......+..  ..
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~--~~  235 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD--GI  235 (284)
T ss_dssp             EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT--TC
T ss_pred             CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc--cc
Confidence            9999999999887665555667899999999999999999999999999999999999988742  2223333333  23


Q ss_pred             CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       333 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      ++..++.++++||.+||+.||.+||     ++.++++|.+.
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~l~~  271 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTV  271 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHH
Confidence            5677899999999999999999999     88999998765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-45  Score=353.09  Aligned_cols=245  Identities=19%  Similarity=0.277  Sum_probs=203.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~  187 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++......     +.+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC-----CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            3579999999999999999999875     7889999987654322     2367899999999988777665555 678


Q ss_pred             CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~  263 (441)
                      ...++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            8999999999 8999999875 4679999999999999999999999999999999999999   789999999999998


Q ss_pred             ccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcccc
Q 013558          264 EIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIINEKVK  332 (441)
Q Consensus       264 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~---~~~~~~i~~~~~~  332 (441)
                      ......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.   ......+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            765432        22356899999999999999999999999999999999999999976432   2334444444443


Q ss_pred             CC-----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          333 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       333 ~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+     ..+++++.+||.+||+.||++||     +++++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  273 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCC-----CHHHHHH
Confidence            33     67899999999999999999999     7788765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=367.49  Aligned_cols=255  Identities=17%  Similarity=0.188  Sum_probs=203.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch--------hHHHHHHHHHHHHHhcCCCCce
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--------NHVDYMKAERDILTKVTHPFIV  178 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv  178 (441)
                      +..++|++.+.||+|+||+||+|+++...  .++..+|+|++........        .....+.+|+.+++.++||||+
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34568999999999999999999987422  2677899999876432111        1112356788899999999999


Q ss_pred             eeeEEEEe----CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC--
Q 013558          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--  252 (441)
Q Consensus       179 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--  252 (441)
                      ++++++..    ...+|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            99999988    78899999999 999999998888999999999999999999999999999999999999999887  


Q ss_pred             cEEEEecCCccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC--CCHHHH
Q 013558          253 HVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKL  322 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~--~~~~~~  322 (441)
                      .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..  .+....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            99999999998753221        12456899999999999999999999999999999999999999965  333333


Q ss_pred             HHHHHhccccCCC---------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIINEKVKLPP---------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~~~~~~p~---------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..........++.         .+++++.+||.+||+.||++||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP-----NYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC-----CHHHHHH
Confidence            3222222222322         7899999999999999999999     7888876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-46  Score=365.44  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=201.0

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.++||+|+||+||+|++       .++.||||++....    ........|+.+|++++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQL-------LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEE-------TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccchhhchhhheecccCceEEEEEEE-------CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhccee
Confidence            345667899999999999999999986       35789999996543    2223455689999999999999999999


Q ss_pred             EeCC----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccccCCCceecCC
Q 013558          185 QTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------GIVHRDLKPENILMDS  250 (441)
Q Consensus       185 ~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------~iiHrDlkp~NILl~~  250 (441)
                      ....    .+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++          ||+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence            8743    58999999999999999976 4599999999999999999999999          9999999999999999


Q ss_pred             CCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCC-----CCCCcchhhhHHHHHHHHHcCCCCCCCCC----
Q 013558          251 DGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHAN----  318 (441)
Q Consensus       251 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltG~~pf~~~~----  318 (441)
                      ++.+||+|||+++.+.....   ....+||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+..    
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            99999999999987644322   3346899999999999873     45567899999999999999999997532    


Q ss_pred             ------------HHHHHHHHHhcccc--CCC-----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          319 ------------RQKLQQRIINEKVK--LPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       319 ------------~~~~~~~i~~~~~~--~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                                  ...+...+......  ++.     ..++++.+||.+||+.||++||     +++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  311 (322)
T 3soc_A          247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-----SAGCVGE  311 (322)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence                        22233333222211  111     1235599999999999999999     7888875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.7e-46  Score=354.92  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=208.6

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+.+..++|++.+.||+|+||+||++++       .++.||||++....     ..+.+.+|+.++++++||||++++++
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY-------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGV   82 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE-------TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE-------cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3456677899999999999999999986       45789999987532     34568899999999999999999998


Q ss_pred             EEeC-CEEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecC
Q 013558          184 FQTR-SKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       184 ~~~~-~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                      +... +.+|+||||+++++|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence            7554 479999999999999999977643  8999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      ++......  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+... ....+..++
T Consensus       163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (278)
T 1byg_A          163 LTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP  240 (278)
T ss_dssp             C--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred             cccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCC
Confidence            99865432  234467899999999999999999999999999999998 99999988877777777654 455677899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.++|.+||+.||.+||     +++++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rp-----s~~~l~~  266 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRP-----SFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCC-----CHHHHHH
Confidence            9999999999999999999     7788875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=377.80  Aligned_cols=250  Identities=29%  Similarity=0.461  Sum_probs=210.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+++|++++||||+++++++...
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   79 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence            34679999999999999999999876     788999999976443  23345677899999999999999999999875


Q ss_pred             C--EEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec----CCCCcEEEEe
Q 013558          188 S--KLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTD  258 (441)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkl~D  258 (441)
                      .  ..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            5  7899999999999999987653   39999999999999999999999999999999999999    7888899999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhcC--------CCCCCcchhhhHHHHHHHHHcCCCCCCC----CCHHHHHHHH
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLS--------KGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRI  326 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvvl~elltG~~pf~~----~~~~~~~~~i  326 (441)
                      ||+++...........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....+...++
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            999998766655667789999999999875        4577899999999999999999999964    2334555555


Q ss_pred             Hhcccc-------------------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          327 INEKVK-------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       327 ~~~~~~-------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ..+...                         ++..+++.+.+||++||+.||++||     +++++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~-----s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-----cHHHHHH
Confidence            544321                         1123456889999999999999999     7788754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.3e-46  Score=357.79  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      ..+|++++.||+|+||.||+|++.... ..+++.||+|++....  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            456999999999999999999864321 2378999999997653  234456788999999999999999999999876 


Q ss_pred             -CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          188 -SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       188 -~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             679999999999999999954 467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---------------HHHHHHHH
Q 013558          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQQRI  326 (441)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---------------~~~~~~~i  326 (441)
                      .....    .....||..|+|||++.+..++.++|||||||++|+|++|..|+....               .......+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            54332    334568889999999999999999999999999999999999864221               11222222


Q ss_pred             Hh-ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          327 IN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       327 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .. .....+..+++++.+||.+||+.||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  295 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT-----SFQNLIE  295 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC-----CHHHHHH
Confidence            22 24456778999999999999999999999     7888875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-45  Score=351.77  Aligned_cols=245  Identities=19%  Similarity=0.281  Sum_probs=207.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~  187 (441)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++......     +.+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            3689999999999999999999875     7899999998754321     2477899999999988766655554 677


Q ss_pred             CEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceec---CCCCcEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkl~DFG~a~  263 (441)
                      ...++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            8899999999 8999999974 4679999999999999999999999999999999999999   488999999999998


Q ss_pred             ccCCCCC--------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcccc
Q 013558          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVK  332 (441)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~~~  332 (441)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+   ..+....+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            7654322        345689999999999999999999999999999999999999998632   33444455444444


Q ss_pred             CC-----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          333 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       333 ~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+     ..+++++.+||.+||+.||.+||     +++++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  273 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCC-----CHHHHHH
Confidence            43     67899999999999999999999     7788775

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.6e-46  Score=361.34  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=213.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-  185 (441)
                      +..++|++++.||+|+||.||+|+++.... .+++.||||++....   ....+.+.+|+++|++++||||+++++++. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSS-SCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCC-CcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            455789999999999999999999653222 378899999987642   344567889999999999999999999987 


Q ss_pred             -eCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 -TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 -~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                       +...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence             456799999999999999999774 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---------------HHHH
Q 013558          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQ  324 (441)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---------------~~~~  324 (441)
                      .......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......               ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            7654332    23456888899999999998999999999999999999999999643321               2222


Q ss_pred             HHHh-ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          325 RIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       325 ~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+.. .....+..+++++.+||.+||+.||.+||     +++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  296 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP-----SFSALGP  296 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            2222 23456778999999999999999999999     7888865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.8e-46  Score=377.48  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.++||+|+||.||++.++      .+..||||++.....    ..+.+.+|+.+|++++||||+++++++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEEC------CCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566778999999999999999999986      345699999976432    235688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+ +.+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence            66 6789999999999999999643  56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +.......  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+ ....|..++
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87643221  223457789999999999999999999999999999999 99999998888888777655 456678899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+||.+||+.||++||     ++++|++
T Consensus       408 ~~l~~li~~cl~~dP~~Rp-----t~~~l~~  433 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERP-----TFEYLQA  433 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999999     7788875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-45  Score=353.22  Aligned_cols=251  Identities=20%  Similarity=0.323  Sum_probs=210.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~  188 (441)
                      .+|++.++||+|+||+||+|.+....  .....+|+|.+...  ......+.+.+|+.++++++||||+++++++ ..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            46999999999999999999876421  14456899988653  2344566788999999999999999999985 4566


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 5689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccc-cCCCCCcHH
Q 013558          268 SS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSE  340 (441)
Q Consensus       268 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~  340 (441)
                      ..     ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+..... ..|..++.+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            22     2334567889999999999999999999999999999999 7788887777777777666543 446778999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+||.+||+.||.+||     +++++++
T Consensus       261 l~~li~~~l~~~p~~Rp-----s~~ell~  284 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRP-----SFSELVS  284 (298)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7888876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-45  Score=387.83  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=212.9

Q ss_pred             CceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      .+.+. ++||+|+||+||+|.++..   ..++.||||+++... ......+.+.+|+++|++++|||||++++++.. +.
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  443 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES  443 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             hccccCCEeccCCCEEEEEEEEcCC---CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            34443 4899999999999976531   256889999997653 334456778999999999999999999999865 45


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            89999999999999999988899999999999999999999999999999999999999999999999999998764332


Q ss_pred             C----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHH
Q 013558          270 R----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (441)
Q Consensus       270 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  343 (441)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..+++++.+
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1    223456789999999999999999999999999999998 99999999988888888765 45678889999999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ||.+||+.||++||     ++++|++
T Consensus       604 li~~cl~~dP~~RP-----s~~~l~~  624 (635)
T 4fl3_A          604 LMNLCWTYDVENRP-----GFAAVEL  624 (635)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHcCCCHhHCc-----CHHHHHH
Confidence            99999999999999     7778765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.1e-47  Score=367.70  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=207.8

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++.+.||+|+||+||+|+++      +++.||||++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4578999999999999999999854      57889999886542   34456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 SKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +.+|+||||+++|+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999999886543    58999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhccc--
Q 013558          264 EIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-------QRIINEKV--  331 (441)
Q Consensus       264 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~-------~~i~~~~~--  331 (441)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..       ........  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            64322   2234457999999999999999999999999999999999999999764432211       11111110  


Q ss_pred             --------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          332 --------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       332 --------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                              .+++..+..+.++|.+||+.||++||     +++++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  309 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP-----SMGDVLWK  309 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence                    11223456789999999999999999     88999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=349.91  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=212.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++.++||+|+||+||+|.+....  ..+..||+|++...  ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            4777899999999999999976522  24457999998653  2344567788999999999999999999999876655


Q ss_pred             -EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          191 -YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       191 -~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                       ++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999976 356899999999999999999999999999999999999999999999999999865322


Q ss_pred             -----CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHHH
Q 013558          269 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (441)
Q Consensus       269 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~  341 (441)
                           .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.... ...+..+++++
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                 22344578899999999999999999999999999999999 666677777777776666543 45677899999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+||.+||+.||.+||     +++++++
T Consensus       258 ~~li~~~l~~~p~~Rp-----s~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRP-----TFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999     7888876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.8e-45  Score=371.45  Aligned_cols=247  Identities=29%  Similarity=0.419  Sum_probs=196.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      +.|.+.++||+|+||+||.+...      +++.||||++....      .+.+.+|+.+|+++ +||||+++++++.+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34667789999999999875432      68899999986532      24567899999886 8999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC----------
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFR-------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------  251 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~-------~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----------  251 (441)
                      .+|+|||||. |+|.+++...+...       +..++.++.||+.||.|||++||+||||||+||||+.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999998765432       33457799999999999999999999999999999754          


Q ss_pred             ---CcEEEEecCCccccCCCCC-----CccccCCCCCCCcchhcC-------CCCCCcchhhhHHHHHHHHHc-CCCCCC
Q 013558          252 ---GHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFT  315 (441)
Q Consensus       252 ---~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~ellt-G~~pf~  315 (441)
                         +.+||+|||+++.......     ....+||+.|+|||++.+       ..++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4899999999987654321     234689999999999976       668999999999999999999 999997


Q ss_pred             CCCHHHHHHHHHhccccCCC-------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          316 HANRQKLQQRIINEKVKLPP-------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       316 ~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ......  ..+.......+.       .+++++.+||.+||+.||.+||     ++.++++||||+..
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP-----TAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSCH
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC-----CHHHHHhCCccCCc
Confidence            654433  344444433322       2458899999999999999999     88999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.7e-45  Score=356.33  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  188 (441)
                      .|++++.||+|+||+||++.++.... .+++.||||++....  .....+.+.+|+.+|++++||||+++++++.+  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            35999999999999999987654322 378899999997652  34456678899999999999999999999987  46


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            899999999999999998664 5999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHh-
Q 013558          269 SR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQRIIN-  328 (441)
Q Consensus       269 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~---------------~~~~~i~~-  328 (441)
                      ..    .....||..|+|||++.+..++.++|||||||++|+|++|..||......               .....+.. 
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            32    23456888999999999989999999999999999999999999653221               11112211 


Q ss_pred             ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          329 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       329 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .....+..+++++.+||++||+.||.+||     +++++++
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  303 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRP-----TFENLIP  303 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            23456678999999999999999999999     7888875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=357.70  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||.||+|+++.     +++.||||++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLH-----DGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecC-----CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            455689999999999999999999875     7889999998653   23445678899999999999999999999873


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEe
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                          ....|+||||+.+|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence                3479999999999999998876    46799999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCC----------CccccCCCCCCCcchhcCCC---CCCcchhhhHHHHHHHHHcCCCCCCCCC--HHHHH
Q 013558          259 FGLAKEIDESSR----------SNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQ  323 (441)
Q Consensus       259 FG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltG~~pf~~~~--~~~~~  323 (441)
                      ||++........          .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||....  .....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            999876432111          12345799999999997654   6889999999999999999999995311  11112


Q ss_pred             HHHHh-ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          324 QRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       324 ~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ..+.. .....+..++.++.+||.+||+.||.+||     ++++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  300 (317)
T 2buj_A          258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP-----HIPLLLSQ  300 (317)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC-----CHHHHHHH
Confidence            22222 12233457899999999999999999999     88999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=382.68  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=216.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.++||+|+||.||++.++      .+..||||+++....    ..+.+.+|+.+|++++||||+++++++.
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEEC------CCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            355667999999999999999999986      345699999976432    2356889999999999999999999986


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      + ..+|+||||+.+|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            6 6799999999999999999643  569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      ......  ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+..+ ....+..+++
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  491 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  491 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            754321  1223456789999999999999999999999999999999 99999998888888877655 4566788999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||.+||+.||++||     ++++|++
T Consensus       492 ~l~~li~~cl~~dP~~RP-----t~~~l~~  516 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERP-----TFEYLQA  516 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999     7788875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=385.49  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=214.3

Q ss_pred             CcCCCCceEEe-eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       106 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .+..+++.+.+ .||+|+||+||+|.++...   .+..||||+++...  .....+.+.+|+++|++++|||||++++++
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~  405 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC  405 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence            34556777777 8999999999999876421   45679999997642  334556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .. +.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       406 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          406 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             ES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             cc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            76 5699999999999999998754 469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      .+.....    .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ...+|..+
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~  564 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  564 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTC
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            7643221    122345689999999999999999999999999999998 99999998888888887765 45678889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++.+||.+||+.||++||     ++++|++
T Consensus       565 ~~~l~~li~~cl~~dP~~RP-----s~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRP-----DFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            99999999999999999999     7777754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=354.01  Aligned_cols=242  Identities=29%  Similarity=0.458  Sum_probs=199.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++.+.||+|+||+||+++++       ++.||||++...     ...+.+.+|+.+|++++||||+++++++.+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN   72 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            45568999999999999999999873       567999998643     334568899999999999999999998763


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccccCCCceecCCCCc-EEEEec
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHK---CGIVHRDLKPENILMDSDGH-VMLTDF  259 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~-vkl~DF  259 (441)
                        ..|+||||++||+|.+++....   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+||
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence              4899999999999999998765   37899999999999999999999   89999999999999998886 799999


Q ss_pred             CCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHh-ccccCCCC
Q 013558          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRIIN-EKVKLPPF  336 (441)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~--~~~~~~i~~-~~~~~p~~  336 (441)
                      |++......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.. ....++..
T Consensus       151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (307)
T 2eva_A          151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN  228 (307)
T ss_dssp             CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT
T ss_pred             ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc
Confidence            999765432  3345799999999999999999999999999999999999999985432  233333333 34456678


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++.+.+||.+||+.||.+||     +++++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  256 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRP-----SMEEIVK  256 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            999999999999999999999     7888876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-46  Score=367.95  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=204.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~  188 (441)
                      ..|++.++||+|+||+||+|.+....  .....||+|.+...  ......+.+.+|+.++++++||||+++++++. .++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            35889999999999999999876311  13456899988653  23445677889999999999999999999865 456


Q ss_pred             EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      ..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            889999999999999999765 4589999999999999999999999999999999999999999999999999986533


Q ss_pred             CC-----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcHH
Q 013558          268 SS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (441)
Q Consensus       268 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~  340 (441)
                      ..     ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+..+. ...|..++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  324 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            22     1233467889999999999999999999999999999999 788998877666666665543 4456789999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+||.+||+.||++||     +++++++
T Consensus       325 l~~li~~cl~~dp~~RP-----s~~ell~  348 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRP-----SFSELVS  348 (373)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7888886

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=365.92  Aligned_cols=250  Identities=15%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~  181 (441)
                      ..+..++|++.++||+|+||+||+|.++...+..+++.||||++....      ...+..|+++++.++   |+||+.++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            345667899999999999999999964433333478899999986532      234667888888887   89999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC------
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS------  250 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~------  250 (441)
                      +++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+||||+.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999974     457999999999999999999999999999999999999998      


Q ss_pred             -----CCcEEEEecCCccccC---CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHH
Q 013558          251 -----DGHVMLTDFGLAKEID---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  322 (441)
Q Consensus       251 -----~~~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~  322 (441)
                           ++.+||+|||+|+.+.   ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 8999999999997543   23334567899999999999999999999999999999999999999964322100


Q ss_pred             HHHHHhccccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIINEKVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                           .....++ ...++.+.+++..||+.+|.+|+.    +++++.+
T Consensus       294 -----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~----~~~~l~~  332 (365)
T 3e7e_A          294 -----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP----SLDLLRQ  332 (365)
T ss_dssp             -----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCC----CHHHHHH
T ss_pred             -----eechhccccCcHHHHHHHHHHHcCCCCCCcch----HHHHHHH
Confidence                 0001111 134778999999999999999973    4455443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=361.74  Aligned_cols=247  Identities=16%  Similarity=0.230  Sum_probs=203.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCC---CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCcee------
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ------  179 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~------  179 (441)
                      .++|++.+.||+|+||.||+|+++.+...   ..++.||||++.+.        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            46899999999999999999998752110   03678999998754        24678999999999999987      


Q ss_pred             ---------eeEEEEe-CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCcee
Q 013558          180 ---------LRYSFQT-RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (441)
Q Consensus       180 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  247 (441)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     6777776 78999999999 99999999886  78999999999999999999999999999999999999


Q ss_pred             cCCCC--cEEEEecCCccccCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC
Q 013558          248 MDSDG--HVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  317 (441)
Q Consensus       248 l~~~~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~  317 (441)
                      ++.++  .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998654221        123458999999999999999999999999999999999999999875


Q ss_pred             C--HHHHHHHHH---hccccCC------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          318 N--RQKLQQRII---NEKVKLP------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       318 ~--~~~~~~~i~---~~~~~~p------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .  ...+...+.   .....++      ..+++++.+||.+||+.||.+||     +++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP-----PYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC-----CHHHHHH
Confidence            3  333333322   2222222      24689999999999999999999     7888876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=357.55  Aligned_cols=248  Identities=26%  Similarity=0.441  Sum_probs=189.3

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  185 (441)
                      +...+|++.++||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.+++++. ||||+++++++.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVG-----SGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECC-----CCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            344579999999999999999999876     78899999986542   344556888999999996 999999999994


Q ss_pred             --------eCCEEEEEEeccCCCchHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecCCCC
Q 013558          186 --------TRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG  252 (441)
Q Consensus       186 --------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~  252 (441)
                              ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+||||+.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence                    3446899999996 688888765   467999999999999999999999999  99999999999999999


Q ss_pred             cEEEEecCCccccCCCCC-------------CccccCCCCCCCcchh---cCCCCCCcchhhhHHHHHHHHHcCCCCCCC
Q 013558          253 HVMLTDFGLAKEIDESSR-------------SNSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLTGQPPFTH  316 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvvl~elltG~~pf~~  316 (441)
                      .+||+|||+++.......             ....+||+.|+|||++   .+..++.++|||||||++|+|++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999987644322             1245699999999998   566788999999999999999999999976


Q ss_pred             CCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       317 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ...........  ....+...+..+.+||.+||+.||.+||     +++++++|
T Consensus       256 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  302 (337)
T 3ll6_A          256 GAKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERL-----SIAEVVHQ  302 (337)
T ss_dssp             ----------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hhHHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            54433322211  2233456788999999999999999999     88999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-45  Score=350.41  Aligned_cols=244  Identities=27%  Similarity=0.424  Sum_probs=196.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSF  184 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~  184 (441)
                      +..++|++++.||+|+||+||++++       +++.||||++....      ...+..|.+++..  ++||||+++++++
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-------QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-------CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            3456899999999999999999986       46789999986532      2344567777776  7999999999987


Q ss_pred             Ee----CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccccCCCceecCCCC
Q 013558          185 QT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       185 ~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NILl~~~~  252 (441)
                      ..    ...+|+||||+++|+|.+++. ...+++..+..++.||+.||.|||        ++||+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence            54    356899999999999999994 457999999999999999999999        99999999999999999999


Q ss_pred             cEEEEecCCccccCCCCC-----CccccCCCCCCCcchhcCC------CCCCcchhhhHHHHHHHHHcC----------C
Q 013558          253 HVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTG----------Q  311 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltG----------~  311 (441)
                      .+||+|||+++.......     ....+||+.|+|||++.+.      .++.++|||||||++|||++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999986544322     2345899999999999876      345689999999999999999          8


Q ss_pred             CCCCCCC----HHHHHHHHHhc---cccCCC-----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          312 PPFTHAN----RQKLQQRIINE---KVKLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       312 ~pf~~~~----~~~~~~~i~~~---~~~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .||....    .......+...   ...+|.     .+++++.+||.+||+.||.+||     +++++++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-----TALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-----CHHHHHH
Confidence            8886432    12222332221   122221     2457899999999999999999     7888875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.2e-46  Score=361.10  Aligned_cols=255  Identities=20%  Similarity=0.310  Sum_probs=206.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++.+.||+|+||+||+|+.+      +++.||||++........  ...+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEe
Confidence            345678999999999999999999743      578899999976542221  225788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccccCCCceecCCCCcEEEEe
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      +....++||||+.+|+|.+++....    .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999998653    499999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccc-
Q 013558          259 FGLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKV-  331 (441)
Q Consensus       259 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~----~~~~~~~~i~~~~~-  331 (441)
                      ||+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...    .............. 
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            99998764322  234456999999999999888999999999999999999999999521    11111111111100 


Q ss_pred             --------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          332 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       332 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                                    .++...++++.+||.+||+.||.+||     +++++++|-.-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L~~  308 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-----KMSEVVRMLEG  308 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-----CHHHHHHHHHT
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-----CHHHHHHHhcC
Confidence                          11122347899999999999999999     88999986543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-44  Score=380.37  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=218.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.+.||+|+||+||+|.++...  ..+..||+|.+....  .....+.+.+|+.+|++++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3455678999999999999999999987532  246789999986532  334456788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      . ++.+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            4 567899999999999999998654 69999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcH
Q 013558          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~  339 (441)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ...+|..+++
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            7644322  223457789999999999999999999999999999997 99999998888888887665 4567889999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++.+||.+||..||.+||     +++++++
T Consensus       620 ~l~~li~~~l~~dP~~RP-----s~~el~~  644 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRP-----RFTELKA  644 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999     7888875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-44  Score=347.02  Aligned_cols=228  Identities=30%  Similarity=0.577  Sum_probs=190.9

Q ss_pred             CCceEE-eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHH-HhcCCCCceeeeEEEEe-
Q 013558          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT-  186 (441)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~-  186 (441)
                      ++|.+. ++||+|+||.||+|.++.     +++.||+|++...        ..+.+|+.++ +.++||||+++++++.. 
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC-----CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            468888 789999999999999876     7889999998643        2356788887 56689999999999987 


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEEe
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~D  258 (441)
                         ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  6999999999999999999999999999999999999998   78999999


Q ss_pred             cCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhccccCC
Q 013558          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR----IINEKVKLP  334 (441)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~----i~~~~~~~p  334 (441)
                      ||++....                     +..++.++|||||||++|||++|..||...+.......    +......++
T Consensus       164 fg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          164 FGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99986543                     24477889999999999999999999987654433221    222233333


Q ss_pred             ----CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          335 ----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       335 ----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                          ..+++++.+||.+||+.||.+||     +++++++||||+..
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~e~l~hp~~~~~  263 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHTG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCC-----CHHHHhcChhhccc
Confidence                56899999999999999999999     89999999999753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=349.96  Aligned_cols=255  Identities=21%  Similarity=0.342  Sum_probs=211.0

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      .+..++|++++.||+|+||.||+|+..... ..+++.||||++...   .....+.+.+|+.+|++++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            345568999999999999999999864322 237889999998753   3445567889999999999999999999987


Q ss_pred             eCC--EEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          186 TRS--KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       186 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      ..+  .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            644  789999999999999999876 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH----------------HH
Q 013558          263 KEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  322 (441)
Q Consensus       263 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~----------------~~  322 (441)
                      +.......    .....++..|+|||++.+..++.++|||||||++|||++|..||......                .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654322    22345778899999999888999999999999999999999998642110                11


Q ss_pred             HHHHHh-ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          323 QQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       323 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ...+.. .....+..+++++.+||.+||+.||.+||     +++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            122221 23456778999999999999999999999     7888875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.5e-46  Score=389.07  Aligned_cols=269  Identities=27%  Similarity=0.404  Sum_probs=218.0

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|++.++||+|+||+||+|.++.     +++.||||++....  .....+.+.+|+.+|++++||||+++++++..  
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~-----tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD-----TGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT-----TTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            3689999999999999999998765     78899999987542  34445678899999999999999999998765  


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc---EEE
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VML  256 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkl  256 (441)
                          .+..|+||||++||+|.+++...+   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999998754   6999999999999999999999999999999999999997765   999


Q ss_pred             EecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHH---------HHH-
Q 013558          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ---------QRI-  326 (441)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~---------~~i-  326 (441)
                      +|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.........         ..+ 
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            9999999877666666788999999999999999999999999999999999999999765332211         000 


Q ss_pred             ----Hhcccc----------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCC
Q 013558          327 ----INEKVK----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK  391 (441)
Q Consensus       327 ----~~~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~  391 (441)
                          ..+...          ++..+++.+.+||.+||..||.+||     +++++++||||+.  +..+..+++-+.|.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP-----Ta~elL~hp~F~~--l~~iL~~kil~~f~  317 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG-----TDPQNPNVGCFQA--LDSILSLKLLSVMN  317 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--------CCTTCCCCTTHHH--HHHHHCCCEEECCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc-----CHHHHhcCHHHHH--HHHHHhcccccccc
Confidence                011111          1123678899999999999999999     7789999999985  45666655544443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-44  Score=349.15  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=202.6

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      |...+.||+|+||+||+|..       .++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence            45568999999999999974       467899999875432 2344567788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      |+||||+++++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            9999999999999998743   4699999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhccc---------
Q 013558          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK----LQQRIINEKV---------  331 (441)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~----~~~~i~~~~~---------  331 (441)
                      ...   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......    +...+.....         
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK  264 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred             ccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence            222   334679999999999875 47899999999999999999999998654332    2222221111         


Q ss_pred             --cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          332 --KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       332 --~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                        ..+...++.+.++|.+||+.||.+||     +++++++
T Consensus       265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~l~~  299 (307)
T 2nru_A          265 MNDADSTSVEAMYSVASQCLHEKKNKRP-----DIKKVQQ  299 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             ccccchHHHHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence              11223457899999999999999999     7888876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=353.32  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=210.5

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+.+..++|++.+.||+|+||.||+|++++        .+|+|++..... .....+.+.+|+.++++++||||++++++
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            456777899999999999999999998753        399999875432 22233456789999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +.+...+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            999999999999999999999997654 699999999999999999999999999999999999998 789999999998


Q ss_pred             cccCC------CCCCccccCCCCCCCcchhcC---------CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 013558          263 KEIDE------SSRSNSMCGTTEYMAPEILLS---------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  327 (441)
Q Consensus       263 ~~~~~------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~  327 (441)
                      +....      ........||+.|+|||++.+         ..++.++|||||||++|||++|..||...+.......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            76421      122334568999999999975         357889999999999999999999999988888877776


Q ss_pred             hccccC--CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          328 NEKVKL--PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       328 ~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ......  +..++.++.+||.+||..||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  295 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERP-----TFTKLMD  295 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC-----CHHHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            654332  235889999999999999999999     7888886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=349.20  Aligned_cols=246  Identities=20%  Similarity=0.358  Sum_probs=190.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH--HHHhcCCCCceeeeE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRY  182 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~--~l~~l~hpnIv~l~~  182 (441)
                      ..+..++|++++.||+|+||+||+|+.       +++.||||++.....      ..+..|.+  .+..++||||+++++
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~   74 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL-------DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIV   74 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE-------CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhhee
Confidence            456778999999999999999999975       567899999975431      22333444  445689999999998


Q ss_pred             EEEe-----CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccccCCCceec
Q 013558          183 SFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILM  248 (441)
Q Consensus       183 ~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NILl  248 (441)
                      .+..     ...+|+||||+++|+|.+++... ..++..+..++.||+.||.|||++         ||+||||||+||||
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence            6643     33689999999999999999765 458999999999999999999999         99999999999999


Q ss_pred             CCCCcEEEEecCCccccCCC---------CCCccccCCCCCCCcchhcC-------CCCCCcchhhhHHHHHHHHHcCCC
Q 013558          249 DSDGHVMLTDFGLAKEIDES---------SRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLTGQP  312 (441)
Q Consensus       249 ~~~~~vkl~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~elltG~~  312 (441)
                      +.++.+||+|||+++.+...         ......+||+.|+|||++.+       ..++.++|||||||++|||++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            99999999999999875432         12235579999999999987       345678999999999999999977


Q ss_pred             CCCCCCH-----------------HHHHHHHHh---ccccCCCC------CcHHHHHHHHHhcccCcCCCCCCCCCChHH
Q 013558          313 PFTHANR-----------------QKLQQRIIN---EKVKLPPF------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDA  366 (441)
Q Consensus       313 pf~~~~~-----------------~~~~~~i~~---~~~~~p~~------~s~~~~~li~~~L~~dP~~R~~~~~~~~~~  366 (441)
                      ||.....                 ......+..   ....+|..      +++++.+||.+||+.||++||     ++++
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~e  308 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-----TAQX  308 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-----CHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-----chHH
Confidence            6632110                 111112211   12233333      345799999999999999999     7888


Q ss_pred             hhh
Q 013558          367 IKH  369 (441)
Q Consensus       367 i~~  369 (441)
                      +++
T Consensus       309 ~l~  311 (336)
T 3g2f_A          309 AEE  311 (336)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=346.31  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=194.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~  187 (441)
                      ++|++.++||+|+||.||+|++       .++.||||++.....      .....|.+++..+  +||||+++++++...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW-------RGEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cceEEEeEeecCCCeEEEEEEE-------CCceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            4799999999999999999986       467899999865321      2234455555544  899999999999887


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCCCceecCCCCcEE
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~vk  255 (441)
                          ..+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                789999999999999999965 4799999999999999999999999        999999999999999999999


Q ss_pred             EEecCCccccCCCCC-----CccccCCCCCCCcchhcCCCCCCc------chhhhHHHHHHHHHcC----------CCCC
Q 013558          256 LTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------QPPF  314 (441)
Q Consensus       256 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvvl~elltG----------~~pf  314 (441)
                      |+|||+++.+.....     ....+||+.|+|||++.+..+...      +|||||||++|||++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            999999976543322     235689999999999988777665      9999999999999999          7777


Q ss_pred             CCCC-----HHHHHHHHHhc--cccCCC-----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          315 THAN-----RQKLQQRIINE--KVKLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       315 ~~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ....     .......+...  ...++.     .+++++.+||.+||+.||.+||     +++++++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL-----TALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC-----CHHHHHHH
Confidence            5432     22222222222  222332     3567799999999999999999     88898874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.4e-46  Score=362.92  Aligned_cols=243  Identities=15%  Similarity=0.242  Sum_probs=194.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcC---------C
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT---------H  174 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h  174 (441)
                      .++|++++.||+|+||+||+|++       +++.||||++.+....     .....+.+.+|+.+|+.++         |
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            35799999999999999999986       4588999999875421     2334467889999999886         7


Q ss_pred             CCceeeeEEEE-----------------e-------------CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHH
Q 013558          175 PFIVQLRYSFQ-----------------T-------------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI  224 (441)
Q Consensus       175 pnIv~l~~~~~-----------------~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi  224 (441)
                      ||||++++++.                 +             .+.+|+||||+++|++.+.+.+ +.+++..++.++.||
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL  170 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence            77777766543                 2             6889999999999977666644 678999999999999


Q ss_pred             HHHHHHHH-HCCCcccccCCCceecCCCC--------------------cEEEEecCCccccCCCCCCccccCCCCCCCc
Q 013558          225 VSAVSHLH-KCGIVHRDLKPENILMDSDG--------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (441)
Q Consensus       225 ~~~L~~LH-~~~iiHrDlkp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aP  283 (441)
                      +.||.||| ++||+||||||+||||+.++                    .+||+|||+|+.....    ..+||+.|+||
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999999 99999999999999999887                    9999999999876542    45899999999


Q ss_pred             chhcCCCCCCcchhhhHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHhc-ccc------CCCCCcHHHHHHHHHhcccCcC
Q 013558          284 EILLSKGHNKDADWWSVGIL-LYEMLTGQPPFTHANR-QKLQQRIINE-KVK------LPPFLTSEAHSLLKGLLHKDPS  354 (441)
Q Consensus       284 E~~~~~~~~~~~DvwslGvv-l~elltG~~pf~~~~~-~~~~~~i~~~-~~~------~p~~~s~~~~~li~~~L~~dP~  354 (441)
                      |++.+.. +.++||||||++ .+++++|..||..... ......+... ...      .++.+++++++||++||++|  
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            9998776 889999998777 7888999999954211 1223333321 111      11247889999999999976  


Q ss_pred             CCCCCCCCChHHhh-hCcccC
Q 013558          355 KRLGSGPGGVDAIK-HHKWFR  374 (441)
Q Consensus       355 ~R~~~~~~~~~~i~-~h~~f~  374 (441)
                              ++++++ +||||+
T Consensus       324 --------sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --------SATDLLCQHSLFK  336 (336)
T ss_dssp             --------SHHHHHHHCGGGC
T ss_pred             --------CHHHHHhcCCCcC
Confidence                    689999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-45  Score=367.84  Aligned_cols=252  Identities=17%  Similarity=0.156  Sum_probs=199.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCce--------
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIV--------  178 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv--------  178 (441)
                      ...+|.+.++||+|+||+||+|++..     +++.||||++...........+.+.+|+.+++.+.| .|+.        
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             CceeEEEecccccCCCEEEEEEEecC-----CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            34468899999999999999999876     788999999875443444445678899999999987 2211        


Q ss_pred             -eee------------EEEEe-----CCEEEEEEeccCCCchHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 013558          179 -QLR------------YSFQT-----RSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYTAEIVSAVSHLHK  233 (441)
Q Consensus       179 -~l~------------~~~~~-----~~~~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qi~~~L~~LH~  233 (441)
                       ...            .++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence             111            11111     22467888876 5689888742       2347788899999999999999999


Q ss_pred             CCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchh----------cCCCCCCcchhhhHHHH
Q 013558          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL----------LSKGHNKDADWWSVGIL  303 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslGvv  303 (441)
                      +||+||||||+||||+.++.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||+
T Consensus       230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             CCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999999875443  456688 999999999          55568889999999999


Q ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          304 LYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       304 l~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      +|||++|+.||...+..+....+..    ....+++++.+||.+||+.||++||     ++.++++||||+.+.
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCc-----CHHHHHhCHHHHHHH
Confidence            9999999999987765544333332    2346789999999999999999999     889999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-43  Score=345.30  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=200.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~  187 (441)
                      ++|++.+.||+|+||.||++++       +++.||||++....      ...+.+|+++++.  ++||||+++++++...
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE-------cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3699999999999999999986       46789999986532      2456678889888  7899999999999887


Q ss_pred             C----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccccCCCceecCCCCcEE
Q 013558          188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       188 ~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                      .    .+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||        ++||+||||||+||||+.++.+|
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            6    89999999999999999976 46899999999999999999999        89999999999999999999999


Q ss_pred             EEecCCccccCCCC-----CCccccCCCCCCCcchhcCCC------CCCcchhhhHHHHHHHHHcC----------CCCC
Q 013558          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------QPPF  314 (441)
Q Consensus       256 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvvl~elltG----------~~pf  314 (441)
                      |+|||++.......     ......||+.|+|||++.+..      ++.++|||||||++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765433     234567999999999998753      23689999999999999999          7898


Q ss_pred             CCC-----CHHHHHHHHHhccc--cCCC-----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          315 THA-----NRQKLQQRIINEKV--KLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       315 ~~~-----~~~~~~~~i~~~~~--~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ...     ....+...+.....  .++.     .+++.+.+||.+||+.||++||     +++++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC-----CHHHHHHH
Confidence            754     23444444433322  2222     2345789999999999999999     88898874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-42  Score=329.07  Aligned_cols=222  Identities=15%  Similarity=0.183  Sum_probs=186.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.+.||+|+||.||+|++..     +++.||||++...........+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            4679999999999999999999875     78999999998765555566678889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..|+||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|        
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999999999854 3 4666788999999999999999999999999999999999999998554        


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhccc----cCCCCCcHHH
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---RIINEKV----KLPPFLTSEA  341 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~---~i~~~~~----~~p~~~s~~~  341 (441)
                                 |++       .++.++|||||||++|||++|+.||.+.+......   +......    .++..+++++
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                       333       37889999999999999999999998765432110   1111111    2335789999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+||.+||++||.+| +     ++++++
T Consensus       237 ~~li~~~l~~dP~~R-s-----~~el~~  258 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-S-----ASTLLN  258 (286)
T ss_dssp             HHHHHHHHCTTSSCC-C-----HHHHHH
T ss_pred             HHHHHHHcccCCccC-C-----HHHHHH
Confidence            999999999999999 4     467665

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.4e-42  Score=366.20  Aligned_cols=242  Identities=24%  Similarity=0.344  Sum_probs=198.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++.++||+|+||+||++.++.    .+++.||||++....  .....+.+.+|+.+|++++||||+++++++...+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4689999999999999999999863    157889999986532  2344567889999999999999999999998765


Q ss_pred             E-----EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          189 K-----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .     .|+||||++|++|.+.+..  .+++.+++.++.||+.||.|||++||+||||||+||||+.+ .+||+|||+++
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            5     7999999999999887654  79999999999999999999999999999999999999875 99999999998


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHH
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  343 (441)
                      .....   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....+.     . .......++.+.+
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----~-~~~~~~~~~~l~~  299 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----E-DDPVLKTYDSYGR  299 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----T-TCHHHHHCHHHHH
T ss_pred             hcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-----c-cccccccCHHHHH
Confidence            76543   456899999999999765 488999999999999999999998752111000     0 0000113578999


Q ss_pred             HHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       344 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ||.+||++||.+||     +..+.+.|+|+.
T Consensus       300 li~~~l~~dP~~R~-----~~~~~l~~~l~~  325 (681)
T 2pzi_A          300 LLRRAIDPDPRQRF-----TTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHTCSSGGGSC-----SSHHHHHHHHHH
T ss_pred             HHhhhccCChhhCC-----CHHHHHHHHHHH
Confidence            99999999999999     557777788875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.2e-37  Score=319.42  Aligned_cols=188  Identities=15%  Similarity=0.130  Sum_probs=137.9

Q ss_pred             eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-------chhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013558          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (441)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  188 (441)
                      .++.|++|.+..++..-     .|+.||+|++.+....       .+...+.+.+|+++|+++ .|+||+++++++++++
T Consensus       241 ~~~~~~~~~h~~~rr~~-----fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF-----FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             C-C--------CCEEEE-----ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             ccccCCccccccccccc-----ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            45677777777666554     6788999999875321       234456789999999999 6999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+||||||++|++|.+++.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999999999999999875   47899999999999999999999999999999999999999999876543


Q ss_pred             -CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCC
Q 013558          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~p  313 (441)
                       ....+.+||+.|||||++.+. +..++|+|++|+++++|.+|..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence             335567899999999999764 66789999999999888766444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.5e-31  Score=273.06  Aligned_cols=185  Identities=19%  Similarity=0.164  Sum_probs=148.0

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      ..++||+|+||+||++..       .++.+++|+.......     .....+.+.+|+++|++++||||+++..++...+
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD  412 (540)
T ss_dssp             --------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred             CCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence            356899999999999943       5677899986543322     2223456889999999999999997666666778


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      ..|+||||++|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+++.....
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            88999999999999998865        6689999999999999999999999999999998  9999999999987543


Q ss_pred             CC--------CccccCCCCCCCcchhcC--CCCCCcchhhhHHHHHHHHHcCCCCCC
Q 013558          269 SR--------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFT  315 (441)
Q Consensus       269 ~~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltG~~pf~  315 (441)
                      ..        ....+||+.|||||++..  ..|+..+|+|+..+-.++.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            21        136789999999999987  678888999999999888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=4.1e-27  Score=224.31  Aligned_cols=148  Identities=21%  Similarity=0.230  Sum_probs=118.6

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---------------hHHHHHHHHHHHHHhcCCC
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------NHVDYMKAERDILTKVTHP  175 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp  175 (441)
                      .|.+.+.||+|+||.||+|.+ .     +++.||||+++.......               .....+.+|+.+|++++  
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            466779999999999999998 4     788999999965332111               13456889999999999  


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEE
Q 013558          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (441)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  255 (441)
                      | +++++++.. +..|+||||++|++|.+ +      .......++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            4 666665544 45699999999999977 3      1234567999999999999999999999999999999 99999


Q ss_pred             EEecCCccccCCCCCCccccCCCCCCCcchhcC
Q 013558          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS  288 (441)
Q Consensus       256 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  288 (441)
                      |+|||+|+.            +..|+|||++..
T Consensus       233 l~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             EEECCCCeE------------CCCCCHHHHHHH
Confidence            999999864            345789999853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.1e-22  Score=191.07  Aligned_cols=141  Identities=21%  Similarity=0.178  Sum_probs=108.2

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcE--EEEEEeechhhcc---------------------hhHHHHHHHHHH
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIK---------------------KNHVDYMKAERD  167 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~--~avK~~~~~~~~~---------------------~~~~~~~~~E~~  167 (441)
                      -|++.+.||+|+||.||+|.+..     +++.  ||||+++......                     ......+.+|+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            37899999999999999999853     6778  9999975432110                     111236788999


Q ss_pred             HHHhcCCCCc--eeeeEEEEeCCEEEEEEeccCC-C----chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCCccc
Q 013558          168 ILTKVTHPFI--VQLRYSFQTRSKLYLILDFING-G----HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHR  239 (441)
Q Consensus       168 ~l~~l~hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~iiHr  239 (441)
                      +|+++.|++|  ..+++.    ...++||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9999988764  333332    356899999942 3    56554322   235578899999999999999 9999999


Q ss_pred             ccCCCceecCCCCcEEEEecCCcccc
Q 013558          240 DLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       240 Dlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=3.5e-19  Score=174.81  Aligned_cols=141  Identities=14%  Similarity=0.179  Sum_probs=101.8

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------------ch---hH----HHHHHHHHHHHHhc
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------KK---NH----VDYMKAERDILTKV  172 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------------~~---~~----~~~~~~E~~~l~~l  172 (441)
                      |++.+.||.|+||.||+|.+.      +|+.||||+++.....            ..   ..    .-...+|...|.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999864      6889999997643210            00   00    01224577777777


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      .+.++.-..-+....  .+|||||++|+.|....      ....+..++.||+.+|.|||++|||||||||.||||+++|
T Consensus       171 ~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          171 YEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             HHTTCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred             HhcCCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence            554443221111222  37999999998885432      2234567889999999999999999999999999998877


Q ss_pred             ----------cEEEEecCCccccC
Q 013558          253 ----------HVMLTDFGLAKEID  266 (441)
Q Consensus       253 ----------~vkl~DFG~a~~~~  266 (441)
                                .+.|+||+.+....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CcccccccccceEEEEeCCcccCC
Confidence                      38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=3e-13  Score=126.59  Aligned_cols=140  Identities=11%  Similarity=0.061  Sum_probs=110.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  188 (441)
                      +.|++...+|.|+.+.||++..       .++.+++|+........   ...+.+|+.+|+.+. +..+.++++++...+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~-------~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             ccceeEeeccCCCCCeEEEEEC-------CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            3699999999999999999863       35689999986532111   124778999999985 677888999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-----------------------------------  233 (441)
                      ..|+||||++|.+|...+     .+......++.++..+|..||+                                   
T Consensus        84 ~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             ceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999999999886652     1223345788899999999998                                   


Q ss_pred             ------------------------CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          234 ------------------------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       234 ------------------------~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                                              ..++|+|+++.|||+++++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    4489999999999998766667999997743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.2e-12  Score=121.71  Aligned_cols=135  Identities=13%  Similarity=0.133  Sum_probs=99.1

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEEEEeC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTR  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~  187 (441)
                      .+|.+..+.+.|..+.||++...      ++..+++|+.....      ...+..|+.+++.+.+.+  +.++++++...
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            35666555556677999998642      45679999975431      134678999999886444  45688888888


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--------------------------------  235 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------  235 (441)
                      +..++||||++|.+|.  .   ....   ...++.+++..|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            8899999999998883  1   1112   2356677777777787643                                


Q ss_pred             --------------------------CcccccCCCceecCCCCcEEEEecCCccc
Q 013558          236 --------------------------IVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       236 --------------------------iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                                                ++|+|++|.|||+++++.+.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      99999999999998776677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=1.2e-11  Score=121.21  Aligned_cols=142  Identities=13%  Similarity=0.261  Sum_probs=105.9

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEee--chhhcchhHHHHHHHHHHHHHhcC--CCCceeeeEEEEeC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQTR  187 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~  187 (441)
                      ...++.|+.|.++.||++..       .+..+++|+..  .....  .....+.+|..+|+.+.  +..+.+++.++.+.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~-------~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVT-------PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEEC-------SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             CceEEEcCCcccceEEEEEE-------CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            44567899999999999874       33578899875  32211  11235778999999997  45577888887766


Q ss_pred             ---CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 013558          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-------------------------------  233 (441)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------  233 (441)
                         +..|+||||++|..+.+.  ....++..+...++.+++..|..||+                               
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence               458999999999877431  12346788888999999999999997                               


Q ss_pred             ---------------------------CCCcccccCCCceecCCCCc--EEEEecCCccc
Q 013558          234 ---------------------------CGIVHRDLKPENILMDSDGH--VMLTDFGLAKE  264 (441)
Q Consensus       234 ---------------------------~~iiHrDlkp~NILl~~~~~--vkl~DFG~a~~  264 (441)
                                                 .+++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                       35899999999999997763  69999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=5e-11  Score=114.07  Aligned_cols=181  Identities=17%  Similarity=0.240  Sum_probs=121.3

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCC--ceeeeEEEEeCC---
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPF--IVQLRYSFQTRS---  188 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---  188 (441)
                      ++.++.|....||++.          ..+++|+....     .....+.+|..+|+.+. +..  +.+++.......   
T Consensus        25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred             eEecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence            3568999999999753          34899986432     23456888999999884 332  333444333322   


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-----------------------------------  233 (441)
                      ..|+|||+++|..|.....  ..++..+...++.+++..|..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            3588999999988865433  346777888888888888888886                                   


Q ss_pred             -----------------------CCCcccccCCCceecCC--CCcEEEEecCCccccCCCCCCccccCCCCC---CCcch
Q 013558          234 -----------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEY---MAPEI  285 (441)
Q Consensus       234 -----------------------~~iiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~  285 (441)
                                             ..++|+|+++.|||+++  ++.+.|+||+.+........   ......+   ..|+.
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHH
Confidence                                   13699999999999998  45688999999875432110   1111111   23332


Q ss_pred             hcC--CCC------------CCcchhhhHHHHHHHHHcCCCCCC
Q 013558          286 LLS--KGH------------NKDADWWSVGILLYEMLTGQPPFT  315 (441)
Q Consensus       286 ~~~--~~~------------~~~~DvwslGvvl~elltG~~pf~  315 (441)
                      ...  ..|            ..-.+.|++|.++|.+.+|..+|.
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            211  011            112589999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=3.4e-07  Score=87.41  Aligned_cols=134  Identities=17%  Similarity=0.241  Sum_probs=92.0

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC---CceeeeEEEE-eCCEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQ-TRSKL  190 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~  190 (441)
                      ++.++.|....||++          ++.+++|+...     ......+.+|..+|+.+.+.   .+.+++.+.. ..+..
T Consensus        24 v~~l~~G~~n~v~~v----------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE----------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred             eeecCCCcceeEEEE----------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence            456788999999987          13488888532     22345688999999999752   2455566654 35567


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC------------------------------------  234 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------  234 (441)
                      |+|||+++|..|.....  ..++..+...++.++...|..||+.                                    
T Consensus        89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            89999999988765321  2234445555555555555555532                                    


Q ss_pred             ------------------------CCcccccCCCceecCC---CCcE-EEEecCCcccc
Q 013558          235 ------------------------GIVHRDLKPENILMDS---DGHV-MLTDFGLAKEI  265 (441)
Q Consensus       235 ------------------------~iiHrDlkp~NILl~~---~~~v-kl~DFG~a~~~  265 (441)
                                              .++|+|+++.|||++.   ++.+ .|+||+.+...
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                    3599999999999987   4554 89999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=7.4e-07  Score=83.12  Aligned_cols=132  Identities=17%  Similarity=0.177  Sum_probs=91.0

Q ss_pred             EcccCCe-EEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEe
Q 013558          118 VGQGAFG-KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       118 lG~G~~g-~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      +..|..| .||++....     .+..+++|+-...      ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||
T Consensus        32 ~~~G~S~~~v~rl~~~~-----~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP-----NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             EECSSSSCEEEEEECCT-----TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ccCCCcCCeEEEEEecC-----CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            4445554 689877543     5567999986543      2345778999999885 3236677888889999999999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-----------------------------------------  234 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------------------------------------  234 (441)
                      +++|.++.+.....    ......+..++...|.-||..                                         
T Consensus       101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            99998776554321    112223444444444444421                                         


Q ss_pred             -----------------CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          235 -----------------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       235 -----------------~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                                       .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             168999999999999877778999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.42  E-value=5.5e-07  Score=89.14  Aligned_cols=81  Identities=16%  Similarity=0.240  Sum_probs=50.2

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cc---hhHHHHHHHHHHHHHhcCC--CCce-eeeEEEE
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK---KNHVDYMKAERDILTKVTH--PFIV-QLRYSFQ  185 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~h--pnIv-~l~~~~~  185 (441)
                      ...+.||.|.++.||++....     .++.++||....... ..   ....+.+..|.++|+.+..  +..+ +++.+  
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--  105 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--  105 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred             eEEEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence            346789999999999996542     456799998653211 00   1123456678999988742  3333 45443  


Q ss_pred             eCCEEEEEEeccCCC
Q 013558          186 TRSKLYLILDFINGG  200 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg  200 (441)
                      +....++|||+++|.
T Consensus       106 d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             ETTTTEEEECCCTTS
T ss_pred             cCCccEEEEEeCCCc
Confidence            344568999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=6.8e-06  Score=79.04  Aligned_cols=136  Identities=15%  Similarity=0.173  Sum_probs=78.3

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceeee-E--EEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y--SFQ  185 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~-~--~~~  185 (441)
                      -++.|+.|..+.||++...       +..+++|+.....       ..+..|..+++.|.     .|.++... +  +..
T Consensus        36 ~~~~l~gG~~n~~~~v~~~-------~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~  101 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD-------SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK  101 (346)
T ss_dssp             EEEECC----CEEEEEEET-------TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred             EeeeccccccCcEEEEEeC-------CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence            3456677788999998753       2359999986521       22334555555442     34444311 0  223


Q ss_pred             eCCEEEEEEeccCCCchH--------------HHHHHc-CCC-------------CHH--------H-------------
Q 013558          186 TRSKLYLILDFINGGHLF--------------FHLYRQ-GIF-------------RED--------Q-------------  216 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~--------------~~l~~~-~~~-------------~~~--------~-------------  216 (441)
                      ..+..++||||++|..+.              ..++.. ..+             .+.        .             
T Consensus       102 ~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  181 (346)
T 2q83_A          102 HGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKE  181 (346)
T ss_dssp             ETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred             ECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccC
Confidence            567899999999986431              112211 101             110        0             


Q ss_pred             ----------HHHHHHHHHHHHHHHH-------------HCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          217 ----------ARFYTAEIVSAVSHLH-------------KCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       217 ----------~~~i~~qi~~~L~~LH-------------~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                                +..+..++..++.+|+             ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          182 DPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                      1111222334566665             2579999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.31  E-value=3.2e-07  Score=89.34  Aligned_cols=91  Identities=11%  Similarity=0.135  Sum_probs=55.4

Q ss_pred             ceEEeeE-cccCCeEEEEEEEcCCCCCC-CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-C--CCceeeeEEEEe
Q 013558          112 FEIFRVV-GQGAFGKVFQVKKKGVDDGD-SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H--PFIVQLRYSFQT  186 (441)
Q Consensus       112 y~~~~~l-G~G~~g~V~~~~~~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~  186 (441)
                      ...++.| +.|....+|++......++. .++.+++|+..............+.+|..+|+.+. +  -.+.+++.++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3446778 88999999998753000000 15678999865432000000123667888888874 2  346667777655


Q ss_pred             C---CEEEEEEeccCCCch
Q 013558          187 R---SKLYLILDFINGGHL  202 (441)
Q Consensus       187 ~---~~~~lv~E~~~gg~L  202 (441)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   356899999988654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.02  E-value=2.1e-05  Score=78.28  Aligned_cols=31  Identities=16%  Similarity=0.306  Sum_probs=27.7

Q ss_pred             HCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       233 ~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ...++|+|+++.|||++.++ ++|+||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            56799999999999998877 99999998865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.00  E-value=6.6e-05  Score=71.60  Aligned_cols=78  Identities=12%  Similarity=0.143  Sum_probs=60.4

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~  188 (441)
                      ..-.+.|+.|....+|++..       .++.+++|+....      ....+..|...|+.|.   ...+.+++.+....+
T Consensus        38 i~~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           38 IKHKEKLYSGEMNEIWLIND-------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             CCEEEEECCSSSSEEEEEES-------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             eeeeEEeCCccceeeeEEEE-------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            34567899999999999863       3567899987542      2456788999998884   356778888888888


Q ss_pred             EEEEEEeccCCCch
Q 013558          189 KLYLILDFINGGHL  202 (441)
Q Consensus       189 ~~~lv~E~~~gg~L  202 (441)
                      ..++||||++|..+
T Consensus       105 ~~~lvme~l~G~~~  118 (312)
T 3jr1_A          105 HSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEEECCCCCCC
T ss_pred             ceEEEEEeccCCCC
Confidence            99999999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.74  E-value=8.9e-05  Score=70.71  Aligned_cols=143  Identities=16%  Similarity=0.232  Sum_probs=80.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceeee-E-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y-  182 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~-~-  182 (441)
                      +...-++.|+.|....+|++...       +..+++|+.....  ..   +.+..|..+++.+.     -|.++... + 
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~-------~g~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~   89 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGE   89 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred             CcceEeeccCCCcccceEEEEeC-------CccEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCC
Confidence            44556778888999999998753       2358899886521  11   23456777777663     23333211 1 


Q ss_pred             -EEEeCCEEEEEEeccCCCchH--------------HHHHHc-CC--------CCHHHHHH---------------HHHH
Q 013558          183 -SFQTRSKLYLILDFINGGHLF--------------FHLYRQ-GI--------FREDQARF---------------YTAE  223 (441)
Q Consensus       183 -~~~~~~~~~lv~E~~~gg~L~--------------~~l~~~-~~--------~~~~~~~~---------------i~~q  223 (441)
                       +....+..++||+|++|..+.              ..++.. ..        ........               +...
T Consensus        90 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~  169 (322)
T 2ppq_A           90 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE  169 (322)
T ss_dssp             SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred             EEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence             122356789999999986431              112211 00        11110000               0112


Q ss_pred             HHHHHHHHHH-------CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       224 i~~~L~~LH~-------~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +...+..+..       .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3444555552       3689999999999998876668999997753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.71  E-value=0.00013  Score=68.93  Aligned_cols=132  Identities=14%  Similarity=0.076  Sum_probs=73.4

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEEEEE
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI  193 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv  193 (441)
                      ++.|+.|....+|++  .         .+++|+........    ....+|..+++.+....+ .++++.  ..+.-++|
T Consensus        23 i~~l~gG~tN~~~~~--~---------~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v   85 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G---------DLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMV   85 (301)
T ss_dssp             CEEEESCSSEEEEEE--T---------TEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEE
T ss_pred             eeEcCCcccccccee--e---------eEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEE
Confidence            678889999999998  2         38999876431110    112457777777642223 345443  33345789


Q ss_pred             Eecc-CCCchHHH------------------HHHcCC-C----C-HHHHHHHHHH--------------HHHHHHHH---
Q 013558          194 LDFI-NGGHLFFH------------------LYRQGI-F----R-EDQARFYTAE--------------IVSAVSHL---  231 (441)
Q Consensus       194 ~E~~-~gg~L~~~------------------l~~~~~-~----~-~~~~~~i~~q--------------i~~~L~~L---  231 (441)
                      +||+ +|..|...                  ++.... +    . ...+..+...              +...+..|   
T Consensus        86 ~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  165 (301)
T 3dxq_A           86 TRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA  165 (301)
T ss_dssp             EECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred             EeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence            9999 66544211                  111110 1    0 1111111111              11111111   


Q ss_pred             -HH----CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          232 -HK----CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       232 -H~----~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                       ..    ..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence             11    23799999999999 5677899999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.67  E-value=0.00035  Score=62.17  Aligned_cols=121  Identities=17%  Similarity=0.088  Sum_probs=81.2

Q ss_pred             chHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCccccCCCCCCccccCCC
Q 013558          201 HLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT  278 (441)
Q Consensus       201 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  278 (441)
                      +|.++|... .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            788888755 689999999999999999877622 2222344557899999999988764 2111           1223


Q ss_pred             CCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHhccc
Q 013558          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  351 (441)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  351 (441)
                      .+.+||... ...+.+.=|||||++||..+--..|=                 ..+..+|+.+.+||..|..-
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            466888763 34456788999999999998632221                 12356899999999999866

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.00061  Score=63.86  Aligned_cols=80  Identities=11%  Similarity=0.057  Sum_probs=55.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC---CCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~  186 (441)
                      .+..-++.+|.|..+.||++...      +|+.|++|+......   .....+..|...|+.|.-   --+.+++++  .
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence            35677889999999999999864      678899998654321   112356789999998842   124444443  2


Q ss_pred             CCEEEEEEeccCCCch
Q 013558          187 RSKLYLILDFINGGHL  202 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L  202 (441)
                      .  -++||||++++..
T Consensus        84 ~--~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 D--RTLAMEWVDERPP   97 (288)
T ss_dssp             T--TEEEEECCCCCCC
T ss_pred             C--ceEEEEeecccCC
Confidence            2  3789999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.0004  Score=66.32  Aligned_cols=136  Identities=15%  Similarity=0.202  Sum_probs=77.0

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEE-----EEeCC
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS-----FQTRS  188 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~-----~~~~~  188 (441)
                      ..|+ |....||++...      .++.+++|+......    ....+..|..+++.+...  .+.+++..     ....+
T Consensus        32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g  100 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG  100 (328)
T ss_dssp             EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred             Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence            4566 888899987532      345799999864321    123456688888776421  13333332     23356


Q ss_pred             EEEEEEeccCCCchH----H----------HHHHc---C------CCCHHHH----H------------------HHHHH
Q 013558          189 KLYLILDFINGGHLF----F----------HLYRQ---G------IFREDQA----R------------------FYTAE  223 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~----~----------~l~~~---~------~~~~~~~----~------------------~i~~q  223 (441)
                      ..++|||+++|..+.    .          .++..   .      .+.....    .                  ..+.+
T Consensus       101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  180 (328)
T 1zyl_A          101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE  180 (328)
T ss_dssp             EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred             EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence            778999999885431    1          11110   0      1111110    1                  11112


Q ss_pred             HHHHHHHH----HHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          224 IVSAVSHL----HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       224 i~~~L~~L----H~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ++..+.-+    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22222211    124589999999999998 4 899999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.0002  Score=68.62  Aligned_cols=32  Identities=34%  Similarity=0.377  Sum_probs=27.6

Q ss_pred             CCCcccccCCCceecCCC----CcEEEEecCCcccc
Q 013558          234 CGIVHRDLKPENILMDSD----GHVMLTDFGLAKEI  265 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~----~~vkl~DFG~a~~~  265 (441)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999875    68999999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00028  Score=70.37  Aligned_cols=79  Identities=14%  Similarity=0.105  Sum_probs=49.2

Q ss_pred             EEeeEcccCCeEEEEEEEcCCC--CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKL  190 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~  190 (441)
                      -++.|+.|....||++......  ....++.+++|+.....     ..+.+..|..+++.+...++ .++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            4567888889999999864210  00124679999874311     11234478888888853333 55666543  2  


Q ss_pred             EEEEeccCCCc
Q 013558          191 YLILDFINGGH  201 (441)
Q Consensus       191 ~lv~E~~~gg~  201 (441)
                      .+|+||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.0012  Score=63.54  Aligned_cols=31  Identities=16%  Similarity=0.371  Sum_probs=27.6

Q ss_pred             CCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3589999999999999888999999987765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.21  E-value=0.0006  Score=66.36  Aligned_cols=80  Identities=14%  Similarity=0.123  Sum_probs=44.1

Q ss_pred             EEeeEcccCCeEEEEEEEcCCC---CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVD---DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~  189 (441)
                      .++.|+.|....+|++......   ....++.+++|+......   . ......|..+++.+...+ +.++++.+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            3556788888999999753200   000125789998754321   1 111356888888775333 34566544  22 


Q ss_pred             EEEEEeccCCCc
Q 013558          190 LYLILDFINGGH  201 (441)
Q Consensus       190 ~~lv~E~~~gg~  201 (441)
                       ++||||++|..
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             68999998854

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.07  E-value=0.0009  Score=65.48  Aligned_cols=146  Identities=17%  Similarity=0.171  Sum_probs=82.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCC--CCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  186 (441)
                      +.+++ +.|..|-...+|++.....  .....++.|++|+....    ......+.+|..+++.+. +.-..++++.+.+
T Consensus        51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            44443 4566688889999875320  00113467999986331    112344568999998874 3323456655533


Q ss_pred             CCEEEEEEeccCCCchH--------------HH---HHHcC-----CC--CHHHHHHHHHHHHH----------------
Q 013558          187 RSKLYLILDFINGGHLF--------------FH---LYRQG-----IF--REDQARFYTAEIVS----------------  226 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~--------------~~---l~~~~-----~~--~~~~~~~i~~qi~~----------------  226 (441)
                          .+||||++|..|.              ..   ++...     ..  -+.++..+..++-.                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                2999999986542              11   11111     11  23455555544422                


Q ss_pred             ---HHHHHH----HC----CCcccccCCCceecCCC----CcEEEEecCCccc
Q 013558          227 ---AVSHLH----KC----GIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (441)
Q Consensus       227 ---~L~~LH----~~----~iiHrDlkp~NILl~~~----~~vkl~DFG~a~~  264 (441)
                         .+..|.    ..    .++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               233332    22    48999999999999876    7899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.00  E-value=0.0048  Score=61.86  Aligned_cols=76  Identities=18%  Similarity=0.303  Sum_probs=47.7

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEEEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL  192 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  192 (441)
                      -++.|+.|-...+|++....     .+..|++|+.....   ....+ ..+|..+|+.|...++ .++++.+.  +  .+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            45678888899999998642     24678999875421   11111 2479999998865444 45666652  2  25


Q ss_pred             EEeccCCCch
Q 013558          193 ILDFINGGHL  202 (441)
Q Consensus       193 v~E~~~gg~L  202 (441)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.02  E-value=0.016  Score=57.47  Aligned_cols=81  Identities=16%  Similarity=0.150  Sum_probs=47.9

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  190 (441)
                      -++.|..|-...+|++.......  ...++.|++|+.....   ...+ ...+|..+++.+. +.-..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            35567778889999998642100  0015779999865421   1111 1346888888874 32234455433  22  


Q ss_pred             EEEEeccCCCch
Q 013558          191 YLILDFINGGHL  202 (441)
Q Consensus       191 ~lv~E~~~gg~L  202 (441)
                      ++||||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.33  E-value=0.14  Score=50.26  Aligned_cols=29  Identities=31%  Similarity=0.518  Sum_probs=24.8

Q ss_pred             CcccccCCCceec------CCCCcEEEEecCCccc
Q 013558          236 IVHRDLKPENILM------DSDGHVMLTDFGLAKE  264 (441)
Q Consensus       236 iiHrDlkp~NILl------~~~~~vkl~DFG~a~~  264 (441)
                      ++|+|+.+.|||+      ++++.++++||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999988754

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=82.19  E-value=12  Score=38.24  Aligned_cols=81  Identities=17%  Similarity=0.246  Sum_probs=49.1

Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCC-----------------CCHHHHHHHHHHHH--HHHHHHHHCCCcc
Q 013558          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-----------------FREDQARFYTAEIV--SAVSHLHKCGIVH  238 (441)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----------------~~~~~~~~i~~qi~--~~L~~LH~~~iiH  238 (441)
                      +..|.+........+ .|++++.++.+.+...+.                 ..+.....+++.++  +-+.|+=..    
T Consensus       402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi----  476 (614)
T 3ls8_A          402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV----  476 (614)
T ss_dssp             CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred             eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence            344555555555554 467766555555433221                 11234445555543  234444333    


Q ss_pred             cccCCCceecCCCCcEEEEecCCcc
Q 013558          239 RDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       239 rDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      +|=.++||||+.+|++.=+|||.+-
T Consensus       477 gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          477 GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             cCCCCcceeEcCCCCEeeeehHHhh
Confidence            4888999999999999999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.05  E-value=2.3  Score=37.53  Aligned_cols=115  Identities=15%  Similarity=0.216  Sum_probs=77.8

Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC
Q 013558          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (441)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (441)
                      .||+++.. .+-.+++.+.+.++.-+.+.=+..+   ..++....+.++.+|+....++  ..-+|--|.|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            68888876 5666777888777765533222223   3467788888888888766433  3456778999999999999


Q ss_pred             cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhh-hHHHHHHHHHcCCCCCC
Q 013558          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW-SVGILLYEMLTGQPPFT  315 (441)
Q Consensus       253 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-slGvvl~elltG~~pf~  315 (441)
                      .+++.--|+-..+                +|.     ..+. .|.| .+=|++..+++++..|.
T Consensus       117 ~p~i~~RGik~~l----------------~P~-----~~~e-e~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 LPIAKTRGLQNVV----------------DPL-----PVSE-AEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CEEESCCEETTTB----------------SCC-----CCCH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CEEEEEccCccCC----------------CCC-----CCCH-HHHHHHHHHHHHHHHcCCCCHH
Confidence            9999877754322                221     1111 2333 47789999999988873

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	441
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-102
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-100
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-96
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-96
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-93
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-91
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-88
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-84
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-80
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-79
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-79
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-77
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-77
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-77
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-76
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-76
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-76
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-74
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-73
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-70
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-68
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-67
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-66
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-65
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-65
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-64
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-55
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-55
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-52
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-50
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-40
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  305 bits (781), Expect = e-102
 Identities = 131/340 (38%), Positives = 207/340 (60%), Gaps = 17/340 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE   + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 404
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

Query: 405 KCWTTMPADDSP-----------APTPTAGEHFKGYTYVA 433
             +T      +P                  E F+ + Y+A
Sbjct: 296 DEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  299 bits (766), Expect = e-100
 Identities = 119/327 (36%), Positives = 187/327 (57%), Gaps = 15/327 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+    E+ +L+
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 171 KV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI+  + 
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
            LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE     +++N+ CGT +Y+APEILL 
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 348
           + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  LL  L
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237

Query: 349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 408
             ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NFDK + 
Sbjct: 238 FVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL 293

Query: 409 TMPADDSPAPTPTAG----EHFKGYTY 431
                 S A            F+ +++
Sbjct: 294 NEKPRLSFADRALINSMDQNMFRNFSF 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  289 bits (741), Expect = 4e-96
 Identities = 116/320 (36%), Positives = 198/320 (61%), Gaps = 9/320 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   ER +L+
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE++ +K 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP 177

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL  L+ 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDKCWTT 409
           +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FDK +  
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPE 296

Query: 410 MPADDSPAPTPTAGEHFKGY 429
              +          + F+ +
Sbjct: 297 EDINYGVQGEDPYADLFRDF 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  287 bits (736), Expect = 9e-96
 Identities = 111/285 (38%), Positives = 170/285 (59%), Gaps = 9/285 (3%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237

Query: 342 HSLLKGLLHKDPSKRLGSG-PGGVDAIKHHKWFRSINWKTLEARE 385
             L++ LL  D +KRLG     G   +K H +F S+ W+ L  + 
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  283 bits (726), Expect = 3e-93
 Identities = 114/343 (33%), Positives = 181/343 (52%), Gaps = 23/343 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 171 KVT---HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+L 
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQ 178

Query: 288 S-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHS 343
               ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC---- 399
           LL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P     +     
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 298

Query: 400 -IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 441
            I +FD+  T               E ++ +       W   V
Sbjct: 299 DIGSFDEEDTKGIKLLDSDQ-----ELYRNFPLTISERWQQEV 336

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  278 bits (711), Expect = 4e-91
 Identities = 125/348 (35%), Positives = 202/348 (58%), Gaps = 10/348 (2%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
            S+   + + + +   + E  S+       F+  + +G G+FG+V  VK K     +S  
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGN 67

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
            YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      +
Sbjct: 188 AKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 381
           + ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305

Query: 382 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY 429
             R+++  F P   G    +NFD  +       S       G+ F  +
Sbjct: 306 YQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKEFTEF 350

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (687), Expect = 1e-88
 Identities = 88/265 (33%), Positives = 146/265 (55%), Gaps = 11/265 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++ E +I +
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240

Query: 351 KDPSKRLGSGPGGVDAIKHHKWFRS 375
            +PS+R       +  +  H W  +
Sbjct: 241 HNPSQRP-----MLREVLEHPWITA 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (664), Expect = 1e-84
 Identities = 144/323 (44%), Positives = 212/323 (65%), Gaps = 14/323 (4%)

Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM 145
           Q+  ++HE   A L   +E+ +G  +FE+ +V+G GA+GKVF V+K  +   D+  +YAM
Sbjct: 1   QLLTVKHELRTANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAM 57

Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 58  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 264 EID--ESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           E    E+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 320 Q----KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
           +    ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 376 INWKTLEAREMQPKFKPDVSGKD 398
           INW  L A+++   FKP +  + 
Sbjct: 298 INWDDLAAKKVPAPFKPVIRDEL 320

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  250 bits (639), Expect = 2e-80
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 20/289 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++
Sbjct: 27  HYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y  ++   + 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K      D WSVG+L Y +L+G  PF   N  +  + + +    +       ++ +   
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 392
            ++ LL  DP+ R+      +     H W    N    +++    ++  
Sbjct: 259 FIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 1e-79
 Identities = 70/317 (22%), Positives = 133/317 (41%), Gaps = 58/317 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  + A K++  +  IK    + +  E  +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 178

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF------------- 336
            ++  +D WS+G+ L EM  G+ P    + ++L+     +                    
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 337 -------------------------------LTSEAHSLLKGLLHKDPSKRLGSGPGGVD 365
                                           + E    +   L K+P++R       + 
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLK 293

Query: 366 AIKHHKWFRSINWKTLE 382
            +  H + +  + + ++
Sbjct: 294 QLMVHAFIKRSDAEEVD 310

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 2e-79
 Identities = 83/299 (27%), Positives = 142/299 (47%), Gaps = 26/299 (8%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P D +EI   +G GAFGKV++ + K     ++  + A KV+       +  ++  
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTK---SEEELEDY 56

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
             E DIL    HP IV+L  +F   + L+++++F  GG +   +   +    E Q +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEY 280
            + + A+++LH   I+HRDLK  NIL   DG + L DFG++ +   +  R +S  GT  +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 281 MAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VK 332
           MAPE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   + 
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236

Query: 333 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
            P   +S     LK  L K+   R          +  H +    + K +  RE+  + K
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARW-----TTSQLLQHPFVTVDSNKPI--RELIAEAK 288

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  246 bits (630), Expect = 6e-79
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 21/289 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYPLDKYTV---KNEISIM 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAV 228
            ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    +
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 229 SHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH 342
             +      D W++G+L Y +L+G  PF   +  +  Q +     +        ++ EA 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 391
             +K LL K+P KRL      V     H W +  +   L +R    ++ 
Sbjct: 261 DFIKNLLQKEPRKRL-----TVHDALEHPWLKG-DHSNLTSRIPSSRYN 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 3e-77
 Identities = 75/272 (27%), Positives = 135/272 (49%), Gaps = 19/272 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D+++ + +G+GA+G+V     +      ++   A+K++     +     + +K E  I 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDC--PENIKKEICIN 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  ++++ V 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     EK         + S   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
           +LL  +L ++PS R+      +  IK  +W+ 
Sbjct: 238 ALLHKILVENPSARI-----TIPDIKKDRWYN 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (612), Expect = 6e-77
 Identities = 90/293 (30%), Positives = 148/293 (50%), Gaps = 20/293 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++   V+G GAF +V   + K      +  + A+K + K  +  +     M+ E  +L 
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A     +++ AV +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CGT  Y+APE+L 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +        ++  A  
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR-EMQPKFKPDVS 395
            ++ L+ KDP KR        +    H W              +  + K + +
Sbjct: 243 FIRHLMEKDPEKRF-----TCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFA 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 7e-77
 Identities = 76/293 (25%), Positives = 141/293 (48%), Gaps = 22/293 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERD 167
            ++    +G G F  V + ++K      +   YA K ++K            + ++ E  
Sbjct: 11  YYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           IL ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ 
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           V +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS 339
           EI+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +         ++
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW-KTLEAREMQPKFK 391
            A   ++ LL KDP KR+      +     H W +  +  + L +    P+F+
Sbjct: 246 LAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 1e-76
 Identities = 76/288 (26%), Positives = 132/288 (45%), Gaps = 22/288 (7%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
               KK  +     E  ++ +  +P IV    S+    +L+++++++ GG L   +    
Sbjct: 56  QQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESS 269
              E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +    I   
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 330 ---KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
              +++ P  L++     L   L  D  KR          +  H++ +
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG-----SAKELLQHQFLK 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  238 bits (607), Expect = 1e-76
 Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 27/281 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
           ++E   ++G+G    V +   K      +   YA+K++        +  +  +       
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 165 ERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV  HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 284 EILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--- 334
           EI+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +     
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238

Query: 335 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
               +     L+   L   P KR        +    H +F+
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQ 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  237 bits (607), Expect = 4e-76
 Identities = 61/268 (22%), Positives = 108/268 (40%), Gaps = 18/268 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +        +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
             ++   D WS+GI   E+   +PP  + N       I   +         +    + + 
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

Query: 347 GLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
             L K P  R        + +  H++  
Sbjct: 249 SCLQKIPQDRP-----TSEVLLKHRFVL 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 4e-74
 Identities = 67/275 (24%), Positives = 137/275 (49%), Gaps = 24/275 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+   +G G++G+  ++++K         I   K +   ++ +      + +E ++L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAE-KQMLVSEVNLLR 58

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEI 224
           ++ HP IV+       +T + LY+++++  GG L   + +    +    E+       ++
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 225 VSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTT 278
             A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL 337
            YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
           + E + ++  +L+     R       V+ I  +  
Sbjct: 239 SDELNEIITRMLNLKDYHRP-----SVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 7e-73
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 29/300 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKV----KGTDQVLVKKEISILN 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVS 229
              H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y  ++  A+ 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
            LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+  
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
               +   D WS+G L+Y +L+G  PF     Q++ + I+N +          ++ EA  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 344 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR----SINWKTLEA----REMQPKFKPDVS 395
            +  LL K+   R+            H W +     ++ K +      R      K D++
Sbjct: 237 FVDRLLVKERKSRM-----TASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 1e-71
 Identities = 60/273 (21%), Positives = 125/273 (45%), Gaps = 23/273 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            +    +G+G+F  V++         ++    A   ++   + K +     K E ++L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 64

Query: 172 VTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           + HP IV+   S+++  K    + L+ + +  G L  +L R  + +    R +  +I+  
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 228 VSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  LH     I+HRDLK +NI +    G V + D GLA  +  +S + ++ GT E+MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPE 183

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTSEA 341
           +   + +++  D ++ G+ + EM T + P++         R +   VK          E 
Sbjct: 184 MY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
             +++G + ++  +R       +  + +H +F+
Sbjct: 243 KEIIEGCIRQNKDERY-----SIKDLLNHAFFQ 270

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (563), Expect = 5e-70
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 23/263 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I  G   + + +G G+FG V++ K  G          A+K++       +  +   K E 
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQ-QLQAFKNEV 55

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            +L K  H  I+     + T  +L ++  +  G  L+ HL+  +  F   +      +  
Sbjct: 56  GVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMA 282
             + +LH   I+HRDLK  NI +  D  V + DFGLA      S   +   + G+  +MA
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 336
           PE++  +  N     +D ++ GI+LYE++TGQ P+++ N +     ++      P     
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 337 ---LTSEAHSLLKGLLHKDPSKR 356
                     L+   L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 3e-68
 Identities = 77/275 (28%), Positives = 128/275 (46%), Gaps = 25/275 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK---AER 166
             +++  ++G G FG V+   +        +   A+K + KD I     +        E 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58

Query: 167 DILTKVT--HPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAE 223
            +L KV+     +++L   F+      LIL+       LF  +  +G  +E+ AR +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           ++ AV H H CG++HRD+K ENIL+D + G + L DFG    + + +      GT  Y  
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 177

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           PE +   + H + A  WS+GILLY+M+ G  PF H         II  +V     ++SE 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231

Query: 342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 376
             L++  L   PS R        + I++H W + +
Sbjct: 232 QHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  215 bits (549), Expect = 6e-68
 Identities = 63/262 (24%), Positives = 129/262 (49%), Gaps = 17/262 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +             A+KV+R D     +     + E    
Sbjct: 7   DRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 170 TKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +  + +  +      Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S    +++ ++ GT +Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL 337
           +PE       +  +D +S+G +LYE+LTG+PPFT  +   +  + + E    P      L
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 338 TSEAHSLLKGLLHKDPSKRLGS 359
           +++  +++   L K+P  R  +
Sbjct: 242 SADLDAVVLKALAKNPENRYQT 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 4e-67
 Identities = 63/255 (24%), Positives = 119/255 (46%), Gaps = 19/255 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +        AE 
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA-----FLAEA 51

Query: 167 DILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAE 223
            ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ +
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ AP
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAP 169

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEA 341
           E L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229

Query: 342 HSLLKGLLHKDPSKR 356
           + ++K   H D + R
Sbjct: 230 YEVMKNCWHLDAAMR 244

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 9e-66
 Identities = 56/258 (21%), Positives = 107/258 (41%), Gaps = 11/258 (4%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+FG V + +             A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L   QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++               + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLT 338
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +L  P    
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 339 SEAHSLLKGLLHKDPSKR 356
            + ++++       P  R
Sbjct: 242 QDIYNVMVQCWAHKPEDR 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 1e-65
 Identities = 51/269 (18%), Positives = 112/269 (41%), Gaps = 13/269 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG V +   +           A+K+++ +        D + AE +++ ++ +P
Sbjct: 13  KELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNP 68

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           +IV++           L+++    G L  +L +    ++        ++   + +L +  
Sbjct: 69  YIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGH 291
            VHRDL   N+L+ +  +  ++DFGL+K +                 ++ APE +     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLL 349
           +  +D WS G+L++E  + GQ P+      ++   +   E++  P     E + L+    
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247

Query: 350 HKDPSKRLGSGPGGVDAIKHHKWFRSINW 378
             D   R G     V+    + ++  +N 
Sbjct: 248 TYDVENRPGF--AAVELRLRNYYYDVVNE 274

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-65
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 32/298 (10%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
            E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K++
Sbjct: 16  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75

Query: 149 RKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++      +  + + +E  ++T++  H  IV L  +      +YLI ++   G L  +L 
Sbjct: 76  KEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 208 RQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
            +                        +   +    +  ++   +  L     VHRDL   
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N+L+     V + DFGLA++I   S      +     ++MAPE L    +   +D WS G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 302 ILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
           ILL+E+ + G  P+          ++I    K+  P + T E + +++     D  KR
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 5e-65
 Identities = 76/284 (26%), Positives = 140/284 (49%), Gaps = 37/284 (13%)

Query: 110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDCPKARR--------EVEL 57

Query: 169 LTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
             + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A    
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C T 
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLP 334
            Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +       ++ RI   + + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 335 ----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
                 ++ E   L++ LL  +P++R+      +    +H W  
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 276

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-64
 Identities = 54/255 (21%), Positives = 118/255 (46%), Gaps = 15/255 (5%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G          A+K++++ ++ +         E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDE----FIEEA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL      +  +++I +++  G L  +L   +  F+  Q      ++ 
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
            A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S        +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 341
           E+L+    +  +D W+ G+L++E+ + G+ P+      +  + I    ++  P   + + 
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230

Query: 342 HSLLKGLLHKDPSKR 356
           ++++    H+   +R
Sbjct: 231 YTIMYSCWHEKADER 245

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 60/261 (22%), Positives = 114/261 (43%), Gaps = 13/261 (4%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           ++I     +I +V+G G FG+V     K    G  +   A+K ++      +       +
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYT--EKQRRDFLS 76

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP ++ L       + + +I +F+  G L  F     G F   Q       
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------RSNSMCGT 277
           I + + +L     VHRDL   NIL++S+    ++DFGL++ +++ +       +      
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPP 335
             + APE +  +     +D WS GI+++E+++ G+ P+     Q +   I  + ++  P 
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 336 FLTSEAHSLLKGLLHKDPSKR 356
              S  H L+     KD + R
Sbjct: 257 DCPSALHQLMLDCWQKDRNHR 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-62
 Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 42/308 (13%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA--ERDILT 170
           E    +G+G F  V++ + K     +++ I A+K ++     +        A  E  +L 
Sbjct: 1   EKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HP I+ L  +F  +S + L+ DF+             +      + Y    +  + +
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLS- 288
           LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+ +    T  Y APE+L   
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------- 331
           + +    D W+VG +L E+L   P     +      RI                      
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 332 -----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 380
                       +      +   L++GL   +P  R+             K+F +    T
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGPT 290

Query: 381 LEAREMQP 388
              +  +P
Sbjct: 291 PGCQLPRP 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 5e-62
 Identities = 58/254 (22%), Positives = 112/254 (44%), Gaps = 17/254 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D E+    G G FG V Q   +           A+KV+++ T  +K   + M  E  I+
Sbjct: 13  ADIEL----GCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGT--EKADTEEMMREAQIM 63

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAV 228
            ++ +P+IV+L    Q    L L+++   GG L   L  +              ++   +
Sbjct: 64  HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPE 284
            +L +   VHRDL   N+L+ +  +  ++DFGL+K +       +  ++     ++ APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAH 342
            +  +  +  +D WS G+ ++E L+ GQ P+      ++   I   ++++ PP    E +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242

Query: 343 SLLKGLLHKDPSKR 356
           +L+          R
Sbjct: 243 ALMSDCWIYKWEDR 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-62
 Identities = 49/255 (19%), Positives = 122/255 (47%), Gaps = 15/255 (5%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V            +    A+K +R+  + +++       E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMSEED----FIEEA 51

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIV 225
           +++ K++HP +VQL      ++ + L+ +F+  G L  +   ++G+F  +       ++ 
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
             +++L +  ++HRDL   N L+  +  + ++DFG+ + +  D+ + S       ++ +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 341
           E+     ++  +D WS G+L++E+ + G+ P+ + +  ++ + I    ++  P   ++  
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 342 HSLLKGLLHKDPSKR 356
           + ++     + P  R
Sbjct: 232 YQIMNHCWKERPEDR 246

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-61
 Identities = 64/256 (25%), Positives = 116/256 (45%), Gaps = 17/256 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I      +   +GQG FG+V+     G          A+K ++  T+  +        E 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMSPEA----FLQEA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I
Sbjct: 64  QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I  +E +         ++ A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE  L       +D WS GILL E+ T G+ P+     +++  ++    ++  PP     
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242

Query: 341 AHSLLKGLLHKDPSKR 356
            H L+     K+P +R
Sbjct: 243 LHDLMCQCWRKEPEER 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 5e-61
 Identities = 51/275 (18%), Positives = 115/275 (41%), Gaps = 31/275 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E  R +G+GAFG+VFQ +  G+   +   + A+K+++++     +     + E  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------- 210
           +  +P IV+L         + L+ +++  G L   L                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                    +      ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-PPFTHANRQKL 322
            +       +      +M PE +    +  ++D W+ G++L+E+ +    P+     +++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 323 QQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKR 356
              + +  +   P     E ++L++    K P+ R
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-61
 Identities = 66/312 (21%), Positives = 116/312 (37%), Gaps = 57/312 (18%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E    +GQG FG+VF+ + +      +    A+K +  +   +   +  ++ E  IL
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALR-EIKIL 63

Query: 170 TKVTHPFIVQLRYSFQTRS--------KLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             + H  +V L    +T++         +YL+ DF               F   + +   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCG 276
             +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    +  S      +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           T  Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      + P
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 336 --------------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGG 363
                                                A  L+  LL  DP++R+      
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----D 298

Query: 364 VDAIKHHKWFRS 375
            D   +H +F S
Sbjct: 299 SDDALNHDFFWS 310

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 9e-61
 Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 44/304 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDI 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T  +   +  ++  A    
Sbjct: 8   QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 169 LTKVTHPFIVQLRYSFQT-----RSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           L    HP +V+L            +KL L+ + ++     +     +     +  +    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------- 331
           PE+LL   +    D WSVG +  EM   +P F  ++      +I++              
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 332 ----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 375
                           K    +      LL   L  +P+KR+        +   H +F+ 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQD 298

Query: 376 INWK 379
           +   
Sbjct: 299 LERC 302

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 10/255 (3%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     E+ R +G+G FG V     +G+     +   A+ +         +  +    E 
Sbjct: 4   IQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
             + +  HP IV+L     T + +++I++    G L   L  R+          Y  ++ 
Sbjct: 60  LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAP 283
           +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+  +++      ++MAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 341
           E +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 342 HSLLKGLLHKDPSKR 356
           +SL+      DPS+R
Sbjct: 239 YSLMTKCWAYDPSRR 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-60
 Identities = 62/296 (20%), Positives = 122/296 (41%), Gaps = 12/296 (4%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAFG V++      +        A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKAN--KEILD 60

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  ++  V +P + +L     T +   +      G  L +    +          +  +I
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
              +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +   +       ++M
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS 339
           A E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T 
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 240

Query: 340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 395
           + + ++      D   R    P   + I           + L  +  +    P  +
Sbjct: 241 DVYMIMVKCWMIDADSR----PKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-60
 Identities = 55/256 (21%), Positives = 114/256 (44%), Gaps = 17/256 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++          AE 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR--EDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L   L      +   ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++            ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +        +D WS GILL E++T G+ P+      ++ Q +    ++  P     E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 341 AHSLLKGLLHKDPSKR 356
            + L++    + P  R
Sbjct: 239 LYQLMRLCWKERPEDR 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-60
 Identities = 60/289 (20%), Positives = 119/289 (41%), Gaps = 27/289 (9%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
           + +  +L  + + +         + +G GAFGKV +    G+   D+    A+K+++   
Sbjct: 6   YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--- 208
            +     + + +E  +L+ +  H  IV L  +        +I ++   G L   L R   
Sbjct: 66  HLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 209 ---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
                          +     +    ++ ++   ++ L     +HRDL   NIL+     
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

Query: 254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT- 309
             + DFGLA++I   S      +     ++MAPE + +  +  ++D WS GI L+E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 310 GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
           G  P+          ++I E  ++  P    +E + ++K     DP KR
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 5e-60
 Identities = 57/270 (21%), Positives = 113/270 (41%), Gaps = 24/270 (8%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +   D +   V+G+G FG+V + + K              + R      K+       E
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--------------- 209
            ++L K+  HP I+ L  + + R  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                  Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII 327
            +         +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 328 -NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
              +++ P     E + L++    + P +R
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 5e-59
 Identities = 77/312 (24%), Positives = 124/312 (39%), Gaps = 57/312 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +   +V+G G+FG V+Q K       DS  + A+K + +D   K         E  I+ 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRFKNR-------ELQIMR 68

Query: 171 KVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLY---RQGIFREDQARFYT 221
           K+ H  IV+LRY F +  +      L L+LD++         +    +        + Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 281 MAP-EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------- 329
            AP  I  +  +    D WS G +L E+L GQP F   +       II            
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 330 -------------------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 370
                                   P    EA +L   LL   P+ RL            H
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAH 303

Query: 371 KWFRSINWKTLE 382
            +F  +    ++
Sbjct: 304 SFFDELRDPNVK 315

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 7e-59
 Identities = 57/256 (22%), Positives = 115/256 (44%), Gaps = 15/256 (5%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V++   K           A+K +++DT+  +        E 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTMEVEE----FLKEA 64

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ ++ HP +VQL          Y+I +F+  G+L  +L              +   +I
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            SA+ +L K   +HRDL   N L+  +  V + DFGL++ +  D  +         ++ A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE 340
           PE L     +  +D W+ G+LL+E+ T G  P+   +  ++ + +  + +++ P     +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244

Query: 341 AHSLLKGLLHKDPSKR 356
            + L++     +PS R
Sbjct: 245 VYELMRACWQWNPSDR 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  192 bits (487), Expect = 1e-58
 Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 43/295 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +     +G+G +G V++ +            +A+K +R +    +        E  IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++++ +++
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + + DFGLA+      R       T  Y AP++L+  
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 290 G-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-------------------- 328
             ++   D WSVG +  EM+ G P F   +      RI                      
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 329 ---------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
                            L      LL  +L  DP++R+            H +F+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 43/299 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++ HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLS 288
             H   ++HRDLKP+N+L++++G + L DFGLA+      R       T  Y APEILL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 289 KGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------- 331
             +     D WS+G +  EM+T +  F   +      RI                     
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 332 -------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 377
                        K+ P L  +  SLL  +LH DP+KR+        A   H +F+ + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-57
 Identities = 55/258 (21%), Positives = 110/258 (42%), Gaps = 10/258 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+V++   K    G  +   A+K ++      +        E
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKT-SSGKKEVPVAIKTLKAG--YTEKQRVDFLGE 59

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEI 224
             I+ + +H  I++L         + +I +++  G    F   + G F   Q       I
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ +++       ++       +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLT 338
            APE +  +     +D WS GI+++E++T               + IN+  +L  P    
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239

Query: 339 SEAHSLLKGLLHKDPSKR 356
           S  + L+     ++ ++R
Sbjct: 240 SAIYQLMMQCWQQERARR 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 60/283 (21%), Positives = 128/283 (45%), Gaps = 26/283 (9%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIK 155
           EL  +   ++      + + +G+GAFG+V   +  G+D    +     A+K+++ D    
Sbjct: 1   ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-- 58

Query: 156 KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---- 210
           +  +  + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L  +     
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 211 ------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
                                   ++   + +L     +HRDL   N+L+  D  + + D
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 259 FGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           FGLA++I       ++ +     ++MAPE L  + +   +D WS G+LL+E+ T G  P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 315 THANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
                ++L + +    ++  P   T+E + +++   H  PS+R
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 64/296 (21%), Positives = 118/296 (39%), Gaps = 43/296 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E    +G+G +G VF+ K +     ++  I A+K +R D    +        E  +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 290 G-HNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIIN------------------- 328
             ++   D WS G +  E+    +P F   +     +RI                     
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 329 ----------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 374
                       V + P L +    LL+ LL  +P +R+       +    H +F 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFS 287

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-55
 Identities = 69/326 (21%), Positives = 121/326 (37%), Gaps = 52/326 (15%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +     +G+GA+G V            +    A+K +       + +      E  IL +
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 172 VTHPFIVQLRYSFQTRS---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             H  I+ +    +  +      + L     G   + L +      D   ++  +I+  +
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEYMAPE 284
            ++H   ++HRDLKP N+L+++   + + DFGLA+  D              T  Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------ 331
           I+L+  G+ K  D WSVG +L EML+ +P F   +       I+                
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 332 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
                              +L P   S+A  LL  +L  +P KR+      V+    H +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPY 297

Query: 373 FRSINWKTLEAREMQPKFKPDVSGKD 398
                +   +    +  FK D+   D
Sbjct: 298 LEQY-YDPSDEPIAEAPFKFDMELDD 322

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  184 bits (467), Expect = 3e-55
 Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 62/311 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ R +G+G + +VF+          ++    +K      I+K      +K E  IL 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVK------ILKPVKKKKIKREIKILE 84

Query: 171 KV-THPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            +   P I+ L    +        L+ + +N               +   RFY  EI+ A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 141

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           + + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  PE+L
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 287 LS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----------- 334
           +  + ++   D WS+G +L  M+  + PF H +    Q   I + +              
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 335 ---------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 367
                                        ++ EA   L  LL  D   RL          
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREA 316

Query: 368 KHHKWFRSINW 378
             H +F ++  
Sbjct: 317 MEHPYFYTVVK 327

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 5e-55
 Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 49/310 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K + +     +        E  +
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L    DF       G     L +     ED+ +F   ++
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D  S       T  Y APE
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPE 188

Query: 285 ILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--------- 334
           ++L+   + +  D WSVG ++ EM+TG+  F  ++     + I+      P         
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248

Query: 335 ----------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
                                    +  A +LL+ +L  D  +R+            H +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPY 303

Query: 373 FRSINWKTLE 382
           F S++    E
Sbjct: 304 FESLHDTEDE 313

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (463), Expect = 6e-55
 Identities = 51/306 (16%), Positives = 104/306 (33%), Gaps = 40/306 (13%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++           +    A+K+        K     + 
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECV-----KTKHPQLH 50

Query: 164 AERDILTKVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            E  I   +     I  +R+         ++++ +         +    F          
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--------RS 271
           +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  ++          +
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
            ++ GT  Y +    L    ++  D  S+G +L     G  P+        +Q+      
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 332 K--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS-------I 376
           K        L     SE  + L          +       +  +  + + R         
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY--SYLRQLFRNLFHRQGFSYDYVF 288

Query: 377 NWKTLE 382
           +W  L+
Sbjct: 289 DWNMLK 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 57/303 (18%), Positives = 121/303 (39%), Gaps = 26/303 (8%)

Query: 95  NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           + A++    E ++      + R +GQG+FG V++   KGV   + +   A+K + +   +
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR- 213
           +         E  ++ +     +V+L           +I++ +  G L  +L        
Sbjct: 65  R--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 214 ---------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                      +      EI   +++L+    VHRDL   N ++  D  V + DFG+ ++
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 265 IDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQ 320
           I E+    +         +M+PE L        +D WS G++L+E+ T  + P+   + +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 321 KLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH-----HKWFR 374
           ++ + ++   +   P         L++     +P  R    P  ++ I          FR
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR----PSFLEIISSIKEEMEPGFR 298

Query: 375 SIN 377
            ++
Sbjct: 299 EVS 301

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-54
 Identities = 60/277 (21%), Positives = 118/277 (42%), Gaps = 24/277 (8%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S+ +      ++ + +G+GAFG+V +    G+D   +    A+K++++       H   M
Sbjct: 6   SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALM 64

Query: 163 KAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG----------- 210
              + ++    H  +V L     +    L +I++F   G+L  +L  +            
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                    +    Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQK 321
            +     R        ++MAPE +  + +   +D WS G+LL+E+ +    P+      +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244

Query: 322 LQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 356
              R + E  ++  P + T E +  +    H +PS+R
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 59/278 (21%), Positives = 111/278 (39%), Gaps = 15/278 (5%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +L   N   ++A     IGP    +    V+G+G FG V+      +D+       A+K 
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY--HGTLLDNDGKKIHCAVKS 62

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLF-FH 205
           + + T      V     E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 63  LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                         +  ++   +  L     VHRDL   N ++D    V + DFGLA+++
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 266 DESS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
            +                ++MA E L ++     +D WS G+LL+E++T G PP+   N 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 320 QKLQQRII-NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 356
             +   ++   ++  P +     + ++    H     R
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  174 bits (442), Expect = 7e-52
 Identities = 44/269 (16%), Positives = 98/269 (36%), Gaps = 32/269 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +++ R +G+G+FG +F+          ++   A+K   +     ++    ++ E    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPR-----RSDAPQLRDEYRTY 54

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +     I  + Y  Q      L++D +              F          ++++ V
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 229 SHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESS--------RSNSMC 275
             +H+  +V+RD+KP+N L+          + + DFG+ K   +             ++ 
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKV- 331
           GT  YM+    L +  ++  D  ++G +    L G  P+     A  ++  +RI  +K  
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234

Query: 332 ----KLPPFLTSEAHSLLKGLLHKDPSKR 356
               +L      E +  +    +      
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 3e-50
 Identities = 67/333 (20%), Positives = 118/333 (35%), Gaps = 64/333 (19%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V             D   A+K + +     + H      E  +
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRP-FQNQTHAKRAYRELVL 69

Query: 169 LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           +  V H  I+ L   F  +        +YL+++ ++                ++  +   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++L  G+ ++ D WSVG ++ EM+  +  F   +      ++I +     P    +  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 343 SLLK------------------------------------------GLLHKDPSKRLGSG 360
             ++                                           +L  DP+KR+   
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI--- 303

Query: 361 PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 393
              VD    H +     W      E  P    D
Sbjct: 304 --SVDDALQHPYIN--VWYDPAEVEAPPPQIYD 332

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-50
 Identities = 68/326 (20%), Positives = 117/326 (35%), Gaps = 51/326 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V            +    A+K + +       H      E  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L     + L     G    ++ +     +D  +F   +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y APE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPE 188

Query: 285 ILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL------ 337
           I+L+  H N+  D WSVG ++ E+LTG+  F   +     + I+         L      
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 338 -------------------------TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 372
                                       A  LL+ +L  D  KR+            H +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAY 303

Query: 373 FRSINWKTLEAREMQPKFKPDVSGKD 398
           F    +   +   +   +      +D
Sbjct: 304 FA--QYHDPDDEPVADPYDQSFESRD 327

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-48
 Identities = 62/293 (21%), Positives = 121/293 (41%), Gaps = 57/293 (19%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
               +   +G+G FG+V++ K +G          A+K+       ++    + +AE    
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGE-------EVAVKIFSS----REERSWFREAEIYQT 51

Query: 170 TKVTHPFIVQLRYSFQ----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + H  I+    +      T ++L+L+ D+   G LF +L R  +  E   +       
Sbjct: 52  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTA 110

Query: 226 SAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RSN 272
           S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++       N
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 273 SMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTGQPPF------------ 314
              GT  YMAPE+L    + K       AD +++G++ +E+                   
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 315 ---THANRQKLQQRIINEKVK--LPPFLTS-----EAHSLLKGLLHKDPSKRL 357
              +  + +++++ +  +K++  +P    S         +++   + + + RL
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 6e-40
 Identities = 62/359 (17%), Positives = 114/359 (31%), Gaps = 79/359 (22%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             + + R +G G F  V+  K        ++   AMK++R D +  +   D +K  + + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 169 ------LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-----LFFHLYRQGIFREDQA 217
                    +    I++L   F  +    + +  +              Y          
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVM----LTDFGLAKEIDESSRSN 272
           +  + +++  + ++H +CGI+H D+KPEN+LM+          +    L           
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ--------- 323
           +   T EY +PE+LL       AD WS   L++E++TG   F                  
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 324 ---------------------------------------QRIINEKVKLPPFLTSEAHSL 344
                                                  + ++ EK K       E    
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 403
           L  +L  DP KR          + +H W +     TL   E++   +        I  +
Sbjct: 308 LSPMLQLDPRKRA-----DAGGLVNHPWLK----DTLGMEEIRVPDRELYGSGSDIPGW 357

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 45/211 (21%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-------------- 161
           +++G+G    VF    +        G   +K  +      K   +               
Sbjct: 6   KLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 162 -MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             + E   L K+    + ++           ++++ I+   L+         R +     
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEV 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
              I+  V+  +  GIVH DL   N+L+  +  + + DF  + E+ E           E 
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREI 160

Query: 281 MAPEIL-----LSKGHNKDADWWSVGILLYE 306
           +  ++       S+ +  + D  S    + +
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	441
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.17
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.35
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.07
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.84

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-73  Score=553.16  Aligned_cols=323  Identities=40%  Similarity=0.800  Sum_probs=292.5

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||+++++|++
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456789999999999999999999986     889999999998876667777889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      .+.+|+|||||+||+|..++.+.+.+++..++.+++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998754


Q ss_pred             C-CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHH
Q 013558          267 E-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (441)
Q Consensus       267 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  345 (441)
                      . .......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.+.+....+.+|..+++++++||
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  236 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence            3 444567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCC-------
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-------  418 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  418 (441)
                      ++||++||.+|+++...+++++++||||++++|..+..+++.|||+|......+..+|+..++......++..       
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~  316 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGL  316 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------------
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCcccccccc
Confidence            9999999999998877789999999999999999999999999999999888888999887654433222211       


Q ss_pred             ----CCCCCCcccCeeeeCC
Q 013558          419 ----TPTAGEHFKGYTYVAP  434 (441)
Q Consensus       419 ----~~~~~~~f~~~~~~~~  434 (441)
                          ....++.|.+|+|++.
T Consensus       317 ~~~~~~~~~~~f~~f~~v~d  336 (337)
T d1o6la_         317 LELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------CCTTTTCCEECC
T ss_pred             ccccchhhhhccCCCEeeCC
Confidence                1235688999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.6e-70  Score=526.23  Aligned_cols=313  Identities=37%  Similarity=0.760  Sum_probs=274.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||++++++.+.+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            4689999999999999999999986     78999999998876666667788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... 
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-  156 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  156 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998654 


Q ss_pred             CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHHh
Q 013558          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  348 (441)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  348 (441)
                       ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..++......+|+.++++++++|.+|
T Consensus       157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (316)
T d1fota_         157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  235 (316)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence             3456799999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCC-cccccCcccccCCCCCCCCCCCCCCCCCccc
Q 013558          349 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-KDCIANFDKCWTTMPADDSPAPTPTAGEHFK  427 (441)
Q Consensus       349 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~  427 (441)
                      |++||.+|+++..+++++|++||||++++|+.+..+.++|||+|.... ..+.++|++ +.+..............+.|+
T Consensus       236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~  314 (316)
T d1fota_         236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEEDINYGVQGEDPYADLFR  314 (316)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSCCTTGGGSC
T ss_pred             hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC-CccccccCCCCCCCchhhhcC
Confidence            999999999887789999999999999999999999999999997643 456778875 333323233333445667888


Q ss_pred             Ce
Q 013558          428 GY  429 (441)
Q Consensus       428 ~~  429 (441)
                      +|
T Consensus       315 ~f  316 (316)
T d1fota_         315 DF  316 (316)
T ss_dssp             CC
T ss_pred             CC
Confidence            77

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-69  Score=525.51  Aligned_cols=293  Identities=41%  Similarity=0.805  Sum_probs=275.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ...++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++|+.++|||||++++++.+
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~-----~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            345789999999999999999999986     889999999988766666677788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ...+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...+..+|....+.+|..+++++.+||+
T Consensus       193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence            4  34567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccc
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  406 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~  406 (441)
                      +||++||.+|+....+++++|++||||++++|..+..++++|||+|......+.++|+..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~  330 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY  330 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCCC
Confidence            999999999987766799999999999999999999999999999999888888999754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-69  Score=519.72  Aligned_cols=312  Identities=38%  Similarity=0.749  Sum_probs=257.5

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~  188 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+..|..++. .++|||||++++++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~-----t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC-----CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence            689999999999999999999986     88999999998876655566666677777765 689999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC-
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-  267 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  267 (441)
                      .+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... 
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHHH
Q 013558          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (441)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  347 (441)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..++....+.+|..+++++++||++
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            33345578999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCCCCCCCCCh-HHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCC----CCCCC
Q 013558          348 LLHKDPSKRLGSGPGGV-DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTA  422 (441)
Q Consensus       348 ~L~~dP~~R~~~~~~~~-~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  422 (441)
                      ||++||.+||     ++ .++++||||++++|+.+..+++.||++|......+..+|+..+.......+..    ....+
T Consensus       237 ~L~~dP~~R~-----s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~  311 (320)
T d1xjda_         237 LFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD  311 (320)
T ss_dssp             HSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------
T ss_pred             hcccCCCCCc-----CHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcccccCchh
Confidence            9999999999     55 48999999999999999999999999999988888899987664332222211    12246


Q ss_pred             CCcccCeee
Q 013558          423 GEHFKGYTY  431 (441)
Q Consensus       423 ~~~f~~~~~  431 (441)
                      ++.|+||+|
T Consensus       312 ~~~f~~f~~  320 (320)
T d1xjda_         312 QNMFRNFSF  320 (320)
T ss_dssp             CCTTTTCCC
T ss_pred             hcccCcCcC
Confidence            789999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-67  Score=518.96  Aligned_cols=326  Identities=33%  Similarity=0.635  Sum_probs=265.4

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHH---HHHHHhcCCCCceeeeEEE
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..++|+++++||+|+||+||+|+++.     +++.||||++.+...........+.+|   +.+++.++|||||+++++|
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~-----t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECC-----CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            46789999999999999999999986     889999999987665444444444444   6666777899999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccccCCCCCcHH
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIINEKVKLPPFLTSE  340 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~---~~~~~~i~~~~~~~p~~~s~~  340 (441)
                      +... .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.+.+.   ..+...+......+|..++++
T Consensus       157 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         157 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             CSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             cCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            7654 3456789999999999974 5789999999999999999999999986543   344555556677788899999


Q ss_pred             HHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcccccCcccccCCCCCCCCCCCCC
Q 013558          341 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP  420 (441)
Q Consensus       341 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (441)
                      +++||.+||++||++||++...+++++++||||++++|..+..++++|||+|.....+....||....+...........
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~~~~~~~~~~  315 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLD  315 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC--------------------CCCCS
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChhhccCCCCCC
Confidence            99999999999999999876667999999999999999999999999999998776665555543211111111112223


Q ss_pred             CCCCcccCeeeeCCCcccc
Q 013558          421 TAGEHFKGYTYVAPNPWLS  439 (441)
Q Consensus       421 ~~~~~f~~~~~~~~~~~~~  439 (441)
                      .+.+.|++|++..+..|++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~  334 (364)
T d1omwa3         316 SDQELYRNFPLTISERWQQ  334 (364)
T ss_dssp             SSSGGGTTCCEECHHHHHH
T ss_pred             hHHHHHhcCCccCchHHHH
Confidence            4567889999887666654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-67  Score=502.00  Aligned_cols=278  Identities=39%  Similarity=0.732  Sum_probs=249.0

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++|++++|||||+++++|.++
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            44689999999999999999999986     7889999999887766666778899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  267 (441)
                      +.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+..
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             C---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHH
Q 013558          268 S---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (441)
Q Consensus       268 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  344 (441)
                      .   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|....+.+|..+++++++|
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL  240 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            2   2344678999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCcCCCCCCCC-CChHHhhhCcccCCCChhhhhhcccCCCCCC
Q 013558          345 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKP  392 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p  392 (441)
                      |++||++||++||++.. .....|++||||++++|+.+..+  .||..|
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~  287 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT  287 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence            99999999999994421 12234799999999999999654  455444

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-65  Score=482.05  Aligned_cols=257  Identities=34%  Similarity=0.634  Sum_probs=241.7

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+++|++++|||||++++++.+
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   77 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   77 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECC-----CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence            345789999999999999999999986     789999999988776666667788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      ++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus        78 ~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHHHHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  346 (441)
                      .. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..++....+.+|+.+++++++||.
T Consensus       158 ~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         158 SS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             CC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             CC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            43 34567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          347 GLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       347 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      +||++||++||     +++|+++||||.
T Consensus       237 ~~L~~dp~~R~-----t~~eil~hp~~~  259 (263)
T d2j4za1         237 RLLKHNPSQRP-----MLREVLEHPWIT  259 (263)
T ss_dssp             HHTCSSGGGSC-----CHHHHHTCHHHH
T ss_pred             HHccCCHhHCc-----CHHHHHcCcCcC
Confidence            99999999999     899999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=471.32  Aligned_cols=268  Identities=27%  Similarity=0.489  Sum_probs=236.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+.....   ....+.+.+|+.+|++++|||||+++++|.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            469999999999999999999986     88999999998754332   2245778999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC----cEEEEecCCc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkl~DFG~a  262 (441)
                      .+.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999999999989999999999999999999999999999999999999998877    5999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCc
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s  338 (441)
                      +...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...++......++    +.++
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            988776667778999999999999999999999999999999999999999999999999999988776655    5789


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  387 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~  387 (441)
                      +++++||++||++||++||     +++|+++||||+..+|.........
T Consensus       245 ~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~~~~~~~l~~~~~  288 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWS  288 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSC-----CHHHHHHSTTTCC------------
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHhcCcccCCCChhHhhccCCC
Confidence            9999999999999999999     8999999999999999876554444

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-62  Score=468.15  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=227.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+++
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccccEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            3579999999999999999999876     789999999986543   23456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999999999987765 57999999999999999999999999999999999999999999999999999986543


Q ss_pred             -CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cccCCCCCcHHHHHH
Q 013558          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  344 (441)
                       ......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...   .+..|..+++++++|
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence             3455678999999999999999999999999999999999999999998887777766654   334567799999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |.+||++||++||     +++|+++||||+.
T Consensus       250 i~~~L~~dP~~R~-----s~~eil~Hp~~~~  275 (293)
T d1yhwa1         250 LNRCLDMDVEKRG-----SAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHTCSSTTTSC-----CHHHHTTCGGGGG
T ss_pred             HHHHccCChhHCc-----CHHHHhcCHhhCC
Confidence            9999999999999     8999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-63  Score=467.53  Aligned_cols=254  Identities=29%  Similarity=0.500  Sum_probs=219.3

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+...  .+..+.+.+|+.+|++++|||||++++++.+++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcceEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence            4689999999999999999999986     789999999976542  223456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      .+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999876432


Q ss_pred             ---CCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccccC--CCCCcHHH
Q 013558          269 ---SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKL--PPFLTSEA  341 (441)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~  341 (441)
                         ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+.. .....+.......  ...+++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence               23456789999999999998776 57899999999999999999999765443 3333333333222  24689999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ++||.+||+.||++||     +++|+++||||+
T Consensus       237 ~~li~~~L~~dP~~R~-----t~~eil~hpwf~  264 (271)
T d1nvra_         237 LALLHKILVENPSARI-----TIPDIKKDRWYN  264 (271)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTCTTTT
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHhcCHhhC
Confidence            9999999999999999     899999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-62  Score=472.04  Aligned_cols=254  Identities=35%  Similarity=0.641  Sum_probs=214.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|++.++||+|+||+||+|+++.     +++.||||++.+.....  ..+.+.+|+.+|++++|||||++++++.+++.
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKR-----TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETT-----TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999886     78999999998765432  23567899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC---CCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~  266 (441)
                      +|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+.   ++|.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999999999999999999999999999999999999999999999999994   57899999999999877


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+......++    +.++++++
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            66666778999999999999999999999999999999999999999999999999999988776554    57899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +||.+||++||++||     +++|+++||||++
T Consensus       242 ~li~~~L~~dP~~R~-----s~~eil~hp~~~~  269 (307)
T d1a06a_         242 DFIRHLMEKDPEKRF-----TCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHSCSSGGGSC-----CHHHHHHSTTTTS
T ss_pred             HHHHHHccCCHhHCc-----CHHHHhcCHhhCC
Confidence            999999999999999     8999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-61  Score=473.04  Aligned_cols=258  Identities=27%  Similarity=0.525  Sum_probs=235.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+..   ....+.+.+|+.+|++++|||||+++++|.+++.
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~-----~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            479999999999999999999986     88999999997653   2334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~~~vkl~DFG~a~~~~  266 (441)
                      +|+|||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||++  .+|.+||+|||+|+.+.
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999999854 46799999999999999999999999999999999999995  46899999999999887


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|......++    ..++++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76667778999999999999999999999999999999999999999999999999999988776655    35899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhh
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  380 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  380 (441)
                      +||.+||++||++||     +++|+++||||+..+|..
T Consensus       258 ~li~~~L~~dP~~R~-----t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         258 DFIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             HHHHHHCCSSGGGSC-----CHHHHHHSTTTSCTTCCS
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCcccCCCCCCC
Confidence            999999999999999     899999999999877643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=462.09  Aligned_cols=254  Identities=30%  Similarity=0.498  Sum_probs=226.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      +.|++++.||+|+||+||+|+++.     +++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+++.
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC-----CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence            359999999999999999999986     78999999997643   2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999999998765 467999999999999999999999999999999999999999999999999999765322


Q ss_pred             -CCCccccCCCCCCCcchhc-----CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---cCCCCCcH
Q 013558          269 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTS  339 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~s~  339 (441)
                       ......+||+.|||||++.     +..|+.++|||||||++|||++|+.||.+.+..+...++.....   ..|..+++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence             2234678999999999984     45688999999999999999999999999988888888887643   34567899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      ++++||.+||++||++||     +++|+++||||+.-
T Consensus       244 ~~~~li~~~L~~dp~~R~-----t~~ell~hp~~~~~  275 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARW-----TTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHccCChhHCc-----CHHHHhcCcccCCC
Confidence            999999999999999999     89999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-61  Score=457.58  Aligned_cols=253  Identities=26%  Similarity=0.513  Sum_probs=217.6

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  187 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+... .....+.+.+|+++|++++|||||++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            579999999999999999999986     789999999987654 34456778899999999999999999999865  4


Q ss_pred             CEEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccccCCCceecCCCCcEEEEe
Q 013558          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTD  258 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkl~D  258 (441)
                      +.+|+|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     ||||||||+||||+.+|.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            569999999999999998864    367999999999999999999999876     99999999999999999999999


Q ss_pred             cCCccccCCCC-CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-cCCCC
Q 013558          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF  336 (441)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~  336 (441)
                      ||+|+.+.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..++..... .+|..
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            99999865433 34567899999999999999999999999999999999999999999999999999887765 46778


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +++++++||++||+.||++||     +++||++|||.
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rp-----s~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRP-----SVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCc-----CHHHHHhCCcC
Confidence            999999999999999999999     89999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-62  Score=475.09  Aligned_cols=262  Identities=28%  Similarity=0.480  Sum_probs=224.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|+++++||+|+||+||+|+++.     +++.||+|++++..  .....+.+.+|+.+|++++|||||+++++|.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            445689999999999999999999986     88999999997643  34445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      .+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999999999999999999999999999999999997 59999999999999999999999999999976


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHH---------------------
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---------------------  324 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~---------------------  324 (441)
                      ... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+......                     
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            432 2456799999999999999999999999999999999999999997654332111                     


Q ss_pred             ---------------------HHHhc-cccCC-CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhh
Q 013558          325 ---------------------RIINE-KVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  381 (441)
Q Consensus       325 ---------------------~i~~~-~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~  381 (441)
                                           .+... ...++ ..++.++++||.+||+.||.+||     +++|+++||||+..+|..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHHHHSCC
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc-----CHHHHhhCHhhCcCCcccc
Confidence                                 11111 01122 23688999999999999999999     8999999999987766543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.5e-61  Score=469.91  Aligned_cols=254  Identities=28%  Similarity=0.521  Sum_probs=233.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999886     789999999976542   233567899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC--CCCcEEEEecCCccccC
Q 013558          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEID  266 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~~~vkl~DFG~a~~~~  266 (441)
                      +|+|||||+||+|.+.+... .++++.+++.|+.||+.||.|||++||+||||||+||||+  .+|.+||+|||+|+.+.
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999999999887655 4699999999999999999999999999999999999998  67899999999999987


Q ss_pred             CCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC----CCCcHHHH
Q 013558          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (441)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  342 (441)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..++......++    ..++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76667778999999999999999999999999999999999999999999999999999988776655    46899999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                      +||.+||++||.+||     +++|+++||||++.
T Consensus       261 ~li~~~L~~dp~~R~-----s~~eil~Hp~~~~~  289 (352)
T d1koba_         261 DFIKNLLQKEPRKRL-----TVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHTSTTTSSC
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCHhhCCC
Confidence            999999999999999     89999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-61  Score=461.58  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=229.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      .|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC-----CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            49999999999999999999886     8899999999877665666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  270 (441)
                      |+|||||.||+|..++...+.+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....   
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999999999988888888999999999999999999999999999999999999999999999999999987543   


Q ss_pred             CccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc--CCCCCcHHHHHHH
Q 013558          271 SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLTSEAHSLL  345 (441)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li  345 (441)
                      ....+||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+...++......  .+..+++++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            345789999999999964   45899999999999999999999999998888888877766443  2346899999999


Q ss_pred             HHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          346 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       346 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      .+||++||++||     +++++++||||..
T Consensus       248 ~~~L~~dP~~Rp-----t~~ell~Hp~~~~  272 (309)
T d1u5ra_         248 DSCLQKIPQDRP-----TSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHTCSSGGGSC-----CHHHHTTCHHHHS
T ss_pred             HHHCcCChhHCc-----CHHHHHhCHHhcC
Confidence            999999999999     8999999999964

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.5e-60  Score=449.47  Aligned_cols=257  Identities=31%  Similarity=0.555  Sum_probs=234.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc------hhHHHHHHHHHHHHHhcC-CCCceeee
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVT-HPFIVQLR  181 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hpnIv~l~  181 (441)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++.+.....      +...+.+.+|+.+|++++ |||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            3689999999999999999999876     78999999998754322      233456889999999997 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +++.+++.+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcC------CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP  335 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~  335 (441)
                      ++.+.........+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+.....+.+..+...++.
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998877666777899999999999863      35688999999999999999999999999999999999888765543


Q ss_pred             ----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          336 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       336 ----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                          .+|+++++||.+||++||++||     +++|+++||||+.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~-----s~~eil~h~~~~~  275 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQ  275 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHHHH
Confidence                6899999999999999999999     8999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-60  Score=446.74  Aligned_cols=251  Identities=24%  Similarity=0.439  Sum_probs=219.8

Q ss_pred             Cc-eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          111 DF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       111 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      +| ++.++||+|+||+||+|+++.     +++.||+|++..... .....+.+.+|+++|++++|||||+++++|.+   
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~-----~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CEEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence            45 777899999999999999886     788999999987653 34456678999999999999999999999875   


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCCCceecC-CCCcEEEEecCCc
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFGLA  262 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkl~DFG~a  262 (441)
                       ...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+||||+ +++.+||+|||+|
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence             4568999999999999999999999999999999999999999999998  99999999999996 5899999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcc--ccCCCCCcH
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEK--VKLPPFLTS  339 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~-~~~~~~~~i~~~~--~~~p~~~s~  339 (441)
                      +.... ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +...+.+.+..+.  ..++..+++
T Consensus       163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         163 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             eeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence            86443 34557799999999999875 5999999999999999999999999764 4555666665543  234567899


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  374 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  374 (441)
                      ++++||.+||++||++||     +++|+++||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~-----s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERY-----SIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCc-----CHHHHhCCcccC
Confidence            999999999999999999     899999999996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=461.73  Aligned_cols=290  Identities=47%  Similarity=0.872  Sum_probs=251.0

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhcCC-CCceeeeEEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSF  184 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~  184 (441)
                      +..++|+++++||+|+||+||+|++...  ..+++.||||++++.... +....+.+.+|+++|++++| |||+++++++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            4557899999999999999999987542  237889999999765432 22334567789999999976 8999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      .+...+++||||+.||+|.+++...+.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC--CCCccccCCCCCCCcchhcCC--CCCCcchhhhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccccCCCC
Q 013558          265 IDES--SRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPF  336 (441)
Q Consensus       265 ~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltG~~pf~~~~~----~~~~~~i~~~~~~~p~~  336 (441)
                      +...  .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+.+.    ..+.+........+|..
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            5432  234567899999999999764  468899999999999999999999977543    34445555666778889


Q ss_pred             CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCCCCcc
Q 013558          337 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD  398 (441)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~~~~~  398 (441)
                      +++++.+||++||++||.+||++...+++|+++||||++++|+.+..++++|||+|...+..
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~  320 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL  320 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-C
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCC
Confidence            99999999999999999999988777899999999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-60  Score=456.19  Aligned_cols=253  Identities=26%  Similarity=0.466  Sum_probs=232.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|++++.||+|+||+||+|.++.     +++.||||++++...    ....+.+|+++|+.++|||||+++++|++++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-----~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            4689999999999999999999986     889999999976532    2345789999999999999999999999999


Q ss_pred             EEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCC--CcEEEEecCCcccc
Q 013558          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~vkl~DFG~a~~~  265 (441)
                      .+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++..
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999999999998765 79999999999999999999999999999999999999854  48999999999987


Q ss_pred             CCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCC----CCcHHH
Q 013558          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (441)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  341 (441)
                      .........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++..+|......++.    .+++++
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            7666666788999999999999999999999999999999999999999999999999999988877763    789999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      ++||++||++||++||     +++|+++||||+.
T Consensus       235 ~~li~~~L~~dp~~R~-----s~~eil~hp~~~~  263 (321)
T d1tkia_         235 MDFVDRLLVKERKSRM-----TASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHTTSCSSGGGSC-----CHHHHHHSHHHHS
T ss_pred             HHHHHHHccCChhHCc-----CHHHHhcCHhhcc
Confidence            9999999999999999     8999999999964

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=437.76  Aligned_cols=251  Identities=30%  Similarity=0.515  Sum_probs=221.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh---HHHHHHHHHHHHHhcC--CCCceeeeEEE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERDILTKVT--HPFIVQLRYSF  184 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--hpnIv~l~~~~  184 (441)
                      ++|++.++||+|+||+||+|+++.     +++.||||++.+.......   ....+.+|+.+|++++  |||||+++++|
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence            579999999999999999999986     7899999999876543221   1223567999999996  89999999999


Q ss_pred             EeCCEEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-CCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkl~DFG~a  262 (441)
                      .+.+.+|+||||+.+ +++.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence            999999999999976 578888888899999999999999999999999999999999999999985 479999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcCCCC-CCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCCCCCcHHH
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA  341 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  341 (441)
                      +..... ...+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..+|+++
T Consensus       159 ~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~  231 (273)
T d1xwsa_         159 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSEC  231 (273)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHH
T ss_pred             eecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHH
Confidence            875443 3456789999999999987665 67799999999999999999999753      356677888999999999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                      ++||++||++||++||     +++|+++||||+++-
T Consensus       232 ~~li~~~L~~dp~~R~-----s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         232 QHLIRWCLALRPSDRP-----TFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSCC
T ss_pred             HHHHHHHccCCHhHCc-----CHHHHhcCHhhCCCC
Confidence            9999999999999999     899999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=442.20  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=216.3

Q ss_pred             eEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013558          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (441)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  190 (441)
                      +.+++||+|+||+||+|+++.     +++.||||++++.....  ....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             CcceEeccCcCeEEEEEEECC-----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            457899999999999999875     78999999997654322  12234688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC-
Q 013558          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (441)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  269 (441)
                      |+||||+.|+++.......+.+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9999999998887777667789999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc----------------
Q 013558          270 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------------  332 (441)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~----------------  332 (441)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+...+|......                
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            3456789999999999875 46899999999999999999999999999888888777642100                


Q ss_pred             ------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          333 ------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       333 ------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                  ..+.+++++++||++||+.||++||     +++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc-----CHHHHhCCHhhCCC
Confidence                        0135689999999999999999999     89999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=434.12  Aligned_cols=257  Identities=29%  Similarity=0.469  Sum_probs=216.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+++|++++|||||+++++|.+++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            689999999999999999999986     788999999976542 23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCC
Q 013558          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  268 (441)
                      +|+||||+.++.+...... ...+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9999999977544333333 356999999999999999999999999999999999999999999999999999876543


Q ss_pred             -CCCccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccc--------------
Q 013558          269 -SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------------  332 (441)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~--------------  332 (441)
                       ......+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+...++......              
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             3345568999999999987765 478999999999999999999999998887777666432110              


Q ss_pred             ----C-----------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCC
Q 013558          333 ----L-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  377 (441)
Q Consensus       333 ----~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  377 (441)
                          +           ...+++++++||++||++||++||     +++|+++||||++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc-----CHHHHhCCHhhccCC
Confidence                0           124678999999999999999999     899999999998763

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=447.66  Aligned_cols=249  Identities=30%  Similarity=0.562  Sum_probs=215.6

Q ss_pred             CCCceEEe-eEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh-cCCCCceeeeEEEEe
Q 013558          109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT  186 (441)
Q Consensus       109 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  186 (441)
                      .++|++++ +||+|+||+||+|+++.     +++.||||++++.        ..+.+|+.++.+ ++|||||+++++|++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC-----CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            45899885 59999999999999886     7899999998653        246679988765 489999999999976


Q ss_pred             ----CCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC---CCcEEEE
Q 013558          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (441)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkl~  257 (441)
                          +..+|+|||||+||+|.+++.+.  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                46799999999999999999875  36999999999999999999999999999999999999985   5679999


Q ss_pred             ecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhccccC
Q 013558          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ----RIINEKVKL  333 (441)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~----~i~~~~~~~  333 (441)
                      |||+|+...........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+......    ++......+
T Consensus       157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            9999998777666778899999999999999999999999999999999999999998765444333    344445555


Q ss_pred             CC----CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          334 PP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       334 p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      |.    .+++++++||++||++||++||     +++|+++||||..
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHhhC
Confidence            53    5899999999999999999999     8999999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=436.51  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=219.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEe
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~  186 (441)
                      ++|+++++||+|+||+||+|+++.    .+++.||||+++...... .....+.+|+.+|+.+   +||||++++++|..
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            589999999999999999999864    146789999997653322 2222345677777665   79999999999863


Q ss_pred             -----CCEEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecC
Q 013558          187 -----RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                           ...+|++|||+.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence                 3578999999998877544443 3569999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------  330 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~----------  330 (441)
                      +++...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...++....          
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            9987666556677899999999999999999999999999999999999999999998888877775320          


Q ss_pred             -----------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCCh
Q 013558          331 -----------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  378 (441)
Q Consensus       331 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  378 (441)
                                       ..++..+++++++||++||++||++||     +++|+++||||+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhcCchh
Confidence                             123456789999999999999999999     8899999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.2e-57  Score=427.82  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=218.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++.+....+....+.+.+|+++|+.++|||||++++++...+ 
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLR-----LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            579999999999999999999886     88999999998876666667778999999999999999999999998654 


Q ss_pred             ---EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                         .+|+||||++|++|..++...+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.++|+|||.++..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               48999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC----CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC----CCCC
Q 013558          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFL  337 (441)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~----p~~~  337 (441)
                      ...    ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+...++.......    .+.+
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            332    23445789999999999999999999999999999999999999999999888888887765443    3578


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      |+++++||.+||++||.+||+    ++++++ |+|.
T Consensus       242 s~~l~~li~~~L~~dp~~R~~----sa~~l~-~~l~  272 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQ----TAAEMR-ADLV  272 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCS----SHHHHH-HHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHh----HHHHHH-HHHH
Confidence            999999999999999999993    456655 4443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-57  Score=429.60  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=220.1

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +++..++|++.++||+|+||+||+|+++.     +++.||||+++++.    ...+.+.+|+++|++++|||||+++++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGG-----GTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECC-----CCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            45667789999999999999999999986     78899999987643    2345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      .+++.+|+|||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999999999765  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCC-CCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~-pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +.......  .....||+.|+|||++.+..|+.++|||||||++|||++|.. ||.+.+...+.+.+..+ .+.+|..++
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence            87654332  233458999999999999999999999999999999999655 55566676666666544 456778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++++||.+||+.||++||     ++++|++
T Consensus       243 ~~l~~li~~cl~~dP~~Rp-----s~~ei~~  268 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRP-----SFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence            9999999999999999999     7888865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-57  Score=437.94  Aligned_cols=260  Identities=24%  Similarity=0.396  Sum_probs=221.8

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+..++|++.++||+|+||+||+|++++.........||+|.+....  .......+.+|+.+|.++ +|||||++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            3556778999999999999999999999875443345579999986543  233345688899999998 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHr  239 (441)
                      ++.+.+.+|+|||||+||+|.+++...                       +.+++..++.|+.||+.||.|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999999999754                       248999999999999999999999999999


Q ss_pred             ccCCCceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCC
Q 013558          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT  315 (441)
Q Consensus       240 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~  315 (441)
                      ||||+|||++.++++||+|||+|+.......   ..+.+||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987644332   235678999999999999999999999999999999998 999999


Q ss_pred             CCCHHHHHHHHHhc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          316 HANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       316 ~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +.+..+...+++..  ++..|..+++++++||.+||+.||++||     ++++|++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            87766666666555  4456788999999999999999999999     88999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=420.98  Aligned_cols=249  Identities=20%  Similarity=0.406  Sum_probs=211.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|+++++||+|+||+||+|+++      +++.||||++++...    ..+.+.+|++++++++|||||++++++..
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceecc
Confidence            45678999999999999999999986      456799999976432    23468899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                      ++.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus        72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            99999999999999999988765 56899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..++.+.+..+ ....|..+++++
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  231 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  231 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence            54322  234679999999999999999999999999999999999 68888888888888888765 455677889999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .+||.+||+.||++||     ++++|++|
T Consensus       232 ~~li~~cl~~~p~~Rp-----s~~~il~~  255 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRP-----AFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHccCCHhHCc-----CHHHHHHH
Confidence            9999999999999999     88999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=424.42  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=210.8

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ++++..++|++.++||+|+||+||+|+.+        ..||||+++.... .....+.+.+|+.+|++++|||||+++++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            35677889999999999999999999743        3599999976543 34566788999999999999999999997


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      +. ++.+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus        73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence            64 56789999999999999999765 56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC---CCccccCCCCCCCcchhcC---CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcc-----
Q 013558          263 KEIDESS---RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEK-----  330 (441)
Q Consensus       263 ~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~-~~~-----  330 (441)
                      +......   .....+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+.......+. .+.     
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence            8764322   3346789999999999975   347899999999999999999999998866554444433 322     


Q ss_pred             ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          331 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       331 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ...+..+++++.+||.+||+.||++||     ++++|+++
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~~il~~  266 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERP-----LFPQILAS  266 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            134567899999999999999999999     88999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-56  Score=426.03  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=213.2

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      ..+..++|++.++||+|+||+||+|+++...  .....||||.+....  .....+.+.+|+++|++++|||||++++++
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3466778999999999999999999987521  133468899876543  344556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      .+.+.+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_          97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence            9999999999999999999988774 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC------CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCC
Q 013558          264 EIDESSR------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPP  335 (441)
Q Consensus       264 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~  335 (441)
                      .+.....      .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ ....|.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  256 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM  256 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            7644322      123457899999999999999999999999999999998 89999999988888888765 456778


Q ss_pred             CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          336 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+++++.+||.+||+.||++||     ++++|++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RP-----s~~ei~~  285 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRP-----KFGQIVN  285 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence            8999999999999999999999     7788875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-57  Score=426.04  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=215.1

Q ss_pred             eeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013558          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (441)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (441)
                      ++||+|+||+||+|.++..   .+++.||||+++... .+....+.+.+|+.+|++++|||||++++++.++ ..|+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC---CcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence            4799999999999987642   256789999997644 3445567789999999999999999999998654 5789999


Q ss_pred             ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC----C
Q 013558          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (441)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~----~  271 (441)
                      ||++|+|.+++.+...+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.....    .
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999987644322    2


Q ss_pred             ccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHHHHHHHhc
Q 013558          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  349 (441)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  349 (441)
                      ....||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ .+.+|..+++++.+||.+||
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            34578999999999999999999999999999999998 99999999888888888764 56788899999999999999


Q ss_pred             ccCcCCCCCCCCCChHHh---hhCcccCC
Q 013558          350 HKDPSKRLGSGPGGVDAI---KHHKWFRS  375 (441)
Q Consensus       350 ~~dP~~R~~~~~~~~~~i---~~h~~f~~  375 (441)
                      +.||++||     ++++|   ++|+|+.-
T Consensus       248 ~~dp~~RP-----s~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         248 TYDVENRP-----GFAAVELRLRNYYYDV  271 (277)
T ss_dssp             CSSTTTSC-----CHHHHHHHHHHHHHHH
T ss_pred             CCCHhHCc-----CHHHHHHHhhCHHhhc
Confidence            99999999     66676   56666543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-56  Score=424.73  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=218.8

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++      +++.||||++..... .....+.+.+|+.+|++++|||||+++++|..++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            58999999999999999999985      678999999976543 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      .|++|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99999999988777777777889999999999999999999999999999999999999999999999999998765432


Q ss_pred             -CCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 013558          270 -RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  330 (441)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------------  330 (441)
                       ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...++....                 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence             24456799999999999764 56899999999999999999999999988877777764311                 


Q ss_pred             ------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          331 ------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       331 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                                  ..++..+++++++||++||++||++||     +++|+++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCc
Confidence                        112345789999999999999999999     8999999999973

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=423.22  Aligned_cols=255  Identities=22%  Similarity=0.385  Sum_probs=222.0

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      .+++..++|++.+.||+|+||+||+|+++      +++.||||+++....    ..+.+.+|+.+|++++|||||+++++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~   76 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEee
Confidence            45677789999999999999999999976      567899999976432    23568899999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      +. ++.+|+||||+++|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        77 ~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence            75 45679999999999998876543  3699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCC
Q 013558          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (441)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (441)
                      |+.+....  ......||+.|||||++.+..++.++|||||||++|||+| |.+||...+..++.+.+..+ ....|..+
T Consensus       156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence            99875432  2345679999999999999999999999999999999999 56677777888888888765 45677889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCCCCCChHHhhh--CcccC
Q 013558          338 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH--HKWFR  374 (441)
Q Consensus       338 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~--h~~f~  374 (441)
                      ++++.+||.+||+.||++||     ++++|++  |+||.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rp-----t~~ei~~~L~~~ft  269 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRP-----TFDYLRSVLEDFFT  269 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCc-----CHHHHHHHhhhhhh
Confidence            99999999999999999999     8899987  78875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=416.48  Aligned_cols=248  Identities=21%  Similarity=0.390  Sum_probs=223.1

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      +.++|+++++||+|+||+||+|+++      +++.||||++++....    .+.+.+|+.++++++|||||++++++.++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            4678999999999999999999985      5778999999875432    34688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                      +.+++||||+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999999998887654 679999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC--CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHHH
Q 013558          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (441)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  342 (441)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++..+ +...|..+++++.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  231 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  231 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence            4322  334679999999999999999999999999999999998 89999999999999888775 4567788999999


Q ss_pred             HHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          343 SLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       343 ~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      +||++||+.||++||     ++++|++|
T Consensus       232 ~li~~cl~~dP~~RP-----t~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERP-----TFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHccCCHhHCc-----CHHHHHHH
Confidence            999999999999999     88999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=423.09  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=220.5

Q ss_pred             cCCCCceEEee-EcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          107 IGPGDFEIFRV-VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       107 ~~~~~y~~~~~-lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      +..++|.+.+. ||+|+||+||+|.++...   ++..||||++++..  .....+.+.+|+++|++++|||||++++++.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            34467888885 999999999999876421   45679999997543  3445677899999999999999999999987


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      + +.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            5 4689999999999999987654 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +.....    ....+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ .+.+|+.++
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  238 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  238 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            654322    234578999999999999999999999999999999998 99999998888888888765 467888999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                      +++.+||.+||+.||++||++.  ++.+.++|.|+
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~--~i~~~L~~~~~  271 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFL--TVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHH--HHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHH--HHHHHHHHHHH
Confidence            9999999999999999999331  33344667766

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=416.52  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=215.5

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|++.+.||+|+||+||+|+++      .++.||||++.....    ..+.+.+|+.+|++++|||||++++++
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~------~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEEC------CCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            4456678999999999999999999986      345799999976532    235688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                      . ++.+|+||||+++|+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        82 ~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          82 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             e-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchh
Confidence            5 4568999999999999888754  357999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +.+....  ......||+.|+|||++....++.++|||||||++|||++ |.+||......++...+..+ ....+..++
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            8764332  2344679999999999999999999999999999999999 56666777777788877655 456788999


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh--CcccCC
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH--HKWFRS  375 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~--h~~f~~  375 (441)
                      +++++||.+||+.||++||     ++++|+.  ++||.+
T Consensus       241 ~~l~~li~~cl~~dP~~Rp-----s~~~i~~~L~~~~~~  274 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERP-----TFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHHcccCHhHCc-----CHHHHHHHHhhhhcC
Confidence            9999999999999999999     8899887  788864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=423.32  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=215.4

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  186 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+... .....+.+.+|+.+|++++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            4689999999999999999999876     889999999876543 33445667889999999999999999999865  


Q ss_pred             ------CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecC
Q 013558          187 ------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (441)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG  260 (441)
                            .+.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                  34689999999888776666666789999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCC-----CCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccCC
Q 013558          261 LAKEIDES-----SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (441)
Q Consensus       261 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~p  334 (441)
                      +++.+...     ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99865432     223456899999999999865 689999999999999999999999998888877777654332222


Q ss_pred             C--------------------------------CCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCC
Q 013558          335 P--------------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  375 (441)
Q Consensus       335 ~--------------------------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  375 (441)
                      +                                ..++++++||.+||+.||++||     +++|+++||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHHcChhhcc
Confidence            1                                1367889999999999999999     8999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=427.39  Aligned_cols=249  Identities=30%  Similarity=0.470  Sum_probs=213.3

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----  186 (441)
                      +|+.+++||+|+||+||+|+++.     +++.||||++.++..       ...+|+++|++++||||++++++|..    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC-----CCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence            59999999999999999999986     889999999976532       12369999999999999999999854    


Q ss_pred             --CCEEEEEEeccCCCchHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecC
Q 013558          187 --RSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFG  260 (441)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG  260 (441)
                        ..++|+|||||+++.+...   ......+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence              3468999999987643332   23456799999999999999999999999999999999999999775 89999999


Q ss_pred             CccccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Q 013558          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  329 (441)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~----------  329 (441)
                      +++.+.......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...+..+....+...          
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9998877666777899999999999875 57899999999999999999999999988877777666431          


Q ss_pred             -------ccc------------CCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          330 -------KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       330 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                             ...            ..+.+++++.+||.+||++||++||     +++|+++||||+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccc
Confidence                   011            1235789999999999999999999     89999999999765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=415.69  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=212.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +++..++|++.++||+|+||+||+|++....  ..+..||||.++..  ......+.+.+|+.+|++++|||||++++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566678999999999999999999987522  24567888887543  2344566788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      . ++.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence            5 56799999999999999887654 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-ccCCCCCcH
Q 013558          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (441)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~  339 (441)
                      .+....  ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++..++..+. ..+|+.+++
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            764332  2345678999999999999999999999999999999998 999999999988888887764 578889999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ++.+||.+||+.||++||     ++++|++|
T Consensus       237 ~~~~li~~cl~~dp~~Rp-----s~~ei~~~  262 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRP-----RFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            999999999999999999     88999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=425.53  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=213.6

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  188 (441)
                      .++|+++++||+|+||+||+|.++.     +++.||||++.+.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            4689999999999999999999886     78999999997654 34455677889999999999999999999998654


Q ss_pred             ------EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCc
Q 013558          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (441)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a  262 (441)
                            .+|+||||+ +.+|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence                  579999999 55666555 4568999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCCCCCCcchhcC-CCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------
Q 013558          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------  330 (441)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~-----------  330 (441)
                      +....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....           
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87654  3456789999999999886 456899999999999999999999999887766655443211           


Q ss_pred             --------------------ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          331 --------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       331 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                                          ......+++++++||++||+.||.+||     +++|+++||||+++.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDT  310 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC--
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhCcCCCc
Confidence                                112346789999999999999999999     89999999999987643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=422.23  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=213.8

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~-  186 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++..      .+.+.+|+++|+.+. ||||++++++|.. 
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            4579999999999999999999886     88999999986532      346788999999995 9999999999985 


Q ss_pred             -CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCC-cEEEEecCCccc
Q 013558          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (441)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkl~DFG~a~~  264 (441)
                       ...+|+|||||.+++|....   +.+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence             45699999999999986653   5799999999999999999999999999999999999998655 699999999998


Q ss_pred             cCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHh-------------c
Q 013558          265 IDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIIN-------------E  329 (441)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~-~~~~~~i~~-------------~  329 (441)
                      ..........+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+..             .
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            8776667788999999999998865 579999999999999999999999976442 222222210             0


Q ss_pred             cc------------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCCChh
Q 013558          330 KV------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  379 (441)
Q Consensus       330 ~~------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  379 (441)
                      ..                        .....+++++++||++||++||++||     +++|+++||||+++.|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTSCCC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCCCCCC
Confidence            00                        01123788999999999999999999     89999999999999885

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=410.05  Aligned_cols=256  Identities=24%  Similarity=0.440  Sum_probs=223.3

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  189 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||+++... ......+.+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC-----CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            589999999999999999999986     88999999997654 345566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCC
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  269 (441)
                      +++|+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999999999999888888999999999999999999999999999999999999999999999999999998865433


Q ss_pred             C-CccccCCCCCCCcchhcCCC-CCCcchhhhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhccc---------------
Q 013558          270 R-SNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKV---------------  331 (441)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltG~~pf-~~~~~~~~~~~i~~~~~---------------  331 (441)
                      . .....+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+...++.....               
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            2 34456788999999988655 689999999999999999999885 55666666666542111               


Q ss_pred             --------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                    ..+..+++++.+||++||+.||.+||     +++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----sa~e~L~Hp~f~~~  289 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGSSC
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcChhhcCC
Confidence                          12245788999999999999999999     89999999999753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-54  Score=408.55  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=212.8

Q ss_pred             CcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013558          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (441)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  185 (441)
                      ++..+.|++.++||+|+||+||+|.++.... .....||||++....  .......+.+|+++|++++|||||++++++.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            4566789999999999999999999875221 133579999986543  2334556889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      +.+.+++|||||.+++|.+.+... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999998887665 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCc
Q 013558          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (441)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s  338 (441)
                      +....    ......||+.|||||++.+..++.++|||||||++|||++ |.+||...+..++.+.+..+ +...|..++
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence            64332    1234568999999999999999999999999999999999 45666667777777777654 456778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .++.+||.+||+.||++||     ++.+|++
T Consensus       240 ~~l~~li~~cl~~~p~~RP-----t~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRP-----KFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCc-----CHHHHHH
Confidence            9999999999999999999     7888876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=415.18  Aligned_cols=260  Identities=23%  Similarity=0.407  Sum_probs=210.9

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      ++.+..++|++.++||+|+||+||+|+++......+++.||||++....  .....+.+.+|..++.++ +|+|||.+++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3456678899999999999999999999876655677899999987543  233345566777777776 6899999999


Q ss_pred             EEEeC-CEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          183 SFQTR-SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       183 ~~~~~-~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      ++... ..+++|||||++|+|.+++...                ..+++.+++.++.||+.||.|||++|||||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            88654 5689999999999999999754                248899999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC-CCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG-~~pf~~~~~~~  321 (441)
                      |||+.++++||+|||+|+......   .....+||+.|||||++.+..++.++|||||||++|||++| ..||.+.+..+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998754332   23456899999999999999999999999999999999986 56888765544


Q ss_pred             HHHH-HHh-ccccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          322 LQQR-IIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       322 ~~~~-i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .... +.. ..+.+|..+++++++||.+||+.||++||     ++++|++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            4443 333 35667788999999999999999999999     88999886

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-54  Score=412.69  Aligned_cols=258  Identities=20%  Similarity=0.347  Sum_probs=226.2

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      .++..++|++++.||+|+||+||+|++++..+..+++.||||++....  .....+.+.+|+.+|++++||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            455667899999999999999999999876666678899999987543  344566789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCchHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 013558          185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (441)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrD  240 (441)
                      .....+++||||+.+|+|.+++....                        .+++..+..|+.||+.||+|||++||||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999997532                        388999999999999999999999999999


Q ss_pred             cCCCceecCCCCcEEEEecCCccccCCC---CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC-CCCCCC
Q 013558          241 LKPENILMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTH  316 (441)
Q Consensus       241 lkp~NILl~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG-~~pf~~  316 (441)
                      |||+||||+.++.+||+|||+|+.....   ....+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999999865332   223456799999999999999999999999999999999998 478999


Q ss_pred             CCHHHHHHHHHhccc-cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          317 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       317 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      .+..++...+..+.. .+|..+++++.+||.+||+.||++||     ++.+|++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP-----t~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999888887653 46778999999999999999999999     7888864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=409.70  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  186 (441)
                      +..++|++++.||+|+||+||+|+++...  .....||||++.+.........+.+.+|+.+|++++|||||++++++.+
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            45578999999999999999999876522  1345799999987766666667789999999999999999999999965


Q ss_pred             CCEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcccc
Q 013558          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (441)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~  265 (441)
                       ..+++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence             4678999999999998877654 57999999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCC----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccc--cCCCCCc
Q 013558          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV--KLPPFLT  338 (441)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~~~--~~p~~~s  338 (441)
                      .....    .....|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+..+...++.....  ..+..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence            54332    234568889999999999999999999999999999998 8999999999999999877644  4567899


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          339 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +++++||.+||+.||++||     ++++|++
T Consensus       242 ~~l~~li~~cl~~dp~~RP-----t~~ei~~  267 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRP-----TFVALRD  267 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999999999     7788863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-54  Score=419.92  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=205.9

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  186 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+... .......+.+|+.+|++++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~-----t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT-----TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC-----CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            579999999999999999999986     889999999987543 45556678899999999999999999999964   


Q ss_pred             ---CCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                         ...+|+|||||.++ +...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++
T Consensus        91 ~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence               46899999999765 44444  4579999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc------------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------  331 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~------------  331 (441)
                      ...........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......++.....            
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            87776677778999999999999999999999999999999999999999998887766665542110            


Q ss_pred             ----------cC--------------C------CCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 ----------KL--------------P------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 ----------~~--------------p------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                ..              +      ..+++++++||++||+.||++||     +++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCcccCCC
Confidence                      00              0      11467899999999999999999     89999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=416.30  Aligned_cols=253  Identities=27%  Similarity=0.439  Sum_probs=210.2

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETT-----TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEECC-----CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            469999999999999999999876     88999999997643  3445567889999999999999999999987643 


Q ss_pred             ----EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                          .+|++ +|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus        81 ~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence                34555 55668999999865 4799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCC----CCCccccCCCCCCCcchhc-CCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Q 013558          265 IDES----SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------  331 (441)
Q Consensus       265 ~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~--------  331 (441)
                      ....    ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+..+..........        
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            5332    2245568999999999985 45678999999999999999999999998876655544432100        


Q ss_pred             -----------------------cCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          332 -----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       332 -----------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                             ...+.++.++++||.+||++||.+||     +++|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----ta~e~L~hpf~~~~  301 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  301 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccC
Confidence                                   11245788999999999999999999     89999999999854

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=413.10  Aligned_cols=254  Identities=22%  Similarity=0.335  Sum_probs=214.2

Q ss_pred             CCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013558          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (441)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  187 (441)
                      ...+|+++++||+|+||+||+|.++.... .....||+|.+....  .....+.+.+|+.+|++++|||||++++++.++
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34679999999999999999999875211 112357888876432  334456789999999999999999999999865


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  266 (441)
                       ..+++|||+.+|+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567888999999998887765 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cccCCCCCcHHH
Q 013558          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (441)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  341 (441)
                      ....   .....||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..++...+..+ ++..|+.+++++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            4332   234568999999999999999999999999999999998 89999998888887777664 467788999999


Q ss_pred             HHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          342 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       342 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      .+||.+||+.||.+||     ++.+|+.|
T Consensus       243 ~~li~~cl~~dP~~RP-----s~~eil~~  266 (317)
T d1xkka_         243 YMIMVKCWMIDADSRP-----KFRELIIE  266 (317)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHhCCCChhhCc-----CHHHHHHH
Confidence            9999999999999999     88999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=414.29  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=218.4

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  183 (441)
                      +..++|++.++||+|+||+||+|+++.     ++.  .||||.+....  .....+.+.+|+++|+++ +|||||+++++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~   79 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   79 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECC-----CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence            556789999999999999999999875     444  46777765432  233455688999999998 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCcee
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  247 (441)
                      +.+++.+|+||||++||+|.+++++.                ..+++.++..++.||+.||.|||++||+||||||+|||
T Consensus        80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL  159 (309)
T d1fvra_          80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  159 (309)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence            99999999999999999999999754                56999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC-CCCCCCCCHHHHHHHH
Q 013558          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRI  326 (441)
Q Consensus       248 l~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG-~~pf~~~~~~~~~~~i  326 (441)
                      ++.++.+||+|||+|+...........+||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999876655555567899999999999999999999999999999999996 5689999999988888


Q ss_pred             Hhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          327 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       327 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      ..+ ++..|..+++++++||.+||+.||++||     ++++|++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            764 5677788999999999999999999999     88999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-54  Score=402.90  Aligned_cols=246  Identities=24%  Similarity=0.436  Sum_probs=210.6

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  184 (441)
                      +.+..++|+++++||+|+||.||+|+++       +..||||+++++.     ..+.+.+|+++|++++|||||++++++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   69 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4567789999999999999999999974       4579999997543     335688999999999999999999998


Q ss_pred             Ee-CCEEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCC
Q 013558          185 QT-RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (441)
Q Consensus       185 ~~-~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~  261 (441)
                      .+ .+.+|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence            54 567899999999999999997653  589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh-ccccCCCCCcH
Q 013558          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS  339 (441)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~~~~~i~~-~~~~~p~~~s~  339 (441)
                      ++.....  .....+|..|+|||++.+..++.++|||||||++|||+| |++||...+..++...+.. .++.+|..+++
T Consensus       150 s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (262)
T d1byga_         150 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  227 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            9876543  345678999999999999999999999999999999998 8999999888888888875 36678889999


Q ss_pred             HHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          340 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       340 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      ++++||.+||+.||.+||     ++.+|++
T Consensus       228 ~~~~li~~cl~~dP~~Rp-----s~~~l~~  252 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRP-----SFLQLRE  252 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence            999999999999999999     7888876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=416.91  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=214.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  187 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+++|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT-----TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            3579999999999999999999886     88999999998654 2344456788999999999999999999999643 


Q ss_pred             ----CEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                          ...++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence                344666777789999988854 579999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCCCccccCCCCCCCcchhcCC-CCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccccC---------
Q 013558          264 EIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---------  333 (441)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i~~~~~~~---------  333 (441)
                      ....  ...+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......         
T Consensus       170 ~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            6543  34567899999999997765 46889999999999999999999999988877777765432111         


Q ss_pred             ----------------------CCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCcccCCC
Q 013558          334 ----------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  376 (441)
Q Consensus       334 ----------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  376 (441)
                                            ...+++++++||++||+.||.+||     +++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc-----CHHHHhcCHhhCCC
Confidence                                  135789999999999999999999     89999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=405.38  Aligned_cols=258  Identities=22%  Similarity=0.406  Sum_probs=219.8

Q ss_pred             cCcCCCCceEEeeEcccCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013558          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (441)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  181 (441)
                      +.+..++|+++++||+|+||.||+|+.......  ..+..||||++.++.  .......+.+|..++.++ +|||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            556778999999999999999999998764321  234579999997653  234456678888888888 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCc
Q 013558          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (441)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  245 (441)
                      ++|.+++.+++|||||++|+|.+++....                .+++.+++.++.||+.||+|||++|||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997553                48999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEEecCCccccCCCC---CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHHH
Q 013558          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (441)
Q Consensus       246 ILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~~  321 (441)
                      ||++.++.+||+|||+++......   .....+||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+..+
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            999999999999999998764432   2345679999999999999999999999999999999998 799999999888


Q ss_pred             HHHHHHhc-cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          322 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       322 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +.+.+..+ .+..|..+++++++||.+||+.||++||     ++.||++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-----CHHHHHH
Confidence            88877654 5667889999999999999999999999     8899876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=408.97  Aligned_cols=259  Identities=20%  Similarity=0.302  Sum_probs=226.6

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  183 (441)
                      ++.+..++|++.+.||+|+||+||+|.+++......+..||||++++..  .......+.+|+.++++++|||||+++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3567778999999999999999999998754443456789999997543  33445678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCchHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCc
Q 013558          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (441)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (441)
                      +..+..+++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+||||+.+++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            99999999999999999999988643          24788999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhc
Q 013558          254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINE  329 (441)
Q Consensus       254 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG-~~pf~~~~~~~~~~~i~~~  329 (441)
                      +||+|||+|+.+.....   ....+||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+..+....+..+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999987643322   3445789999999999999999999999999999999997 6899999999988888775


Q ss_pred             c-ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          330 K-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       330 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      . +..|..+++.+.+||.+||+.||++||     ++++|++
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  287 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIIS  287 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            4 456788999999999999999999999     8888886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=404.04  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=224.6

Q ss_pred             hcCcCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013558          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (441)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  182 (441)
                      .+.+..++|++.++||+|+||.||+|++++..+..+++.||||++++..  .......+.+|+.+++++ +|||||++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3556677999999999999999999998776555688899999997653  234456788999999999 6999999999


Q ss_pred             EEEeCCEEEEEEeccCCCchHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCC
Q 013558          183 SFQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (441)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~  244 (441)
                      ++.+...+|+|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||++||+||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997653                  5899999999999999999999999999999999


Q ss_pred             ceecCCCCcEEEEecCCccccCCCCC---CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHc-CCCCCCCCCHH
Q 013558          245 NILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ  320 (441)
Q Consensus       245 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-G~~pf~~~~~~  320 (441)
                      |||++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654322   234688999999999999999999999999999999998 77778776666


Q ss_pred             HHHHHHHhc--cccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          321 KLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       321 ~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                      +...++...  ....|..+++++.+||.+||+.||++||     ++++|++
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            666555544  3455678999999999999999999999     7888875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=387.06  Aligned_cols=248  Identities=20%  Similarity=0.297  Sum_probs=206.2

Q ss_pred             EEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCEEEE
Q 013558          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSKLYL  192 (441)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l  192 (441)
                      +.++||+|+||+||+|++....  .+...||||++++.  ......+.+.+|+++|++++|||||++++++.. ++.+++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC------CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            3678999999999999986421  13346899998643  345556789999999999999999999999875 568999


Q ss_pred             EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEEEecCCccccCCCCC-
Q 013558          193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-  270 (441)
Q Consensus       193 v~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-  270 (441)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||++++.+||+|||+++....... 
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999988755 4578889999999999999999999999999999999999999999999999987643322 


Q ss_pred             ----CccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc-cccCCCCCcHHHHHH
Q 013558          271 ----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINE-KVKLPPFLTSEAHSL  344 (441)
Q Consensus       271 ----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  344 (441)
                          .....||+.|+|||++.+..++.++||||||+++|||++|..||.. .+..++...+..+ .+..|..+++++.+|
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence                2335689999999999999999999999999999999997776654 4444555665554 455778899999999


Q ss_pred             HHHhcccCcCCCCCCCCCChHHhhhC
Q 013558          345 LKGLLHKDPSKRLGSGPGGVDAIKHH  370 (441)
Q Consensus       345 i~~~L~~dP~~R~~~~~~~~~~i~~h  370 (441)
                      |.+||+.||++||     +++||++|
T Consensus       267 i~~cl~~dP~~RP-----s~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRP-----SFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHcCCCHhHCc-----CHHHHHHH
Confidence            9999999999999     88999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-50  Score=387.02  Aligned_cols=251  Identities=18%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCC
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRS  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~  188 (441)
                      ++|++++.||+|+||+||+|+++.     +++.||||++......     +.+..|+++++.++|+|+ +.+.+++.+.+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC-----CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            469999999999999999999876     7889999998764321     236789999999987665 55566667888


Q ss_pred             EEEEEEeccCCCchHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecC---CCCcEEEEecCCccc
Q 013558          189 KLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKE  264 (441)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkl~DFG~a~~  264 (441)
                      ..++||||+.+ +|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++   .+..+||+|||+|+.
T Consensus        77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99999999955 5555554 456899999999999999999999999999999999999875   455799999999997


Q ss_pred             cCCCC--------CCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHHHHHHHH---Hhcc---
Q 013558          265 IDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI---INEK---  330 (441)
Q Consensus       265 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~~~~~~i---~~~~---  330 (441)
                      +....        .....+||+.|||||++.+..++.++|||||||++|||++|+.||...........+   ....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            64332        234568999999999999999999999999999999999999999876544333222   1111   


Q ss_pred             --ccCCCCCcHHHHHHHHHhcccCcCCCCCCCCCChHHhhhCccc
Q 013558          331 --VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  373 (441)
Q Consensus       331 --~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  373 (441)
                        ..++..+++++.+||.+||+.||++||++.  .+.++++|+|.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~--~i~~~l~~~~~  278 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS--YLRQLFRNLFH  278 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH--HHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHH--HHHHHHHHHHH
Confidence              123467899999999999999999999432  34566777664

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-48  Score=370.48  Aligned_cols=238  Identities=19%  Similarity=0.275  Sum_probs=202.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~  187 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||++......     ..+.+|+++++.+.| +||+.+++++...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   73 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   73 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence            3689999999999999999999886     7899999998654321     236678999999975 8999999999999


Q ss_pred             CEEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCC-----CCcEEEEecCC
Q 013558          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGL  261 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-----~~~vkl~DFG~  261 (441)
                      ...|+||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||||+.     ++.+||+|||+
T Consensus        74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence            9999999999 67998888765 47999999999999999999999999999999999999974     57899999999


Q ss_pred             ccccCCC--------CCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcc
Q 013558          262 AKEIDES--------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEK  330 (441)
Q Consensus       262 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~---~~~~~~~i~~~~  330 (441)
                      |+.+...        ......+||+.|||||++.+..++.++|||||||++|||++|..||.+..   ......++....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9875432        12345689999999999999999999999999999999999999997543   333344443322


Q ss_pred             c-----cCCCCCcHHHHHHHHHhcccCcCCCC
Q 013558          331 V-----KLPPFLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       331 ~-----~~p~~~s~~~~~li~~~L~~dP~~R~  357 (441)
                      .     .++..+++++.+++..|+..+|++||
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP  264 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATP  264 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence            2     23457899999999999999999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=375.54  Aligned_cols=243  Identities=24%  Similarity=0.342  Sum_probs=192.7

Q ss_pred             CCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013558          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (441)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  188 (441)
                      .+|.+.++||+|+||+||+|++       +++.||||++..+..    .......|+..+..++|||||++++++.+.+ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-------~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            3689999999999999999986       467899999865431    1122334555666789999999999998654 


Q ss_pred             ---EEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcccccCCCceecCCCCcEEEE
Q 013558          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--------CGIVHRDLKPENILMDSDGHVMLT  257 (441)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~--------~~iiHrDlkp~NILl~~~~~vkl~  257 (441)
                         .+|+|||||++|+|.+++++. .+++.++..++.|++.||.|||+        +||+||||||+||||+.++.+||+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence               689999999999999999765 68999999999999999999996        599999999999999999999999


Q ss_pred             ecCCccccCCCC-----CCccccCCCCCCCcchhcCCC------CCCcchhhhHHHHHHHHHcCCCCCCCC---------
Q 013558          258 DFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQPPFTHA---------  317 (441)
Q Consensus       258 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvvl~elltG~~pf~~~---------  317 (441)
                      |||+++......     .....+||+.|||||++.+..      ++.++|||||||+||||+||..||...         
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            999998764432     234578999999999987653      567899999999999999998877421         


Q ss_pred             ------CHHHHHHHHHhccc--cCCCC-----CcHHHHHHHHHhcccCcCCCCCCCCCChHHhhh
Q 013558          318 ------NRQKLQQRIINEKV--KLPPF-----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  369 (441)
Q Consensus       318 ------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  369 (441)
                            ........+.....  .+|..     ...++.+|+.+||+.||++||     ++.||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ei~~  290 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                  22334444433332  22222     234689999999999999999     7888876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-47  Score=375.72  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=204.7

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----------CCCc
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPFI  177 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI  177 (441)
                      .++|+++++||+|+||+||+|+++.     +++.||||+++++..    ..+.+.+|+++|+.++           |+||
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~-----~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            3569999999999999999999886     889999999986532    2345678898888775           5789


Q ss_pred             eeeeEEEEe--CCEEEEEEeccCCCchHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCCCceecCCC
Q 013558          178 VQLRYSFQT--RSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD  251 (441)
Q Consensus       178 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l---~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~  251 (441)
                      +++++++..  ....+++|+++..+......   .....+++..++.++.||+.||.|||+ +||+||||||+||||+.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999988764  45777777776665433322   233579999999999999999999998 899999999999999876


Q ss_pred             C------cEEEEecCCccccCCCCCCccccCCCCCCCcchhcCCCCCCcchhhhHHHHHHHHHcCCCCCCCCCHH-----
Q 013558          252 G------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----  320 (441)
Q Consensus       252 ~------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltG~~pf~~~~~~-----  320 (441)
                      +      .+||+|||.+.....  .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...+..     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            5      399999999986543  345678999999999999999999999999999999999999999754321     


Q ss_pred             -HHHHHHH------------------------------------------hccccCCCCCcHHHHHHHHHhcccCcCCCC
Q 013558          321 -KLQQRII------------------------------------------NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL  357 (441)
Q Consensus       321 -~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~  357 (441)
                       +....+.                                          .....++...++++++||.+||+.||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             1111110                                          001112223467899999999999999999


Q ss_pred             CCCCCChHHhhhCcccCCCChhhhhhcccCCCCCCCC
Q 013558          358 GSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV  394 (441)
Q Consensus       358 ~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~p~~~p~~  394 (441)
                           +++|+++||||+++.+    ..+++.|..+..
T Consensus       321 -----ta~e~L~Hp~f~~~~~----~~~~~~p~~~~~  348 (362)
T d1q8ya_         321 -----DAGGLVNHPWLKDTLG----MEEIRVPDRELY  348 (362)
T ss_dssp             -----CHHHHHTCGGGTTCTT----CTTCCCTTSCTT
T ss_pred             -----CHHHHhcCcccCCCCC----cccCCCCCcccC
Confidence                 8999999999996542    233444444433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=5e-27  Score=208.63  Aligned_cols=167  Identities=19%  Similarity=0.213  Sum_probs=123.1

Q ss_pred             ceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---------------chhHHHHHHHHHHHHHhcCCCC
Q 013558          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------KKNHVDYMKAERDILTKVTHPF  176 (441)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpn  176 (441)
                      +.+.++||+|+||+||+|.+.      +++.||||+++.....               .........+|...+.++.|.+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            467899999999999999874      6788999987542110               0111234557889999999999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCCCceecCCCCcEEE
Q 013558          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (441)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkl  256 (441)
                      ++..+++.  .  .+++|||+++..+.       .+++..+..++.|++.+|.|||++||+||||||+|||++++ .++|
T Consensus        76 v~~~~~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          76 VPKVYAWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             SCCEEEEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred             cceEEEec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence            99887653  2  37999999886552       35566678899999999999999999999999999999865 4899


Q ss_pred             EecCCccccCCCCCCccccCCCCCCCc------chhcCCCCCCcchhhhHHHHH
Q 013558          257 TDFGLAKEIDESSRSNSMCGTTEYMAP------EILLSKGHNKDADWWSVGILL  304 (441)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslGvvl  304 (441)
                      +|||+|.........       .|...      +. ..+.|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999999775432211       11110      11 135678899999986444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=1.4e-07  Score=85.36  Aligned_cols=139  Identities=11%  Similarity=0.058  Sum_probs=90.0

Q ss_pred             CceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013558          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (441)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  189 (441)
                      .|++.+..+.++.+.||++..       .++.++||.........   ...+.+|..+|..+. +--+.+++.+...++.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            577777766566679998762       45668888876543221   223567888888774 3335667788888899


Q ss_pred             EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013558          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-------------------------------------  232 (441)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH-------------------------------------  232 (441)
                      .|+||++++|..+.......     .....++.++...|..||                                     
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999987764332110     011112222222222222                                     


Q ss_pred             ----------------HC------CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          233 ----------------KC------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       233 ----------------~~------~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                                      +.      .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            21      268999999999998776677999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.17  E-value=2.7e-06  Score=81.69  Aligned_cols=81  Identities=15%  Similarity=0.265  Sum_probs=49.1

Q ss_pred             EeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-hcc---hhHHHHHHHHHHHHHhcC-C--CCceeeeEEEEeC
Q 013558          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIK---KNHVDYMKAERDILTKVT-H--PFIVQLRYSFQTR  187 (441)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~-~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~  187 (441)
                      .+.||.|....||++....     +++.++||.-.... ...   ....++...|..+|+.+. +  ..+.+++.+  +.
T Consensus        31 ~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            5678999999999997543     56789999654311 111   112334566888887763 2  334555443  44


Q ss_pred             CEEEEEEeccCCCch
Q 013558          188 SKLYLILDFINGGHL  202 (441)
Q Consensus       188 ~~~~lv~E~~~gg~L  202 (441)
                      ...++|||++.+..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            556789999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=6.4e-06  Score=73.61  Aligned_cols=135  Identities=14%  Similarity=0.131  Sum_probs=81.3

Q ss_pred             EcccC-CeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCCEEEEEE
Q 013558          118 VGQGA-FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLIL  194 (441)
Q Consensus       118 lG~G~-~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~  194 (441)
                      +..|. -+.||++...      .+..+++|.......      ..+..|..+|+.+..  -.+.+++.+..+.+..++||
T Consensus        18 ~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~   85 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   85 (255)
T ss_dssp             CSCTTSSCEEEEEECT------TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             cCCcccCCeEEEEEeC------CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence            34444 3689988753      456688898654321      236678888887743  23556777788888999999


Q ss_pred             eccCCCchHH--------------HHHHcC-------CCC--HHHHH-----HHH---------------HHHHHHHHHH
Q 013558          195 DFINGGHLFF--------------HLYRQG-------IFR--EDQAR-----FYT---------------AEIVSAVSHL  231 (441)
Q Consensus       195 E~~~gg~L~~--------------~l~~~~-------~~~--~~~~~-----~i~---------------~qi~~~L~~L  231 (441)
                      ++++|.++..              .+.+-.       .+.  .....     .+.               ......+..+
T Consensus        86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  165 (255)
T d1nd4a_          86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  165 (255)
T ss_dssp             ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence            9998865521              111100       000  00000     000               0012233344


Q ss_pred             HHC-------CCcccccCCCceecCCCCcEEEEecCCccc
Q 013558          232 HKC-------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (441)
Q Consensus       232 H~~-------~iiHrDlkp~NILl~~~~~vkl~DFG~a~~  264 (441)
                      ...       .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            332       279999999999998877778999997753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.35  E-value=0.00037  Score=64.48  Aligned_cols=71  Identities=11%  Similarity=0.222  Sum_probs=45.5

Q ss_pred             cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-----ceee--eEEEEeCCEEEEE
Q 013558          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-----IVQL--RYSFQTRSKLYLI  193 (441)
Q Consensus       121 G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----Iv~l--~~~~~~~~~~~lv  193 (441)
                      +---.||++...      +|..|++|+.+....    ..+.+..|..+|..|....     .+..  -..+...+..+.+
T Consensus        33 s~EN~vy~v~~~------dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l  102 (325)
T d1zyla1          33 SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  102 (325)
T ss_dssp             CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             cccceeEEEEcC------CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEE
Confidence            334689998754      677899999875432    2345677888888774221     1111  1233557788999


Q ss_pred             EeccCCCc
Q 013558          194 LDFINGGH  201 (441)
Q Consensus       194 ~E~~~gg~  201 (441)
                      ++++.|..
T Consensus       103 ~~~~~G~~  110 (325)
T d1zyla1         103 FPSVGGRQ  110 (325)
T ss_dssp             EECCCCEE
T ss_pred             EeecCCcC
Confidence            99998743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.07  E-value=0.0011  Score=62.99  Aligned_cols=84  Identities=15%  Similarity=0.138  Sum_probs=52.2

Q ss_pred             CCCceEEeeEcccCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 013558          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (441)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  185 (441)
                      .+++++ +.|+.|-.-.+|++.......  ....+.|.+++.-..    ... ....+|..+++.+. +.-..++++++.
T Consensus        42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            344554 578888889999998753211  113456777776421    112 23457899998885 433346666654


Q ss_pred             eCCEEEEEEeccCCCch
Q 013558          186 TRSKLYLILDFINGGHL  202 (441)
Q Consensus       186 ~~~~~~lv~E~~~gg~L  202 (441)
                      +    .+|+||++|..|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            2    689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.84  E-value=0.0043  Score=56.41  Aligned_cols=145  Identities=14%  Similarity=0.190  Sum_probs=78.6

Q ss_pred             cCCCCceEEeeEcccCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-----CCceee-
Q 013558          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-----PFIVQL-  180 (441)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----pnIv~l-  180 (441)
                      .+.++..-++.|..|---+.|+++..       +..|++|+..+..  ..   +.+..|+.+|..|..     |..+.. 
T Consensus        15 Y~lg~~~~~~~i~~G~~N~ny~v~t~-------~g~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1          15 YDVGSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             BCCCCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCCCCceEeecCCCCcccCeEEEEEC-------CCcEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceec
Confidence            44566666777878888899998753       3459999986532  12   234456666666632     322221 


Q ss_pred             --eEEEEeCCEEEEEEeccCCCchH--------------HHHHHcC---------CCCH------------------HHH
Q 013558          181 --RYSFQTRSKLYLILDFINGGHLF--------------FHLYRQG---------IFRE------------------DQA  217 (441)
Q Consensus       181 --~~~~~~~~~~~lv~E~~~gg~L~--------------~~l~~~~---------~~~~------------------~~~  217 (441)
                        ..+.......+.++.++.|....              ..++...         ....                  ...
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence              01123355667777777664321              0111000         0001                  111


Q ss_pred             HHHHHHHHHHHHHHH----HCCCcccccCCCceecCCCCcEEEEecCCcc
Q 013558          218 RFYTAEIVSAVSHLH----KCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (441)
Q Consensus       218 ~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkl~DFG~a~  263 (441)
                      ...+..+...+.-.+    ..|+||+|+.++||+++.+...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            122222333333333    2469999999999999988877899999774